Streptococcus B B_BACTERIUM[BIO]
ursoris I I_BACTERIUM[BIO]
sp I I_BACTERIUM[BIO]
. I I_BACTERIUM[BIO]
nov I I_BACTERIUM[BIO]
. I I_BACTERIUM[BIO]
, O O
isolated O O
from O O
the O O
oral O O
cavities O O
of O O
bears O O
. O O

Three O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BACTERIUM[BIO]
Gram O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_BACTERIUM[BIO]
- O O
positive O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
catalase O B_ENZYME[GENE]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- O O
negative O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
coccus O B_BIO/B_BODY_PART_OR_ORGAN_COMPONENT
- O O
shaped O O
organisms O B_BIO
were O O
isolated O O
from O O
the O O
oral O B_BODY_PART_OR_ORGAN_COMPONENT/B_DISEASE_ADJECTIVE[DISEASE]
cavities O I_BODY_PART_OR_ORGAN_COMPONENT/I_DISEASE_ADJECTIVE[DISEASE]
of O O
bears O B_SPECIES[BIO]/B_PERSON
. O O

The O O
isolates O B_BIO
were O O
tentatively O O
identified O O
as O O
a O O
streptococcal O B_BACTERIUM[BIO]
species O I_BACTERIUM[BIO]
based O O
on O O
the O O
results O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
of O O
biochemical O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
tests O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

Comparative O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
16S O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
rRNA O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
gene O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
sequencing O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
studies O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
confirmed O O
that O O
the O O
organisms O B_BIO/B_GENE
were O O
members O B_PERSON/B_LOCATION
of O O
the O O
genus O B_BIO/B_MEASURE
Streptococcus O I_BIO/I_MEASURE
, O O
but O O
they O O
did O O
not O O
correspond O O
to O O
any O O
recognized O O
species O B_BIO/B_PERSON
of O O
the O O
genus O B_BACTERIUM[BIO]/B_MEASURE
. O O

The O O
nearest O O
phylogenetic O O
relative O O
of O O
the O O
new O O
isolates O O
was O O
Streptococcus B B_BACTERIUM[BIO]/B_PROTEIN[GENE]
ratti I B_BACTERIUM[BIO]/I_PROTEIN[GENE]
ATCC I B_BACTERIUM[BIO]/I_PROTEIN[GENE]
19645 I B_BACTERIUM[BIO]/I_PROTEIN[GENE]
( O O
T O O
) O O
( O O
98 O O
. O O
6 O O
% O O
) O O
, O O
however O O
, O O
DNA O O
- O O
DNA O O
hybridization O O
analysis O O
showed O O
that O O
the O O
isolates O O
displayed O O
less O O
than O O
15 O O
% O O
DNA O O
- O O
DNA O O
relatedness O O
with O O
the O O
type O O
strain O O
of O O
S B B_BACTERIUM[BIO]/B_DISEASE
. I I_BACTERIUM[BIO]/I_DISEASE
ratti I I_BACTERIUM[BIO]/I_DISEASE
. O O

Colonies O B_LOCATION/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
the O O
novel O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
strains O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
grown O O
on O O
mitis O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BACTERIUM[BIO]
salivarius O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_BACTERIUM[BIO]
agar O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_BACTERIUM[BIO]
showed O O
an O O
extracellular O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BACTERIUM[BIO]
polysaccharide O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_BACTERIUM[BIO]
- O O
producing O O
colony O B_MEASURE/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
morphology O B_MEASURE/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

Based O O
on O O
phenotypic O O
and O O
phylogenetic O O
evidence O O
, O O
it O O
is O O
proposed O O
that O O
the O O
novel O O
isolates O O
are O O
classified O O
in O O
the O O
genus O O
Streptococcus O O
as O O
Streptococcus B B_BACTERIUM[BIO]/B_DISEASE_ADJECTIVE[DISEASE]
ursoris I B_BACTERIUM[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
sp I B_BACTERIUM[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
. I B_BACTERIUM[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
nov I B_BACTERIUM[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
. I B_BACTERIUM[BIO]/I_DISEASE_ADJECTIVE[DISEASE]

The O O
type O O
strain O O
of O O
S B B_BACTERIUM[BIO]/B_LOCATION
. I B_BACTERIUM[BIO]/I_LOCATION
ursoris I B_BACTERIUM[BIO]/I_LOCATION
is O O
NUM B B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
1615 I I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
( I I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
T I I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
) I I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
( O O
= O O
JCM O O
16316 O O
( O O
T O O
) O O
= O O
DSM O O
22768 O O
( O O
T O O
) O O
) O O
. O O

Larkinella B B_BACTERIUM[BIO]/B_MEASURE
bovis I I_BACTERIUM[BIO]/I_MEASURE
sp O O
. O O
nov O O
. O O
, O O
isolated O O
from O O
fermented O O
bovine O O
products O O
, O O
and O O
emended O O
descriptions O O
of O O
the O O
genus O O
Larkinella O O
and O O
of O O
Larkinella B B_BIO/B_PERSON
insperata I I_BIO/I_PERSON
Vancanneyt O O
et O O
al O O
. O O

2006 O B_NUMBER[MEASURE]
. O O

A O O
novel O O
bacterial O O
strain O O
, O O
designated O O
M2T2B15 B B_PROTEIN[GENE]/B_LOCATION
( O O
T O O
) O O
, O O
was O O
isolated O O
from O O
fermented O O
bovine O O
products O O
and O O
was O O
characterized O O
by O O
using O O
a O O
polyphasic O O
approach O O
. O O

Colonies O B_LOCATION/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
were O O
reddish O B_DISEASE_ADJECTIVE[DISEASE]/B_BACTERIUM[BIO]
pink O I_DISEASE_ADJECTIVE[DISEASE]/I_BACTERIUM[BIO]
and O O
circular O B_TIME[MEASURE]/B_DISEASE_ADJECTIVE[DISEASE]
with O O
entire O B_COLOR/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
margins O I_COLOR/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

Cells O B_BIO/B_CELL[BODY_PART_OR_ORGAN_COMPONENT]
were O O
strictly O O
aerobic O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
, O O
Gram O B_BACTERIUM[BIO]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- O O
reaction O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
- O O
negative O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
oxidase O B_ENZYME[GENE]
- O O
and O O
catalase O B_ENZYME[GENE]
- O O
positive O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
rods O I_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
that O O
lacked O O
flagella O B_BACTERIUM[BIO]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
were O O
motile O B_CELL[BODY_PART_OR_ORGAN_COMPONENT]/B_DISEASE_ADJECTIVE[DISEASE]
by O O
gliding O O
. O O

Flexirubin O B_DISEASE_ADJECTIVE[DISEASE]/B_BIO
- O O
type O B_CHEMICAL_CLASS[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
pigments O I_CHEMICAL_CLASS[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_BIO
were O O
absent O B_DISEASE_ADJECTIVE[DISEASE]/B_CELL[BODY_PART_OR_ORGAN_COMPONENT]
. O O

16S O O
rRNA O O
gene O O
sequence O O
analysis O O
indicated O O
that O O
strain O O
M2T2B15 B B_MEASURE/B_GENE
( O O
T O O
) O O
was O O
related O O
most O O
closely O O
to O O
Larkinella B B_BIO/B_LOCATION
insperata I I_BIO/I_LOCATION
LMG O O
22510 O O
( O O
T O O
) O O
( O O
94 O O
. O O
4 O O
% O O
similarity O O
) O O
but O O
shared O O
& O O
lt O O
; O O
87 O O
% O O
similarity O O
with O O
other O O
members O O
of O O
the O O
phylum O O
Bacteroidetes O O
. O O

The O O
major O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
cellular O I_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
fatty O I_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
acids O I_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
were O O
C O B_PROTEIN[GENE]/B_LOCATION
( O O
16 O B_MEASURE
: O O
1 O B_MEASURE
) O O
omega5c O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
, O O
iso O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BACTERIUM[BIO]
- O O
C O B_PROTEIN[GENE]/B_LOCATION
( O O
15 O B_MEASURE
: O O
0 O B_MEASURE
) O O
and O O
iso O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BACTERIUM[BIO]
- O O
C O B_PROTEIN[GENE]/B_LOCATION
( O O
17 O B_MEASURE
: O O
0 O B_MEASURE
) O O
3 O B_MEASURE/B_LOCATION
- O O
OH O O
. O O

The O O
polar O B_CHEMICAL_CLASS[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
lipids O I_CHEMICAL_CLASS[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
were O O
phosphatidylethanolamine O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
, O O
phosphatidylserine O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
two O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
unidentified O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
aminophospholipids O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
and O O
two O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
unidentified O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
polar O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
lipids O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

Menaquinone O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
7 O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
( O O
MK O B_PROTEIN[GENE]/B_LOCATION
- O O
7 O B_MEASURE
) O O
was O O
the O O
major O B_PERSON
respiratory O I_PERSON
quinone O I_PERSON
. O O

The O O
G O O
+ O O
C O O
content O O
of O O
the O O
DNA O O
of O O
strain O O
M2T2B15 B B_MEASURE/B_PROTEIN[GENE]
( O O
T O O
) O O
was O O
52 O O
& O O
amp O O
; O O
emsp14 O O
; O O
mol O O
% O O
. O O

The O O
phenotypic O O
, O O
genotypic O O
and O O
phylogenetic O O
data O O
presented O O
clearly O O
indicate O O
that O O
strain O O
M2T2B15 B B_NUMBER[MEASURE]/B_PERSON
( O O
T O O
) O O
represents O O
a O O
novel O O
species O O
of O O
the O O
genus O O
Larkinella O O
, O O
for O O
which O O
the O O
name O O
Larkinella B B_BACTERIUM[BIO]
bovis I I_BACTERIUM[BIO]
sp O O
. O O
nov O O
. O O

is O B_LOCATION/B_ORGANIZATION
proposed O O
. O O

The O O
type O O
strain O O
is O O
M2T2B15 B B_PROTEIN[GENE]/B_DISEASE
( O O
T O O
) O O
( O O
= O O
KACC O O
14040 O O
( O O
T O O
) O O
= O O
NBRC O O
106324 O O
( O O
T O O
) O O
) O O
. O O

Emended O O
descriptions O O
of O O
the O O
genus O O
Larkinella O O
and O O
of O O
Larkinella B B_BIO/B_LOCATION
insperata I I_BIO/I_LOCATION
Vancanneyt O O
et O O
al O O
. O O

2006 O B_NUMBER[MEASURE]/B_LOCATION
are O O
also O O
proposed O O
. O O

Methanobacterium O B_MEASURE/B_BACTERIUM[BIO]
arcticum O I_MEASURE/I_BACTERIUM[BIO]
sp O I_MEASURE/I_BACTERIUM[BIO]
. O O
nov O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
. O O
, O O
a O O
methanogenic O B_BIO/B_LOCATION
archaeon O I_BIO/I_LOCATION
from O O
Holocene O B_LOCATION
Arctic O I_LOCATION
permafrost O I_LOCATION
. O O

A O O
mesophilic O O
, O O
non O O
- O O
motile O O
, O O
hydrogenotrophic O O
, O O
rod O O
- O O
shaped O O
methanogen O O
, O O
designated O O
M2 B B_PROTEIN[GENE]/B_MEASURE
( I I_PROTEIN[GENE]/I_MEASURE
T I I_PROTEIN[GENE]/I_MEASURE
) I I_PROTEIN[GENE]/I_MEASURE
, O O
was O O
isolated O O
from O O
Holocene O O
permafrost O O
sediments O O
of O O
the O O
Kolyma O O
lowland O O
in O O
the O O
Russian O O
Arctic O O
. O O

Cells O B_BIO/B_CELL[BODY_PART_OR_ORGAN_COMPONENT]
were O O
3 O B_NUMBER[MEASURE]
- O O
6 O B_MEASURE/B_PERSON
mum O I_MEASURE/I_PERSON
long O O
and O O
0 O B_MEASURE/B_LOCATION
. O O
45 O B_MEASURE
- O O
0 O B_MEASURE
. O O
5 O B_MEASURE/B_PERSON
mum O I_MEASURE/I_PERSON
wide O O
. O O

Strain O O
M2 B B_GENE/B_MEASURE
( I B_GENE/I_MEASURE
T I B_GENE/I_MEASURE
) I B_GENE/I_MEASURE
grew O O
on O O
H O O
( O O
2 O O
) O O
/ O O
CO O O
( O O
2 O O
) O O
and O O
formate O O
. O O

Optimum O B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
conditions O I_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
for O O
growth O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
were O O
37 O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
^ O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
0C O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
, O O
pH O O
6 O B_MEASURE
. O O
8 O B_MEASURE
- O O
7 O B_MEASURE
. O O
2 O B_MEASURE
and O O
0 O B_MEASURE
. O O
1 O B_MEASURE
M O I_MEASURE
NaCl O I_MEASURE
. O O

The O O
DNA O B_MEASURE/B_ORGANIZATION
G O I_MEASURE/I_ORGANIZATION
+ O I_MEASURE/I_ORGANIZATION
C O I_MEASURE/I_ORGANIZATION
content O I_MEASURE/I_ORGANIZATION
was O O
38 O B_MEASURE
. O O
1 O B_MEASURE
mol O I_MEASURE
% O I_MEASURE
. O O

On O O
the O O
basis O O
of O O
16S O O
rRNA O O
gene O O
sequence O O
comparison O O
with O O
known O O
methanogens O O
, O O
strain O O
M2 B B_MEASURE/B_GENE
( I I_MEASURE/I_GENE
T I I_MEASURE/I_GENE
) I I_MEASURE/I_GENE
was O O
affiliated O O
with O O
the O O
genus O O
Methanobacterium O O
and O O
was O O
most O O
closely O O
related O O
to O O
Methanobacterium B B_BACTERIUM[BIO]
veterum I I_BACTERIUM[BIO]
MK4 I I_BACTERIUM[BIO]
( I I_BACTERIUM[BIO]
T I I_BACTERIUM[BIO]
) I I_BACTERIUM[BIO]
and O O
Methanobacterium B B_PROTEIN[GENE]/B_BACTERIUM[BIO]
bryantii I I_PROTEIN[GENE]/I_BACTERIUM[BIO]
DSM B I_PROTEIN[GENE]/I_BACTERIUM[BIO]
863 I I_PROTEIN[GENE]/I_BACTERIUM[BIO]
( I I_PROTEIN[GENE]/I_BACTERIUM[BIO]
T I I_PROTEIN[GENE]/I_BACTERIUM[BIO]
) I I_PROTEIN[GENE]/I_BACTERIUM[BIO]
( O O
both O O
99 O O
% O O
16S O O
rRNA O O
gene O O
sequence O O
similarity O O
) O O
. O O

However O O
, O O
no O O
significant O O
DNA O O
- O O
DNA O O
relatedness O O
was O O
observed O O
between O O
strain O O
M2 B B_PROTEIN[GENE]/B_MEASURE
( I I_PROTEIN[GENE]/I_MEASURE
T I I_PROTEIN[GENE]/I_MEASURE
) I I_PROTEIN[GENE]/I_MEASURE
and O O
these O O
type O O
strains O O
. O O

We O O
propose O O
that O O
strain O O
M2 B B_PROTEIN[GENE]
( I I_PROTEIN[GENE]
T I I_PROTEIN[GENE]
) I I_PROTEIN[GENE]
represents O O
a O O
novel O O
species O O
, O O
with O O
the O O
name O O
Methanobacterium O O
arcticum O O
sp O O
. O O
nov O O
. O O
, O O
with O O
type O O
strain O O
M2 B B_PROTEIN[GENE]/B_DISEASE
( I I_PROTEIN[GENE]/I_DISEASE
T I I_PROTEIN[GENE]/I_DISEASE
) I I_PROTEIN[GENE]/I_DISEASE
( O O
= O O
DSM O O
19844 O O
( O O
T O O
) O O
= O O
VKM O O
B O O
- O O
2371 O O
( O O
T O O
) O O
) O O
. O O

Thiomonas B B_BACTERIUM[BIO]
islandica I I_BACTERIUM[BIO]
sp O O
. O O
nov O O
. O O
, O O
a O O
moderately O O
thermophilic O O
, O O
hydrogen O O
- O O
and O O
sulfur O O
- O O
oxidizing O O
betaproteobacterium B B_BIO
isolated O O
from O O
a O O
hot O O
spring O O
. O O

A O O
novel O O
, O O
hydrogen O O
- O O
and O O
sulfur O O
- O O
oxidizing O O
bacterium O O
, O O
designated O O
strain O O
6C B B_MEASURE/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
( I I_MEASURE/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
T I I_MEASURE/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
) I I_MEASURE/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
was O O
isolated O O
from O O
a O O
hot O O
spring O O
in O O
Graendalur O O
, O O
south O O
- O O
western O O
Iceland O O
. O O

Cells O B_BIO/B_CELL[BODY_PART_OR_ORGAN_COMPONENT]
of O O
this O O
organism O B_BIO
were O O
Gram O B_BACTERIUM[BIO]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- O O
reaction O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
- O O
negative O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
rod O B_BODY_PART_OR_ORGAN_COMPONENT/B_BIO
- O O
shaped O O
and O O
motile O B_CELL[BODY_PART_OR_ORGAN_COMPONENT]/B_DISEASE_ADJECTIVE[DISEASE]
. O O

The O O
strain O B_BIO/B_DISEASE
grew O O
aerobically O O
and O O
was O O
capable O B_PERSON
of O O
chemolithotrophic O B_ORGANISM_FUNCTION/B_BACTERIUM[BIO]
growth O I_ORGANISM_FUNCTION/I_BACTERIUM[BIO]
on O O
thiosulfate O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
hydrogen O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
heterotrophic O B_DISEASE_ADJECTIVE[DISEASE]/B_ORGANISM_FUNCTION
growth O B_DISEASE_ADJECTIVE[DISEASE]/I_ORGANISM_FUNCTION
on O O
pyruvate O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
oxalate O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
acetate O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
on O O
glutamate O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
in O O
the O O
presence O B_LOCATION/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
of O O
yeast O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
extract O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
mixotrophic O B_DISEASE_ADJECTIVE[DISEASE]/B_ORGANISM_FUNCTION
growth O B_DISEASE_ADJECTIVE[DISEASE]/I_ORGANISM_FUNCTION
on O O
several O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
organic O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
compounds O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
, O O
thiosulfate O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
/ O O
or O O
hydrogen O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

During O O
growth O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
on O O
thiosulfate O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
the O O
final O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
product O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_BIO
was O O
sulfate O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
resulting O O
in O O
a O O
drop O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
in O O
pH O B_MEASURE
from O O
6 O B_MEASURE
. O O
8 O B_MEASURE
to O O
2 O B_MEASURE
. O O
7 O B_MEASURE
. O O

Heterotrophic O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BACTERIUM[BIO]
growth O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_BACTERIUM[BIO]
on O O
pyruvate O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
was O O
observed O O
at O O
pH O B_MEASURE
4 O I_MEASURE
- O O
7 O B_MEASURE
( O O
optimum O B_MEASURE/B_LOCATION
pH O B_MEASURE/I_LOCATION
4 O B_MEASURE/I_LOCATION
) O O
and O O
35 O B_MEASURE
- O O
50 O B_MEASURE
^ O O
0C O B_MEASURE
( O O
optimum O B_MEASURE/B_LOCATION
45 O I_MEASURE/I_LOCATION
^ O I_MEASURE/I_LOCATION
0C O I_MEASURE/I_LOCATION
) O O
. O O

The O O
DNA O B_MEASURE/B_ORGANIZATION
G O I_MEASURE/I_ORGANIZATION
+ O I_MEASURE/I_ORGANIZATION
C O I_MEASURE/I_ORGANIZATION
content O I_MEASURE/I_ORGANIZATION
was O O
65 O B_MEASURE
. O O
2 O B_MEASURE
mol O I_MEASURE
% O I_MEASURE
. O O

As O O
determined O O
by O O
16S O O
rRNA O O
gene O O
sequence O O
analysis O O
, O O
strain O O
6C B B_MEASURE/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
( I I_MEASURE/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
T I I_MEASURE/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
) I I_MEASURE/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
represents O O
a O O
distinct O O
species O O
belonging O O
to O O
the O O
class O O
Betaproteobacteria B B_BACTERIUM[BIO]
and O O
is O O
most O O
closely O O
related O O
to O O
Thiomonas B B_BACTERIUM[BIO]
intermedia I I_BACTERIUM[BIO]
DSM B I_BACTERIUM[BIO]
18155 I I_BACTERIUM[BIO]
( I I_BACTERIUM[BIO]
T I I_BACTERIUM[BIO]
) I I_BACTERIUM[BIO]
and O O
Thiomonas B B_BACTERIUM[BIO]/B_LOCATION
perometabolis I B_BACTERIUM[BIO]/I_LOCATION
DSM B B_BACTERIUM[BIO]/I_LOCATION
18570 I B_BACTERIUM[BIO]/I_LOCATION
( I B_BACTERIUM[BIO]/I_LOCATION
T I B_BACTERIUM[BIO]/I_LOCATION
) I B_BACTERIUM[BIO]/I_LOCATION
. O O

DNA O O
- O O
DNA O O
hybridization O O
between O O
strain O O
6C B B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PROTEIN[GENE]
( I B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PROTEIN[GENE]
T I B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PROTEIN[GENE]
) I B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PROTEIN[GENE]
and O O
Thiomonas B B_BIO/B_PROTEIN[GENE]
intermedia I B_BIO/I_PROTEIN[GENE]
DSM B B_BIO/I_PROTEIN[GENE]
18155 I B_BIO/I_PROTEIN[GENE]
( I B_BIO/I_PROTEIN[GENE]
T I B_BIO/I_PROTEIN[GENE]
) I B_BIO/I_PROTEIN[GENE]
and O O
Thiomonas B B_BIO/B_GENE
perometabolis I B_BIO/I_GENE
DSM B B_BIO/I_GENE
18570 I B_BIO/I_GENE
( I B_BIO/I_GENE
T I B_BIO/I_GENE
) I B_BIO/I_GENE
gave O O
relatedness O O
values O O
below O O
32 O O
% O O
. O O

These O O
results O O
, O O
together O O
with O O
physiological O O
characteristics O O
, O O
showed O O
that O O
strain O O
6C B B_NUMBER[MEASURE]
( I I_NUMBER[MEASURE]
T I I_NUMBER[MEASURE]
) I I_NUMBER[MEASURE]
represents O O
a O O
novel O O
species O O
within O O
the O O
genus O O
Thiomonas O O
, O O
for O O
which O O
the O O
name O O
Thiomonas B B_BACTERIUM[BIO]
islandica I I_BACTERIUM[BIO]
sp O O
. O O
nov O O
. O O

is O B_LOCATION/B_ORGANIZATION
proposed O O
. O O

The O O
type O O
strain O O
is O O
6C B B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
( I I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE
T I I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE
) I I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE
( O O
= O O
DSM B B_DISEASE
21436 I I_DISEASE
( I I_DISEASE
T I I_DISEASE
) I I_DISEASE
= O O
JCM B B_MEASURE/B_DISEASE
16107 I I_MEASURE/I_DISEASE
( I I_MEASURE/I_DISEASE
T I I_MEASURE/I_DISEASE
) I I_MEASURE/I_DISEASE
) O O
. O O

Nocardioides B B_NUMBER[MEASURE]/B_DISEASE_ADJECTIVE[DISEASE]
caricicola I I_NUMBER[MEASURE]/I_DISEASE_ADJECTIVE[DISEASE]
sp I I_NUMBER[MEASURE]/I_DISEASE_ADJECTIVE[DISEASE]
. I I_NUMBER[MEASURE]/I_DISEASE_ADJECTIVE[DISEASE]
nov I I_NUMBER[MEASURE]/I_DISEASE_ADJECTIVE[DISEASE]
. I I_NUMBER[MEASURE]/I_DISEASE_ADJECTIVE[DISEASE]
, O O
an O O
endophytic O O
bacterium O O
isolated O O
from O O
a O O
halophyte O O
, O O
Carex B B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BACTERIUM[BIO]
scabrifolia I B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_BACTERIUM[BIO]
Steud O O
. O O

A O O
Gram O O
- O O
staining O O
- O O
positive O O
, O O
coccoid O O
to O O
rod O O
- O O
shaped O O
bacterium O O
, O O
designated O O
strain O O
YC6903 B B_MEASURE/B_PERSON
( O O
T O O
) O O
, O O
was O O
isolated O O
from O O
a O O
halophytic O O
plant O O
( O O
Carex B B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BACTERIUM[BIO]
scabrifolia I B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_BACTERIUM[BIO]
Steud O O
. O O
) O O
collected O O
from O O
sand O O
dunes O O
at O O
Namhae O O
Island O O
, O O
Korea O O
, O O
and O O
its O O
taxonomic O O
position O O
was O O
investigated O O
by O O
using O O
a O O
polyphasic O O
approach O O
. O O

Strain O O
YC6903 B B_PROTEIN[GENE]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
( O O
T O O
) O O
grew O O
optimally O O
at O O
30 O O
^ O O
0C O O
and O O
at O O
pH O O
8 O O
. O O
0 O O
. O O

Phylogenetic O O
analysis O O
based O O
on O O
16S O O
rRNA O O
gene O O
sequences O O
indicated O O
that O O
strain O O
YC6903 B B_MEASURE/B_PERSON
( O O
T O O
) O O
belongs O O
to O O
the O O
genus O O
Nocardioides O O
in O O
the O O
family O O
Nocardioidaceae O O
. O O

Strain O O
YC6903 B B_MEASURE/B_PERSON
( O O
T O O
) O O
was O O
related O O
most O O
closely O O
to O O
Nocardioides B B_BACTERIUM[BIO]
pyridinolyticus I I_BACTERIUM[BIO]
OS4 I I_BACTERIUM[BIO]
( O O
T O O
) O O
( O O
97 O O
. O O
0 O O
% O O
16S O O
rRNA O O
gene O O
sequence O O
similarity O O
) O O
, O O
Nocardioides B B_BIO/B_PROTEIN[GENE]
dokdonensis I B_BIO/I_PROTEIN[GENE]
FR1436 I B_BIO/I_PROTEIN[GENE]
( O O
T O O
) O O
( O O
96 O O
. O O
6 O O
% O O
) O O
, O O
Nocardioides B B_BACTERIUM[BIO]/B_PROTEIN[GENE]
aquiterrae I B_BACTERIUM[BIO]/I_PROTEIN[GENE]
GW I B_BACTERIUM[BIO]/I_PROTEIN[GENE]
- I B_BACTERIUM[BIO]/I_PROTEIN[GENE]
9 I B_BACTERIUM[BIO]/I_PROTEIN[GENE]
( O O
T O O
) O O
( O O
96 O O
. O O
6 O O
% O O
) O O
and O O
Nocardioides B B_BIO/B_MEASURE
hankookensis I B_BIO/I_MEASURE
DS I B_BIO/I_MEASURE
- I B_BIO/I_MEASURE
30 I B_BIO/I_MEASURE
( O O
T O O
) O O
( O O
96 O O
. O O
6 O O
% O O
) O O
. O O

The O O
cell O B_BODY_PART_OR_ORGAN_COMPONENT/B_MEASURE
- O O
wall O B_CELL_COMPONENT[BODY_PART_OR_ORGAN_COMPONENT]/B_BACTERIUM[BIO]
peptidoglycan O I_CELL_COMPONENT[BODY_PART_OR_ORGAN_COMPONENT]/I_BACTERIUM[BIO]
contained O O
LL O B_MEASURE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- O O
diaminopimelic O B_MEASURE
acid O I_MEASURE
and O O
MK O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- O O
8 O B_NUMBER[MEASURE]
( O O
H O B_OTHER/B_PROTEIN[GENE]
( O O
4 O B_NUMBER[MEASURE]/B_LOCATION
) O O
) O O
was O O
the O O
major O B_PERSON/B_BACTERIUM[BIO]
respiratory O I_PERSON/I_BACTERIUM[BIO]
quinone O I_PERSON/I_BACTERIUM[BIO]
. O O

The O O
mean O O
( O O
+ O O
/ O O
- O O
SD O O
) O O
level O O
of O O
DNA O O
- O O
DNA O O
relatedness O O
between O O
strain O O
YC6903 B B_MEASURE/B_PERSON
( O O
T O O
) O O
and O O
N B B_BACTERIUM[BIO]
. I I_BACTERIUM[BIO]
pyridinolyticus I I_BACTERIUM[BIO]
OS4 I I_BACTERIUM[BIO]
( O O
T O O
) O O
was O O
53 O O
. O O
5 O O
+ O O
/ O O
- O O
5 O O
. O O
5 O O
% O O
. O O

The O O
predominant O O
cellular O O
fatty O O
acid O O
of O O
strain O O
YC6903 B B_MEASURE/B_PERSON
( O O
T O O
) O O
was O O
iso O O
- O O
C O O
( O O
16 O O
: O O
0 O O
) O O
( O O
28 O O
. O O
9 O O
% O O
) O O
. O O

The O O
DNA O B_MEASURE/B_ORGANIZATION
G O I_MEASURE/I_ORGANIZATION
+ O I_MEASURE/I_ORGANIZATION
C O I_MEASURE/I_ORGANIZATION
content O I_MEASURE/I_ORGANIZATION
was O O
71 O B_MEASURE
. O O
7 O B_MEASURE
mol O I_MEASURE
% O I_MEASURE
. O O

Phenotypic O O
, O O
phylogenetic O O
and O O
chemotaxonomic O O
data O O
indicated O O
that O O
strain O O
YC6903 B B_NUMBER[MEASURE]/B_PERSON
( O O
T O O
) O O
represents O O
a O O
novel O O
species O O
of O O
the O O
genus O O
Nocardioides O O
, O O
for O O
which O O
the O O
name O O
Nocardioides B B_TIME[MEASURE]/B_DISEASE
caricicola I I_TIME[MEASURE]/I_DISEASE
sp I I_TIME[MEASURE]/I_DISEASE
. I I_TIME[MEASURE]/I_DISEASE
nov I I_TIME[MEASURE]/I_DISEASE
. I I_TIME[MEASURE]/I_DISEASE

is O B_LOCATION/B_ORGANIZATION
proposed O O
. O O

The O O
type O O
strain O O
is O O
YC6903 B B_PROTEIN[GENE]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
( O O
T O O
) O O
( O O
= O O
KACC O O
13778 O O
( O O
T O O
) O O
= O O
DSM O O
22177 O O
( O O
T O O
) O O
) O O
. O O

Radionuclide O B_DIAGNOSTIC_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
and O O
hybrid O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
imaging O I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
of O O
recurrent O B_DISEASE/B_BODY_PART_OR_ORGAN_COMPONENT
prostate O I_DISEASE/I_BODY_PART_OR_ORGAN_COMPONENT
cancer O I_DISEASE/I_BODY_PART_OR_ORGAN_COMPONENT
. O O

Prostate O B_DISEASE/B_BODY_PART_OR_ORGAN_COMPONENT
cancer O I_DISEASE/I_BODY_PART_OR_ORGAN_COMPONENT
is O O
one O B_NUMBER[MEASURE]/B_LOCATION
of O O
the O O
most O O
common O B_DISEASE_ADJECTIVE[DISEASE]
cancers O I_DISEASE_ADJECTIVE[DISEASE]
in O O
men O B_PERSON/B_LOCATION
, O O
leading O O
to O O
substantial O B_DISEASE
morbidity O I_DISEASE
and O O
mortality O B_DISEASE/B_MEASURE
. O O

After O O
definitive O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
therapy O I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
with O O
surgery O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
or O O
radiation O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
, O O
many O B_PERSON/B_BIO
patients O I_PERSON/I_BIO
have O O
biochemical O B_DISEASE_ADJECTIVE[DISEASE]
relapse O I_DISEASE_ADJECTIVE[DISEASE]
of O O
disease O B_DISEASE/B_GENE
- O O
- O O
ie O B_DISEASE_ADJECTIVE[DISEASE]/B_LOCATION
, O O
an O O
increase O B_DISEASE_ADJECTIVE[DISEASE]/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
in O O
their O O
prostate O B_DISEASE/B_BODY_PART_OR_ORGAN_COMPONENT
- O O
specific O B_MEASURE/B_DISEASE
antigen O I_MEASURE/I_DISEASE
level O I_MEASURE/I_DISEASE
- O O
- O O
which O O
often O O
precedes O O
clinically O O
apparent O B_DISEASE_ADJECTIVE[DISEASE]
disease O I_DISEASE_ADJECTIVE[DISEASE]
by O O
months O B_TIME[MEASURE]
or O O
even O B_TIME[MEASURE]/B_ENT
years O I_TIME[MEASURE]/I_ENT
. O O

Therefore O O
, O O
imaging O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
the O O
site O B_LOCATION/B_MEASURE
and O O
extent O B_DISEASE/B_MEASURE
of O O
tumour O B_DISEASE/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
recurrence O I_DISEASE/I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
( O O
local O B_LOCATION/B_DISEASE_ADJECTIVE[DISEASE]
, O O
regional O B_BODY_PART_OR_ORGAN_COMPONENT/B_DISEASE
, O O
distant O B_LOCATION/B_DISEASE_ADJECTIVE[DISEASE]
, O O
or O O
a O O
combination O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_ORGANIZATION
) O O
is O O
of O O
great O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ENT
interest O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_ENT
. O O

Conventional O B_DIAGNOSTIC_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
morphological O I_DIAGNOSTIC_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
imaging O I_DIAGNOSTIC_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
methods O I_DIAGNOSTIC_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
showed O O
limited O B_DISEASE_ADJECTIVE[DISEASE]/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
accuracy O B_DISEASE_ADJECTIVE[DISEASE]/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
for O O
assessment O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
recurrent O B_DISEASE
prostate O I_DISEASE
cancer O I_DISEASE
; O O
however O O
, O O
in O O
recent O B_DISEASE_ADJECTIVE[DISEASE]/B_TIME[MEASURE]
years O I_DISEASE_ADJECTIVE[DISEASE]/I_TIME[MEASURE]
, O O
functional O B_DIAGNOSTIC_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
and O O
molecular O B_DIAGNOSTIC_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
imaging O I_DIAGNOSTIC_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
have O O
offered O O
the O O
possibility O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
of O O
imaging O O
molecular O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BODY_PART_OR_ORGAN_COMPONENT
or O O
cellular O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
processes O B_DISEASE_ADJECTIVE[DISEASE]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
individual O B_DISEASE/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
tumours O I_DISEASE/I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
, O O
often O O
with O O
more O B_MEASURE/B_DISEASE_ADJECTIVE[DISEASE]
accuracy O B_MEASURE/I_DISEASE_ADJECTIVE[DISEASE]
than O O
morphological O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
imaging O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

Hybrid O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
imaging O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
modalities O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
( O O
PET O B_DIAGNOSTIC_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- O O
CT O B_DIAGNOSTIC_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
, O O
and O O
single O B_NUMBER[MEASURE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- O O
photon O B_DIAGNOSTIC_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
emission O I_DIAGNOSTIC_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
CT O I_DIAGNOSTIC_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
[ O I_DIAGNOSTIC_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
SPECT O I_DIAGNOSTIC_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
] O I_DIAGNOSTIC_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
- O O
CT O B_DIAGNOSTIC_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
) O O
have O O
been O O
introduced O O
that O O
combine O O
functional O B_DIAGNOSTIC_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
and O O
morphological O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
data O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
allow O O
whole O B_NUMBER[MEASURE]/B_PERSON
- O O
body O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BODY_PART_OR_ORGAN_COMPONENT
imaging O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_BODY_PART_OR_ORGAN_COMPONENT
. O O

Here O O
, O O
we O O
review O O
the O O
contribution O B_PERSON/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
radionuclide O B_DIAGNOSTIC_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
imaging O I_DIAGNOSTIC_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
and O O
hybrid O B_DIAGNOSTIC_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
imaging O I_DIAGNOSTIC_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
for O O
assessment O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
recurrent O B_DISEASE_ADJECTIVE[DISEASE]
prostate O I_DISEASE_ADJECTIVE[DISEASE]
cancer O I_DISEASE_ADJECTIVE[DISEASE]
( O O
local O B_DISEASE
vs O I_DISEASE
regional O I_DISEASE
vs O I_DISEASE
distant O I_DISEASE
disease O I_DISEASE
) O O
. O O

We O O
discuss O O
available O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
data O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
on O O
PET O B_LOCATION
- O O
CT O B_DIAGNOSTIC_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
and O O
SPECT O B_LOCATION
- O O
CT O B_LOCATION/B_DIAGNOSTIC_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
and O O
provide O O
an O O
overview O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
experimental O B_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
tracers O I_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
and O O
their O O
preclinical O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_EDU[ORGANIZATION]
and O O
clinical O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
development O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

Finally O O
, O O
we O O
present O O
a O O
perspective O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANIZATION
on O O
the O O
potential O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
of O O
future O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PROTEIN[GENE]
hybrid O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PROTEIN[GENE]
magnetic O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PROTEIN[GENE]
resonance O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PROTEIN[GENE]
- O O
PET O B_DIAGNOSTIC_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
imaging O I_DIAGNOSTIC_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
. O O

Fertility O B_BODY_PART_OR_ORGAN_COMPONENT
- O O
sparing O O
surgery O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
in O O
patients O B_PERSON
with O O
cervical O B_DISEASE/B_LOCATION
cancer O I_DISEASE/I_LOCATION
. O O

There O O
are O O
several O B_MEASURE
types O I_MEASURE
of O O
fertility O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
saving O I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
procedures O I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
that O O
can O O
be O O
done O O
in O O
patients O B_PERSON
with O O
cervical O B_DISEASE
cancer O I_DISEASE
, O O
which O O
differ O O
in O O
terms O B_LOCATION/B_MEASURE
of O O
surgical O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_MEASURE
approach O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/I_MEASURE
and O O
extent O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
of O O
paracervical O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_DISEASE
resection O I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/I_DISEASE
. O O

This O O
review O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
assesses O O
oncological O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_DISEASE
and O O
pregnancy O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
results O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE
after O O
different O B_DISEASE/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
procedures O B_DISEASE/I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
. O O

The O O
oncological O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
results O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
vaginal O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_BODY_PART_OR_ORGAN_COMPONENT
radical O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/I_BODY_PART_OR_ORGAN_COMPONENT
trachelectomies O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/I_BODY_PART_OR_ORGAN_COMPONENT
( O O
VRT O B_LOCATION/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
) O O
and O O
abdominal O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_DISEASE
radical O I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/I_DISEASE
trachelectomies O I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/I_DISEASE
( O O
ART O B_PERSON/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
) O O
are O O
similar O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
for O O
tumours O B_MEASURE/B_DISEASE_ADJECTIVE[DISEASE]
less O I_MEASURE/I_DISEASE_ADJECTIVE[DISEASE]
than O O
2 O B_MEASURE/B_LOCATION
cm O I_MEASURE/I_LOCATION
in O O
size O B_MEASURE/B_LOCATION
, O O
and O O
are O O
now O O
considered O O
safe O B_DISEASE_ADJECTIVE[DISEASE]/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
surgical O I_DISEASE_ADJECTIVE[DISEASE]/I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
procedures O I_DISEASE_ADJECTIVE[DISEASE]/I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
. O O

Oncological O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
outcomes O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
VRT O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_PROTEIN[GENE]
and O O
ART O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_GENE
in O O
tumours O B_MEASURE/B_PERSON
larger O I_MEASURE/I_PERSON
than O O
2 O B_NUMBER[MEASURE]/B_PERSON
cm O I_NUMBER[MEASURE]/I_PERSON
are O O
also O O
identical O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
, O O
but O O
the O O
results O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
cannot O O
be O O
considered O O
satisfactory O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
. O O

Preliminary O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
findings O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
of O O
less O O
radical O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_DISEASE
procedures O I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/I_DISEASE
( O O
ie O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_DISEASE
, O O
deep O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_DISEASE_ADJECTIVE[DISEASE]
cone O I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/I_DISEASE_ADJECTIVE[DISEASE]
and O O
simple O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_PROTEIN[GENE]
trachelectomy O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/I_PROTEIN[GENE]
) O O
in O O
patients O B_PERSON/B_BIO
with O O
tumours O B_TIME[MEASURE]/B_ENT
less O I_TIME[MEASURE]/I_ENT
than O O
2 O B_NUMBER[MEASURE]
cm O I_NUMBER[MEASURE]
, O O
and O O
negative O B_BODY_PART_OR_ORGAN_COMPONENT/B_DISEASE_ADJECTIVE[DISEASE]
sentinel O I_BODY_PART_OR_ORGAN_COMPONENT/I_DISEASE_ADJECTIVE[DISEASE]
and O O
other O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
pelvic O I_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
lymph O I_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
nodes O I_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
, O O
are O O
comparable O B_TIME[MEASURE]/B_DISEASE_ADJECTIVE[DISEASE]
with O O
the O O
results O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
of O O
VRT O B_PERSON
and O O
ART O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
. O O

Downstaging O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
tumours O B_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
larger O B_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
than O O
2 O B_NUMBER[MEASURE]/B_PERSON
cm O I_NUMBER[MEASURE]/I_PERSON
by O O
neoadjuvant O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
chemotherapy O I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
is O O
still O O
an O O
experimental O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
procedure O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
and O O
will O O
need O O
multicentre O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
cooperation O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
to O O
verify O O
its O O
oncological O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
safety O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
. O O

Pregnancy O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
results O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
vary O O
statistically O O
with O O
the O O
different O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
methods O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

Morphology O O
and O O
ultrastructure O O
of O O
multiple O O
life O O
cycle O O
stages O O
of O O
the O O
photosynthetic O O
relative O O
of O O
apicomplexa O O
, O O
Chromera B B_BIO/B_GENE
velia I B_BIO/I_GENE
. O O

Chromera B B_BACTERIUM[BIO]/B_DISEASE
velia I I_BACTERIUM[BIO]/I_DISEASE
is O O
a O O
photosynthetic O O
alga O O
with O O
a O O
secondary O O
plastid O O
that O O
represents O O
the O O
closest O O
known O O
photosynthetic O O
relative O O
of O O
the O O
apicomplexan O O
parasites O O
. O O

The O O
original O O
description O O
of O O
this O O
organism O O
was O O
based O O
on O O
brownish O O
, O O
immotile O O
coccoid O O
cells O O
, O O
which O O
is O O
the O O
predominating O O
stage O O
of O O
C B B_DISEASE_ADJECTIVE[DISEASE]/B_ORGANISM_FUNCTION
. I B_DISEASE_ADJECTIVE[DISEASE]/I_ORGANISM_FUNCTION
velia I B_DISEASE_ADJECTIVE[DISEASE]/I_ORGANISM_FUNCTION
in O O
the O O
culture O O
. O O

Here O O
we O O
provide O O
a O O
detailed O O
light O O
and O O
electron O O
microscopy O O
description O O
of O O
coccoid O O
cells O O
of O O
C B B_SPECIES[BIO]/B_PERSON
. I I_SPECIES[BIO]/I_PERSON
velia I I_SPECIES[BIO]/I_PERSON
and O O
a O O
previously O O
undocumented O O
bi O O
- O O
flagellated O O
stage O O
that O O
is O O
highly O O
motile O O
and O O
moves O O
in O O
a O O
characteristic O O
zig O O
- O O
zag O O
pattern O O
. O O

Transformation O B_DISEASE/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
from O O
a O O
coccoid O B_SPECIES[BIO]
into O O
a O O
flagellate O B_SPECIES[BIO]/B_DISEASE_ADJECTIVE[DISEASE]
stage O I_SPECIES[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
occurs O O
in O O
exponentially O O
growing O O
cultures O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
, O O
and O O
is O O
accelerated O O
by O O
exposure O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
to O O
light O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
. O O

The O O
C B B_PERSON/B_DISEASE_ADJECTIVE[DISEASE]
. I I_PERSON/I_DISEASE_ADJECTIVE[DISEASE]
velia I I_PERSON/I_DISEASE_ADJECTIVE[DISEASE]
cells O O
contain O O
a O O
pseudoconoid O O
, O O
which O O
is O O
likely O O
homologous O O
to O O
the O O
corresponding O O
structure O O
in O O
the O O
apical O O
complex O O
of O O
Apicomplexa O O
, O O
cortical O O
alveoli O O
subtended O O
by O O
subpellicular O O
microtubules O O
, O O
mitochondrion O O
with O O
tubular O O
cristae O O
, O O
a O O
micropyle O O
, O O
and O O
a O O
distinctive O O
chromerosome O O
, O O
an O O
apparently O O
novel O O
type O O
of O O
extrusion O O
organelle O O
. O O

Ultrastructural O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
analysis O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
the O O
flagellate O B_BIO/B_GENE
supports O O
its O O
close O B_PERSON
association O I_PERSON
with O O
colpodellids O B_SPECIES[BIO]
and O O
apicomplexans O B_SPECIES[BIO]
and O O
provides O O
important O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
insight O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
into O O
their O O
evolution O B_ORGANIZATION/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

Introns O O
, O O
alternative O O
splicing O O
, O O
spliced O O
leader O O
trans O O
- O O
splicing O O
and O O
differential O O
expression O O
of O O
pcna O O
and O O
cyclin O O
in O O
Perkinsus B B_DISEASE/B_BIO
marinus I I_DISEASE/I_BIO
. O O

To O O
gain O O
understanding O O
on O O
the O O
structure O O
and O O
regulation O O
of O O
growth O O
- O O
related O O
genes O O
of O O
the O O
parasitic O O
alveolate O O
Perkinsus B B_SPECIES[BIO]/B_LOCATION
marinus I I_SPECIES[BIO]/I_LOCATION
, O O
we O O
analyzed O O
genes O O
encoding O O
proliferating O O
cell O O
nuclear O O
antigen O O
( O O
pcna O O
) O O
and O O
cyclins O O
( O O
cyclin O O
) O O
. O O

Comparison O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
the O O
full O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
- O O
length O B_GENE/B_MEASURE
cDNAs O I_GENE/I_MEASURE
with O O
the O O
corresponding O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
genomic O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
sequences O O
revealedtrans O B_DISEASE_ADJECTIVE[DISEASE]/B_LOCATION
- O O
splicing O B_GENE/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
the O O
mRNAs O B_SEQUENCE[MEASURE]/B_PERSON
of O O
these O O
genes O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
with O O
a O O
conserved O B_MEASURE/B_LOCATION
21 O I_MEASURE/I_LOCATION
- O O
22 O B_MEASURE/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
nt O B_MEASURE/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
spliced O O
leader O B_PERSON/B_LOCATION
. O O

Over O O
10 O B_MEASURE/B_GENE
copies O I_MEASURE/I_GENE
of O O
pcna O B_GENE
were O O
detected O O
, O O
with O O
identical O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
gene O I_DISEASE_ADJECTIVE[DISEASE]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
structures O I_DISEASE_ADJECTIVE[DISEASE]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
similar O B_LOCATION/B_GENE
nucleotide O B_LOCATION/I_GENE
( O O
nt O B_LOCATION
) O O
sequences O B_LOCATION/B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
( O O
88 O B_MEASURE
- O O
99 O B_MEASURE/B_PERSON
% O I_MEASURE/I_PERSON
) O O
, O O
encoding O O
largely O O
identical O B_GENE/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
amino O B_GENE/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
acid O B_GENE/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
sequences O B_GENE/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
( O O
aa O B_GENE/B_DISEASE
) O O
. O O

Two O B_NUMBER[MEASURE]/B_PERSON
distinct O I_NUMBER[MEASURE]/I_PERSON
types O I_NUMBER[MEASURE]/I_PERSON
ofcyclin O O
( O O
Pmacyclin1 O B_PROTEIN[GENE]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
Pmacyclin2 O B_PROTEIN[GENE]/B_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
) O O
were O O
identified O O
, O O
with O O
66 O B_MEASURE
- O O
69 O B_MEASURE
% O I_MEASURE
nt O I_MEASURE
and O O
81 O B_MEASURE
- O O
85 O B_MEASURE/B_DISEASE_ADJECTIVE[DISEASE]
% O I_MEASURE/I_DISEASE_ADJECTIVE[DISEASE]
aa O I_MEASURE/I_DISEASE_ADJECTIVE[DISEASE]
similarities O I_MEASURE/I_DISEASE_ADJECTIVE[DISEASE]
. O O
Pmacyclin2 O B_GENE/B_PERSON
was O O
organized O O
in O O
tandem O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
repeats O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
, O O
and O O
was O O
alternatively O O
spliced O O
, O O
giving O O
rise O B_NUMBER[MEASURE]/B_LOCATION
to O O
five O B_DISEASE_ADJECTIVE[DISEASE]/B_LOCATION
subtypes O B_DISEASE_ADJECTIVE[DISEASE]/I_LOCATION
of O O
transcripts O B_GENE/B_CELL[BODY_PART_OR_ORGAN_COMPONENT]
. O O

For O O
both O O
pcna O B_GENE
and O O
cyclin O B_GENE
genes O I_GENE
, O O
6 O B_NUMBER[MEASURE]/B_LOCATION
- O O
10 O B_GENE/B_LOCATION
introns O I_GENE/I_LOCATION
were O O
found O O
. O O

Quantitative O B_MEASURE/B_LOCATION
RT O B_MEASURE/I_LOCATION
- O O
PCR O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
assays O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
showed O O
that O O
pcna O B_GENE
and O O
Pmacyclin2 O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
expression O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
levels O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
were O O
low O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
with O O
small O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
variations O B_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
during O O
a O O
28 O B_MEASURE
- O O
h O B_TIME[MEASURE]/B_LOCATION
time O I_TIME[MEASURE]/I_LOCATION
course O I_TIME[MEASURE]/I_LOCATION
, O O
whereas O O
Pmacyclin1 O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
transcript O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
abundance O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
was O O
10 O B_MEASURE
- O O
100 O B_MEASURE
times O I_MEASURE
higher O I_MEASURE
, O O
and O O
increased O O
markedly O O
during O O
active O B_DISEASE_ADJECTIVE[DISEASE]/B_ORGANISM_FUNCTION
cell O B_DISEASE_ADJECTIVE[DISEASE]/I_ORGANISM_FUNCTION
division O B_DISEASE_ADJECTIVE[DISEASE]/I_ORGANISM_FUNCTION
, O O
suggesting O O
that O O
it O O
is O O
a O O
mitoticcyclinand O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
can O O
be O O
a O O
useful O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
growth O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
marker O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
for O O
this O O
species O B_BIO
. O O

The O O
gene O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
structure O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
and O O
expression O B_GENE
features O O
along O O
with O O
phylogenetic O B_TIME[MEASURE]/B_LOCATION
results O I_TIME[MEASURE]/I_LOCATION
position O I_TIME[MEASURE]/I_LOCATION
this O O
organism O B_BIO/B_GENE
between O O
dinoflagellates O B_SPECIES[BIO]
and O O
apicomplexans O B_SPECIES[BIO]
, O O
but O O
its O O
definitive O B_PERSON/B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
affiliation O B_PERSON/I_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
among O O
alveolates O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
requires O O
further O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
studies O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

Highly O O
diverse O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
and O O
seasonally O O
dynamic O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
protist O I_DISEASE_ADJECTIVE[DISEASE]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
community O I_DISEASE_ADJECTIVE[DISEASE]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
in O O
a O O
pristine O B_LOCATION/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
peat O I_LOCATION/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
bog O I_LOCATION/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

Culture O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
- O O
independent O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
molecular O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
methods O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
based O O
on O O
the O O
amplification O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
, O O
cloning O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
and O O
sequencing O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
of O O
small O B_NUMBER[MEASURE]/B_DISEASE
- O O
subunit O B_GENE/B_LOCATION
ribosomal O I_GENE/I_LOCATION
RNA O I_GENE/I_LOCATION
genes O I_GENE/I_LOCATION
( O O
SSU O B_GENE/B_BIO
rDNAs O I_GENE/I_BIO
) O O
are O O
powerful O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
tools O I_DISEASE_ADJECTIVE[DISEASE]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
to O O
study O O
the O O
diversity O B_PERSON/B_BIO
of O O
microorganisms O B_SPECIES[BIO]/B_GENE
. O O

Despite O O
so O O
, O O
the O O
eukaryotic O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
microbial O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_BIO
diversity O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_BIO
of O O
many O B_LOCATION/B_BIO
ecosystems O I_LOCATION/I_BIO
, O O
including O O
peatlands O B_LOCATION/B_BIO
has O O
not O O
yet O O
received O O
much O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
attention O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
. O O

We O O
analysed O O
the O O
eukaryotic O B_BIO/B_LOCATION
diversity O I_BIO/I_LOCATION
by O O
molecular O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
surveys O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
in O O
water O B_MEASURE/B_BIO
from O O
the O O
centre O B_LOCATION/B_BIO
of O O
a O O
pristine O B_BIO/B_LOCATION
Sphagnum O I_BIO/I_LOCATION
- O O
dominated O O
peatland O B_LOCATION
in O O
the O O
Jura O B_LOCATION
Mountains O I_LOCATION
of O O
Switzerland O B_LOCATION
during O O
a O O
complete O B_TIME[MEASURE]/B_LOCATION
seasonal O B_TIME[MEASURE]/I_LOCATION
cycle O B_TIME[MEASURE]/I_LOCATION
. O O

The O O
clone O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
libraries O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
constructed O O
from O O
five O B_BIO/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
different O I_BIO/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
temporal O I_BIO/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
samplings O I_BIO/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
revealed O O
a O O
high O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
diversity O I_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
of O O
protists O B_BIO/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
with O O
representatives O B_PERSON
of O O
all O O
major O B_BIO/B_MEASURE
eukaryotic O I_BIO/I_MEASURE
phyla O I_BIO/I_MEASURE
. O O

In O O
addition O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
, O O
four O B_BIO/B_PERSON
sequence O I_BIO/I_PERSON
types O I_BIO/I_PERSON
could O O
not O O
be O O
assigned O O
to O O
any O O
known O O
high O B_GENE/B_BIO
- O O
level O B_BIO/B_MEASURE
eukaryotic O B_BIO/I_MEASURE
taxon O B_BIO/I_MEASURE
but O O
branched O O
together O O
with O O
a O O
rather O O
good O B_MEASURE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
statistic O I_MEASURE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
support O I_MEASURE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
raising O O
the O O
possibility O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
of O O
a O O
novel O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
, O O
deep O B_BIO/B_MEASURE
branching O I_BIO/I_MEASURE
eukaryotic O I_BIO/I_MEASURE
clade O I_BIO/I_MEASURE
. O O

The O O
analysis O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
seasonal O B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
patterns O I_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
of O O
phylotypes O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
showed O O
a O O
clear O B_MEASURE
change O I_MEASURE
in O O
the O O
eukaryotic O B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
communities O I_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
between O O
the O O
warm O B_TIME[MEASURE]/B_DISEASE
period O I_TIME[MEASURE]/I_DISEASE
( O O
late O B_TIME[MEASURE]/B_LOCATION
spring O I_TIME[MEASURE]/I_LOCATION
and O O
summer O B_TIME[MEASURE]
) O O
and O O
the O O
cold O B_TIME[MEASURE]/B_LOCATION
period O I_TIME[MEASURE]/I_LOCATION
( O O
autumn O B_TIME[MEASURE]/B_LOCATION
and O O
winter O B_TIME[MEASURE]/B_LOCATION
) O O
. O O

Chrysophytes O B_BACTERIUM[BIO]/B_PERSON
dominated O O
the O O
samples O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
in O O
the O O
cold O B_TIME[MEASURE]/B_LOCATION
period O I_TIME[MEASURE]/I_LOCATION
while O O
testate O B_BIO/B_PERSON
amoebae O I_BIO/I_PERSON
( O O
Arcellinida O B_BACTERIUM[BIO]
and O O
Euglyphida O B_BACTERIUM[BIO]
) O O
and O O
a O O
few O B_BIO
other O I_BIO
groups O I_BIO
peaked O O
in O O
summer O B_MEASURE/B_LOCATION
. O O

A O O
few O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
phylotypes O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
( O O
such O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
as O O
a O O
cryptomonad O B_SPECIES[BIO]
and O O
a O O
perkinsid O B_BACTERIUM[BIO]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
) O O
were O O
abundant O B_DISEASE_ADJECTIVE[DISEASE]
at O O
given O O
sampling O O
times O B_MEASURE/B_LOCATION
and O O
then O O
almost O O
disappeared O O
, O O
suggesting O O
bloom O B_LOCATION/B_DISEASE_ADJECTIVE[DISEASE]
- O O
like O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
dynamics O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
. O O

Comparing O O
potential O B_DISEASE/B_GENE
COI O B_DISEASE/I_GENE
and O O
SSU O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
rDNA O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_BIO
barcodes O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_BIO
for O O
assessing O O
the O O
diversity O B_BIO
and O O
phylogenetic O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
relationships O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
of O O
cyphoderiid O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
testate O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
amoebae O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
( O O
Rhizaria O B_BIO/B_PERSON
: O O
Euglyphida O B_MEASURE/B_LOCATION
) O O
. O O

The O O
mitochondrial O B_GENE
Cytochrome O I_GENE
Oxidase O I_GENE
Subunit O I_GENE
1 O I_GENE
gene O I_GENE
( O O
COI O B_GENE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
) O O
has O O
been O O
promoted O O
as O O
an O O
ideal O B_DISEASE_ADJECTIVE[DISEASE]/B_GENE
& O O
quot O B_LOCATION/B_BIO
; O O
DNA O B_GENE/B_MEASURE
barcode O B_GENE/I_MEASURE
& O O
quot O B_LOCATION/B_BIO
; O O
for O O
animal O B_SPECIES[BIO]/B_DISEASE_ADJECTIVE[DISEASE]
species O I_SPECIES[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
and O O
other O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
groups O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
of O O
eukaryotes O B_BIO
. O O

However O O
, O O
the O O
utility O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
of O O
the O O
COI O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
marker O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
for O O
species O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
level O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
discrimination O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
and O O
for O O
phylogenetic O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANISM_FUNCTION
analyses O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_ORGANISM_FUNCTION
has O O
yet O O
to O O
be O O
tested O O
within O O
the O O
Rhizaria O B_BIO/B_LOCATION
. O O

Accordingly O O
, O O
we O O
analysed O O
mitochondrial O B_GENE/B_CELL_COMPONENT[BODY_PART_OR_ORGAN_COMPONENT]
COI O B_GENE/I_CELL_COMPONENT[BODY_PART_OR_ORGAN_COMPONENT]
gene O B_GENE/I_CELL_COMPONENT[BODY_PART_OR_ORGAN_COMPONENT]
sequences O B_GENE/I_CELL_COMPONENT[BODY_PART_OR_ORGAN_COMPONENT]
and O O
nuclear O B_GENE
small O I_GENE
subunit O I_GENE
rDNA O I_GENE
( O O
SSU O B_DISEASE/B_GENE
) O O
sequences O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
from O O
several O B_BIO/B_GENE
morphospecies O I_BIO/I_GENE
of O O
euglyphid O B_BIO
testate O I_BIO
amoebae O I_BIO
( O O
Cercozoa O B_BACTERIUM[BIO]/B_LOCATION
, O O
Rhizaria O B_MEASURE/B_BACTERIUM[BIO]
) O O
in O O
order O B_LOCATION/B_DISEASE
to O O
evaluate O O
the O O
utility O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
of O O
these O O
DNA O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
markers O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
for O O
species O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
discrimination O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
and O O
phylogenetic O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
reconstructions O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
. O O

Sequences O B_LOCATION/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
were O O
obtained O O
from O O
eleven O B_BIO/B_PERSON
populations O I_BIO/I_PERSON
belonging O O
to O O
six O B_BIO/B_PERSON
Cyphoderia O I_BIO/I_PERSON
morphospecies O I_BIO/I_PERSON
that O O
were O O
isolated O O
from O O
field O B_LOCATION/B_BIO
samples O I_LOCATION/I_BIO
in O O
North O B_LOCATION
America O I_LOCATION
and O O
Europe O B_LOCATION
. O O

Mean O B_MEASURE/B_LOCATION
inter O I_MEASURE/I_LOCATION
- O O
population O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
COI O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
sequence O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
dissimilarities O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
were O O
on O O
average O B_MEASURE
2 O I_MEASURE
. O O
9 O B_TIME[MEASURE]
times O I_TIME[MEASURE]
greater O I_TIME[MEASURE]
than O O
in O O
the O O
SSU O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
, O O
while O O
the O O
intra O B_DISEASE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- O O
population O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
sequence O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
dissimilarities O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
were O O
higher O B_MEASURE/B_DISEASE_ADJECTIVE[DISEASE]
in O O
the O O
SSU O B_DISEASE/B_LOCATION
( O O
0 O B_MEASURE/B_LOCATION
- O O
0 O B_MEASURE
. O O
95 O B_MEASURE/B_PERSON
% O I_MEASURE/I_PERSON
) O O
than O O
in O O
the O O
COI O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PROTEIN[GENE]
( O O
0 O B_MEASURE
% O I_MEASURE
) O O
; O O
this O O
suggests O O
that O O
the O O
COI O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
fragment O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
is O O
valuable O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
for O O
discriminating O O
Cyphoderiidae O B_BIO/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
isolates O I_BIO/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

Our O O
study O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
also O O
demonstrated O O
that O O
COI O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
sequences O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
are O O
useful O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
for O O
inferring O O
phylogenetic O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
relationships O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_BIO
among O O
Cyphoderiidae O B_BIO
isolates O I_BIO
. O O

COI O B_DISEASE/B_LOCATION
and O O
SSU O B_DISEASE/B_LOCATION
tree O I_DISEASE/I_LOCATION
topologies O I_DISEASE/I_LOCATION
were O O
very O O
similar O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
even O O
though O O
the O O
COI O B_GENE
fragment O I_GENE
used O O
in O O
these O O
analyses O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
( O O
500bp O B_MEASURE/B_PROTEIN[GENE]
) O O
was O O
much O O
shorter O B_TIME[MEASURE]
than O O
the O O
SSU O B_MEASURE/B_DISEASE_ADJECTIVE[DISEASE]
sequences O I_MEASURE/I_DISEASE_ADJECTIVE[DISEASE]
( O O
1600bp O B_MEASURE/B_GENE
) O O
. O O

Altogether O O
, O O
these O O
results O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
demonstrate O O
the O O
utility O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
the O O
COI O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
as O O
a O O
potential O B_BIO/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
taxonomic O I_BIO/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
DNA O I_BIO/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
barcode O I_BIO/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
for O O
assessing O O
cyphoderiid O B_MEASURE/B_BIO
species O I_MEASURE/I_BIO
diversity O I_MEASURE/I_BIO
and O O
for O O
inferring O O
phylogenetic O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
relationships O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
within O O
the O O
group O B_ORGANIZATION/B_PERSON
. O O

Expanding O O
character O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
sampling O O
for O O
ciliate O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
phylogenetic O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
inference O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
using O O
mitochondrial O B_PROTEIN[GENE]/B_BACTERIUM[BIO]
SSU O I_PROTEIN[GENE]/I_BACTERIUM[BIO]
- O O
rDNA O B_MEASURE/B_BIO
as O O
a O O
molecular O B_GENE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
marker O I_GENE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

Molecular O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
systematics O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
of O O
ciliates O B_BIO/B_ORGANISM_FUNCTION
, O O
particularly O O
at O O
deep O B_DISEASE_ADJECTIVE[DISEASE]/B_BIO
nodes O B_DISEASE_ADJECTIVE[DISEASE]/I_BIO
, O O
has O O
largely O O
focused O O
on O O
increasing O O
taxon O B_BIO/B_GENE
sampling O O
using O O
the O O
nuclear O B_GENE
small O I_GENE
subunit O I_GENE
rDNA O I_GENE
( O O
nSSU O B_PROTEIN[GENE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- O O
rDNA O B_MEASURE/B_GENE
) O O
locus O B_GENE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

These O O
previous O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
analyses O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_BIO
have O O
generally O O
been O O
congruent O B_DISEASE_ADJECTIVE[DISEASE]
with O O
morphologically O O
- O O
based O O
classifications O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
, O O
although O O
there O O
is O O
extensive O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
non O O
- O O
monophyly O O
at O O
many O B_TIME[MEASURE]/B_PERSON
levels O I_TIME[MEASURE]/I_PERSON
. O O

However O O
, O O
caution O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
is O O
needed O O
in O O
interpreting O O
these O O
results O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
as O O
nSSU O B_PROTEIN[GENE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- O O
rDNA O B_MEASURE
is O O
just O O
a O O
single O B_MEASURE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
molecular O B_MEASURE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
marker O B_MEASURE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

Here O O
the O O
mitochondrial O B_GENE
small O I_GENE
subunit O I_GENE
rDNA O I_GENE
( O O
mtSSU O B_LOCATION
- O O
rDNA O B_MEASURE/B_PROTEIN[GENE]
) O O
is O O
evaluated O O
for O O
deep O B_DISEASE_ADJECTIVE[DISEASE]/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
ciliate O B_DISEASE_ADJECTIVE[DISEASE]/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
nodes O B_DISEASE_ADJECTIVE[DISEASE]/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
using O O
the O O
Colpodea O B_BIO/B_BODY_PART_OR_ORGAN_COMPONENT
as O O
an O O
example O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
. O O

Overall O B_DISEASE_ADJECTIVE[DISEASE]/B_LOCATION
, O O
well O O
- O O
supported O O
nodes O B_LOCATION/B_PERSON
in O O
the O O
mtSSU O B_PROTEIN[GENE]/B_DISEASE_ADJECTIVE[DISEASE]
- O O
rDNA O B_GENE/B_BIO
and O O
concatenated O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
topologies O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
are O O
well O O
supported O O
in O O
the O O
nSSU O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PROTEIN[GENE]
- O O
rDNA O B_GENE/B_BIO
topology O I_GENE/I_BIO
; O O
e O O
. O O
g O B_GENE/B_CELL[BODY_PART_OR_ORGAN_COMPONENT]
. O O
, O O
the O O
non O B_DISEASE
- O O
monophyly O B_LOCATION/B_PERSON
of O O
the O O
Cyrtolophosidida O B_BIO/B_BODY_PART_OR_ORGAN_COMPONENT
. O O

The O O
two O O
moderately O O
- O O
to O O
well O O
- O O
supported O O
incongruences O O
between O O
the O O
loci O O
are O O
the O O
placement O O
of O O
the O O
Sorogenida O O
and O O
Colpoda B B_BACTERIUM[BIO]/B_PERSON
aspera I I_BACTERIUM[BIO]/I_PERSON
. O O
Our O O
analyses O O
of O O
mtSSU O O
- O O
rDNA O O
support O O
the O O
conclusion O O
, O O
originally O O
derived O O
from O O
nSSU O O
- O O
rDNA O O
, O O
that O O
the O O
morphological O O
characters O O
used O O
in O O
taxonomic O O
circumscriptions O O
of O O
the O O
Colpodea O O
represent O O
a O O
mixture O O
of O O
ancestral O O
and O O
derived O O
states O O
. O O

This O O
demonstration O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
the O O
efficacy O B_MEASURE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
the O O
mtSSU O B_PROTEIN[GENE]/B_DISEASE_ADJECTIVE[DISEASE]
- O O
rDNA O B_BIO/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
will O O
enable O O
phylogenetic O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
reconstructions O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
of O O
deep O B_DISEASE_ADJECTIVE[DISEASE]/B_BIO
nodes O B_DISEASE_ADJECTIVE[DISEASE]/I_BIO
in O O
the O O
ciliate O B_BIO/B_LOCATION
tree O B_BIO/I_LOCATION
of O O
life O B_BIO/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
to O O
move O O
from O O
a O O
single O B_NUMBER[MEASURE]/B_LOCATION
- O O
locus O B_GENE/B_MEASURE
to O O
a O O
multi O B_NUMBER[MEASURE]/B_ENT
- O O
locus O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
approach O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
. O O

Diversification O O
and O O
evolution O O
of O O
the O O
avirulence O O
gene O O
AVR O O
- O O
Pita1 O O
in O O
field O O
isolates O O
of O O
Magnaporthe B B_BACTERIUM[BIO]/B_DISEASE
oryzae I I_BACTERIUM[BIO]/I_DISEASE
. O O

Rice O O
blast O O
disease O O
is O O
the O O
single O O
most O O
destructive O O
plant O O
disease O O
that O O
threatens O O
stable O O
rice B B_BIO/B_LOCATION
production O O
worldwide O O
. O O

Race O B_PERSON/B_BIO
- O O
specific O B_DISEASE_ADJECTIVE[DISEASE]/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
resistance O I_DISEASE_ADJECTIVE[DISEASE]/I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
to O O
the O O
rice O B_BIO/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
blast O B_BIO/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
pathogen O B_BIO/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
has O O
not O O
been O O
durable O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
the O O
mechanism O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
by O O
which O O
the O O
resistance O B_DISEASE_ADJECTIVE[DISEASE]
is O O
overcome O O
remains O O
largely O O
unknown O B_DISEASE_ADJECTIVE[DISEASE]
. O O

Here O O
we O O
report O O
the O O
molecular O O
mechanisms O O
of O O
diversification O O
and O O
the O O
instability O O
of O O
the O O
avirulence O O
gene O O
AVR O O
- O O
Pita1 O O
in O O
field O O
strains O O
of O O
Magnaporthe B B_SPECIES[BIO]/B_DISEASE
oryzae I I_SPECIES[BIO]/I_DISEASE
interacting O O
with O O
the O O
host O O
resistance O O
gene O O
Pi O O
- O O
ta O O
and O O
triggering O O
race O O
- O O
specific O O
resistance O O
. O O

Two O B_NUMBER[MEASURE]/B_LOCATION
- O O
base O B_LOCATION/B_BIO
- O O
pair O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
insertions O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
resulting O O
in O O
frame O B_LOCATION
- O O
shift O B_DISEASE_ADJECTIVE[DISEASE]
mutations O I_DISEASE_ADJECTIVE[DISEASE]
and O O
partial O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
and O O
complete O B_CELL_OR_MOLECULAR_DYSFUNCTION[DISEASE]/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
deletions O I_CELL_OR_MOLECULAR_DYSFUNCTION[DISEASE]/I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
of O O
AVR O B_DISEASE/B_GENE
- O O
Pita1 O B_PROTEIN[GENE]/B_MEASURE
were O O
identified O O
in O O
virulent O B_SPECIES[BIO]/B_DISEASE_ADJECTIVE[DISEASE]
isolates O I_SPECIES[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
. O O

Moreover O O
, O O
a O O
total O B_MEASURE
of O O
38 O B_MEASURE/B_DISEASE_ADJECTIVE[DISEASE]
AVR O I_MEASURE/I_DISEASE_ADJECTIVE[DISEASE]
- O O
Pita1 O B_PROTEIN[GENE]/B_DISEASE_ADJECTIVE[DISEASE]
haplotypes O I_PROTEIN[GENE]/I_DISEASE_ADJECTIVE[DISEASE]
encoding O O
27 O B_DISEASE/B_GENE
AVR O B_DISEASE/I_GENE
- O O
Pita1 O B_DISEASE_ADJECTIVE[DISEASE]/B_GENE
variants O B_DISEASE_ADJECTIVE[DISEASE]/I_GENE
were O O
identified O O
among O O
151 O B_PERSON
avirulent O I_PERSON
isolates O I_PERSON
. O O

Most O B_CELL_OR_MOLECULAR_DYSFUNCTION[DISEASE]/B_GENE
DNA O I_CELL_OR_MOLECULAR_DYSFUNCTION[DISEASE]/I_GENE
sequence O I_CELL_OR_MOLECULAR_DYSFUNCTION[DISEASE]/I_GENE
variation O I_CELL_OR_MOLECULAR_DYSFUNCTION[DISEASE]/I_GENE
was O O
found O O
to O O
occur O O
in O O
the O O
exon O B_GENE/B_LOCATION
region O I_GENE/I_LOCATION
resulting O O
in O O
amino O B_CELL_OR_MOLECULAR_DYSFUNCTION[DISEASE]/B_GENE
acid O I_CELL_OR_MOLECULAR_DYSFUNCTION[DISEASE]/I_GENE
substitution O I_CELL_OR_MOLECULAR_DYSFUNCTION[DISEASE]/I_GENE
. O O

These O O
findings O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
demonstrate O O
that O O
AVR O B_DISEASE/B_PROTEIN[GENE]
- O O
Pita1 O B_PROTEIN[GENE]/B_MEASURE
is O O
under O O
positive O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
selection O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
mutations O B_CELL_OR_MOLECULAR_DYSFUNCTION[DISEASE]/B_GENE
of O O
AVR O B_DISEASE/B_PROTEIN[GENE]
- O O
Pita1 O B_PROTEIN[GENE]/B_MEASURE
are O O
responsible O B_PERSON/B_DISEASE_ADJECTIVE[DISEASE]
for O O
defeating O O
race O B_SPORT[ENT]/B_PERSON
- O O
specific O B_DISEASE_ADJECTIVE[DISEASE]/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
resistance O I_DISEASE_ADJECTIVE[DISEASE]/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
in O O
nature O B_BIO/B_DISEASE
. O O

Analysis O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
spatial O B_DISEASE_ADJECTIVE[DISEASE]/B_ORGANISM_FUNCTION
niche O B_DISEASE_ADJECTIVE[DISEASE]/I_ORGANISM_FUNCTION
structure O B_DISEASE_ADJECTIVE[DISEASE]/I_ORGANISM_FUNCTION
in O O
coexisting O O
tidepool O B_LOCATION/B_ORGANIZATION
fishes O I_LOCATION/I_ORGANIZATION
: O O
null O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
models O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
based O O
on O O
multi O B_DISEASE/B_LOCATION
- O O
scale O B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
experiments O I_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
. O O

1 O B_NUMBER[MEASURE]
. O O

Fundamental O O
and O O
realized O O
spatial O O
niches O O
were O O
investigated O O
through O O
a O O
combination O O
of O O
laboratory O O
and O O
mesocosm O O
experiments O O
, O O
field O O
observations O O
and O O
null O O
model O O
analysis O O
in O O
three O O
intertidal O O
gobiid O O
species O O
( O O
Bathygobius B B_BIO/B_LOCATION
fuscus I I_BIO/I_LOCATION
, O O
Chaenogobius B B_SPECIES[BIO]/B_LOCATION
annularis I I_SPECIES[BIO]/I_LOCATION
and O O
C B B_SPECIES[BIO]
. I I_SPECIES[BIO]
gulosus I I_SPECIES[BIO]
) O O
. O O

Null O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
models O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
based O O
on O O
the O O
results O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANIZATION
of O O
single O B_NUMBER[MEASURE]/B_LOCATION
- O O
species O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
experiments O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
were O O
used O O
to O O
assess O O
interspecific O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
spatial O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
use O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
coexistence O B_DISEASE_ADJECTIVE[DISEASE]/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
on O O
two O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
different O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
scales O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
: O O
( O O
i O O
) O O
microhabitats O B_DISEASE_ADJECTIVE[DISEASE]/B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
within O O
a O O
tidepool O B_LOCATION/B_BIO
( O O
' O O
microhabitat O B_LOCATION/B_MEASURE
' O O
scale O B_MEASURE/B_LOCATION
) O O
; O O
and O O
( O O
ii O B_TIME[MEASURE]/B_PROTEIN[GENE]
) O O
distribution O B_ORGANIZATION/B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
among O O
a O O
set O B_PROTEIN[GENE]/B_LOCATION
of O O
tidepools O B_LOCATION/B_BIO
( O O
' O O
habitat O B_LOCATION
- O O
wide O B_LOCATION/B_DISEASE
' O O
scale O B_MEASURE
) O O
. O O

2 O B_NUMBER[MEASURE]
. O O

Patterns O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
of O O
microhabitat O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
use O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE
varied O O
from O O
single O B_MEASURE/B_PERSON
to O O
paired O O
treatments O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_BIO
, O O
depending O O
on O O
paired O O
species O B_BIO/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

Realized O O
overlap O B_MEASURE/B_PERSON
of O O
microhabitat O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
use O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
was O O
smaller O B_MEASURE
than O O
would O O
be O O
expected O O
from O O
single O B_PERSON/B_DISEASE
- O O
individual O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
situations O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
for O O
intraspecific O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
combinations O I_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
, O O
but O O
not O O
for O O
interspecific O B_PERSON/B_ENT
ones O I_PERSON/I_ENT
. O O

3 O B_NUMBER[MEASURE]
. O O

Patterns O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
of O O
tidepool O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
occupancy O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
( O O
a O O
measure O B_MEASURE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
spatial O B_DISEASE_ADJECTIVE[DISEASE]/B_ORGANISM_FUNCTION
niche O B_DISEASE_ADJECTIVE[DISEASE]/I_ORGANISM_FUNCTION
breadth O B_DISEASE_ADJECTIVE[DISEASE]/I_ORGANISM_FUNCTION
) O O
in O O
the O O
mesocosm O B_LOCATION
were O O
influenced O O
by O O
interspecific O B_LOCATION
interactions O I_LOCATION
. O O

Two O O
Chaenogobius O O
species O O
, O O
but O O
not O O
B B B_NUMBER[MEASURE]/B_BIO
. I I_NUMBER[MEASURE]/I_BIO
fuscus I I_NUMBER[MEASURE]/I_BIO
, O O
decreased O O
tidepool O O
occupancy O O
in O O
the O O
hetero O O
- O O
specific O O
treatments O O
compared O O
with O O
the O O
mono O O
- O O
specific O O
ones O O
. O O

For O O
all O O
interspecific O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
combinations O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
, O O
spatial O B_LOCATION/B_BIO
overlap O O
( O O
habitat O B_LOCATION/B_MEASURE
- O O
wide O B_MEASURE/B_LOCATION
scale O I_MEASURE/I_LOCATION
) O O
was O O
significantly O O
lower O B_MEASURE/B_DISEASE_ADJECTIVE[DISEASE]
than O O
the O O
values O B_MEASURE
expected O O
from O O
mono O B_LOCATION/B_DISEASE
- O O
specific O B_LOCATION/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
situations O I_LOCATION/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

The O O
results O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
also O O
indicated O O
a O O
possible O B_DISEASE/B_LOCATION
trade O I_DISEASE/I_LOCATION
- O O
off O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_LOCATION
between O O
competitiveness O B_DISEASE_ADJECTIVE[DISEASE]/B_ORGANISM_FUNCTION
and O O
growth O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
efficiency O I_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
in O O
these O O
fishes O B_BIO/B_LOCATION
. O O

4 O B_NUMBER[MEASURE]
. O O

Interspecific O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
spatial O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
overlap O O
in O O
the O O
field O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
was O O
similar O B_PERSON/B_DISEASE_ADJECTIVE[DISEASE]
to O O
that O O
in O O
the O O
mesocosm O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
experiment O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
and O O
the O O
pattern O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
of O O
coexistence O B_DISEASE_ADJECTIVE[DISEASE]/B_ORGANISM_FUNCTION
of O O
gobiids O B_BIO/B_LOCATION
can O O
be O O
explained O O
by O O
the O O
results O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
of O O
our O O
experiments O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

5 O B_NUMBER[MEASURE]
. O O

This O O
study O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
demonstrates O O
that O O
niches O B_PERSON/B_DISEASE_ADJECTIVE[DISEASE]
of O O
intertidal O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
fishes O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
may O O
experience O O
modifications O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_ORGANISM_FUNCTION
under O O
the O O
influence O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
of O O
species O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
interactions O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
and O O
that O O
null O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
models O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
based O O
on O O
controlled O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
experiments O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_BIO
can O O
greatly O O
facilitate O O
the O O
deciphering O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
of O O
such O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
changes O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
in O O
niche O B_LOCATION/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
structure O I_LOCATION/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

Linking O O
disease O O
and O O
community O O
ecology O O
through O O
behavioural O O
indicators O O
: O O
immunochallenge O O
of O O
white B B_DISEASE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- I I_DISEASE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
footed I I_DISEASE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
mice I I_DISEASE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
its O O
ecological O O
impacts O O
. O O

1 O B_NUMBER[MEASURE]
. O O

Pathogens O B_DISEASE
and O O
immune O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
challenges O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
can O O
induce O O
changes O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
in O O
host O B_DISEASE_ADJECTIVE[DISEASE]/B_BIO
phenotype O B_DISEASE_ADJECTIVE[DISEASE]/I_BIO
in O O
ways O B_LOCATION/B_BIO
that O O
indirectly O O
impact O O
important O B_DISEASE/B_BIO
community O I_DISEASE/I_BIO
interactions O I_DISEASE/I_BIO
, O O
including O O
those O O
that O O
affect O O
host O B_PERSON/B_SPECIES[BIO]
- O O
pathogen O B_DISEASE_ADJECTIVE[DISEASE]/B_BIO
interactions O B_DISEASE_ADJECTIVE[DISEASE]/I_BIO
. O O

2 O B_NUMBER[MEASURE]
. O O

To O O
explore O O
host O O
behavioural O O
response O O
to O O
immune O O
challenge O O
, O O
we O O
exposed O O
wild O O
white B B_SPECIES[BIO]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- I I_SPECIES[BIO]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
footed I I_SPECIES[BIO]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
mice I I_SPECIES[BIO]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
( O O
Peromyscus B B_PROTEIN[GENE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
leucopus I I_PROTEIN[GENE]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
) O O
to O O
an O O
immunogen O O
from O O
an O O
endemic O O
, O O
zoonotic O O
pathogen O O
, O O
the O O
spirochete O O
Borrelia B B_BACTERIUM[BIO]
burgdorferi I I_BACTERIUM[BIO]
. O O

White B B_BIO/B_PERSON
- I I_BIO/I_PERSON
footed I I_BIO/I_PERSON
mice I I_BIO/I_PERSON
are O O
a O O
major O O
reservoir O O
host O O
of O O
Lyme O O
disease O O
( O O
LD O O
) O O
spirochetes O O
in O O
northeastern O O
USA O O
and O O
an O O
abundant O O
member O O
of O O
forest O O
communities O O
. O O

The O O
activity O O
patterns O O
, O O
foraging O O
behaviour O O
, O O
and O O
space O O
use O O
of O O
white B B_SPECIES[BIO]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- I I_SPECIES[BIO]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
footed I I_SPECIES[BIO]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
mice I I_SPECIES[BIO]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
have O O
implications O O
for O O
population O O
growth O O
rates O O
of O O
community O O
members O O
upon O O
which O O
mice O O
incidentally O O
prey O O
( O O
i O O
. O O
e O O
. O O
gypsy O O
moths O O
and O O
native O O
thrushes O O
) O O
, O O
as O O
well O O
as O O
potentially O O
determining O O
host O O
- O O
vector O O
encounter O O
rates O O
and O O
human B B_PERSON/B_SPECIES[BIO]
risk O O
of O O
LD O O
. O O

3 O B_NUMBER[MEASURE]
. O O

Immunochallenge O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
led O O
to O O
specific O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
humoral O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
( O O
antibody O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
) O O
and O O
cellular O B_BODY_PART_OR_ORGAN_COMPONENT/B_DISEASE
( O O
i O O
. O O
e O O
. O O
elevated O O
neutrophils O B_CELL[BODY_PART_OR_ORGAN_COMPONENT]/B_GENE
and O O
eosinophils O B_CELL[BODY_PART_OR_ORGAN_COMPONENT]/B_GENE
) O O
immune O B_DISEASE_ADJECTIVE[DISEASE]/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
responses O B_DISEASE_ADJECTIVE[DISEASE]/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
supporting O O
use O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
the O O
immunogen O B_BIO/B_BODY_PART_OR_ORGAN_COMPONENT
as O O
a O O
surrogate O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
for O O
pathogenic O B_DISEASE/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
infection O I_DISEASE/I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
. O O

4 O B_NUMBER[MEASURE]
. O O

Immunochallenged O B_PERSON
mice O I_PERSON
had O O
reduced O O
wheel O B_LOCATION
- O O
running O O
activity O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
early O O
in O O
the O O
night O B_TIME[MEASURE]
when O O
measured O O
in O O
the O O
lab O B_LOCATION/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

However O O
, O O
mouse O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANISM_FUNCTION
activity O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_ORGANISM_FUNCTION
, O O
as O O
measured O O
by O O
track O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
plates O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
in O O
natural O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
field O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_BIO
experiments O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_BIO
, O O
did O O
not O O
differ O O
between O O
mice O B_BIO/B_PERSON
exposed O O
to O O
the O O
immunogen O B_CHEMICAL_CLASS[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_SPECIES[BIO]
and O O
unexposed O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
mice O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_BIO
. O O

5 O B_NUMBER[MEASURE]
. O O

Foraging O O
behaviour O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
wild O B_BIO/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
mice O I_BIO/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
in O O
the O O
field O B_LOCATION
- O O
assessed O O
with O O
giving O O
- O O
up O O
densities O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
of O O
seed O B_BIO/B_PERSON
at O O
artificial O B_ORGANISM_FUNCTION/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
feeding O I_ORGANISM_FUNCTION/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
stations O I_ORGANISM_FUNCTION/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- O O
was O O
affected O O
by O O
exposure O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
to O O
the O O
immunogen O B_CHEMICAL_CLASS[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_SPECIES[BIO]
. O O

Whereas O O
immunochallenge O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
did O O
not O O
influence O O
whether O O
foraging O O
mice O B_BIO/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
gained O O
information O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
on O O
patch O B_MEASURE/B_BIO
quality O B_MEASURE/I_BIO
while O O
foraging O O
, O O
it O O
led O O
to O O
reductions O B_DISEASE_ADJECTIVE[DISEASE]/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
in O O
predator O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
avoidance O B_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
during O O
foraging O O
, O O
suggesting O O
that O O
the O O
proportion O B_MEASURE/B_LOCATION
of O O
space O B_LOCATION/B_BIO
used O O
by O O
foraging O O
mice O B_SPECIES[BIO]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
may O O
be O O
greater O B_DISEASE_ADJECTIVE[DISEASE]
as O O
a O O
result O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
of O O
immunochallenge O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_DISEASE
. O O

This O O
increased O O
space O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
use O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
is O O
predicted O O
to O O
increase O O
encounter O B_MEASURE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
rates O I_MEASURE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
with O O
patchily O O
distributed O O
LD O B_BIO/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
vectors O I_BIO/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
( O O
ticks O B_BIO/B_PROTEIN[GENE]
) O O
and O O
with O O
incidental O B_SPECIES[BIO]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
prey O I_SPECIES[BIO]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
items O I_SPECIES[BIO]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

6 O B_NUMBER[MEASURE]
. O O

Thus O O
, O O
immunochallenge O O
in O O
white B B_DISEASE/B_BIO
- I B_DISEASE/I_BIO
footed I B_DISEASE/I_BIO
mice I B_DISEASE/I_BIO
, O O
and O O
potentially O O
pathogenic O O
infection O O
, O O
have O O
the O O
potential O O
to O O
indirectly O O
impact O O
community O O
interactions O O
, O O
including O O
those O O
important O O
for O O
pathogen O O
transmission O O
. O O

Amino O O
acid O O
divergence O O
between O O
the O O
CHS O O
domain O O
contributes O O
to O O
the O O
different O O
intracellular O O
behaviour O O
of O O
Family O O
II O O
fungal O O
chitin O O
synthases O O
in O O
Saccharomyces B B_SPECIES[BIO]
cerevisiae I I_SPECIES[BIO]
. O O

Family O B_BIO/B_GENE
II O I_BIO/I_GENE
chitin O I_BIO/I_GENE
synthases O I_BIO/I_GENE
( O O
CS O B_DISEASE
) O O
, O O
including O O
classes O B_PROTEIN[GENE]/B_MEASURE
IV O I_PROTEIN[GENE]/I_MEASURE
and O O
V O B_TIME[MEASURE]/B_PROTEIN[GENE]
enzymes O I_TIME[MEASURE]/I_PROTEIN[GENE]
, O O
share O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
conserved O O
catalytic O B_LOCATION/B_PERSON
domains O I_LOCATION/I_PERSON
flanked O O
by O O
transmembrane O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
regions O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
. O O

Here O O
we O O
addressed O O
the O O
characterization O O
of O O
Family O O
II O O
fungal O O
CSs O O
by O O
heterologous O O
expression O O
in O O
Saccharomyces B B_BIO
cerevisiae I I_BIO
. O O

Full O O
- O O
length O O
CSs O O
from O O
classes O O
V O O
or O O
IV O O
were O O
not O O
functional O O
when O O
expressed O O
in O O
S B B_BIO/B_CELL[BODY_PART_OR_ORGAN_COMPONENT]
. I B_BIO/I_CELL[BODY_PART_OR_ORGAN_COMPONENT]
cerevisiae I B_BIO/I_CELL[BODY_PART_OR_ORGAN_COMPONENT]
and O O
accumulated O O
in O O
different O O
intracellular O O
compartments O O
. O O

However O O
, O O
the O O
exchange O B_ORGANIZATION/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
between O O
different O B_MEASURE
class O I_MEASURE
IV O I_MEASURE
, O O
but O O
not O O
of O O
class O B_NUMBER[MEASURE]/B_DISEASE_ADJECTIVE[DISEASE]
V O I_NUMBER[MEASURE]/I_DISEASE_ADJECTIVE[DISEASE]
, O O
CHS O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
domains O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
resulted O O
in O O
functional O B_DISEASE_ADJECTIVE[DISEASE]
proteins O I_DISEASE_ADJECTIVE[DISEASE]
both O O
in O O
vivo O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
and O O
in O O
vitro O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
. O O

The O O
different O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
domains O B_DISEASE_ADJECTIVE[DISEASE]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
afford O O
the O O
chimeric O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
proteins O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
distinct O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
intracellular O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
behaviours O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
, O O
ranging O O
from O O
endoplasmic O B_DISEASE_ADJECTIVE[DISEASE]/B_CELL_FUNCTION[ORGANISM_FUNCTION]
reticulum O B_DISEASE_ADJECTIVE[DISEASE]/I_CELL_FUNCTION[ORGANISM_FUNCTION]
retention O B_DISEASE_ADJECTIVE[DISEASE]/I_CELL_FUNCTION[ORGANISM_FUNCTION]
to O O
reduced O O
endocytic O B_DISEASE_ADJECTIVE[DISEASE]/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
turnover O B_DISEASE_ADJECTIVE[DISEASE]/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
at O O
the O O
plasma O B_CELL_COMPONENT[BODY_PART_OR_ORGAN_COMPONENT]/B_DISEASE_ADJECTIVE[DISEASE]
membrane O I_CELL_COMPONENT[BODY_PART_OR_ORGAN_COMPONENT]/I_DISEASE_ADJECTIVE[DISEASE]
. O O

These O O
results O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
allow O O
a O O
role O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_LOCATION
in O O
chitin O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
synthesis O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
to O O
be O O
assigned O O
to O O
all O O
class O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
IV O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
enzymes O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
, O O
but O O
they O O
also O O
highlight O O
the O O
involvement O B_PERSON/B_DISEASE
of O O
the O O
intracellular O B_LOCATION/B_MEASURE
globular O I_LOCATION/I_MEASURE
domain O I_LOCATION/I_MEASURE
of O O
these O O
CSs O B_ENZYME[GENE]/B_DISEASE
, O O
not O O
only O O
in O O
enzymatic O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
activity O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
but O O
also O O
in O O
the O O
regulation O B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
of O O
their O O
intracellular O B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
turnover O I_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
. O O

Activation O O
of O O
the O O
heat O O
shock O O
transcription O O
factor O O
Hsf1 O O
is O O
essential O O
for O O
the O O
full O O
virulence O O
of O O
the O O
fungal O O
pathogen O O
Candida B B_BACTERIUM[BIO]/B_DISEASE
albicans I I_BACTERIUM[BIO]/I_DISEASE
. O O

The O O
evolutionarily O O
conserved O O
heat O O
shock O O
transcription O O
factor O O
Hsf1 O O
plays O O
a O O
central O O
role O O
in O O
thermal O O
adaptation O O
in O O
the O O
major O O
fungal O O
pathogen O O
of O O
humans B B_SPECIES[BIO]/B_LOCATION
, O O
Candida B B_SPECIES[BIO]/B_DISEASE
albicans I I_SPECIES[BIO]/I_DISEASE
. O O

Hsf1 O B_GENE
becomes O O
hyperphosphorylated O O
in O O
response O B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
to O O
heat O B_DISEASE/B_MEASURE
shock O I_DISEASE/I_MEASURE
and O O
activates O O
the O O
transcription O B_GENE
of O O
genes O B_GENE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
with O O
heat O B_GENE/B_PERSON
shock O I_GENE/I_PERSON
elements O I_GENE/I_PERSON
( O O
HSEs O B_DISEASE/B_GENE
) O O
in O O
their O O
promoters O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
, O O
these O O
genes O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
contributing O O
to O O
thermal O B_DISEASE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
adaptation O I_DISEASE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

However O O
, O O
the O O
relevance O O
of O O
Hsf1 O O
activation O O
to O O
C B B_SPECIES[BIO]
. I I_SPECIES[BIO]
albicans I I_SPECIES[BIO]
virulence O O
is O O
not O O
clear O O
as O O
this O O
pathogen O O
is O O
thought O O
to O O
be O O
obligately O O
associated O O
with O O
warm O O
blooded O O
animals O O
, O O
and O O
this O O
issue O O
has O O
not O O
been O O
tested O O
because O O
HSF1 O O
is O O
essential O O
for O O
viability O O
in O O
C B B_SPECIES[BIO]
. I I_SPECIES[BIO]
albicans I I_SPECIES[BIO]
. O O

In O O
this O O
study O O
, O O
we O O
demonstrate O O
that O O
the O O
HSE O O
regulon O O
is O O
active O O
in O O
C B B_PERSON/B_SPECIES[BIO]
. I I_PERSON/I_SPECIES[BIO]
albicans I I_PERSON/I_SPECIES[BIO]
cells O O
infecting O O
the O O
kidney O O
. O O

We O O
also O O
show O O
the O O
CE2 O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
region O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
of O O
Hsf1 O B_GENE
is O O
required O O
for O O
activation O B_GENE
and O O
that O O
the O O
phosphorylation O B_GENE/B_LOCATION
of O O
specific O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
residues O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
in O O
this O O
domain O B_LOCATION
contributes O O
to O O
Hsf1 O B_GENE/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
activation O B_GENE/I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
. O O

C B B_PERSON/B_DISEASE_ADJECTIVE[DISEASE]
. I I_PERSON/I_DISEASE_ADJECTIVE[DISEASE]
albicans I I_PERSON/I_DISEASE_ADJECTIVE[DISEASE]
HSF1 O O
mutants O O
that O O
lack O O
this O O
CE2 O O
region O O
are O O
viable O O
. O O

However O O
, O O
they O O
are O O
unable O B_DISEASE_ADJECTIVE[DISEASE]/B_PERSON
to O O
activate O O
HSE O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
- O O
containing O O
genes O B_GENE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
in O O
response O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
to O O
heat O B_DISEASE
shock O I_DISEASE
, O O
and O O
they O O
are O O
thermosensitive O B_DISEASE_ADJECTIVE[DISEASE]
. O O

Using O O
this O O
HSF1 O O
CE2 O O
deletion O O
mutant O O
we O O
demonstrate O O
that O O
Hsf1 O O
activation O O
, O O
and O O
hence O O
thermal O O
adaptation O O
, O O
contributes O O
significantly O O
to O O
the O O
virulence O O
of O O
C B B_BACTERIUM[BIO]/B_DISEASE
. I I_BACTERIUM[BIO]/I_DISEASE
albicans I I_BACTERIUM[BIO]/I_DISEASE
. O O

Early O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_DISEASE
response O I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/I_DISEASE
of O O
plant O B_BIO/B_CELL[BODY_PART_OR_ORGAN_COMPONENT]
cell O B_BIO/I_CELL[BODY_PART_OR_ORGAN_COMPONENT]
to O O
carbon O B_DISEASE_ADJECTIVE[DISEASE]
deprivation O I_DISEASE_ADJECTIVE[DISEASE]
: O O
in O O
vivo O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
31P O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- O O
NMR O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
spectroscopy O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
shows O O
a O O
quasi O B_DISEASE/B_MEASURE
- O O
instantaneous O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
disruption O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
on O O
cytosolic O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
sugars O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
phosphorylated O O
intermediates O B_CHEMICAL_CLASS[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
of O O
energy O B_PHYSIOLOGIC_FUNCTION[ORGANISM_FUNCTION]/B_DISEASE_ADJECTIVE[DISEASE]
metabolism O I_PHYSIOLOGIC_FUNCTION[ORGANISM_FUNCTION]/I_DISEASE_ADJECTIVE[DISEASE]
, O O
phosphate O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
partitioning O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
, O O
and O O
intracellular O B_DISEASE_ADJECTIVE[DISEASE]/B_PHYSIOLOGIC_FUNCTION[ORGANISM_FUNCTION]
pHs O B_DISEASE_ADJECTIVE[DISEASE]/I_PHYSIOLOGIC_FUNCTION[ORGANISM_FUNCTION]
. O O

* O B_OTHER/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
In O O
plant O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
cells O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
, O O
sugar O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
starvation O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
triggers O O
a O O
cascade O B_DISEASE/B_MEASURE
of O O
effects O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
at O O
the O O
scale O B_MEASURE/B_LOCATION
of O O
1 O B_NUMBER[MEASURE]
- O O
2 O B_MEASURE/B_ENT
days O I_MEASURE/I_ENT
. O O

However O O
, O O
very O O
early O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
metabolic O B_DISEASE_ADJECTIVE[DISEASE]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
response O B_DISEASE_ADJECTIVE[DISEASE]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
has O O
not O O
yet O O
been O O
investigated O O
. O O

* O O
Soluble O O
phosphorus O O
( O O
P O O
) O O
compounds O O
and O O
intracellular O O
pHs O O
were O O
analysed O O
each O O
2 O O
. O O
5 O O
min O O
intervals O O
in O O
heterotrophic O O
sycamore B B_BIO/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
( O O
Acer B B_LOCATION/B_BIO
pseudoplatanus I I_LOCATION/I_BIO
) O O
cells O O
using O O
in O O
vivo O O
phosphorus O O
nuclear O O
magnetic O O
resonance O O
( O O
( O O
31 O O
) O O
P O O
- O O
NMR O O
) O O
. O O

* O B_MEASURE/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
Upon O O
external O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
- O O
sugar O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_DISEASE
withdrawal O I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/I_DISEASE
, O O
the O O
glucose O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
6 O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
- O O
P O B_MEASURE/B_LOCATION
concentration O B_MEASURE/I_LOCATION
dropped O O
in O O
the O O
cytosol O B_CELL_COMPONENT[BODY_PART_OR_ORGAN_COMPONENT]/B_BIO
, O O
but O O
not O O
in O O
plastids O B_CELL_COMPONENT[BODY_PART_OR_ORGAN_COMPONENT]/B_BIO
. O O

The O O
released O O
inorganic O B_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
phosphate O I_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
( O O
Pi O B_PROTEIN[GENE]
) O O
accumulated O O
transiently O O
in O O
the O O
cytosol O B_CELL_COMPONENT[BODY_PART_OR_ORGAN_COMPONENT]/B_LOCATION
before O O
influx O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_ORGANISM_FUNCTION
into O O
the O O
vacuole O B_CELL_COMPONENT[BODY_PART_OR_ORGAN_COMPONENT]/B_DISEASE_ADJECTIVE[DISEASE]
; O O
nucleotide O B_MEASURE
triphosphate O I_MEASURE
concentration O I_MEASURE
doubled O O
, O O
intracellular O B_CELL_COMPONENT[BODY_PART_OR_ORGAN_COMPONENT]/B_GENE
pH O O
increased O O
and O O
cell O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
respiration O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
decreased O O
. O O

It O O
was O O
deduced O O
that O O
the O O
cytosolic O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_CELL[BODY_PART_OR_ORGAN_COMPONENT]
free O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_CELL[BODY_PART_OR_ORGAN_COMPONENT]
- O O
sugar O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
concentration O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
was O O
low O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
, O O
corresponding O O
to O O
only O O
0 O B_MEASURE
. O O
5 O B_MEASURE
mM O I_MEASURE
sucrose O I_MEASURE
in O O
sugar O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- O O
supplied O O
cells O B_CELL[BODY_PART_OR_ORGAN_COMPONENT]/B_BIO
. O O

* O B_OTHER/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
The O O
release O B_ENT/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
of O O
sugar O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
from O O
the O O
vacuole O B_BIO/B_CELL_COMPONENT[BODY_PART_OR_ORGAN_COMPONENT]
and O O
from O O
plastids O B_BIO/B_CELL_COMPONENT[BODY_PART_OR_ORGAN_COMPONENT]
is O O
insufficient O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
to O O
fully O O
sustain O O
the O O
cell O B_DISEASE_ADJECTIVE[DISEASE]/B_CELL_COMPONENT[BODY_PART_OR_ORGAN_COMPONENT]
metabolism O B_DISEASE_ADJECTIVE[DISEASE]/I_CELL_COMPONENT[BODY_PART_OR_ORGAN_COMPONENT]
during O O
starvation O B_DISEASE/B_ORGANISM_FUNCTION
, O O
particularly O O
in O O
the O O
very O O
short O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
term O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
. O O

Similarly O O
to O O
Pi O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
- O O
starvation O B_DISEASE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
the O O
cell O B_CELL[BODY_PART_OR_ORGAN_COMPONENT]/B_BIO
' O O
s O B_DISEASE_ADJECTIVE[DISEASE]/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
first O B_DISEASE_ADJECTIVE[DISEASE]/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
response O B_DISEASE_ADJECTIVE[DISEASE]/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
to O O
sugar O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
starvation O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
occurs O O
in O O
the O O
cytosol O B_CELL_COMPONENT[BODY_PART_OR_ORGAN_COMPONENT]/B_BIO
and O O
is O O
of O O
a O O
metabolic O B_DISEASE_ADJECTIVE[DISEASE]/B_CELL_COMPONENT[BODY_PART_OR_ORGAN_COMPONENT]
nature O B_DISEASE_ADJECTIVE[DISEASE]/I_CELL_COMPONENT[BODY_PART_OR_ORGAN_COMPONENT]
. O O

Unlike O O
the O O
cytoplasm O B_CELL_COMPONENT[BODY_PART_OR_ORGAN_COMPONENT]
, O O
cytosolic O B_DISEASE_ADJECTIVE[DISEASE]/B_CELL_COMPONENT[BODY_PART_OR_ORGAN_COMPONENT]
homeostasis O B_DISEASE_ADJECTIVE[DISEASE]/I_CELL_COMPONENT[BODY_PART_OR_ORGAN_COMPONENT]
is O O
not O O
maintained O O
during O O
starvation O B_DISEASE/B_ORGANISM_FUNCTION
. O O

The O O
important O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
metabolic O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
changes O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
following O O
cytosolic O B_DISEASE/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
sugar O I_DISEASE/I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
exhaustion O I_DISEASE/I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
deliver O O
early O B_DISEASE_ADJECTIVE[DISEASE]/B_CHEMICAL_CLASS[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
endogenous O B_DISEASE_ADJECTIVE[DISEASE]/I_CHEMICAL_CLASS[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
signals O B_DISEASE_ADJECTIVE[DISEASE]/I_CHEMICAL_CLASS[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
that O O
may O O
contribute O O
to O O
trigger O O
rescue O B_DISEASE/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
metabolism O I_DISEASE/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

Habitat O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
contrasts O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
reveal O O
a O O
shift O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
in O O
the O O
trophic O B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
position O I_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
of O O
ant O B_BIO/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
assemblages O I_BIO/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

1 O B_NUMBER[MEASURE]
. O O

Trophic O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
structure O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
within O O
a O O
guild O B_LOCATION/B_DISEASE_ADJECTIVE[DISEASE]
can O O
be O O
influenced O O
by O O
factors O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
such O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
as O O
resource O B_MEASURE/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
availability O I_MEASURE/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
competition O B_SPORT[ENT]/B_MEASURE
. O O

While O O
ants O B_BIO/B_PERSON
occupy O O
a O O
wide O B_MEASURE/B_LOCATION
range O I_MEASURE/I_LOCATION
of O O
positions O B_LOCATION
in O O
food O B_LOCATION/B_ORGANIZATION
webs O I_LOCATION/I_ORGANIZATION
, O O
and O O
ant O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
community O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
composition O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
changes O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
with O O
habitat O B_LOCATION/B_MEASURE
, O O
it O O
is O O
not O O
well O O
understood O O
if O O
ant O B_BIO/B_PERSON
genera O I_BIO/I_PERSON
tend O O
to O O
maintain O O
their O O
position O B_LOCATION/B_PERSON
in O O
the O O
trophic O B_LOCATION
structure O I_LOCATION
, O O
or O O
if O O
trophic O B_MEASURE/B_PERSON
position O I_MEASURE/I_PERSON
varies O O
across O O
habitats O B_LOCATION/B_BIO
. O O

2 O B_NUMBER[MEASURE]
. O O

We O O
used O O
ratios O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
of O O
stable O B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
isotopes O I_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
of O O
carbon O B_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
nitrogen O B_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
to O O
test O O
for O O
differences O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
in O O
the O O
trophic O B_MEASURE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
structure O I_MEASURE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
position O B_LOCATION/B_MEASURE
of O O
assemblages O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
of O O
ants O B_BIO
among O O
habitat O B_LOCATION/B_MEASURE
types O I_LOCATION/I_MEASURE
. O O

We O O
tested O O
for O O
differences O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
between O O
assemblages O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
in O O
replicate O B_NUMBER[MEASURE]/B_PERSON
sites O I_NUMBER[MEASURE]/I_PERSON
of O O
the O O
land O B_LOCATION
use O I_LOCATION
categories O I_LOCATION
: O O
( O O
i O O
) O O
pastures O O
with O O
old O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
large O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
trees O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
; O O
( O O
ii O B_TIME[MEASURE]/B_PROTEIN[GENE]
) O O
recently O O
revegetated O O
pastures O B_LOCATION
with O O
small O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
young O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
trees O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
; O O
and O O
( O O
iii O B_TIME[MEASURE]/B_PROTEIN[GENE]
) O O
remnant O B_LOCATION/B_BIO
woodlands O I_LOCATION/I_BIO
. O O

Known O O
insect O B_BIO
herbivores O I_BIO
and O O
predatory O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
spiders O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
provided O O
baselines O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
for O O
herbivorous O B_DISEASE_ADJECTIVE[DISEASE]/B_BIO
and O O
predaceous O B_BIO/B_PERSON
arthropods O I_BIO/I_PERSON
. O O

Soil O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
samples O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
were O O
used O O
to O O
correct O O
for O O
the O O
base O B_MEASURE/B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
level O B_MEASURE/I_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
isotopic O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
enrichment O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_BIO
at O O
each O O
site O B_LOCATION/B_MEASURE
. O O

3 O B_NUMBER[MEASURE]
. O O

We O O
found O O
no O O
significant O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
interactions O I_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
between O O
land O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
use O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
and O O
ant O B_BIO/B_MEASURE
genus O B_BIO/I_MEASURE
for O O
isotope O B_BIO/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
enrichment O I_BIO/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
indicating O O
that O O
trophic O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
structure O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_BIO
is O O
conserved O O
across O O
land O B_LOCATION/B_BIO
use O I_LOCATION/I_BIO
categories O I_LOCATION/I_BIO
. O O

The O O
fixed O B_PERSON/B_MEASURE
relative O I_PERSON/I_MEASURE
positions O I_PERSON/I_MEASURE
of O O
genera O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
in O O
the O O
trophic O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
structure O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_BIO
might O O
be O O
re O B_DISEASE/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- O O
enforced O O
by O O
competition O B_SPORT[ENT]/B_PERSON
or O O
some O O
other O B_MEASURE/B_DISEASE_ADJECTIVE[DISEASE]
factor O I_MEASURE/I_DISEASE_ADJECTIVE[DISEASE]
. O O

However O O
, O O
the O O
entire O B_BIO/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
ant O I_BIO/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
assemblage O I_BIO/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
had O O
significantly O O
lower O B_MEASURE/B_DISEASE_ADJECTIVE[DISEASE]
delta O B_MEASURE/I_DISEASE_ADJECTIVE[DISEASE]
( O O
15 O B_MEASURE/B_LOCATION
) O O
N O B_TIME[MEASURE]/B_BIO
values O I_TIME[MEASURE]/I_BIO
in O O
revegetated O B_MEASURE/B_DISEASE_ADJECTIVE[DISEASE]
sites O I_MEASURE/I_DISEASE_ADJECTIVE[DISEASE]
, O O
suggesting O O
that O O
ants O B_BIO/B_PERSON
feed O O
lower O O
down O O
in O O
the O O
food O B_LOCATION/B_ORGANIZATION
chain O I_LOCATION/I_ORGANIZATION
i O O
. O O
e O O
. O O
they O O
are O O
more O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
' O O
herbivorous O B_DISEASE_ADJECTIVE[DISEASE]/B_BIO
' O O
in O O
revegetated O B_DISEASE_ADJECTIVE[DISEASE]/B_LOCATION
sites O B_DISEASE_ADJECTIVE[DISEASE]/I_LOCATION
. O O

This O O
may O O
be O O
a O O
result O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
of O O
the O O
high O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_DISEASE_ADJECTIVE[DISEASE]
availability O I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/I_DISEASE_ADJECTIVE[DISEASE]
of O O
plant O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
sugars O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
, O O
honeydew O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
herbivorous O B_BIO
arthropod O I_BIO
prey O I_BIO
. O O

4 O B_NUMBER[MEASURE]
. O O

Surprisingly O O
, O O
ants O B_BIO/B_LOCATION
in O O
remnants O B_LOCATION/B_PERSON
and O O
pastures O B_LOCATION/B_ORGANIZATION
with O O
trees O B_BIO/B_LOCATION
displayed O O
similar O B_DISEASE_ADJECTIVE[DISEASE]
isotopic O I_DISEASE_ADJECTIVE[DISEASE]
compositions O I_DISEASE_ADJECTIVE[DISEASE]
. O O

Interactions O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
within O O
ant O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
assemblages O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
are O O
thus O O
likely O B_TIME[MEASURE]/B_DISEASE_ADJECTIVE[DISEASE]
to O O
be O O
resilient O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
to O O
changes O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
in O O
land O B_LOCATION/B_MEASURE
use O I_LOCATION/I_MEASURE
, O O
but O O
ant O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
diets O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
in O O
early O B_DISEASE_ADJECTIVE[DISEASE]/B_LOCATION
successional O I_DISEASE_ADJECTIVE[DISEASE]/I_LOCATION
habitats O I_DISEASE_ADJECTIVE[DISEASE]/I_LOCATION
may O O
reflect O O
the O O
simplicity O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANISM_FUNCTION
of O O
communities O B_LOCATION/B_BIO
, O O
which O O
may O O
have O O
comparatively O O
lower O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
rates O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
of O O
saprophagy O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_ORGANISM_FUNCTION
and O O
predation O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANISM_FUNCTION
. O O

Hypoxia O B_DISEASE/B_TIME[MEASURE]
responsive O I_DISEASE/I_TIME[MEASURE]
gene O I_DISEASE/I_TIME[MEASURE]
expression O I_DISEASE/I_TIME[MEASURE]
is O O
mediated O O
by O O
various O B_DISEASE_ADJECTIVE[DISEASE]/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
subsets O B_DISEASE_ADJECTIVE[DISEASE]/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
transcription O B_GENE
factors O I_GENE
and O O
miRNAs O B_GENE
that O O
are O O
determined O O
by O O
the O O
actual O B_MEASURE/B_BIO
oxygen O B_MEASURE/I_BIO
availability O B_MEASURE/I_BIO
. O O

* O B_OTHER/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
Reduced O O
oxygen O B_DISEASE_ADJECTIVE[DISEASE]/B_ORGANISM_FUNCTION
availability O B_DISEASE_ADJECTIVE[DISEASE]/I_ORGANISM_FUNCTION
is O O
not O O
only O O
associated O O
with O O
flooding O B_DISEASE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
but O O
occurs O O
also O O
during O O
growth O B_ORGANISM_FUNCTION/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
development O B_DISEASE/B_ORGANISM_FUNCTION
. O O

It O O
is O O
largely O O
unknown O B_DISEASE_ADJECTIVE[DISEASE]
how O O
hypoxia O B_DISEASE
is O O
perceived O O
and O O
what O O
signaling O O
cascade O B_DISEASE/B_LOCATION
is O O
involved O O
in O O
activating O O
adaptive O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_CELL[BODY_PART_OR_ORGAN_COMPONENT]
responses O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_CELL[BODY_PART_OR_ORGAN_COMPONENT]
. O O

* O B_OTHER/B_TIME[MEASURE]
We O O
analysed O O
the O O
expression O B_GENE/B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
over O O
1900 O B_GENE
transcription O I_GENE
factors O I_GENE
( O O
TFs O B_GENE/B_MEASURE
) O O
and O O
180 O B_GENE/B_BIO
microRNA O I_GENE/I_BIO
primary O I_GENE/I_BIO
transcripts O I_GENE/I_BIO
( O O
pri O B_GENE/B_DISEASE
- O O
miRNAs O B_GENE
) O O
in O O
Arabidopsis O B_CELL[BODY_PART_OR_ORGAN_COMPONENT]/B_BIO
roots O I_CELL[BODY_PART_OR_ORGAN_COMPONENT]/I_BIO
exposed O O
to O O
different O B_DISEASE/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
hypoxic O B_DISEASE/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
conditions O B_DISEASE/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
by O O
means O B_LOCATION/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
quantitative O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
PCR O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
. O O

We O O
also O O
analysed O O
the O O
promoters O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
genes O B_GENE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
induced O O
by O O
hypoxia O B_DISEASE/B_PROTEIN[GENE]
with O O
respect O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
to O O
over O O
- O O
represented O O
DNA O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
elements O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
that O O
can O O
act O O
as O O
potential O B_GENE/B_MEASURE
TF O I_GENE/I_MEASURE
binding O I_GENE/I_MEASURE
sites O I_GENE/I_MEASURE
and O O
their O O
in O O
vivo O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
interaction O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
was O O
verified O O
. O O

* O B_OTHER/B_MEASURE
We O O
identified O O
various O B_LOCATION/B_ENT
subsets O I_LOCATION/I_ENT
of O O
TFs O B_CELL[BODY_PART_OR_ORGAN_COMPONENT]/B_GENE
that O O
responded O O
differentially O O
through O O
time O B_MEASURE
and O O
in O O
an O O
oxygen O B_MEASURE
concentration O I_MEASURE
- O O
dependent O B_LOCATION/B_PERSON
manner O I_LOCATION/I_PERSON
. O O

The O O
regulatory O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
potential O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
of O O
selected O O
TFs O B_GENE/B_BIO
and O O
their O O
predicted O O
DNA O B_GENE/B_CELL[BODY_PART_OR_ORGAN_COMPONENT]
binding O O
elements O B_MEASURE/B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
was O O
validated O O
. O O

Although O O
the O O
expression O B_GENE/B_MEASURE
of O O
pri O B_DISEASE/B_MEASURE
- O O
miRNAs O B_GENE
was O O
differentially O O
regulated O O
under O O
hypoxia O B_DISEASE
, O O
only O O
one O B_GENE/B_MEASURE
corresponding O I_GENE/I_MEASURE
mature O I_GENE/I_MEASURE
miRNA O I_GENE/I_MEASURE
changed O O
accordingly O O
. O O

Putative O B_NUMBER[MEASURE]/B_PERSON
target O I_NUMBER[MEASURE]/I_PERSON
transcripts O I_NUMBER[MEASURE]/I_PERSON
of O O
the O O
miRNAs O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
were O O
not O O
significantly O O
affected O O
. O O

* O B_OTHER/B_TIME[MEASURE]
Our O O
results O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
show O O
that O O
the O O
regulation O B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE_EXPRESSION_ADJECTIVE[GENE]
of O O
hypoxia O B_DISEASE/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- O O
induced O O
genes O B_GENE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
is O O
controlled O O
via O O
simultaneous O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANIZATION
interaction O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_ORGANIZATION
of O O
various O B_MEASURE/B_DISEASE_ADJECTIVE[DISEASE]
combinations O I_MEASURE/I_DISEASE_ADJECTIVE[DISEASE]
of O O
TFs O B_GENE
. O O

Under O O
anoxic O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_DISEASE_ADJECTIVE[DISEASE]
conditions O I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/I_DISEASE_ADJECTIVE[DISEASE]
, O O
an O O
additional O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
set O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
of O O
TFs O B_GENE
is O O
induced O O
. O O

Regulation O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
gene O B_GENE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
expression O I_GENE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
via O O
miRNAs O B_GENE
appears O O
to O O
play O O
a O O
minor O B_DISEASE_ADJECTIVE[DISEASE]/B_LOCATION
role O I_DISEASE_ADJECTIVE[DISEASE]/I_LOCATION
during O O
hypoxia O B_DISEASE/B_ORGANISM_FUNCTION
. O O

Rarity O B_DISEASE_ADJECTIVE[DISEASE]/B_EDU[ORGANIZATION]
, O O
life O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
history O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
and O O
scaling O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
of O O
the O O
dynamics O B_DISEASE_ADJECTIVE[DISEASE]/B_LOCATION
in O O
time O B_TIME[MEASURE]/B_LOCATION
and O O
space O B_LOCATION/B_MEASURE
of O O
British O B_TIME[MEASURE]/B_BIO
birds O I_TIME[MEASURE]/I_BIO
. O O

1 O B_NUMBER[MEASURE]
. O O

Many O B_DISEASE_ADJECTIVE[DISEASE]/B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
patterns O B_DISEASE_ADJECTIVE[DISEASE]/I_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
in O O
macroecology O B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
are O O
closely O O
related O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
to O O
the O O
total O B_MEASURE/B_LOCATION
abundance O B_MEASURE/I_LOCATION
of O O
a O O
species O B_BIO/B_LOCATION
in O O
a O O
region O B_LOCATION/B_BIO
. O O

Here O O
we O O
show O O
that O O
interspecific O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
differences O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
in O O
the O O
pattern O B_MEASURE/B_DISEASE
of O O
population O B_DISEASE_ADJECTIVE[DISEASE]/B_ORGANISM_FUNCTION
fluctuations O B_DISEASE_ADJECTIVE[DISEASE]/I_ORGANISM_FUNCTION
of O O
British O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
bird O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
species O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
can O O
be O O
predicted O O
from O O
knowledge O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
of O O
their O O
overall O B_DISEASE_ADJECTIVE[DISEASE]/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
abundance O B_DISEASE_ADJECTIVE[DISEASE]/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
some O O
basic O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
life O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
- O O
history O B_PERSON/B_TIME[MEASURE]
characteristics O B_PERSON/I_TIME[MEASURE]
. O O

2 O B_NUMBER[MEASURE]
. O O

We O O
identify O O
a O O
rarity O B_DISEASE_ADJECTIVE[DISEASE]/B_LOCATION
syndrome O B_DISEASE_ADJECTIVE[DISEASE]/I_LOCATION
that O O
arises O O
through O O
an O O
increased O O
stochastic O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
influence O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
on O O
population O B_DISEASE_ADJECTIVE[DISEASE]/B_LOCATION
fluctuations O I_DISEASE_ADJECTIVE[DISEASE]/I_LOCATION
with O O
decreasing O O
population O B_MEASURE/B_LOCATION
size O I_MEASURE/I_LOCATION
, O O
mainly O O
resulting O O
from O O
an O O
inverse O B_MEASURE/B_LOCATION
density O I_MEASURE/I_LOCATION
- O O
dependent O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
effect O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
of O O
demographic O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
stochasticity O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE
. O O

This O O
syndrome O B_DISEASE
involves O O
an O O
increase O B_DISEASE_ADJECTIVE[DISEASE]
in O O
the O O
annual O B_MEASURE
changes O I_MEASURE
in O O
population O B_MEASURE/B_LOCATION
size O I_MEASURE/I_LOCATION
with O O
increasing O O
rarity O B_DISEASE/B_MEASURE
in O O
the O O
United O B_LOCATION/B_PERSON
Kingdom O I_LOCATION/I_PERSON
. O O

3 O B_NUMBER[MEASURE]
. O O

The O O
relationship O B_PERSON/B_MEASURE
between O O
the O O
magnitude O B_MEASURE
of O O
temporal O B_MEASURE/B_DISEASE_ADJECTIVE[DISEASE]
variation O B_MEASURE/I_DISEASE_ADJECTIVE[DISEASE]
and O O
local O B_MEASURE/B_BIO
mean O I_MEASURE/I_BIO
population O I_MEASURE/I_BIO
size O I_MEASURE/I_BIO
differs O O
between O O
species O B_BIO/B_PERSON
dependent O I_BIO/I_PERSON
on O O
their O O
life O B_LOCATION/B_ORGANIZATION
history O I_LOCATION/I_ORGANIZATION
, O O
i O O
. O O
e O O
. O O
species O B_BIO/B_PERSON
with O O
larger O B_MEASURE
clutch O I_MEASURE
size O I_MEASURE
and O O
lower O B_MEASURE/B_LOCATION
survival O I_MEASURE/I_LOCATION
tended O O
to O O
have O O
larger O B_MEASURE/B_DISEASE_ADJECTIVE[DISEASE]
annual O B_MEASURE/I_DISEASE_ADJECTIVE[DISEASE]
changes O B_MEASURE/I_DISEASE_ADJECTIVE[DISEASE]
in O O
population O B_MEASURE/B_LOCATION
size O I_MEASURE/I_LOCATION
than O O
low O O
- O O
reproducing O O
long O O
- O O
lived O O
species O B_BIO/B_PERSON
. O O

4 O B_NUMBER[MEASURE]
. O O

The O O
probability O B_MEASURE
of O O
local O B_DISEASE_ADJECTIVE[DISEASE]/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
disappearance O B_DISEASE_ADJECTIVE[DISEASE]/I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
from O O
a O O
study O B_LOCATION/B_BIO
plot O I_LOCATION/I_BIO
depended O O
on O O
the O O
population O B_MEASURE/B_LOCATION
size O B_MEASURE/I_LOCATION
and O O
was O O
hence O O
closely O O
related O O
to O O
the O O
overall O B_DISEASE_ADJECTIVE[DISEASE]/B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
abundance O B_DISEASE_ADJECTIVE[DISEASE]/I_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
the O O
species O B_BIO
in O O
UK O B_LOCATION
. O O

For O O
a O O
given O O
population O B_MEASURE/B_BIO
size O B_MEASURE/I_BIO
, O O
this O O
probability O B_MEASURE
was O O
also O O
related O O
to O O
species O B_BIO/B_MEASURE
- O O
specific O B_TIME[MEASURE]/B_PERSON
life O I_TIME[MEASURE]/I_PERSON
- O O
history O B_MEASURE/B_LOCATION
characteristics O B_MEASURE/I_LOCATION
, O O
being O O
higher O B_MEASURE
in O O
species O B_BIO/B_PERSON
with O O
larger O B_MEASURE
clutch O I_MEASURE
sizes O I_MEASURE
and O O
smaller O B_MEASURE/B_LOCATION
survival O B_MEASURE/I_LOCATION
rates O B_MEASURE/I_LOCATION
. O O

5 O B_NUMBER[MEASURE]
. O O

Rareness O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
results O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
in O O
a O O
spatial O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
decoupling O I_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
of O O
the O O
temporal O B_MEASURE
variation O I_MEASURE
in O O
population O B_MEASURE
size O I_MEASURE
. O O

6 O B_NUMBER[MEASURE]
. O O

These O O
patterns O O
show O O
that O O
once O O
a O O
species O O
has O O
become O O
rare O O
, O O
e O O
. O O
g O O
. O O
due O O
to O O
human B B_PERSON/B_BIO
activities O O
, O O
key O O
population O O
dynamical O O
characteristics O O
will O O
change O O
because O O
of O O
density O O
- O O
dependent O O
stochastic O O
effects O O
, O O
which O O
in O O
turn O O
are O O
dependent O O
on O O
species O O
- O O
specific O O
life O O
- O O
history O O
characteristics O O
. O O

Mannitol O O
permeation O O
and O O
radial O O
flow O O
of O O
water O O
in O O
maize B B_BIO/B_BODY_PART_OR_ORGAN_COMPONENT
roots O O
. O O

* O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
The O O
postulated O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
nonselective O B_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
hydraulic O B_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
route O B_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
through O O
the O O
root O B_CELL[BODY_PART_OR_ORGAN_COMPONENT]/B_DISEASE_ADJECTIVE[DISEASE]
apoplast O I_CELL[BODY_PART_OR_ORGAN_COMPONENT]/I_DISEASE_ADJECTIVE[DISEASE]
has O O
not O O
yet O O
been O O
supported O O
by O O
experimental O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
findings O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
on O O
solvent O B_BIO
drag O I_BIO
. O O

* O O
Therefore O O
, O O
mannitol O O
transport O O
from O O
the O O
medium O O
to O O
the O O
shoot O O
of O O
young O O
maize B B_BIO
plants O O
was O O
studied O O
at O O
different O O
rates O O
of O O
transpiration O O
in O O
hydroculture O O
. O O

The O O
concentration O B_MEASURE/B_LOCATION
of O O
mannitol O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
was O O
determined O O
by O O
gas O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
chromatography O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
. O O

* O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
Mannitol O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
utilization O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
in O O
shoot O B_CELL[BODY_PART_OR_ORGAN_COMPONENT]/B_DISEASE_ADJECTIVE[DISEASE]
metabolism O I_CELL[BODY_PART_OR_ORGAN_COMPONENT]/I_DISEASE_ADJECTIVE[DISEASE]
was O O
not O O
detectable O B_DISEASE_ADJECTIVE[DISEASE]
. O O

Experiments O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
with O O
exuding O O
roots O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
showed O O
that O O
the O O
radial O B_PHYSIOLOGIC_FUNCTION[ORGANISM_FUNCTION]/B_DISEASE_ADJECTIVE[DISEASE]
transport O I_PHYSIOLOGIC_FUNCTION[ORGANISM_FUNCTION]/I_DISEASE_ADJECTIVE[DISEASE]
of O O
mannitol O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
was O O
mainly O O
apoplastic O B_DISEASE_ADJECTIVE[DISEASE]
. O O

The O O
ratio O B_MEASURE
alpha O I_MEASURE
between O O
the O O
mannitol O B_MEASURE/B_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
concentration O B_MEASURE/I_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
in O O
xylem O B_DISEASE_ADJECTIVE[DISEASE]/B_BIO
vessels O B_DISEASE_ADJECTIVE[DISEASE]/I_BIO
and O O
that O O
of O O
the O O
external O B_BIO
medium O I_BIO
was O O
calculated O O
from O O
mannitol O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_DISEASE_ADJECTIVE[DISEASE]
translocation O I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/I_DISEASE_ADJECTIVE[DISEASE]
to O O
the O O
shoot O B_BIO/B_BODY_PART_OR_ORGAN_COMPONENT
or O O
measurement O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
of O O
the O O
mannitol O B_MEASURE
concentration O I_MEASURE
in O O
the O O
root O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
exudate O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
, O O
where O O
it O O
reached O O
c O B_OTHER/B_MEASURE
. O O

0 O O
. O O
07 O B_MEASURE
in O O
the O O
steady O B_LOCATION
state O I_LOCATION
. O O

In O O
transpiring O O
plants O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
, O O
alpha O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
decreased O O
with O O
increasing O O
water O B_LOCATION/B_MEASURE
flux O B_LOCATION/I_MEASURE
from O O
0 O B_MEASURE
. O O
04 O B_MEASURE
to O O
values O B_MEASURE/B_PROTEIN[GENE]
below O O
0 O B_NUMBER[MEASURE]
. O O
01 O B_MEASURE
. O O

These O O
findings O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
demonstrate O O
that O O
the O O
root O B_MEASURE
reflection O I_MEASURE
coefficient O I_MEASURE
for O O
mannitol O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
is O O
above O O
0 O B_MEASURE
. O O
99 O B_MEASURE
. O O

* O B_MEASURE/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
It O O
is O O
concluded O O
that O O
the O O
radial O B_MEASURE/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
movement O B_MEASURE/I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
of O O
water O B_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
to O O
the O O
vessels O B_BODY_PART_OR_ORGAN_COMPONENT/B_BIO
is O O
under O O
complete O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
protoplastic O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
control O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
, O O
whereas O O
solutes O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
can O O
diffuse O O
on O O
an O O
apoplastic O B_DISEASE_ADJECTIVE[DISEASE]/B_BODY_PART_OR_ORGAN_COMPONENT
path O B_DISEASE_ADJECTIVE[DISEASE]/I_BODY_PART_OR_ORGAN_COMPONENT
. O O

The O O
absence O B_DISEASE_ADJECTIVE[DISEASE]/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
of O O
a O O
significant O B_LOCATION
volume O I_LOCATION
flux O I_LOCATION
through O O
the O O
root O B_BODY_PART_OR_ORGAN_COMPONENT/B_DISEASE_ADJECTIVE[DISEASE]
apoplast O I_BODY_PART_OR_ORGAN_COMPONENT/I_DISEASE_ADJECTIVE[DISEASE]
is O O
of O O
physiological O B_DISEASE_ADJECTIVE[DISEASE]/B_TIME[MEASURE]
importance O I_DISEASE_ADJECTIVE[DISEASE]/I_TIME[MEASURE]
as O O
it O O
prevents O O
the O O
coupling O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_DISEASE
of O O
the O O
apoplastic O B_DISEASE_ADJECTIVE[DISEASE]/B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
permeation O B_DISEASE_ADJECTIVE[DISEASE]/I_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
ballast O B_CHEMICAL_CLASS[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
solutes O I_CHEMICAL_CLASS[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
, O O
such O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
as O O
NaCl O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
to O O
transpiration O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
. O O

Genomic O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
evidence O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
repeat O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
- O O
induced O O
point O B_DISEASE_ADJECTIVE[DISEASE]/B_ORGANISM_FUNCTION
mutation O I_DISEASE_ADJECTIVE[DISEASE]/I_ORGANISM_FUNCTION
( O O
RIP O B_DISEASE/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
) O O
in O O
filamentous O B_SPECIES[BIO]/B_DISEASE
ascomycetes O I_SPECIES[BIO]/I_DISEASE
. O O

The O O
genomes O B_GENE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
49 O B_BIO
filamentous O I_BIO
ascomycetes O I_BIO
( O O
subphylum O B_DISEASE/B_PROTEIN[GENE]
Pezizomycotina O B_DISEASE/I_PROTEIN[GENE]
) O O
were O O
examined O O
by O O
two O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
independent O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
methods O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
for O O
evidence O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
of O O
multiple O B_DISEASE_ADJECTIVE[DISEASE]/B_PROTEIN[GENE]
C O B_DISEASE_ADJECTIVE[DISEASE]/I_PROTEIN[GENE]
- O O
> O B_DISEASE_ADJECTIVE[DISEASE]/B_LOCATION
T O B_DISEASE_ADJECTIVE[DISEASE]/I_LOCATION
transitions O B_DISEASE_ADJECTIVE[DISEASE]/I_LOCATION
typical O B_DISEASE_ADJECTIVE[DISEASE]/I_LOCATION
of O O
RIP O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_SPECIES[BIO]
. O O

At O O
least O O
one O B_NUMBER[MEASURE]/B_BIO
transposable O I_NUMBER[MEASURE]/I_BIO
element O I_NUMBER[MEASURE]/I_BIO
or O O
other O B_GENE
repeat O I_GENE
family O I_GENE
was O O
identified O O
in O O
each O O
genome O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
, O O
and O O
members O B_PERSON/B_BIO
were O O
assessed O O
for O O
transition O B_DISEASE/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
and O O
transversion O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
mutations O I_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
relative O I_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
to O O
a O O
model O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
of O O
their O O
intact O B_PERSON/B_CELL[BODY_PART_OR_ORGAN_COMPONENT]
progenitor O I_PERSON/I_CELL[BODY_PART_OR_ORGAN_COMPONENT]
. O O

Occurrence O B_DISEASE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
RIP O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
was O O
indicated O O
where O O
family O B_MEASURE/B_LOCATION
members O I_MEASURE/I_LOCATION
differed O O
by O O
excess O B_DISEASE/B_MEASURE
of O O
directional O B_MEASURE/B_DISEASE_ADJECTIVE[DISEASE]
transitions O I_MEASURE/I_DISEASE_ADJECTIVE[DISEASE]
over O O
transversions O B_TIME[MEASURE]/B_PERSON
. O O

Transition O B_DISEASE/B_PERSON
mutations O I_DISEASE/I_PERSON
were O O
quantified O O
by O O
an O O
algorithm O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_EDU[ORGANIZATION]
taking O O
double O B_DISEASE_ADJECTIVE[DISEASE]
mutations O I_DISEASE_ADJECTIVE[DISEASE]
in O O
CpG O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PROTEIN[GENE]
and O O
CpC O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
dinucleotides O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
into O O
account O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
. O O

A O O
second O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
method O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
assessed O O
dinucleotide O B_CELL_OR_MOLECULAR_DYSFUNCTION[DISEASE]/B_GENE
frequency O I_CELL_OR_MOLECULAR_DYSFUNCTION[DISEASE]/I_GENE
distribution O I_CELL_OR_MOLECULAR_DYSFUNCTION[DISEASE]/I_GENE
anomalies O I_CELL_OR_MOLECULAR_DYSFUNCTION[DISEASE]/I_GENE
in O O
whole O B_SPECIES[BIO]/B_DISEASE_ADJECTIVE[DISEASE]
genomes O I_SPECIES[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
, O O
a O O
procedure O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
that O O
allowed O O
quantification O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
fractions O B_CELL[BODY_PART_OR_ORGAN_COMPONENT]/B_LOCATION
of O O
the O O
non O B_GENE/B_DISEASE
- O O
coding O B_GENE/B_BIO
genome O I_GENE/I_BIO
that O O
had O O
been O O
subject O B_PERSON/B_DISEASE_ADJECTIVE[DISEASE]
to O O
extensive O B_DISEASE_ADJECTIVE[DISEASE]
directional O I_DISEASE_ADJECTIVE[DISEASE]
mutation O I_DISEASE_ADJECTIVE[DISEASE]
. O O

The O O
results O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
of O O
both O O
methods O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
revealed O O
that O O
RIP O B_ENZYME[GENE]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- O O
like O B_LOCATION/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
activity O I_LOCATION/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
varied O O
greatly O O
, O O
both O O
in O O
extent O B_LOCATION/B_DISEASE
of O O
mutation O B_CELL_OR_MOLECULAR_DYSFUNCTION[DISEASE]/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
in O O
dinucleotide O B_MEASURE
context O I_MEASURE
for O O
C O B_OTHER/B_LOCATION
- O O
> O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
T O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
transitions O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
. O O

In O O
the O O
most O O
extreme O O
case O O
, O O
75 O O
% O O
of O O
a O O
Blastomyces B B_DISEASE_ADJECTIVE[DISEASE]/B_BIO
dermatitidis I B_DISEASE_ADJECTIVE[DISEASE]/I_BIO
genome O O
had O O
suffered O O
conspicuous O O
GC O O
- O O
depletion O O
, O O
all O O
of O O
it O O
in O O
the O O
non O O
- O O
coding O O
fraction O O
. O O

Many O B_PERSON
genomes O I_PERSON
carried O O
both O O
intact O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
repeats O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
as O O
well O O
as O O
others O B_PERSON/B_LOCATION
that O O
had O O
suffered O O
heavily O O
from O O
transitions O B_DISEASE
. O O

Only O O
one O O
species O O
, O O
Chaetomium B B_LOCATION/B_DISEASE_ADJECTIVE[DISEASE]
globosum I I_LOCATION/I_DISEASE_ADJECTIVE[DISEASE]
, O O
showed O O
no O O
evidence O O
of O O
directional O O
mutation O O
. O O

Accelerometry O O
estimates O O
field O O
metabolic O O
rate O O
in O O
giant B B_BIO
Australian I I_BIO
cuttlefish I I_BIO
Sepia B I_BIO
apama I I_BIO
during O O
breeding O O
. O O

1 O B_NUMBER[MEASURE]
. O O

Estimating O O
the O O
metabolic O B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANISM_FUNCTION
rate O I_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_ORGANISM_FUNCTION
of O O
animals O B_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
in O O
nature O B_LOCATION/B_DISEASE
is O O
central O B_DISEASE_ADJECTIVE[DISEASE]/B_LOCATION
to O O
understanding O O
the O O
physiological O B_EDU[ORGANIZATION]/B_DISEASE_ADJECTIVE[DISEASE]
, O O
behavioural O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
and O O
evolutionary O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANISM_FUNCTION
ecology O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_ORGANISM_FUNCTION
of O O
animals O B_BIO/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

Doubly O O
labelled O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
water O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
and O O
heart O B_DISEASE/B_MEASURE
- O O
rate O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_BODY_PART_OR_ORGAN_COMPONENT
methods O I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/I_BODY_PART_OR_ORGAN_COMPONENT
are O O
the O O
most O O
commonly O O
used O O
approaches O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
but O O
both O O
have O O
limitations O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
that O O
preclude O O
their O O
application O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
to O O
some O O
systems O B_LOCATION/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

2 O B_NUMBER[MEASURE]
. O O

Accelerometry O B_DIAGNOSTIC_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
has O O
emerged O O
as O O
a O O
powerful O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
tool O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
for O O
estimating O O
energy O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
expenditure O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
in O O
a O O
range O B_MEASURE
of O O
animals O B_BIO/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
but O O
is O O
yet O O
to O O
be O O
used O O
to O O
estimate O O
field O B_MEASURE/B_ORGANIZATION
metabolic O B_MEASURE/I_ORGANIZATION
rate O B_MEASURE/I_ORGANIZATION
in O O
aquatic O B_SPECIES[BIO]/B_DISEASE_ADJECTIVE[DISEASE]
taxa O I_SPECIES[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
. O O

We O O
combined O O
two O O
- O O
dimensional O O
accelerometry O O
and O O
swim O O
- O O
tunnel O O
respirometry O O
to O O
estimate O O
patterns O O
of O O
energy O O
expenditure O O
in O O
giant B B_SPECIES[BIO]/B_PERSON
Australian I I_SPECIES[BIO]/I_PERSON
cuttlefish I I_SPECIES[BIO]/I_PERSON
Sepia B I_SPECIES[BIO]/I_PERSON
apama I I_SPECIES[BIO]/I_PERSON
during O O
breeding O O
. O O

3 O B_NUMBER[MEASURE]
. O O

Both O O
oxygen O B_MEASURE
consumption O I_MEASURE
rate O I_MEASURE
( O O
Vo2 O B_PROTEIN[GENE]/B_LOCATION
) O O
and O O
swimming O B_MEASURE/B_DISEASE
speed O I_MEASURE/I_DISEASE
showed O O
strong O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
positive O I_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
associations O I_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
with O O
body O B_DISEASE
acceleration O I_DISEASE
, O O
with O O
coefficients O B_MEASURE
of O O
determination O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
comparable O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
to O O
those O O
using O O
similar O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
accelerometers O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
on O O
terrestrial O B_LOCATION
vertebrates O I_LOCATION
. O O

Despite O O
increased O O
activity O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
during O O
the O O
day O B_TIME[MEASURE]
, O O
field O B_MEASURE/B_PERSON
metabolic O B_MEASURE/I_PERSON
rate O B_MEASURE/I_PERSON
rarely O O
approached O O
Vo2 O B_MEASURE/B_LOCATION
, O O
and O O
night O B_TIME[MEASURE]/B_LOCATION
- O O
time O B_MEASURE/B_ORGANISM_FUNCTION
Vo2 O I_MEASURE/I_ORGANISM_FUNCTION
was O O
similar O B_PERSON/B_DISEASE_ADJECTIVE[DISEASE]
to O O
that O O
at O O
rest O B_LOCATION/B_TIME[MEASURE]
. O O

4 O B_NUMBER[MEASURE]
. O O

These O O
results O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
are O O
consistent O B_DISEASE_ADJECTIVE[DISEASE]/B_GENE
with O O
the O O
life O B_TIME[MEASURE]/B_PERSON
- O O
history O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
strategy O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
of O O
this O O
species O B_SPECIES[BIO]
, O O
which O O
has O O
a O O
poor O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
capacity O I_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
to O O
exercise O O
anaerobically O O
, O O
and O O
a O O
mating O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
strategy O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
that O O
is O O
visually O O
based O O
. O O

With O O
the O O
logistical O B_DISEASE_ADJECTIVE[DISEASE]
difficulties O I_DISEASE_ADJECTIVE[DISEASE]
associated O O
with O O
observation O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
in O O
aquatic O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
environments O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
, O O
accelerometry O B_DIAGNOSTIC_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
is O O
likely O B_TIME[MEASURE]/B_DISEASE_ADJECTIVE[DISEASE]
to O O
prove O O
a O O
valuable O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
tool O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
for O O
estimating O O
energy O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
expenditure O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
in O O
aquatic O B_BIO/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
animals O I_BIO/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

Generation O O
of O O
Se O O
- O O
fortified O O
broccoli B B_BIO
as O O
functional O O
food O O
: O O
impact O O
of O O
Se O O
fertilization O O
on O O
S O O
metabolism O O
. O O

Selenium O O
( O O
Se O O
) O O
- O O
fortified O O
broccoli B B_BIO
( O O
Brassica B B_LOCATION/B_ORGANIZATION
oleracea I I_LOCATION/I_ORGANIZATION
var I I_LOCATION/I_ORGANIZATION
. I I_LOCATION/I_ORGANIZATION
italica I I_LOCATION/I_ORGANIZATION
) O O
has O O
been O O
proposed O O
as O O
a O O
functional O O
food O O
for O O
cancer O O
prevention O O
, O O
based O O
on O O
its O O
high O O
glucosinolate O O
( O O
GSL O O
) O O
content O O
and O O
capacity O O
for O O
Se O O
accumulation O O
. O O

However O O
, O O
as O O
selenate O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
and O O
sulphate O B_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
share O I_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
the O O
initial O B_LOCATION/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
assimilation O B_LOCATION/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
route O B_LOCATION/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
Se O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
fertilization O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
could O O
interfere O O
with O O
sulphur O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
metabolism O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
and O O
plant O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PHYSIOLOGIC_FUNCTION[ORGANISM_FUNCTION]
growth O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PHYSIOLOGIC_FUNCTION[ORGANISM_FUNCTION]
. O O

Consequently O O
, O O
GSL O B_DISEASE_ADJECTIVE[DISEASE]/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
accumulation O B_DISEASE_ADJECTIVE[DISEASE]/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
could O O
be O O
compromised O O
. O O

To O O
evaluate O O
these O O
potentially O O
adverse O O
effects O O
of O O
Se O O
fertilization O O
, O O
we O O
performed O O
a O O
comprehensive O O
study O O
on O O
sand O O
- O O
grown O O
young O O
broccoli B B_BIO
plants O O
( O O
weekly O O
selenate O O
applications O O
of O O
0 O O
. O O
8 O O
mumol O O
plant O O
( O O
- O O
1 O O
) O O
via O O
the O O
root O O
) O O
and O O
field O O
- O O
grown O O
adult O O
broccoli B B_BIO/B_PERSON
plants O O
during O O
head O O
formation O O
( O O
single O O
foliar O O
selenate O O
application O O
: O O
25 O O
. O O
3 O O
or O O
253 O O
mumol O O
plant O O
( O O
- O O
1 O O
) O O
) O O
. O O

The O O
results O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
show O O
that O O
under O O
these O O
conditions O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
, O O
Se O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
application O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
does O O
not O O
affect O O
plant O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANISM_FUNCTION
growth O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_ORGANISM_FUNCTION
, O O
contents O B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
cysteine O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
glutathione O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
total O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
GSL O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
, O O
glucoraphanin O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
( O O
major O B_LOCATION/B_PROTEIN[GENE]
aliphatic O B_LOCATION/I_PROTEIN[GENE]
GSL O B_LOCATION/I_PROTEIN[GENE]
) O O
or O O
the O O
expression O B_GENE/B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
BoMYB28 O B_GENE/B_DISEASE
( O O
encoding O O
a O O
functionally O O
confirmed O O
master O B_ENZYME[GENE]/B_PERSON
regulator O I_ENZYME[GENE]/I_PERSON
for O O
aliphatic O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
GSL O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
biosynthesis O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
) O O
. O O

Conversely O O
, O O
due O O
to O O
the O O
changed O O
expression O B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
of O O
sulphate O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
transporters O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
( O O
BoSULTR1 O B_PROTEIN[GENE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
; O O
1 O B_MEASURE/B_LOCATION
, O O
1 O B_NUMBER[MEASURE]/B_LOCATION
; O O
2 O B_NUMBER[MEASURE]/B_LOCATION
, O O
2 O B_NUMBER[MEASURE]/B_LOCATION
; O O
1 O B_NUMBER[MEASURE]
, O O
and O O
2 O B_NUMBER[MEASURE]
; O O
2 O B_NUMBER[MEASURE]
) O O
, O O
sulphate O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
and O O
total O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
S O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
contents O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
increased O O
in O O
the O O
shoot O B_BIO/B_BODY_PART_OR_ORGAN_COMPONENT
of O O
young O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
plants O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
while O O
decreasing O O
in O O
the O O
root O B_TIME[MEASURE]/B_BIO
. O O

We O O
conclude O O
that O O
broccoli B B_BIO
can O O
be O O
fertilized O O
with O O
Se O O
without O O
reduction O O
in O O
GSL O O
content O O
, O O
even O O
with O O
Se O O
accumulation O O
exceeding O O
the O O
level O O
recommended O O
for O O
human B B_BIO/B_LOCATION
consumption O O
. O O

Arbuscular O B_TIME[MEASURE]/B_PERSON
mycorrhizal O I_TIME[MEASURE]/I_PERSON
hyphopodia O I_TIME[MEASURE]/I_PERSON
and O O
germinated O B_BIO
spore O I_BIO
exudates O I_BIO
trigger O O
Ca2 O B_DISEASE/B_GENE
+ O I_DISEASE/I_GENE
spiking O I_DISEASE/I_GENE
in O O
the O O
legume O B_BIO/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
nonlegume O B_BIO
root O I_BIO
epidermis O I_BIO
. O O

* O O
The O O
aim O O
of O O
this O O
study O O
was O O
to O O
investigate O O
Ca O O
( O O
2 O O
+ O O
) O O
responses O O
to O O
endosymbiotic O O
arbuscular O O
mycorrhizal O O
( O O
AM O O
) O O
fungi O O
in O O
the O O
host O O
root O O
epidermis O O
following O O
pre O O
- O O
infection O O
hyphopodium O O
formation O O
in O O
both O O
legumes O O
and O O
nonlegumes O O
, O O
and O O
to O O
determine O O
to O O
what O O
extent O O
these O O
responses O O
could O O
be O O
mimicked O O
by O O
germinated O O
fungal B B_BIO/B_DISEASE
spore O O
exudate O O
. O O

* O O
Root O O
organ O O
cultures O O
of O O
both O O
Medicago B B_BIO
truncatula I I_BIO
and O O
Daucus B B_BIO
carota I I_BIO
, O O
expressing O O
the O O
nuclear O O
- O O
localized O O
cameleon O O
reporter O O
NupYC2 O O
. O O
1 O O
, O O
were O O
used O O
to O O
monitor O O
AM O O
- O O
elicited O O
Ca O O
( O O
2 O O
+ O O
) O O
responses O O
in O O
host O O
root O O
tissues O O
. O O

* O B_OTHER/B_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
Ca O I_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
( O O
2 O B_MEASURE/B_LOCATION
+ O O
) O O
spiking O O
was O O
observed O O
in O O
cells O B_BODY_PART_OR_ORGAN_COMPONENT/B_BIO
contacted O O
by O O
AM O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_SPECIES[BIO]
hyphopodia O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_SPECIES[BIO]
for O O
both O O
hosts O B_PERSON/B_LOCATION
, O O
with O O
highest O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
frequencies O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
correlating O O
with O O
the O O
epidermal O B_CELL[BODY_PART_OR_ORGAN_COMPONENT]/B_BIO
nucleus O B_CELL[BODY_PART_OR_ORGAN_COMPONENT]/I_BIO
positioned O O
facing O O
the O O
fungal O B_LOCATION/B_BODY_PART_OR_ORGAN_COMPONENT
contact O I_LOCATION/I_BODY_PART_OR_ORGAN_COMPONENT
site O I_LOCATION/I_BODY_PART_OR_ORGAN_COMPONENT
. O O

Treatment O O
with O O
AM O O
spore O O
exudate O O
also O O
elicited O O
Ca O O
( O O
2 O O
+ O O
) O O
spiking O O
within O O
the O O
AM O O
- O O
responsive O O
zone O O
of O O
the O O
root O O
and O O
, O O
in O O
both O O
cases O O
, O O
spiking O O
was O O
dependent O O
on O O
the O O
M B B_BIO
. I I_BIO
truncatula I I_BIO
common O O
SYM O O
genes O O
DMI1 O O
/ O O
2 O O
, O O
but O O
not O O
on O O
the O O
rhizobial O O
Nod O O
factor O O
perception O O
gene O O
NFP O O
. O O

* O B_OTHER/B_MEASURE
These O O
findings O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
support O O
the O O
conclusion O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANIZATION
that O O
AM O B_DISEASE_ADJECTIVE[DISEASE]/B_ORGANISM_FUNCTION
fungal O B_DISEASE_ADJECTIVE[DISEASE]/I_ORGANISM_FUNCTION
root O B_DISEASE_ADJECTIVE[DISEASE]/I_ORGANISM_FUNCTION
penetration O B_DISEASE_ADJECTIVE[DISEASE]/I_ORGANISM_FUNCTION
is O O
preceded O O
by O O
a O O
SYM O B_MEASURE/B_GENE
pathway O I_MEASURE/I_GENE
- O O
dependent O B_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
oscillatory O B_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
Ca O B_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
( O O
2 O B_MEASURE/B_PROTEIN[GENE]
+ O I_MEASURE/I_PROTEIN[GENE]
) O O
response O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
, O O
whose O O
evolutionary O B_DISEASE_ADJECTIVE[DISEASE]/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
origin O I_DISEASE_ADJECTIVE[DISEASE]/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
predates O O
the O O
divergence O B_MEASURE/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
between O O
asterid O B_BIO
and O O
rosid O B_BIO
clades O I_BIO
. O O

Our O O
results O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
further O O
show O O
that O O
fungal O B_DISEASE_ADJECTIVE[DISEASE]/B_GENE
symbiotic O B_DISEASE_ADJECTIVE[DISEASE]/I_GENE
signals O B_DISEASE_ADJECTIVE[DISEASE]/I_GENE
are O O
already O O
generated O O
during O O
spore O B_DISEASE_ADJECTIVE[DISEASE]/B_ORGANISM_FUNCTION
germination O B_DISEASE_ADJECTIVE[DISEASE]/I_ORGANISM_FUNCTION
, O O
and O O
that O O
cameleon O B_GENE/B_LOCATION
- O O
expressing O O
root O B_BIO/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
organ O I_BIO/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
cultures O I_BIO/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
represent O O
a O O
novel O B_BIO/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
AM O I_BIO/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- O O
specific O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
bio O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
- O O
assay O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
for O O
such O B_DISEASE_ADJECTIVE[DISEASE]/B_BIO
signals O B_DISEASE_ADJECTIVE[DISEASE]/I_BIO
. O O

The O O
Perigord B B_GENE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
black I I_GENE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
truffle I I_GENE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
responds O O
to O O
cold O O
temperature O O
with O O
an O O
extensive O O
reprogramming O O
of O O
its O O
transcriptional O O
activity O O
. O O

The O O
Tuber B B_SPECIES[BIO]
melanosporum I I_SPECIES[BIO]
genome O O
has O O
been O O
analysed O O
with O O
the O O
aim O O
of O O
identifying O O
and O O
characterizing O O
the O O
genes O O
involved O O
in O O
the O O
environmental O O
stress O O
response O O
. O O

A O O
whole O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
genome O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
array O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
( O O
7496 O B_GENE
genes O I_GENE
/ O O
probe O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
) O O
was O O
used O O
to O O
verify O O
the O O
fungal O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
transcriptional O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
profiling O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
upon O O
a O O
cold O B_TIME[MEASURE]/B_BIO
temperature O B_TIME[MEASURE]/I_BIO
period O B_TIME[MEASURE]/I_BIO
( O O
7 O B_MEASURE/B_ENT
days O I_MEASURE/I_ENT
at O O
4 O B_MEASURE/B_LOCATION
^ O I_MEASURE/I_LOCATION
0C O I_MEASURE/I_LOCATION
) O O
. O O

A O O
total O B_MEASURE
of O O
423 O B_MEASURE
genes O I_MEASURE
resulted O O
to O O
be O O
differentially O O
expressed O O
in O O
a O O
significant O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
manner O I_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
( O O
> O O
2 O B_MEASURE
. O O
5 O B_MEASURE
- O O
fold O B_MEASURE/B_BODY_PART_OR_ORGAN_COMPONENT
; O O
p O B_PROTEIN[GENE]/B_LOCATION
- O O
value O B_MEASURE/B_LOCATION
& O O
lt O B_PROTEIN[GENE]/B_DISEASE
; O O
0 O B_MEASURE/B_LOCATION
. O O
05 O B_MEASURE
) O O
in O O
the O O
mycelia O B_BIO
exposed O O
to O O
cold O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
, O O
compared O O
to O O
the O O
control O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
ones O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
: O O
187 O B_MEASURE
of O O
these O O
genes O B_GENE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
were O O
up O O
- O O
regulated O O
, O O
while O O
236 O B_MEASURE
were O O
down O O
- O O
regulated O O
. O O

Sixty O B_NUMBER[MEASURE]
- O O
six O B_NUMBER[MEASURE]
and O O
fifty O B_NUMBER[MEASURE]
- O O
one O B_NUMBER[MEASURE]
percent O I_NUMBER[MEASURE]
, O O
respectively O O
, O O
of O O
the O O
up O O
- O O
or O O
down O O
- O O
regulated O O
transcripts O B_BIO/B_GENE
had O O
no O O
KOG O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
classification O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
and O O
were O O
clustered O O
as O O
unclassified O B_PROTEIN[GENE]/B_MEASURE
proteins O I_PROTEIN[GENE]/I_MEASURE
, O O
which O O
was O O
the O O
most O O
abundant O B_DISEASE_ADJECTIVE[DISEASE]
category O I_DISEASE_ADJECTIVE[DISEASE]
in O O
the O O
both O O
up O O
- O O
and O O
down O O
- O O
regulated O O
genes O B_GENE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

A O O
gene O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
subset O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
, O O
containing O O
a O O
range O B_LOCATION/B_MEASURE
of O O
biological O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
functions O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
, O O
was O O
chosen O O
to O O
validate O O
the O O
microarray O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
experiment O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
through O O
quantitative O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
real O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
time O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
PCR O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
( O O
qRT O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PROTEIN[GENE]
- O O
PCR O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
) O O
. O O

The O O
analysis O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
confirmed O O
the O O
array O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
data O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
for O O
16 O B_NUMBER[MEASURE]
out O O
of O O
22 O B_MEASURE
of O O
the O O
considered O O
genes O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
, O O
confirming O O
that O O
a O O
cold O B_GENE
temperature O I_GENE
period O I_GENE
influences O O
the O O
truffle O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
global O B_DISEASE_ADJECTIVE[DISEASE]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
gene O B_DISEASE_ADJECTIVE[DISEASE]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
expression O B_DISEASE_ADJECTIVE[DISEASE]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

The O O
expressed O O
genes O B_PROTEIN[GENE]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
which O O
mostly O O
resulted O O
to O O
be O O
genes O B_GENE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
for O O
heat O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
shock O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
proteins O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
( O O
HSPs O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
) O O
and O O
genes O B_PROTEIN[GENE]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
involved O O
in O O
cell O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
wall O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
and O O
lipid O B_DISEASE_ADJECTIVE[DISEASE]/B_CELL_FUNCTION[ORGANISM_FUNCTION]
metabolism O B_DISEASE_ADJECTIVE[DISEASE]/I_CELL_FUNCTION[ORGANISM_FUNCTION]
, O O
could O O
be O O
involved O O
in O O
mechanisms O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
, O O
which O O
are O O
responsible O B_DISEASE_ADJECTIVE[DISEASE]
for O O
fungal O B_DISEASE
adaptation O I_DISEASE
. O O

Since O O
truffle O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
ascomata O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
develop O O
during O O
the O O
winter O B_TIME[MEASURE]/B_LOCATION
period O I_TIME[MEASURE]/I_LOCATION
, O O
we O O
hypothesize O O
that O O
these O O
differentially O O
expressed O O
genes O B_GENE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
may O O
help O O
the O O
truffle O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
to O O
adapt O O
to O O
low O B_DISEASE/B_LOCATION
temperatures O I_DISEASE/I_LOCATION
and O O
/ O O
or O O
perceive O O
environmental O B_DISEASE_ADJECTIVE[DISEASE]/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
signals O B_DISEASE_ADJECTIVE[DISEASE]/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
that O O
regulate O O
the O O
fructification O B_DISEASE_ADJECTIVE[DISEASE]/B_ORGANISM_FUNCTION
. O O

The O O
rapid O O
production O O
of O O
high O O
- O O
titer O O
porcine B B_VIRUS[BIO]/B_DISEASE_ADJECTIVE[DISEASE]
endogenous I I_VIRUS[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
retrovirus I I_VIRUS[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
( O O
PERV O O
) O O
- O O
B O O
env O O
pseudotype O O
and O O
construction O O
of O O
an O O
EGFP O O
- O O
expressing O O
replication O O
competent O O
PERV O O
- O O
A O O
vector O O
. O O

Porcine B B_VIRUS[BIO]/B_DISEASE_ADJECTIVE[DISEASE]
endogenous I I_VIRUS[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
retroviruses I I_VIRUS[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
( O O
PERVs B B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
) O O
present O O
a O O
unique O O
concern O O
associated O O
with O O
xenotransplantation O O
because O O
they O O
have O O
been O O
shown O O
to O O
infect O O
certain O O
human B B_PERSON/B_SPECIES[BIO]
cells O O
in O O
vitro O O
and O O
it O O
is O O
also O O
difficult O O
to O O
generate O O
herds O O
of O O
pigs B B_SPECIES[BIO]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
free O O
of O O
PERVs B B_DISEASE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

A O O
simple O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
system O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
for O O
the O O
production O B_ENT/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
high O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
- O O
titer O B_MEASURE
MoMLV O I_MEASURE
- O O
PERV O B_DISEASE_ADJECTIVE[DISEASE]/B_PROTEIN[GENE]
pseudotypes O B_DISEASE_ADJECTIVE[DISEASE]/I_PROTEIN[GENE]
is O O
reported O O
; O O
an O O
EGFP O B_GENE/B_DISEASE
- O O
expressing O O
replication O B_TIME[MEASURE]/B_GENE
- O O
competent O B_GENE/B_LOCATION
molecular O I_GENE/I_LOCATION
clone O I_GENE/I_LOCATION
that O O
allows O O
direct O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
measurement O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
titer O B_GENE/B_DISEASE
was O O
also O O
constructed O O
. O O

To O O
improve O O
the O O
MLV O O
- O O
based O O
retroviral B B_DISEASE/B_VIRUS[BIO]
vector O O
system O O
, O O
a O O
2 O O
. O O
1 O O
- O O
kb O O
PERV B B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PROTEIN[GENE]
- O O
B O O
env O O
product O O
was O O
amplified O O
from O O
PK O O
- O O
15 O O
genomic O O
DNA O O
and O O
cloned O O
into O O
the O O
pCL O O
- O O
Eco O O
retroviral O O
vector O O
. O O

The O O
titer O O
of O O
lacZ O O
( O O
PERV B B_GENE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- I I_GENE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
B I I_GENE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
) O O
from O O
the O O
293 O O
cells O O
was O O
about O O
1 O O
. O O
0x10 O O
( O O
4 O O
) O O
CFU O O
/ O O
ml O O
. O O

In O O
contrast O O
, O O
the O O
titer O O
of O O
lacZ O O
( O O
PERV O O
- O O
B O O
) O O
from O O
a O O
conventional O O
murine O O
retroviral B B_DISEASE/B_VIRUS[BIO]
vector O O
( O O
split O O
genome O O
) O O
was O O
found O O
to O O
be O O
1 O O
. O O
2x10 O O
( O O
2 O O
) O O
CFU O O
/ O O
ml O O
when O O
the O O
PERV B B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_SPECIES[BIO]
- I B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_SPECIES[BIO]
B I B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_SPECIES[BIO]
env O O
expression O O
vector O O
was O O
transfected O O
into O O
TELCeB6 O O
cells O O
, O O
which O O
harbor O O
MFGnlslacZ O O
and O O
the O O
gag O O
- O O
pol O O
- O O
expressing O O
vector O O
. O O

In O O
addition O O
, O O
an O O
infectious O O
PERV B B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_VIRUS[BIO]
- I B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_VIRUS[BIO]
A I B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_VIRUS[BIO]
clone O O
containing O O
enhanced O O
GFP O O
( O O
EGFP O O
) O O
by O O
using O O
a O O
PCR O O
- O O
based O O
method O O
was O O
developed O O
. O O

This O O
EGFP O B_GENE/B_DISEASE
- O O
expressing O O
PERV O B_GENE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- O O
A O B_OTHER/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- O O
IRES O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PROTEIN[GENE]
- O O
EGFP O B_PROTEIN[GENE]/B_LOCATION
molecular O I_PROTEIN[GENE]/I_LOCATION
clone O I_PROTEIN[GENE]/I_LOCATION
was O O
found O O
to O O
be O O
stable O B_DISEASE_ADJECTIVE[DISEASE]
genetically O O
on O O
transfection O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_GENE
in O O
293 O B_CELL[BODY_PART_OR_ORGAN_COMPONENT]/B_BIO
cells O B_CELL[BODY_PART_OR_ORGAN_COMPONENT]/I_BIO
. O O

Rhizomastix O B_MEASURE/B_BIO
biflagellata O I_MEASURE/I_BIO
sp O I_MEASURE/I_BIO
. O O
nov O B_LOCATION/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O
, O O
a O O
new O B_SPECIES[BIO]
amoeboflagellate O I_SPECIES[BIO]
of O O
uncertain O B_SPECIES[BIO]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
phylogenetic O I_SPECIES[BIO]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
position O I_SPECIES[BIO]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
isolated O O
from O O
frogs O B_LOCATION/B_BIO
. O O

The O O
genus O B_BIO/B_BODY_PART_OR_ORGAN_COMPONENT
Rhizomastix O I_BIO/I_BODY_PART_OR_ORGAN_COMPONENT
contains O O
five O B_BIO/B_ENT
species O I_BIO/I_ENT
of O O
amoeboflagellates O B_SPECIES[BIO]
with O O
a O O
single O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
anterior O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_BIO
flagellum O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_BIO
, O O
which O O
live O O
as O O
intestinal O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
symbionts O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
of O O
insects O B_SPECIES[BIO]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
amphibians O B_BIO
. O O

Though O O
established O O
in O O
1911 O B_MEASURE
, O O
Rhizomastix O B_SPECIES[BIO]/B_PERSON
has O O
been O O
neglected O O
for O O
decades O B_TIME[MEASURE]
and O O
its O O
phylogenetic O B_DISEASE_ADJECTIVE[DISEASE]/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
position O B_DISEASE_ADJECTIVE[DISEASE]/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
is O O
uncertain O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

This O O
paper O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PRODUCT[OBJECT]
describes O O
the O O
morphology O B_TIME[MEASURE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
the O O
first O B_BIO/B_BODY_PART_OR_ORGAN_COMPONENT
cultivated O I_BIO/I_BODY_PART_OR_ORGAN_COMPONENT
strain O I_BIO/I_BODY_PART_OR_ORGAN_COMPONENT
of O O
Rhizomastix O B_BACTERIUM[BIO]
. O O

The O O
organism O B_BIO
was O O
isolated O O
from O O
an O O
argentine O B_BIO/B_LOCATION
horned O I_BIO/I_LOCATION
frog O I_BIO/I_LOCATION
and O O
differs O O
from O O
the O O
known O O
Rhizomastix O B_BIO/B_PERSON
species O I_BIO/I_PERSON
by O O
the O O
presence O B_LOCATION/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
biflagellate O B_BACTERIUM[BIO]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
cells O B_BACTERIUM[BIO]/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

The O O
isolate O B_BIO/B_MEASURE
is O O
described O O
as O O
Rhizomastix O B_BIO/B_GENE
biflagellata O B_BIO/I_GENE
sp O B_BIO/I_GENE
. O O
nov O B_LOCATION/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

A O O
possible O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
relationship O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
of O O
Rhizomastix O B_BACTERIUM[BIO]
to O O
Archamoebae O B_DISEASE/B_SPECIES[BIO]
is O O
discussed O O
. O O

Whole O O
- O O
genome O O
sequences O O
of O O
thirteen O O
isolates O O
of O O
Borrelia B B_BACTERIUM[BIO]/B_LOCATION
burgdorferi I B_BACTERIUM[BIO]/I_LOCATION
. O O

Borrelia B B_BACTERIUM[BIO]/B_DISEASE
burgdorferi I I_BACTERIUM[BIO]/I_DISEASE
is O O
a O O
causative O O
agent O O
of O O
Lyme O O
disease O O
in O O
North O O
America O O
and O O
Eurasia O O
. O O

The O O
first O O
complete O O
genome O O
sequence O O
of O O
B B B_SPECIES[BIO]/B_DISEASE
. I I_SPECIES[BIO]/I_DISEASE
burgdorferi I I_SPECIES[BIO]/I_DISEASE
strain I I_SPECIES[BIO]/I_DISEASE
31 I I_SPECIES[BIO]/I_DISEASE
, O O
available O O
for O O
more O O
than O O
a O O
decade O O
, O O
has O O
assisted O O
research O O
on O O
the O O
pathogenesis O O
of O O
Lyme O O
disease O O
. O O

Because O O
a O O
single O O
genome O O
sequence O O
is O O
not O O
sufficient O O
to O O
understand O O
the O O
relationship O O
between O O
genotypic O O
and O O
geographic O O
variation O O
and O O
disease O O
phenotype O O
, O O
we O O
determined O O
the O O
whole O O
- O O
genome O O
sequences O O
of O O
13 O O
additional O O
B B B_SPECIES[BIO]/B_DISEASE
. I I_SPECIES[BIO]/I_DISEASE
burgdorferi I I_SPECIES[BIO]/I_DISEASE
isolates O O
that O O
span O O
the O O
range O O
of O O
natural O O
variation O O
. O O

These O O
sequences O B_LOCATION/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
should O O
allow O O
improved O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
understanding O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
pathogenesis O B_DISEASE
and O O
provide O O
a O O
foundation O B_ORGANIZATION/B_LOCATION
for O O
novel O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
detection O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
diagnosis O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
and O O
prevention O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
strategies O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

Association O O
between O O
nonsynonymous O O
mutations O O
of O O
starch O O
synthase O O
IIa O O
and O O
starch O O
quality O O
in O O
rice B B_BIO
( O O
Oryza B B_MEASURE/B_BIO
sativa I I_MEASURE/I_BIO
) O O
. O O

Starch O O
quality O O
is O O
one O O
of O O
the O O
most O O
important O O
agronomic O O
traits O O
in O O
Asian B B_BIO/B_LOCATION
rice I I_BIO/I_LOCATION
, O O
Oryza B B_LOCATION/B_BIO
sativa I I_LOCATION/I_BIO
. O O

Starch O B_PROTEIN[GENE]
synthase O I_PROTEIN[GENE]
IIa O I_PROTEIN[GENE]
( O O
SsIIa O B_GENE/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
) O O
is O O
a O O
major O B_PERSON/B_MEASURE
candidate O I_PERSON/I_MEASURE
gene O I_PERSON/I_MEASURE
for O O
starch O B_DISEASE
quality O I_DISEASE
variation O I_DISEASE
. O O

Within O O
SsIIa O O
, O O
three O O
nonsynonymous O O
mutations O O
in O O
exon O O
8 O O
have O O
been O O
shown O O
to O O
affect O O
enzyme O O
activity O O
when O O
expressed O O
in O O
Escherichia B B_BIO/B_CELL[BODY_PART_OR_ORGAN_COMPONENT]
coli I B_BIO/I_CELL[BODY_PART_OR_ORGAN_COMPONENT]
. O O

To O O
search O O
for O O
the O O
variation O O
in O O
SsIIa O O
that O O
is O O
responsible O O
for O O
starch O O
quality O O
variation O O
in O O
rice B B_BIO/B_LOCATION
, O O
we O O
sequenced O O
the O O
SsIIa O O
exon O O
8 O O
region O O
and O O
measured O O
starch O O
quality O O
as O O
starch O O
disintegration O O
in O O
alkali O O
for O O
289 O O
accessions O O
of O O
cultivated O O
rice B B_BIO/B_GENE
and O O
57 O O
accessions O O
of O O
its O O
wild O O
ancestor O O
, O O
Oryza B B_LOCATION/B_BIO
rufipogon I B_LOCATION/I_BIO
. O O

A O O
general O B_MEASURE
linear O I_MEASURE
model O I_MEASURE
and O O
nested O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
clade O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
analysis O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
were O O
used O O
to O O
identify O O
the O O
associations O B_ORGANIZATION/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
between O O
the O O
three O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
nonsynonymous O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
single O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
nucleotide O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
polymorphisms O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
( O O
SNPs O B_GENE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
) O O
and O O
starch O B_DISEASE/B_LOCATION
quality O I_DISEASE/I_LOCATION
. O O

Among O O
the O O
three O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
nonsynonymous O I_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
SNPs O I_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
, O O
we O O
found O O
strong O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
evidence O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
of O O
association O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_CELL_OR_MOLECULAR_DYSFUNCTION[DISEASE]
at O O
one O B_PROTEIN[GENE]
nucleotide O I_PROTEIN[GENE]
site O I_PROTEIN[GENE]
( O O
' O O
SNP O B_PROTEIN[GENE]/B_LOCATION
3 O I_PROTEIN[GENE]/I_LOCATION
' O O
) O O
, O O
corresponding O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
to O O
a O O
Leu O B_LOCATION/B_METABOLITE[BODY_PART_OR_ORGAN_COMPONENT]
/ O O
Phe O B_METABOLITE[BODY_PART_OR_ORGAN_COMPONENT]/B_LOCATION
replacement O I_METABOLITE[BODY_PART_OR_ORGAN_COMPONENT]/I_LOCATION
at O O
codon O B_TIME[MEASURE]/B_PERSON
781 O I_TIME[MEASURE]/I_PERSON
. O O

A O O
second O B_GENE
SNP O I_GENE
, O O
corresponding O B_TIME[MEASURE]/B_DISEASE_ADJECTIVE[DISEASE]
to O O
a O O
Val O B_METABOLITE[BODY_PART_OR_ORGAN_COMPONENT]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
/ O O
Met O B_METABOLITE[BODY_PART_OR_ORGAN_COMPONENT]/B_DISEASE_ADJECTIVE[DISEASE]
replacement O I_METABOLITE[BODY_PART_OR_ORGAN_COMPONENT]/I_DISEASE_ADJECTIVE[DISEASE]
at O O
codon O B_PROTEIN[GENE]
737 O I_PROTEIN[GENE]
, O O
could O O
potentially O O
show O O
an O O
association O B_ORGANIZATION/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
with O O
increased O O
sample O B_DISEASE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
sizes O I_DISEASE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

Variation O O
in O O
SsIIa O O
enzyme O O
activity O O
is O O
associated O O
with O O
the O O
cohesiveness O O
of O O
rice B B_PERSON/B_BIO
grains O O
when O O
cooked O O
, O O
and O O
our O O
findings O O
are O O
consistent O O
with O O
selection O O
for O O
more O O
cohesive O O
grains O O
during O O
the O O
domestication O O
of O O
tropical B B_BIO/B_LOCATION
japonica I I_BIO/I_LOCATION
rice I I_BIO/I_LOCATION
. O O

Ecological O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
differentiation O B_DISEASE_ADJECTIVE[DISEASE]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
in O O
xylem O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
cavitation O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
resistance O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
is O O
associated O O
with O O
stem O B_BIO/B_CELL[BODY_PART_OR_ORGAN_COMPONENT]
and O O
leaf O B_BIO/B_BODY_PART_OR_ORGAN_COMPONENT
structural O I_BIO/I_BODY_PART_OR_ORGAN_COMPONENT
traits O I_BIO/I_BODY_PART_OR_ORGAN_COMPONENT
. O O

Cavitation O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
resistance O B_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
is O O
a O O
critical O B_MEASURE/B_LOCATION
determinant O I_MEASURE/I_LOCATION
of O O
drought O B_DISEASE_ADJECTIVE[DISEASE]/B_ORGANISM_FUNCTION
tolerance O B_DISEASE_ADJECTIVE[DISEASE]/I_ORGANISM_FUNCTION
in O O
tropical O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
tree O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
species O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
, O O
but O O
little O B_PERSON
is O O
known O O
of O O
its O O
association O B_ORGANIZATION/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
with O O
life O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
history O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
strategies O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
, O O
particularly O O
for O O
seasonal O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
dry O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
forests O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
, O O
a O O
system O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
critically O O
driven O O
by O O
variation O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
in O O
water O B_LOCATION/B_BIO
availability O I_LOCATION/I_BIO
. O O

We O O
analysed O O
vulnerability O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
curves O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
for O O
saplings O B_BIO/B_PERSON
of O O
13 O B_BIO/B_PERSON
tropical O I_BIO/I_PERSON
dry O I_BIO/I_PERSON
forest O I_BIO/I_PERSON
tree O I_BIO/I_PERSON
species O I_BIO/I_PERSON
differing O O
in O O
life O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
history O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_BIO
and O O
leaf O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
phenology O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
. O O

We O O
examined O O
how O O
vulnerability O B_DISEASE/B_MEASURE
to O O
cavitation O B_DISEASE_ADJECTIVE[DISEASE]
( O O
P50 O B_LOCATION
) O O
related O O
to O O
dry O B_BIO/B_MEASURE
season O I_BIO/I_MEASURE
leaf O I_BIO/I_MEASURE
water O I_BIO/I_MEASURE
potentials O I_BIO/I_MEASURE
and O O
stem O B_BIO/B_CELL[BODY_PART_OR_ORGAN_COMPONENT]
and O O
leaf O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
traits O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
. O O

P50 O B_PROTEIN[GENE]/B_MEASURE
- O O
values O B_MEASURE/B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
ranged O O
from O O
- O O
0 O B_MEASURE
. O O
8 O B_MEASURE
to O O
- O O
6 O B_MEASURE
. O O
2 O B_MEASURE
MPa O I_MEASURE
, O O
with O O
pioneers O B_PERSON/B_BIO
on O O
average O B_LOCATION/B_BIO
38 O I_LOCATION/I_BIO
% O I_LOCATION/I_BIO
more O O
vulnerable O B_DISEASE_ADJECTIVE[DISEASE]
to O O
cavitation O B_DISEASE/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
than O O
shade O B_LOCATION/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- O O
tolerants O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
. O O

Vulnerability O B_DISEASE
to O O
cavitation O B_DISEASE
was O O
related O O
to O O
structural O B_DISEASE_ADJECTIVE[DISEASE]/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
traits O B_DISEASE_ADJECTIVE[DISEASE]/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
conferring O O
tissue O B_DISEASE_ADJECTIVE[DISEASE]/B_ORGANISM_FUNCTION
stress O I_DISEASE_ADJECTIVE[DISEASE]/I_ORGANISM_FUNCTION
vulnerability O I_DISEASE_ADJECTIVE[DISEASE]/I_ORGANISM_FUNCTION
, O O
being O O
negatively O O
correlated O O
with O O
wood O B_MEASURE/B_DISEASE
density O I_MEASURE/I_DISEASE
, O O
and O O
surprisingly O O
maximum O B_MEASURE/B_DISEASE_ADJECTIVE[DISEASE]
vessel O B_MEASURE/I_DISEASE_ADJECTIVE[DISEASE]
length O B_MEASURE/I_DISEASE_ADJECTIVE[DISEASE]
. O O

Vulnerability O B_DISEASE
to O O
cavitation O B_DISEASE_ADJECTIVE[DISEASE]
was O O
negatively O O
related O O
to O O
the O O
Huber O B_DISEASE/B_PROTEIN[GENE]
- O O
value O B_MEASURE/B_BIO
and O O
leaf O B_MEASURE
dry O I_MEASURE
matter O I_MEASURE
content O I_MEASURE
, O O
and O O
positively O O
with O O
leaf O B_MEASURE/B_LOCATION
size O I_MEASURE/I_LOCATION
. O O

It O O
was O O
not O O
related O O
to O O
SLA O B_PERSON/B_LOCATION
. O O

We O O
found O O
a O O
strong O B_DISEASE_ADJECTIVE[DISEASE]/B_LOCATION
trade O I_DISEASE_ADJECTIVE[DISEASE]/I_LOCATION
- O O
off O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
between O O
cavitation O B_MEASURE
resistance O I_MEASURE
and O O
hydraulic O B_MEASURE/B_DISEASE_ADJECTIVE[DISEASE]
efficiency O B_MEASURE/I_DISEASE_ADJECTIVE[DISEASE]
. O O

Most O B_BIO/B_LOCATION
species O I_BIO/I_LOCATION
in O O
the O O
field O B_LOCATION/B_BIO
were O O
operating O O
at O O
leaf O B_MEASURE/B_LOCATION
water O B_MEASURE/I_LOCATION
potentials O B_MEASURE/I_LOCATION
well O O
above O O
their O O
P50 O B_MEASURE/B_LOCATION
, O O
but O O
pioneers O B_DISEASE_ADJECTIVE[DISEASE]/B_LOCATION
and O O
deciduous O B_PERSON
species O I_PERSON
had O O
smaller O B_MEASURE/B_DISEASE_ADJECTIVE[DISEASE]
hydraulic O B_MEASURE/I_DISEASE_ADJECTIVE[DISEASE]
safety O B_MEASURE/I_DISEASE_ADJECTIVE[DISEASE]
margins O B_MEASURE/I_DISEASE_ADJECTIVE[DISEASE]
than O O
shade O B_LOCATION/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- O O
tolerants O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
and O O
evergreens O B_LOCATION/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

A O O
trade O B_ORGANIZATION/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- O O
off O B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
between O O
hydraulic O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANIZATION
safety O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_ORGANIZATION
and O O
efficiency O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_LOCATION
underlies O O
ecological O B_DISEASE_ADJECTIVE[DISEASE]/B_ORGANISM_FUNCTION
differentiation O I_DISEASE_ADJECTIVE[DISEASE]/I_ORGANISM_FUNCTION
across O O
these O O
tropical O B_LOCATION/B_ORGANIZATION
dry O I_LOCATION/I_ORGANIZATION
forest O I_LOCATION/I_ORGANIZATION
tree O I_LOCATION/I_ORGANIZATION
species O I_LOCATION/I_ORGANIZATION
. O O

Genetics O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
of O O
lung O B_DISEASE/B_BODY_PART_OR_ORGAN_COMPONENT
- O O
cancer O B_DISEASE/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
susceptibility O I_DISEASE/I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
. O O

Lung O B_DISEASE/B_LOCATION
cancer O I_DISEASE/I_LOCATION
is O O
the O O
most O O
common O B_DISEASE_ADJECTIVE[DISEASE]
form O I_DISEASE_ADJECTIVE[DISEASE]
of O O
cancer O B_DISEASE
death O I_DISEASE
worldwide O I_DISEASE
. O O

Although O O
reduction O O
of O O
tobacco B B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
consumption O O
remains O O
the O O
most O O
appropriate O O
strategy O O
to O O
reduce O O
lung O O
- O O
cancer O O
burden O O
, O O
identification O O
of O O
genes O O
involved O O
in O O
the O O
cause O O
of O O
disease O O
could O O
contribute O O
to O O
further O O
understanding O O
of O O
the O O
underlying O O
mechanisms O O
, O O
and O O
eventually O O
lead O O
to O O
additional O O
prevention O O
strategies O O
and O O
targeted O O
treatments O O
. O O

Common O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
gene O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
variants O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
involved O O
in O O
lung O B_DISEASE/B_LOCATION
cancer O I_DISEASE/I_LOCATION
have O O
been O O
recently O O
identified O O
through O O
large O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
, O O
collaborative O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
, O O
genome O B_BIO/B_GENE
- O O
wide O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
association O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
studies O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
. O O

These O O
studies O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
identified O O
three O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
separate O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
loci O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
that O O
are O O
associated O O
with O O
lung O B_DISEASE
cancer O I_DISEASE
( O O
5p15 O B_GENE/B_DISEASE
, O O
6p21 O B_MEASURE/B_GENE
, O O
and O O
15q25 O B_MEASURE/B_GENE
) O O
and O O
include O O
genes O B_PROTEIN[GENE]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
that O O
regulate O O
acetylcholine O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
nicotinic O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
receptors O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
and O O
telomerase O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
production O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
. O O

However O O
, O O
much O B_TIME[MEASURE]/B_PERSON
about O O
genetic O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
risk O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE
remains O O
to O O
be O O
discovered O O
, O O
and O O
rarer O B_GENE/B_DISEASE
gene O I_GENE/I_DISEASE
variants O I_GENE/I_DISEASE
, O O
such O B_DISEASE_ADJECTIVE[DISEASE]/B_TIME[MEASURE]
as O O
those O O
of O O
the O O
CHEK2 O B_GENE/B_PERSON
gene O I_GENE/I_PERSON
, O O
likely O O
account O O
for O O
most O B_DISEASE/B_MEASURE
of O O
the O O
remaining O O
risk O B_MEASURE/B_DISEASE_ADJECTIVE[DISEASE]
. O O

There O O
is O O
also O O
a O O
need O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
for O O
studies O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
that O O
investigate O O
how O O
genetic O B_DISEASE/B_GENE
susceptibility O I_DISEASE/I_GENE
is O O
associated O O
with O O
clinical O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
outcome O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE
measures O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE
, O O
including O O
treatment O B_DISEASE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
response O I_DISEASE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
tumour O B_DISEASE_ADJECTIVE[DISEASE]
relapse O I_DISEASE_ADJECTIVE[DISEASE]
. O O

The O O
validation O O
of O O
a O O
real O O
- O O
time O O
RT O O
- O O
PCR O O
assay O O
which O O
detects O O
influenza O O
A O O
and O O
types O O
simultaneously O O
for O O
influenza B B_DISEASE/B_MEASURE
A I I_DISEASE/I_MEASURE
H1N1 I I_DISEASE/I_MEASURE
( O O
2009 O O
) O O
and O O
oseltamivir O O
- O O
resistant O O
( O O
H275Y O O
) O O
influenza O O
A O O
H1N1 O O
( O O
2009 O O
) O O
. O O

Influenza O B_LOCATION/B_DISEASE
A O I_LOCATION/I_DISEASE
H1N1 O I_LOCATION/I_DISEASE
( O O
2009 O B_MEASURE
) O O
was O O
declared O O
by O O
the O O
World O B_PERSON/B_ORGANIZATION
Health O B_PERSON/I_ORGANIZATION
Organisation O B_PERSON/I_ORGANIZATION
( O O
WHO O B_ORGANIZATION/B_MEASURE
) O O
as O O
the O O
first O B_DISEASE
influenza O I_DISEASE
pandemic O I_DISEASE
of O O
the O O
21st O B_LOCATION/B_ENT
century O I_LOCATION/I_ENT
. O O

Rapid O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
detection O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
influenza O B_DISEASE/B_BIO
A O I_DISEASE/I_BIO
and O O
differentiation O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_CELL[BODY_PART_OR_ORGAN_COMPONENT]
of O O
influenza O B_DISEASE_ADJECTIVE[DISEASE]/B_LOCATION
A O I_DISEASE_ADJECTIVE[DISEASE]/I_LOCATION
H1N1 O I_DISEASE_ADJECTIVE[DISEASE]/I_LOCATION
( O O
2009 O B_NUMBER[MEASURE]/B_LOCATION
) O O
and O O
seasonal O B_DISEASE/B_LOCATION
influenza O B_DISEASE/I_LOCATION
A O B_DISEASE/I_LOCATION
is O O
beneficial O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
. O O

In O O
addition O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
the O O
rapid O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANISM_FUNCTION
detection O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_ORGANISM_FUNCTION
of O O
antiviral O B_DISEASE/B_ORGANISM_FUNCTION
resistant O I_DISEASE/I_ORGANISM_FUNCTION
strains O I_DISEASE/I_ORGANISM_FUNCTION
of O O
influenza O B_DISEASE
A O I_DISEASE
H1N1 O I_DISEASE
( O O
2009 O B_NUMBER[MEASURE]/B_LOCATION
) O O
would O O
be O O
useful O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
for O O
clinicians O B_PERSON/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
to O O
allow O O
for O O
change O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
to O O
an O O
effective O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
treatment O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE
at O O
a O O
much O O
earlier O B_MEASURE
stage O I_MEASURE
if O O
resistance O B_DISEASE
is O O
found O O
. O O

It O O
was O O
the O O
aim O O
of O O
this O O
study O O
to O O
develop O O
a O O
real O O
- O O
time O O
RT O O
- O O
PCR O O
that O O
can O O
detect O O
all O O
influenza B B_BIO/B_GENE
A I I_BIO/I_GENE
viruses I I_BIO/I_GENE
and O O
type O O
simultaneously O O
for O O
influenza B B_DISEASE_ADJECTIVE[DISEASE]
A I I_DISEASE_ADJECTIVE[DISEASE]
H1N1 I I_DISEASE_ADJECTIVE[DISEASE]
( O O
2009 O O
) O O
and O O
oseltamivir O O
resistant O O
( O O
H275Y O O
) O O
influenza B B_DISEASE/B_PROTEIN[GENE]
A I B_DISEASE/I_PROTEIN[GENE]
H1N1 I B_DISEASE/I_PROTEIN[GENE]
( O O
2009 O O
) O O
. O O

This O O
multiplex O O
assay O O
will O O
allow O O
laboratories O O
to O O
screen O O
respiratory O O
samples O O
for O O
all O O
types O O
of O O
influenza B B_VIRUS[BIO]/B_DISEASE
A I I_VIRUS[BIO]/I_DISEASE
, O O
influenza B B_DISEASE_ADJECTIVE[DISEASE]/B_LOCATION
A I B_DISEASE_ADJECTIVE[DISEASE]/I_LOCATION
H1N1 I B_DISEASE_ADJECTIVE[DISEASE]/I_LOCATION
( O O
2009 O O
) O O
virus O O
and O O
oseltamivir O O
resistant O O
( O O
H275Y O O
) O O
influenza B B_DISEASE/B_PROTEIN[GENE]
A I B_DISEASE/I_PROTEIN[GENE]
H1N1 I B_DISEASE/I_PROTEIN[GENE]
( O O
2009 O O
) O O
virus O O
in O O
a O O
rapid O O
and O O
cost O O
effective O O
format O O
, O O
ensuring O O
that O O
typing O O
methods O O
for O O
seasonal O O
and O O
avian O O
viruses O O
are O O
used O O
on O O
a O O
smaller O O
subset O O
of O O
samples O O
. O O

Since O O
most O B_MEASURE/B_PERSON
virology O B_MEASURE/I_PERSON
laboratories O B_MEASURE/I_PERSON
already O O
offer O O
a O O
molecular O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
service O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
for O O
influenza O B_DISEASE/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
A O B_DISEASE/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
this O O
assay O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
could O O
easily O O
be O O
implemented O O
into O O
most O B_LOCATION/B_BIO
areas O I_LOCATION/I_BIO
at O O
little O B_LOCATION/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
cost O I_LOCATION/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
therefore O O
increasing O O
local O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_LOCATION
access O I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/I_LOCATION
to O O
resistance O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
testing O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
. O O

Comparison O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
seasonal O B_DISEASE_ADJECTIVE[DISEASE]/B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
variations O B_DISEASE_ADJECTIVE[DISEASE]/I_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
in O O
water O B_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
- O O
use O B_MEASURE/B_DISEASE_ADJECTIVE[DISEASE]
efficiency O I_MEASURE/I_DISEASE_ADJECTIVE[DISEASE]
calculated O O
from O O
the O O
carbon O B_MEASURE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
isotope O B_MEASURE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
composition O B_MEASURE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
tree O B_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
rings O B_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_BIO
and O O
flux O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
data O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_BIO
in O O
a O O
temperate O B_LOCATION
forest O I_LOCATION
. O O

Tree O B_BIO/B_NUMBER[MEASURE]
- O O
ring O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
delta O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_BIO
( O O
13 O B_MEASURE/B_LOCATION
) O O
C O B_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
is O O
often O O
interpreted O O
in O O
terms O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
of O O
intrinsic O B_MEASURE/B_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
water O B_MEASURE/I_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- O O
use O B_MEASURE/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
efficiency O I_MEASURE/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
( O O
WUE O B_PROTEIN[GENE]/B_LOCATION
) O O
using O O
a O O
carbon O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
isotope O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
discrimination O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
model O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
established O O
at O O
the O O
leaf O B_MEASURE/B_LOCATION
level O B_MEASURE/I_LOCATION
. O O

We O O
examined O O
whether O O
intra O B_NUMBER[MEASURE]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- O O
ring O B_LOCATION
delta O I_LOCATION
( O O
13 O B_MEASURE/B_LOCATION
) O O
C O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
could O O
be O O
used O O
to O O
assess O O
variations O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
in O O
intrinsic O B_DISEASE_ADJECTIVE[DISEASE]/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
WUE O B_DISEASE_ADJECTIVE[DISEASE]/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
( O O
W O B_PROTEIN[GENE]/B_BODY_PART_OR_ORGAN_COMPONENT
( O O
g O B_PROTEIN[GENE]/B_CELL[BODY_PART_OR_ORGAN_COMPONENT]
) O O
, O O
the O O
ratio O B_MEASURE/B_PERSON
of O O
carbon O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
assimilation O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
and O O
stomatal O B_ORGANISM_FUNCTION/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
conductance O I_ORGANISM_FUNCTION/I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
to O O
water O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
) O O
and O O
variations O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
in O O
ecosystem O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
WUE O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
( O O
W O B_PROTEIN[GENE]/B_BODY_PART_OR_ORGAN_COMPONENT
( O O
t O B_MEASURE/B_DISEASE
) O O
, O O
the O O
ratio O B_MEASURE/B_PERSON
of O O
C O B_BIO/B_ORGANISM_FUNCTION
assimilation O B_BIO/I_ORGANISM_FUNCTION
and O O
transpiration O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PHYSIOLOGIC_FUNCTION[ORGANISM_FUNCTION]
) O O
at O O
a O O
seasonal O B_MEASURE/B_LOCATION
scale O I_MEASURE/I_LOCATION
. O O

Intra O O
- O O
ring O O
delta O O
( O O
13 O O
) O O
C O O
was O O
measured O O
in O O
30 O O
- O O
to O O
60 O O
- O O
mum O O
- O O
thick O O
slices O O
in O O
eight O O
oak O O
trees O O
( O O
Quercus B B_MEASURE/B_PERSON
petraea I I_MEASURE/I_PERSON
) O O
. O O

Canopy O B_LOCATION/B_PERSON
W O I_LOCATION/I_PERSON
( O O
g O B_MEASURE/B_CELL[BODY_PART_OR_ORGAN_COMPONENT]
) O O
was O O
simulated O O
using O O
a O O
physiologically O O
process O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
- O O
based O O
model O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
. O O

High O B_MEASURE/B_DISEASE_ADJECTIVE[DISEASE]
between O O
- O O
tree O B_MEASURE/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
variability O B_MEASURE/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
was O O
observed O O
in O O
the O O
seasonal O B_LOCATION
variations O I_LOCATION
of O O
intra O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_NUMBER[MEASURE]
- O O
ring O B_LOCATION/B_TIME[MEASURE]
delta O B_LOCATION/I_TIME[MEASURE]
( O O
13 O B_TIME[MEASURE]/B_LOCATION
) O O
C O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
. O O

Six O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ENT
trees O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_ENT
showed O O
significant O B_MEASURE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
positive O I_MEASURE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
correlations O I_MEASURE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
between O O
W O B_PROTEIN[GENE]/B_BODY_PART_OR_ORGAN_COMPONENT
( O O
g O B_MEASURE/B_CELL[BODY_PART_OR_ORGAN_COMPONENT]
) O O
calculated O O
from O O
intra O B_NUMBER[MEASURE]/B_LOCATION
- O O
ring O B_LOCATION
delta O I_LOCATION
( O O
13 O B_MEASURE/B_LOCATION
) O O
C O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
and O O
canopy O B_LOCATION/B_ORGANIZATION
W O I_LOCATION/I_ORGANIZATION
( O O
g O B_MEASURE/B_CELL[BODY_PART_OR_ORGAN_COMPONENT]
) O O
averaged O O
over O O
several O B_NUMBER[MEASURE]/B_ENT
days O I_NUMBER[MEASURE]/I_ENT
during O O
latewood O B_DISEASE_ADJECTIVE[DISEASE]/B_TIME[MEASURE]
formation O B_DISEASE_ADJECTIVE[DISEASE]/I_TIME[MEASURE]
. O O

These O O
results O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
suggest O O
that O O
latewood O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
is O O
a O O
seasonal O B_PERSON/B_MEASURE
recorder O I_PERSON/I_MEASURE
of O O
W O B_PROTEIN[GENE]/B_LOCATION
( O O
g O B_PROTEIN[GENE]/B_MEASURE
) O O
trends O B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PHYSIOLOGIC_FUNCTION[ORGANISM_FUNCTION]
, O O
with O O
a O O
temporal O B_MEASURE/B_PERSON
lag O I_MEASURE/I_PERSON
corresponding O I_MEASURE/I_PERSON
to O O
the O O
mixing O O
time O B_MEASURE
of O O
sugars O B_CHEMICAL_CLASS[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
in O O
the O O
phloem O B_LOCATION/B_BIO
. O O

These O O
six O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
trees O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_BIO
also O O
showed O O
significant O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
negative O I_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
correlations O I_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
between O O
photosynthetic O B_MEASURE
discrimination O I_MEASURE
Delta O I_MEASURE
calculated O O
from O O
intra O B_NUMBER[MEASURE]/B_LOCATION
- O O
ring O B_LOCATION
delta O I_LOCATION
( O O
13 O B_MEASURE/B_LOCATION
) O O
C O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
, O O
and O O
ecosystem O B_PROTEIN[GENE]/B_LOCATION
W O I_PROTEIN[GENE]/I_LOCATION
( O O
t O B_OTHER/B_MEASURE
) O O
, O O
during O O
latewood O B_DISEASE_ADJECTIVE[DISEASE]/B_LOCATION
formation O B_DISEASE_ADJECTIVE[DISEASE]/I_LOCATION
. O O

Despite O O
the O O
observed O O
between O O
- O O
tree O B_MEASURE/B_LOCATION
variability O I_MEASURE/I_LOCATION
, O O
these O O
results O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
indicate O O
that O O
intra O B_NUMBER[MEASURE]/B_LOCATION
- O O
ring O B_LOCATION/B_TIME[MEASURE]
delta O B_LOCATION/I_TIME[MEASURE]
( O O
13 O B_TIME[MEASURE]/B_LOCATION
) O O
C O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
can O O
be O O
used O O
to O O
access O O
seasonal O B_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
variations O I_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
in O O
past O B_PROTEIN[GENE]/B_LOCATION
W O I_PROTEIN[GENE]/I_LOCATION
( O O
t O B_OTHER/B_MEASURE
) O O
. O O

Resistance O O
and O O
recovery O O
of O O
soil O O
microbial O O
communities O O
in O O
the O O
face O O
of O O
Alliaria B B_BIO/B_LOCATION
petiolata I I_BIO/I_LOCATION
invasions O O
. O O

Invaders O B_PERSON/B_BIO
can O O
gain O O
ecological O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
advantages O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
because O O
of O O
their O O
evolutionary O B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
novelty O B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
, O O
but O O
little O B_PERSON/B_DISEASE_ADJECTIVE[DISEASE]
is O O
known O O
about O O
how O O
these O O
novel O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
advantages O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
will O O
change O O
over O O
time O B_TIME[MEASURE]
as O O
the O O
invader O B_PERSON/B_DISEASE_ADJECTIVE[DISEASE]
and O O
invaded O O
community O B_ORGANIZATION/B_LOCATION
evolve O O
in O O
response O B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
to O O
each O O
other O B_TIME[MEASURE]/B_DISEASE
. O O

Invasive O B_PERSON/B_BIO
plants O I_PERSON/I_BIO
often O O
gain O O
such O O
an O O
advantage O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
through O O
alteration O B_DISEASE_ADJECTIVE[DISEASE]/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
of O O
soil O B_DISEASE_ADJECTIVE[DISEASE]/B_ORGANISM_FUNCTION
microbial O B_DISEASE_ADJECTIVE[DISEASE]/I_ORGANISM_FUNCTION
communities O B_DISEASE_ADJECTIVE[DISEASE]/I_ORGANISM_FUNCTION
. O O

In O O
soil O O
communities O O
sampled O O
from O O
sites O O
along O O
a O O
gradient O O
of O O
invasion O O
history O O
with O O
Alliaria B B_BIO/B_TIME[MEASURE]
petiolata I B_BIO/I_TIME[MEASURE]
, O O
microbial O O
richness O O
tended O O
to O O
decline O O
, O O
but O O
the O O
community O O
' O O
s O O
resistance O O
to O O
A B B_BIO/B_DISEASE
. I B_BIO/I_DISEASE
petiolata I B_BIO/I_DISEASE
' O O
s O O
effects O O
generally O O
increased O O
with O O
increasing O O
history O O
of O O
invasion O O
. O O

However O O
, O O
sensitive O B_BIO/B_MEASURE
microbial O I_BIO/I_MEASURE
taxa O I_BIO/I_MEASURE
appeared O O
to O O
recover O O
in O O
the O O
two O B_TIME[MEASURE]/B_LOCATION
oldest O I_TIME[MEASURE]/I_LOCATION
sites O I_TIME[MEASURE]/I_LOCATION
, O O
leading O O
to O O
an O O
increase O B_DISEASE_ADJECTIVE[DISEASE]/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
in O O
richness O B_MEASURE/B_DISEASE
, O O
but O O
consequent O B_DISEASE_ADJECTIVE[DISEASE]/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
decrease O I_DISEASE_ADJECTIVE[DISEASE]/I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
in O O
resistance O B_DISEASE_ADJECTIVE[DISEASE]/B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

This O O
may O O
be O O
because O O
of O O
evolutionary O O
changes O O
in O O
the O O
A B B_BIO
. I I_BIO
petiolata I I_BIO
populations O O
, O O
which O O
tend O O
to O O
reduce O O
their O O
investment O O
to O O
allelopathic O O
compounds O O
over O O
time O O
. O O

These O O
results O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
show O O
that O O
, O O
over O O
time O B_TIME[MEASURE]/B_LOCATION
, O O
microbial O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
communities O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
can O O
develop O O
resistance O B_PERSON/B_DISEASE_ADJECTIVE[DISEASE]
to O O
an O O
invasive O B_DISEASE_ADJECTIVE[DISEASE]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
plant O B_DISEASE_ADJECTIVE[DISEASE]/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
but O O
at O O
the O O
cost O B_MEASURE/B_LOCATION
of O O
lower O B_DISEASE_ADJECTIVE[DISEASE]/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
richness O I_DISEASE_ADJECTIVE[DISEASE]/I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
. O O

However O O
, O O
over O O
longer O B_TIME[MEASURE]
time O I_TIME[MEASURE]
- O O
scales O B_TIME[MEASURE]/B_DISEASE_ADJECTIVE[DISEASE]
evolution O I_TIME[MEASURE]/I_DISEASE_ADJECTIVE[DISEASE]
in O O
the O O
invasive O B_BIO/B_LOCATION
species O B_BIO/I_LOCATION
may O O
allow O O
for O O
the O O
recovery O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_ORGANISM_FUNCTION
of O O
soil O B_DISEASE_ADJECTIVE[DISEASE]/B_LOCATION
microbial O I_DISEASE_ADJECTIVE[DISEASE]/I_LOCATION
communities O I_DISEASE_ADJECTIVE[DISEASE]/I_LOCATION
. O O

Differentiating O O
between O O
effects O B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
of O O
invasion O B_DISEASE/B_BIO
and O O
diversity O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
: O O
impacts O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
of O O
aboveground O B_DISEASE_ADJECTIVE[DISEASE]/B_BIO
plant O B_DISEASE_ADJECTIVE[DISEASE]/I_BIO
communities O B_DISEASE_ADJECTIVE[DISEASE]/I_BIO
on O O
belowground O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
fungal O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
communities O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
. O O

Exotic O B_BIO/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
plant O B_BIO/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
species O B_BIO/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
can O O
affect O O
soil O B_LOCATION/B_BIO
microbial O I_LOCATION/I_BIO
communities O I_LOCATION/I_BIO
with O O
the O O
potential O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
for O O
community O B_EDU[ORGANIZATION]/B_PERSON
and O O
ecosystem O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANIZATION
feedbacks O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_ORGANIZATION
. O O

Yet O O
, O O
separating O O
the O O
effects O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
exotics O B_DISEASE_ADJECTIVE[DISEASE]
from O O
confounded O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
changes O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
in O O
plant O B_DISEASE_ADJECTIVE[DISEASE]/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
community O B_DISEASE_ADJECTIVE[DISEASE]/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
diversity O B_DISEASE_ADJECTIVE[DISEASE]/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
still O O
remains O O
a O O
challenge O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
. O O

We O O
focused O O
on O O
how O O
plant O B_DISEASE_ADJECTIVE[DISEASE]/B_BIO
diversity O B_DISEASE_ADJECTIVE[DISEASE]/I_BIO
and O O
native O B_PERSON/B_LOCATION
or O O
exotic O B_PERSON/B_LOCATION
life O I_PERSON/I_LOCATION
history O I_PERSON/I_LOCATION
affected O O
root O B_DISEASE_ADJECTIVE[DISEASE]/B_BIO
fungi O B_DISEASE_ADJECTIVE[DISEASE]/I_BIO
because O O
of O O
their O O
significant O B_DISEASE_ADJECTIVE[DISEASE]/B_PERSON
roles O I_DISEASE_ADJECTIVE[DISEASE]/I_PERSON
in O O
community O B_BIO/B_LOCATION
and O O
ecosystem O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANISM_FUNCTION
processes O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_ORGANISM_FUNCTION
. O O

Specifically O O
, O O
we O O
examined O O
how O O
fungi O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
colonizing O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_BIO
plant O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_BIO
roots O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_BIO
were O O
affected O O
by O O
plant O B_BIO/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
richness O I_BIO/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
( O O
one O B_NUMBER[MEASURE]/B_LOCATION
, O O
two O B_NUMBER[MEASURE]/B_PERSON
or O O
four O B_NUMBER[MEASURE]/B_ENT
species O I_NUMBER[MEASURE]/I_ENT
) O O
replicated O O
across O O
a O O
range O B_LOCATION/B_MEASURE
of O O
plant O B_LOCATION/B_ORGANIZATION
community O I_LOCATION/I_ORGANIZATION
mixtures O I_LOCATION/I_ORGANIZATION
( O O
natives O B_PERSON/B_BIO
, O O
exotics O B_DISEASE_ADJECTIVE[DISEASE]/B_PERSON
, O O
native O B_PERSON/B_LOCATION
- O O
exotic O B_DISEASE_ADJECTIVE[DISEASE]/B_PERSON
mixtures O I_DISEASE_ADJECTIVE[DISEASE]/I_PERSON
) O O
. O O

Fungal O B_BIO/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
biomass O B_BIO/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
inside O O
roots O B_BIO/B_LOCATION
was O O
affected O O
independently O O
by O O
plant O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
richness O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
and O O
mixture O B_MEASURE/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
while O O
root O B_BIO
fungal O I_BIO
community O I_BIO
composition O I_BIO
was O O
affected O O
only O O
by O O
plant O B_BIO/B_LOCATION
richness O B_BIO/I_LOCATION
. O O

Extraradical O B_PERSON/B_ORGANIZATION
networks O I_PERSON/I_ORGANIZATION
also O O
increased O O
in O O
size O B_MEASURE/B_LOCATION
with O O
plant O B_MEASURE/B_DISEASE_ADJECTIVE[DISEASE]
richness O I_MEASURE/I_DISEASE_ADJECTIVE[DISEASE]
. O O

By O O
contrast O B_MEASURE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
plant O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
biomass O B_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
was O O
a O O
function O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
of O O
plant O B_BIO/B_LOCATION
mixture O B_BIO/I_LOCATION
, O O
with O O
natives O B_PERSON/B_BIO
consistently O O
smaller O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
than O O
exotics O B_DISEASE_ADJECTIVE[DISEASE]/B_PERSON
and O O
native O B_PERSON/B_LOCATION
- O O
exotic O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
mixtures O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
intermediate O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
. O O

Plant O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
invasions O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
may O O
have O O
an O O
impact O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
on O O
the O O
belowground O B_LOCATION/B_BIO
community O I_LOCATION/I_BIO
primarily O O
through O O
their O O
effects O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
on O O
diversity O B_BIO/B_LOCATION
, O O
at O O
least O O
in O O
the O O
short O B_PERSON/B_MEASURE
- O O
term O B_TIME[MEASURE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

Disentangling O O
the O O
effects O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ENT
of O O
diversity O B_PERSON/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
invasion O B_MEASURE/B_DISEASE
on O O
belowground O B_DISEASE_ADJECTIVE[DISEASE]/B_BIO
microbial O B_DISEASE_ADJECTIVE[DISEASE]/I_BIO
communities O B_DISEASE_ADJECTIVE[DISEASE]/I_BIO
can O O
help O O
us O O
to O O
understand O O
both O O
the O O
controllers O B_PERSON/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
belowground O B_DISEASE_ADJECTIVE[DISEASE]/B_LOCATION
resilience O I_DISEASE_ADJECTIVE[DISEASE]/I_LOCATION
and O O
mechanisms O B_LOCATION/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
successful O B_DISEASE_ADJECTIVE[DISEASE]/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
colonization O I_DISEASE_ADJECTIVE[DISEASE]/I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
and O O
spread O B_DISEASE/B_ORGANISM_FUNCTION
of O O
exotic O B_BIO/B_DISEASE
plants O I_BIO/I_DISEASE
. O O

Neuropeptide O O
precursor O O
gene O O
discovery O O
in O O
the O O
Chagas O O
disease O O
vector O O
Rhodnius B B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
prolixus I B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
. O O

We O O
show O O
a O O
straightforward O O
workflow O O
combining O O
homology O O
search O O
in O O
Rhodnius B B_PERSON/B_SPECIES[BIO]
prolixus I I_PERSON/I_SPECIES[BIO]
genome O O
sequence O O
with O O
cloning O O
by O O
rapid O O
amplification O O
of O O
cDNA O O
ends O O
and O O
mass O O
spectrometry O O
. O O

We O O
have O O
identified O O
32 O B_GENE/B_BIO
genes O I_GENE/I_BIO
and O O
their O O
transcripts O B_GENE/B_LOCATION
that O O
encode O O
a O O
number O B_MEASURE/B_LOCATION
of O O
neuropeptide O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PROTEIN[GENE]
precursors O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PROTEIN[GENE]
leading O O
to O O
194 O B_DISEASE/B_ORGANISM_FUNCTION
putative O I_DISEASE/I_ORGANISM_FUNCTION
peptides O I_DISEASE/I_ORGANISM_FUNCTION
. O O

We O O
validated O O
by O O
mass O O
spectrometry O O
82 O O
of O O
those O O
predicted O O
neuropeptides O O
in O O
the O O
brain O O
of O O
R B B_SPECIES[BIO]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. I I_SPECIES[BIO]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
prolixus I I_SPECIES[BIO]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
to O O
achieve O O
the O O
first O O
comprehensive O O
genomic O O
, O O
transcriptomic O O
and O O
neuropeptidomic O O
analysis O O
of O O
an O O
insect O O
disease O O
vector O O
. O O

Comparisons O O
of O O
available O O
insect O O
neuropeptide O O
sequences O O
revealed O O
that O O
the O O
R B B_SPECIES[BIO]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. I I_SPECIES[BIO]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
prolixus I I_SPECIES[BIO]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
genome O O
contains O O
most O O
of O O
the O O
conserved O O
neuropeptides O O
in O O
insects O O
, O O
many O O
of O O
them O O
displaying O O
specific O O
features O O
at O O
the O O
sequence O O
level O O
. O O

Some O O
gene O O
families O O
reported O O
here O O
are O O
identified O O
for O O
the O O
first O O
time O O
in O O
the O O
order O O
Hemiptera O O
, O O
a O O
highly O O
biodiverse O O
group O O
of O O
insects O O
that O O
includes O O
many O O
human B B_SPECIES[BIO]
, O O
animal O O
and O O
plant O O
disease O O
agents O O
. O O

The O O
alphaherpesvirus O B_GENE/B_BIO
US3 O I_GENE/I_BIO
/ O O
ORF66 O B_NUMBER[MEASURE]/B_PERSON
protein O I_NUMBER[MEASURE]/I_PERSON
kinases O O
direct O B_GENE_EXPRESSION_ADJECTIVE[GENE]/B_LOCATION
phosphorylation O I_GENE_EXPRESSION_ADJECTIVE[GENE]/I_LOCATION
of O O
the O O
nuclear O B_GENE
matrix O I_GENE
protein O I_GENE
matrin O I_GENE
3 O I_GENE
. O O

The O O
protein O O
kinase O O
found O O
in O O
the O O
short O O
region O O
of O O
alphaherpesviruses O O
, O O
termed O O
US3 O O
in O O
herpes B B_DISEASE/B_VIRUS[BIO]
simplex I B_DISEASE/I_VIRUS[BIO]
virus I B_DISEASE/I_VIRUS[BIO]
type I B_DISEASE/I_VIRUS[BIO]
1 I B_DISEASE/I_VIRUS[BIO]
( O O
HSV B B_VIRUS[BIO]/B_DISEASE
- I I_VIRUS[BIO]/I_DISEASE
1 I I_VIRUS[BIO]/I_DISEASE
) O O
and O O
pseudorabies B B_DISEASE/B_PROTEIN[GENE]
virus I B_DISEASE/I_PROTEIN[GENE]
( O O
PRV B B_PROTEIN[GENE]/B_DISEASE
) O O
and O O
ORF66 O O
in O O
varicella B B_DISEASE/B_VIRUS[BIO]
- I B_DISEASE/I_VIRUS[BIO]
zoster I B_DISEASE/I_VIRUS[BIO]
virus I B_DISEASE/I_VIRUS[BIO]
( O O
VZV B B_VIRUS[BIO]/B_DISEASE
) O O
, O O
affects O O
several O O
viral O O
and O O
host O O
cell O O
processes O O
, O O
and O O
its O O
specific O O
targets O O
remain O O
an O O
area O O
of O O
active O O
investigation O O
. O O

Reports O O
suggesting O O
that O O
HSV B B_DISEASE_ADJECTIVE[DISEASE]/B_CELL_COMPONENT[BODY_PART_OR_ORGAN_COMPONENT]
- I B_DISEASE_ADJECTIVE[DISEASE]/I_CELL_COMPONENT[BODY_PART_OR_ORGAN_COMPONENT]
1 I B_DISEASE_ADJECTIVE[DISEASE]/I_CELL_COMPONENT[BODY_PART_OR_ORGAN_COMPONENT]
US3 O O
substrates O O
overlap O O
with O O
those O O
of O O
cellular O O
protein O O
kinase O O
A O O
( O O
PKA O O
) O O
prompted O O
the O O
use O O
of O O
an O O
antibody O O
specific O O
for O O
phosphorylated O O
PKA O O
substrates O O
to O O
identify O O
US3 O O
/ O O
ORF66 O O
targets O O
. O O

HSV B B_VIRUS[BIO]/B_MEASURE
- I I_VIRUS[BIO]/I_MEASURE
1 I I_VIRUS[BIO]/I_MEASURE
, O O
VZV B B_VIRUS[BIO]/B_DISEASE
, O O
and O O
PRV B B_VIRUS[BIO]/B_DISEASE
induced O O
very O O
different O O
substrate O O
profiles O O
that O O
were O O
US3 O O
/ O O
ORF66 O O
kinase O O
dependent O O
. O O

The O O
predominant O O
VZV B B_DISEASE/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- O O
phosphorylated O O
125 O O
- O O
kDa O O
species O O
was O O
identified O O
as O O
matrin O O
3 O O
, O O
one O O
of O O
the O O
major O O
nuclear O O
matrix O O
proteins O O
. O O

Matrin O O
3 O O
was O O
also O O
phosphorylated O O
by O O
HSV B B_VIRUS[BIO]/B_DISEASE
- I I_VIRUS[BIO]/I_DISEASE
1 I I_VIRUS[BIO]/I_DISEASE
and O O
PRV B B_GENE/B_VIRUS[BIO]
in O O
a O O
US3 O O
kinase O O
- O O
dependent O O
manner O O
and O O
by O O
VZV B B_VIRUS[BIO]/B_DISEASE
ORF66 O O
kinase O O
at O O
a O O
novel O O
residue O O
( O O
KRRRT150EE O O
) O O
. O O

Since O O
VZV B B_VIRUS[BIO]/B_GENE
- O O
directed O O
T150 O O
phosphorylation O O
was O O
not O O
blocked O O
by O O
PKA O O
inhibitors O O
and O O
was O O
not O O
induced O O
by O O
PKA O O
activation O O
, O O
and O O
since O O
PKA O O
predominantly O O
targeted O O
matrin O O
3 O O
S188 O O
, O O
it O O
was O O
concluded O O
that O O
phosphorylation O O
by O O
VZV B B_VIRUS[BIO]/B_GENE
was O O
PKA O O
independent O O
. O O

However O O
, O O
purified O O
VZV B B_SPECIES[BIO]
ORF66 O O
kinase O O
did O O
not O O
phosphorylate O O
matrin O O
3 O O
in O O
vitro O O
, O O
suggesting O O
that O O
additional O O
cellular O O
factors O O
were O O
required O O
. O O

In O O
VZV B B_DISEASE/B_VIRUS[BIO]
- O O
infected O O
cells O O
in O O
the O O
absence O O
of O O
the O O
ORF66 O O
kinase O O
, O O
matrin O O
3 O O
displayed O O
intranuclear O O
changes O O
, O O
while O O
matrin O O
3 O O
showed O O
a O O
pronounced O O
cytoplasmic O O
distribution O O
in O O
late O O
- O O
stage O O
cells O O
infected O O
with O O
US3 O O
- O O
negative O O
HSV B B_VIRUS[BIO]/B_GENE
- I I_VIRUS[BIO]/I_GENE
1 I I_VIRUS[BIO]/I_GENE
or O O
PRV B B_VIRUS[BIO]/B_DISEASE
. O O

This O O
work O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
identifies O O
phosphorylation O B_TIME[MEASURE]/B_LOCATION
of O O
the O O
nuclear O B_GENE
matrix O I_GENE
protein O I_GENE
matrin O I_GENE
3 O I_GENE
as O O
a O O
new O B_PERSON/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
conserved O I_PERSON/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
target O I_PERSON/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
this O O
kinase O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
group O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

Small O O
- O O
molecule O O
inhibition O O
of O O
human B B_DISEASE/B_VIRUS[BIO]
immunodeficiency I B_DISEASE/I_VIRUS[BIO]
virus I B_DISEASE/I_VIRUS[BIO]
type I B_DISEASE/I_VIRUS[BIO]
1 I B_DISEASE/I_VIRUS[BIO]
infection O O
by O O
virus O O
capsid O O
destabilization O O
. O O

Human B B_DISEASE
immunodeficiency I I_DISEASE
virus I I_DISEASE
type I I_DISEASE
1 I I_DISEASE
( O O
HIV B B_DISEASE
- I I_DISEASE
1 I I_DISEASE
) O O
infection O O
is O O
dependent O O
on O O
the O O
proper O O
disassembly O O
of O O
the O O
viral O O
capsid O O
, O O
or O O
& O O
quot O O
; O O
uncoating O O
, O O
& O O
quot O O
; O O
in O O
target O O
cells O O
. O O

The O O
HIV B B_VIRUS[BIO]/B_DISEASE
- I I_VIRUS[BIO]/I_DISEASE
1 I I_VIRUS[BIO]/I_DISEASE
capsid O O
consists O O
of O O
a O O
conical O O
multimeric O O
complex O O
of O O
the O O
viral O O
capsid O O
protein O O
( O O
CA O O
) O O
arranged O O
in O O
a O O
hexagonal O O
lattice O O
. O O

Mutations O B_CELL_OR_MOLECULAR_DYSFUNCTION[DISEASE]
in O O
CA O B_GENE/B_DISEASE
that O O
destabilize O O
the O O
viral O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
capsid O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
result O O
in O O
impaired O B_DISEASE
infection O I_DISEASE
owing O O
to O O
defects O B_DISEASE_ADJECTIVE[DISEASE]
in O O
reverse O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
transcription O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
in O O
target O B_SPECIES[BIO]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
cells O I_SPECIES[BIO]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

We O O
describe O O
here O O
the O O
mechanism O O
of O O
action O O
of O O
a O O
small O O
molecule O O
HIV B B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
- I I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
1 I I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
inhibitor O O
, O O
PF O O
- O O
3450074 O O
( O O
PF74 O O
) O O
, O O
which O O
targets O O
CA O O
. O O

PF74 O O
acts O O
at O O
an O O
early O O
stage O O
of O O
HIV B B_VIRUS[BIO]/B_DISEASE_ADJECTIVE[DISEASE]
- I I_VIRUS[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
1 I I_VIRUS[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
infection O O
and O O
inhibits O O
reverse O O
transcription O O
in O O
target O O
cells O O
. O O

We O O
show O O
that O O
PF74 O O
binds O O
specifically O O
to O O
HIV B B_DISEASE/B_GENE
- I I_DISEASE/I_GENE
1 I I_DISEASE/I_GENE
particles O O
, O O
and O O
substitutions O O
in O O
CA O O
that O O
confer O O
resistance O O
to O O
the O O
compound O O
prevent O O
binding O O
. O O

A O O
single O O
point O O
mutation O O
in O O
CA O O
that O O
stabilizes O O
the O O
HIV B B_VIRUS[BIO]/B_PROTEIN[GENE]
- I B_VIRUS[BIO]/I_PROTEIN[GENE]
1 I B_VIRUS[BIO]/I_PROTEIN[GENE]
core O O
also O O
conferred O O
strong O O
resistance O O
to O O
the O O
virus O O
without O O
inhibiting O O
compound O O
binding O O
. O O

Treatment O O
of O O
HIV B B_DISEASE_ADJECTIVE[DISEASE]/B_PERSON
- I I_DISEASE_ADJECTIVE[DISEASE]/I_PERSON
1 I I_DISEASE_ADJECTIVE[DISEASE]/I_PERSON
particles O O
or O O
purified O O
cores O O
with O O
PF74 O O
destabilized O O
the O O
viral O O
capsid O O
in O O
vitro O O
. O O

Furthermore O O
, O O
the O O
compound O O
induced O O
the O O
rapid O O
dissolution O O
of O O
the O O
HIV B B_DISEASE/B_VIRUS[BIO]
- I B_DISEASE/I_VIRUS[BIO]
1 I B_DISEASE/I_VIRUS[BIO]
capsid O O
in O O
target O O
cells O O
. O O

PF74 O O
antiviral O O
activity O O
was O O
promoted O O
by O O
binding O O
of O O
the O O
host O O
protein O O
cyclophilin O O
A O O
to O O
the O O
HIV B B_VIRUS[BIO]/B_DISEASE_ADJECTIVE[DISEASE]
- I I_VIRUS[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
1 I I_VIRUS[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
capsid O O
, O O
and O O
PF74 O O
and O O
cyclosporine O O
exhibited O O
mutual O O
antagonism O O
. O O

Our O O
data O O
suggest O O
that O O
PF74 O O
triggers O O
premature O O
HIV B B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
- I I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
1 I I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
uncoating O O
in O O
target O O
cells O O
, O O
thereby O O
mimicking O O
the O O
activity O O
of O O
the O O
retrovirus O O
restriction O O
factor O O
TRIM5alpha O O
. O O

This O O
study O O
highlights O O
uncoating O O
as O O
a O O
step O O
in O O
the O O
HIV B B_SPECIES[BIO]/B_DISEASE_ADJECTIVE[DISEASE]
- I I_SPECIES[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
1 I I_SPECIES[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
life O O
cycle O O
that O O
is O O
susceptible O O
to O O
small O O
molecule O O
intervention O O
. O O

PB2 O O
residue O O
158 O O
is O O
a O O
pathogenic O O
determinant O O
of O O
pandemic O O
H1N1 B B_DISEASE/B_PROTEIN[GENE]
and O O
H5 B B_DISEASE/B_BIO
influenza I I_DISEASE/I_BIO
a I I_DISEASE/I_BIO
viruses I I_DISEASE/I_BIO
in O O
mice B B_LOCATION/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

Influenza B B_BACTERIUM[BIO]/B_DISEASE
A I I_BACTERIUM[BIO]/I_DISEASE
viruses I I_BACTERIUM[BIO]/I_DISEASE
are O O
human B B_PERSON/B_SPECIES[BIO]
and O O
animal O O
pathogens O O
that O O
cause O O
morbidity O O
and O O
mortality O O
, O O
which O O
range O O
from O O
mild O O
to O O
severe O O
. O O

The O O
2009 O O
H1N1 B B_DISEASE
pandemic O O
was O O
caused O O
by O O
the O O
emergence O O
of O O
a O O
reassortant O O
H1N1 B B_DISEASE/B_PROTEIN[GENE]
subtype O O
( O O
H1N1pdm B B_DISEASE/B_PROTEIN[GENE]
) O O
influenza B B_DISEASE/B_GENE
A I B_DISEASE/I_GENE
virus I B_DISEASE/I_GENE
containing O O
gene O O
segments O O
that O O
originally O O
circulated O O
in O O
human B B_SPECIES[BIO]/B_LOCATION
, O O
avian O O
, O O
and O O
swine B B_SPECIES[BIO]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
virus O O
reservoirs O O
. O O

The O O
molecular O O
determinants O O
of O O
replication O O
and O O
pathogenesis O O
of O O
H1N1pdm B B_DISEASE
viruses I I_DISEASE
in O O
humans B B_SPECIES[BIO]
and O O
other O O
mammals O O
are O O
poorly O O
understood O O
. O O

Therefore O O
, O O
we O O
set O O
out O O
to O O
elucidate O O
viral O O
determinants O O
critical O O
to O O
the O O
pathogenesis O O
of O O
this O O
novel O O
reassortant O O
using O O
a O O
mouse B B_SPECIES[BIO]/B_DISEASE
model O O
. O O

We O O
found O O
that O O
a O O
glutamate O O
- O O
to O O
- O O
glycine O O
substitution O O
at O O
residue O O
158 O O
of O O
the O O
PB2 O O
gene O O
( O O
PB2 O O
- O O
E158G O O
) O O
increased O O
the O O
morbidity O O
and O O
mortality O O
of O O
the O O
parental O O
H1N1pdm B B_SPECIES[BIO]/B_PERSON
virus I I_SPECIES[BIO]/I_PERSON
. O O

Results O O
from O O
mini O O
- O O
genome O O
replication O O
assays O O
in O O
human B B_PERSON/B_SPECIES[BIO]
cells O O
and O O
virus O O
titration O O
in O O
mouse B B_SPECIES[BIO]/B_DISEASE
tissues O O
demonstrated O O
that O O
PB2 O O
- O O
E158G O O
is O O
a O O
pathogenic O O
determinant O O
, O O
because O O
it O O
significantly O O
increases O O
viral O O
replication O O
rates O O
. O O

The O O
virus O O
load O O
in O O
PB2 O O
- O O
E158G O O
- O O
infected O O
mouse B B_SPECIES[BIO]/B_DISEASE
lungs O O
was O O
1 O O
, O O
300 O O
- O O
fold O O
higher O O
than O O
that O O
of O O
the O O
wild O O
- O O
type O O
virus O O
. O O

Our O O
data O O
also O O
show O O
that O O
PB2 O O
- O O
E158G O O
had O O
a O O
much O O
stronger O O
influence O O
on O O
the O O
RNA O O
replication O O
and O O
pathogenesis O O
of O O
H1N1pdm B B_DISEASE
viruses I I_DISEASE
than O O
PB2 O O
- O O
E627K O O
, O O
which O O
is O O
a O O
known O O
pathogenic O O
determinant O O
. O O

Remarkably O O
, O O
PB2 O O
- O O
E158G O O
substitutions O O
also O O
altered O O
the O O
pathotypes O O
of O O
two O O
avian O O
H5 B B_DISEASE/B_BIO
viruses I I_DISEASE/I_BIO
in O O
mice B B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
, O O
indicating O O
that O O
this O O
residue O O
impacts O O
genetically O O
divergent O O
influenza B B_BIO/B_DISEASE
A I I_BIO/I_DISEASE
viruses I I_BIO/I_DISEASE
and O O
suggesting O O
that O O
this O O
region O O
of O O
PB2 O O
could O O
be O O
a O O
new O O
antiviral O O
target O O
. O O

Collectively O O
, O O
the O O
data O O
presented O O
in O O
this O O
study O O
demonstrate O O
that O O
PB2 O O
- O O
E158G O O
is O O
a O O
novel O O
pathogenic O O
determinant O O
of O O
influenza B B_DISEASE/B_BIO
A I I_DISEASE/I_BIO
viruses I I_DISEASE/I_BIO
in O O
the O O
mouse B B_SPECIES[BIO]/B_DISEASE
model O O
. O O

We O O
speculate O O
that O O
PB2 O O
- O O
E158G O O
may O O
be O O
important O O
in O O
the O O
adaptation O O
of O O
avian O O
PB2 O O
genes O O
to O O
other O O
mammals O O
, O O
and O O
BLAST O O
sequence O O
analysis O O
identified O O
a O O
naturally O O
occurring O O
human B B_SPECIES[BIO]/B_DISEASE_ADJECTIVE[DISEASE]
H1N1pdm B I_SPECIES[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
isolate O O
that O O
has O O
this O O
substitution O O
. O O

Therefore O O
, O O
future O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
surveillance O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
efforts O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
should O O
include O O
scrutiny O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
this O O
region O B_LOCATION/B_MEASURE
of O O
PB2 O B_GENE/B_LOCATION
because O O
of O O
its O O
potential O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
impact O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
on O O
pathogenesis O B_DISEASE/B_BIO
. O O

Hepatitis B B_DISEASE
C I I_DISEASE
virus I I_DISEASE
NS2 O O
protein O O
serves O O
as O O
a O O
scaffold O O
for O O
virus O O
assembly O O
by O O
interacting O O
with O O
both O O
structural O O
and O O
nonstructural O O
proteins O O
. O O

Many O O
aspects O O
of O O
the O O
assembly O O
of O O
hepatitis B B_DISEASE/B_VIRUS[BIO]
C I B_DISEASE/I_VIRUS[BIO]
virus I B_DISEASE/I_VIRUS[BIO]
( O O
HCV B B_DISEASE
) O O
remain O O
incompletely O O
understood O O
. O O

To O O
characterize O O
the O O
role O O
of O O
NS2 O O
in O O
the O O
production O O
of O O
infectious O O
virus O O
, O O
we O O
determined O O
NS2 O O
interaction O O
partners O O
among O O
other O O
HCV B B_DISEASE/B_CELL_COMPONENT[BODY_PART_OR_ORGAN_COMPONENT]
proteins O O
during O O
productive O O
infection O O
. O O

Pulldown O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
assays O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
showed O O
that O O
NS2 O B_GENE/B_PERSON
forms O I_GENE/I_PERSON
complexes O I_GENE/I_PERSON
with O O
both O O
structural O B_CELL_COMPONENT[BODY_PART_OR_ORGAN_COMPONENT]/B_DISEASE
and O O
nonstructural O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
proteins O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
, O O
including O O
E1 O B_PROTEIN[GENE]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
E2 O O
, O O
p7 O O
, O O
NS3 O B_PROTEIN[GENE]
, O O
and O O
NS5A O B_PROTEIN[GENE]/B_DISEASE_ADJECTIVE[DISEASE]
. O O

Confocal O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
microscopy O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
also O O
demonstrated O O
that O O
NS2 O B_DISEASE_ADJECTIVE[DISEASE]/B_BIO
colocalizes O I_DISEASE_ADJECTIVE[DISEASE]/I_BIO
with O O
E1 O B_PROTEIN[GENE]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
E2 O B_PROTEIN[GENE]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
and O O
NS5A O B_PROTEIN[GENE]/B_DISEASE_ADJECTIVE[DISEASE]
in O O
dot O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_CELL_COMPONENT[BODY_PART_OR_ORGAN_COMPONENT]
- O O
like O B_LOCATION/B_MEASURE
structures O I_LOCATION/I_MEASURE
near O O
lipid O B_CELL_COMPONENT[BODY_PART_OR_ORGAN_COMPONENT]/B_DISEASE_ADJECTIVE[DISEASE]
droplets O I_CELL_COMPONENT[BODY_PART_OR_ORGAN_COMPONENT]/I_DISEASE_ADJECTIVE[DISEASE]
. O O

However O O
, O O
NS5A O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
did O O
not O O
coprecipitate O B_LOCATION/B_MEASURE
with O O
E2 O B_GENE/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
interacted O O
only O O
weakly O O
with O O
NS3 O B_GENE
in O O
pulldown O B_DISEASE_ADJECTIVE[DISEASE]/B_CELL[BODY_PART_OR_ORGAN_COMPONENT]
assays O B_DISEASE_ADJECTIVE[DISEASE]/I_CELL[BODY_PART_OR_ORGAN_COMPONENT]
. O O

Also O O
, O O
there O O
was O O
no O O
demonstrable O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
interaction O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
between O O
p7 O B_GENE
and O O
E2 O B_GENE/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
or O O
NS3 O B_GENE
in O O
such O B_CELL[BODY_PART_OR_ORGAN_COMPONENT]/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
assays O I_CELL[BODY_PART_OR_ORGAN_COMPONENT]/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

Therefore O O
, O O
NS2 O B_GENE/B_SPECIES[BIO]
is O O
uniquely O O
capable O B_PERSON
of O O
interacting O O
with O O
both O O
structural O B_CELL_COMPONENT[BODY_PART_OR_ORGAN_COMPONENT]/B_DISEASE
and O O
nonstructural O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
proteins O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
. O O

Among O O
mutations O B_CELL_OR_MOLECULAR_DYSFUNCTION[DISEASE]/B_GENE
in O O
p7 O B_PROTEIN[GENE]
, O O
NS2 O B_PROTEIN[GENE]/B_SPECIES[BIO]
, O O
and O O
NS3 O B_PROTEIN[GENE]/B_MEASURE
that O O
prevent O O
production O B_ENT/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
infectious O B_DISEASE/B_GENE
virus O B_DISEASE/I_GENE
, O O
only O O
p7 O B_NUMBER[MEASURE]/B_PERSON
mutations O I_NUMBER[MEASURE]/I_PERSON
significantly O O
reduced O O
NS2 O B_GENE/B_SPECIES[BIO]
- O O
mediated O O
protein O B_DISEASE/B_GENE
interactions O I_DISEASE/I_GENE
. O O

These O O
p7 O B_DISEASE_ADJECTIVE[DISEASE]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
mutations O B_DISEASE_ADJECTIVE[DISEASE]/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
altered O O
the O O
intracellular O B_LOCATION
distribution O I_LOCATION
of O O
NS2 O B_PROTEIN[GENE]/B_SPECIES[BIO]
and O O
E2 O B_PROTEIN[GENE]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
appeared O O
to O O
modulate O O
the O O
membrane O B_LOCATION/B_TIME[MEASURE]
topology O B_LOCATION/I_TIME[MEASURE]
of O O
the O O
C O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
- O O
terminal O B_LOCATION/B_MEASURE
domain O I_LOCATION/I_MEASURE
of O O
NS2 O B_PROTEIN[GENE]/B_SPECIES[BIO]
. O O

These O O
results O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
suggest O O
that O O
NS2 O B_DISEASE/B_LOCATION
acts O B_DISEASE/I_LOCATION
to O O
coordinate O O
virus O B_DISEASE/B_ORGANISM_FUNCTION
assembly O I_DISEASE/I_ORGANISM_FUNCTION
by O O
mediating O O
interactions O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANIZATION
between O O
envelope O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
proteins O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
and O O
NS3 O B_PROTEIN[GENE]/B_DISEASE
and O O
NS5A O B_DISEASE_ADJECTIVE[DISEASE]/B_LOCATION
within O O
replication O B_LOCATION/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
complexes O B_LOCATION/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
adjacent O B_LOCATION/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
to O O
lipid O B_DISEASE_ADJECTIVE[DISEASE]/B_CELL_COMPONENT[BODY_PART_OR_ORGAN_COMPONENT]
droplets O B_DISEASE_ADJECTIVE[DISEASE]/I_CELL_COMPONENT[BODY_PART_OR_ORGAN_COMPONENT]
, O O
where O O
virus O B_DISEASE_ADJECTIVE[DISEASE]/B_CELL_FUNCTION[ORGANISM_FUNCTION]
particle O B_DISEASE_ADJECTIVE[DISEASE]/I_CELL_FUNCTION[ORGANISM_FUNCTION]
assembly O B_DISEASE_ADJECTIVE[DISEASE]/I_CELL_FUNCTION[ORGANISM_FUNCTION]
is O O
thought O O
to O O
occur O O
. O O

p7 O O
may O O
play O O
an O O
accessory O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
role O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
by O O
regulating O O
NS2 O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
membrane O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
topology O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
, O O
which O O
is O O
important O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
for O O
NS2 O B_GENE/B_SPECIES[BIO]
- O O
mediated O O
protein O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
interactions O I_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
and O O
therefore O O
NS2 O B_DISEASE/B_GENE
function O I_DISEASE/I_GENE
. O O

Alcohol O O
dehydrogenase O O
and O O
hydrogenase O O
transcript O O
fluctuations O O
during O O
a O O
day O O
- O O
night O O
cycle O O
in O O
Chlamydomonas B B_BIO
reinhardtii I I_BIO
: O O
the O O
role O O
of O O
anoxia O O
. O O

* O O
The O O
unicellular O O
green O O
alga O O
Chlamydomonas B B_BIO
reinhardtii I I_BIO
contains O O
two O O
iron O O
( O O
Fe O O
) O O
- O O
hydrogenases O O
which O O
are O O
responsible O O
for O O
hydrogen O O
production O O
under O O
anoxia O O
. O O

In O O
the O O
present O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
work O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_BIO
the O O
patterns O B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
of O O
expression O B_GENE/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
alcohol O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
dehydrogenase O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
, O O
a O O
typical O B_BACTERIUM[BIO]/B_ENZYME[GENE]
anaerobic O B_BACTERIUM[BIO]/I_ENZYME[GENE]
gene O B_BACTERIUM[BIO]/I_ENZYME[GENE]
in O O
plants O B_BIO/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
of O O
the O O
hydrogenases O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
genes O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
( O O
HYD1 O B_PROTEIN[GENE]/B_DISEASE
, O O
HYD2 O B_PROTEIN[GENE]/B_DISEASE
) O O
and O O
of O O
the O O
genes O B_GENE/B_LOCATION
responsible O I_GENE/I_LOCATION
for O O
their O O
maturation O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_CELL[BODY_PART_OR_ORGAN_COMPONENT]
( O O
HYDEF O B_DISEASE/B_GENE
, O O
HYDG O B_PROTEIN[GENE]/B_DISEASE
) O O
, O O
were O O
analysed O O
. O O

* O B_GENE/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
The O O
expression O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
patterns O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
were O O
analysed O O
by O O
real O B_MEASURE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- O O
time O B_MEASURE/B_BIO
reverse O I_MEASURE/I_BIO
- O O
transcription O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
polymerase O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
chain O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
reaction O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
in O O
Chlamydomonas O B_BIO/B_BODY_PART_OR_ORGAN_COMPONENT
cultures O B_BIO/I_BODY_PART_OR_ORGAN_COMPONENT
during O O
the O O
day O B_TIME[MEASURE]
- O O
night O B_TIME[MEASURE]/B_ENT
cycle O I_TIME[MEASURE]/I_ENT
, O O
as O O
well O O
as O O
in O O
response O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
to O O
oxygen O B_DISEASE_ADJECTIVE[DISEASE]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
availability O B_DISEASE_ADJECTIVE[DISEASE]/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

* O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
The O O
results O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
indicated O O
that O O
ADH1 O B_GENE
, O O
HYD1 O B_GENE
, O O
HYD2 O B_GENE/B_DISEASE
, O O
HYDEF O B_PROTEIN[GENE]/B_DISEASE_ADJECTIVE[DISEASE]
and O O
HYDG O B_GENE
were O O
expressed O O
following O O
precise O B_TIME[MEASURE]
day O I_TIME[MEASURE]
- O O
night O B_TIME[MEASURE]/B_LOCATION
fluctuations O I_TIME[MEASURE]/I_LOCATION
. O O

ADH1 O B_GENE
and O O
HYD2 O B_GENE
were O O
modulated O O
by O O
the O O
day O B_TIME[MEASURE]/B_LOCATION
- O O
night O B_TIME[MEASURE]/B_LOCATION
cycle O B_TIME[MEASURE]/I_LOCATION
. O O

Low O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
oxygen O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
plays O O
an O O
important O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
role O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
for O O
the O O
induction O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_GENE_EXPRESSION_ADJECTIVE[GENE]
of O O
HYD1 O B_GENE
, O O
HYDEF O B_DISEASE/B_GENE
and O O
HYDG O B_GENE/B_LOCATION
, O O
while O O
ADH1 O B_GENE/B_DISEASE
and O O
HYD2 O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
expression O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
was O O
relatively O O
insensitive O B_DISEASE_ADJECTIVE[DISEASE]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
to O O
oxygen O B_DISEASE/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
availability O B_DISEASE/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

* O B_MEASURE/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
The O O
regulation O B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
of O O
the O O
anaerobic O B_GENE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
gene O I_GENE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
expression O I_GENE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
in O O
Chlamydomonas O B_BIO/B_CELL[BODY_PART_OR_ORGAN_COMPONENT]
is O O
only O O
partly O O
explained O O
by O O
responses O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
to O O
anoxia O B_DISEASE_ADJECTIVE[DISEASE]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

The O O
cell O B_MEASURE/B_COLOR
cycle O I_MEASURE/I_COLOR
and O O
light O B_COLOR
- O O
dark O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_GENE
cycles O I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/I_GENE
are O O
equally O O
important O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
elements O I_DISEASE_ADJECTIVE[DISEASE]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
in O O
the O O
regulatory O B_LOCATION/B_ORGANIZATION
network O I_LOCATION/I_ORGANIZATION
modulating O O
the O O
anaerobic O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANISM_FUNCTION
response O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_ORGANISM_FUNCTION
in O O
Chlamydomonas O B_BIO
. O O

Evaluation O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANIZATION
of O O
the O O
Virus O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
Counter O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
( O O
R O B_OTHER/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
) O O
for O O
rapid O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
baculovirus O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE
quantitation O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE
. O O

The O O
utility O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
of O O
a O O
new O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
instrument O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
for O O
rapid O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
virus O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE
quantitation O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE
, O O
the O O
Virus O B_ORGANIZATION/B_LOCATION
Counter O I_ORGANIZATION/I_LOCATION
, O O
was O O
evaluated O O
in O O
a O O
blind O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
study O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
conducted O O
at O O
three O B_LOCATION/B_ENT
sites O I_LOCATION/I_ENT
. O O

This O O
instrument O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
is O O
a O O
substantially O O
improved O O
version O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_TIME[MEASURE]
of O O
the O O
original O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
academic O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
research O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
instrument O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
described O O
previously O O
by O O
Stoffel O B_PERSON/B_LOCATION
and O O
Rowlen O B_PERSON
( O O
2005a O B_TIME[MEASURE]
) O O
. O O

The O O
addition O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_LOCATION
of O O
hydrodynamic O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PRODUCT[OBJECT]
focusing O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PRODUCT[OBJECT]
, O O
a O O
self O B_PERSON/B_LOCATION
- O O
contained O O
fluidics O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
system O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
and O O
customized O B_ORGANIZATION/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
software O I_ORGANIZATION/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
for O O
system O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
control O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
data O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANIZATION
analysis O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_ORGANIZATION
has O O
resulted O O
in O O
a O O
commercially O O
viable O B_PROTEIN[GENE]/B_DISEASE_ADJECTIVE[DISEASE]
and O O
available O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_TIME[MEASURE]
design O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_TIME[MEASURE]
. O O

Baculovirus O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
samples O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
were O O
provided O O
by O O
Protein O B_PERSON/B_ORGANIZATION
Sciences O I_PERSON/I_ORGANIZATION
Corporation O I_PERSON/I_ORGANIZATION
and O O
blinded O O
to O O
InDevR O B_ORGANIZATION/B_LOCATION
and O O
Baylor O B_LOCATION/B_ORGANIZATION
College O B_LOCATION/I_ORGANIZATION
of O O
Medicine O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
. O O

Protein O B_ORGANIZATION/B_LOCATION
Sciences O B_ORGANIZATION/I_LOCATION
Corporation O B_ORGANIZATION/I_LOCATION
and O O
Baylor O B_LOCATION/B_ORGANIZATION
College O B_LOCATION/I_ORGANIZATION
of O O
Medicine O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
analyzed O O
the O O
samples O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
by O O
plaque O B_LOCATION/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
assay O I_LOCATION/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
InDevR O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
analyzed O O
the O O
samples O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
using O O
the O O
Virus O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
Counter O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

Serial O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
dilution O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
of O O
stock O B_BIO/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
viruses O I_BIO
into O O
growth O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
media O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
and O O
buffer O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
allowed O O
for O O
comparison O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
measured O B_MEASURE/B_PERSON
versus O B_MEASURE/I_PERSON
intended O O
concentrations O B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
. O O

Direct O B_MEASURE/B_PERSON
log O I_MEASURE/I_PERSON
- O O
scale O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
comparison O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
between O O
pooled O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
Virus O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
Counter O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
results O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
and O O
pooled O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
plaque O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
assay O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
results O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
indicated O O
a O O
linear O B_MEASURE/B_LOCATION
relationship O I_MEASURE/I_LOCATION
( O O
slope O B_PROTEIN[GENE]/B_MEASURE
= O O
1 O B_MEASURE
. O O
1 O B_MEASURE/B_LOCATION
+ O I_MEASURE/I_LOCATION
/ O O
- O O
0 O B_MEASURE
. O O
2 O B_MEASURE
, O O
R O B_OTHER/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
( O O
2 O B_MEASURE
) O O
= O O
0 O B_MEASURE
. O O
86 O B_MEASURE
) O O
with O O
statistically O O
significant O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
Pearson O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
correlation O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
( O O
r O B_PROTEIN[GENE]/B_OTHER
= O O
0 O B_MEASURE
. O O
93 O B_MEASURE
, O O
p O O
& O O
lt O B_PERSON/B_GENE
; O O
0 O B_MEASURE/B_LOCATION
. O O
001 O B_MEASURE
) O O
. O O

Applied O O
biotechnology O O
for O O
production O O
of O O
immunoglobulin O O
Y O O
specific O O
to O O
hepatitis B B_DISEASE
A I I_DISEASE
virus I I_DISEASE
. O O

A O O
new O O
protocol O O
for O O
producing O O
polyclonal O O
antibody O O
against O O
hepatitis B B_DISEASE
A I I_DISEASE
virus I I_DISEASE
( O O
HAV B B_DISEASE
) O O
is O O
described O O
. O O

Twenty O O
hens B B_PERSON/B_SPECIES[BIO]
were O O
immunized O O
three O O
times O O
with O O
a O O
commercial O O
HAV B B_DISEASE/B_GENE
vaccine O O
and O O
HAV B B_DISEASE/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
from O O
a O O
cell O O
culture O O
with O O
three O O
types O O
of O O
adjuvants O O
: O O
CpG O O
oligodeoxynucleotides O O
( O O
CpG O O
- O O
ODN O O
) O O
, O O
incomplete O O
Freund O O
' O O
s O O
adjuvant O O
and O O
an O O
alum O O
adjuvant O O
. O O

In O O
each O O
of O O
the O O
last O O
two O O
booster O O
inoculations O O
, O O
blood O O
from O O
the O O
birds O O
was O O
collected O O
and O O
tested O O
for O O
HAV B B_DISEASE
antibodies O O
. O O

Egg O B_GENE/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
yolk O I_GENE/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
was O O
separated O O
from O O
egg O B_CELL[BODY_PART_OR_ORGAN_COMPONENT]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
white O I_CELL[BODY_PART_OR_ORGAN_COMPONENT]/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
immunoglobulin O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
Y O O
( O O
IgY O B_PROTEIN[GENE]/B_LOCATION
) O O
antibody O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
was O O
then O O
purified O O
by O O
polyethylene O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
glycol O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
6000 O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

The O O
mean O B_MEASURE
yield O I_MEASURE
of O O
total O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
protein O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
in O O
yolk O B_BODY_SUBSTANCE[BODY_PART_OR_ORGAN_COMPONENT]
was O O
22 O B_MEASURE
. O O
62 O B_MEASURE
mg O I_MEASURE
/ O O
mL O B_MEASURE/B_LOCATION
. O O

Specific O O
activity O O
of O O
the O O
antibody O O
was O O
tested O O
using O O
commercial O O
ELISA O O
, O O
Western O O
blotting O O
, O O
and O O
in O O
vitro O O
neutralization O O
assay O O
demonstrating O O
that O O
anti O O
- O O
HAV B B_SPECIES[BIO]/B_DISEASE
IgY O O
bound O O
specifically O O
. O O

After O O
the O O
first O O
immunization O O
, O O
birds O O
immunized O O
with O O
HAV B B_DISEASE/B_CELL[BODY_PART_OR_ORGAN_COMPONENT]
from O O
cell O O
culture O O
plus O O
incomplete O O
Freund O O
' O O
s O O
adjuvant O O
with O O
/ O O
without O O
CpG O O
- O O
ODN O O
showed O O
highest O O
levels O O
of O O
anti O O
- O O
HAV B B_DISEASE
IgY O O
in O O
serum O O
( O O
p O O
& O O
lt O O
; O O
0 O O
. O O
05 O O
) O O
. O O

Viral O O
combination O O
with O O
CpG O O
- O O
ODN O O
resulted O O
in O O
early O O
response O O
of O O
anti O O
- O O
HAV B B_GENE/B_DISEASE
serum O O
in O O
hens B B_PERSON/B_SPECIES[BIO]
, O O
reflecting O O
the O O
amount O O
of O O
IgY O O
transferred O O
to O O
the O O
egg O O
yolk O O
( O O
p O O
& O O
lt O O
; O O
0 O O
. O O
05 O O
) O O
. O O

The O O
results O O
suggest O O
that O O
egg O O
yolk O O
may O O
be O O
a O O
large O O
scale O O
source O O
of O O
specific O O
antibodies O O
against O O
hepatitis B B_DISEASE/B_VIRUS[BIO]
A I B_DISEASE/I_VIRUS[BIO]
virus I B_DISEASE/I_VIRUS[BIO]
. O O

Further O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
applications O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
this O O
method O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
have O O
yet O O
to O O
be O O
tested O O
. O O

Cotterillia B B_BIO/B_SEQUENCE[MEASURE]
bromelicola I B_BIO/I_SEQUENCE[MEASURE]
nov I B_BIO/I_SEQUENCE[MEASURE]
. I B_BIO/I_SEQUENCE[MEASURE]
gen I B_BIO/I_SEQUENCE[MEASURE]
. I B_BIO/I_SEQUENCE[MEASURE]
, I B_BIO/I_SEQUENCE[MEASURE]
nov I B_BIO/I_SEQUENCE[MEASURE]
. I B_BIO/I_SEQUENCE[MEASURE]
spec I B_BIO/I_SEQUENCE[MEASURE]
. I B_BIO/I_SEQUENCE[MEASURE]
, O O
a O O
gonostomatid O O
ciliate O O
( O O
Ciliophora O O
, O O
Hypotricha O O
) O O
from O O
tank O O
bromeliads O O
( O O
Bromeliaceae O O
) O O
with O O
de O O
novo O O
originating O O
dorsal O O
kineties O O
. O O

Cotterillia B B_BIO
bromelicola I I_BIO
nov I I_BIO
. I I_BIO
gen I I_BIO
. I I_BIO
, I I_BIO
nov I I_BIO
. I I_BIO
spec I I_BIO
. I I_BIO

was O O
discovered O O
in O O
the O O
tanks O O
of O O
the O O
Mexican O O
bromeliad O O
Tillandsia B B_BIO/B_LOCATION
heterophylla I B_BIO/I_LOCATION
. O O

Its O O
morphology O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
, O O
ontogenesis O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
, O O
and O O
18S O B_GENE/B_ORGANISM_FUNCTION
rDNA O B_GENE/I_ORGANISM_FUNCTION
were O O
studied O O
with O O
standard O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
methods O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

Cotterillia B B_PERSON/B_DISEASE_ADJECTIVE[DISEASE]
has O O
many O O
cirral O O
rows O O
on O O
both O O
sides O O
of O O
the O O
body O O
. O O

Uniquely O O
, O O
and O O
thus O O
used O O
to O O
diagnose O O
the O O
new O O
genus O O
Cotterillia B B_DISEASE_ADJECTIVE[DISEASE]/B_LOCATION
, O O
it O O
has O O
dorsal O O
kineties O O
originating O O
de O O
novo O O
, O O
producing O O
neokinetal O O
waves O O
where O O
the O O
parental O O
dorsal O O
kineties O O
reorganize O O
to O O
& O O
quot O O
; O O
combined O O
rows O O
& O O
quot O O
; O O
, O O
consisting O O
of O O
dorsal O O
bristles O O
anteriorly O O
and O O
of O O
cirri O O
posteriorly O O
. O O

Thus O O
, O O
up O O
to O O
four O B_NUMBER[MEASURE]
generations O I_NUMBER[MEASURE]
of O O
bristles O B_BIO/B_BODY_PART_OR_ORGAN_COMPONENT
and O O
cirri O B_BODY_PART_OR_ORGAN_COMPONENT/B_DISEASE_ADJECTIVE[DISEASE]
occur O O
on O O
the O O
dorsal O B_BODY_PART_OR_ORGAN_COMPONENT/B_BIO
body O B_BODY_PART_OR_ORGAN_COMPONENT/I_BIO
surface O B_BODY_PART_OR_ORGAN_COMPONENT/I_BIO
. O O

Cotterillia B B_PERSON/B_BIO
bromelicola I I_PERSON/I_BIO
has O O
a O O
gonostomatid O O
body O O
and O O
adoral O O
zone O O
of O O
membranelles O O
, O O
while O O
the O O
dense O O
ciliature O O
and O O
the O O
neokinetal O O
waves O O
resemble O O
kahliellid O O
hypotrichs O O
. O O

However O O
, O O
the O O
de O O
novo O O
origin O O
of O O
anlage O O
1 O O
and O O
the O O
molecular O O
analyses O O
show O O
convincingly O O
that O O
Cotterillia B B_DISEASE_ADJECTIVE[DISEASE]/B_BIO
belongs O O
to O O
the O O
Gonostomatidae O O
Small O O
and O O
Lynn O O
, O O
1985 O O
, O O
for O O
which O O
an O O
improved O O
diagnosis O O
is O O
provided O O
. O O

Thus O O
, O O
neokinetal O B_PERSON/B_LOCATION
waves O I_PERSON/I_LOCATION
originated O O
several O B_MEASURE/B_LOCATION
times O I_MEASURE/I_LOCATION
independently O O
. O O

The O O
molecular O O
differences O O
between O O
Trachelostyla O O
, O O
Gonostomum O O
, O O
and O O
Cotterillia B B_BACTERIUM[BIO]/B_DISEASE_ADJECTIVE[DISEASE]
are O O
small O O
( O O
= O O
< O O
5 O O
% O O
) O O
compared O O
to O O
their O O
distinct O O
morphologies O O
and O O
ontogeneses O O
, O O
suggesting O O
that O O
the O O
18S O O
rDNA O O
underestimates O O
generic O O
diversity O O
. O O

Our O O
study O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
emphasizes O O
the O O
need O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
combined O O
morphological O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
, O O
ontogenetic O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
, O O
and O O
molecular O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
investigations O B_DISEASE_ADJECTIVE[DISEASE]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
to O O
unravel O O
the O O
complex O B_ORGANIZATION/B_LOCATION
phylogeny O I_ORGANIZATION/I_LOCATION
and O O
evolution O B_EDU[ORGANIZATION]/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
hypotrich O B_BIO
ciliates O I_BIO
. O O

The O O
nodulation O O
of O O
alfalfa O O
by O O
the O O
acid O O
- O O
tolerant O O
Rhizobium B B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
sp I I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
. I I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
strain I I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
LPU83 I I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
does O O
not O O
require O O
sulfated O O
forms O O
of O O
lipochitooligosaccharide O O
nodulation O O
signals O O
. O O

The O O
induction O B_TIME[MEASURE]/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
of O O
root O B_DISEASE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
nodules O I_DISEASE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
by O O
the O O
majority O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
of O O
rhizobia O B_BIO
has O O
a O O
strict O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
requirement O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
for O O
the O O
secretion O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_GENE
of O O
symbiosis O B_DISEASE_ADJECTIVE[DISEASE]/B_BIO
- O O
specific O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
lipochitooligosaccharides O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
( O O
nodulation O B_DISEASE/B_PROTEIN[GENE]
factors O B_DISEASE/I_PROTEIN[GENE]
[ O B_DISEASE/I_PROTEIN[GENE]
NFs O B_DISEASE/I_PROTEIN[GENE]
] O B_DISEASE/I_PROTEIN[GENE]
) O O
. O O

The O O
nature O B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
of O O
the O O
chemical O B_DISEASE_ADJECTIVE[DISEASE]
substitution O I_DISEASE_ADJECTIVE[DISEASE]
on O O
the O O
NFs O B_DISEASE_ADJECTIVE[DISEASE]/B_BIO
depends O O
on O O
the O O
particular O B_BIO/B_LOCATION
rhizobium O B_BIO/I_LOCATION
and O O
contributes O O
to O O
the O O
host O B_DISEASE_ADJECTIVE[DISEASE]/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
specificity O B_DISEASE_ADJECTIVE[DISEASE]/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
imparted O O
by O O
the O O
NFs O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
. O O

We O O
present O O
here O O
a O O
description O O
of O O
the O O
genetic O O
organization O O
of O O
the O O
nod O O
gene O O
cluster O O
and O O
the O O
characterization O O
of O O
the O O
chemical O O
structure O O
of O O
the O O
NFs O O
associated O O
with O O
the O O
broad O O
- O O
host O O
- O O
range O O
Rhizobium B B_BACTERIUM[BIO]/B_DISEASE_ADJECTIVE[DISEASE]
sp I I_BACTERIUM[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
. I I_BACTERIUM[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
strain I I_BACTERIUM[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
LPU83 I I_BACTERIUM[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
, O O
a O O
bacterium O O
capable O O
of O O
nodulating O O
at O O
least O O
alfalfa B B_BIO/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
bean O O
, O O
and O O
Leucena B B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
leucocephala I I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
. O O

The O O
nod O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
gene O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
cluster O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
was O O
located O O
on O O
the O O
plasmid O B_GENE/B_LOCATION
pLPU83b O I_GENE/I_LOCATION
. O O

The O O
organization O O
of O O
the O O
cluster O O
showed O O
synteny O O
with O O
those O O
of O O
the O O
alfalfa B B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
- O O
nodulating O O
rhizobia O O
, O O
Sinorhizobium B B_BIO
meliloti I I_BIO
and O O
Sinorhizobium B B_BIO/B_GENE
medicae I I_BIO/I_GENE
. O O

Interestingly O O
, O O
the O O
strongest O O
sequence O O
similarity O O
observed O O
was O O
between O O
the O O
partial O O
nod O O
sequences O O
of O O
Rhizobium B B_BIO
mongolense I I_BIO
USDA I I_BIO
1844 I I_BIO
and O O
the O O
corresponding O O
LPU83 B B_DISEASE_ADJECTIVE[DISEASE]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
nod O O
genes O O
sequences O O
. O O

The O O
phylogenetic O O
analysis O O
of O O
the O O
intergenic O O
region O O
nodEG O O
positions O O
strain O O
LPU83 B B_MEASURE
and O O
the O O
type O O
strain O O
R B B_LOCATION/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. I I_LOCATION/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
mongolense I I_LOCATION/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
1844 I I_LOCATION/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
in O O
the O O
same O O
branch O O
, O O
which O O
indicates O O
that O O
Rhizobium B B_PERSON/B_LOCATION
sp I I_PERSON/I_LOCATION
. I I_PERSON/I_LOCATION
strain I I_PERSON/I_LOCATION
LPU83 I I_PERSON/I_LOCATION
might O O
represent O O
an O O
early O O
alfalfa B B_PERSON/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- O O
nodulating O O
genotype O O
. O O

The O O
NF O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
chemical O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
structures O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
obtained O O
for O O
the O O
wild O B_BIO
- O O
type O B_BIO/B_GENE
strain O I_BIO/I_GENE
consist O O
of O O
a O O
trimeric O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BACTERIUM[BIO]
, O O
tetrameric O B_BACTERIUM[BIO]/B_CHEMICAL_CLASS[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
and O O
pentameric O B_LOCATION/B_PROTEIN[GENE]
chitin O B_LOCATION/I_PROTEIN[GENE]
backbone O B_LOCATION/I_PROTEIN[GENE]
that O O
shares O O
some O O
substitutions O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
with O O
both O O
alfalfa O B_BIO/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- O O
and O O
bean O B_BIO/B_DISEASE
- O O
nodulating O O
rhizobia O B_BIO/B_PROTEIN[GENE]
. O O

Remarkably O O
, O O
while O O
in O O
strain O O
LPU83 B B_PROTEIN[GENE]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
most O O
of O O
the O O
NFs O O
were O O
sulfated O O
in O O
their O O
reducing O O
terminal O O
residue O O
, O O
none O O
of O O
the O O
NFs O O
isolated O O
from O O
the O O
nodH O O
mutant O O
LPU83 B B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
- I B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_BIO
H I B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_BIO
were O O
sulfated O O
. O O

The O O
evidence O O
obtained O O
supports O O
the O O
notion O O
that O O
the O O
sulfate O O
decoration O O
of O O
NFs O O
in O O
LPU83 B B_BIO/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
is O O
not O O
necessary O O
for O O
alfalfa B B_DISEASE_ADJECTIVE[DISEASE]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
nodulation O O
. O O

The O O
Rcs O O
signal O O
transduction O O
pathway O O
is O O
triggered O O
by O O
enterobacterial O O
common O O
antigen O O
structure O O
alterations O O
in O O
Serratia B B_SPECIES[BIO]
marcescens I I_SPECIES[BIO]
. O O

The O O
enterobacterial O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BACTERIUM[BIO]
common O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_BACTERIUM[BIO]
antigen O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_BACTERIUM[BIO]
( O O
ECA O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
) O O
is O O
a O O
highly O O
conserved O B_DISEASE_ADJECTIVE[DISEASE]/B_GENE
exopolysaccharide O I_DISEASE_ADJECTIVE[DISEASE]/I_GENE
in O O
Gram O B_BACTERIUM[BIO]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- O O
negative O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
bacteria O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
whose O O
role O B_MEASURE/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
remains O O
largely O O
uncharacterized O B_DISEASE_ADJECTIVE[DISEASE]/B_BACTERIUM[BIO]
. O O

In O O
a O O
previous O O
work O O
, O O
we O O
have O O
demonstrated O O
that O O
disrupting O O
the O O
integrity O O
of O O
the O O
ECA O O
biosynthetic O O
pathway O O
imposed O O
severe O O
deficiencies O O
to O O
the O O
Serratia B B_BACTERIUM[BIO]/B_DISEASE_ADJECTIVE[DISEASE]
marcescens I B_BACTERIUM[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
motile O O
( O O
swimming O O
and O O
swarming O O
) O O
capacity O O
. O O

In O O
this O O
work O B_LOCATION/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
we O O
show O O
that O O
alterations O B_CELL_OR_MOLECULAR_DYSFUNCTION[DISEASE]/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
in O O
the O O
ECA O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
structure O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
activate O O
the O O
Rcs O B_GENE/B_CELL[BODY_PART_OR_ORGAN_COMPONENT]
phosphorelay O I_GENE/I_CELL[BODY_PART_OR_ORGAN_COMPONENT]
, O O
which O O
results O O
in O O
the O O
repression O B_DISEASE_ADJECTIVE[DISEASE]/B_GENE
of O O
the O O
flagellar O B_GENE/B_LOCATION
biogenesis O I_GENE/I_LOCATION
regulatory O I_GENE/I_LOCATION
cascade O I_GENE/I_LOCATION
. O O

In O O
addition O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
, O O
a O O
detailed O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
analysis O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
of O O
wec O B_DISEASE_ADJECTIVE[DISEASE]/B_CHEMICAL_CLASS[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
cluster O B_DISEASE_ADJECTIVE[DISEASE]/I_CHEMICAL_CLASS[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
mutant O B_DISEASE_ADJECTIVE[DISEASE]/I_CHEMICAL_CLASS[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
strains O B_DISEASE_ADJECTIVE[DISEASE]/I_CHEMICAL_CLASS[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
which O O
provoke O O
the O O
disruption O B_DISEASE/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
of O O
the O O
ECA O B_GENE/B_BACTERIUM[BIO]
biosynthesis O I_GENE/I_BACTERIUM[BIO]
at O O
different O B_LOCATION/B_MEASURE
levels O I_LOCATION/I_MEASURE
of O O
the O O
pathway O B_DISEASE/B_GENE
, O O
suggests O O
that O O
the O O
absence O B_DISEASE_ADJECTIVE[DISEASE]/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
of O O
the O O
periplasmic O B_GENE/B_MEASURE
ECA O I_GENE/I_MEASURE
cyclic O I_GENE/I_MEASURE
structure O I_GENE/I_MEASURE
could O O
constitute O O
a O O
potential O B_DISEASE_ADJECTIVE[DISEASE]
signal O I_DISEASE_ADJECTIVE[DISEASE]
detected O O
by O O
the O O
RcsF O B_DISEASE/B_GENE
- O O
RcsCDB O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
phosphorelay O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
. O O

We O O
also O O
identify O O
SMA1167 O O
as O O
a O O
member O O
of O O
the O O
S B B_SPECIES[BIO]
. I I_SPECIES[BIO]
marcescens I I_SPECIES[BIO]
Rcs O O
regulon O O
and O O
show O O
that O O
high O O
osmolarity O O
induces O O
Rcs O O
activity O O
in O O
this O O
bacterium O O
. O O

These O O
results O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
provide O O
a O O
new O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
perspective O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
from O O
which O O
to O O
understand O O
the O O
phylogenetic O B_DISEASE_ADJECTIVE[DISEASE]/B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
conservation O B_DISEASE_ADJECTIVE[DISEASE]/I_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
ECA O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
among O O
enterobacteria O B_BACTERIUM[BIO]
and O O
the O O
basis O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
for O O
the O O
virulence O B_DISEASE_ADJECTIVE[DISEASE]
attenuation O I_DISEASE_ADJECTIVE[DISEASE]
detected O O
in O O
wec O B_DISEASE_ADJECTIVE[DISEASE]/B_BIO
mutant O I_DISEASE_ADJECTIVE[DISEASE]/I_BIO
strains O I_DISEASE_ADJECTIVE[DISEASE]/I_BIO
in O O
other O B_BIO
pathogenic O I_BIO
bacteria O I_BIO
. O O

A O O
cis O O
- O O
encoded O O
antisense O O
small O O
RNA O O
regulated O O
by O O
the O O
HP0165 O O
- O O
HP0166 O O
two O O
- O O
component O O
system O O
controls O O
expression O O
of O O
ureB O O
in O O
Helicobacter B B_BIO
pylori I I_BIO
. O O

Expression O O
of O O
urease O O
is O O
essential O O
for O O
gastric O O
colonization O O
by O O
Helicobacter B B_BACTERIUM[BIO]/B_DISEASE
pylori I I_BACTERIUM[BIO]/I_DISEASE
. O O

The O O
increased O O
level O B_MEASURE
of O O
urease O B_BACTERIUM[BIO]/B_DISEASE_ADJECTIVE[DISEASE]
in O O
gastric O B_DISEASE_ADJECTIVE[DISEASE]/B_BIO
acidity O B_DISEASE_ADJECTIVE[DISEASE]/I_BIO
is O O
due O B_DISEASE_ADJECTIVE[DISEASE]/B_PERSON
, O O
in O O
part O B_MEASURE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
to O O
acid O O
activation O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
of O O
the O O
two O B_NUMBER[MEASURE]/B_DISEASE
- O O
component O B_LOCATION/B_PERSON
system O I_LOCATION/I_PERSON
( O O
TCS O B_DISEASE/B_LOCATION
) O O
consisting O O
of O O
the O O
membrane O B_ENZYME[GENE]
sensor O I_ENZYME[GENE]
HP0165 O I_ENZYME[GENE]
and O O
its O O
response O B_GENE/B_PERSON
regulator O I_GENE/I_PERSON
, O O
HP0166 O B_GENE/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
which O O
regulates O O
transcription O B_NUMBER[MEASURE]/B_GENE
of O O
the O O
seven O B_GENE/B_MEASURE
genes O I_GENE/I_MEASURE
of O O
the O O
urease O B_DISEASE_ADJECTIVE[DISEASE]/B_LOCATION
gene O B_DISEASE_ADJECTIVE[DISEASE]/I_LOCATION
cluster O B_DISEASE_ADJECTIVE[DISEASE]/I_LOCATION
. O O

We O O
now O O
find O O
that O O
there O O
are O O
two O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
major O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
ureAB O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
transcripts O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
: O O
a O O
2 O B_MEASURE
. O O
7 O B_MEASURE
- O O
kb O B_MEASURE/B_LOCATION
full O I_MEASURE/I_LOCATION
- O O
length O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
ureAB O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
transcript O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
and O O
a O O
1 O B_MEASURE
. O O
4 O B_MEASURE
- O O
kb O B_GENE/B_MEASURE
truncated O B_GENE/I_MEASURE
transcript O B_GENE/I_MEASURE
lacking O O
3 O B_NUMBER[MEASURE]
' O O
ureB O B_BACTERIUM[BIO]/B_GENE
. O O

Acidic O B_MEASURE/B_COLOR
pH O I_MEASURE/I_COLOR
( O O
pH O O
4 O B_MEASURE
. O O
5 O B_MEASURE
) O O
results O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
in O O
a O O
significant O B_DISEASE/B_LOCATION
increase O I_DISEASE/I_LOCATION
in O O
transcription O B_GENE
of O O
ureAB O B_GENE/B_BACTERIUM[BIO]
, O O
while O O
neutral O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
pH O O
( O O
pH O B_MEASURE
7 O I_MEASURE
. O O
4 O B_MEASURE
) O O
increases O O
the O O
truncated O O
1 O B_MEASURE
. O O
4 O B_MEASURE
- O O
kb O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
transcript O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
. O O

Northern O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
blot O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
analysis O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
with O O
sense O B_DISEASE_ADJECTIVE[DISEASE]/B_BIO
RNA O I_DISEASE_ADJECTIVE[DISEASE]/I_BIO
and O O
strand O B_GENE/B_CELL[BODY_PART_OR_ORGAN_COMPONENT]
- O O
specific O B_DISEASE_ADJECTIVE[DISEASE]/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
oligonucleotide O B_DISEASE_ADJECTIVE[DISEASE]/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
probes O B_DISEASE_ADJECTIVE[DISEASE]/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
followed O O
by O O
5 O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
' O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
rapid O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
amplification O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
cDNA O B_GENE
ends O I_GENE
detects O O
an O O
antisense O B_GENE/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
small O I_GENE/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
RNA O I_GENE/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
( O O
sRNA O B_GENE/B_BIO
) O O
encoded O O
by O O
the O O
5 O B_NUMBER[MEASURE]
' O O
ureB O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
noncoding O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
strand O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
consisting O O
of O O
- O O
290 O B_MEASURE
nucleotides O I_MEASURE
( O O
5 O B_NUMBER[MEASURE]
' O O
ureB O B_BACTERIUM[BIO]/B_LOCATION
- O O
sRNA O B_GENE/B_BIO
) O O
. O O

Deletion O B_DISEASE_ADJECTIVE[DISEASE]/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
of O O
HP0165 O B_GENE/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
elevates O O
the O O
level O B_MEASURE/B_LOCATION
of O O
the O O
truncated O O
1 O B_MEASURE
. O O
4 O B_MEASURE
- O O
kb O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
transcript O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
along O O
with O O
that O O
of O O
the O O
5 O B_MEASURE
' O O
ureB O B_BACTERIUM[BIO]/B_DISEASE
- O O
sRNA O B_GENE/B_BIO
at O O
both O O
pH O B_MEASURE
7 O I_MEASURE
. O O
4 O B_MEASURE
and O O
pH O B_MEASURE
4 O I_MEASURE
. O O
5 O B_MEASURE
. O O

Overexpression O B_GENE/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
of O O
5 O B_MEASURE/B_LOCATION
' O O
ureB O B_BACTERIUM[BIO]/B_PROTEIN[GENE]
- O O
sRNA O B_GENE/B_BIO
increases O O
the O O
1 O B_MEASURE
. O O
4 O B_MEASURE
- O O
kb O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
transcript O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
, O O
decreases O O
the O O
2 O B_MEASURE
. O O
7 O B_MEASURE
- O O
kb O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
transcript O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
, O O
and O O
decreases O O
urease O B_GENE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
activity O I_GENE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

Electrophoretic O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
mobility O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
shift O O
assay O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
shows O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
that O O
unphosphorylated O O
HP0166 O B_GENE/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
binds O I_GENE/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
specifically O O
to O O
the O O
5 O B_GENE/B_DISEASE
' O B_GENE/I_DISEASE
ureB O B_GENE/I_DISEASE
- O O
sRNA O B_GENE/B_LOCATION
promoter O I_GENE/I_LOCATION
. O O

The O O
ability O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
of O O
the O O
HP0165 O B_PROTEIN[GENE]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- O O
HP0166 O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
TCS O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_BIO
to O O
both O O
increase O O
and O O
decrease O O
ureB O B_DISEASE_ADJECTIVE[DISEASE]/B_PHYSIOLOGIC_FUNCTION[ORGANISM_FUNCTION]
expression O B_DISEASE_ADJECTIVE[DISEASE]/I_PHYSIOLOGIC_FUNCTION[ORGANISM_FUNCTION]
at O O
low O B_DISEASE_ADJECTIVE[DISEASE]
and O O
high O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
pHs O I_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
, O O
respectively O O
, O O
facilitates O O
gastric O B_DISEASE/B_ORGANISM_FUNCTION
habitation O I_DISEASE/I_ORGANISM_FUNCTION
and O O
colonization O B_DISEASE/B_ORGANISM_FUNCTION
over O O
the O O
wide O B_MEASURE/B_LOCATION
range O I_MEASURE/I_LOCATION
of O O
intragastric O B_DISEASE_ADJECTIVE[DISEASE]/B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
pHs O B_DISEASE_ADJECTIVE[DISEASE]/I_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
experienced O O
by O O
the O O
organism O B_BIO/B_BODY_PART_OR_ORGAN_COMPONENT
. O O

Non O O
- O O
structural O O
protein O O
1 O O
( O O
NS1 O O
) O O
antibody O O
- O O
based O O
assays O O
to O O
differentiate O O
West B B_DISEASE
Nile I I_DISEASE
( O O
WN O O
) O O
virus O O
from O O
Japanese O O
encephalitis O O
virus O O
infections O O
in O O
horses O O
: O O
effects O O
of O O
WN B B_DISEASE_ADJECTIVE[DISEASE]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
virus I B_DISEASE_ADJECTIVE[DISEASE]/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
NS1 O O
antibodies O O
induced O O
by O O
inactivated O O
WN O O
vaccine O O
. O O

Antibodies O O
to O O
non O O
- O O
structural O O
protein O O
1 O O
( O O
NS1 O O
) O O
of O O
West O O
Nile O O
virus O O
( O O
WNV O O
) O O
have O O
been O O
used O O
to O O
differentiate O O
WNV O O
infection O O
from O O
infection O O
by O O
serologically O O
cross O O
- O O
reactive O O
flaviviruses O O
, O O
including O O
Japanese B B_VIRUS[BIO]/B_DISEASE
encephalitis I B_VIRUS[BIO]/I_DISEASE
virus I B_VIRUS[BIO]/I_DISEASE
( O O
JEV O O
) O O
, O O
in O O
horses O O
. O O

However O O
, O O
since O O
the O O
inactivated O O
West O O
Nile O O
( O O
WN B B_PROTEIN[GENE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
) O O
vaccine O O
has O O
been O O
reported O O
to O O
induce O O
NS1 O O
antibodies O O
, O O
there O O
is O O
concern O O
about O O
the O O
reliability O O
of O O
using O O
NS1 O O
- O O
based O O
assays O O
for O O
testing O O
vaccinated O O
horses O O
. O O

Therefore O O
, O O
the O O
effect O O
of O O
inactivated O O
WN B B_DISEASE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
vaccine O O
- O O
induced O O
antibodies O O
on O O
an O O
epitope O O
- O O
blocking O O
ELISA O O
and O O
complement O O
- O O
dependent O O
cytotoxicity O O
( O O
CDC O O
) O O
assay O O
were O O
investigated O O
. O O

Both O O
assays O O
are O O
based O O
on O O
NS1 O O
antibodies O O
and O O
were O O
established O O
previously O O
to O O
differentiate O O
WNV B B_DISEASE/B_VIRUS[BIO]
from O O
JEV O O
infections O O
in O O
horses O O
. O O

Groups O B_ORGANIZATION/B_NUMBER[MEASURE]
of O O
three O B_SPECIES[BIO]/B_PERSON
horses O I_SPECIES[BIO]/I_PERSON
were O O
vaccinated O O
with O O
two O B_NUMBER[MEASURE]/B_LOCATION
or O O
three O B_NUMBER[MEASURE]/B_PERSON
doses O I_NUMBER[MEASURE]/I_PERSON
of O O
a O O
commercial O B_ORGANIZATION/B_MEASURE
inactivated O O
WN O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
vaccine O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE
and O O
NS1 O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
antibodies O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
were O O
detected O O
by O O
a O O
conventional O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
ELISA O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
after O O
the O O
second O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_DISEASE_ADJECTIVE[DISEASE]
vaccination O I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/I_DISEASE_ADJECTIVE[DISEASE]
. O O

Vaccine O O
- O O
induced O O
NS1 O O
antibodies O O
were O O
also O O
detected O O
by O O
blocking O O
ELISA O O
and O O
a O O
CDC O O
assay O O
and O O
affected O O
the O O
ability O O
of O O
these O O
assays O O
to O O
differentiate O O
WNV B B_DISEASE/B_VIRUS[BIO]
from O O
JEV B B_DISEASE/B_BIO
infections O O
. O O

However O O
, O O
the O O
effect O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
was O O
less O O
significant O B_DISEASE_ADJECTIVE[DISEASE]
in O O
the O O
CDC O B_LOCATION
assay O I_LOCATION
, O O
where O O
use O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
of O O
a O O
low O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
serum O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
concentration O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
ensured O O
effective O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
differentiation O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
. O O

The O O
more O O
efficient O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
detection O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
of O O
infection O B_DISEASE/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- O O
induced O O
antibodies O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
over O O
vaccine O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
- O O
induced O O
antibodies O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
by O O
the O O
CDC O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
assay O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
was O O
potentially O O
attributable O B_DISEASE_ADJECTIVE[DISEASE]
to O O
the O O
different O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_DISEASE_ADJECTIVE[DISEASE]
IgG O I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/I_DISEASE_ADJECTIVE[DISEASE]
isotype O I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/I_DISEASE_ADJECTIVE[DISEASE]
profiles O I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/I_DISEASE_ADJECTIVE[DISEASE]
of O O
these O O
antibodies O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
. O O

The O O
B O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
cell O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
response O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
is O O
redundant O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
highly O O
focused O O
on O O
V1V2 O B_GENE/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
during O O
early O B_DISEASE/B_ORGANISM_FUNCTION
subtype O I_DISEASE/I_ORGANISM_FUNCTION
C O I_DISEASE/I_ORGANISM_FUNCTION
infection O I_DISEASE/I_ORGANISM_FUNCTION
in O O
a O O
Zambian O B_SPECIES[BIO]/B_PERSON
seroconverter O I_SPECIES[BIO]/I_PERSON
. O O

High O O
- O O
titer O O
autologous O O
neutralizing O O
antibody O O
responses O O
have O O
been O O
demonstrated O O
during O O
early O O
subtype O O
C O O
human B B_DISEASE/B_VIRUS[BIO]
immunodeficiency I B_DISEASE/I_VIRUS[BIO]
virus I B_DISEASE/I_VIRUS[BIO]
type I B_DISEASE/I_VIRUS[BIO]
1 I B_DISEASE/I_VIRUS[BIO]
( O O
HIV B B_DISEASE
- I I_DISEASE
1 I I_DISEASE
) O O
infection O O
. O O

However O O
, O O
characterization O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
this O O
response O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
against O O
autologous O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
virus O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
at O O
the O O
monoclonal O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
antibody O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
( O O
MAb O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
) O O
level O B_MEASURE/B_LOCATION
has O O
only O O
recently O O
begun O O
to O O
be O O
elucidated O O
. O O

Here O O
we O O
describe O O
five O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_CELL[BODY_PART_OR_ORGAN_COMPONENT]
monoclonal O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_CELL[BODY_PART_OR_ORGAN_COMPONENT]
antibodies O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_CELL[BODY_PART_OR_ORGAN_COMPONENT]
derived O O
from O O
a O O
subtype O B_DISEASE
C O I_DISEASE
- O O
infected O O
seroconverter O B_SPECIES[BIO]/B_DISEASE_ADJECTIVE[DISEASE]
and O O
their O O
neutralizing O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
activities O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
against O O
pseudoviruses O B_BIO/B_GENE
that O O
carry O O
envelope O B_DISEASE/B_GENE
glycoproteins O B_DISEASE/I_GENE
from O O
48 O B_TIME[MEASURE]/B_ENT
days O I_TIME[MEASURE]/I_ENT
( O O
0 O B_TIME[MEASURE]
month O I_TIME[MEASURE]
) O O
, O O
2 O B_TIME[MEASURE]
months O I_TIME[MEASURE]
, O O
and O O
8 O B_TIME[MEASURE]
months O I_TIME[MEASURE]
after O O
the O O
estimated O O
time O B_TIME[MEASURE]/B_LOCATION
of O O
infection O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_DISEASE
. O O

Sequence O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
analysis O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
indicated O O
that O O
the O O
MAbs O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
arose O O
from O O
three O B_DISEASE/B_VIRUS[BIO]
distinct O B_DISEASE/I_VIRUS[BIO]
B O B_DISEASE/I_VIRUS[BIO]
cell O B_DISEASE/I_VIRUS[BIO]
clones O B_DISEASE/I_VIRUS[BIO]
, O O
and O O
their O O
pattern O B_MEASURE/B_DISEASE
of O O
neutralization O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANISM_FUNCTION
compared O O
to O O
that O O
in O O
patient O B_SPECIES[BIO]/B_CELL[BODY_PART_OR_ORGAN_COMPONENT]
plasma O I_SPECIES[BIO]/I_CELL[BODY_PART_OR_ORGAN_COMPONENT]
suggested O O
that O O
they O O
circulated O O
between O O
2 O B_NUMBER[MEASURE]
and O O
8 O B_TIME[MEASURE]
months O I_TIME[MEASURE]
after O O
infection O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_DISEASE
. O O

Neutralization O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_DISEASE
by O O
MAbs O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PROTEIN[GENE]
representative O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PROTEIN[GENE]
of O O
each O O
B O B_GENE/B_MEASURE
cell O I_GENE/I_MEASURE
clone O I_GENE/I_MEASURE
was O O
mapped O O
to O O
two O B_LOCATION
residues O I_LOCATION
: O O
position O B_MEASURE/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
134 O I_MEASURE/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
in O O
V1 O B_PROTEIN[GENE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
position O B_MEASURE/B_PERSON
189 O I_MEASURE/I_PERSON
in O O
V2 O B_PROTEIN[GENE]
. O O

Mutational O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
analysis O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
revealed O O
cooperative O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANIZATION
effects O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_ORGANIZATION
between O O
glycans O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BACTERIUM[BIO]
and O O
residues O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
at O O
these O O
two O B_LOCATION/B_BIO
positions O I_LOCATION/I_BIO
, O O
arguing O O
that O O
they O O
contribute O O
to O O
a O O
single O B_GENE/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
epitope O B_GENE/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

Analysis O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
the O O
cognate O B_LOCATION/B_GENE
gp120 O I_LOCATION/I_GENE
sequence O I_LOCATION/I_GENE
through O O
homology O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
modeling O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
places O O
this O O
potential O B_GENE/B_LOCATION
epitope O B_GENE/I_LOCATION
near O O
the O O
interface O B_LOCATION
between O O
the O O
V1 O B_PROTEIN[GENE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
V2 O B_PROTEIN[GENE]/B_DISEASE_ADJECTIVE[DISEASE]
loops O I_PROTEIN[GENE]/I_DISEASE_ADJECTIVE[DISEASE]
. O O

Additionally O O
, O O
the O O
escape O B_CELL_OR_MOLECULAR_DYSFUNCTION[DISEASE]/B_GENE
mutation O I_CELL_OR_MOLECULAR_DYSFUNCTION[DISEASE]/I_GENE
R189S O I_CELL_OR_MOLECULAR_DYSFUNCTION[DISEASE]/I_GENE
in O O
V2 O B_PROTEIN[GENE]
, O O
which O O
conferred O O
resistance O B_DISEASE
against O O
all O O
three O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
MAbs O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
had O O
no O O
detrimental O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
effect O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
on O O
virus O B_DISEASE
replication O I_DISEASE
in O O
vitro O B_CELL[BODY_PART_OR_ORGAN_COMPONENT]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

Taken O O
together O O
, O O
our O O
data O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
demonstrate O O
that O O
independent O B_PROTEIN[GENE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
B O I_PROTEIN[GENE]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
cells O I_PROTEIN[GENE]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
repeatedly O O
targeted O O
a O O
single O B_DISEASE_ADJECTIVE[DISEASE]/B_GENE
structure O B_DISEASE_ADJECTIVE[DISEASE]/I_GENE
in O O
V1V2 O B_GENE/B_CELL[BODY_PART_OR_ORGAN_COMPONENT]
during O O
early O B_DISEASE_ADJECTIVE[DISEASE]/B_ORGANISM_FUNCTION
infection O B_DISEASE_ADJECTIVE[DISEASE]/I_ORGANISM_FUNCTION
. O O

Despite O O
this O O
assault O B_DISEASE_ADJECTIVE[DISEASE]
, O O
a O O
single O B_GENE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
amino O I_GENE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
acid O I_GENE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
change O I_GENE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
was O O
sufficient O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
to O O
confer O O
complete O B_DISEASE_ADJECTIVE[DISEASE]
escape O I_DISEASE_ADJECTIVE[DISEASE]
with O O
minimal O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
impact O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
on O O
replication O B_MEASURE/B_DISEASE_ADJECTIVE[DISEASE]
fitness O B_MEASURE/I_DISEASE_ADJECTIVE[DISEASE]
. O O

A O O
nuclear O B_GENE/B_MEASURE
inhibitor O I_GENE/I_MEASURE
of O O
NF O B_DISEASE/B_GENE
- O O
kappaB O B_PROTEIN[GENE]/B_LOCATION
encoded O O
by O O
a O O
poxvirus O B_SPECIES[BIO]/B_GENE
. O O

Poxviruses O B_BIO/B_PERSON
have O O
evolved O O
various O B_DISEASE_ADJECTIVE[DISEASE]/B_GENE
strategies O B_DISEASE_ADJECTIVE[DISEASE]/I_GENE
to O O
inhibit O O
cytoplasmic O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
events O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
leading O O
to O O
activation O B_GENE/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
of O O
the O O
nuclear O B_GENE/B_DISEASE
factor O I_GENE/I_DISEASE
kappaB O I_GENE/I_DISEASE
( O O
NF O B_DISEASE/B_GENE
- O O
kappaB O B_GENE
) O O
signaling O O
pathway O B_LOCATION/B_BIO
, O O
with O O
individual O B_BIO/B_PERSON
viruses O I_BIO/I_PERSON
often O O
encoding O O
multiple O B_DISEASE_ADJECTIVE[DISEASE]/B_GENE
NF O B_DISEASE_ADJECTIVE[DISEASE]/I_GENE
- O O
kappaB O B_DISEASE_ADJECTIVE[DISEASE]/B_GENE
inhibitors O B_DISEASE_ADJECTIVE[DISEASE]/I_GENE
. O O

Here O O
, O O
the O O
novel O O
orf B B_VIRUS[BIO]/B_DISEASE
virus I I_VIRUS[BIO]/I_DISEASE
( O O
ORFV B B_VIRUS[BIO]
) O O
- O O
encoded O O
protein O O
ORFV002 B B_PROTEIN[GENE]/B_DISEASE_ADJECTIVE[DISEASE]
was O O
shown O O
to O O
inhibit O O
nuclear O O
events O O
regulating O O
NF O O
- O O
kappaB O O
transcriptional O O
activity O O
. O O

ORFV002 O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
expression O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
in O O
cell O B_CELL[BODY_PART_OR_ORGAN_COMPONENT]/B_DISEASE_ADJECTIVE[DISEASE]
cultures O I_CELL[BODY_PART_OR_ORGAN_COMPONENT]/I_DISEASE_ADJECTIVE[DISEASE]
significantly O O
decreased O O
wild O B_VIRUS[BIO]/B_DISEASE
- O O
type O B_DISEASE/B_MEASURE
- O O
virus O B_GENE/B_BIO
- O O
, O O
tumor O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
necrosis O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
factor O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
alpha O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
( O O
TNF O B_GENE/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- O O
alpha O B_PROTEIN[GENE]/B_LOCATION
) O O
- O O
, O O
and O O
lipopolysaccharide O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
( O O
LPS O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
) O O
- O O
induced O O
NF O B_DISEASE/B_GENE
- O O
kappaB O B_PROTEIN[GENE]/B_LOCATION
- O O
mediated O O
gene O B_GENE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
expression O I_GENE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

Expression O B_GENE/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
of O O
ORFV002 O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
in O O
cells O B_CELL[BODY_PART_OR_ORGAN_COMPONENT]
, O O
while O O
not O O
affecting O O
phosphorylation O B_GENE
or O O
nuclear O B_GENE_EXPRESSION_ADJECTIVE[GENE]/B_DISEASE_ADJECTIVE[DISEASE]
translocation O I_GENE_EXPRESSION_ADJECTIVE[GENE]/I_DISEASE_ADJECTIVE[DISEASE]
of O O
NF O B_DISEASE/B_GENE
- O O
kappaB O B_GENE
- O O
p65 O B_GENE
, O O
markedly O O
decreased O O
TNF O B_GENE/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- O O
alpha O B_PROTEIN[GENE]
- O O
and O O
wild O B_PERSON/B_VIRUS[BIO]
- O O
type O B_DISEASE/B_MEASURE
- O O
virus O B_GENE/B_BIO
- O O
induced O O
acetylation O B_GENE_EXPRESSION_ADJECTIVE[GENE]/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
of O O
NF O B_DISEASE/B_GENE
- O O
kappaB O B_GENE
- O O
p65 O B_GENE
, O O
a O O
p300 O B_GENE/B_DIAGNOSTIC_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- O O
mediated O O
nuclear O B_ENZYME[GENE]/B_DISEASE_ADJECTIVE[DISEASE]
modification O I_ENZYME[GENE]/I_DISEASE_ADJECTIVE[DISEASE]
of O O
NF O B_DISEASE/B_GENE
- O O
kappaB O B_GENE
- O O
p65 O B_GENE
that O O
regulates O O
its O O
transactivating O B_GENE_EXPRESSION_ADJECTIVE[GENE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
activity O I_GENE_EXPRESSION_ADJECTIVE[GENE]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

ORFV002 O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
was O O
shown O O
to O O
colocalize O O
and O O
interact O O
with O O
NF O B_GENE/B_DISEASE
- O O
kappaB O B_GENE
- O O
p65 O B_GENE
, O O
and O O
expression O B_GENE/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
of O O
ORFV002 O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
in O O
cell O B_DISEASE_ADJECTIVE[DISEASE]/B_CELL[BODY_PART_OR_ORGAN_COMPONENT]
cultures O B_DISEASE_ADJECTIVE[DISEASE]/I_CELL[BODY_PART_OR_ORGAN_COMPONENT]
resulted O O
in O O
a O O
reduced O O
interaction O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
of O O
NF O B_DISEASE/B_GENE
- O O
kappaB O B_GENE
- O O
p65 O B_GENE
with O O
p300 O B_GENE/B_DIAGNOSTIC_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
suggesting O O
that O O
ORFV002 O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
interferes O O
with O O
NF O B_DISEASE/B_GENE
- O O
kappaB O B_GENE
- O O
p65 O B_GENE
/ O O
p300 O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
association O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
. O O

Deletion O B_CELL_OR_MOLECULAR_DYSFUNCTION[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
ORFV002 O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
from O O
the O O
OV O B_PROTEIN[GENE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- O O
IA82 O B_GENE/B_BIO
genome O I_GENE/I_BIO
had O O
no O O
significant O B_DISEASE_ADJECTIVE[DISEASE]/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
effect O B_DISEASE_ADJECTIVE[DISEASE]/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
on O O
ORFV O B_DISEASE
pathogenesis O I_DISEASE
in O O
sheep O B_BIO
, O O
indicating O O
that O O
ORFV002 O B_GENE/B_MEASURE
is O O
nonessential O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
for O O
virus O B_DISEASE_ADJECTIVE[DISEASE]/B_ORGANISM_FUNCTION
virulence O I_DISEASE_ADJECTIVE[DISEASE]/I_ORGANISM_FUNCTION
in O O
the O O
natural O B_SPECIES[BIO]/B_BODY_PART_OR_ORGAN_COMPONENT
host O I_SPECIES[BIO]/I_BODY_PART_OR_ORGAN_COMPONENT
. O O

This O O
represents O O
the O O
first O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
description O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
of O O
a O O
nuclear O B_GENE/B_MEASURE
inhibitor O I_GENE/I_MEASURE
of O O
NF O B_DISEASE/B_GENE
- O O
kappaB O B_PROTEIN[GENE]/B_LOCATION
encoded O O
by O O
a O O
poxvirus O B_SPECIES[BIO]/B_GENE
. O O

Norovirus O B_MEASURE
GII O I_MEASURE
. O O
4 O B_MEASURE/B_PERSON
strain O O
antigenic O B_PROTEIN[GENE]/B_DISEASE_ADJECTIVE[DISEASE]
variation O I_PROTEIN[GENE]/I_DISEASE_ADJECTIVE[DISEASE]
. O O

Noroviruses O B_BACTERIUM[BIO]/B_PERSON
are O O
the O O
principal O B_DISEASE_ADJECTIVE[DISEASE]/B_BIO
cause O I_DISEASE_ADJECTIVE[DISEASE]/I_BIO
of O O
epidemic O B_DISEASE
gastroenteritis O I_DISEASE
worldwide O I_DISEASE
. O O

Multiple O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
reports O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
have O O
concluded O O
that O O
the O O
major O B_BIO/B_GENE
capsid O B_BIO/I_GENE
proteins O B_BIO/I_GENE
of O O
GII O B_MEASURE/B_PROTEIN[GENE]
. O O
4 O B_MEASURE
strains O I_MEASURE
, O O
which O O
cause O O
80 O B_MEASURE/B_DISEASE
% O I_MEASURE/I_DISEASE
of O O
norovirus O B_DISEASE/B_PERSON
infections O I_DISEASE/I_PERSON
worldwide O I_DISEASE/I_PERSON
, O O
are O O
evolving O O
rapidly O O
, O O
resulting O O
in O O
new O B_DISEASE_ADJECTIVE[DISEASE]/B_ORGANISM_FUNCTION
epidemic O I_DISEASE_ADJECTIVE[DISEASE]/I_ORGANISM_FUNCTION
strains O I_DISEASE_ADJECTIVE[DISEASE]/I_ORGANISM_FUNCTION
. O O

Surrogate O O
neutralization O O
assays O O
using O O
sera O O
from O O
outbreaks O O
and O O
from O O
immunized O O
mice O O
suggest O O
that O O
, O O
as O O
with O O
influenza B B_DISEASE
virus I I_DISEASE
, O O
antigenic O O
variation O O
maintains O O
GII O O
. O O
4 O O
persistence O O
in O O
the O O
face O O
of O O
human B B_PERSON/B_DISEASE_ADJECTIVE[DISEASE]
population O O
herd O O
immunity O O
. O O

To O O
test O O
this O O
hypothesis O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
, O O
mice O B_SPECIES[BIO]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
were O O
hyperimmunized O O
with O O
virus O B_VIRUS[BIO]/B_DISEASE
- O O
like O B_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
particles O I_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
( O O
VLPs O B_PROTEIN[GENE]/B_DISEASE_ADJECTIVE[DISEASE]
) O O
representing O O
an O O
early O B_TIME[MEASURE]/B_DISEASE_ADJECTIVE[DISEASE]
( O O
GII O B_TIME[MEASURE]/B_PROTEIN[GENE]
. O O
4 O B_NUMBER[MEASURE]
- O O
1987 O B_MEASURE
) O O
and O O
a O O
contemporary O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
( O O
GII O B_MEASURE/B_DISEASE
. O O
4 O B_MEASURE
- O O
2006 O B_MEASURE
) O O
GII O B_PROTEIN[GENE]/B_DISEASE_ADJECTIVE[DISEASE]
. O O
4 O B_MEASURE
strain O I_MEASURE
. O O

Anti O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
- O O
GII O B_DISEASE_ADJECTIVE[DISEASE]/B_PROTEIN[GENE]
. O O
4 O B_MEASURE
- O O
1987 O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
IgG O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
monoclonal O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
antibodies O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
( O O
MAbs O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
) O O
strongly O O
reacted O O
with O O
GII O B_MEASURE/B_DISEASE
. O O
4 O B_NUMBER[MEASURE]/B_LOCATION
VLPs O I_NUMBER[MEASURE]/I_LOCATION
derived O O
between O O
only O O
1987 O B_MEASURE
and O O
2002 O B_MEASURE
. O O

Ligand O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
binding O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE
blockade O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE
was O O
more O O
efficient O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
with O O
GII O B_TIME[MEASURE]/B_PROTEIN[GENE]
. O O
4 O B_MEASURE
- O O
1987 O B_MEASURE
and O O
GII O B_MEASURE/B_PROTEIN[GENE]
. O O
4 O B_MEASURE
- O O
1997 O B_MEASURE/B_ENT
VLPs O I_MEASURE/I_ENT
than O O
with O O
GII O B_TIME[MEASURE]/B_PROTEIN[GENE]
. O O
4 O B_MEASURE
- O O
2002 O B_MEASURE
. O O

Anti O B_PROTEIN[GENE]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- O O
GII O B_TIME[MEASURE]/B_DISEASE_ADJECTIVE[DISEASE]
. O O
4 O B_MEASURE
- O O
2006 O B_MEASURE/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
IgG O I_MEASURE/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
MAbs O I_MEASURE/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
recognized O O
either O O
a O O
broad O B_MEASURE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
panel O I_MEASURE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
GII O B_MEASURE/B_DISEASE
. O O
4 O B_MEASURE
VLPs O I_MEASURE
( O O
1987 O B_MEASURE
to O O
2006 O B_MEASURE
) O O
or O O
a O O
subset O B_MEASURE/B_LOCATION
of O O
contemporary O B_TIME[MEASURE]/B_LOCATION
( O O
2004 O B_MEASURE
to O O
2006 O B_MEASURE
) O O
VLPs O B_PERSON/B_BIO
. O O

Most O B_MEASURE/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
2006 O I_MEASURE/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
antibodies O I_MEASURE/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
did O O
not O O
recognize O O
or O O
only O O
poorly O O
recognized O O
GII O B_MEASURE/B_PROTEIN[GENE]
. O O
4 O B_TIME[MEASURE]/B_PERSON
VLPs O I_TIME[MEASURE]/I_PERSON
of O O
2007 O B_MEASURE
or O O
2008 O B_TIME[MEASURE]/B_LOCATION
, O O
documenting O O
rapid O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
antigenic O I_DISEASE_ADJECTIVE[DISEASE]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
evolution O I_DISEASE_ADJECTIVE[DISEASE]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
GII O B_MEASURE/B_PROTEIN[GENE]
. O O
4 O B_NUMBER[MEASURE]
capsids O I_NUMBER[MEASURE]
. O O

Generally O O
, O O
2006 O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
MAbs O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
blocked O O
homotypic O B_GENE
VLP O I_GENE
- O O
ligand O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PROTEIN[GENE]
binding O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PROTEIN[GENE]
but O O
were O O
unable O B_DISEASE_ADJECTIVE[DISEASE]
to O O
block O O
VLPs O B_DISEASE_ADJECTIVE[DISEASE]/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
representing O O
strains O B_BIO/B_PERSON
primarily O O
circulating O O
during O O
or O O
earlier O B_TIME[MEASURE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
than O O
2002 O B_TIME[MEASURE]/B_PERSON
. O O

These O O
analyses O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
demonstrate O O
that O O
both O O
subtle O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
and O O
significant O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
evolutionary O I_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
change O I_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
has O O
occurred O O
within O O
antibody O B_DISEASE_ADJECTIVE[DISEASE]/B_LOCATION
epitopes O I_DISEASE_ADJECTIVE[DISEASE]/I_LOCATION
between O O
epidemic O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
strains O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
, O O
providing O O
direct O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
evidence O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
that O O
the O O
GII O B_DISEASE/B_PROTEIN[GENE]
. O O
4 O B_SPECIES[BIO]
noroviruses O I_SPECIES[BIO]
are O O
undergoing O O
antigenic O B_DISEASE_ADJECTIVE[DISEASE]/B_ORGANISM_FUNCTION
variation O B_DISEASE_ADJECTIVE[DISEASE]/I_ORGANISM_FUNCTION
, O O
likely O O
in O O
response O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
to O O
herd O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
immunity O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE
. O O

As O O
with O O
influenza B B_DISEASE
virus I I_DISEASE
, O O
HIV O O
, O O
and O O
hepatitis B B_DISEASE
C I I_DISEASE
virus I I_DISEASE
, O O
norovirus O O
antigenic O O
variation O O
will O O
significantly O O
influence O O
the O O
design O O
of O O
efficacious O O
vaccines O O
and O O
immunotherapeutics O O
against O O
these O O
important O O
human B B_SPECIES[BIO]/B_DISEASE_ADJECTIVE[DISEASE]
pathogens O O
. O O

Dominant O B_DISEASE_ADJECTIVE[DISEASE]/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
inhibition O B_DISEASE_ADJECTIVE[DISEASE]/I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
of O O
Akt O B_GENE
/ O O
protein O B_GENE
kinase O I_GENE
B O I_GENE
signaling O O
by O O
the O O
matrix O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_DISEASE_ADJECTIVE[DISEASE]
protein O I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/I_DISEASE_ADJECTIVE[DISEASE]
of O O
a O O
negative O B_MEASURE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- O O
strand O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
RNA O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_BIO
virus O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_BIO
. O O

Vesicular B B_VIRUS[BIO]/B_DISEASE_ADJECTIVE[DISEASE]
stomatitis I I_VIRUS[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
virus I I_VIRUS[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
( O O
VSV B B_PROTEIN[GENE]/B_DISEASE_ADJECTIVE[DISEASE]
) O O
is O O
a O O
rhabdovirus O O
that O O
alters O O
host O O
nuclear O O
and O O
cytoplasmic O O
function O O
upon O O
infection O O
. O O

We O O
have O O
investigated O O
the O O
effect O O
of O O
VSV B B_DISEASE/B_VIRUS[BIO]
infection O O
on O O
cellular O O
signaling O O
through O O
the O O
phosphatidylinositol O O
- O O
3 O O
kinase O O
( O O
PI3k O O
) O O
/ O O
Akt O O
signaling O O
pathway O O
. O O

Akt O O
phosphorylation O O
at O O
both O O
threonine O O
308 O O
( O O
Thr308 O O
) O O
and O O
serine O O
473 O O
( O O
Ser473 O O
) O O
was O O
inhibited O O
in O O
cells O O
infected O O
with O O
VSV B B_DISEASE/B_VIRUS[BIO]
. O O

This O O
inhibition O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
was O O
rapid O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
( O O
beginning O O
within O O
the O O
first O B_SEQUENCE[MEASURE]/B_LOCATION
2 O I_SEQUENCE[MEASURE]/I_LOCATION
to O O
3 O B_MEASURE
h O O
postinfection O B_DISEASE_ADJECTIVE[DISEASE]/B_TIME[MEASURE]
) O O
and O O
correlated O O
with O O
the O O
dephosphorylation O B_ENZYME[GENE]/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
of O O
downstream O B_DISEASE_ADJECTIVE[DISEASE]/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
effectors O I_DISEASE_ADJECTIVE[DISEASE]/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
Akt O B_GENE
, O O
such O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
as O O
glycogen O B_GENE/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
synthase O I_GENE/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
kinase O I_GENE/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
3Beta O I_GENE/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
( O O
GSK3Beta O B_GENE
) O O
and O O
mammalian O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
target O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
of O O
rapamycin O B_GENE/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
( O O
mTOR O B_GENE
) O O
. O O

The O O
dephosphorylation O B_GENE_EXPRESSION_ADJECTIVE[GENE]/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
of O O
Akt O B_GENE
occurred O O
in O O
the O O
presence O B_DISEASE_ADJECTIVE[DISEASE]/B_LOCATION
of O O
growth O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
factor O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
stimulation O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
and O O
was O O
not O O
overcome O O
through O O
constitutive O B_DISEASE_ADJECTIVE[DISEASE]/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
membrane O B_DISEASE_ADJECTIVE[DISEASE]/I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
targeting O B_DISEASE_ADJECTIVE[DISEASE]/I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
of O O
Akt O B_GENE
or O O
high O B_DISEASE_ADJECTIVE[DISEASE]/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
levels O B_DISEASE_ADJECTIVE[DISEASE]/I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
of O O
phosphatidylinositol O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- O O
3 O B_NUMBER[MEASURE]
, O O
4 O B_NUMBER[MEASURE]
, O O
5 O B_NUMBER[MEASURE]
- O O
triphosphate O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
( O O
PIP3 O B_GENE
) O O
accumulation O B_DISEASE_ADJECTIVE[DISEASE]/B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
in O O
the O O
membrane O B_CELL_COMPONENT[BODY_PART_OR_ORGAN_COMPONENT]/B_GENE
. O O

Akt O B_DISEASE_ADJECTIVE[DISEASE]/B_PERSON
dephosphorylation O I_DISEASE_ADJECTIVE[DISEASE]/I_PERSON
was O O
not O O
a O O
result O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
of O O
alterations O B_DISEASE_ADJECTIVE[DISEASE]/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
in O O
PDK1 O B_GENE
phosphorylation O I_GENE
or O O
activity O B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE_EXPRESSION_ADJECTIVE[GENE]
, O O
changes O B_DISEASE_ADJECTIVE[DISEASE]/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
in O O
phosphatase O B_ENZYME[GENE]
and O O
tensin O B_GENE/B_DISEASE
homologue O I_GENE/I_DISEASE
deleted O O
on O O
chromosome O B_NUMBER[MEASURE]/B_GENE
10 O I_NUMBER[MEASURE]/I_GENE
( O O
PTEN O B_GENE/B_DISEASE
) O O
levels O B_GENE
, O O
or O O
the O O
downregulation O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
of O O
PI3k O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
signaling O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
. O O

Inactivation O B_DISEASE_ADJECTIVE[DISEASE]/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
of O O
Akt O B_GENE
was O O
caused O O
by O O
the O O
expression O B_GENE/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
of O O
the O O
viral O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
M O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
protein O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
in O O
the O O
absence O B_DISEASE/B_LOCATION
of O O
other O B_DISEASE/B_GENE
viral O B_DISEASE/I_GENE
components O B_DISEASE/I_GENE
, O O
and O O
an O O
M O B_GENE
protein O I_GENE
mutant O I_GENE
that O O
does O O
not O O
inhibit O O
RNA O B_GENE
polymerase O I_GENE
II O I_GENE
( O O
Pol O B_PROTEIN[GENE]/B_DISEASE
II O I_PROTEIN[GENE]/I_DISEASE
) O O
transcription O B_GENE
and O O
nuclear O B_CELL_COMPONENT[BODY_PART_OR_ORGAN_COMPONENT]/B_GENE
/ O O
cytoplasmic O B_DISEASE_ADJECTIVE[DISEASE]/B_CELL_COMPONENT[BODY_PART_OR_ORGAN_COMPONENT]
transport O B_DISEASE_ADJECTIVE[DISEASE]/I_CELL_COMPONENT[BODY_PART_OR_ORGAN_COMPONENT]
was O O
also O O
defective O B_DISEASE_ADJECTIVE[DISEASE]/B_PERSON
in O O
inhibiting O O
Akt O B_GENE
phosphorylation O I_GENE
. O O

These O O
data O O
illustrate O O
that O O
VSV B B_DISEASE/B_GENE
utilizes O O
a O O
novel O O
mechanism O O
to O O
alter O O
this O O
central O O
player O O
in O O
cell O O
signaling O O
and O O
oncogenesis O O
. O O

It O O
also O O
suggests O O
an O O
inside O O
- O O
out O O
model O O
of O O
signal O O
transduction O O
where O O
VSV B B_DISEASE_ADJECTIVE[DISEASE]/B_LOCATION
interruption O O
of O O
nuclear O O
events O O
has O O
a O O
rapid O O
and O O
significant O O
effect O O
on O O
membrane O O
signaling O O
events O O
. O O

Activation O O
of O O
plasmacytoid O O
dendritic O O
cells O O
by O O
Kaposi B B_DISEASE/B_GENE
' I B_DISEASE/I_GENE
s I B_DISEASE/I_GENE
sarcoma I B_DISEASE/I_GENE
- I B_DISEASE/I_GENE
associated I B_DISEASE/I_GENE
herpesvirus I B_DISEASE/I_GENE
. O O

Kaposi B B_VIRUS[BIO]/B_DISEASE_ADJECTIVE[DISEASE]
' I I_VIRUS[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
s I I_VIRUS[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
sarcoma I I_VIRUS[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
- I I_VIRUS[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
associated I I_VIRUS[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
herpesvirus I I_VIRUS[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
( O O
KSHV B B_VIRUS[BIO]/B_LOCATION
) O O
is O O
associated O O
with O O
multiple O O
human B B_PERSON/B_BIO
malignancies O O
, O O
including O O
Kaposi O O
' O O
s O O
sarcoma O O
, O O
primary O O
effusion O O
lymphoma O O
, O O
and O O
multicentric O O
Castleman O O
' O O
s O O
disease O O
. O O

Following O O
primary O O
infection O O
, O O
KSHV B B_DISEASE_ADJECTIVE[DISEASE]/B_BIO
typically O O
goes O O
through O O
a O O
brief O O
period O O
of O O
lytic O O
replication O O
prior O O
to O O
the O O
establishment O O
of O O
latency O O
. O O

Plasmacytoid O B_CELL[BODY_PART_OR_ORGAN_COMPONENT]/B_BIO
dendritic O I_CELL[BODY_PART_OR_ORGAN_COMPONENT]/I_BIO
cells O I_CELL[BODY_PART_OR_ORGAN_COMPONENT]/I_BIO
( O O
pDCs O B_GENE/B_LOCATION
) O O
are O O
the O O
major O B_PERSON/B_LOCATION
producers O I_PERSON/I_LOCATION
of O O
type O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
1 O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
interferon O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
( O O
IFN O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
) O O
, O O
primarily O O
in O O
response O B_MEASURE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
to O O
virus O B_DISEASE_ADJECTIVE[DISEASE]
infection O I_DISEASE_ADJECTIVE[DISEASE]
. O O

Toll O B_GENE
- O O
like O B_GENE/B_LOCATION
receptors O I_GENE/I_LOCATION
( O O
TLRs O B_GENE
) O O
are O O
key O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
components O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
of O O
the O O
innate O B_DISEASE_ADJECTIVE[DISEASE]/B_CELL[BODY_PART_OR_ORGAN_COMPONENT]
immune O B_DISEASE_ADJECTIVE[DISEASE]/I_CELL[BODY_PART_OR_ORGAN_COMPONENT]
system O B_DISEASE_ADJECTIVE[DISEASE]/I_CELL[BODY_PART_OR_ORGAN_COMPONENT]
, O O
and O O
they O O
serve O O
as O O
pathogen O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
recognition O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
receptors O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
that O O
stimulate O O
the O O
host O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_CELL[BODY_PART_OR_ORGAN_COMPONENT]
antiviral O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_CELL[BODY_PART_OR_ORGAN_COMPONENT]
response O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_CELL[BODY_PART_OR_ORGAN_COMPONENT]
. O O

pDCs O B_PERSON/B_CELL[BODY_PART_OR_ORGAN_COMPONENT]
express O O
exclusively O O
TLR7 O B_GENE
and O O
TLR9 O B_MEASURE/B_GENE
, O O
and O O
it O O
is O O
through O O
these O O
TLRs O B_GENE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
that O O
the O O
type O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
1 O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
interferon O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
response O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
is O O
activated O O
in O O
pDCs O B_DISEASE/B_LOCATION
. O O

Currently O O
, O O
it O O
is O O
not O O
known O O
whether O O
KSHV B B_VIRUS[BIO]/B_GENE
is O O
recognized O O
by O O
pDCs O O
and O O
whether O O
activation O O
of O O
pDCs O O
occurs O O
in O O
response O O
to O O
KSHV B B_VIRUS[BIO]/B_DISEASE_ADJECTIVE[DISEASE]
infection O O
. O O

We O O
now O O
report O O
evidence O O
that O O
KSHV B B_VIRUS[BIO]
can O O
infect O O
human B B_PERSON/B_SPECIES[BIO]
pDCs O O
and O O
that O O
pDCs O O
are O O
activated O O
upon O O
KSHV B B_DISEASE_ADJECTIVE[DISEASE]/B_BIO
infection O O
, O O
as O O
measured O O
by O O
upregulation O O
of O O
CD83 O O
and O O
CD86 O O
and O O
by O O
IFN O O
- O O
alpha O O
secretion O O
. O O

We O O
further O O
show O O
that O O
induction O O
of O O
IFN O O
- O O
alpha O O
occurs O O
through O O
activation O O
of O O
TLR9 O O
signaling O O
and O O
that O O
a O O
TLR9 O O
inhibitor O O
diminishes O O
the O O
production O O
and O O
secretion O O
of O O
IFN O O
- O O
alpha O O
by O O
KSHV B B_VIRUS[BIO]/B_DISEASE
- O O
infected O O
pDCs O O
. O O

An O O
in O O
- O O
depth O O
analysis O O
of O O
original O O
antigenic O O
sin O O
in O O
dengue B B_DISEASE/B_SPECIES[BIO]
virus I I_DISEASE/I_SPECIES[BIO]
infection O O
. O O

The O O
evolution O O
of O O
dengue B B_VIRUS[BIO]/B_DISEASE
viruses I B_VIRUS[BIO]/I_DISEASE
has O O
resulted O O
in O O
four O O
antigenically O O
similar O O
yet O O
distinct O O
serotypes O O
. O O

Infection O B_DISEASE/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
with O O
one O B_DISEASE
serotype O I_DISEASE
likely O O
elicits O O
lifelong O B_DISEASE/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
immunity O B_DISEASE/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
to O O
that O O
serotype O B_BACTERIUM[BIO]/B_DISEASE
, O O
but O O
generally O O
not O O
against O O
the O O
other O B_NUMBER[MEASURE]/B_PERSON
three O B_NUMBER[MEASURE]/I_PERSON
. O O

Secondary O B_LOCATION/B_DISEASE_ADJECTIVE[DISEASE]
or O O
sequential O B_DISEASE_ADJECTIVE[DISEASE]
infections O I_DISEASE_ADJECTIVE[DISEASE]
are O O
common O B_DISEASE_ADJECTIVE[DISEASE]
, O O
as O O
multiple O B_DISEASE/B_PERSON
viral O I_DISEASE/I_PERSON
serotypes O I_DISEASE/I_PERSON
frequently O O
cocirculate O O
. O O

Dengue B B_DISEASE
infection O O
, O O
although O O
frequently O O
mild O O
, O O
can O O
lead O O
to O O
dengue B B_DISEASE_ADJECTIVE[DISEASE]
hemorrhagic O O
fever O O
( O O
DHF O O
) O O
which O O
can O O
be O O
life O O
threatening O O
. O O

DHF O O
is O O
more O O
common O O
in O O
secondary O O
dengue B B_DISEASE/B_VIRUS[BIO]
infections O O
, O O
implying O O
a O O
role O O
for O O
the O O
adaptive O O
immune O O
response O O
in O O
the O O
disease O O
. O O

There O O
is O O
currently O O
much O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
effort O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
toward O O
the O O
design O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
and O O
implementation O B_PERSON/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
a O O
dengue O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
vaccine O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
but O O
these O O
efforts O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANIZATION
are O O
made O O
more O O
difficult O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
by O O
the O O
challenge O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
of O O
inducing O O
durable O B_DISEASE/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
neutralizing O B_DISEASE/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
immunity O B_DISEASE/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
to O O
all O O
four O B_BIO
viruses O I_BIO
. O O

Domain O O
3 O O
of O O
the O O
dengue B B_SPECIES[BIO]
virus I I_SPECIES[BIO]
envelope O O
protein O O
( O O
ED3 O O
) O O
has O O
been O O
suggested O O
as O O
one O O
such O O
candidate O O
because O O
it O O
contains O O
neutralizing O O
epitopes O O
and O O
it O O
was O O
originally O O
thought O O
that O O
relatively O O
few O O
cross O O
- O O
reactive O O
antibodies O O
are O O
directed O O
to O O
this O O
domain O O
. O O

In O O
this O O
study O O
, O O
we O O
performed O O
a O O
detailed O O
analysis O O
of O O
the O O
anti O O
- O O
ED3 O O
response O O
in O O
a O O
cohort O O
of O O
patients O O
suffering O O
either O O
primary O O
or O O
secondary O O
dengue B B_DISEASE/B_VIRUS[BIO]
infections O O
. O O

The O O
results O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
show O O
dramatic O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
evidence O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
of O O
original O B_DISEASE_ADJECTIVE[DISEASE]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
antigenic O I_DISEASE_ADJECTIVE[DISEASE]/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
sin O I_DISEASE_ADJECTIVE[DISEASE]/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
in O O
secondary O B_DISEASE_ADJECTIVE[DISEASE]/B_BIO
infections O B_DISEASE_ADJECTIVE[DISEASE]/I_BIO
both O O
in O O
terms O B_LOCATION/B_MEASURE
of O O
binding O B_GENE/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
enhancement O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
activity O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

This O O
has O O
important O O
implications O O
for O O
dengue B B_DISEASE
vaccine O O
design O O
because O O
heterologous O O
boosting O O
is O O
likely O O
to O O
maintain O O
the O O
immunological O O
footprint O O
of O O
the O O
first O O
vaccination O O
. O O

On O O
the O O
basis O O
of O O
these O O
findings O O
, O O
we O O
propose O O
a O O
simple O O
in O O
vitro O O
enzyme O O
- O O
linked O O
immunosorbent O O
assay O O
( O O
ELISA O O
) O O
to O O
diagnose O O
the O O
original O O
dengue B B_DISEASE
infection O O
in O O
secondary O O
dengue B B_DISEASE/B_PERSON
cases O O
. O O

When O O
it O O
is O O
too O O
hot O B_DISEASE_ADJECTIVE[DISEASE]/B_BODY_PART_OR_ORGAN_COMPONENT
for O O
photosynthesis O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANISM_FUNCTION
: O O
heat O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
- O O
induced O O
instability O B_DISEASE
of O O
photosynthesis O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_CELL_COMPONENT[BODY_PART_OR_ORGAN_COMPONENT]
in O O
relation O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
to O O
respiratory O B_DISEASE_ADJECTIVE[DISEASE]/B_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
burst O B_DISEASE_ADJECTIVE[DISEASE]/I_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
cell O B_DISEASE_ADJECTIVE[DISEASE]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
permeability O B_DISEASE_ADJECTIVE[DISEASE]/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
changes O B_DISEASE_ADJECTIVE[DISEASE]/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
H2O2 O B_DISEASE
formation O I_DISEASE
. O O

Photosynthesis O B_MEASURE/B_LOCATION
rate O I_MEASURE/I_LOCATION
( O O
A O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PROTEIN[GENE]
( O O
n O B_MEASURE/B_PROTEIN[GENE]
) O O
) O O
becomes O O
unstable O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
above O O
a O O
threshold O B_MEASURE/B_LOCATION
temperature O I_MEASURE/I_LOCATION
, O O
and O O
the O O
recovery O B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
upon O O
return O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
to O O
low O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
temperature O B_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
varies O O
because O O
of O O
reasons O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
not O O
fully O O
understood O O
. O O

We O O
investigated O O
responses O O
of O O
A O O
( O O
n O O
) O O
, O O
dark O O
respiration O O
and O O
chlorophyll O O
fluorescence O O
to O O
supraoptimal O O
temperatures O O
of O O
varying O O
duration O O
and O O
kinetics O O
in O O
Phaseolus B B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
vulgaris I I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
asking O O
whether O O
the O O
instability O O
of O O
photosynthesis O O
under O O
severe O O
heat O O
stress O O
is O O
associated O O
with O O
cellular O O
damage O O
. O O

Cellular O B_DISEASE/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
damage O I_DISEASE/I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
was O O
assessed O O
by O O
Evans O B_DISEASE/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
blue O B_DISEASE/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
penetration O B_DISEASE/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
( O O
enhanced O B_GENE/B_LOCATION
membrane O I_GENE/I_LOCATION
permeability O I_GENE/I_LOCATION
) O O
and O O
by O O
H2O2 O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
generation O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
[ O I_MEASURE
3 O I_MEASURE
, O O
3 O B_NUMBER[MEASURE]
' O I_MEASURE
- O O
diaminobenzidine O B_PROTEIN[GENE]
4HCl O I_PROTEIN[GENE]
( O O
DAB O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
) O O
- O O
staining O O
] O O
. O O

Critical O B_MEASURE
temperature O I_MEASURE
for O O
dark O B_MEASURE/B_LOCATION
fluorescence O I_MEASURE/I_LOCATION
( O O
F O B_PROTEIN[GENE]/B_DISEASE
( O O
0 O B_MEASURE/B_LOCATION
) O O
) O O
rise O O
( O O
T O B_PROTEIN[GENE]/B_LOCATION
( O O
F O B_MEASURE/B_DISEASE
) O O
) O O
was O O
at O O
46 O B_MEASURE
- O O
48 O B_MEASURE
^ O I_MEASURE
0C O I_MEASURE
, O O
and O O
a O O
burst O B_DISEASE/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
of O O
respiration O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BODY_PART_OR_ORGAN_COMPONENT
was O O
observed O O
near O O
T O B_PROTEIN[GENE]/B_LOCATION
( O O
F O B_MEASURE/B_PROTEIN[GENE]
) O O
. O O

However O O
, O O
A O O
( O O
n O B_OTHER/B_MEASURE
) O O
was O O
strongly O O
inhibited O O
already O O
before O O
T O B_PROTEIN[GENE]/B_LOCATION
( O O
F O B_MEASURE/B_DISEASE
) O O
was O O
reached O O
. O O

Membrane O B_DISEASE/B_MEASURE
permeability O I_DISEASE/I_MEASURE
increased O O
with O O
temperature O B_MEASURE
according O O
to O O
a O O
switch O B_BODY_PART_OR_ORGAN_COMPONENT/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- O O
type O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
response O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
, O O
with O O
enhanced O O
permeability O B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BODY_PART_OR_ORGAN_COMPONENT
observed O O
above O O
48 O B_MEASURE
^ O O
0C O B_MEASURE/B_PROTEIN[GENE]
. O O

Experiments O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
with O O
varying O O
heat O B_MEASURE
pulse O I_MEASURE
lengths O I_MEASURE
and O O
intensities O B_MEASURE/B_LOCATION
underscored O O
the O O
threshold O B_DISEASE_ADJECTIVE[DISEASE]/B_DIAGNOSTIC_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- O O
type O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
loss O B_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
of O O
photosynthetic O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
function O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_BIO
, O O
and O O
indicated O O
that O O
the O O
degree O B_MEASURE
of O O
photosynthetic O B_DISEASE_ADJECTIVE[DISEASE]
deterioration O I_DISEASE_ADJECTIVE[DISEASE]
and O O
cellular O B_DISEASE/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
damage O I_DISEASE/I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
depended O O
on O O
accumulated O O
heat O B_DISEASE/B_BIO
- O O
dose O B_MEASURE/B_DISEASE
. O O

Beyond O O
the O O
' O O
point O B_LOCATION/B_MEASURE
of O O
no O O
return O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_DISEASE
' O O
, O O
propagation O B_DISEASE_ADJECTIVE[DISEASE]/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
of O O
cellular O B_DISEASE_ADJECTIVE[DISEASE]/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
damage O I_DISEASE_ADJECTIVE[DISEASE]/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
reduction O B_DISEASE_ADJECTIVE[DISEASE]/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
of O O
photosynthesis O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
continued O O
upon O O
transfer O B_LOCATION/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
to O O
lower O B_LOCATION/B_DISEASE_ADJECTIVE[DISEASE]
temperatures O I_LOCATION/I_DISEASE_ADJECTIVE[DISEASE]
and O O
photosynthetic O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANISM_FUNCTION
recovery O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_ORGANISM_FUNCTION
was O O
slow O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
or O O
absent O B_DISEASE_ADJECTIVE[DISEASE]/B_CELL[BODY_PART_OR_ORGAN_COMPONENT]
. O O

We O O
conclude O O
that O O
instability O B_DISEASE/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
of O O
photosynthesis O B_CELL[BODY_PART_OR_ORGAN_COMPONENT]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
under O O
severe O B_DISEASE/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
heat O I_DISEASE/I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
stress O I_DISEASE/I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
is O O
associated O O
with O O
time O B_MEASURE/B_LOCATION
- O O
dependent O B_MEASURE/B_DISEASE_ADJECTIVE[DISEASE]
propagation O I_MEASURE/I_DISEASE_ADJECTIVE[DISEASE]
of O O
cellular O B_DISEASE/B_BIO
lesions O I_DISEASE/I_BIO
. O O

A O O
fluorescence O O
resonance O O
energy O O
transfer O O
- O O
based O O
fluorometer O O
assay O O
for O O
screening O O
anti O O
- O O
coxsackievirus B B_DISEASE/B_BIO
B3 I I_DISEASE/I_BIO
compounds O O
. O O

In O O
view O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
of O O
the O O
need O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
to O O
develop O O
a O O
simple O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
rapid O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
method O I_DISEASE_ADJECTIVE[DISEASE]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
to O O
screen O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
for O O
antiviral O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
therapeutic O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE
agents O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE
, O O
a O O
fluorescence O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
resonance O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
energy O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
transfer O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
( O O
FRET O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
) O O
- O O
based O O
reporter O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
system O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
consisting O O
of O O
engineered O B_BIO/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
mammalian O I_BIO/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
cells O I_BIO/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
expressing O O
a O O
cyan O B_COLOR/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
fluorescent O I_COLOR/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
protein O I_COLOR/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- O O
yellow O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PROTEIN[GENE]
fluorescent O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PROTEIN[GENE]
protein O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PROTEIN[GENE]
( O O
CFP O B_PROTEIN[GENE]/B_DISEASE_ADJECTIVE[DISEASE]
- O O
YFP O B_PROTEIN[GENE]
) O O
pair O B_PERSON/B_LOCATION
linked O O
by O O
a O O
short O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
peptide O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
containing O O
the O O
cleavage O B_GENE/B_LOCATION
site O I_GENE/I_LOCATION
of O O
viral O B_PROTEIN[GENE]/B_DISEASE_ADJECTIVE[DISEASE]
protease O I_PROTEIN[GENE]/I_DISEASE_ADJECTIVE[DISEASE]
2A O I_PROTEIN[GENE]/I_DISEASE_ADJECTIVE[DISEASE]
( O O
2A O B_PROTEIN[GENE]/B_DISEASE
( O O
pro O B_PROTEIN[GENE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
) O O
) O O
was O O
developed O O
. O O

By O O
detecting O O
the O O
2A O O
( O O
pro O O
) O O
produced O O
early O O
during O O
the O O
virus O O
infection O O
cycle O O
, O O
the O O
CFP O O
- O O
YFP O O
pair O O
effectively O O
identifies O O
infectious O O
coxsackievirus B B_VIRUS[BIO]/B_PROTEIN[GENE]
B3 I B_VIRUS[BIO]/I_PROTEIN[GENE]
( O O
CVB3 B B_PROTEIN[GENE]/B_BIO
) O O
, O O
a O O
picornavirus O O
that O O
causes O O
viral O O
myocarditis O O
in O O
humans B B_SPECIES[BIO]
. O O

The O O
reporter O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANIZATION
system O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_ORGANIZATION
was O O
used O O
to O O
screen O O
a O O
library O B_LOCATION/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
2000 O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
drugs O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_BIO
and O O
natural O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
products O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
for O O
potential O B_DISEASE/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
antiviral O I_DISEASE/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
compounds O I_DISEASE/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

The O O
reporter O O
cells O O
were O O
treated O O
with O O
the O O
test O O
compounds O O
, O O
challenged O O
with O O
CVB3 B B_SPECIES[BIO]
, O O
and O O
then O O
examined O O
using O O
a O O
fluorometer O O
at O O
24h O O
post O O
- O O
infection O O
. O O

Sixty O B_NUMBER[MEASURE]/B_PERSON
- O O
four O B_NUMBER[MEASURE]
compounds O I_NUMBER[MEASURE]
, O O
mostly O O
therapeutic O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
drugs O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
, O O
antimicrobial O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
compounds O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
and O O
compounds O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
with O O
unknown O B_CHEMICAL_CLASS[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ENZYME[GENE]
functions O I_CHEMICAL_CLASS[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_ENZYME[GENE]
, O O
caused O O
at O O
least O O
50 O B_MEASURE/B_DISEASE
% O I_MEASURE/I_DISEASE
inhibition O I_MEASURE/I_DISEASE
of O O
2A O B_GENE/B_DISEASE
( O O
pro O O
) O O
activity O B_ENZYME[GENE]/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
. O O

Three O B_NUMBER[MEASURE]/B_PERSON
known O O
antiviral O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
compounds O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
cosmosiin O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BACTERIUM[BIO]
, O O
ribavirin O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
baicalein O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
, O O
were O O
also O O
identified O O
in O O
the O O
screening O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
. O O

The O O
developed O O
method O O
is O O
an O O
effective O O
strategy O O
for O O
rapid O O
screening O O
, O O
and O O
identifies O O
compounds O O
that O O
inhibit O O
CVB3 B B_ENZYME[GENE]/B_BIO
2A O O
( O O
pro O O
) O O
. O O

This O O
method O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
should O O
be O O
a O O
valuable O B_PERSON/B_SPORT[ENT]
aid O I_PERSON/I_SPORT[ENT]
in O O
the O O
antiviral O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
drug O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
discovery O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
effort O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
. O O

One O O
- O O
step O O
real O O
- O O
time O O
reverse O O
transcription O O
- O O
PCR O O
assays O O
for O O
detecting O O
and O O
subtyping O O
pandemic B B_DISEASE/B_LOCATION
influenza I I_DISEASE/I_LOCATION
A I I_DISEASE/I_LOCATION
/ I I_DISEASE/I_LOCATION
H1N1 I I_DISEASE/I_LOCATION
2009 I I_DISEASE/I_LOCATION
, O O
seasonal B B_MEASURE/B_DISEASE
influenza I I_MEASURE/I_DISEASE
A I I_MEASURE/I_DISEASE
/ I I_MEASURE/I_DISEASE
H1N1 I I_MEASURE/I_DISEASE
, O O
and O O
seasonal B B_DISEASE/B_LOCATION
influenza I I_DISEASE/I_LOCATION
A I I_DISEASE/I_LOCATION
/ I I_DISEASE/I_LOCATION
H3N2 I I_DISEASE/I_LOCATION
viruses I I_DISEASE/I_LOCATION
. O O

Pandemic B B_DISEASE
influenza I I_DISEASE
A I I_DISEASE
/ I I_DISEASE
H1N1 I I_DISEASE
2009 I I_DISEASE
( I I_DISEASE
A I I_DISEASE
/ I I_DISEASE
H1N1pdm I I_DISEASE
) I I_DISEASE
virus I I_DISEASE
has O O
caused O O
significant O O
outbreaks O O
worldwide O O
. O O

A O O
previous O O
one O O
- O O
step O O
real O O
- O O
time O O
reverse O O
transcription O O
- O O
PCR O O
( O O
rRT O O
- O O
PCR O O
) O O
assay O O
for O O
detecting O O
A B B_DISEASE/B_VIRUS[BIO]
/ I B_DISEASE/I_VIRUS[BIO]
H1N1pdm I B_DISEASE/I_VIRUS[BIO]
virus I B_DISEASE/I_VIRUS[BIO]
( O O
H1pdm O O
rRT O O
- O O
PCR O O
assay O O
) O O
was O O
improved O O
since O O
the O O
former O O
probe O O
had O O
a O O
low O O
melting O O
temperature O O
and O O
low O O
tolerance O O
to O O
viral O O
mutation O O
. O O

To O O
help O O
with O O
the O O
screening O O
of O O
the O O
A B B_DISEASE/B_BIO
/ I B_DISEASE/I_BIO
H1N1pdm I B_DISEASE/I_BIO
virus I B_DISEASE/I_BIO
, O O
rRT O O
- O O
PCR O O
assays O O
were O O
also O O
developed O O
for O O
detecting O O
human B B_DISEASE/B_PROTEIN[GENE]
seasonal B B_DISEASE/I_PROTEIN[GENE]
A I B_DISEASE/I_PROTEIN[GENE]
/ I B_DISEASE/I_PROTEIN[GENE]
H1N1 I B_DISEASE/I_PROTEIN[GENE]
( O O
H1 O O
rRT O O
- O O
PCR O O
assay O O
) O O
and O O
A B B_DISEASE/B_PROTEIN[GENE]
/ I B_DISEASE/I_PROTEIN[GENE]
H3N2 I B_DISEASE/I_PROTEIN[GENE]
influenza I B_DISEASE/I_PROTEIN[GENE]
viruses I B_DISEASE/I_PROTEIN[GENE]
( O O
H3 O O
rRT O O
- O O
PCR O O
assay O O
) O O
. O O

H1pdm O B_PROTEIN[GENE]
, O O
H1 O O
, O O
and O O
H3 O B_PROTEIN[GENE]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
rRT O I_PROTEIN[GENE]/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- O O
PCR O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
assays O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
were O O
evaluated O O
using O O
in O O
vitro O B_LOCATION
- O O
transcribed O O
control O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
RNA O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
, O O
isolated O B_VIRUS[BIO]/B_GENE
viruses O B_VIRUS[BIO]/I_GENE
, O O
and O O
other O B_BIO/B_GENE
respiratory O B_BIO/I_GENE
pathogenic O B_BIO/I_GENE
viruses O B_BIO/I_GENE
, O O
and O O
were O O
shown O O
to O O
have O O
high O B_DISEASE_ADJECTIVE[DISEASE]/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
sensitivity O B_DISEASE_ADJECTIVE[DISEASE]/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
good O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
linearity O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
( O O
R O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PROTEIN[GENE]
( O O
2 O B_MEASURE/B_LOCATION
) O O
= O O
0 O B_MEASURE
. O O
99 O B_MEASURE
) O O
, O O
and O O
high O B_DISEASE_ADJECTIVE[DISEASE]/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
specificity O B_DISEASE_ADJECTIVE[DISEASE]/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

In O O
addition O O
, O O
the O O
improved O O
H1pdm O O
rRT O O
- O O
PCR O O
assay O O
could O O
detect O O
two O O
viral B B_DISEASE/B_BIO
strains I B_DISEASE/I_BIO
of I B_DISEASE/I_BIO
A I B_DISEASE/I_BIO
/ I B_DISEASE/I_BIO
H1N1pdm I B_DISEASE/I_BIO
, O O
namely O O
, O O
A B B_DISEASE/B_PROTEIN[GENE]
/ I B_DISEASE/I_PROTEIN[GENE]
Aichi I B_DISEASE/I_PROTEIN[GENE]
/ I B_DISEASE/I_PROTEIN[GENE]
472 I B_DISEASE/I_PROTEIN[GENE]
/ I B_DISEASE/I_PROTEIN[GENE]
2009 I B_DISEASE/I_PROTEIN[GENE]
( I B_DISEASE/I_PROTEIN[GENE]
H1N1 I B_DISEASE/I_PROTEIN[GENE]
) I B_DISEASE/I_PROTEIN[GENE]
pdm I B_DISEASE/I_PROTEIN[GENE]
and O O
A B B_DISEASE/B_PROTEIN[GENE]
/ I B_DISEASE/I_PROTEIN[GENE]
Sakai I B_DISEASE/I_PROTEIN[GENE]
/ I B_DISEASE/I_PROTEIN[GENE]
89 I B_DISEASE/I_PROTEIN[GENE]
/ I B_DISEASE/I_PROTEIN[GENE]
2009 I B_DISEASE/I_PROTEIN[GENE]
( I B_DISEASE/I_PROTEIN[GENE]
H1N1 I B_DISEASE/I_PROTEIN[GENE]
) I B_DISEASE/I_PROTEIN[GENE]
pdm I B_DISEASE/I_PROTEIN[GENE]
, O O
which O O
have O O
mutation O O
( O O
s O O
) O O
in O O
the O O
probe O O
- O O
binding O O
region O O
of O O
the O O
hemagglutinin O O
gene O O
, O O
without O O
loss O O
of O O
sensitivity O O
. O O

Using O O
the O O
three O B_PROTEIN[GENE]/B_LOCATION
rRT O I_PROTEIN[GENE]/I_LOCATION
- O O
PCR O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
assays O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
developed O O
, O O
90 O B_BODY_SUBSTANCE[BODY_PART_OR_ORGAN_COMPONENT]/B_BIO
clinical O I_BODY_SUBSTANCE[BODY_PART_OR_ORGAN_COMPONENT]/I_BIO
specimens O I_BODY_SUBSTANCE[BODY_PART_OR_ORGAN_COMPONENT]/I_BIO
collected O O
between O O
May O B_TIME[MEASURE]/B_LOCATION
and O O
October O B_TIME[MEASURE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
2009 O I_TIME[MEASURE]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
were O O
then O O
tested O O
. O O

Of O O
these O O
, O O
26 O O
, O O
20 O O
, O O
and O O
2 O O
samples O O
were O O
identified O O
as O O
positive O O
for O O
A B B_PROTEIN[GENE]/B_DISEASE
/ I I_PROTEIN[GENE]/I_DISEASE
H1pdm I I_PROTEIN[GENE]/I_DISEASE
, O O
A B B_PROTEIN[GENE]/B_DISEASE
/ I I_PROTEIN[GENE]/I_DISEASE
H3 I I_PROTEIN[GENE]/I_DISEASE
, O O
and O O
A B B_GENE/B_VIRUS[BIO]
/ I B_GENE/I_VIRUS[BIO]
H1 I B_GENE/I_VIRUS[BIO]
, O O
respectively O O
, O O
while O O
42 O O
samples O O
were O O
negative O O
for O O
influenza B B_VIRUS[BIO]/B_PROTEIN[GENE]
A I B_VIRUS[BIO]/I_PROTEIN[GENE]
viruses I B_VIRUS[BIO]/I_PROTEIN[GENE]
. O O

The O O
present O O
results O O
suggest O O
that O O
these O O
highly O O
sensitive O O
and O O
specific O O
H1pdm O O
, O O
H1 O O
, O O
and O O
H3 O O
rRT O O
- O O
PCR O O
assays O O
are O O
useful O O
not O O
only O O
for O O
diagnosing O O
influenza B B_DISEASE/B_BIO
viruses I I_DISEASE/I_BIO
, O O
but O O
also O O
for O O
the O O
surveillance O O
of O O
influenza B B_DISEASE/B_BIO
viruses I I_DISEASE/I_BIO
. O O

Comparison O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
commercial O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
systems O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
for O O
extraction O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
nucleic O B_GENE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
acids O I_GENE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
from O O
DNA O B_GENE/B_CELL[BODY_PART_OR_ORGAN_COMPONENT]
/ O O
RNA O B_DISEASE_ADJECTIVE[DISEASE]/B_GENE
respiratory O B_DISEASE_ADJECTIVE[DISEASE]/I_GENE
pathogens O B_DISEASE_ADJECTIVE[DISEASE]/I_GENE
. O O

This O O
study O O
compared O O
six O O
automated O O
nucleic O O
acid O O
extraction O O
systems O O
and O O
one O O
manual O O
kit O O
for O O
their O O
ability O O
to O O
recover O O
nucleic O O
acids O O
from O O
human B B_PERSON/B_SPECIES[BIO]
nasal O O
wash O O
specimens O O
spiked O O
with O O
five O O
respiratory O O
pathogens O O
, O O
representing O O
Gram O O
- O O
positive O O
bacteria O O
( O O
Streptococcus B B_BACTERIUM[BIO]/B_DISEASE
pyogenes I I_BACTERIUM[BIO]/I_DISEASE
) O O
, O O
Gram O O
- O O
negative O O
bacteria O O
( O O
Legionella B B_BACTERIUM[BIO]/B_DISEASE
pneumophila I I_BACTERIUM[BIO]/I_DISEASE
) O O
, O O
DNA O O
viruses O O
( O O
adenovirus O O
) O O
, O O
segmented O O
RNA O O
viruses O O
( O O
human B B_VIRUS[BIO]/B_DISEASE_ADJECTIVE[DISEASE]
influenza I I_VIRUS[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
virus I I_VIRUS[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
A I I_VIRUS[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
) O O
, O O
and O O
non O O
- O O
segmented O O
RNA O O
viruses O O
( O O
respiratory B B_VIRUS[BIO]/B_DISEASE_ADJECTIVE[DISEASE]
syncytial I I_VIRUS[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
virus I I_VIRUS[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
) O O
. O O

The O O
robots O B_PRODUCT[OBJECT]/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
kit O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PRODUCT[OBJECT]
evaluated O O
represent O O
major O B_NUMBER[MEASURE]/B_DISEASE
commercially O O
available O B_MEASURE/B_ORGANIZATION
methods O B_MEASURE/I_ORGANIZATION
that O O
are O O
capable O B_PERSON
of O O
simultaneous O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
extraction O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
of O O
DNA O B_GENE/B_CELL[BODY_PART_OR_ORGAN_COMPONENT]
and O O
RNA O B_GENE/B_BIO
from O O
respiratory O B_BODY_SUBSTANCE[BODY_PART_OR_ORGAN_COMPONENT]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
specimens O I_BODY_SUBSTANCE[BODY_PART_OR_ORGAN_COMPONENT]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
and O O
included O O
platforms O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
based O O
on O O
magnetic O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
- O O
bead O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
technology O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
( O O
KingFisher O B_ORGANIZATION/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
mL O I_ORGANIZATION/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
Biorobot O B_PERSON/B_ORGANIZATION
EZ1 O B_PERSON/I_ORGANIZATION
, O O
easyMAG O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
, O O
KingFisher O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANIZATION
Flex O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_ORGANIZATION
, O O
and O O
MagNA O B_GENE/B_LOCATION
Pure O I_GENE/I_LOCATION
Compact O I_GENE/I_LOCATION
) O O
or O O
glass O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANIZATION
fiber O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_ORGANIZATION
filter O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_ORGANIZATION
technology O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_ORGANIZATION
( O O
Biorobot O B_PERSON/B_ORGANIZATION
MDX O B_PERSON/I_ORGANIZATION
and O O
the O O
manual O B_SEQUENCE[MEASURE]/B_PERSON
kit O I_SEQUENCE[MEASURE]/I_PERSON
Allprep O I_SEQUENCE[MEASURE]/I_PERSON
) O O
. O O

All O O
methods O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
yielded O O
extracts O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
free O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
of O O
cross O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
- O O
contamination O B_DISEASE/B_BIO
and O O
RT O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_GENE
- O O
PCR O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
inhibition O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE
. O O

All O O
automated O O
systems O O
recovered O O
L B B_VIRUS[BIO]/B_DISEASE
. I I_VIRUS[BIO]/I_DISEASE
pneumophila I I_VIRUS[BIO]/I_DISEASE
and O O
adenovirus O O
DNA O O
equivalently O O
. O O

However O O
, O O
the O O
MagNA O O
Pure O O
protocol O O
demonstrated O O
more O O
than O O
4 O O
- O O
fold O O
higher O O
DNA O O
recovery O O
from O O
the O O
S B B_BIO/B_BODY_PART_OR_ORGAN_COMPONENT
. I B_BIO/I_BODY_PART_OR_ORGAN_COMPONENT
pyogenes I B_BIO/I_BODY_PART_OR_ORGAN_COMPONENT
than O O
other O O
methods O O
. O O

The O O
KingFisher O O
mL O O
and O O
easyMAG O O
protocols O O
provided O O
1 O O
- O O
to O O
3 O O
- O O
log O O
wider O O
linearity O O
and O O
extracted O O
3 O O
- O O
to O O
4 O O
- O O
fold O O
more O O
RNA O O
from O O
the O O
human B B_VIRUS[BIO]/B_DISEASE_ADJECTIVE[DISEASE]
influenza I I_VIRUS[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
virus I I_VIRUS[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
and O O
respiratory B B_DISEASE/B_GENE
syncytial I B_DISEASE/I_GENE
virus I B_DISEASE/I_GENE
. O O

These O O
findings O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
suggest O O
that O O
systems O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
differed O O
in O O
nucleic O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
acid O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
recovery O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
, O O
reproducibility O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
, O O
and O O
linearity O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
in O O
a O O
pathogen O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
specific O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
manner O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

Aerosol O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
drug O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
delivery O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
: O O
developments O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
in O O
device O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
design O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
clinical O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANIZATION
use O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_ORGANIZATION
. O O

Aerosolised O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
drugs O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
are O O
prescribed O O
for O O
use O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
in O O
a O O
range O B_LOCATION/B_MEASURE
of O O
inhaler O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
devices O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
and O O
systems O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_LOCATION
. O O

Delivering O O
drugs O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
by O O
inhalation O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BODY_PART_OR_ORGAN_COMPONENT
requires O O
a O O
formulation O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
that O O
can O O
be O O
successfully O O
aerosolised O O
and O O
a O O
delivery O B_CHEMICAL_CLASS[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
system O I_CHEMICAL_CLASS[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
that O O
produces O O
a O O
useful O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_MEASURE
aerosol O I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/I_MEASURE
of O O
the O O
drug O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BODY_PART_OR_ORGAN_COMPONENT
; O O
the O O
particles O B_CHEMICAL_CLASS[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BODY_PART_OR_ORGAN_COMPONENT
or O O
droplets O B_CHEMICAL_CLASS[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_CELL[BODY_PART_OR_ORGAN_COMPONENT]
need O O
to O O
be O O
of O O
sufficient O B_MEASURE/B_LOCATION
size O I_MEASURE/I_LOCATION
and O O
mass O B_MEASURE/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
to O O
be O O
carried O O
to O O
the O O
distal O B_BODY_PART_OR_ORGAN_COMPONENT/B_DISEASE_ADJECTIVE[DISEASE]
lung O I_BODY_PART_OR_ORGAN_COMPONENT/I_DISEASE_ADJECTIVE[DISEASE]
or O O
deposited O O
on O O
proximal O B_BODY_PART_OR_ORGAN_COMPONENT
airways O I_BODY_PART_OR_ORGAN_COMPONENT
to O O
give O O
rise O B_LOCATION/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
to O O
a O O
therapeutic O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
effect O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE
. O O

Patients O B_PERSON
and O O
caregivers O B_PERSON
must O O
use O O
and O O
maintain O O
these O O
aerosol O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PRODUCT[OBJECT]
drug O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PRODUCT[OBJECT]
delivery O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PRODUCT[OBJECT]
devices O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PRODUCT[OBJECT]
correctly O O
. O O

In O O
recent O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
years O I_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
, O O
several O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
technical O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
innovations O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
have O O
led O O
to O O
aerosol O O
drug O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_DISEASE_ADJECTIVE[DISEASE]
delivery O I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/I_DISEASE_ADJECTIVE[DISEASE]
devices O I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/I_DISEASE_ADJECTIVE[DISEASE]
with O O
efficient O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
drug O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
delivery O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
with O O
novel O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
features O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
that O O
take O O
into O O
account O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
factors O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
such O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
as O O
dose O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
tracking O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
, O O
portability O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
, O O
materials O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
of O O
manufacture O B_PERSON/B_CHEMICAL_CLASS[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
breath O B_MEASURE/B_PERSON
actuation O I_MEASURE/I_PERSON
, O O
the O O
interface O B_LOCATION/B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
with O O
the O O
patient O B_PERSON
, O O
combination O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_DISEASE_ADJECTIVE[DISEASE]
therapies O I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/I_DISEASE_ADJECTIVE[DISEASE]
, O O
and O O
systemic O B_DISEASE_ADJECTIVE[DISEASE]/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
delivery O I_DISEASE_ADJECTIVE[DISEASE]/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

These O O
changes O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_TIME[MEASURE]
have O O
improved O O
performance O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
in O O
all O O
four O B_MEASURE/B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
categories O B_MEASURE/I_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
devices O B_PRODUCT[OBJECT]/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
: O O
metered O O
dose O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PRODUCT[OBJECT]
inhalers O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PRODUCT[OBJECT]
, O O
spacers O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_BODY_PART_OR_ORGAN_COMPONENT
and O O
holding O O
chambers O B_PERSON/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
dry O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PRODUCT[OBJECT]
powder O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PRODUCT[OBJECT]
inhalers O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PRODUCT[OBJECT]
, O O
and O O
nebulisers O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
. O O

Additionally O O
, O O
several O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
therapies O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
usually O O
given O O
by O O
injection O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_PERSON
are O O
now O O
prescribed O O
as O O
aerosols O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_LOCATION
for O O
use O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_ORGANIZATION
in O O
a O O
range O B_LOCATION/B_MEASURE
of O O
drug O B_DISEASE_ADJECTIVE[DISEASE]/B_LOCATION
delivery O I_DISEASE_ADJECTIVE[DISEASE]/I_LOCATION
devices O I_DISEASE_ADJECTIVE[DISEASE]/I_LOCATION
. O O

In O O
this O O
Review O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANIZATION
, O O
we O O
discuss O O
recent O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
developments O I_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
in O O
the O O
design O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
and O O
clinical O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_ORGANIZATION
use O I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/I_ORGANIZATION
of O O
aerosol O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
devices O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
over O O
the O O
past O B_TIME[MEASURE]
10 O I_TIME[MEASURE]
- O O
15 O B_TIME[MEASURE]
years O I_TIME[MEASURE]
with O O
an O O
emphasis O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
on O O
the O O
treatment O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
of O O
respiratory O B_DISEASE
disorders O I_DISEASE
. O O

Regulation O O
of O O
horizontal O O
gene O O
transfer O O
in O O
Bacillus B B_SPECIES[BIO]
subtilis I I_SPECIES[BIO]
by O O
activation O O
of O O
a O O
conserved O O
site O O
- O O
specific O O
protease O O
. O O

The O O
mobile O O
genetic O O
element O O
ICEBs1 O O
is O O
an O O
integrative O O
and O O
conjugative O O
element O O
( O O
a O O
conjugative O O
transposon O O
) O O
found O O
in O O
Bacillus B B_SPECIES[BIO]
subtilis I I_SPECIES[BIO]
. O O

The O O
RecA O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
- O O
dependent O O
SOS O B_ENZYME[GENE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
response O I_ENZYME[GENE]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
the O O
RapI O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
- O O
PhrI O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
cell O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
sensory O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
system O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
activate O O
ICEBs1 O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
gene O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
expression O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
by O O
stimulating O O
cleavage O B_GENE_EXPRESSION_ADJECTIVE[GENE]/B_DISEASE
of O O
ImmR O B_GENE
, O O
the O O
ICEBs1 O B_GENE/B_PERSON
immunity O I_GENE/I_PERSON
repressor O I_GENE/I_PERSON
, O O
by O O
the O O
protease O B_GENE/B_LOCATION
ImmA O I_GENE/I_LOCATION
. O O

We O O
found O O
that O O
increasing O O
the O O
amount O B_MEASURE
of O O
wild O B_BIO/B_CELL[BODY_PART_OR_ORGAN_COMPONENT]
- O O
type O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
ImmA O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
in O O
vivo O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
caused O O
partial O B_DISEASE_ADJECTIVE[DISEASE]/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
derepression O I_DISEASE_ADJECTIVE[DISEASE]/I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
of O O
ICEBs1 O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
gene O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
expression O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
. O O

However O O
, O O
during O O
RapI O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
- O O
mediated O O
derepression O B_DISEASE_ADJECTIVE[DISEASE]/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
of O O
ICEBs1 O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
gene O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
expression O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
, O O
ImmA O B_GENE
levels O I_GENE
did O O
not O O
detectably O O
increase O O
, O O
indicating O O
that O O
RapI O B_GENE/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
likely O I_GENE/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
activates O O
the O O
protease O B_ENZYME[GENE]/B_LOCATION
ImmA O I_ENZYME[GENE]/I_LOCATION
by O O
increasing O O
its O O
specific O B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
activity O I_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

We O O
also O O
isolated O O
and O O
characterized O O
mutations O B_CELL_OR_MOLECULAR_DYSFUNCTION[DISEASE]/B_GENE
in O O
immA O B_GENE/B_DISEASE
( O O
immA O B_GENE/B_DISEASE
( O O
h O O
) O O
) O O
that O O
cause O O
partial O B_DISEASE_ADJECTIVE[DISEASE]/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
derepression O I_DISEASE_ADJECTIVE[DISEASE]/I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
of O O
ICEBs1 O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
gene O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
expression O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
in O O
the O O
absence O B_DISEASE/B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
inducing O O
signals O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
. O O

We O O
obtained O O
two O B_MEASURE/B_LOCATION
types O B_MEASURE/I_LOCATION
of O O
immA O B_GENE/B_DISEASE
( O O
h O B_PROTEIN[GENE]/B_DISEASE
) O O
mutations O B_CELL_OR_MOLECULAR_DYSFUNCTION[DISEASE]/B_GENE
: O O
one O B_NUMBER[MEASURE]/B_PERSON
type O I_NUMBER[MEASURE]/I_PERSON
caused O O
increased O O
amounts O B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
of O O
the O O
mutant O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
proteins O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
in O O
vivo O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BODY_PART_OR_ORGAN_COMPONENT
but O O
no O O
detectable O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
effect O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
on O O
specific O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
activity O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_BIO
in O O
vitro O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
; O O
the O O
other O B_SEQUENCE[MEASURE]/B_PERSON
type O I_SEQUENCE[MEASURE]/I_PERSON
had O O
no O O
detectable O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
effect O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
on O O
the O O
amount O B_MEASURE
of O O
the O O
mutant O B_GENE
protein O I_GENE
in O O
vivo O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BODY_PART_OR_ORGAN_COMPONENT
but O O
caused O O
increased O O
specific O B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PHYSIOLOGIC_FUNCTION[ORGANISM_FUNCTION]
activity O B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PHYSIOLOGIC_FUNCTION[ORGANISM_FUNCTION]
of O O
the O O
protein O B_ENZYME[GENE]/B_BACTERIUM[BIO]
( O O
as O O
measured O O
in O O
vitro O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_CELL[BODY_PART_OR_ORGAN_COMPONENT]
) O O
. O O

Together O O
, O O
these O O
findings O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
indicate O O
that O O
derepression O B_DISEASE_ADJECTIVE[DISEASE]/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
of O O
ICEBs1 O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
gene O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
expression O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
is O O
likely O O
caused O O
by O O
an O O
increase O B_DISEASE_ADJECTIVE[DISEASE]/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
in O O
the O O
specific O B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
activity O I_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
ImmA O B_GENE/B_DISEASE
. O O

Homologs O B_TIME[MEASURE]/B_LOCATION
of O O
ImmA O B_GENE/B_DISEASE
and O O
ImmR O B_GENE/B_LOCATION
are O O
found O O
in O O
many O B_SPECIES[BIO]/B_DISEASE_ADJECTIVE[DISEASE]
mobile O I_SPECIES[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
genetic O I_SPECIES[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
elements O I_SPECIES[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
, O O
so O O
the O O
mechanisms O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
that O O
regulate O O
ImmA O B_GENE/B_DISEASE
- O O
mediated O O
cleavage O B_GENE_EXPRESSION_ADJECTIVE[GENE]/B_DISEASE
of O O
ImmR O B_GENE
may O O
be O O
widely O O
conserved O O
. O O

Orientation O B_ORGANIZATION/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
SecA O B_GENE/B_BACTERIUM[BIO]
and O O
SecB O B_GENE/B_BACTERIUM[BIO]
in O O
complex O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
derived O O
from O O
disulfide O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
cross O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- O O
linking O B_TIME[MEASURE]/B_LOCATION
. O O

SecA O O
is O O
the O O
ATPase O O
that O O
acts O O
as O O
the O O
motor O O
for O O
protein O O
export O O
in O O
the O O
general O O
secretory O O
, O O
or O O
Sec O O
, O O
system O O
of O O
Escherichia B B_BIO
coli I I_BIO
. O O

The O O
tetrameric O B_LOCATION
cytoplasmic O I_LOCATION
chaperone O I_LOCATION
SecB O I_LOCATION
binds O I_LOCATION
to O O
precursors O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
of O O
exported O O
proteins O B_GENE/B_DISEASE
before O O
they O O
can O O
become O O
stably O O
folded O O
and O O
delivers O O
them O O
to O O
SecA O B_CELL_COMPONENT[BODY_PART_OR_ORGAN_COMPONENT]/B_BIO
. O O

During O O
this O O
delivery O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
step O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
, O O
SecB O B_GENE/B_BACTERIUM[BIO]
binds O O
to O O
SecA O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
. O O

The O O
complex O B_LOCATION
between O O
SecA O B_GENE/B_BACTERIUM[BIO]
and O O
SecB O B_GENE/B_BACTERIUM[BIO]
that O O
is O O
maximally O O
active O B_TIME[MEASURE]/B_DISEASE_ADJECTIVE[DISEASE]
in O O
translocation O B_DISEASE/B_BIO
contains O O
two O B_CHEMICAL_CLASS[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
protomers O I_CHEMICAL_CLASS[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
of O O
SecA O B_GENE/B_BACTERIUM[BIO]
bound O O
to O O
a O O
tetramer O B_GENE/B_LOCATION
of O O
SecB O B_GENE/B_BACTERIUM[BIO]
. O O

The O O
aminoacyl O B_LOCATION/B_BIO
residues O I_LOCATION/I_BIO
on O O
each O O
protein O B_PROTEIN[GENE]/B_BACTERIUM[BIO]
that O O
are O O
involved O O
in O O
binding O O
the O O
other O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
have O O
previously O O
been O O
identified O O
by O O
site O B_LOCATION
- O O
directed O O
spin O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
labeling O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
electron O B_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
paramagnetic O I_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
resonance O I_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
( O O
EPR O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
) O O
spectroscopy O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
; O O
however O O
, O O
that O O
study O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
provided O O
no O O
information O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
concerning O O
the O O
relative O B_LOCATION/B_MEASURE
orientation O I_LOCATION/I_MEASURE
of O O
the O O
proteins O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
within O O
the O O
complex O B_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PROTEIN[GENE]
. O O

Here O O
we O O
used O O
our O O
extensive O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
collection O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
of O O
single O B_MEASURE/B_PROTEIN[GENE]
- O O
cysteine O B_DISEASE_ADJECTIVE[DISEASE]/B_GENE
variants O B_DISEASE_ADJECTIVE[DISEASE]/I_GENE
of O O
the O O
two O B_GENE/B_MEASURE
proteins O I_GENE/I_MEASURE
and O O
subjected O O
pairwise O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
combinations O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
SecA O B_GENE/B_BACTERIUM[BIO]
and O O
SecB O B_GENE/B_BACTERIUM[BIO]
to O O
brief O O
oxidation O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
to O O
identify O O
residues O B_MEASURE/B_LOCATION
in O O
close O B_PERSON/B_LOCATION
proximity O I_PERSON/I_LOCATION
. O O

These O O
data O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
were O O
used O O
to O O
generate O O
a O O
model O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
for O O
the O O
orientation O B_ORGANIZATION/B_DISEASE_ADJECTIVE[DISEASE]
of O O
the O O
two O B_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
proteins O I_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
within O O
the O O
complex O B_CELL_COMPONENT[BODY_PART_OR_ORGAN_COMPONENT]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

Inactivation O O
of O O
the O O
RluD O O
pseudouridine O O
synthase O O
has O O
minimal O O
effects O O
on O O
growth O O
and O O
ribosome O O
function O O
in O O
wild O O
- O O
type O O
Escherichia B B_BACTERIUM[BIO]
coli I I_BACTERIUM[BIO]
and O O
Salmonella B B_SPECIES[BIO]
enterica I I_SPECIES[BIO]
. O O

The O O
Escherichia B B_SPECIES[BIO]/B_DISEASE
coli I I_SPECIES[BIO]/I_DISEASE
rluD O O
gene O O
encodes O O
a O O
pseudouridine O O
synthase O O
responsible O O
for O O
the O O
pseudouridine O O
( O O
Psi O O
) O O
modifications O O
at O O
positions O O
1911 O O
, O O
1915 O O
, O O
and O O
1917 O O
in O O
helix O O
69 O O
of O O
23S O O
rRNA O O
. O O

It O O
has O O
been O O
reported O O
that O O
deletion O O
of O O
rluD O O
in O O
K B B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
- I I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
12 I I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
strains I I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
of I I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
E I I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
. I I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
coli I I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
is O O
associated O O
with O O
extremely O O
slow O O
growth O O
, O O
increased O O
readthrough O O
of O O
stop O O
codons O O
, O O
and O O
defects O O
in O O
50S O O
ribosomal O O
subunit O O
assembly O O
and O O
30S O O
- O O
50S O O
subunit O O
association O O
. O O

Suppressor O B_CELL_OR_MOLECULAR_DYSFUNCTION[DISEASE]/B_GENE
mutations O I_CELL_OR_MOLECULAR_DYSFUNCTION[DISEASE]/I_GENE
in O O
the O O
prfB O B_BACTERIUM[BIO]/B_GENE
and O O
prfC O B_GENE/B_BIO
genes O I_GENE/I_BIO
encoding O O
release O B_GENE/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
factor O I_GENE/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
2 O I_GENE/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
( O O
RF2 O B_GENE/B_LOCATION
) O O
and O O
RF3 O B_GENE
that O O
restore O O
the O O
wild O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
type O B_GENE/I_DISEASE_ADJECTIVE[DISEASE]
- O O
growth O B_MEASURE/B_BIO
rate O B_MEASURE/I_BIO
and O O
also O O
correct O O
the O O
ribosomal O B_DISEASE_ADJECTIVE[DISEASE]/B_GENE
defects O I_DISEASE_ADJECTIVE[DISEASE]/I_GENE
have O O
now O O
been O O
isolated O O
. O O

These O O
suppressors O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
link O O
helix O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
69 O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
Psi O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
residues O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
with O O
the O O
termination O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
phase O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
of O O
protein O B_DISEASE_ADJECTIVE[DISEASE]/B_GENE
synthesis O B_DISEASE_ADJECTIVE[DISEASE]/I_GENE
. O O

However O O
, O O
further O O
genetic O O
analysis O O
reported O O
here O O
also O O
reveals O O
that O O
the O O
slow O O
growth O O
and O O
other O O
defects O O
associated O O
with O O
inactivation O O
of O O
rluD O O
in O O
E B B_DISEASE_ADJECTIVE[DISEASE]/B_NUMBER[MEASURE]
. I I_DISEASE_ADJECTIVE[DISEASE]/I_NUMBER[MEASURE]
coli I I_DISEASE_ADJECTIVE[DISEASE]/I_NUMBER[MEASURE]
K I I_DISEASE_ADJECTIVE[DISEASE]/I_NUMBER[MEASURE]
- I I_DISEASE_ADJECTIVE[DISEASE]/I_NUMBER[MEASURE]
12 I I_DISEASE_ADJECTIVE[DISEASE]/I_NUMBER[MEASURE]
strains O O
are O O
due O O
to O O
a O O
defective O O
RF2 O O
protein O O
, O O
with O O
a O O
threonine O O
at O O
position O O
246 O O
, O O
which O O
is O O
present O O
in O O
all O O
K B B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
- I B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
12 I B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
strains O O
. O O

This O O
is O O
in O O
contrast O O
to O O
the O O
more O O
typical O O
alanine O O
found O O
at O O
this O O
position O O
in O O
most O O
bacterial O O
RF2s O O
, O O
including O O
those O O
of O O
other O O
E B B_BACTERIUM[BIO]/B_DISEASE
. I I_BACTERIUM[BIO]/I_DISEASE
coli I I_BACTERIUM[BIO]/I_DISEASE
strains O O
. O O

Inactivation O O
of O O
rluD O O
in O O
E B B_PERSON/B_BACTERIUM[BIO]
. I I_PERSON/I_BACTERIUM[BIO]
coli I I_PERSON/I_BACTERIUM[BIO]
strains O O
containing O O
the O O
prfB O O
allele O O
from O O
E B B_BACTERIUM[BIO]
. I I_BACTERIUM[BIO]
coli I I_BACTERIUM[BIO]
B I I_BACTERIUM[BIO]
or O O
in O O
Salmonella B B_BIO/B_PERSON
enterica I I_BIO/I_PERSON
, O O
both O O
carrying O O
an O O
RF2 O O
with O O
Ala246 O O
, O O
has O O
negligible O O
effects O O
on O O
growth O O
, O O
termination O O
, O O
or O O
ribosome O O
function O O
. O O

The O O
results O O
indicate O O
that O O
, O O
in O O
contrast O O
to O O
those O O
in O O
wild O O
bacteria O O
, O O
termination O O
functions O O
in O O
E B B_BACTERIUM[BIO]/B_PERSON
. I I_BACTERIUM[BIO]/I_PERSON
coli I I_BACTERIUM[BIO]/I_PERSON
K I I_BACTERIUM[BIO]/I_PERSON
- I I_BACTERIUM[BIO]/I_PERSON
12 I I_BACTERIUM[BIO]/I_PERSON
strains O O
carrying O O
a O O
partially O O
defective O O
RF2 O O
protein O O
are O O
especially O O
susceptible O O
to O O
perturbation O O
of O O
ribosome O O
- O O
RF O O
interactions O O
, O O
such O O
as O O
that O O
caused O O
by O O
loss O O
of O O
h69 O O
Psi O O
modifications O O
. O O

Effect O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
energetic O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
constraints O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
on O O
distribution O B_ORGANIZATION/B_TIME[MEASURE]
and O O
winter O B_MEASURE/B_ORGANISM_FUNCTION
survival O B_MEASURE/I_ORGANISM_FUNCTION
of O O
weasel O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
males O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
. O O

1 O B_NUMBER[MEASURE]
. O O

The O O
absolute O B_MEASURE
energy O I_MEASURE
needs O I_MEASURE
of O O
small O B_BIO/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
animals O I_BIO/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
are O O
generally O O
lower O B_MEASURE/B_DISEASE_ADJECTIVE[DISEASE]
than O O
those O O
of O O
larger O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
animals O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_BIO
. O O

This O O
should O O
drive O O
higher O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANISM_FUNCTION
mortality O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_ORGANISM_FUNCTION
of O O
larger O B_BIO/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
animals O I_BIO/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
when O O
the O O
environmental O B_DISEASE_ADJECTIVE[DISEASE]/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
conditions O B_DISEASE_ADJECTIVE[DISEASE]/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
deteriorate O O
. O O

However O O
, O O
demonstration O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
the O O
effect O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
energy O B_DISEASE/B_MEASURE
constraints O B_DISEASE/I_MEASURE
on O O
survivals O B_MEASURE/B_ORGANIZATION
proved O O
difficult O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
because O O
the O O
range O B_LOCATION/B_MEASURE
of O O
body O B_MEASURE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
mass O I_MEASURE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
within O O
species O B_BIO/B_PERSON
is O O
generally O O
too O O
small O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
to O O
produce O O
enough O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
variation O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
for O O
studying O O
such O O
an O O
effect O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PROTEIN[GENE]
. O O

An O O
opportunity O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
for O O
an O O
intraspecific O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
study O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
comes O O
from O O
weasels O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
inhabiting O O
the O O
Bialowieza O B_LOCATION
Forest O I_LOCATION
( O O
north O O
- O O
eastern O B_LOCATION
Poland O I_LOCATION
) O O
, O O
which O O
are O O
characterized O O
by O O
a O O
threefold O B_MEASURE
variation O I_MEASURE
in O O
body O B_MEASURE/B_LOCATION
mass O B_MEASURE/I_LOCATION
. O O

2 O B_NUMBER[MEASURE]
. O O

We O O
assumed O O
that O O
in O O
summer O B_PERSON/B_BIO
larger O I_PERSON/I_BIO
weasel O I_PERSON/I_BIO
males O I_PERSON/I_BIO
are O O
favoured O O
by O O
sexual O B_PERSON/B_BIO
selection O I_PERSON/I_BIO
, O O
because O O
they O O
are O O
more O O
successful O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
when O O
competing O O
for O O
mates O B_PERSON/B_LOCATION
. O O

We O O
then O O
tested O O
whether O O
they O O
suffer O O
higher O B_DISEASE/B_BIO
mortality O I_DISEASE/I_BIO
in O O
winter O B_TIME[MEASURE]/B_LOCATION
, O O
because O O
they O O
have O O
difficulty O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
finding O O
sufficient O B_PERSON/B_LOCATION
food O I_PERSON/I_LOCATION
to O O
satisfy O O
their O O
energy O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
needs O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
and O O
/ O O
or O O
because O O
the O O
additional O B_TIME[MEASURE]/B_DISEASE
foraging O B_TIME[MEASURE]/I_DISEASE
time O B_TIME[MEASURE]/I_DISEASE
would O O
result O O
in O O
increased O O
exposure O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
to O O
predation O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
. O O

3 O B_NUMBER[MEASURE]
. O O

We O O
measured O O
daily O B_MEASURE/B_LOCATION
energy O I_MEASURE/I_LOCATION
expenditures O I_MEASURE/I_LOCATION
( O O
DEE O B_LOCATION
) O O
of O O
overwintering O O
weasel O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
males O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
using O O
the O O
doubly O O
labelled O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
water O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
( O O
DLW O B_PROTEIN[GENE]/B_DISEASE_ADJECTIVE[DISEASE]
) O O
technique O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
. O O

We O O
constructed O O
an O O
energetic O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
model O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
predicting O O
how O O
individuals O B_PERSON/B_BIO
of O O
different O B_BIO/B_MEASURE
size O I_BIO/I_MEASURE
are O O
able O B_TIME[MEASURE]/B_PERSON
to O O
balance O O
their O O
energy O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_ORGANIZATION
budgets O I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/I_ORGANIZATION
feeding O O
on O O
large O B_DISEASE_ADJECTIVE[DISEASE]/B_GENE
and O O
small O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
prey O B_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
while O O
minimizing O O
time O B_TIME[MEASURE]/B_LOCATION
spent O O
hunting O B_PERSON/B_BIO
, O O
thereby O O
reducing O O
their O O
own O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
exposure O I_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
to O O
predation O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
. O O

4 O B_NUMBER[MEASURE]
. O O

The O O
range O B_MEASURE
of O O
body O B_MEASURE
mass O I_MEASURE
in O O
overwintering O O
weasels O B_BIO/B_LOCATION
predicted O O
by O O
our O O
model O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
corresponded O O
very O O
well O O
with O O
the O O
distribution O B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
of O O
prey O B_MEASURE/B_BIO
body O B_MEASURE/I_BIO
mass O B_MEASURE/I_BIO
in O O
three O B_BIO/B_LOCATION
different O I_BIO/I_LOCATION
habitats O I_BIO/I_LOCATION
within O O
our O O
study O B_LOCATION/B_PERSON
area O I_LOCATION/I_PERSON
. O O

Larger O B_PERSON/B_BIO
individuals O I_PERSON/I_BIO
were O O
able O B_TIME[MEASURE]/B_PERSON
to O O
compensate O O
for O O
higher O B_DISEASE_ADJECTIVE[DISEASE]/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
food O I_DISEASE_ADJECTIVE[DISEASE]/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
requirements O I_DISEASE_ADJECTIVE[DISEASE]/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
by O O
using O O
habitats O B_LOCATION/B_BIO
with O O
larger O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
prey O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
species O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
than O O
those O O
available O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
to O O
smaller O B_PERSON/B_BIO
male O I_PERSON/I_BIO
weasels O I_PERSON/I_BIO
. O O

This O O
effectively O O
offset O O
the O O
expected O B_MEASURE/B_DISEASE_ADJECTIVE[DISEASE]
negative O I_MEASURE/I_DISEASE_ADJECTIVE[DISEASE]
association O I_MEASURE/I_DISEASE_ADJECTIVE[DISEASE]
between O O
body O B_TIME[MEASURE]/B_LOCATION
mass O B_TIME[MEASURE]/I_LOCATION
and O O
winter O B_DISEASE/B_MEASURE
survival O I_DISEASE/I_MEASURE
predicted O O
from O O
considerations O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
of O O
energy O B_DISEASE_ADJECTIVE[DISEASE]
balance O I_DISEASE_ADJECTIVE[DISEASE]
. O O

5 O B_NUMBER[MEASURE]
. O O

Our O O
results O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
show O O
how O O
energetic O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
constraints O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
affect O O
body O B_MEASURE/B_LOCATION
mass O B_MEASURE/I_LOCATION
and O O
spatial O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
segregation O B_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
of O O
a O O
species O B_BIO/B_GENE
at O O
the O O
intra O B_LOCATION/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- O O
specific O B_MEASURE/B_LOCATION
level O B_MEASURE/I_LOCATION
not O O
only O O
across O O
large O B_DISEASE_ADJECTIVE[DISEASE]/B_LOCATION
geographical O I_DISEASE_ADJECTIVE[DISEASE]/I_LOCATION
ranges O I_DISEASE_ADJECTIVE[DISEASE]/I_LOCATION
, O O
but O O
also O O
within O O
a O O
relatively O O
small O B_MEASURE/B_LOCATION
area O I_MEASURE/I_LOCATION
. O O

Bud O B_PERSON/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
set O O
in O O
poplar O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
- O O
- O O
genetic O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
dissection O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
of O O
a O O
complex O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
trait O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
in O O
natural O B_ORGANIZATION/B_PERSON
and O O
hybrid O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
populations O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
. O O

* O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
The O O
seasonal O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
timing O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
growth O B_LOCATION/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
events O I_LOCATION/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
is O O
crucial O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
to O O
tree O B_MEASURE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
distribution O I_MEASURE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
conservation O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANISM_FUNCTION
. O O

The O O
seasonal O B_TIME[MEASURE]/B_LOCATION
growth O B_TIME[MEASURE]/I_LOCATION
cycle O B_TIME[MEASURE]/I_LOCATION
is O O
strongly O O
adapted O O
to O O
the O O
local O B_LOCATION/B_MEASURE
climate O I_LOCATION/I_MEASURE
that O O
is O O
changing O O
because O O
of O O
global O B_LOCATION/B_DISEASE_ADJECTIVE[DISEASE]
warming O I_LOCATION/I_DISEASE_ADJECTIVE[DISEASE]
. O O

We O O
studied O O
bud O B_LOCATION/B_BODY_PART_OR_ORGAN_COMPONENT
set O O
as O O
one O B_PERSON/B_LOCATION
cornerstone O I_PERSON/I_LOCATION
of O O
the O O
seasonal O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
growth O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
cycle O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
in O O
an O O
integrative O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
approach O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
. O O

* O B_PERSON/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
Bud O I_PERSON/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
set O O
was O O
dissected O O
at O O
the O O
phenotypic O B_MEASURE/B_LOCATION
level O B_MEASURE/I_LOCATION
into O O
several O B_DISEASE_ADJECTIVE[DISEASE]/B_BODY_PART_OR_ORGAN_COMPONENT
components O B_DISEASE_ADJECTIVE[DISEASE]/I_BODY_PART_OR_ORGAN_COMPONENT
, O O
and O O
phenotypic O B_PERSON/B_MEASURE
components O I_PERSON/I_MEASURE
with O O
most O B_DISEASE_ADJECTIVE[DISEASE]/B_BIO
genetic O B_DISEASE_ADJECTIVE[DISEASE]/I_BIO
variation O B_DISEASE_ADJECTIVE[DISEASE]/I_BIO
were O O
identified O O
. O O

While O O
phenotypic O B_MEASURE
variation O I_MEASURE
resided O O
in O O
the O O
timing O B_TIME[MEASURE]/B_LOCATION
of O O
growth O B_DISEASE_ADJECTIVE[DISEASE]/B_ORGANISM_FUNCTION
cessation O B_DISEASE_ADJECTIVE[DISEASE]/I_ORGANISM_FUNCTION
, O O
and O O
even O O
so O O
more O O
in O O
the O O
duration O B_TIME[MEASURE]/B_LOCATION
from O O
growth O B_DISEASE_ADJECTIVE[DISEASE]/B_BIO
cessation O B_DISEASE_ADJECTIVE[DISEASE]/I_BIO
to O O
bud O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANISM_FUNCTION
set O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_ORGANISM_FUNCTION
, O O
the O O
timing O B_MEASURE
of O O
growth O B_DISEASE_ADJECTIVE[DISEASE]/B_ORGANISM_FUNCTION
cessation O B_DISEASE_ADJECTIVE[DISEASE]/I_ORGANISM_FUNCTION
had O O
a O O
stronger O B_MEASURE/B_PERSON
genetic O I_MEASURE/I_PERSON
component O I_MEASURE/I_PERSON
in O O
both O O
natural O B_ORGANIZATION/B_PERSON
and O O
hybrid O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
populations O B_DISEASE_ADJECTIVE[DISEASE]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

* O B_GENE/B_PERSON
Quantitative O I_GENE/I_PERSON
trait O I_GENE/I_PERSON
loci O I_GENE/I_PERSON
( O O
QTL O B_PROTEIN[GENE]/B_LOCATION
) O O
were O O
identified O O
for O O
the O O
most O O
discriminative O B_MEASURE/B_LOCATION
phenotypic O I_MEASURE/I_LOCATION
bud O I_MEASURE/I_LOCATION
- O O
set O B_MEASURE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
components O I_MEASURE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
across O O
four O B_MEASURE/B_LOCATION
poplar O I_MEASURE/I_LOCATION
pedigrees O I_MEASURE/I_LOCATION
. O O

The O O
QTL O B_GENE
from O O
different O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
pedigrees O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
were O O
recurrently O O
detected O O
in O O
six O B_LOCATION
regions O I_LOCATION
of O O
the O O
poplar O B_GENE/B_LOCATION
genome O I_GENE/I_LOCATION
. O O

* O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
These O O
regions O B_LOCATION/B_DISEASE
of O O
1 O B_MEASURE
. O O
83 O B_MEASURE
- O O
4 O B_MEASURE
. O O
25 O B_MEASURE
Mbp O I_MEASURE
in O O
size O B_MEASURE/B_LOCATION
, O O
containing O O
between O O
202 O B_MEASURE
and O O
394 O B_MEASURE
genes O I_MEASURE
, O O
form O O
the O O
basis O B_PERSON/B_LOCATION
for O O
further O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
molecular O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
- O O
genetic O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
dissection O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
of O O
bud O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
set O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE
. O O

Alphacoronavirus O O
transmissible B B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
gastroenteritis I B_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
virus I B_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
nsp1 O O
protein O O
suppresses O O
protein O O
translation O O
in O O
mammalian O O
cells O O
and O O
in O O
cell O O
- O O
free O O
HeLa O O
cell O O
extracts O O
but O O
not O O
in O O
rabbit B B_SPECIES[BIO]/B_DISEASE
reticulocyte O O
lysate O O
. O O

The O O
nsp1 O O
protein O O
of O O
transmissible B B_SPECIES[BIO]/B_DISEASE_ADJECTIVE[DISEASE]
gastroenteritis I I_SPECIES[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
virus I I_SPECIES[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
( O O
TGEV B B_DISEASE/B_SPECIES[BIO]
) O O
, O O
an O O
alphacoronavirus O O
, O O
efficiently O O
suppressed O O
protein O O
synthesis O O
in O O
mammalian O O
cells O O
. O O

Unlike O O
the O O
nsp1 O O
protein O O
of O O
severe B B_DISEASE/B_VIRUS[BIO]
acute I B_DISEASE/I_VIRUS[BIO]
respiratory I B_DISEASE/I_VIRUS[BIO]
syndrome I B_DISEASE/I_VIRUS[BIO]
coronavirus I B_DISEASE/I_VIRUS[BIO]
, O O
a O O
betacoronavirus O O
, O O
the O O
TGEV B B_DISEASE_ADJECTIVE[DISEASE]/B_SPECIES[BIO]
nsp1 O O
protein O O
was O O
unable O O
to O O
bind O O
40S O O
ribosomal O O
subunits O O
or O O
promote O O
host O O
mRNA O O
degradation O O
. O O

TGEV B B_SPECIES[BIO]/B_DISEASE
nsp1 O O
also O O
suppressed O O
protein O O
translation O O
in O O
cell O O
- O O
free O O
HeLa O O
cell O O
extract O O
; O O
however O O
, O O
it O O
did O O
not O O
affect O O
translation O O
in O O
rabbit B B_SPECIES[BIO]
reticulocyte O O
lysate O O
( O O
RRL O O
) O O
. O O

Our O O
data O O
suggested O O
that O O
HeLa O O
cell O O
extracts O O
and O O
cultured O O
host O O
cells O O
, O O
but O O
not O O
RRL O O
, O O
contain O O
a O O
host O O
factor O O
( O O
s O O
) O O
that O O
is O O
essential O O
for O O
TGEV B B_DISEASE_ADJECTIVE[DISEASE]/B_SPECIES[BIO]
nsp1 O O
- O O
induced O O
translational O O
suppression O O
. O O

Modification O O
of O O
nonstructural O O
protein O O
1 O O
of O O
influenza B B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
A I I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
virus I I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
by O O
SUMO1 O O
. O O

Nonstructural O O
protein O O
1 O O
( O O
NS1 O O
) O O
is O O
one O O
of O O
the O O
major O O
factors O O
resulting O O
in O O
the O O
efficient O O
infection O O
rate O O
and O O
high O O
level O O
of O O
virulence O O
of O O
influenza B B_BACTERIUM[BIO]/B_DISEASE_ADJECTIVE[DISEASE]
A I I_BACTERIUM[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
virus I I_BACTERIUM[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
. O O

Although O O
consisting O O
of O O
only O O
approximately O O
230 O B_NUMBER[MEASURE]
amino O I_NUMBER[MEASURE]
acids O I_NUMBER[MEASURE]
, O O
NS1 O B_PROTEIN[GENE]/B_BIO
has O O
the O O
ability O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
to O O
interfere O O
with O O
several O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
systems O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
of O O
the O O
host O B_DISEASE_ADJECTIVE[DISEASE]/B_CELL[BODY_PART_OR_ORGAN_COMPONENT]
viral O B_DISEASE_ADJECTIVE[DISEASE]/I_CELL[BODY_PART_OR_ORGAN_COMPONENT]
defense O B_DISEASE_ADJECTIVE[DISEASE]/I_CELL[BODY_PART_OR_ORGAN_COMPONENT]
. O O

In O O
the O O
present O O
study O O
, O O
we O O
demonstrate O O
that O O
NS1 O O
of O O
the O O
highly O O
pathogenic O O
avian O O
influenza B B_VIRUS[BIO]/B_DISEASE_ADJECTIVE[DISEASE]
A B I_VIRUS[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
/ I I_VIRUS[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
Duck I I_VIRUS[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
/ I I_VIRUS[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
Hubei I I_VIRUS[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
/ I I_VIRUS[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
L I I_VIRUS[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
- I I_VIRUS[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
1 I I_VIRUS[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
/ I I_VIRUS[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
2004 I I_VIRUS[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
( I I_VIRUS[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
H5N1 I I_VIRUS[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
) I I_VIRUS[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
virus I I_VIRUS[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
interacts O O
with O O
human B B_SPECIES[BIO]/B_GENE
Ubc9 O O
, O O
which O O
is O O
the O O
E2 O O
conjugating O O
enzyme O O
for O O
sumoylation O O
, O O
and O O
we O O
show O O
that O O
SUMO1 O O
is O O
conjugated O O
to O O
H5N1 B B_DISEASE/B_PERSON
NS1 O O
in O O
both O O
transfected O O
and O O
infected O O
cells O O
. O O

Furthermore O O
, O O
two O B_LOCATION/B_BIO
lysine O I_LOCATION/I_BIO
residues O I_LOCATION/I_BIO
in O O
the O O
C O B_LOCATION/B_BODY_PART_OR_ORGAN_COMPONENT
terminus O I_LOCATION/I_BODY_PART_OR_ORGAN_COMPONENT
of O O
NS1 O B_GENE/B_BIO
were O O
identified O O
as O O
SUMO1 O B_DISEASE_ADJECTIVE[DISEASE]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
acceptor O B_DISEASE_ADJECTIVE[DISEASE]/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
sites O B_DISEASE_ADJECTIVE[DISEASE]/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

When O O
the O O
SUMO1 O B_DISEASE_ADJECTIVE[DISEASE]/B_GENE
acceptor O B_DISEASE_ADJECTIVE[DISEASE]/I_GENE
sites O B_DISEASE_ADJECTIVE[DISEASE]/I_GENE
were O O
removed O O
by O O
mutation O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
, O O
NS1 O B_GENE/B_BIO
underwent O O
rapid O B_DISEASE_ADJECTIVE[DISEASE]/B_PHYSIOLOGIC_FUNCTION[ORGANISM_FUNCTION]
degradation O B_DISEASE_ADJECTIVE[DISEASE]/I_PHYSIOLOGIC_FUNCTION[ORGANISM_FUNCTION]
. O O

Studies O O
of O O
different O O
influenza B B_DISEASE/B_SPECIES[BIO]
A I B_DISEASE/I_SPECIES[BIO]
virus I B_DISEASE/I_SPECIES[BIO]
strains O O
of O O
human B B_SPECIES[BIO]/B_LOCATION
and O O
avian O O
origin O O
showed O O
that O O
the O O
majority O O
of O O
viruses O O
possess O O
an O O
NS1 O O
protein O O
that O O
is O O
modified O O
by O O
SUMO1 O O
, O O
except O O
for O O
the O O
recently O O
emerged O O
swine B B_DISEASE_ADJECTIVE[DISEASE]/B_BIO
- I B_DISEASE_ADJECTIVE[DISEASE]/I_BIO
origin I B_DISEASE_ADJECTIVE[DISEASE]/I_BIO
influenza I B_DISEASE_ADJECTIVE[DISEASE]/I_BIO
A I B_DISEASE_ADJECTIVE[DISEASE]/I_BIO
virus I B_DISEASE_ADJECTIVE[DISEASE]/I_BIO
( I B_DISEASE_ADJECTIVE[DISEASE]/I_BIO
S I B_DISEASE_ADJECTIVE[DISEASE]/I_BIO
- I B_DISEASE_ADJECTIVE[DISEASE]/I_BIO
OIV I B_DISEASE_ADJECTIVE[DISEASE]/I_BIO
) I B_DISEASE_ADJECTIVE[DISEASE]/I_BIO
( I B_DISEASE_ADJECTIVE[DISEASE]/I_BIO
H1N1 I B_DISEASE_ADJECTIVE[DISEASE]/I_BIO
) I B_DISEASE_ADJECTIVE[DISEASE]/I_BIO
. O O

Interestingly O O
, O O
growth O B_DISEASE_ADJECTIVE[DISEASE]/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
a O O
sumoylation O B_GENE
- O O
deficient O B_DISEASE_ADJECTIVE[DISEASE]/B_GENE
WSN O I_DISEASE_ADJECTIVE[DISEASE]/I_GENE
virus O I_DISEASE_ADJECTIVE[DISEASE]/I_GENE
mutant O I_DISEASE_ADJECTIVE[DISEASE]/I_GENE
was O O
retarded O O
compared O O
to O O
that O O
of O O
wild O B_PERSON/B_BIO
- O O
type O B_BIO/B_MEASURE
virus O B_BIO/I_MEASURE
. O O

Together O O
, O O
these O O
results O O
indicate O O
that O O
sumoylation O O
enhances O O
NS1 O O
stability O O
and O O
thus O O
promotes O O
rapid O O
growth O O
of O O
influenza B B_VIRUS[BIO]/B_DISEASE_ADJECTIVE[DISEASE]
A I I_VIRUS[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
virus I I_VIRUS[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
. O O

Acclimation O O
to O O
high O O
CO2 O O
in O O
maize B B_BIO/B_LOCATION
is O O
related O O
to O O
water O O
status O O
and O O
dependent O O
on O O
leaf O O
rank O O
. O O

The O O
responses O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
C O B_PROTEIN[GENE]/B_LOCATION
( O O
3 O B_NUMBER[MEASURE]/B_LOCATION
) O O
plants O B_BIO/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
to O O
rising O O
atmospheric O B_LOCATION/B_ORGANIZATION
CO O I_LOCATION/I_ORGANIZATION
( O O
2 O B_NUMBER[MEASURE]/B_LOCATION
) O O
levels O B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
are O O
considered O O
to O O
be O O
largely O O
dependent O B_PERSON/B_DISEASE_ADJECTIVE[DISEASE]
on O O
effects O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
exerted O O
through O O
altered O B_DISEASE/B_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
photosynthesis O B_DISEASE/I_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

In O O
contrast O B_MEASURE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
the O O
nature O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
of O O
the O O
responses O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
of O O
C O B_PROTEIN[GENE]/B_LOCATION
( O O
4 O B_TIME[MEASURE]/B_LOCATION
) O O
plants O B_BIO/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
to O O
high O B_LOCATION
CO O I_LOCATION
( O O
2 O B_NUMBER[MEASURE]
) O O
remains O O
controversial O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
because O O
of O O
the O O
absence O B_DISEASE_ADJECTIVE[DISEASE]
of O O
CO O B_LOCATION
( O O
2 O B_NUMBER[MEASURE]
) O O
- O O
dependent O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
effects O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE
on O O
photosynthesis O B_ORGANISM_FUNCTION/B_BIO
. O O

In O O
this O O
study O O
, O O
the O O
effects O O
of O O
atmospheric O O
CO O O
( O O
2 O O
) O O
availability O O
on O O
the O O
transcriptome O O
, O O
proteome O O
and O O
metabolome O O
profiles O O
of O O
two O O
ranks O O
of O O
source O O
leaves O O
in O O
maize B B_BIO
( O O
Zea B B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
mays I B_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
L O O
. O O
) O O
were O O
studied O O
in O O
plants O O
grown O O
under O O
ambient O O
CO O O
( O O
2 O O
) O O
conditions O O
( O O
350 O O
+ O O
/ O O
- O O
20 O O
muL O O
L O O
( O O
- O O
1 O O
) O O
CO O O
( O O
2 O O
) O O
) O O
or O O
with O O
CO O O
( O O
2 O O
) O O
enrichment O O
( O O
700 O O
+ O O
/ O O
- O O
20 O O
muL O O
L O O
( O O
- O O
1 O O
) O O
CO O O
( O O
2 O O
) O O
) O O
. O O

Growth O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_TIME[MEASURE]
at O O
high O B_MEASURE/B_LOCATION
CO O I_MEASURE/I_LOCATION
( O O
2 O B_MEASURE/B_LOCATION
) O O
had O O
no O O
effect O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
on O O
photosynthesis O B_ORGANISM_FUNCTION/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
photorespiration O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANISM_FUNCTION
, O O
leaf O B_LOCATION
C O I_LOCATION
/ O O
N O B_LOCATION/B_MEASURE
ratios O I_LOCATION/I_MEASURE
or O O
anthocyanin O B_DISEASE_ADJECTIVE[DISEASE]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
contents O B_DISEASE_ADJECTIVE[DISEASE]/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

However O O
, O O
leaf O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
transpiration O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
rates O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
carbohydrate O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
metabolism O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
and O O
protein O B_DISEASE_ADJECTIVE[DISEASE]/B_ORGANISM_FUNCTION
carbonyl O B_DISEASE_ADJECTIVE[DISEASE]/I_ORGANISM_FUNCTION
accumulation O B_DISEASE_ADJECTIVE[DISEASE]/I_ORGANISM_FUNCTION
were O O
altered O O
at O O
high O B_LOCATION/B_DISEASE_ADJECTIVE[DISEASE]
CO O I_LOCATION/I_DISEASE_ADJECTIVE[DISEASE]
( O O
2 O B_MEASURE/B_LOCATION
) O O
in O O
a O O
leaf O B_MEASURE/B_BODY_PART_OR_ORGAN_COMPONENT
- O O
rank O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
specific O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
manner O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
. O O

Although O O
no O O
significant O B_DISEASE_ADJECTIVE[DISEASE]/B_LOCATION
CO O B_DISEASE_ADJECTIVE[DISEASE]/I_LOCATION
( O O
2 O B_NUMBER[MEASURE]
) O O
- O O
dependent O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
changes O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
in O O
the O O
leaf O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
transcriptome O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
were O O
observed O O
, O O
qPCR O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
analysis O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
revealed O O
that O O
the O O
abundance O B_MEASURE/B_LOCATION
of O O
transcripts O B_GENE/B_MEASURE
encoding O O
a O O
Bowman O B_DISEASE/B_GENE
- O O
Birk O B_GENE/B_TIME[MEASURE]
protease O I_GENE/I_TIME[MEASURE]
inhibitor O I_GENE/I_TIME[MEASURE]
and O O
a O O
serpin O B_ENZYME[GENE]/B_DISEASE_ADJECTIVE[DISEASE]
were O O
changed O O
by O O
the O O
growth O B_LOCATION/B_PERSON
CO O I_LOCATION/I_PERSON
( O O
2 O B_NUMBER[MEASURE]
) O O
level O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_MEASURE
in O O
a O O
leaf O B_LOCATION/B_BIO
rank O B_LOCATION/I_BIO
specific O B_LOCATION/I_BIO
manner O B_LOCATION/I_BIO
. O O

Moreover O O
, O O
CO O B_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
( O O
2 O B_NUMBER[MEASURE]/B_LOCATION
) O O
- O O
dependent O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
changes O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
in O O
the O O
leaf O B_BIO/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
proteome O B_BIO/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
were O O
most O O
evident O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
in O O
the O O
oldest O B_BIO/B_TIME[MEASURE]
source O I_BIO/I_TIME[MEASURE]
leaves O I_BIO/I_TIME[MEASURE]
. O O

Small O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
changes O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
in O O
water O B_MEASURE/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
status O I_MEASURE/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
may O O
be O O
responsible O B_PERSON/B_DISEASE_ADJECTIVE[DISEASE]
for O O
the O O
observed O O
responses O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
to O O
high O B_LOCATION/B_DISEASE_ADJECTIVE[DISEASE]
CO O I_LOCATION/I_DISEASE_ADJECTIVE[DISEASE]
( O O
2 O B_MEASURE/B_LOCATION
, O O
) O O
particularly O O
in O O
the O O
older O B_TIME[MEASURE]/B_BODY_PART_OR_ORGAN_COMPONENT
leaf O I_TIME[MEASURE]/I_BODY_PART_OR_ORGAN_COMPONENT
ranks O I_TIME[MEASURE]/I_BODY_PART_OR_ORGAN_COMPONENT
. O O

Seasonal O O
dynamics O O
in O O
the O O
stable O O
carbon O O
isotope O O
composition O O
delta O O
^ O O
1 O O
^ O O
3C O O
from O O
non O O
- O O
leafy O O
branch O O
, O O
trunk O O
and O O
coarse O O
root O O
CO2 O O
efflux O O
of O O
adult O O
deciduous O O
( O O
Fagus B B_BIO/B_LOCATION
sylvatica I B_BIO/I_LOCATION
) O O
and O O
evergreen O O
( O O
Picea B B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
abies I I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
) O O
trees O O
. O O

Respiration O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BODY_PART_OR_ORGAN_COMPONENT
is O O
a O O
substantial O B_PERSON
driver O I_PERSON
of O O
carbon O B_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
( O O
C O B_PROTEIN[GENE]/B_LOCATION
) O O
flux O B_MEASURE/B_DISEASE
in O O
forest O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
ecosystems O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
and O O
stable O B_LOCATION/B_PERSON
C O I_LOCATION/I_PERSON
isotopes O I_LOCATION/I_PERSON
provide O O
an O O
excellent O B_PERSON/B_LOCATION
tool O B_PERSON/I_LOCATION
for O O
its O O
investigation O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

We O O
studied O O
seasonal O O
dynamics O O
in O O
delta O O
^ O O
1 O O
^ O O
3C O O
of O O
CO2 O O
efflux O O
( O O
delta O O
^ O O
1 O O
^ O O
3C O O
( O O
E O O
) O O
) O O
from O O
non O O
- O O
leafy O O
branches O O
, O O
upper O O
and O O
lower O O
trunks O O
and O O
coarse O O
roots O O
of O O
adult O O
trees O O
, O O
comparing O O
deciduous O O
Fagus B B_BIO/B_LOCATION
sylvatica I I_BIO/I_LOCATION
( O O
European B B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
beech I I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
) O O
with O O
evergreen O O
Picea B B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
abies I I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
( O O
Norway B B_DISEASE_ADJECTIVE[DISEASE]/B_BIO
spruce I B_DISEASE_ADJECTIVE[DISEASE]/I_BIO
) O O
. O O

In O O
both O O
species O B_BIO/B_LOCATION
, O O
we O O
observed O O
strong O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
and O O
similar O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
seasonal O I_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
dynamics O I_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
in O O
the O O
delta O B_PROTEIN[GENE]
^ O O
1 O B_PROTEIN[GENE]/B_LOCATION
^ O I_PROTEIN[GENE]/I_LOCATION
3C O I_PROTEIN[GENE]/I_LOCATION
( O O
E O B_OTHER/B_PROTEIN[GENE]
) O O
of O O
above O O
- O O
ground O B_BIO/B_LOCATION
plant O I_BIO/I_LOCATION
components O I_BIO/I_LOCATION
, O O
whereas O O
delta O B_PROTEIN[GENE]
^ O O
1 O B_PROTEIN[GENE]/B_MEASURE
^ O I_PROTEIN[GENE]/I_MEASURE
3C O I_PROTEIN[GENE]/I_MEASURE
( O O
E O B_OTHER/B_PROTEIN[GENE]
) O O
of O O
coarse O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
roots O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
was O O
rather O O
stable O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
. O O

During O O
summer O B_TIME[MEASURE]/B_LOCATION
, O O
delta O B_MEASURE/B_PERSON
^ O I_MEASURE/I_PERSON
1 O I_MEASURE/I_PERSON
^ O I_MEASURE/I_PERSON
3C O I_MEASURE/I_PERSON
( O O
E O B_MEASURE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
) O O
of O O
trunks O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
was O O
about O O
- O O
28 O B_MEASURE
. O O
2 O B_MEASURE
% O I_MEASURE
( O O
Beech O B_BIO/B_LOCATION
) O O
and O O
- O O
26 O B_MEASURE
. O O
8 O B_MEASURE/B_PERSON
% O I_MEASURE/I_PERSON
( O O
Spruce O B_LOCATION/B_DISEASE
) O O
. O O

During O O
winter O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_ORGANISM_FUNCTION
dormancy O I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/I_ORGANISM_FUNCTION
, O O
delta O B_LOCATION/B_PROTEIN[GENE]
^ O O
1 O B_MEASURE
^ O I_MEASURE
3C O I_MEASURE
( O O
E O B_OTHER/B_MEASURE
) O O
increased O O
by O O
5 O B_NUMBER[MEASURE]
. O O
6 O B_MEASURE
- O O
9 O B_MEASURE
. O O
1 O B_MEASURE
% O I_MEASURE
. O O

The O O
observed O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
dynamics O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
are O O
likely O O
related O O
to O O
a O O
switch O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
from O O
growth O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PHYSIOLOGIC_FUNCTION[ORGANISM_FUNCTION]
to O O
starch O B_DISEASE_ADJECTIVE[DISEASE]/B_ORGANISM_FUNCTION
accumulation O B_DISEASE_ADJECTIVE[DISEASE]/I_ORGANISM_FUNCTION
during O O
fall O B_DISEASE/B_TIME[MEASURE]
and O O
remobilization O B_DISEASE_ADJECTIVE[DISEASE]/B_PHYSIOLOGIC_FUNCTION[ORGANISM_FUNCTION]
of O O
starch O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
, O O
low O B_PHYSIOLOGIC_FUNCTION[ORGANISM_FUNCTION]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
TCA O I_PHYSIOLOGIC_FUNCTION[ORGANISM_FUNCTION]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
cycle O I_PHYSIOLOGIC_FUNCTION[ORGANISM_FUNCTION]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
activity O I_PHYSIOLOGIC_FUNCTION[ORGANISM_FUNCTION]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
accumulation O B_PHYSIOLOGIC_FUNCTION[ORGANISM_FUNCTION]/B_DISEASE
of O O
malate O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
by O O
PEPc O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
during O O
winter O B_TIME[MEASURE]/B_LOCATION
. O O

The O O
seasonal O B_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
delta O I_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
^ O I_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
1 O I_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
^ O I_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
3C O I_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
( O O
E O B_OTHER/B_MEASURE
) O O
pattern O B_MEASURE/B_DISEASE
of O O
branches O B_BODY_PART_OR_ORGAN_COMPONENT/B_DISEASE
of O O
Beech O B_BODY_PART_OR_ORGAN_COMPONENT/B_LOCATION
and O O
upper O B_DISEASE_ADJECTIVE[DISEASE]/B_BIO
trunks O B_DISEASE_ADJECTIVE[DISEASE]/I_BIO
of O O
Spruce O B_DISEASE/B_BIO
was O O
less O O
variable O B_DISEASE_ADJECTIVE[DISEASE]/B_LOCATION
, O O
probably O O
because O O
these O O
organs O B_BODY_PART_OR_ORGAN_COMPONENT/B_BIO
were O O
additionally O O
supplied O O
by O O
winter O B_BODY_PART_OR_ORGAN_COMPONENT/B_DISEASE_ADJECTIVE[DISEASE]
photosynthesis O I_BODY_PART_OR_ORGAN_COMPONENT/I_DISEASE_ADJECTIVE[DISEASE]
. O O

In O O
view O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
of O O
our O O
results O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
pervious O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
studies O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
, O O
we O O
conclude O O
that O O
the O O
pronounced O O
increases O B_DISEASE_ADJECTIVE[DISEASE]
in O O
delta O B_LOCATION/B_PROTEIN[GENE]
^ O O
1 O B_MEASURE/B_LOCATION
^ O I_MEASURE/I_LOCATION
3C O I_MEASURE/I_LOCATION
( O O
E O B_OTHER/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
) O O
of O O
trunks O B_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
during O O
the O O
winter O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
results O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
from O O
interrupted O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_ORGANISM_FUNCTION
access O I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/I_ORGANISM_FUNCTION
to O O
recent O B_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
photosynthates O I_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
. O O

The O O
atypical O O
OmpR O O
/ O O
PhoB O O
response O O
regulator O O
ChxR O O
from O O
Chlamydia B B_BACTERIUM[BIO]
trachomatis I I_BACTERIUM[BIO]
forms O O
homodimers O O
in O O
vivo O O
and O O
binds O O
a O O
direct O O
repeat O O
of O O
nucleotide O O
sequences O O
. O O

Two O B_NUMBER[MEASURE]
- O O
component O B_LOCATION/B_PERSON
signal O I_LOCATION/I_PERSON
transduction O I_LOCATION/I_PERSON
systems O I_LOCATION/I_PERSON
are O O
widespread O B_DISEASE_ADJECTIVE[DISEASE]
in O O
bacteria O B_BIO
and O O
are O O
essential O B_DISEASE_ADJECTIVE[DISEASE]
regulatory O I_DISEASE_ADJECTIVE[DISEASE]
mechanisms O I_DISEASE_ADJECTIVE[DISEASE]
for O O
many O B_DISEASE/B_ORGANISM_FUNCTION
biological O I_DISEASE/I_ORGANISM_FUNCTION
processes O I_DISEASE/I_ORGANISM_FUNCTION
. O O

These O O
systems O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
predominantly O O
rely O O
on O O
a O O
sensor O B_ENZYME[GENE]/B_LOCATION
kinase O I_ENZYME[GENE]/I_LOCATION
to O O
phosphorylate O O
a O O
response O B_GENE/B_MEASURE
regulator O I_GENE/I_MEASURE
for O O
controlling O O
activity O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE_EXPRESSION_ADJECTIVE[GENE]
, O O
which O O
is O O
frequently O O
transcriptional O B_DISEASE_ADJECTIVE[DISEASE]/B_GENE
regulation O I_DISEASE_ADJECTIVE[DISEASE]/I_GENE
. O O

In O O
recent O B_TIME[MEASURE]/B_LOCATION
years O I_TIME[MEASURE]/I_LOCATION
, O O
an O O
increasing O O
number O B_MEASURE/B_LOCATION
of O O
atypical O B_GENE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
response O I_GENE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
regulators O I_GENE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
have O O
been O O
discovered O O
in O O
phylogenetically O O
diverse O B_BIO
bacteria O I_BIO
. O O

These O O
atypical O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
response O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
regulators O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
are O O
not O O
controlled O O
by O O
phosphorylation O B_GENE
and O O
exhibit O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE_EXPRESSION_ADJECTIVE[GENE]
transcriptional O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE_EXPRESSION_ADJECTIVE[GENE]
activity O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE_EXPRESSION_ADJECTIVE[GENE]
in O O
their O O
wild O B_BIO/B_GENE
- O O
type O B_MEASURE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
form O I_MEASURE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

Relatively O O
little O B_PERSON/B_DISEASE_ADJECTIVE[DISEASE]
is O O
known O O
regarding O O
the O O
mechanisms O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
utilized O O
by O O
these O O
atypical O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
response O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
regulators O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
and O O
the O O
conserved O O
characteristics O B_LOCATION/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
these O O
atypical O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
response O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
regulators O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
. O O

Chlamydia O B_BACTERIUM[BIO]
spp O I_BACTERIUM[BIO]
. O O
are O O
medically O O
important O B_DISEASE_ADJECTIVE[DISEASE]/B_BACTERIUM[BIO]
bacteria O I_DISEASE_ADJECTIVE[DISEASE]/I_BACTERIUM[BIO]
and O O
encode O O
an O O
atypical O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
OmpR O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
/ O O
PhoB O B_LOCATION/B_BACTERIUM[BIO]
subfamily O O
response O B_GENE/B_TIME[MEASURE]
regulator O I_GENE/I_TIME[MEASURE]
termed O O
ChxR O B_GENE/B_DISEASE
. O O

In O O
this O O
study O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
, O O
protein O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
expression O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
analysis O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
supports O O
that O O
ChxR O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
is O O
likely O O
exerting O O
its O O
effect O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
during O O
the O O
middle O B_DISEASE_ADJECTIVE[DISEASE]
and O O
late O B_MEASURE/B_DISEASE_ADJECTIVE[DISEASE]
stages O I_MEASURE/I_DISEASE_ADJECTIVE[DISEASE]
of O O
the O O
chlamydial O B_DISEASE/B_BIO
developmental O I_DISEASE/I_BIO
cycle O I_DISEASE/I_BIO
, O O
stages O B_DISEASE/B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
that O O
include O O
the O O
formation O B_PERSON/B_DISEASE_ADJECTIVE[DISEASE]
of O O
infectious O B_DISEASE/B_CELL_COMPONENT[BODY_PART_OR_ORGAN_COMPONENT]
elementary O B_DISEASE/I_CELL_COMPONENT[BODY_PART_OR_ORGAN_COMPONENT]
bodies O B_DISEASE/I_CELL_COMPONENT[BODY_PART_OR_ORGAN_COMPONENT]
. O O

In O O
the O O
absence O B_DISEASE/B_LOCATION
of O O
detectable O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ENZYME[GENE]
phosphorylation O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_ENZYME[GENE]
, O O
ChxR O B_GENE/B_BIO
formed O O
homodimers O B_CHEMICAL_CLASS[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
in O O
vitro O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
and O O
in O O
vivo O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
, O O
similar O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
to O O
a O O
phosphorylated O B_GENE/B_DISEASE
OmpR O I_GENE/I_DISEASE
/ O O
PhoB O B_LOCATION
subfamily O O
response O B_GENE/B_MEASURE
regulator O I_GENE/I_MEASURE
. O O

ChxR O B_GENE
was O O
demonstrated O O
to O O
bind O O
to O O
its O O
own O B_PERSON/B_GENE
promoter O I_PERSON/I_GENE
in O O
vivo O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
, O O
supporting O O
the O O
role O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
of O O
ChxR O B_GENE
as O O
an O O
autoactivator O B_GENE/B_PERSON
. O O

Detailed O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
analysis O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
the O O
ChxR O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
binding O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
sites O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
within O O
its O O
own O B_GENE/B_LOCATION
promoter O I_GENE/I_LOCATION
revealed O O
a O O
conserved O B_GENE/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
cis O B_GENE/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- O O
acting O O
motif O B_LOCATION/B_GENE
that O O
includes O O
a O O
tandem O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
repeat O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
sequence O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
. O O

ChxR O B_GENE
binds O O
specifically O O
to O O
each O O
of O O
the O O
individual O B_PROTEIN[GENE]/B_LOCATION
sites O I_PROTEIN[GENE]/I_LOCATION
and O O
exhibits O O
a O O
relatively O O
large O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
spectrum O B_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
of O O
differential O B_GENE/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
affinity O B_GENE/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

Taken O O
together O O
, O O
these O O
observations O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
support O O
the O O
conclusion O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANIZATION
that O O
ChxR O B_GENE/B_DISEASE
, O O
in O O
the O O
absence O B_DISEASE/B_LOCATION
of O O
phosphorylation O B_GENE
, O O
exhibits O O
many O B_NUMBER[MEASURE]/B_PERSON
of O O
the O O
characteristics O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
of O O
a O O
phosphorylated O B_ENZYME[GENE]/B_DISEASE_ADJECTIVE[DISEASE]
( O O
active O B_DISEASE
) O O
OmpR O B_GENE/B_BACTERIUM[BIO]
/ O O
PhoB O B_LOCATION
subfamily O O
response O B_GENE/B_MEASURE
regulator O I_GENE/I_MEASURE
. O O

Cold O O
stress O O
contributes O O
to O O
aberrant O O
cytokinesis O O
during O O
male O O
meiosis O O
I O O
in O O
a O O
wheat B B_DISEASE_ADJECTIVE[DISEASE]/B_BIO
thermosensitive O O
genic O O
male O O
sterile O O
line O O
. O O

The O O
male O O
sterility O O
of O O
a O O
wheat B B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
thermosensitive O O
genic O O
male O O
sterile O O
( O O
TGMS O O
) O O
line O O
is O O
strictly O O
controlled O O
by O O
temperature O O
. O O

When O O
the O O
TGMS O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
line O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_BIO
BS366 O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_BIO
was O O
exposed O O
to O O
10 O B_MEASURE/B_LOCATION
^ O O
0C O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
from O O
the O O
pollen O B_BIO/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
mother O I_BIO/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
cell O I_BIO/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
stage O I_BIO/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
to O O
the O O
meiosis O B_BIO/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
stage O I_BIO/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
a O O
few O B_DISEASE_ADJECTIVE[DISEASE]/B_BODY_PART_OR_ORGAN_COMPONENT
pollen O B_DISEASE_ADJECTIVE[DISEASE]/I_BODY_PART_OR_ORGAN_COMPONENT
grains O B_DISEASE_ADJECTIVE[DISEASE]/I_BODY_PART_OR_ORGAN_COMPONENT
were O O
formed O O
and O O
devoid O B_LOCATION/B_DISEASE_ADJECTIVE[DISEASE]
of O O
starch O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_CELL_COMPONENT[BODY_PART_OR_ORGAN_COMPONENT]
. O O

We O O
report O O
here O O
a O O
large O O
- O O
scale O O
transcriptomic O O
study O O
using O O
the O O
Affymetrix O O
wheat B B_SPECIES[BIO]/B_LOCATION
GeneChip O O
to O O
follow O O
gene O O
expression O O
in O O
BS366 O O
line O O
anthers O O
in O O
response O O
to O O
cold O O
stress O O
. O O

Notably O O
, O O
many O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
cytoskeletal O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
signaling O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
components O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
were O O
gradually O O
induced O O
in O O
response O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
to O O
cold O B_DISEASE/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
stress O B_DISEASE/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
in O O
BS366 O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
line O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_BIO
anthers O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_BIO
. O O

However O O
, O O
the O O
cytoskeleton O B_CELL_COMPONENT[BODY_PART_OR_ORGAN_COMPONENT]/B_DISEASE
- O O
associated O O
genes O B_CHEMICAL_CLASS[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
that O O
play O O
key O B_DISEASE_ADJECTIVE[DISEASE]/B_LOCATION
roles O I_DISEASE_ADJECTIVE[DISEASE]/I_LOCATION
in O O
the O O
dynamic O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
organization O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
of O O
the O O
cytoskeleton O B_CELL_COMPONENT[BODY_PART_OR_ORGAN_COMPONENT]/B_GENE
were O O
dramatically O O
repressed O O
. O O

Histological O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
studies O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
revealed O O
that O O
the O O
separation O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
of O O
dyads O B_CELL[BODY_PART_OR_ORGAN_COMPONENT]/B_BIO
occurred O O
abnormally O O
during O O
male O B_TIME[MEASURE]/B_DISEASE_ADJECTIVE[DISEASE]
meiosis O I_TIME[MEASURE]/I_DISEASE_ADJECTIVE[DISEASE]
I O O
, O O
indicating O O
defective O B_DISEASE/B_ORGANISM_FUNCTION
male O I_DISEASE/I_ORGANISM_FUNCTION
meiotic O I_DISEASE/I_ORGANISM_FUNCTION
cytokinesis O I_DISEASE/I_ORGANISM_FUNCTION
. O O

Fluorescence O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
labelling O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
and O O
subcellular O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
histological O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
observations O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
revealed O O
that O O
the O O
phragmoplast O B_CELL_COMPONENT[BODY_PART_OR_ORGAN_COMPONENT]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
was O O
defectively O O
formed O O
and O O
the O O
cell O B_CELL_COMPONENT[BODY_PART_OR_ORGAN_COMPONENT]/B_GENE
plate O I_CELL_COMPONENT[BODY_PART_OR_ORGAN_COMPONENT]/I_GENE
was O O
abnormally O O
assembled O O
during O O
meiosis O B_TIME[MEASURE]/B_LOCATION
I O O
under O O
cold O B_DISEASE_ADJECTIVE[DISEASE]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
stress O B_DISEASE_ADJECTIVE[DISEASE]/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

Based O O
on O O
the O O
transcriptomic O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
analysis O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
observations O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
characterized O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
histological O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE
changes O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE
, O O
our O O
results O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
suggest O O
that O O
cold O B_DISEASE/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
stress O B_DISEASE/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
repressed O O
transcription O B_GENE
of O O
cytoskeleton O B_GENE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
dynamic O I_GENE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
factors O I_GENE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
subsequently O O
caused O O
the O O
defective O B_DISEASE_ADJECTIVE[DISEASE]
cytokinesis O I_DISEASE_ADJECTIVE[DISEASE]
during O O
meiosis O B_DISEASE/B_PROTEIN[GENE]
I O O
. O O

The O O
results O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
may O O
explain O O
the O O
male O B_DISEASE_ADJECTIVE[DISEASE]
sterility O I_DISEASE_ADJECTIVE[DISEASE]
caused O O
by O O
low O B_DISEASE/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
temperature O B_DISEASE/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
in O O
wheat O B_LOCATION/B_ORGANIZATION
TGMS O I_LOCATION/I_ORGANIZATION
lines O I_LOCATION/I_ORGANIZATION
. O O

Characterizing O O
the O O
role O O
of O O
RNA O O
silencing O O
components O O
in O O
Cryptococcus B B_DISEASE/B_SPECIES[BIO]
neoformans I I_DISEASE/I_SPECIES[BIO]
. O O

The O O
RNA O B_DISEASE_ADJECTIVE[DISEASE]/B_GENE
interference O B_DISEASE_ADJECTIVE[DISEASE]/I_GENE
( O O
RNAi O B_LOCATION/B_ORGANIZATION
) O O
mediated O O
by O O
homology O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
- O O
dependent O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
degradation O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
of O O
the O O
target O B_GENE
mRNA O I_GENE
with O O
small O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
RNA O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
molecules O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
plays O O
a O O
key O B_PERSON/B_LOCATION
role O I_PERSON/I_LOCATION
in O O
controlling O O
transcription O B_GENE
and O O
translation O B_GENE/B_ORGANISM_FUNCTION
processes O B_GENE/I_ORGANISM_FUNCTION
in O O
a O O
number O B_MEASURE/B_PERSON
of O O
eukaryotic O B_BIO/B_LOCATION
organisms O I_BIO/I_LOCATION
. O O

The O O
RNAi O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
machinery O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
is O O
also O O
evolutionarily O O
conserved O O
in O O
a O O
wide O B_MEASURE/B_ENT
variety O I_MEASURE/I_ENT
of O O
fungal O B_BIO
species O I_BIO
, O O
including O O
pathogenic O B_SPECIES[BIO]
fungi O I_SPECIES[BIO]
. O O

To O O
elucidate O O
the O O
physiological O O
functions O O
of O O
the O O
RNAi O O
pathway O O
in O O
Cryptococcus B B_SPECIES[BIO]/B_DISEASE
neoformans I I_SPECIES[BIO]/I_DISEASE
that O O
causes O O
fungal O O
meningitis O O
, O O
here O O
we O O
performed O O
genetic O O
analyses O O
for O O
genes O O
encoding O O
Argonaute O O
( O O
AGO1 O O
and O O
AGO2 O O
) O O
, O O
RNA O O
- O O
dependent O O
RNA O O
polymerase O O
( O O
RDP1 O O
) O O
, O O
and O O
Dicers O O
( O O
DCR1 O O
and O O
DCR2 O O
) O O
in O O
both O O
serotype O O
A O O
and O O
D O O
C B B_BIO/B_DISEASE
. I I_BIO/I_DISEASE
neoformans I I_BIO/I_DISEASE
. O O

The O O
present O O
study O O
shows O O
that O O
Ago1 O O
, O O
Rdp1 O O
, O O
and O O
Dcr2 O O
are O O
the O O
major O O
components O O
of O O
the O O
RNAi O O
process O O
occurring O O
in O O
C B B_BIO
. I I_BIO
neoformans I I_BIO
. O O

However O O
, O O
the O O
RNAi O B_GENE/B_BIO
machinery O I_GENE/I_BIO
is O O
not O O
involved O O
in O O
regulation O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_LOCATION
of O O
production O B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_CELL_FUNCTION[ORGANISM_FUNCTION]
of O O
two O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
virulence O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
factors O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
( O O
capsule O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
and O O
melanin O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
) O O
, O O
sexual O B_DISEASE_ADJECTIVE[DISEASE]
differentiation O I_DISEASE_ADJECTIVE[DISEASE]
, O O
and O O
diverse O B_DISEASE/B_ORGANISM_FUNCTION
stress O I_DISEASE/I_ORGANISM_FUNCTION
response O I_DISEASE/I_ORGANISM_FUNCTION
. O O

Comparative O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
transcriptome O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
analysis O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
of O O
the O O
serotype O B_PROTEIN[GENE]/B_BACTERIUM[BIO]
A O I_PROTEIN[GENE]/I_BACTERIUM[BIO]
and O O
D O B_PROTEIN[GENE]/B_BIO
RNAi O I_PROTEIN[GENE]/I_BIO
mutants O I_PROTEIN[GENE]/I_BIO
revealed O O
that O O
only O B_DISEASE_ADJECTIVE[DISEASE]
modest O I_DISEASE_ADJECTIVE[DISEASE]
changes O I_DISEASE_ADJECTIVE[DISEASE]
occur O O
in O O
the O O
genome O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
- O O
wide O B_MEASURE/B_LOCATION
transcriptome O I_MEASURE/I_LOCATION
profiles O I_MEASURE/I_LOCATION
when O O
the O O
RNAi O B_GENE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
process O I_GENE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
was O O
perturbed O O
. O O

Notably O O
, O O
the O O
serotype O O
D O O
rdp1Delta O O
mutants O O
showed O O
an O O
increase O O
in O O
transcript O O
abundance O O
of O O
active O O
retrotransposons O O
and O O
transposons O O
, O O
such O O
as O O
T2 O O
and O O
T3 O O
, O O
the O O
latter O O
of O O
which O O
is O O
a O O
novel O O
serotype O O
D O O
- O O
specific O O
transposon O O
of O O
C B B_SPECIES[BIO]/B_LOCATION
. I I_SPECIES[BIO]/I_LOCATION
neoformans I I_SPECIES[BIO]/I_LOCATION
. O O

In O O
a O O
wild O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
type O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
background O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
both O O
T2 O B_PROTEIN[GENE]
and O O
T3 O B_PROTEIN[GENE]
were O O
found O O
to O O
be O O
weakly O O
active O B_DISEASE_ADJECTIVE[DISEASE]
mobile O I_DISEASE_ADJECTIVE[DISEASE]
elements O I_DISEASE_ADJECTIVE[DISEASE]
, O O
although O O
we O O
found O O
no O O
evidence O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
Cnl1 O B_DISEASE_ADJECTIVE[DISEASE]/B_GENE_EXPRESSION_ADJECTIVE[GENE]
retrotransposon O B_DISEASE_ADJECTIVE[DISEASE]/I_GENE_EXPRESSION_ADJECTIVE[GENE]
mobility O B_DISEASE_ADJECTIVE[DISEASE]/I_GENE_EXPRESSION_ADJECTIVE[GENE]
. O O

In O O
contrast O B_MEASURE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
all O O
three O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
transposable O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
elements O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
exhibited O O
enhanced O B_DISEASE_ADJECTIVE[DISEASE]
mobility O I_DISEASE_ADJECTIVE[DISEASE]
in O O
the O O
rdp1Delta O B_GENE/B_CELL[BODY_PART_OR_ORGAN_COMPONENT]
mutant O B_GENE/I_CELL[BODY_PART_OR_ORGAN_COMPONENT]
strain O B_GENE/I_CELL[BODY_PART_OR_ORGAN_COMPONENT]
. O O

In O O
conclusion O O
, O O
the O O
RNAi O O
pathway O O
plays O O
an O O
important O O
role O O
in O O
controlling O O
transposon O O
activity O O
and O O
genome O O
integrity O O
of O O
C B B_SPECIES[BIO]/B_GENE
. I I_SPECIES[BIO]/I_GENE
neoformans I I_SPECIES[BIO]/I_GENE
. O O

Fur O O
negatively O O
regulates O O
hns O O
and O O
is O O
required O O
for O O
the O O
expression O O
of O O
HilA O O
and O O
virulence O O
in O O
Salmonella B B_BACTERIUM[BIO]
enterica I I_BACTERIUM[BIO]
serovar O O
Typhimurium O O
. O O

Iron O B_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
is O O
an O O
essential O B_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
element O I_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
for O O
the O O
survival O B_DISEASE_ADJECTIVE[DISEASE]/B_ORGANISM_FUNCTION
of O O
living O O
cells O B_BIO/B_CELL[BODY_PART_OR_ORGAN_COMPONENT]
. O O

However O O
, O O
excess O B_DISEASE_ADJECTIVE[DISEASE]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
iron O B_DISEASE_ADJECTIVE[DISEASE]/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
is O O
toxic O B_DISEASE_ADJECTIVE[DISEASE]
, O O
and O O
its O O
uptake O B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
is O O
exquisitely O O
regulated O O
by O O
the O O
ferric O B_PROTEIN[GENE]/B_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
uptake O I_PROTEIN[GENE]/I_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
regulator O I_PROTEIN[GENE]/I_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
Fur O B_GENE
. O O

In O O
Salmonella O B_SPECIES[BIO]
, O O
the O O
Salmonella O B_BACTERIUM[BIO]/B_GENE
pathogenicity O B_BACTERIUM[BIO]/I_GENE
island O B_BACTERIUM[BIO]/I_GENE
1 O B_BACTERIUM[BIO]/I_GENE
( O O
SPI O B_LOCATION/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- O O
1 O B_NUMBER[MEASURE]
) O O
encodes O B_GENE/B_MEASURE
a O O
type O B_ENZYME[GENE]/B_DISEASE_ADJECTIVE[DISEASE]
three O I_ENZYME[GENE]/I_DISEASE_ADJECTIVE[DISEASE]
secretion O I_ENZYME[GENE]/I_DISEASE_ADJECTIVE[DISEASE]
system O I_ENZYME[GENE]/I_DISEASE_ADJECTIVE[DISEASE]
, O O
which O O
is O O
required O O
for O O
invasion O B_DISEASE_ADJECTIVE[DISEASE]/B_ORGANISM_FUNCTION
of O O
host O B_BACTERIUM[BIO]/B_DISEASE
epithelial O I_BACTERIUM[BIO]/I_DISEASE
cells O I_BACTERIUM[BIO]/I_DISEASE
in O O
the O O
small O B_BODY_PART_OR_ORGAN_COMPONENT/B_DISEASE_ADJECTIVE[DISEASE]
intestine O I_BODY_PART_OR_ORGAN_COMPONENT/I_DISEASE_ADJECTIVE[DISEASE]
. O O

A O O
major O B_GENE/B_MEASURE
activator O I_GENE/I_MEASURE
of O O
SPI O B_LOCATION
- O O
1 O B_NUMBER[MEASURE]
is O O
HilA O B_GENE/B_BACTERIUM[BIO]
, O O
which O O
is O O
encoded O O
within O O
SPI O B_LOCATION/B_ORGANIZATION
- O O
1 O B_NUMBER[MEASURE]
. O O

One O B_NUMBER[MEASURE]/B_PERSON
known O O
regulator O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
of O O
hilA O B_BACTERIUM[BIO]/B_DISEASE
is O O
Fur O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
. O O

The O O
mechanism O B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
of O O
hilA O B_DISEASE_ADJECTIVE[DISEASE]/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
regulation O B_DISEASE_ADJECTIVE[DISEASE]/I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
by O O
Fur O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
is O O
unknown O B_DISEASE_ADJECTIVE[DISEASE]
. O O

We O O
report O O
here O O
that O O
Fur O O
is O O
required O O
for O O
virulence O O
in O O
Salmonella B B_BACTERIUM[BIO]
enterica I I_BACTERIUM[BIO]
serovar O O
Typhimurium O O
and O O
that O O
Fur O O
is O O
required O O
for O O
the O O
activation O O
of O O
hilA O O
, O O
as O O
well O O
as O O
of O O
other O O
HilA O O
- O O
dependent O O
genes O O
, O O
invF O O
and O O
sipC O O
. O O

The O O
Fur O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
- O O
dependent O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
regulation O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
of O O
hilA O B_BACTERIUM[BIO]/B_GENE
was O O
independent O B_DISEASE_ADJECTIVE[DISEASE]/B_LOCATION
of O O
PhoP O B_GENE/B_BACTERIUM[BIO]
, O O
a O O
known O O
repressor O B_GENE/B_PERSON
of O O
hilA O B_BACTERIUM[BIO]/B_GENE
. O O

Instead O O
, O O
the O O
expression O B_GENE
of O O
the O O
gene O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
coding O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
for O O
the O O
histone O B_GENE
- O O
like O B_ENZYME[GENE]/B_DISEASE_ADJECTIVE[DISEASE]
protein O I_ENZYME[GENE]/I_DISEASE_ADJECTIVE[DISEASE]
, O O
hns O B_GENE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
was O O
significantly O O
derepressed O O
in O O
the O O
fur O B_DISEASE/B_BODY_PART_OR_ORGAN_COMPONENT
mutant O B_DISEASE/I_BODY_PART_OR_ORGAN_COMPONENT
. O O

Indeed O O
, O O
the O O
activation O B_GENE/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
of O O
hilA O B_GENE/B_BACTERIUM[BIO]
by O O
Fur O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
was O O
dependent O B_DISEASE_ADJECTIVE[DISEASE]/B_LOCATION
on O O
28 O B_GENE/B_LOCATION
nucleotides O I_GENE/I_LOCATION
located O O
upstream O O
of O O
hns O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
. O O

Moreover O O
, O O
we O O
used O O
chromatin O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
immunoprecipitation O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
to O O
show O O
that O O
Fur O B_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
bound O O
, O O
in O O
vivo O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
, O O
to O O
the O O
upstream O B_LOCATION/B_MEASURE
region O I_LOCATION/I_MEASURE
of O O
hns O B_GENE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
in O O
a O O
metal O B_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
- O O
dependent O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
fashion O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

Finally O O
, O O
deletion O B_DISEASE_ADJECTIVE[DISEASE]/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
of O O
fur O B_GENE/B_LOCATION
in O O
an O O
hns O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
mutant O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
resulted O O
in O O
Fur O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
- O O
independent O B_DISEASE_ADJECTIVE[DISEASE]/B_GENE_EXPRESSION_ADJECTIVE[GENE]
activation O B_DISEASE_ADJECTIVE[DISEASE]/I_GENE_EXPRESSION_ADJECTIVE[GENE]
of O O
hilA O B_GENE/B_BACTERIUM[BIO]
. O O

In O O
conclusion O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
, O O
Fur O B_DISEASE_ADJECTIVE[DISEASE]/B_CELL[BODY_PART_OR_ORGAN_COMPONENT]
activates O I_DISEASE_ADJECTIVE[DISEASE]/I_CELL[BODY_PART_OR_ORGAN_COMPONENT]
hilA O O
by O O
repressing O O
the O O
expression O B_GENE
of O O
hns O B_GENE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

MexT O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
regulates O O
the O O
type O B_DISEASE_ADJECTIVE[DISEASE]/B_CELL_FUNCTION[ORGANISM_FUNCTION]
III O B_DISEASE_ADJECTIVE[DISEASE]/I_CELL_FUNCTION[ORGANISM_FUNCTION]
secretion O B_DISEASE_ADJECTIVE[DISEASE]/I_CELL_FUNCTION[ORGANISM_FUNCTION]
system O B_DISEASE_ADJECTIVE[DISEASE]/I_CELL_FUNCTION[ORGANISM_FUNCTION]
through O O
MexS O B_GENE/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
PtrC O B_DISEASE/B_GENE
in O O
Pseudomonas O B_SPECIES[BIO]
aeruginosa O I_SPECIES[BIO]
. O O

The O O
type O B_DISEASE_ADJECTIVE[DISEASE]/B_PERSON
III O I_DISEASE_ADJECTIVE[DISEASE]/I_PERSON
secretion O I_DISEASE_ADJECTIVE[DISEASE]/I_PERSON
system O I_DISEASE_ADJECTIVE[DISEASE]/I_PERSON
( O O
T3SS O B_DISEASE/B_LOCATION
) O O
is O O
the O O
most O O
important O B_DISEASE_ADJECTIVE[DISEASE]/B_BACTERIUM[BIO]
virulence O I_DISEASE_ADJECTIVE[DISEASE]/I_BACTERIUM[BIO]
factor O I_DISEASE_ADJECTIVE[DISEASE]/I_BACTERIUM[BIO]
in O O
Pseudomonas O B_BACTERIUM[BIO]
aeruginosa O I_BACTERIUM[BIO]
, O O
and O O
its O O
expression O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
level O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
varies O O
in O O
different O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
isolates O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
. O O

We O O
studied O O
the O O
molecular O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
basis O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
for O O
such O B_DISEASE/B_ORGANISM_FUNCTION
differences O I_DISEASE/I_ORGANISM_FUNCTION
in O O
two O B_MEASURE/B_BACTERIUM[BIO]
laboratory O I_MEASURE/I_BACTERIUM[BIO]
strains O I_MEASURE/I_BACTERIUM[BIO]
, O O
PAK O B_PROTEIN[GENE]/B_BACTERIUM[BIO]
and O O
PAO1 O B_SPECIES[BIO]/B_PERSON
. O O

A O O
chromosomal O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
clone O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
library O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
from O O
the O O
high O B_DISEASE/B_GENE
- O O
T3SS O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
- O O
producer O B_LOCATION/B_PERSON
strain O I_LOCATION/I_PERSON
PAK O I_LOCATION/I_PERSON
was O O
introduced O O
into O O
the O O
low O B_DISEASE/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- O O
producer O B_LOCATION/B_MEASURE
strain O I_LOCATION/I_MEASURE
PAO1 O I_LOCATION/I_MEASURE
, O O
and O O
we O O
found O O
that O O
a O O
mexS O B_GENE
gene O I_GENE
from O O
PAK O B_PERSON/B_LOCATION
confers O O
high O B_DISEASE_ADJECTIVE[DISEASE]/B_GENE
T3SS O I_DISEASE_ADJECTIVE[DISEASE]/I_GENE
expression O I_DISEASE_ADJECTIVE[DISEASE]/I_GENE
in O O
the O O
PAO1 O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
background O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_BIO
. O O

Further O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
tests O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
demonstrated O O
that O O
both O O
mexS O B_GENE/B_LOCATION
and O O
its O O
neighboring O B_GENE/B_PERSON
mexT O I_GENE/I_PERSON
gene O I_GENE/I_PERSON
are O O
required O O
for O O
the O O
repression O B_GENE_EXPRESSION_ADJECTIVE[GENE]
of O O
the O O
T3SS O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
in O O
PAO1 O B_GENE
, O O
while O O
the O O
PAK O B_GENE/B_SEQUENCE[MEASURE]
genome O I_GENE/I_SEQUENCE[MEASURE]
encodes O O
a O O
defective O B_ENZYME[GENE]/B_DISEASE_ADJECTIVE[DISEASE]
MexS O I_ENZYME[GENE]/I_DISEASE_ADJECTIVE[DISEASE]
, O O
accounting O O
for O O
the O O
derepression O B_DISEASE_ADJECTIVE[DISEASE]
of O O
the O O
T3SS O B_DISEASE_ADJECTIVE[DISEASE]/B_GENE
in O O
PAK O B_BIO
and O O
the O O
dominant O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
negative O I_DISEASE_ADJECTIVE[DISEASE]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
effect O I_DISEASE_ADJECTIVE[DISEASE]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
when O O
it O O
is O O
introduced O O
into O O
PAO1 O B_GENE
. O O

MexS O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
is O O
a O O
probable O B_ENZYME[GENE]
oxidoreductase O I_ENZYME[GENE]
whose O O
expression O B_GENE/B_PHYSIOLOGIC_FUNCTION[ORGANISM_FUNCTION]
is O O
dependent O B_PERSON/B_DISEASE_ADJECTIVE[DISEASE]
on O O
MexT O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
, O O
a O O
LysR O B_GENE/B_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- O O
type O B_ENZYME[GENE]/B_PERSON
transcriptional O I_ENZYME[GENE]/I_PERSON
regulator O I_ENZYME[GENE]/I_PERSON
. O O

Various O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
genetic O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
data O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
support O O
the O O
idea O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANIZATION
that O O
MexS O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
modulates O O
the O O
transcriptional O B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
regulator O I_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
function O I_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
of O O
MexT O B_GENE/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

In O O
searching O O
for O O
the O O
MexT O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
- O O
dependent O B_GENE/B_LOCATION
repressor O I_GENE/I_LOCATION
of O O
the O O
T3SS O B_DISEASE_ADJECTIVE[DISEASE]/B_GENE
, O O
a O O
small O B_GENE/B_MEASURE
gene O I_GENE/I_MEASURE
product O I_GENE/I_MEASURE
of O O
PA2486 O B_SPECIES[BIO]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
( O O
ptrC O B_PROTEIN[GENE]/B_DISEASE_ADJECTIVE[DISEASE]
) O O
was O O
found O O
effective O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
in O O
suppressing O O
the O O
T3SS O B_DISEASE_ADJECTIVE[DISEASE]/B_GENE
upon O O
overexpression O B_GENE/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
. O O

However O O
, O O
deletion O B_CELL_OR_MOLECULAR_DYSFUNCTION[DISEASE]/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
of O O
ptrC O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
in O O
the O O
PAO1 O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
background O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
did O O
not O O
result O O
in O O
derepression O B_DISEASE_ADJECTIVE[DISEASE]/B_GENE_EXPRESSION_ADJECTIVE[GENE]
of O O
the O O
T3SS O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
, O O
indicating O O
the O O
presence O B_LOCATION/B_DISEASE_ADJECTIVE[DISEASE]
of O O
another O O
repressor O B_GENE/B_PERSON
for O O
the O O
T3SS O B_DISEASE_ADJECTIVE[DISEASE]/B_GENE
. O O

Interestingly O O
, O O
overexpression O B_GENE/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
of O O
functional O B_GENE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
mexS O I_GENE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
alone O O
was O O
sufficient O B_DISEASE_ADJECTIVE[DISEASE]/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
to O O
repress O O
T3SS O B_DISEASE_ADJECTIVE[DISEASE]/B_GENE
even O O
in O O
the O O
absence O B_DISEASE/B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
MexT O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
, O O
suggesting O O
that O O
MexS O B_GENE/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
is O O
another O O
mediator O B_PERSON/B_MEASURE
of O O
MexT O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
- O O
dependent O O
T3SS O B_DISEASE_ADJECTIVE[DISEASE]/B_GENE_EXPRESSION_ADJECTIVE[GENE]
repression O B_DISEASE_ADJECTIVE[DISEASE]/I_GENE_EXPRESSION_ADJECTIVE[GENE]
. O O

Overexpression O B_GENE/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
of O O
mexS O B_GENE/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
alone O O
had O O
no O O
effect O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
on O O
the O O
well O O
- O O
known O O
MexT O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANISM_FUNCTION
- O O
dependent O B_GENE/B_LOCATION
genes O I_GENE/I_LOCATION
, O O
including O O
those O O
encoding O O
MexEF O B_ENZYME[GENE]
efflux O I_ENZYME[GENE]
pump O I_ENZYME[GENE]
, O O
elastase O B_GENE
, O O
and O O
pyocyanin O B_ENZYME[GENE]/B_BIO
, O O
indicating O O
alternative O B_DISEASE_ADJECTIVE[DISEASE]
regulatory O I_DISEASE_ADJECTIVE[DISEASE]
mechanisms O I_DISEASE_ADJECTIVE[DISEASE]
. O O

A O O
model O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
has O O
been O O
proposed O O
for O O
the O O
MexS O B_GENE/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
/ O O
MexT O B_LOCATION/B_ORGANIZATION
- O O
mediated O O
regulation O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_CELL_FUNCTION[ORGANISM_FUNCTION]
of O O
the O O
T3SS O B_ENZYME[GENE]/B_DISEASE_ADJECTIVE[DISEASE]
, O O
the O O
MexEF O B_GENE
efflux O I_GENE
pump O I_GENE
, O O
and O O
the O O
production O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PHYSIOLOGIC_FUNCTION[ORGANISM_FUNCTION]
of O O
elastase O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ENZYME[GENE]
and O O
pyocyanin O B_ENZYME[GENE]/B_BIO
. O O

Complete O O
genome O O
sequence O O
of O O
the O O
haloaromatic O O
acid O O
- O O
degrading O O
bacterium O O
Achromobacter B B_BACTERIUM[BIO]/B_LOCATION
xylosoxidans I B_BACTERIUM[BIO]/I_LOCATION
A8 I B_BACTERIUM[BIO]/I_LOCATION
. O O

Achromobacter B B_BACTERIUM[BIO]
xylosoxidans I I_BACTERIUM[BIO]
strain I I_BACTERIUM[BIO]
A8 I I_BACTERIUM[BIO]
was O O
isolated O O
from O O
soil O O
contaminated O O
with O O
polychlorinated O O
biphenyls O O
. O O

It O O
can O O
use O O
2 O B_MEASURE
- O O
chlorobenzoate O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
2 O B_NUMBER[MEASURE]
, O O
5 O B_NUMBER[MEASURE]
- O O
dichlorobenzoate O B_LOCATION/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
as O O
sole O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
sources O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
of O O
carbon O B_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
energy O B_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

This O O
property O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
makes O O
it O O
a O O
good O B_BACTERIUM[BIO]/B_PERSON
starting O I_BACTERIUM[BIO]/I_PERSON
microorganism O I_BACTERIUM[BIO]/I_PERSON
for O O
further O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANISM_FUNCTION
development O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_ORGANISM_FUNCTION
toward O O
a O O
bioremediation O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
tool O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
. O O

The O O
genome O O
of O O
A B B_BACTERIUM[BIO]
. I I_BACTERIUM[BIO]
xylosoxidans I I_BACTERIUM[BIO]
consists O O
of O O
a O O
7 O O
- O O
Mb O O
chromosome O O
and O O
two O O
large O O
plasmids O O
( O O
98 O O
kb O O
and O O
248 O O
kb O O
) O O
. O O

Besides O O
genes O B_PROTEIN[GENE]/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
for O O
the O O
utilization O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_PHYSIOLOGIC_FUNCTION[ORGANISM_FUNCTION]
of O O
xenobiotic O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
organic O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
substrates O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
, O O
it O O
contains O O
genes O B_GENE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
associated O O
with O O
pathogenesis O B_DISEASE/B_ORGANISM_FUNCTION
, O O
toxin O B_DISEASE/B_ORGANISM_FUNCTION
production O I_DISEASE/I_ORGANISM_FUNCTION
, O O
and O O
resistance O B_DISEASE/B_ORGANISM_FUNCTION
. O O

Here O O
, O O
we O O
report O O
the O O
complete O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
genome O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
sequence O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
. O O

Complete O O
genome O O
sequences O O
of O O
three O O
Erwinia B B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
amylovora I B_BIO/I_DISEASE_ADJECTIVE[DISEASE]
phages O O
isolated O O
in O O
north O O
america O O
and O O
a O O
bacteriophage O O
induced O O
from O O
an O O
Erwinia B B_BIO/B_LOCATION
tasmaniensis I B_BIO/I_LOCATION
strain O O
. O O

Fire O O
blight O O
, O O
a O O
plant O O
disease O O
of O O
economic O O
importance O O
caused O O
by O O
Erwinia B B_BIO
amylovora I I_BIO
, O O
may O O
be O O
controlled O O
by O O
the O O
application O O
of O O
bacteriophages O O
. O O

Here O O
, O O
we O O
provide O O
the O O
complete O O
genome O O
sequences O O
and O O
the O O
annotation O O
of O O
three O O
E B B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
. I I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
amylovora I I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
- O O
specific O O
phages O O
isolated O O
in O O
North O O
America O O
and O O
genomic O O
information O O
about O O
a O O
bacteriophage O O
induced O O
by O O
mitomycin O O
C O O
treatment O O
of O O
an O O
Erwinia B B_SPECIES[BIO]
tasmaniensis I I_SPECIES[BIO]
strain O O
that O O
is O O
antagonistic O O
for O O
E B B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
. I I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
amylovora I I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
. O O

The O O
American O O
phages O O
resemble O O
two O O
already O O
- O O
described O O
viral O O
genomes O O
, O O
whereas O O
the O O
E B B_LOCATION/B_PERSON
. I I_LOCATION/I_PERSON
tasmaniensis I I_LOCATION/I_PERSON
phage O O
displays O O
a O O
singular O O
genomic O O
sequence O O
in O O
BLAST O O
searches O O
. O O

Promoter O O
discrimination O O
at O O
class O O
I O O
MarA O O
regulon O O
promoters O O
mediated O O
by O O
glutamic O O
acid O O
89 O O
of O O
the O O
MarA O O
transcriptional O O
activator O O
of O O
Escherichia B B_BACTERIUM[BIO]/B_GENE
coli I B_BACTERIUM[BIO]/I_GENE
. O O

Three O O
paralogous O O
transcriptional O O
activators O O
MarA O O
, O O
SoxS O O
, O O
and O O
Rob O O
, O O
activate O O
> O O
40 O O
Escherichia B B_BACTERIUM[BIO]/B_PERSON
coli I I_BACTERIUM[BIO]/I_PERSON
promoters O O
. O O

To O O
understand O O
why O O
MarA O B_GENE/B_DISEASE
does O O
not O O
activate O O
certain O B_GENE/B_MEASURE
promoters O I_GENE/I_MEASURE
as O O
strongly O O
as O O
SoxS O B_GENE/B_LOCATION
, O O
we O O
compared O O
MarA O B_PERSON/B_GENE
, O O
MarA O B_LOCATION/B_PERSON
mutants O I_LOCATION/I_PERSON
, O O
and O O
SoxS O B_GENE/B_BIO
for O O
their O O
abilities O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
to O O
activate O O
16 O B_GENE/B_PERSON
promoters O I_GENE/I_PERSON
and O O
to O O
bind O O
their O O
cognate O B_PERSON/B_DISEASE_ADJECTIVE[DISEASE]
marbox O I_PERSON/I_DISEASE_ADJECTIVE[DISEASE]
binding O O
sites O B_LOCATION/B_ENT
. O O

Replacement O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
of O O
the O O
MarA O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
glutamic O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
acid O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
residue O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
89 O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
with O O
alanine O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
greatly O O
increased O O
the O O
marbox O B_GENE_EXPRESSION_ADJECTIVE[GENE]/B_DISEASE_ADJECTIVE[DISEASE]
binding O I_GENE_EXPRESSION_ADJECTIVE[GENE]/I_DISEASE_ADJECTIVE[DISEASE]
and O O
activation O B_GENE
of O O
many O B_MEASURE/B_LOCATION
class O I_MEASURE/I_LOCATION
I O O
promoters O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
. O O

Like O O
cells O B_GENE/B_PERSON
constitutive O I_GENE/I_PERSON
for O O
SoxS O B_GENE
, O O
cells O B_CELL[BODY_PART_OR_ORGAN_COMPONENT]/B_BIO
expressing O O
the O O
MarA O B_GENE/B_DISEASE
with O O
the O O
E89A O B_DISEASE_ADJECTIVE[DISEASE]/B_GENE
mutation O B_DISEASE_ADJECTIVE[DISEASE]/I_GENE
were O O
more O O
resistant O B_DISEASE_ADJECTIVE[DISEASE]
to O O
superoxides O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
than O O
those O O
harboring O O
WT O B_PERSON/B_DISEASE_ADJECTIVE[DISEASE]
MarA O I_PERSON/I_DISEASE_ADJECTIVE[DISEASE]
. O O

The O O
activities O B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
of O O
several O B_PERSON/B_ORGANIZATION
other O I_PERSON/I_ORGANIZATION
E89 O I_PERSON/I_ORGANIZATION
substitutions O I_PERSON/I_ORGANIZATION
ranked O O
as O O
follows O O
: O O
E89A O B_LOCATION
> O I_LOCATION
E89G O I_LOCATION
> O I_LOCATION
E89V O I_LOCATION
> O O
WT O B_GENE
> O I_GENE
E89D O I_GENE
. O O

Increased O O
binding O B_GENE
and O O
activation O B_GENE
occurred O O
only O O
at O O
class O B_PERSON/B_MEASURE
I O O
promoters O O
when O O
the O O
12th O B_LOCATION/B_MEASURE
base O I_LOCATION/I_MEASURE
of O O
the O O
promoter O B_GENE/B_LOCATION
' O O
s O B_LOCATION/B_PERSON
marbox O I_LOCATION/I_PERSON
( O O
a O O
position O B_LOCATION/B_MEASURE
at O O
which O O
there O O
is O O
no O O
known O O
interaction O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
between O O
the O O
marbox O B_GENE/B_LOCATION
and O O
MarA O B_GENE/B_DISEASE
) O O
was O O
not O O
a O O
T O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
residue O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
. O O

Furthermore O O
, O O
WT O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
MarA O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
binding O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
to O O
a O O
synthetic O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
marbox O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
in O O
vitro O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
was O O
enhanced O O
when O O
the O O
phosphate O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
group O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
between O O
positions O B_NUMBER[MEASURE]
12 O I_NUMBER[MEASURE]
and O O
13 O B_MEASURE
was O O
eliminated O O
on O O
one O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
strand O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

The O O
results O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
demonstrate O O
that O O
relatively O O
minor O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
changes O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
in O O
a O O
single O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
amino O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
acid O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
side O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
chain O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
( O O
e O O
. O O
g O B_PROTEIN[GENE]/B_CELL[BODY_PART_OR_ORGAN_COMPONENT]
. O O
, O O
alanine O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
to O O
valine O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
or O O
glutamic O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
acid O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
to O O
aspartic O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
acid O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
) O O
can O O
strongly O O
influence O O
activity O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
despite O O
any O O
evidence O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
that O O
the O O
side O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
chain O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
is O O
involved O O
in O O
positive O B_DISEASE_ADJECTIVE[DISEASE]/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
interactions O I_DISEASE_ADJECTIVE[DISEASE]/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
with O O
either O O
DNA O B_GENE/B_CELL[BODY_PART_OR_ORGAN_COMPONENT]
or O O
RNA O B_GENE
polymerase O I_GENE
. O O

We O O
present O O
a O O
model O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
which O O
attributes O O
the O O
differences O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
in O O
binding O O
and O O
activation O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
to O O
the O O
interference O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
between O O
the O O
Beta O B_PROTEIN[GENE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- O O
and O O
gamma O B_PROTEIN[GENE]/B_MEASURE
- O O
carbons O B_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
of O O
the O O
amino O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
acid O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
at O O
position O B_MEASURE/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
89 O I_MEASURE/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
the O O
phosphate O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
group O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
between O O
positions O B_NUMBER[MEASURE]
12 O I_NUMBER[MEASURE]
and O O
13 O B_MEASURE
. O O

A O O
model O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
- O O
driven O O
approach O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
to O O
quantify O O
migration O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
patterns O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
: O O
individual O B_PERSON/B_LOCATION
, O O
regional O B_LOCATION/B_ORGANIZATION
and O O
yearly O B_MEASURE/B_LOCATION
differences O B_MEASURE/I_LOCATION
. O O

1 O B_NUMBER[MEASURE]
. O O

Animal O B_DISEASE_ADJECTIVE[DISEASE]/B_LOCATION
migration O B_DISEASE_ADJECTIVE[DISEASE]/I_LOCATION
has O O
long O O
intrigued O O
scientists O B_PERSON/B_SPORT[ENT]
and O O
wildlife O B_PERSON/B_ORGANIZATION
managers O I_PERSON/I_ORGANIZATION
alike O O
, O O
yet O O
migratory O B_PERSON/B_BIO
species O I_PERSON/I_BIO
face O O
increasing O O
challenges O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
because O O
of O O
habitat O B_DISEASE_ADJECTIVE[DISEASE]/B_LOCATION
fragmentation O I_DISEASE_ADJECTIVE[DISEASE]/I_LOCATION
, O O
climate O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
change O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE
and O O
over O B_MEASURE/B_DISEASE
- O O
exploitation O B_ORGANIZATION/B_PERSON
. O O

Central O B_LOCATION/B_DISEASE_ADJECTIVE[DISEASE]
to O O
the O O
understanding O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
migratory O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
species O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
is O O
the O O
objective O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
discrimination O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
between O O
migratory O B_PERSON/B_LOCATION
and O O
nonmigratory O B_PERSON/B_LOCATION
individuals O I_PERSON/I_LOCATION
in O O
a O O
given O O
population O B_PERSON/B_LOCATION
, O O
quantifying O O
the O O
timing O B_MEASURE/B_LOCATION
, O O
duration O B_MEASURE/B_LOCATION
and O O
distance O B_MEASURE/B_LOCATION
of O O
migration O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
and O O
the O O
ability O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
to O O
predict O O
migratory O B_DISEASE_ADJECTIVE[DISEASE]/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
movements O I_DISEASE_ADJECTIVE[DISEASE]/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

2 O B_NUMBER[MEASURE]
. O O

Here O O
, O O
we O O
propose O O
a O O
uniform O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
statistical O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
framework O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
to O O
( O O
i O O
) O O
separate O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
migration O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
from O O
other O B_DISEASE_ADJECTIVE[DISEASE]/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
movement O B_DISEASE_ADJECTIVE[DISEASE]/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
behaviours O B_DISEASE_ADJECTIVE[DISEASE]/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
( O O
ii O B_TIME[MEASURE]/B_PROTEIN[GENE]
) O O
quantify O O
migration O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
parameters O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
without O O
the O O
need O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PROTEIN[GENE]
for O O
arbitrary O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
cut O O
- O O
off O O
criteria O B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
and O O
( O O
iii O B_DISEASE/B_PROTEIN[GENE]
) O O
test O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
predictability O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
across O O
individuals O B_PERSON/B_MEASURE
, O O
time O B_MEASURE/B_LOCATION
and O O
space O B_LOCATION/B_MEASURE
. O O

3 O B_NUMBER[MEASURE]
. O O

We O O
first O O
validated O O
our O O
novel O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
approach O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
by O O
simulating O O
data O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANISM_FUNCTION
based O O
on O O
established O O
theoretical O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
movement O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
patterns O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

We O O
then O O
formulated O O
the O O
expected O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
shapes O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
of O O
squared O B_MEASURE/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
displacement O B_MEASURE/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
patterns O B_MEASURE/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
as O O
nonlinear O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
models O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
for O O
a O O
suite O B_MEASURE
of O O
movement O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
behaviours O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
to O O
test O O
the O O
ability O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
of O O
our O O
method O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
to O O
distinguish O O
between O O
migratory O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
movement O I_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
and O O
other O B_DISEASE_ADJECTIVE[DISEASE]/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
movement O B_DISEASE_ADJECTIVE[DISEASE]/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
types O B_DISEASE_ADJECTIVE[DISEASE]/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

4 O B_NUMBER[MEASURE]
. O O

We O O
then O O
tested O O
our O O
approached O O
empirically O O
using O O
108 O O
wild O O
Global O O
Positioning O O
System O O
( O O
GPS O O
) O O
- O O
collared O O
moose B B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
Alces B I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
alces I I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
in O O
Scandinavia O O
as O O
a O O
study O O
system O O
because O O
they O O
exhibit O O
a O O
wide O O
range O O
of O O
movement O O
behaviours O O
, O O
including O O
resident O O
, O O
migrating O O
and O O
dispersing O O
individuals O O
, O O
within O O
the O O
same O O
population O O
. O O

Applying O O
our O O
approach O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
showed O O
that O O
87 O B_MEASURE/B_PERSON
% O I_MEASURE/I_PERSON
and O O
67 O B_MEASURE/B_PERSON
% O I_MEASURE/I_PERSON
of O O
our O O
Swedish O B_PERSON/B_LOCATION
and O O
Norwegian O B_PERSON/B_LOCATION
subpopulations O I_PERSON/I_LOCATION
, O O
respectively O O
, O O
can O O
be O O
classified O O
as O O
migratory O B_PERSON/B_LOCATION
. O O

5 O B_NUMBER[MEASURE]
. O O

Using O O
nonlinear O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
mixed O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
effects O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
models O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
for O O
all O O
migratory O B_PERSON/B_BIO
individuals O I_PERSON/I_BIO
we O O
showed O O
that O O
the O O
distance O B_MEASURE/B_LOCATION
, O O
timing O B_MEASURE/B_LOCATION
and O O
duration O B_MEASURE/B_LOCATION
of O O
migration O B_PERSON/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
differed O O
between O O
the O O
sexes O B_BIO/B_PERSON
and O O
between O O
years O B_TIME[MEASURE]/B_PERSON
, O O
with O O
additional O B_MEASURE/B_PERSON
individual O B_MEASURE/I_PERSON
differences O B_MEASURE/I_PERSON
accounting O O
for O O
a O O
large O B_MEASURE
part O I_MEASURE
of O O
the O O
variation O B_MEASURE
in O O
the O O
distance O B_MEASURE/B_LOCATION
of O O
migration O B_PERSON/B_LOCATION
but O O
not O O
in O O
the O O
timing O B_MEASURE/B_LOCATION
or O O
duration O B_MEASURE/B_LOCATION
. O O

Overall O O
, O O
the O O
model O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
explained O O
most O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
of O O
the O O
variation O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
( O O
92 O B_MEASURE/B_PERSON
% O I_MEASURE/I_PERSON
) O O
and O O
also O O
had O O
high O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
predictive O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
power O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
for O O
the O O
same O B_PERSON/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
individuals O B_PERSON/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
over O O
time O B_TIME[MEASURE]/B_PERSON
( O O
69 O B_MEASURE/B_PERSON
% O I_MEASURE/I_PERSON
) O O
as O O
well O O
as O O
between O O
study O B_PERSON/B_LOCATION
populations O I_PERSON/I_LOCATION
( O O
74 O B_MEASURE/B_PERSON
% O I_MEASURE/I_PERSON
) O O
. O O

6 O B_NUMBER[MEASURE]
. O O

The O O
high O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
predictive O I_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
ability O I_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
of O O
the O O
approach O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
suggests O O
that O O
it O O
can O O
help O O
increase O O
our O O
understanding O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
of O O
the O O
drivers O B_PERSON/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
migration O B_DISEASE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
could O O
provide O O
key O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
quantitative O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
information O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
for O O
understanding O O
and O O
managing O O
a O O
broad O B_MEASURE/B_LOCATION
range O I_MEASURE/I_LOCATION
of O O
migratory O B_DISEASE_ADJECTIVE[DISEASE]/B_PERSON
species O I_DISEASE_ADJECTIVE[DISEASE]/I_PERSON
. O O

Citrate O O
uptake O O
in O O
exchange O O
with O O
intermediates O O
in O O
the O O
citrate O O
metabolic O O
pathway O O
in O O
Lactococcus B B_SPECIES[BIO]
lactis I I_SPECIES[BIO]
IL1403 O O
. O O

Carbohydrate O O
/ O O
citrate O O
cometabolism O O
in O O
Lactococcus B B_BIO/B_BODY_PART_OR_ORGAN_COMPONENT
lactis I I_BIO/I_BODY_PART_OR_ORGAN_COMPONENT
results O O
in O O
the O O
formation O O
of O O
the O O
flavor O O
compound O O
acetoin O O
. O O

Resting O O
cells O O
of O O
strain O O
IL1403 B B_PROTEIN[GENE]
( O O
pFL3 O O
) O O
rapidly O O
consumed O O
citrate O O
while O O
producing O O
acetoin O O
when O O
substoichiometric O O
concentrations O O
of O O
glucose O O
or O O
l O O
- O O
lactate O O
were O O
present O O
. O O

A O O
proton O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
motive O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
force O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
was O O
generated O O
by O O
electrogenic O B_DISEASE_ADJECTIVE[DISEASE]/B_PHYSIOLOGIC_FUNCTION[ORGANISM_FUNCTION]
exchange O B_DISEASE_ADJECTIVE[DISEASE]/I_PHYSIOLOGIC_FUNCTION[ORGANISM_FUNCTION]
of O O
citrate O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
lactate O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
catalyzed O O
by O O
the O O
citrate O B_ENZYME[GENE]/B_LOCATION
transporter O I_ENZYME[GENE]/I_LOCATION
CitP O I_ENZYME[GENE]/I_LOCATION
and O O
proton O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
consumption O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
in O O
decarboxylation O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
reactions O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
in O O
the O O
pathway O B_DISEASE/B_CELL[BODY_PART_OR_ORGAN_COMPONENT]
. O O

In O O
the O O
absence O B_DISEASE/B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
glucose O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BODY_PART_OR_ORGAN_COMPONENT
or O O
l O B_PROTEIN[GENE]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- O O
lactate O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
citrate O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PHYSIOLOGIC_FUNCTION[ORGANISM_FUNCTION]
consumption O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PHYSIOLOGIC_FUNCTION[ORGANISM_FUNCTION]
was O O
biphasic O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
. O O

During O O
the O O
first O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
phase O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
hardly O O
any O O
citrate O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
was O O
consumed O O
. O O

In O O
the O O
second O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BODY_PART_OR_ORGAN_COMPONENT
phase O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_BODY_PART_OR_ORGAN_COMPONENT
, O O
citrate O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
was O O
converted O O
rapidly O O
, O O
but O O
without O O
the O O
formation O B_PERSON/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
acetoin O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

Instead O O
, O O
significant O B_DISEASE_ADJECTIVE[DISEASE]/B_CHEMICAL_CLASS[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
amounts O B_DISEASE_ADJECTIVE[DISEASE]/I_CHEMICAL_CLASS[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
the O O
intermediates O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
pyruvate O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
alpha O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
- O O
acetolactate O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
and O O
the O O
end O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
product O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
acetate O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
were O O
excreted O O
from O O
the O O
cells O B_BODY_PART_OR_ORGAN_COMPONENT
. O O

It O O
is O O
shown O O
that O O
the O O
intermediates O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
acetate O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
are O O
excreted O O
in O O
exchange O B_ORGANIZATION/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
with O O
the O O
uptake O B_CHEMICAL_CLASS[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
of O O
citrate O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
catalyzed O O
by O O
CitP O B_ENZYME[GENE]/B_BACTERIUM[BIO]
. O O

The O O
availability O B_PERSON/B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
exchangeable O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
substrates O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
in O O
the O O
cytoplasm O B_CELL[BODY_PART_OR_ORGAN_COMPONENT]
determines O O
both O O
the O O
rate O B_MEASURE
of O O
citrate O B_PHYSIOLOGIC_FUNCTION[ORGANISM_FUNCTION]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
consumption O I_PHYSIOLOGIC_FUNCTION[ORGANISM_FUNCTION]/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
the O O
end O B_MEASURE/B_ORGANIZATION
product O I_MEASURE/I_ORGANIZATION
profile O I_MEASURE/I_ORGANIZATION
. O O

It O O
follows O O
that O O
citrate O O
metabolism O O
in O O
L B B_BACTERIUM[BIO]/B_DISEASE
. I I_BACTERIUM[BIO]/I_DISEASE
lactis I I_BACTERIUM[BIO]/I_DISEASE
IL1403 O O
( O O
pFL3 O O
) O O
splits O O
up O O
in O O
two O O
routes O O
after O O
the O O
formation O O
of O O
pyruvate O O
, O O
one O O
the O O
well O O
- O O
characterized O O
route O O
yielding O O
acetoin O O
and O O
the O O
other O O
a O O
new O O
route O O
yielding O O
acetate O O
. O O

The O O
flux O B_MEASURE/B_LOCATION
distribution O I_MEASURE/I_LOCATION
between O O
the O O
two O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
branches O I_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
changes O I_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
from O O
85 O B_MEASURE
: O O
15 O B_MEASURE
in O O
the O O
presence O B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
of O O
l O B_PROTEIN[GENE]/B_DISEASE
- O O
lactate O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
to O O
30 O B_MEASURE
: O O
70 O B_MEASURE
in O O
the O O
presence O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_DISEASE
of O O
pyruvate O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

The O O
proton O B_MEASURE/B_PERSON
motive O I_MEASURE/I_PERSON
force O I_MEASURE/I_PERSON
generated O O
was O O
greatest O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
in O O
the O O
presence O B_LOCATION/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
of O O
l O B_PROTEIN[GENE]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- O O
lactate O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
zero O B_MEASURE
in O O
the O O
presence O B_LOCATION/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
of O O
pyruvate O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
suggesting O O
that O O
the O O
pathway O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
to O O
acetate O O
does O O
not O O
generate O O
proton O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
motive O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
force O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
. O O

Interbacterial O O
macromolecular O O
transfer O O
by O O
the O O
Campylobacter B B_SPECIES[BIO]/B_BODY_PART_OR_ORGAN_COMPONENT
fetus I I_SPECIES[BIO]/I_BODY_PART_OR_ORGAN_COMPONENT
subsp I I_SPECIES[BIO]/I_BODY_PART_OR_ORGAN_COMPONENT
. I I_SPECIES[BIO]/I_BODY_PART_OR_ORGAN_COMPONENT
venerealis I I_SPECIES[BIO]/I_BODY_PART_OR_ORGAN_COMPONENT
type O O
IV O O
secretion O O
system O O
. O O

We O O
report O O
here O O
the O O
first O O
demonstration O O
of O O
intra O O
- O O
and O O
interspecies O O
conjugative O O
plasmid O O
DNA O O
transfer O O
for O O
Campylobacter B B_SPECIES[BIO]/B_DISEASE_ADJECTIVE[DISEASE]
fetus I I_SPECIES[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
. O O

Gene O O
regions O O
carried O O
by O O
a O O
Campylobacter B B_BACTERIUM[BIO]/B_GENE
coli I B_BACTERIUM[BIO]/I_GENE
plasmid O O
were O O
identified O O
that O O
are O O
sufficient O O
for O O
conjugative O O
mobilization O O
to O O
Escherichia B B_SPECIES[BIO]
coli I I_SPECIES[BIO]
and O O
C B B_PERSON/B_SPECIES[BIO]
. I I_PERSON/I_SPECIES[BIO]
fetus I I_PERSON/I_SPECIES[BIO]
recipients O O
. O O

A O O
broader O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
functional O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
range O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
is O O
predicted O O
. O O

Efficient O O
DNA O O
transfer O O
involves O O
the O O
virB9 O O
and O O
virD4 O O
genes O O
of O O
the O O
type O O
IV O O
bacterial O O
secretion O O
system O O
encoded O O
by O O
a O O
pathogenicity O O
island O O
of O O
C B B_BACTERIUM[BIO]
. I I_BACTERIUM[BIO]
fetus I I_BACTERIUM[BIO]
subsp I I_BACTERIUM[BIO]
. I I_BACTERIUM[BIO]
venerealis I I_BACTERIUM[BIO]
. O O

Complementation O O
of O O
these O O
phenotypes O O
from O O
expression O O
constructions O O
based O O
on O O
the O O
promoter O O
of O O
the O O
C B B_DISEASE/B_SPECIES[BIO]
. I B_DISEASE/I_SPECIES[BIO]
fetus I B_DISEASE/I_SPECIES[BIO]
surface O O
antigen O O
protein O O
( O O
sap O O
) O O
locus O O
was O O
temperature O O
dependent O O
, O O
and O O
a O O
temperature O O
regulation O O
of O O
the O O
sap O O
promoter O O
was O O
subsequently O O
confirmed O O
under O O
laboratory O O
conditions O O
. O O

Gene O O
transfer O O
was O O
sensitive O O
to O O
surface O O
or O O
entry O O
exclusion O O
functions O O
in O O
potential O O
recipient O O
cells O O
carrying O O
IncPalpha O O
plasmid O O
RP4 O O
implying O O
functional O O
relatedness O O
to O O
C B B_PERSON/B_DISEASE_ADJECTIVE[DISEASE]
. I I_PERSON/I_DISEASE_ADJECTIVE[DISEASE]
fetus I I_PERSON/I_DISEASE_ADJECTIVE[DISEASE]
proteins O O
. O O

The O O
virB O O
/ O O
virD4 O O
locus O O
is O O
also O O
known O O
to O O
be O O
involved O O
in O O
bacterial O O
invasion O O
and O O
killing O O
of O O
cultured O O
human B B_SPECIES[BIO]
cells O O
in O O
vitro O O
. O O

Whether O O
specifically O O
secreted O O
effector O B_GENE
proteins O I_GENE
contribute O O
to O O
host O B_DISEASE_ADJECTIVE[DISEASE]
colonization O I_DISEASE_ADJECTIVE[DISEASE]
and O O
infection O B_DISEASE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
activities O I_DISEASE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
is O O
currently O O
unknown O B_DISEASE_ADJECTIVE[DISEASE]
. O O

Two O O
putative O O
effector O O
proteins O O
carrying O O
an O O
FIC O O
domain O O
conserved O O
in O O
a O O
few O O
bacterial O O
type O O
III O O
and O O
type O O
IV O O
secreted O O
proteins O O
of O O
pathogens O O
were O O
analyzed O O
for O O
secretion O O
by O O
the O O
C B B_PERSON/B_SPECIES[BIO]
. I I_PERSON/I_SPECIES[BIO]
fetus I I_PERSON/I_SPECIES[BIO]
or O O
heterologous O O
conjugative O O
systems O O
. O O

No O O
evidence O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
for O O
interbacterial O B_DISEASE_ADJECTIVE[DISEASE]/B_GENE_EXPRESSION_ADJECTIVE[GENE]
translocation O B_DISEASE_ADJECTIVE[DISEASE]/I_GENE_EXPRESSION_ADJECTIVE[GENE]
of O O
the O O
Fic O B_GENE/B_BIO
proteins O B_GENE/I_BIO
was O O
found O O
. O O

Canopy O B_MEASURE/B_LOCATION
connectivity O I_MEASURE/I_LOCATION
and O O
the O O
availability O B_PERSON/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
diverse O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
nesting O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
resources O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
affect O O
species O B_DISEASE_ADJECTIVE[DISEASE]/B_ORGANISM_FUNCTION
coexistence O B_DISEASE_ADJECTIVE[DISEASE]/I_ORGANISM_FUNCTION
in O O
arboreal O B_LOCATION/B_BIO
ants O I_LOCATION/I_BIO
. O O

1 O B_NUMBER[MEASURE]
. O O

Arboreal O B_BIO/B_PERSON
ants O I_BIO/I_PERSON
are O O
both O O
diverse O B_PERSON/B_LOCATION
and O O
ecologically O O
dominant O B_DISEASE_ADJECTIVE[DISEASE]
in O O
the O O
tropics O B_LOCATION/B_BIO
. O O

Such O B_NUMBER[MEASURE]/B_PERSON
ecologically O O
important O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANIZATION
groups O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_ORGANIZATION
are O O
likely O B_TIME[MEASURE]/B_DISEASE_ADJECTIVE[DISEASE]
to O O
be O O
particularly O O
useful O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
in O O
ongoing O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
empirical O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
efforts O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
to O O
understand O O
the O O
processes O B_LOCATION/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
that O O
regulate O O
species O B_MEASURE/B_DISEASE_ADJECTIVE[DISEASE]
diversity O I_MEASURE/I_DISEASE_ADJECTIVE[DISEASE]
and O O
coexistence O B_DISEASE_ADJECTIVE[DISEASE]/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

2 O B_NUMBER[MEASURE]
. O O

Our O O
study O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
addresses O O
how O O
access O B_LOCATION/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
to O O
tree O B_BIO/B_LOCATION
- O O
based O O
resources O B_LOCATION/B_ORGANIZATION
and O O
the O O
diversity O B_PERSON/B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
pre O B_DISEASE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- O O
existing O O
nesting O B_LOCATION/B_DISEASE_ADJECTIVE[DISEASE]
cavities O I_LOCATION/I_DISEASE_ADJECTIVE[DISEASE]
affect O O
species O B_MEASURE/B_DISEASE_ADJECTIVE[DISEASE]
diversity O I_MEASURE/I_DISEASE_ADJECTIVE[DISEASE]
and O O
coexistence O B_DISEASE_ADJECTIVE[DISEASE]/B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
in O O
tropical O B_LOCATION/B_BIO
arboreal O I_LOCATION/I_BIO
ant O I_LOCATION/I_BIO
assemblages O I_LOCATION/I_BIO
. O O

We O O
focus O O
on O O
assemblage O B_LOCATION/B_MEASURE
- O O
level O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
responses O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
to O O
these O O
variables O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
at O O
local O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
scales O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
. O O

We O O
first O O
surveyed O O
arboreal O B_LOCATION/B_BIO
ant O I_LOCATION/I_BIO
diversity O I_LOCATION/I_BIO
across O O
three O B_NUMBER[MEASURE]
naturally O O
occurring O O
levels O B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
of O O
canopy O B_MEASURE/B_LOCATION
connectivity O I_MEASURE/I_LOCATION
and O O
a O O
gradient O B_MEASURE
of O O
tree O B_MEASURE/B_LOCATION
size O I_MEASURE/I_LOCATION
. O O

We O O
then O O
conducted O O
whole O B_NUMBER[MEASURE]/B_LOCATION
- O O
tree O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
experimental O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_BIO
manipulations O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_BIO
of O O
canopy O B_MEASURE/B_LOCATION
connectivity O I_MEASURE/I_LOCATION
and O O
the O O
diversity O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
of O O
cavity O B_BIO/B_LOCATION
entrance O I_BIO/I_LOCATION
sizes O I_BIO/I_LOCATION
. O O

All O O
work O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
was O O
conducted O O
in O O
the O O
Brazilian O B_LOCATION
savanna O I_LOCATION
or O O
' O O
cerrado O B_LOCATION/B_PERSON
' O O
. O O

3 O B_NUMBER[MEASURE]
. O O

Our O O
survey O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
suggested O O
that O O
species O B_MEASURE/B_LOCATION
richness O I_MEASURE/I_LOCATION
was O O
equivalent O B_DISEASE_ADJECTIVE[DISEASE]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
among O O
levels O B_LOCATION
of O O
connectivity O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

However O O
, O O
there O O
was O O
a O O
consistent O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
trend O B_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
of O O
lower O B_DISEASE_ADJECTIVE[DISEASE]/B_LOCATION
species O B_DISEASE_ADJECTIVE[DISEASE]/I_LOCATION
density O B_DISEASE_ADJECTIVE[DISEASE]/I_LOCATION
with O O
low O B_DISEASE_ADJECTIVE[DISEASE]/B_TIME[MEASURE]
canopy O B_DISEASE_ADJECTIVE[DISEASE]/I_TIME[MEASURE]
connectivity O B_DISEASE_ADJECTIVE[DISEASE]/I_TIME[MEASURE]
. O O

This O O
was O O
confirmed O O
at O O
the O O
scale O B_MEASURE/B_LOCATION
of O O
individual O B_MEASURE/B_BIO
trees O I_MEASURE/I_BIO
, O O
with O O
low O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
- O O
connectivity O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
trees O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
having O O
significantly O O
fewer O B_MEASURE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
species O I_MEASURE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
across O O
all O O
tree O B_MEASURE/B_LOCATION
sizes O B_MEASURE/I_LOCATION
. O O

Our O O
experiment O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
demonstrated O O
directly O O
that O O
low O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
canopy O I_DISEASE_ADJECTIVE[DISEASE]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
connectivity O I_DISEASE_ADJECTIVE[DISEASE]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
results O I_DISEASE_ADJECTIVE[DISEASE]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
in O O
significantly O O
fewer O B_MEASURE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
species O I_MEASURE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
coexisting O O
per O O
tree O B_BIO/B_LOCATION
. O O

4 O B_NUMBER[MEASURE]
. O O

A O O
diverse O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
array O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
of O O
cavity O B_BIO/B_GENE
entrance O I_BIO/I_GENE
sizes O I_BIO/I_GENE
did O O
not O O
significantly O O
increase O O
overall O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
species O B_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
per O O
tree O B_BIO/B_LOCATION
. O O

Nevertheless O O
, O O
cavity O B_MEASURE/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
diversity O I_MEASURE/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
did O O
significantly O O
increase O O
the O O
species O B_BIO/B_MEASURE
using O O
new O B_DISEASE_ADJECTIVE[DISEASE]/B_LOCATION
cavities O B_DISEASE_ADJECTIVE[DISEASE]/I_LOCATION
on O O
each O O
tree O B_BIO/B_LOCATION
, O O
the O O
species O B_BIO/B_MEASURE
per O O
tree O B_MEASURE/B_PERSON
unique O I_MEASURE/I_PERSON
to O O
new O B_LOCATION/B_DISEASE_ADJECTIVE[DISEASE]
cavities O I_LOCATION/I_DISEASE_ADJECTIVE[DISEASE]
, O O
total O B_BIO/B_MEASURE
species O I_BIO/I_MEASURE
using O O
new O B_DISEASE_ADJECTIVE[DISEASE]/B_BODY_PART_OR_ORGAN_COMPONENT
cavities O B_DISEASE_ADJECTIVE[DISEASE]/I_BODY_PART_OR_ORGAN_COMPONENT
, O O
and O O
total O B_DISEASE_ADJECTIVE[DISEASE]/B_BIO
cavity O B_DISEASE_ADJECTIVE[DISEASE]/I_BIO
use O B_DISEASE_ADJECTIVE[DISEASE]/I_BIO
. O O

The O O
populations O B_LOCATION
of O O
occupied O O
cavities O B_LOCATION/B_BIO
were O O
consistent O B_DISEASE_ADJECTIVE[DISEASE]/B_GENE
with O O
newly O O
founded O O
colonies O B_LOCATION/B_BIO
and O O
new O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
nests O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
of O O
established O O
colonies O B_LOCATION/B_BIO
from O O
other O B_LOCATION/B_ENT
trees O I_LOCATION/I_ENT
. O O

Cavity O B_DISEASE/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
diversity O I_DISEASE/I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
thus O O
appears O O
to O O
greatly O O
affect O O
new O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
colony O I_DISEASE_ADJECTIVE[DISEASE]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
founding O I_DISEASE_ADJECTIVE[DISEASE]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
colony O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_ORGANISM_FUNCTION
growth O I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/I_ORGANISM_FUNCTION
. O O

5 O B_NUMBER[MEASURE]
. O O

These O O
results O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
contribute O O
strong O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
evidence O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
that O O
greater O B_DISEASE_ADJECTIVE[DISEASE]/B_BIO
resource O B_DISEASE_ADJECTIVE[DISEASE]/I_BIO
access O B_DISEASE_ADJECTIVE[DISEASE]/I_BIO
and O O
greater O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
cavity O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
diversity O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
have O O
positive O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
effects O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
on O O
species O B_DISEASE_ADJECTIVE[DISEASE]/B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
coexistence O B_DISEASE_ADJECTIVE[DISEASE]/I_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
in O O
local O B_LOCATION/B_BIO
arboreal O I_LOCATION/I_BIO
ant O I_LOCATION/I_BIO
assemblages O I_LOCATION/I_BIO
. O O

More O O
generally O O
, O O
these O O
positive O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
effects O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
are O O
broadly O O
consistent O B_DISEASE_ADJECTIVE[DISEASE]/B_GENE
with O O
niche O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
differentiation O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
promoting O O
local O B_BIO/B_PERSON
species O I_BIO/I_PERSON
coexistence O O
in O O
diverse O B_LOCATION/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
arboreal O I_LOCATION/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
ant O I_LOCATION/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
assemblages O I_LOCATION/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

The O O
contributions O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
of O O
this O O
study O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
to O O
the O O
understanding O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
the O O
processes O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
of O O
species O B_DISEASE_ADJECTIVE[DISEASE]/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
coexistence O I_DISEASE_ADJECTIVE[DISEASE]/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
are O O
discussed O O
, O O
along O O
with O O
the O O
potential O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
the O O
focal O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
system O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
for O O
future O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
work O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
on O O
this O O
issue O B_PERSON/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

Ontogeny O B_BODY_PART_OR_ORGAN_COMPONENT/B_BIO
and O O
leaf O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANISM_FUNCTION
gas O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_ORGANISM_FUNCTION
exchange O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_ORGANISM_FUNCTION
mediate O O
the O O
carbon O B_MEASURE/B_DISEASE_ADJECTIVE[DISEASE]
isotopic O I_MEASURE/I_DISEASE_ADJECTIVE[DISEASE]
signature O I_MEASURE/I_DISEASE_ADJECTIVE[DISEASE]
of O O
herbaceous O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
plants O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
. O O

Values O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
( O O
Delta O B_PROTEIN[GENE]/B_LOCATION
( O O
i O B_DISEASE/B_PROTEIN[GENE]
) O O
) O O
predicted O O
by O O
a O O
simplified O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
photosynthetic O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
discrimination O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
model O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
, O O
based O O
only O O
on O O
diffusion O B_DISEASE/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
through O O
air O B_DISEASE/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
followed O O
by O O
carboxylation O B_BIO
, O O
are O O
often O O
used O O
to O O
infer O O
ecological O B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
conditions O I_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
from O O
the O O
^ O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
1 O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
^ O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
3C O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
signature O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
of O O
plant O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
organs O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
( O O
delta O B_PROTEIN[GENE]/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
^ O I_PROTEIN[GENE]/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
1 O I_PROTEIN[GENE]/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
^ O I_PROTEIN[GENE]/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
3C O I_PROTEIN[GENE]/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
( O O
p O B_MEASURE/B_PROTEIN[GENE]
) O O
) O O
. O O

Recent O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
studies O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
showed O O
that O O
additional O B_LOCATION/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
isotope O B_LOCATION/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
discrimination O B_LOCATION/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
( O O
d O B_OTHER/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
that O O
includes O O
mesophyll O B_BIO/B_ORGANISM_FUNCTION
conductance O B_BIO/I_ORGANISM_FUNCTION
, O O
photorespiration O B_TIME[MEASURE]
and O O
day O B_TIME[MEASURE]/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
respiration O I_TIME[MEASURE]/I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
, O O
and O O
post O B_LOCATION/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- O O
carboxylation O B_LOCATION/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
discrimination O B_LOCATION/I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
) O O
can O O
strongly O O
affect O O
delta O B_PROTEIN[GENE]/B_LOCATION
^ O O
1 O B_NUMBER[MEASURE]
^ O O
3C O B_MEASURE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
( O O
p O O
) O O
; O O
however O O
, O O
little O B_PERSON/B_DISEASE_ADJECTIVE[DISEASE]
is O O
known O O
about O O
its O O
variability O B_MEASURE/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
during O O
plant O B_BIO/B_ORGANISM_FUNCTION
ontogeny O B_BIO/I_ORGANISM_FUNCTION
for O O
different O B_BIO/B_ENT
species O I_BIO/I_ENT
. O O

Effect O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PROTEIN[GENE]
of O O
ontogeny O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
on O O
leaf O B_MEASURE/B_BIO
gas O B_MEASURE/I_BIO
exchange O B_MEASURE/I_BIO
rates O B_MEASURE/I_BIO
, O O
Delta O B_PROTEIN[GENE]/B_LOCATION
( O O
i O B_OTHER/B_DISEASE
) O O
, O O
observed O B_PROTEIN[GENE]/B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
discrimination O I_PROTEIN[GENE]/I_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
( O O
Delta O B_PROTEIN[GENE]/B_LOCATION
( O O
p O B_OTHER/B_PROTEIN[GENE]
) O O
) O O
and O O
d O B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
in O O
leaf O B_BIO/B_BODY_PART_OR_ORGAN_COMPONENT
, O O
phloem O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
and O O
root O B_BIO/B_BODY_PART_OR_ORGAN_COMPONENT
of O O
seven O B_BIO
herbaceous O I_BIO
species O I_BIO
at O O
three O B_LOCATION/B_DISEASE_ADJECTIVE[DISEASE]
ontogenetic O I_LOCATION/I_DISEASE_ADJECTIVE[DISEASE]
stages O I_LOCATION/I_DISEASE_ADJECTIVE[DISEASE]
were O O
investigated O O
under O O
controlled O O
conditions O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_LOCATION
. O O

Functional O B_TIME[MEASURE]/B_PERSON
group O I_TIME[MEASURE]/I_PERSON
identity O I_TIME[MEASURE]/I_PERSON
and O O
ontogeny O B_PERSON/B_LOCATION
significantly O O
affected O O
Delta O B_PROTEIN[GENE]/B_MEASURE
( O O
i O B_PROTEIN[GENE]/B_DISEASE
) O O
and O O
Delta O B_PROTEIN[GENE]/B_MEASURE
( O O
p O B_OTHER/B_MEASURE
) O O
. O O

However O O
, O O
predicted O O
Delta O B_PROTEIN[GENE]/B_MEASURE
( O O
i O B_OTHER/B_DISEASE
) O O
did O O
not O O
match O O
Delta O B_PROTEIN[GENE]/B_MEASURE
( O O
p O B_OTHER/B_MEASURE
) O O
. O O

d O O
, O O
strongly O O
affected O O
by O O
functional O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_TIME[MEASURE]
group O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_TIME[MEASURE]
identity O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_TIME[MEASURE]
and O O
ontogeny O B_PERSON/B_BIO
, O O
varied O O
by O O
up O O
to O O
14 O B_NUMBER[MEASURE]/B_PERSON
% O I_NUMBER[MEASURE]/I_PERSON
. O O

d O B_OTHER/B_DISEASE
scaled O O
tightly O O
with O O
stomatal O B_MEASURE/B_LOCATION
conductance O I_MEASURE/I_LOCATION
, O O
suggesting O O
complex O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
controls O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
including O O
changes O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
in O O
mesophyll O B_MEASURE
conductance O I_MEASURE
. O O

The O O
magnitude O B_MEASURE
of O O
the O O
changes O B_DISEASE_ADJECTIVE[DISEASE]/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
in O O
delta O B_PROTEIN[GENE]/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
^ O I_PROTEIN[GENE]/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
1 O I_PROTEIN[GENE]/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
^ O I_PROTEIN[GENE]/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
3C O I_PROTEIN[GENE]/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
( O O
p O B_MEASURE
) O O
due O O
to O O
ontogeny O B_BIO/B_ORGANISM_FUNCTION
was O O
similar O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
to O O
that O O
due O O
to O O
environmental O B_DISEASE_ADJECTIVE[DISEASE]/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
factors O I_DISEASE_ADJECTIVE[DISEASE]/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
reported O O
in O O
other O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
studies O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
. O O

d O O
and O O
ontogeny O B_LOCATION/B_PROTEIN[GENE]
should O O
, O O
therefore O O
, O O
be O O
considered O O
in O O
ecosystem O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
studies O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
, O O
integrated O O
in O O
ecosystem O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
models O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
using O O
delta O B_PROTEIN[GENE]
^ O O
1 O B_MEASURE/B_PROTEIN[GENE]
^ O I_MEASURE/I_PROTEIN[GENE]
3C O I_MEASURE/I_PROTEIN[GENE]
( O O
p O B_BIO/B_LOCATION
) O O
and O O
limit O O
the O O
applicability O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
of O O
delta O B_PROTEIN[GENE]
^ O O
1 O B_LOCATION
^ O I_LOCATION
3C O I_LOCATION
( O O
leaf O B_LOCATION/B_BODY_PART_OR_ORGAN_COMPONENT
) O O
as O O
a O O
proxy O B_MEASURE
for O O
water O B_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
- O O
use O B_MEASURE/B_DISEASE_ADJECTIVE[DISEASE]
efficiency O I_MEASURE/I_DISEASE_ADJECTIVE[DISEASE]
in O O
herbaceous O B_BIO/B_LOCATION
plants O B_BIO/I_LOCATION
. O O

The O O
pH O O
regulatory O O
factor O O
Pac1 O O
regulates O O
Tri O O
gene O O
expression O O
and O O
trichothecene O O
production O O
in O O
Fusarium B B_BIO
graminearum I I_BIO
. O O

Fungi O B_BIO
manage O O
the O O
adaptation O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_CELL[BODY_PART_OR_ORGAN_COMPONENT]
to O O
extra O B_DISEASE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- O O
cellular O B_LOCATION/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
pH O B_LOCATION/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
through O O
the O O
PacC O B_GENE
transcription O I_GENE
factor O I_GENE
, O O
a O O
key O B_PERSON/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
component O I_PERSON/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
the O O
pH O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_GENE
regulatory O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/I_GENE
system O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/I_GENE
. O O

PacC O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
regulates O O
the O O
production O B_ENT/B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
various O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
secondary O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
metabolites O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
in O O
filamentous O B_BIO
fungi O I_BIO
. O O

In O O
the O O
important O O
cereal O O
pathogen O O
Fusarium B B_BIO
graminearum I I_BIO
, O O
the O O
production O O
of O O
trichothecene O O
is O O
induced O O
only O O
under O O
acidic O O
pH O O
conditions O O
. O O

Here O O
, O O
we O O
examined O O
the O O
role O O
of O O
the O O
PacC O O
homologue O O
from O O
F B B_BIO
. I I_BIO
graminearum I I_BIO
, O O
FgPac1 O O
, O O
on O O
the O O
regulation O O
of O O
trichothecene O O
production O O
. O O

An O O
FgDeltaPac1 O O
deletion O O
mutant O O
was O O
constructed O O
in O O
F B B_BIO
. I I_BIO
graminearum I I_BIO
which O O
showed O O
a O O
reduced O O
development O O
under O O
neutral O O
and O O
alkaline O O
pH O O
, O O
increased O O
sensitivity O O
to O O
H O O
( O O
2 O O
) O O
O O O
( O O
2 O O
) O O
and O O
an O O
earlier O O
Tri O O
gene O O
induction O O
and O O
toxin O O
accumulation O O
at O O
acidic O O
pH O O
. O O

A O O
strain O B_BIO
expressing O O
the O O
FgPac1 O B_GENE
( O O
c O B_DISEASE/B_PROTEIN[GENE]
) O O
constitutively O O
active O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
form O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
of O O
Pac1 O B_GENE/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
exhibited O O
a O O
strongly O O
repressed O B_DISEASE_ADJECTIVE[DISEASE]
Tri O I_DISEASE_ADJECTIVE[DISEASE]
gene O I_DISEASE_ADJECTIVE[DISEASE]
expression O I_DISEASE_ADJECTIVE[DISEASE]
and O O
reduced O O
toxin O B_DISEASE_ADJECTIVE[DISEASE]/B_ORGANISM_FUNCTION
accumulation O I_DISEASE_ADJECTIVE[DISEASE]/I_ORGANISM_FUNCTION
at O O
acidic O B_TIME[MEASURE]/B_PERSON
pH O I_TIME[MEASURE]/I_PERSON
. O O

These O O
results O O
demonstrate O O
that O O
Pac1 O O
negatively O O
regulates O O
Tri O O
gene O O
expression O O
and O O
toxin O O
production O O
in O O
F B B_BIO
. I I_BIO
graminearum I I_BIO
. O O

Tracking O O
a O O
century O O
of O O
global O O
expansion O O
and O O
evolution O O
of O O
HIV B B_DISEASE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
to O O
drive O O
understanding O O
and O O
to O O
combat O O
disease O O
. O O

Since O O
the O O
isolation O O
of O O
HIV B B_SPECIES[BIO]/B_DISEASE
, O O
multiple O O
transmissions O O
are O O
thought O O
to O O
have O O
occurred O O
between O O
man O O
and O O
other O O
old O O
- O O
world O O
primates O O
. O O

Assessment O O
of O O
samples O O
from O O
apes O O
and O O
human B B_PERSON/B_SPECIES[BIO]
beings O O
with O O
African O O
equatorial O O
forest O O
ancestry O O
has O O
traced O O
the O O
origin O O
of O O
HIV B B_SPECIES[BIO]/B_DISEASE_ADJECTIVE[DISEASE]
- I I_SPECIES[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
1 I I_SPECIES[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
to O O
chimpanzees B B_MEASURE/B_LOCATION
, O O
and O O
dated O O
its O O
most O O
recent O O
common O O
ancestor O O
to O O
1908 O O
. O O

The O O
evolution O O
of O O
HIV B B_DISEASE
- I I_DISEASE
1 I I_DISEASE
has O O
been O O
rapid O O
, O O
which O O
has O O
resulted O O
in O O
a O O
complex O O
classification O O
, O O
worldwide O O
spread O O
, O O
and O O
intermixing O O
of O O
strains O O
; O O
at O O
least O O
48 O O
circulating O O
recombinant O O
forms O O
are O O
currently O O
identified O O
. O O

In O O
addition O O
to O O
posing O O
a O O
nearly O O
insurmountable O O
challenge O O
for O O
diagnosis O O
, O O
treatment O O
, O O
vaccine O O
development O O
, O O
and O O
prevention O O
, O O
this O O
extreme O O
and O O
divergent O O
evolution O O
has O O
led O O
to O O
differences O O
in O O
virulence O O
between O O
HIV B B_DISEASE_ADJECTIVE[DISEASE]/B_BIO
- I I_DISEASE_ADJECTIVE[DISEASE]/I_BIO
1 I I_DISEASE_ADJECTIVE[DISEASE]/I_BIO
groups O O
, O O
subtypes O O
, O O
or O O
both O O
. O O

Coincidental O O
changes O O
in O O
human B B_SPECIES[BIO]/B_LOCATION
migration O O
in O O
the O O
Congo O O
river O O
basin O O
also O O
affected O O
spread O O
of O O
disease O O
. O O

Research O O
over O O
the O O
past O O
25 O O
years O O
and O O
advances O O
in O O
genomic O O
sequencing O O
methods O O
, O O
such O O
as O O
deep O O
DNA O O
sequencing O O
, O O
have O O
greatly O O
improved O O
understanding O O
and O O
analysis O O
of O O
the O O
thousands O O
to O O
millions O O
of O O
full O O
infectious O O
HIV B B_VIRUS[BIO]/B_DISEASE_ADJECTIVE[DISEASE]
- I I_VIRUS[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
1 I I_VIRUS[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
genomes O O
. O O

A O O
caffeyl O O
- O O
coenzyme O O
A O O
synthetase O O
initiates O O
caffeate O O
activation O O
prior O O
to O O
caffeate O O
reduction O O
in O O
the O O
acetogenic O O
bacterium O O
Acetobacterium B B_BACTERIUM[BIO]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
woodii I B_BACTERIUM[BIO]/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

The O O
anaerobic O O
acetogenic O O
bacterium O O
Acetobacterium B B_DISEASE_ADJECTIVE[DISEASE]/B_BACTERIUM[BIO]
woodii I I_DISEASE_ADJECTIVE[DISEASE]/I_BACTERIUM[BIO]
couples O O
the O O
reduction O O
of O O
caffeate O O
with O O
electrons O O
derived O O
from O O
hydrogen O O
to O O
the O O
synthesis O O
of O O
ATP O O
by O O
a O O
chemiosmotic O O
mechanism O O
using O O
sodium O O
ions O O
as O O
coupling O O
ions O O
, O O
but O O
the O O
enzymes O O
involved O O
remain O O
to O O
be O O
established O O
. O O

Previously O O
, O O
the O O
electron O B_GENE/B_DISEASE
transfer O I_GENE/I_DISEASE
flavoproteins O I_GENE/I_DISEASE
EtfA O I_GENE/I_DISEASE
and O O
EtfB O B_BACTERIUM[BIO]/B_GENE
were O O
found O O
to O O
be O O
involved O O
in O O
caffeate O B_DISEASE_ADJECTIVE[DISEASE]
respiration O I_DISEASE_ADJECTIVE[DISEASE]
. O O

By O O
inverse O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
PCR O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
we O O
identified O O
three O B_GENE/B_LOCATION
genes O I_GENE/I_LOCATION
upstream O O
of O O
etfA O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BACTERIUM[BIO]
and O O
etfB O B_BACTERIUM[BIO]/B_DISEASE
: O O
carA O B_DISEASE/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
carB O B_PROTEIN[GENE]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
and O O
carC O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
. O O

carA O B_PERSON/B_GENE
encodes O O
a O O
potential O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
coenzyme O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
A O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
( O O
CoA O B_DISEASE/B_MEASURE
) O O
transferase O B_ENZYME[GENE]
, O O
carB O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
an O O
acyl O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
- O O
CoA O B_ENZYME[GENE]/B_PERSON
synthetase O I_ENZYME[GENE]/I_PERSON
, O O
and O O
carC O O
an O O
acyl O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
- O O
CoA O B_ENZYME[GENE]/B_DISEASE_ADJECTIVE[DISEASE]
dehydrogenase O I_ENZYME[GENE]/I_DISEASE_ADJECTIVE[DISEASE]
. O O

carA O B_DISEASE/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
- O O
B O B_LOCATION/B_DISEASE
, O O
and O O
- O O
C O B_OTHER/B_PROTEIN[GENE]
are O O
located O O
together O O
with O O
etfA O B_LOCATION
/ O O
carE O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
and O O
etfB O B_LOCATION
/ O O
carD O B_LOCATION/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
on O O
one O B_GENE/B_LOCATION
polycistronic O B_GENE/I_LOCATION
message O B_GENE/I_LOCATION
, O O
indicating O O
that O O
CarA O B_DISEASE/B_LOCATION
, O O
CarB O B_LOCATION/B_ORGANIZATION
, O O
and O O
CarC O B_LOCATION
are O O
also O O
part O B_MEASURE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
the O O
caffeate O B_LOCATION/B_MEASURE
respiration O I_LOCATION/I_MEASURE
pathway O I_LOCATION/I_MEASURE
. O O

The O O
genetic O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
data O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
suggest O O
an O O
initial O B_GENE
ATP O I_GENE
- O O
dependent O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PHYSIOLOGIC_FUNCTION[ORGANISM_FUNCTION]
activation O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PHYSIOLOGIC_FUNCTION[ORGANISM_FUNCTION]
of O O
caffeate O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
by O O
CarB O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
. O O

To O O
prove O O
the O O
proposed O O
function O O
of O O
CarB O O
, O O
the O O
protein O O
was O O
overproduced O O
in O O
Escherichia B B_BIO
coli I I_BIO
, O O
and O O
the O O
recombinant O O
protein O O
was O O
purified O O
. O O

Purified O B_DRUG_ADJECTIVE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BACTERIUM[BIO]
CarB O I_DRUG_ADJECTIVE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
activates O I_DRUG_ADJECTIVE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
caffeate O O
to O O
caffeyl O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
- O O
CoA O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
in O O
an O O
ATP O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
- O O
and O O
CoA O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
- O O
dependent O B_DISEASE_ADJECTIVE[DISEASE]/B_LOCATION
reaction O I_DISEASE_ADJECTIVE[DISEASE]/I_LOCATION
. O O

The O O
enzyme O B_ENZYME[GENE]
has O O
broad O B_MEASURE
pH O I_MEASURE
and O O
temperature O B_MEASURE/B_LOCATION
optima O I_MEASURE/I_LOCATION
and O O
requires O O
K O B_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
( O O
+ O B_DISEASE/B_MEASURE
) O O
for O O
activity O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

In O O
addition O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
to O O
caffeate O O
, O O
it O O
can O O
use O O
p O B_GENE/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- O O
coumarate O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
, O O
ferulate O O
, O O
and O O
cinnamate O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
as O O
substrates O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
, O O
with O O
50 O B_MEASURE
, O O
15 O B_MEASURE
, O O
and O O
9 O B_MEASURE/B_PERSON
% O I_MEASURE/I_PERSON
, O O
respectively O O
, O O
of O O
the O O
activity O B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
obtained O O
with O O
caffeate O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
. O O

Expression O B_GENE_EXPRESSION_ADJECTIVE[GENE]/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
of O O
the O O
car O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
operon O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
is O O
induced O O
not O O
only O O
by O O
caffeate O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
, O O
p O B_MEASURE/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- O O
coumarate O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
, O O
ferulate O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
and O O
cinnamate O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
but O O
also O O
by O O
sinapate O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

There O O
is O O
no O O
induction O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
by O O
p O B_GENE
- O O
hydroxybenzoate O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BACTERIUM[BIO]
or O O
syringate O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

Complete O O
genome O O
sequence O O
of O O
Burkholderia B B_BACTERIUM[BIO]
rhizoxinica I I_BACTERIUM[BIO]
, O O
an O O
Endosymbiont O O
of O O
Rhizopus B B_BIO/B_LOCATION
microsporus I I_BIO/I_LOCATION
. O O

Burkholderia B B_BACTERIUM[BIO]
rhizoxinica I I_BACTERIUM[BIO]
is O O
an O O
intracellular O O
symbiont O O
of O O
the O O
phytopathogenic O O
fungus O O
Rhizopus B B_BACTERIUM[BIO]
microsporus I I_BACTERIUM[BIO]
. O O

The O O
vertically O O
transmitted O O
endosymbiont O B_SPECIES[BIO]/B_GENE
not O O
only O O
delivers O O
the O O
antimitotic O B_BIO
macrolide O I_BIO
rhizoxin O I_BIO
to O O
its O O
host O B_PERSON/B_BIO
but O O
is O O
also O O
essential O B_DRUG_ADJECTIVE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_TIME[MEASURE]
for O O
vegetative O B_DISEASE_ADJECTIVE[DISEASE]/B_ORGANISM_FUNCTION
spore O I_DISEASE_ADJECTIVE[DISEASE]/I_ORGANISM_FUNCTION
formation O I_DISEASE_ADJECTIVE[DISEASE]/I_ORGANISM_FUNCTION
of O O
the O O
fungus O B_SPECIES[BIO]
. O O

To O O
shed O O
light O O
on O O
the O O
genetic O O
equipment O O
of O O
this O O
model O O
organism O O
, O O
we O O
sequenced O O
the O O
whole O O
genome O O
of O O
B B B_SPECIES[BIO]/B_LOCATION
. I I_SPECIES[BIO]/I_LOCATION
rhizoxinica I I_SPECIES[BIO]/I_LOCATION
HKI I I_SPECIES[BIO]/I_LOCATION
0454 I I_SPECIES[BIO]/I_LOCATION
, O O
thus O O
providing O O
the O O
first O O
genomic O O
insight O O
into O O
an O O
intracellular O O
mutualist O O
of O O
a O O
fungal O O
species O O
. O O

The O O
3 O B_MEASURE
. O O
75 O B_MEASURE
- O O
Mb O B_GENE/B_LOCATION
genome O I_GENE/I_LOCATION
consists O O
of O O
a O O
chromosome O B_GENE
and O O
two O B_BIO/B_GENE
strain O I_BIO/I_GENE
- O O
specific O B_LOCATION/B_PERSON
plasmids O I_LOCATION/I_PERSON
. O O

The O O
primary O B_DISEASE_ADJECTIVE[DISEASE]/B_BODY_PART_OR_ORGAN_COMPONENT
metabolism O B_DISEASE_ADJECTIVE[DISEASE]/I_BODY_PART_OR_ORGAN_COMPONENT
appears O O
to O O
be O O
specialized O O
for O O
the O O
uptake O B_PHYSIOLOGIC_FUNCTION[ORGANISM_FUNCTION]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
fungal O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
metabolites O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
. O O

Besides O O
the O O
rhizoxin O B_GENE/B_BIO
biosynthesis O I_GENE/I_BIO
gene O I_GENE/I_BIO
cluster O I_GENE/I_BIO
, O O
there O O
are O O
14 O B_GENE/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
loci O I_GENE/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
coding O I_GENE/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
for O O
nonribosomal O B_DISEASE/B_ENZYME[GENE]
peptide O B_DISEASE/I_ENZYME[GENE]
synthetase O B_DISEASE/I_ENZYME[GENE]
( O O
NRPS O B_DISEASE/B_LOCATION
) O O
assembly O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
lines O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
, O O
which O O
represent O O
novel O B_DISEASE_ADJECTIVE[DISEASE]/B_LOCATION
targets O I_DISEASE_ADJECTIVE[DISEASE]/I_LOCATION
for O O
genomic O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANIZATION
mining O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_ORGANIZATION
of O O
cryptic O B_DISEASE_ADJECTIVE[DISEASE]/B_BIO
natural O B_DISEASE_ADJECTIVE[DISEASE]/I_BIO
products O B_DISEASE_ADJECTIVE[DISEASE]/I_BIO
. O O

Furthermore O O
, O O
the O O
endosymbionts O B_BIO
are O O
equipped O O
with O O
a O O
repertoire O B_PERSON/B_LOCATION
of O O
virulence O B_DISEASE_ADJECTIVE[DISEASE]/B_BIO
- O O
related O O
factors O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
, O O
which O O
can O O
now O O
be O O
studied O O
to O O
elucidate O O
molecular O B_DISEASE_ADJECTIVE[DISEASE]/B_PERSON
mechanisms O I_DISEASE_ADJECTIVE[DISEASE]/I_PERSON
underlying O O
bacterial O B_SPECIES[BIO]
- O O
fungal O B_DISEASE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
interaction O I_DISEASE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

Network O B_MEASURE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
topology O I_MEASURE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
: O O
patterns O B_LOCATION/B_ORGANIZATION
and O O
mechanisms O B_LOCATION/B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
in O O
plant O B_BIO/B_DISEASE
- O O
herbivore O B_SPECIES[BIO]/B_DISEASE_ADJECTIVE[DISEASE]
and O O
host O B_BIO
- O O
parasitoid O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
food O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
webs O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
. O O

1 O B_NUMBER[MEASURE]
. O O

Biological O B_PERSON/B_DISEASE_ADJECTIVE[DISEASE]
communities O I_PERSON/I_DISEASE_ADJECTIVE[DISEASE]
are O O
organized O O
in O O
complex O B_LOCATION/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
interaction O I_LOCATION/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
networks O I_LOCATION/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
such O I_LOCATION/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
as O O
food O B_DISEASE_ADJECTIVE[DISEASE]/B_BIO
webs O B_DISEASE_ADJECTIVE[DISEASE]/I_BIO
, O O
which O O
topology O O
appears O O
to O O
be O O
non O B_DISEASE
- O O
random O B_PERSON/B_TIME[MEASURE]
. O O

Gradients O B_MEASURE/B_LOCATION
, O O
compartments O B_LOCATION/B_ORGANIZATION
, O O
nested O O
subsets O B_LOCATION/B_ORGANIZATION
and O O
even O B_LOCATION/B_DISEASE_ADJECTIVE[DISEASE]
combinations O I_LOCATION/I_DISEASE_ADJECTIVE[DISEASE]
of O O
these O O
structures O B_LOCATION/B_ORGANIZATION
have O O
been O O
shown O O
in O O
bipartite O B_ORGANIZATION/B_DISEASE_ADJECTIVE[DISEASE]
networks O I_ORGANIZATION/I_DISEASE_ADJECTIVE[DISEASE]
. O O

However O O
, O O
in O O
most O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
studies O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
only O O
one O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
pattern O I_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
is O O
tested O O
against O O
randomness O B_PERSON
and O O
mechanistic O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
hypotheses O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
are O O
generally O O
lacking O O
. O O

2 O B_NUMBER[MEASURE]
. O O

Here O O
we O O
examined O O
the O O
topology O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
of O O
regional O B_LOCATION/B_DISEASE_ADJECTIVE[DISEASE]
, O O
coexisting O O
plant O B_BIO/B_DISEASE
- O O
herbivore O B_SPECIES[BIO]/B_DISEASE_ADJECTIVE[DISEASE]
and O O
host O B_BIO
- O O
parasitoid O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
food O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
webs O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
to O O
discriminate O O
between O O
the O O
mentioned O O
network O B_DISEASE_ADJECTIVE[DISEASE]/B_LOCATION
patterns O B_DISEASE_ADJECTIVE[DISEASE]/I_LOCATION
. O O

We O O
also O O
evaluated O O
the O O
role O B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
of O O
species O B_MEASURE/B_LOCATION
body O I_MEASURE/I_LOCATION
size O I_MEASURE/I_LOCATION
, O O
local O B_MEASURE/B_LOCATION
abundance O I_MEASURE/I_LOCATION
, O O
regional O B_MEASURE/B_LOCATION
frequency O B_MEASURE/I_LOCATION
and O O
phylogeny O B_MEASURE/B_PERSON
as O O
determinants O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
of O O
network O B_DISEASE_ADJECTIVE[DISEASE]
topology O I_DISEASE_ADJECTIVE[DISEASE]
. O O

3 O B_NUMBER[MEASURE]
. O O

We O O
found O O
both O O
food O B_LOCATION/B_DISEASE_ADJECTIVE[DISEASE]
webs O I_LOCATION/I_DISEASE_ADJECTIVE[DISEASE]
to O O
be O O
compartmented O O
, O O
with O O
interaction O B_DISEASE_ADJECTIVE[DISEASE]/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
range O B_DISEASE_ADJECTIVE[DISEASE]/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
boundaries O B_DISEASE_ADJECTIVE[DISEASE]/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
imposed O O
by O O
host O B_BIO/B_MEASURE
phylogeny O I_BIO/I_MEASURE
. O O

Species O B_MEASURE/B_ORGANIZATION
degree O B_MEASURE/I_ORGANIZATION
within O O
compartments O B_LOCATION/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
was O O
mostly O O
related O O
to O O
their O O
regional O B_MEASURE/B_LOCATION
frequency O I_MEASURE/I_LOCATION
and O O
local O B_MEASURE/B_LOCATION
abundance O I_MEASURE/I_LOCATION
. O O

Only O O
one O B_BIO/B_BODY_PART_OR_ORGAN_COMPONENT
compartment O I_BIO/I_BODY_PART_OR_ORGAN_COMPONENT
showed O O
an O O
internal O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
nested O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
structure O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
in O O
the O O
distribution O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
of O O
interactions O B_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
between O O
species O B_BIO/B_PERSON
, O O
but O O
species O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
position O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
within O O
this O O
compartment O B_LOCATION/B_PERSON
was O O
unrelated O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
to O O
species O B_MEASURE/B_LOCATION
size O I_MEASURE/I_LOCATION
or O O
abundance O B_MEASURE/B_LOCATION
. O O

4 O B_NUMBER[MEASURE]
. O O

These O O
results O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
suggest O O
that O O
compartmentalization O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
may O O
be O O
more O O
common O B_DISEASE_ADJECTIVE[DISEASE]
than O O
previously O O
considered O O
, O O
and O O
that O O
network O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANISM_FUNCTION
structure O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_ORGANISM_FUNCTION
is O O
a O O
result O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
of O O
multiple O B_TIME[MEASURE]/B_DISEASE_ADJECTIVE[DISEASE]
, O O
hierarchical O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
, O O
non O B_DISEASE/B_LOCATION
- O O
exclusive O B_DISEASE_ADJECTIVE[DISEASE]/B_LOCATION
processes O I_DISEASE_ADJECTIVE[DISEASE]/I_LOCATION
. O O

Gel O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
- O O
based O O
mass O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
spectrometric O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
and O O
computational O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
approaches O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
to O O
the O O
mitochondrial O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
proteome O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
of O O
Neurospora O B_SPECIES[BIO]
. O O

We O O
have O O
used O O
gel O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
electrophoretic O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
techniques O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
including O O
isoelectric O B_MEASURE/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
focusing O O
, O O
blue O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
native O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
, O O
acid O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
- O O
urea O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
16 O B_MEASURE
- O O
benzyldimethyl O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
- O O
n O B_MEASURE/B_OTHER
- O O
hexadecylammonium O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
chloride O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
or O O
SDS O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
first O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
dimensions O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
SDS O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
Laemmli O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
or O O
tricine O O
second O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
dimensions O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
to O O
separate O O
the O O
proteins O B_PROTEIN[GENE]/B_DISEASE
from O O
highly O O
- O O
purified O O
Neurospora O B_CELL_COMPONENT[BODY_PART_OR_ORGAN_COMPONENT]/B_BIO
mitochondria O I_CELL_COMPONENT[BODY_PART_OR_ORGAN_COMPONENT]/I_BIO
and O O
sub O B_DISEASE
- O O
mitochondrial O B_DISEASE_ADJECTIVE[DISEASE]/B_CELL_COMPONENT[BODY_PART_OR_ORGAN_COMPONENT]
fractions O B_DISEASE_ADJECTIVE[DISEASE]/I_CELL_COMPONENT[BODY_PART_OR_ORGAN_COMPONENT]
( O O
membrane O B_CELL_COMPONENT[BODY_PART_OR_ORGAN_COMPONENT]/B_GENE
, O O
soluble O B_CELL_COMPONENT[BODY_PART_OR_ORGAN_COMPONENT]/B_PROTEIN[GENE]
, O O
protein O B_CELL_COMPONENT[BODY_PART_OR_ORGAN_COMPONENT]/B_DISEASE_ADJECTIVE[DISEASE]
complexes O I_CELL_COMPONENT[BODY_PART_OR_ORGAN_COMPONENT]/I_DISEASE_ADJECTIVE[DISEASE]
and O O
ribonucleoproteins O B_CELL_COMPONENT[BODY_PART_OR_ORGAN_COMPONENT]/B_BIO
) O O
. O O

The O O
products O B_ORGANIZATION/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
260 O B_GENE/B_BIO
genes O I_GENE/I_BIO
, O O
many O B_NUMBER[MEASURE]
of O O
them O O
in O O
multiple O B_DISEASE_ADJECTIVE[DISEASE]
processed O O
or O O
modified O O
forms O B_DISEASE/B_LOCATION
, O O
were O O
identified O O
by O O
MALDI O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PROTEIN[GENE]
- O O
TOF O B_MEASURE/B_DISEASE
mass O I_MEASURE/I_DISEASE
spectrometry O I_MEASURE/I_DISEASE
. O O

This O O
work O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
confirms O O
the O O
existence O B_DISEASE/B_LOCATION
, O O
expression O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
, O O
and O O
mitochondrial O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
localization O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
of O O
the O O
products O B_ORGANIZATION/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
55 O B_GENE/B_BIO
Neurospora O I_GENE/I_BIO
genes O I_GENE/I_BIO
previously O O
annotated O O
only O O
as O O
predicted O B_DISEASE_ADJECTIVE[DISEASE]
or O O
hypothetical O B_DISEASE_ADJECTIVE[DISEASE]
, O O
and O O
of O O
101 O B_MEASURE/B_PERSON
genes O I_MEASURE/I_PERSON
not O O
identified O O
in O O
previous O B_SPECIES[BIO]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
mass O I_SPECIES[BIO]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
spectrometry O I_SPECIES[BIO]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
studies O I_SPECIES[BIO]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

Combined O O
with O O
previous O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
mass O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
spectrometry O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
studies O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
and O O
re O B_LOCATION/B_DISEASE
- O O
evaluation O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANIZATION
of O O
genome O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
annotations O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
, O O
we O O
have O O
compiled O O
a O O
curated O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
list O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
of O O
358 O B_PROTEIN[GENE]/B_BIO
proteins O I_PROTEIN[GENE]/I_BIO
identified O O
in O O
proteomic O B_MEASURE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
studies O I_MEASURE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
that O O
are O O
likely O B_TIME[MEASURE]/B_DISEASE_ADJECTIVE[DISEASE]
to O O
be O O
bona O B_DISEASE_ADJECTIVE[DISEASE]/B_GENE
fide O I_DISEASE_ADJECTIVE[DISEASE]/I_GENE
mitochondrial O I_DISEASE_ADJECTIVE[DISEASE]/I_GENE
proteins O I_DISEASE_ADJECTIVE[DISEASE]/I_GENE
plus O O
80 O B_NUMBER[MEASURE]
other O I_NUMBER[MEASURE]
identified O O
proteins O B_BIO/B_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
that O O
may O O
be O O
mitochondrial O B_DISEASE_ADJECTIVE[DISEASE]/B_BIO
. O O

Literature O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
data O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
mining O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
and O O
computational O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
predictions O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
suggest O O
that O O
Neurospora O B_BIO/B_PERSON
mitochondria O I_BIO/I_PERSON
also O O
contain O O
another O O
299 O B_GENE/B_LOCATION
proteins O I_GENE/I_LOCATION
not O O
yet O O
identified O O
in O O
proteomics O B_SPECIES[BIO]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
projects O I_SPECIES[BIO]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

Taken O O
together O O
, O O
these O O
data O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
suggest O O
that O O
the O O
products O B_ORGANIZATION/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
at O O
least O O
738 O B_NUMBER[MEASURE]
genes O I_NUMBER[MEASURE]
comprise O O
the O O
Neurospora O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
mitochondrial O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
proteome O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
. O O

Sequenced O B_MEASURE/B_PERSON
dermatophyte O B_MEASURE/I_PERSON
strains O B_MEASURE/I_PERSON
: O O
growth O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANISM_FUNCTION
rate O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_ORGANISM_FUNCTION
, O O
conidiation O B_DISEASE_ADJECTIVE[DISEASE]
, O O
drug O B_DISEASE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
susceptibilities O I_DISEASE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
and O O
virulence O B_DISEASE
in O O
an O O
invertebrate O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
model O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_BIO
. O O

Although O O
dermatophytes O B_SPECIES[BIO]/B_DISEASE_ADJECTIVE[DISEASE]
are O O
the O O
most O O
common O B_DISEASE_ADJECTIVE[DISEASE]
cause O I_DISEASE_ADJECTIVE[DISEASE]
of O O
fungal O B_DISEASE
infections O I_DISEASE
in O O
the O O
world O B_LOCATION/B_BODY_PART_OR_ORGAN_COMPONENT
, O O
their O O
basic O B_DISEASE_ADJECTIVE[DISEASE]
biology O I_DISEASE_ADJECTIVE[DISEASE]
is O O
not O O
well O O
understood O O
. O O

The O O
recent O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANIZATION
sequencing O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_ORGANIZATION
and O O
annotation O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANIZATION
of O O
the O O
genomes O B_GENE/B_MEASURE
of O O
five O B_SPECIES[BIO]/B_DISEASE_ADJECTIVE[DISEASE]
representative O I_SPECIES[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
dermatophyte O I_SPECIES[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
species O I_SPECIES[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
allows O O
for O O
the O O
creation O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_TIME[MEASURE]
of O O
hypotheses O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
as O O
to O O
how O O
they O O
cause O O
disease O B_DISEASE
and O O
have O O
adapted O O
to O O
their O O
distinct O B_LOCATION
environments O I_LOCATION
. O O

An O O
understanding O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
the O O
microbiology O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_EDU[ORGANIZATION]
of O O
these O O
strains O B_BIO/B_DISEASE
will O O
be O O
essential O B_DRUG_ADJECTIVE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_TIME[MEASURE]
for O O
testing O O
these O O
hypotheses O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
. O O

This O O
study O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
is O O
the O O
first O B_SEQUENCE[MEASURE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
to O O
generally O O
characterize O O
these O O
five O B_BIO/B_MEASURE
sequenced O I_BIO/I_MEASURE
strains O I_BIO/I_MEASURE
of O O
dermatophytes O B_DISEASE/B_BACTERIUM[BIO]
for O O
their O O
microbiological O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
aspects O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

We O O
measured O O
the O O
growth O O
rate O O
on O O
solid O O
medium O O
and O O
found O O
differences O O
between O O
species O O
, O O
with O O
Microsporum B B_BACTERIUM[BIO]
gypseum I I_BACTERIUM[BIO]
CBS118893 O O
having O O
the O O
fastest O O
growth O O
and O O
Trichophyton B B_BACTERIUM[BIO]/B_DISEASE
rubrum I I_BACTERIUM[BIO]/I_DISEASE
CBS118892 O O
the O O
slowest O O
. O O

We O O
also O O
compared O O
different O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
media O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
for O O
conidia O B_DISEASE_ADJECTIVE[DISEASE]/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
production O B_DISEASE_ADJECTIVE[DISEASE]/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
found O O
that O O
the O O
highest O B_MEASURE
numbers O I_MEASURE
of O O
conidia O B_BIO/B_BODY_PART_OR_ORGAN_COMPONENT
were O O
produced O O
when O O
dermatophytes O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
were O O
grown O O
on O O
MAT O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BACTERIUM[BIO]
agar O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_BACTERIUM[BIO]
. O O

We O O
determined O O
the O O
Minimum O B_MEASURE/B_LOCATION
Inhibitory O B_MEASURE/I_LOCATION
Concentration O B_MEASURE/I_LOCATION
( O O
MIC O B_MEASURE/B_LOCATION
) O O
of O O
nine O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
antifungal O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
agents O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
and O O
confirmed O O
susceptibility O B_DISEASE/B_MEASURE
to O O
antifungals O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_NUMBER[MEASURE]
commonly O O
used O O
as O O
selectable O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
markers O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
. O O

Finally O O
, O O
we O O
tested O O
virulence O O
in O O
the O O
Galleria B B_BIO
mellonella I I_BIO
( O O
wax B B_SPECIES[BIO]/B_PROTEIN[GENE]
moth I B_SPECIES[BIO]/I_PROTEIN[GENE]
) O O
larvae O O
model O O
but O O
found O O
the O O
results O O
variable O O
. O O

These O O
results O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
increase O O
our O O
understanding O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
of O O
the O O
microbiology O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_EDU[ORGANIZATION]
and O O
molecular O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
biology O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
these O O
dermatophyte O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
strains O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
and O O
will O O
be O O
of O O
use O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
in O O
advancing O O
hypothesis O O
- O O
driven O O
research O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
about O O
dermatophytes O B_DISEASE
. O O

Relating O O
the O O
physical O O
properties O O
of O O
Pseudomonas B B_BACTERIUM[BIO]
aeruginosa I I_BACTERIUM[BIO]
lipopolysaccharides O O
to O O
virulence O O
by O O
atomic O O
force O O
microscopy O O
. O O

Lipopolysaccharides O O
( O O
LPS O O
) O O
are O O
an O O
important O O
class O O
of O O
macromolecules O O
that O O
are O O
components O O
of O O
the O O
outer O O
membrane O O
of O O
Gram O O
- O O
negative O O
bacteria O O
such O O
as O O
Pseudomonas B B_BACTERIUM[BIO]
aeruginosa I I_BACTERIUM[BIO]
. O O

P B B_DISEASE/B_GENE
. I B_DISEASE/I_GENE
aeruginosa I B_DISEASE/I_GENE
contains O O
two O O
different O O
sugar O O
chains O O
, O O
the O O
homopolymer O O
common O O
antigen O O
( O O
A O O
band O O
) O O
and O O
the O O
heteropolymer O O
O O O
antigen O O
( O O
B O O
band O O
) O O
, O O
which O O
impart O O
serospecificity O O
. O O

The O O
characteristics O B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
of O O
LPS O B_BIO/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
are O O
generally O O
assessed O O
after O O
isolation O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
rather O O
than O O
in O O
the O O
context O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
of O O
whole O B_DISEASE/B_BACTERIUM[BIO]
bacteria O I_DISEASE/I_BACTERIUM[BIO]
. O O

Here O O
we O O
used O O
atomic O O
force O O
microscopy O O
( O O
AFM O O
) O O
to O O
probe O O
the O O
physical O O
properties O O
of O O
the O O
LPS O O
of O O
P B B_BACTERIUM[BIO]/B_DISEASE_ADJECTIVE[DISEASE]
. I I_BACTERIUM[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
aeruginosa I I_BACTERIUM[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
strain I I_BACTERIUM[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
PA103 I I_BACTERIUM[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
( O O
serogroup O O
O11 O O
) O O
in O O
situ O O
. O O

This O O
strain O B_BIO/B_GENE
contains O O
a O O
mixture O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
of O O
long O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
and O O
very O O
long O B_DISEASE_ADJECTIVE[DISEASE]/B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
polymers O B_DISEASE_ADJECTIVE[DISEASE]/I_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
O O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_SPECIES[BIO]
antigen O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_SPECIES[BIO]
, O O
regulated O O
by O O
two O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
different O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
genes O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
. O O

For O O
this O O
analysis O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
, O O
we O O
studied O O
the O O
wild O B_BIO/B_PROTEIN[GENE]
- O O
type O B_BIO/B_MEASURE
strain O B_BIO/I_MEASURE
and O O
four O B_CELL_OR_MOLECULAR_DYSFUNCTION[DISEASE]/B_GENE
mutants O I_CELL_OR_MOLECULAR_DYSFUNCTION[DISEASE]/I_GENE
, O O
DeltaWzz1 O B_PROTEIN[GENE]/B_LOCATION
( O O
producing O O
only O O
very O O
long O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
LPS O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
) O O
, O O
DeltaWzz2 O B_PROTEIN[GENE]/B_LOCATION
( O O
producing O O
only O B_DISEASE_ADJECTIVE[DISEASE]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
long O B_DISEASE_ADJECTIVE[DISEASE]/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
LPS O B_DISEASE_ADJECTIVE[DISEASE]/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
) O O
, O O
DDeltaM O B_PROTEIN[GENE]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
( O O
with O O
both O O
the O O
wzz1 O B_GENE/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
wzz2 O B_PROTEIN[GENE]/B_DISEASE
genes O I_PROTEIN[GENE]/I_DISEASE
deleted O O
) O O
, O O
and O O
Wzy O B_PROTEIN[GENE]/B_LOCATION
: O O
: O O
GM O B_ORGANIZATION/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
( O O
producing O O
an O O
LPS O B_PROTEIN[GENE]/B_DISEASE_ADJECTIVE[DISEASE]
core O I_PROTEIN[GENE]/I_DISEASE_ADJECTIVE[DISEASE]
oligosaccharide O I_PROTEIN[GENE]/I_DISEASE_ADJECTIVE[DISEASE]
plus O O
one O B_LOCATION/B_MEASURE
unit O B_LOCATION/I_MEASURE
of O O
O O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_SPECIES[BIO]
antigen O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_SPECIES[BIO]
) O O
. O O

Forces O B_PERSON/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
adhesion O B_DISEASE/B_MEASURE
between O O
the O O
LPS O B_CHEMICAL_CLASS[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
on O O
these O O
strains O B_BIO/B_CHEMICAL_CLASS[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
the O O
silicon O B_CHEMICAL_CLASS[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
nitride O I_CHEMICAL_CLASS[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
AFM O I_CHEMICAL_CLASS[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
tip O I_CHEMICAL_CLASS[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
were O O
measured O O
, O O
and O O
the O O
Alexander O B_PERSON
and O O
de O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
Gennes O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
model O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
of O O
steric O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
repulsion O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE
between O O
a O O
flat O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
surface O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE
and O O
a O O
polymer O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_CELL[BODY_PART_OR_ORGAN_COMPONENT]
brush O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_CELL[BODY_PART_OR_ORGAN_COMPONENT]
was O O
used O O
to O O
calculate O O
the O O
LPS O B_MEASURE/B_DISEASE
layer O I_MEASURE/I_DISEASE
thickness O I_MEASURE/I_DISEASE
( O O
which O O
we O O
refer O O
to O O
as O O
length O B_MEASURE
) O O
, O O
compressibility O B_MEASURE/B_LOCATION
, O O
and O O
spacing O O
between O O
the O O
individual O B_DISEASE_ADJECTIVE[DISEASE]/B_BODY_PART_OR_ORGAN_COMPONENT
molecules O B_DISEASE_ADJECTIVE[DISEASE]/I_BODY_PART_OR_ORGAN_COMPONENT
. O O

LPS O B_MEASURE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
chains O I_MEASURE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
were O O
longest O B_MEASURE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
for O O
the O O
wild O B_BIO/B_PROTEIN[GENE]
- O O
type O B_BIO/B_MEASURE
strain O B_BIO/I_MEASURE
and O O
DeltaWzz1 O B_MEASURE/B_GENE
, O O
at O O
170 O B_MEASURE
. O O
6 O B_MEASURE
and O O
212 O B_MEASURE
. O O
4 O B_MEASURE
nm O I_MEASURE
, O O
respectively O O
, O O
and O O
these O O
values O B_MEASURE/B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
were O O
not O O
statistically O O
significantly O O
different O B_DISEASE_ADJECTIVE[DISEASE]/B_TIME[MEASURE]
from O O
one O B_NUMBER[MEASURE]/B_LOCATION
another O O
. O O

Wzy O B_PROTEIN[GENE]/B_LOCATION
: O O
: O O
GM O B_ORGANIZATION/B_PROTEIN[GENE]
and O O
DDeltaM O B_ORGANIZATION/B_LOCATION
have O O
reduced O O
LPS O B_MEASURE
lengths O I_MEASURE
, O O
at O O
34 O B_MEASURE
. O O
6 O B_MEASURE
and O O
37 O B_MEASURE
. O O
7 O B_MEASURE
nm O I_MEASURE
, O O
respectively O O
. O O

Adhesion O O
forces O O
were O O
not O O
correlated O O
with O O
LPS O O
length O O
, O O
but O O
a O O
relationship O O
between O O
adhesion O O
force O O
and O O
bacterial O O
pathogenicity O O
was O O
found O O
in O O
a O O
mouse B B_SPECIES[BIO]/B_DISEASE
acute O O
pneumonia O O
model O O
of O O
infection O O
. O O

The O O
adhesion O B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
forces O I_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
with O O
the O O
AFM O B_LOCATION/B_CHEMICAL_CLASS[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
probe O B_LOCATION/I_CHEMICAL_CLASS[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
were O O
lower O B_MEASURE/B_DISEASE_ADJECTIVE[DISEASE]
for O O
strains O B_BIO/B_DISEASE
with O O
LPS O B_CELL_OR_MOLECULAR_DYSFUNCTION[DISEASE]/B_GENE
mutations O I_CELL_OR_MOLECULAR_DYSFUNCTION[DISEASE]/I_GENE
, O O
suggesting O O
that O O
the O O
wild O B_BIO/B_PROTEIN[GENE]
- O O
type O B_BIO/B_GENE
strain O B_BIO/I_GENE
is O O
optimized O O
for O O
maximal O B_DISEASE_ADJECTIVE[DISEASE]
adhesion O I_DISEASE_ADJECTIVE[DISEASE]
. O O

Our O O
research O O
contributes O O
to O O
further O O
understanding O O
of O O
the O O
role O O
of O O
LPS O O
in O O
the O O
adhesion O O
and O O
virulence O O
of O O
P B B_BACTERIUM[BIO]/B_DISEASE
. I I_BACTERIUM[BIO]/I_DISEASE
aeruginosa I I_BACTERIUM[BIO]/I_DISEASE
. O O

The O O
minor O O
pilin O O
subunit O O
Sgp2 O O
is O O
necessary O O
for O O
assembly O O
of O O
the O O
pilus O O
encoded O O
by O O
the O O
srtG O O
cluster O O
of O O
Streptococcus B B_BACTERIUM[BIO]/B_GENE
suis I I_BACTERIUM[BIO]/I_GENE
. O O

Gram O B_PERSON/B_BACTERIUM[BIO]
- O O
positive O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
pili O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_BIO
are O O
composed O O
of O O
covalently O O
bound O O
pilin O B_PROTEIN[GENE]/B_CHEMICAL_CLASS[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
subunits O B_PROTEIN[GENE]/I_CHEMICAL_CLASS[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
whose O O
assembly O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PHYSIOLOGIC_FUNCTION[ORGANISM_FUNCTION]
is O O
mediated O O
via O O
a O O
pilus O B_DISEASE_ADJECTIVE[DISEASE]/B_BIO
- O O
specific O B_ENZYME[GENE]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
sortase O I_ENZYME[GENE]/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
( O O
s O O
) O O
. O O

Major O B_PERSON/B_LOCATION
subunits O I_PERSON/I_LOCATION
constitute O O
the O O
pilus O B_BACTERIUM[BIO]/B_GENE
backbone O B_BACTERIUM[BIO]/I_GENE
and O O
are O O
therefore O O
essential O B_DRUG_ADJECTIVE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_TIME[MEASURE]
for O O
pilus O B_DISEASE_ADJECTIVE[DISEASE]/B_ORGANISM_FUNCTION
formation O I_DISEASE_ADJECTIVE[DISEASE]/I_ORGANISM_FUNCTION
. O O

Minor O B_MEASURE/B_DISEASE_ADJECTIVE[DISEASE]
subunits O I_MEASURE/I_DISEASE_ADJECTIVE[DISEASE]
are O O
also O O
incorporated O O
into O O
the O O
pilus O B_CHEMICAL_CLASS[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
, O O
but O O
they O O
are O O
considered O O
to O O
be O O
dispensable O B_DISEASE_ADJECTIVE[DISEASE]
for O O
backbone O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
formation O I_DISEASE_ADJECTIVE[DISEASE]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

The O O
srtG O O
cluster O O
is O O
one O O
of O O
the O O
putative O O
pilus O O
gene O O
clusters O O
identified O O
in O O
the O O
major O O
swine B B_SPECIES[BIO]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
pathogen O O
Streptococcus B B_BACTERIUM[BIO]/B_LOCATION
suis I I_BACTERIUM[BIO]/I_LOCATION
. O O

It O O
consists O O
of O O
one O B_GENE
sortase O I_GENE
gene O I_GENE
( O O
srtG O B_GENE
) O O
and O O
two O B_NUMBER[MEASURE]/B_PERSON
putative O I_NUMBER[MEASURE]/I_PERSON
pilin O I_NUMBER[MEASURE]/I_PERSON
subunit O I_NUMBER[MEASURE]/I_PERSON
genes O I_NUMBER[MEASURE]/I_PERSON
( O O
sgp1 O B_PROTEIN[GENE]/B_LOCATION
and O O
sgp2 O B_PROTEIN[GENE]
) O O
. O O

In O O
this O O
study O O
, O O
by O O
constructing O O
mutants O O
for O O
each O O
of O O
the O O
genes O O
in O O
the O O
cluster O O
and O O
by O O
both O O
immunoblotting O O
and O O
immunogold O O
electron O O
microscopic O O
analysis O O
with O O
antibodies O O
against O O
Sgp1 O O
and O O
Sgp2 O O
, O O
we O O
found O O
that O O
the O O
srtG O O
cluster O O
mediates O O
the O O
expression O O
of O O
pilus O O
- O O
like O O
structures O O
in O O
S B B_SPECIES[BIO]
. I I_SPECIES[BIO]
suis I I_SPECIES[BIO]
strain I I_SPECIES[BIO]
89 I I_SPECIES[BIO]
/ I I_SPECIES[BIO]
1591 I I_SPECIES[BIO]
. O O

In O O
this O O
pilus O B_LOCATION/B_PERSON
, O O
Sgp1 O B_PROTEIN[GENE]
forms O O
the O O
backbone O B_LOCATION/B_MEASURE
, O O
whereas O O
Sgp2 O B_GENE
is O O
incorporated O O
as O O
the O O
minor O B_GENE/B_BODY_PART_OR_ORGAN_COMPONENT
subunit O B_GENE/I_BODY_PART_OR_ORGAN_COMPONENT
. O O

In O O
accordance O B_TIME[MEASURE]/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
with O O
the O O
current O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
model O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
of O O
pilus O B_BACTERIUM[BIO]/B_PHYSIOLOGIC_FUNCTION[ORGANISM_FUNCTION]
assembly O B_BACTERIUM[BIO]/I_PHYSIOLOGIC_FUNCTION[ORGANISM_FUNCTION]
by O O
Gram O B_BACTERIUM[BIO]/B_GENE
- O O
positive O B_DISEASE_ADJECTIVE[DISEASE]/B_BIO
organisms O B_DISEASE_ADJECTIVE[DISEASE]/I_BIO
, O O
the O O
major O B_GENE
subunit O I_GENE
Sgp1 O I_GENE
was O O
indispensable O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
for O O
backbone O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PHYSIOLOGIC_FUNCTION[ORGANISM_FUNCTION]
formation O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PHYSIOLOGIC_FUNCTION[ORGANISM_FUNCTION]
and O O
the O O
cognate O B_ENZYME[GENE]/B_DISEASE_ADJECTIVE[DISEASE]
sortase O I_ENZYME[GENE]/I_DISEASE_ADJECTIVE[DISEASE]
SrtG O I_ENZYME[GENE]/I_DISEASE_ADJECTIVE[DISEASE]
mediated O O
the O O
polymerization O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_PHYSIOLOGIC_FUNCTION[ORGANISM_FUNCTION]
of O O
both O O
subunits O B_CHEMICAL_CLASS[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BODY_PART_OR_ORGAN_COMPONENT
. O O

However O O
, O O
unlike O O
other O B_NUMBER[MEASURE]/B_LOCATION
well O O
- O O
characterized O O
Gram O B_BACTERIUM[BIO]/B_GENE
- O O
positive O B_DISEASE_ADJECTIVE[DISEASE]/B_BIO
bacterial O I_DISEASE_ADJECTIVE[DISEASE]/I_BIO
pili O I_DISEASE_ADJECTIVE[DISEASE]/I_BIO
, O O
the O O
minor O B_GENE
subunit O I_GENE
Sgp2 O I_GENE
was O O
required O O
for O O
polymerization O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_PHYSIOLOGIC_FUNCTION[ORGANISM_FUNCTION]
of O O
the O O
major O B_GENE/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
subunit O B_GENE/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
Sgp1 O B_GENE/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

Because O O
Sgp2 O B_PERSON/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
homologues O I_PERSON/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
are O O
encoded O O
in O O
several O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
other O I_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
Gram O I_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
- O O
positive O B_DISEASE_ADJECTIVE[DISEASE]/B_BIO
bacterial O B_DISEASE_ADJECTIVE[DISEASE]/I_BIO
pilus O B_DISEASE_ADJECTIVE[DISEASE]/I_BIO
gene O B_DISEASE_ADJECTIVE[DISEASE]/I_BIO
clusters O B_DISEASE_ADJECTIVE[DISEASE]/I_BIO
, O O
in O O
some O O
types O B_PERSON/B_DISEASE
of O O
pili O B_BACTERIUM[BIO]/B_DISEASE_ADJECTIVE[DISEASE]
, O O
minor O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
pilin O I_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
subunits O I_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
may O O
contribute O O
to O O
backbone O B_DISEASE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
formation O I_DISEASE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
by O O
a O O
novel O B_LOCATION/B_ENZYME[GENE]
mechanism O B_LOCATION/I_ENZYME[GENE]
. O O

Growth O O
and O O
reproductive O O
costs O O
of O O
larval O O
defence O O
in O O
the O O
aposematic O O
lepidopteran O O
Pieris B B_SPECIES[BIO]/B_LOCATION
brassicae I I_SPECIES[BIO]/I_LOCATION
. O O

1 O B_NUMBER[MEASURE]
. O O

Utilization O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
plant O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
secondary O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_BIO
compounds O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_BIO
for O O
antipredator O B_DISEASE_ADJECTIVE[DISEASE]/B_ORGANISM_FUNCTION
defence O B_DISEASE_ADJECTIVE[DISEASE]/I_ORGANISM_FUNCTION
is O O
common O B_DISEASE_ADJECTIVE[DISEASE]
in O O
immature O B_LOCATION
herbivorous O I_LOCATION
insects O I_LOCATION
. O O

Such O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
defences O I_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
may O O
incur O O
a O O
cost O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
to O O
the O O
animal O B_BIO/B_PERSON
, O O
either O O
in O O
terms O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
of O O
survival O B_DISEASE_ADJECTIVE[DISEASE]/B_ORGANISM_FUNCTION
, O O
growth O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANISM_FUNCTION
rate O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_ORGANISM_FUNCTION
or O O
in O O
the O O
reproductive O B_LOCATION/B_MEASURE
success O I_LOCATION/I_MEASURE
. O O

2 O B_NUMBER[MEASURE]
. O O

A O O
common O B_DISEASE_ADJECTIVE[DISEASE]/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
defence O B_DISEASE_ADJECTIVE[DISEASE]/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
in O O
lepidopterans O B_BIO/B_LOCATION
is O O
the O O
regurgitation O B_BODY_PART_OR_ORGAN_COMPONENT/B_PHYSIOLOGIC_FUNCTION[ORGANISM_FUNCTION]
of O O
semi O B_DISEASE/B_ENZYME[GENE]
- O O
digested O O
material O B_BODY_PART_OR_ORGAN_COMPONENT/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
containing O O
the O O
defensive O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
compounds O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_BIO
of O O
the O O
food O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
plant O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
, O O
a O O
defence O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
which O O
has O O
led O O
to O O
gut O B_DISEASE/B_BIO
specialization O I_DISEASE/I_BIO
in O O
this O O
order O B_BIO/B_PERSON
. O O

Regurgitation O B_DISEASE/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
is O O
often O O
swift O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
in O O
response O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
to O O
cuticular O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_BIO
stimulation O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/I_BIO
and O O
deters O O
predators O B_BIO/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
from O O
consuming O O
or O O
parasitizing O O
the O O
larva O B_DISEASE_ADJECTIVE[DISEASE]/B_BIO
. O O

The O O
loss O B_MEASURE/B_DISEASE_ADJECTIVE[DISEASE]
of O O
food O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BACTERIUM[BIO]
and O O
other O B_DISEASE_ADJECTIVE[DISEASE]/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
gut O B_DISEASE_ADJECTIVE[DISEASE]/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
material O B_DISEASE_ADJECTIVE[DISEASE]/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
seems O O
likely O B_DISEASE_ADJECTIVE[DISEASE]/B_LOCATION
to O O
impact O O
on O O
fitness O B_DISEASE/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
but O O
evidence O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANIZATION
is O O
lacking O O
. O O

3 O B_NUMBER[MEASURE]
. O O

Here O O
, O O
we O O
raised O O
larvae O O
of O O
the O O
common O O
crop O O
pest O O
Pieris B B_BIO
brassicae I I_BIO
on O O
commercial O O
cabbage B B_BIO
leaves O O
, O O
simulated O O
predator O O
attacks O O
throughout O O
the O O
larval O O
period O O
, O O
and O O
measured O O
life O O
- O O
history O O
responses O O
. O O

4 O B_NUMBER[MEASURE]
. O O

We O O
found O O
that O O
the O O
probability O B_MEASURE/B_PERSON
of O O
survival O B_TIME[MEASURE]/B_DISEASE_ADJECTIVE[DISEASE]
to O O
pupation O B_DISEASE_ADJECTIVE[DISEASE]/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
decreased O O
with O O
increasing O O
frequency O B_MEASURE/B_LOCATION
of O O
attacks O B_DISEASE/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
, O O
but O O
this O O
was O O
because O O
of O O
regurgitation O B_DISEASE/B_BODY_PART_OR_ORGAN_COMPONENT
rather O O
than O O
the O O
stimulation O B_DISEASE/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
itself O O
. O O

There O O
was O O
a O O
growth O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
cost O B_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
to O O
the O O
defence O B_PERSON/B_BIO
such O I_PERSON/I_BIO
that O O
the O O
more O O
regurgitant O B_PERSON/B_BIO
that O O
individuals O B_PERSON/B_BIO
produced O O
over O O
the O O
growth O B_TIME[MEASURE]
period O I_TIME[MEASURE]
, O O
the O O
smaller O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
they O O
were O O
at O O
pupation O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
. O O

5 O B_NUMBER[MEASURE]
. O O

The O O
number O B_MEASURE
of O O
mature O B_MEASURE/B_PERSON
eggs O I_MEASURE/I_PERSON
in O O
adult O B_PERSON/B_BIO
females O I_PERSON/I_BIO
was O O
positively O O
related O O
to O O
pupal O B_DISEASE/B_MEASURE
mass O I_DISEASE/I_MEASURE
, O O
but O O
this O O
relationship O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
was O O
only O O
found O O
when O O
individuals O B_PERSON/B_BIO
were O O
not O O
subjected O O
to O O
a O O
high O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
frequency O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
of O O
predator O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_ORGANISM_FUNCTION
simulation O I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/I_ORGANISM_FUNCTION
. O O

This O O
suggests O O
that O O
there O O
might O O
be O O
cryptic O B_DISEASE_ADJECTIVE[DISEASE]/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
fitness O B_DISEASE_ADJECTIVE[DISEASE]/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
costs O B_DISEASE_ADJECTIVE[DISEASE]/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
to O O
common O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
defensive O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
responses O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
that O O
are O O
paid O O
despite O O
apparent O B_MEASURE/B_LOCATION
growth O B_MEASURE/I_LOCATION
rate O B_MEASURE/I_LOCATION
being O O
maintained O O
. O O

6 O B_NUMBER[MEASURE]
. O O

Our O O
results O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
demonstrate O O
a O O
clear O B_TIME[MEASURE]/B_ENT
life O I_TIME[MEASURE]/I_ENT
- O O
history O B_MEASURE/B_LOCATION
cost O B_MEASURE/I_LOCATION
of O O
an O O
antipredator O B_DISEASE_ADJECTIVE[DISEASE]/B_PERSON
defence O I_DISEASE_ADJECTIVE[DISEASE]/I_PERSON
in O O
a O O
model O B_BIO/B_LOCATION
pest O I_BIO/I_LOCATION
species O I_BIO/I_LOCATION
and O O
show O O
that O O
under O O
certain O B_DISEASE_ADJECTIVE[DISEASE]
conditions O I_DISEASE_ADJECTIVE[DISEASE]
, O O
such O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
as O O
high O B_DISEASE/B_ORGANISM_FUNCTION
predation O I_DISEASE/I_ORGANISM_FUNCTION
threat O I_DISEASE/I_ORGANISM_FUNCTION
, O O
the O O
expected O O
relationship O B_PERSON/B_MEASURE
between O O
female O B_PERSON/B_MEASURE
body O I_PERSON/I_MEASURE
size O I_PERSON/I_MEASURE
and O O
potential O B_DISEASE_ADJECTIVE[DISEASE]/B_ORGANISM_FUNCTION
fecundity O B_DISEASE_ADJECTIVE[DISEASE]/I_ORGANISM_FUNCTION
can O O
be O O
disrupted O O
. O O

Huntington O B_DISEASE/B_LOCATION
' O O
s O O
disease O B_DISEASE
: O O
from O O
molecular O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
pathogenesis O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
to O O
clinical O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
treatment O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE
. O O

Huntington O B_DISEASE
' O I_DISEASE
s O I_DISEASE
disease O I_DISEASE
is O O
a O O
progressive O B_DISEASE_ADJECTIVE[DISEASE]/B_GENE
, O O
fatal O B_DISEASE_ADJECTIVE[DISEASE]
, O O
neurodegenerative O B_DISEASE
disorder O I_DISEASE
caused O O
by O O
an O O
expanded O O
CAG O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
repeat O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
in O O
the O O
huntingtin O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
gene O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
, O O
which O O
encodes O O
an O O
abnormally O O
long O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
polyglutamine O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
repeat O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
in O O
the O O
huntingtin O B_GENE/B_CELL[BODY_PART_OR_ORGAN_COMPONENT]
protein O B_GENE/I_CELL[BODY_PART_OR_ORGAN_COMPONENT]
. O O

Huntington O B_DISEASE/B_SPECIES[BIO]
' O B_DISEASE/I_SPECIES[BIO]
s O B_DISEASE/I_SPECIES[BIO]
disease O B_DISEASE/I_SPECIES[BIO]
has O O
served O O
as O O
a O O
model O B_PERSON/B_LOCATION
for O O
the O O
study O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
other O B_NUMBER[MEASURE]/B_DISEASE_ADJECTIVE[DISEASE]
more O O
common O B_DISEASE/B_LOCATION
neurodegenerative O I_DISEASE/I_LOCATION
disorders O I_DISEASE/I_LOCATION
, O O
such O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
as O O
Alzheimer O B_DISEASE/B_GENE
' O I_DISEASE/I_GENE
s O I_DISEASE/I_GENE
disease O I_DISEASE/I_GENE
and O O
Parkinson O B_DISEASE/B_GENE
' O I_DISEASE/I_GENE
s O I_DISEASE/I_GENE
disease O I_DISEASE/I_GENE
. O O

These O O
disorders O B_DISEASE
all O O
share O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
features O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
including O O
: O O
delayed O O
onset O B_DISEASE/B_ORGANISM_FUNCTION
; O O
selective O B_DISEASE_ADJECTIVE[DISEASE]
neuronal O I_DISEASE_ADJECTIVE[DISEASE]
vulnerability O I_DISEASE_ADJECTIVE[DISEASE]
, O O
despite O O
widespread O B_DISEASE_ADJECTIVE[DISEASE]/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
expression O B_DISEASE_ADJECTIVE[DISEASE]/I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
of O O
disease O B_DISEASE
- O O
related O O
proteins O B_DISEASE_ADJECTIVE[DISEASE]/B_GENE
during O O
the O O
whole O B_TIME[MEASURE]
lifetime O I_TIME[MEASURE]
; O O
abnormal O B_DISEASE_ADJECTIVE[DISEASE]
protein O I_DISEASE_ADJECTIVE[DISEASE]
processing O I_DISEASE_ADJECTIVE[DISEASE]
and O O
aggregation O B_DISEASE/B_PHYSIOLOGIC_FUNCTION[ORGANISM_FUNCTION]
; O O
and O O
cellular O B_DISEASE_ADJECTIVE[DISEASE]
toxic O I_DISEASE_ADJECTIVE[DISEASE]
effects O I_DISEASE_ADJECTIVE[DISEASE]
involving O O
both O O
cell O B_CELL[BODY_PART_OR_ORGAN_COMPONENT]/B_GENE
autonomous O I_CELL[BODY_PART_OR_ORGAN_COMPONENT]/I_GENE
and O O
cell O B_CELL[BODY_PART_OR_ORGAN_COMPONENT]
- O O
cell O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
interaction O I_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
mechanisms O I_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
. O O

Pathogenic O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
pathways O B_DISEASE_ADJECTIVE[DISEASE]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
Huntington O B_DISEASE/B_LOCATION
' O I_DISEASE/I_LOCATION
s O I_DISEASE/I_LOCATION
disease O I_DISEASE/I_LOCATION
are O O
beginning O O
to O O
be O O
unravelled O O
, O O
offering O O
targets O B_PERSON/B_LOCATION
for O O
treatments O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_DISEASE
. O O

Additionally O O
, O O
predictive O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
genetic O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
testing O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
and O O
findings O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
of O O
neuroimaging O O
studies O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
show O O
that O O
, O O
as O O
in O O
some O O
other O B_DISEASE_ADJECTIVE[DISEASE]/B_PERSON
neurodegenerative O I_DISEASE_ADJECTIVE[DISEASE]/I_PERSON
disorders O I_DISEASE_ADJECTIVE[DISEASE]/I_PERSON
, O O
neurodegeneration O B_DISEASE
in O O
affected O O
individuals O B_PERSON/B_BIO
begins O O
many O B_TIME[MEASURE]/B_ENT
years O I_TIME[MEASURE]/I_ENT
before O O
onset O B_DISEASE_ADJECTIVE[DISEASE]/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
diagnosable O B_DISEASE/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
signs O I_DISEASE/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
symptoms O B_DISEASE
of O O
Huntington O B_DISEASE
' O I_DISEASE
s O I_DISEASE
disease O I_DISEASE
, O O
and O O
it O O
is O O
accompanied O O
by O O
subtle O B_DISEASE_ADJECTIVE[DISEASE]/B_BODY_PART_OR_ORGAN_COMPONENT
cognitive O I_DISEASE_ADJECTIVE[DISEASE]/I_BODY_PART_OR_ORGAN_COMPONENT
, O O
motor O B_DISEASE_ADJECTIVE[DISEASE]
, O O
and O O
psychiatric O B_DISEASE_ADJECTIVE[DISEASE]
changes O I_DISEASE_ADJECTIVE[DISEASE]
( O O
so O O
- O O
called O O
prodromal O B_DISEASE
disease O I_DISEASE
) O O
. O O

Thus O O
, O O
Huntington O B_DISEASE/B_PERSON
' O I_DISEASE/I_PERSON
s O O
disease O B_DISEASE/B_PERSON
is O O
also O O
emerging O O
as O O
a O O
model O B_PERSON/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
for O O
strategies O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
to O O
develop O O
therapeutic O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
interventions O I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
, O O
not O O
only O O
to O O
slow O O
progression O B_DISEASE_ADJECTIVE[DISEASE]/B_ORGANISM_FUNCTION
of O O
manifest O B_DISEASE
disease O I_DISEASE
but O O
also O O
to O O
delay O O
, O O
or O O
ideally O O
prevent O O
, O O
its O O
onset O B_DISEASE_ADJECTIVE[DISEASE]
. O O

Natural O O
history O O
and O O
intragenomic O O
dynamics O O
of O O
the O O
Transib O O
transposon O O
Hztransib O O
in O O
the O O
cotton B B_SPECIES[BIO]/B_LOCATION
bollworm I I_SPECIES[BIO]/I_LOCATION
Helicoverpa B I_SPECIES[BIO]/I_LOCATION
zea I I_SPECIES[BIO]/I_LOCATION
. O O

Hztransib O O
, O O
recently O O
identified O O
from O O
Helicoverpa B B_SPECIES[BIO]
zea I I_SPECIES[BIO]
, O O
represents O O
the O O
first O O
intact O O
and O O
transcriptionally O O
active O O
Transib O O
element O O
. O O

Its O O
open O O
reading O O
frame O O
was O O
detected O O
in O O
Helicoverpa B B_BIO
armigera I I_BIO
, O O
from O O
which O O
H B B_PERSON/B_BIO
. I I_PERSON/I_BIO
zea I I_PERSON/I_BIO
evolved O O
, O O
and O O
in O O
Helicoverpa B B_BIO/B_LOCATION
assulta I I_BIO/I_LOCATION
, O O
the O O
common O O
ancestor O O
of O O
H B B_BIO
. I I_BIO
zea I I_BIO
and O O
H B B_BIO
. I I_BIO
armigera I I_BIO
, O O
but O O
its O O
remaining O O
parts O O
were O O
found O O
only O O
in O O
H B B_BIO/B_LOCATION
. I I_BIO/I_LOCATION
armigera I I_BIO/I_LOCATION
. O O

Thirty O O
- O O
nine O O
Hztransib O O
insertion O O
sites O O
, O O
all O O
of O O
which O O
are O O
polymorphic O O
, O O
were O O
detected O O
from O O
eight O O
populations O O
of O O
H B B_BIO
. I I_BIO
zea I I_BIO
. O O

Out O O
of O O
the O O
39 O B_NUMBER[MEASURE]
insertion O I_NUMBER[MEASURE]
sites O I_NUMBER[MEASURE]
, O O
35 O B_NUMBER[MEASURE]
were O O
not O O
frequently O O
occupied O O
, O O
with O O
1 O B_MEASURE
- O O
33 O B_SEQUENCE[MEASURE]
occurrences O I_SEQUENCE[MEASURE]
in O O
a O O
total O B_MEASURE/B_LOCATION
of O O
128 O B_NUMBER[MEASURE]/B_PERSON
individuals O I_NUMBER[MEASURE]/I_PERSON
from O O
the O O
eight O B_MEASURE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
populations O I_MEASURE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
( O O
16 O B_NUMBER[MEASURE]
larvae O I_NUMBER[MEASURE]
per O O
population O B_PERSON/B_LOCATION
) O O
. O O

Its O O
copy O B_MEASURE
number O I_MEASURE
ranged O O
from O O
5 O B_MEASURE
. O O
8 O B_MEASURE
to O O
14 O B_MEASURE
. O O
2 O B_MEASURE
per O O
individual O B_PERSON/B_TIME[MEASURE]
, O O
with O O
putative O B_GENE
intact O I_GENE
copies O I_GENE
always O O
more O O
abundant O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
than O O
internally O O
deleted O O
ones O B_PERSON/B_ENT
. O O

Taking O O
this O O
evidence O O
together O O
, O O
Hztransib O O
probably O O
transferred O O
to O O
H B B_BIO/B_GENE
. I B_BIO/I_GENE
zea I B_BIO/I_GENE
from O O
H B B_BIO/B_ORGANISM_FUNCTION
. I I_BIO/I_ORGANISM_FUNCTION
armigera I I_BIO/I_ORGANISM_FUNCTION
and O O
most O O
likely O O
still O O
retains O O
its O O
capacity O O
to O O
maintain O O
structural O O
integrity O O
, O O
increase O O
copy O O
number O O
and O O
remobilize O O
in O O
H B B_BIO
. I I_BIO
zea I I_BIO
. O O

Identification O O
of O O
an O O
extracellular O O
polysaccharide O O
network O O
essential O O
for O O
cytochrome O O
anchoring O O
and O O
biofilm O O
formation O O
in O O
Geobacter B B_BIO/B_DISEASE
sulfurreducens I I_BIO/I_DISEASE
. O O

Transposon O O
insertions O O
in O O
Geobacter B B_BIO/B_GENE
sulfurreducens I B_BIO/I_GENE
GSU1501 O O
, O O
part O O
of O O
an O O
ATP O O
- O O
dependent O O
exporter O O
within O O
an O O
operon O O
of O O
polysaccharide O O
biosynthesis O O
genes O O
, O O
were O O
previously O O
shown O O
to O O
eliminate O O
insoluble O O
Fe O O
( O O
III O O
) O O
reduction O O
and O O
use O O
of O O
an O O
electrode O O
as O O
an O O
electron O O
acceptor O O
. O O

Replacement O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
of O O
GSU1501 O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
with O O
a O O
kanamycin O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
resistance O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
cassette O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
produced O O
a O O
similarly O O
defective O B_CELL_OR_MOLECULAR_DYSFUNCTION[DISEASE]/B_GENE
mutant O B_CELL_OR_MOLECULAR_DYSFUNCTION[DISEASE]/I_GENE
, O O
which O O
could O O
be O O
partially O O
complemented O O
by O O
expression O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_GENE
of O O
GSU1500 O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
to O O
GSU1505 O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
in O O
trans O B_BIO/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

The O O
Delta1501 O B_CHEMICAL_CLASS[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
mutant O I_CHEMICAL_CLASS[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
demonstrated O O
limited O B_DISEASE/B_ORGANIZATION
cell O I_DISEASE/I_ORGANIZATION
- O O
cell O B_DISEASE_ADJECTIVE[DISEASE]/B_BACTERIUM[BIO]
agglutination O I_DISEASE_ADJECTIVE[DISEASE]/I_BACTERIUM[BIO]
, O O
enhanced O B_DISEASE_ADJECTIVE[DISEASE]
attachment O I_DISEASE_ADJECTIVE[DISEASE]
to O O
negatively O O
charged O O
surfaces O B_CHEMICAL_CLASS[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
and O O
poor O B_DISEASE_ADJECTIVE[DISEASE]
attachment O I_DISEASE_ADJECTIVE[DISEASE]
to O O
positively O O
charged O O
poly O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- O O
d O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
- O O
lysine O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- O O
or O O
Fe O B_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
( O O
III O B_PROTEIN[GENE]/B_LOCATION
) O O
- O O
coated O O
surfaces O B_CHEMICAL_CLASS[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
. O O

Wild O B_PERSON/B_BIO
- O O
type O B_MEASURE/B_LOCATION
and O O
mutant O B_DISEASE/B_MEASURE
cells O I_DISEASE/I_MEASURE
attached O O
to O O
graphite O B_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
electrodes O I_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_BIO
, O O
but O O
when O O
electrodes O B_MEDICAL_DEVICE[OBJECT]/B_PERSON
were O O
poised O O
at O O
an O O
oxidizing O O
potential O B_MEASURE/B_PERSON
inducing O O
a O O
positive O B_DISEASE_ADJECTIVE[DISEASE]
surface O I_DISEASE_ADJECTIVE[DISEASE]
charge O I_DISEASE_ADJECTIVE[DISEASE]
( O O
+ O B_MEASURE
0 O I_MEASURE
. O O
24 O B_MEASURE
V O I_MEASURE
versus O I_MEASURE
the O O
standard O B_LOCATION/B_MEASURE
hydrogen O B_LOCATION/I_MEASURE
electrode O B_LOCATION/I_MEASURE
[ O O
SHE O O
] O B_MEDICAL_DEVICE[OBJECT]/B_DISEASE
) O O
, O O
Delta1501 O B_DISEASE_ADJECTIVE[DISEASE]/B_TIME[MEASURE]
mutant O I_DISEASE_ADJECTIVE[DISEASE]/I_TIME[MEASURE]
cells O I_DISEASE_ADJECTIVE[DISEASE]/I_TIME[MEASURE]
detached O O
. O O

Scanning O O
electron O O
microscopy O O
revealed O O
fibrils O O
surrounding O O
wild O O
- O O
type O O
G B B_BIO/B_GENE
. I B_BIO/I_GENE
sulfurreducens I B_BIO/I_GENE
which O O
were O O
absent O O
from O O
the O O
Delta1501 O O
mutant O O
. O O

Similar O B_MEASURE/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
amounts O I_MEASURE/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
type O B_DISEASE_ADJECTIVE[DISEASE]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
IV O B_DISEASE_ADJECTIVE[DISEASE]/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
pili O B_DISEASE_ADJECTIVE[DISEASE]/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
pilus O B_CELL[BODY_PART_OR_ORGAN_COMPONENT]/B_DISEASE_ADJECTIVE[DISEASE]
- O O
associated O O
cytochromes O B_GENE/B_BIO
were O O
detected O O
on O O
both O O
cell O B_DISEASE_ADJECTIVE[DISEASE]/B_CHEMICAL_CLASS[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
types O B_DISEASE_ADJECTIVE[DISEASE]/I_CHEMICAL_CLASS[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
but O O
shearing O B_PERSON/B_LOCATION
released O O
a O O
stable O B_MEASURE/B_LOCATION
matrix O I_MEASURE/I_LOCATION
of O O
c O B_DISEASE/B_PROTEIN[GENE]
- O O
type O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
cytochromes O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
and O O
other O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
proteins O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
bound O O
to O O
polysaccharides O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_CELL[BODY_PART_OR_ORGAN_COMPONENT]
. O O

The O O
matrix O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
from O O
the O O
mutant O B_DISEASE/B_BIO
contained O O
60 O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
% O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
less O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
sugar O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
and O O
was O O
nearly O O
devoid O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
of O O
c O B_DISEASE/B_PROTEIN[GENE]
- O O
type O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
cytochromes O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
such O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
as O O
OmcZ O B_GENE/B_BACTERIUM[BIO]
. O O

The O O
addition O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
of O O
wild O B_BIO/B_CELL[BODY_PART_OR_ORGAN_COMPONENT]
- O O
type O B_CELL[BODY_PART_OR_ORGAN_COMPONENT]/B_PROTEIN[GENE]
extracellular O B_CELL[BODY_PART_OR_ORGAN_COMPONENT]/I_PROTEIN[GENE]
matrix O B_CELL[BODY_PART_OR_ORGAN_COMPONENT]/I_PROTEIN[GENE]
to O O
Delta1501 O B_DISEASE_ADJECTIVE[DISEASE]/B_CELL[BODY_PART_OR_ORGAN_COMPONENT]
cultures O B_DISEASE_ADJECTIVE[DISEASE]/I_CELL[BODY_PART_OR_ORGAN_COMPONENT]
restored O O
agglutination O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_CELL_FUNCTION[ORGANISM_FUNCTION]
and O O
Fe O B_LOCATION/B_MEASURE
( O O
III O B_PROTEIN[GENE]/B_LOCATION
) O O
reduction O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_DISEASE
. O O

The O O
polysaccharide O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
binding O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_BIO
dye O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_BIO
Congo O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_BIO
red O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_BIO
preferentially O O
bound O O
wild O B_PERSON/B_SPECIES[BIO]
- O O
type O B_MEASURE/B_LOCATION
cells O I_MEASURE/I_LOCATION
and O O
extracellular O B_DISEASE_ADJECTIVE[DISEASE]/B_GENE
matrix O I_DISEASE_ADJECTIVE[DISEASE]/I_GENE
material O I_DISEASE_ADJECTIVE[DISEASE]/I_GENE
over O O
mutant O B_DISEASE/B_MEASURE
cells O I_DISEASE/I_MEASURE
, O O
and O O
Congo O B_DISEASE_ADJECTIVE[DISEASE]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
red O I_DISEASE_ADJECTIVE[DISEASE]/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
inhibited O O
agglutination O B_DISEASE/B_CELL_FUNCTION[ORGANISM_FUNCTION]
and O O
Fe O B_LOCATION/B_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
( O O
III O B_PROTEIN[GENE]/B_LOCATION
) O O
reduction O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_DISEASE
by O O
wild O B_SPECIES[BIO]/B_CELL_OR_MOLECULAR_DYSFUNCTION[DISEASE]
- O O
type O B_CELL[BODY_PART_OR_ORGAN_COMPONENT]/B_BIO
cells O B_CELL[BODY_PART_OR_ORGAN_COMPONENT]/I_BIO
. O O

These O O
results O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
demonstrate O O
a O O
crucial O B_PERSON/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
role O I_PERSON/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
for O O
the O O
xap O B_PROTEIN[GENE]/B_SPECIES[BIO]
( O O
extracellular O B_LOCATION/B_PROTEIN[GENE]
anchoring O B_LOCATION/I_PROTEIN[GENE]
polysaccharide O B_LOCATION/I_PROTEIN[GENE]
) O O
locus O B_PROTEIN[GENE]/B_LOCATION
in O O
metal O B_DISEASE_ADJECTIVE[DISEASE]/B_CELL_FUNCTION[ORGANISM_FUNCTION]
oxide O B_DISEASE_ADJECTIVE[DISEASE]/I_CELL_FUNCTION[ORGANISM_FUNCTION]
attachment O B_DISEASE_ADJECTIVE[DISEASE]/I_CELL_FUNCTION[ORGANISM_FUNCTION]
, O O
cell O B_LOCATION/B_CELL[BODY_PART_OR_ORGAN_COMPONENT]
- O O
cell O B_DISEASE_ADJECTIVE[DISEASE]/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
agglutination O B_DISEASE_ADJECTIVE[DISEASE]/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
and O O
localization O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
of O O
essential O B_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
cytochromes O I_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
beyond O O
the O O
Geobacter O B_CELL_COMPONENT[BODY_PART_OR_ORGAN_COMPONENT]/B_GENE
outer O I_CELL_COMPONENT[BODY_PART_OR_ORGAN_COMPONENT]/I_GENE
membrane O I_CELL_COMPONENT[BODY_PART_OR_ORGAN_COMPONENT]/I_GENE
. O O

Hyphal O O
and O O
cytoskeleton O O
polarization O O
in O O
Tuber B B_SPECIES[BIO]/B_BODY_PART_OR_ORGAN_COMPONENT
melanosporum I I_SPECIES[BIO]/I_BODY_PART_OR_ORGAN_COMPONENT
: O O
a O O
genomic O O
and O O
cellular O O
analysis O O
. O O

Filamentous O B_CELL[BODY_PART_OR_ORGAN_COMPONENT]/B_BIO
polarized O O
growth O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANISM_FUNCTION
involves O O
a O O
series O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
of O O
events O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
including O O
polarization O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
of O O
the O O
cytoskeleton O B_CELL[BODY_PART_OR_ORGAN_COMPONENT]
to O O
selected O O
growth O B_LOCATION/B_ORGANIZATION
sites O I_LOCATION/I_ORGANIZATION
, O O
and O O
the O O
transport O B_ORGANIZATION/B_ORGANISM_FUNCTION
of O O
secretory O B_CELL[BODY_PART_OR_ORGAN_COMPONENT]/B_CHEMICAL_CLASS[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
vesicles O B_CELL[BODY_PART_OR_ORGAN_COMPONENT]/I_CHEMICAL_CLASS[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
containing O O
the O O
components O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
required O O
for O O
growth O B_ORGANISM_FUNCTION/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

The O O
availability O B_PERSON/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
fungal O B_GENE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
genome O I_GENE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
sequences O I_GENE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
has O O
recently O O
led O O
to O O
the O O
identification O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
a O O
large O B_MEASURE/B_LOCATION
number O I_MEASURE/I_LOCATION
of O O
proteins O B_BIO/B_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
involved O O
in O O
these O O
processes O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
. O O

We O O
have O O
explored O O
the O O
Tuber B B_SPECIES[BIO]/B_MEASURE
melanosporum I I_SPECIES[BIO]/I_MEASURE
genome O O
sequence O O
by O O
searching O O
for O O
homologs O O
of O O
genes O O
known O O
to O O
play O O
crucial O O
roles O O
in O O
the O O
morphogenesis O O
and O O
cell O O
polarity O O
of O O
yeasts B B_SPECIES[BIO]/B_LOCATION
and O O
filamentous O O
fungi O O
. O O

One O B_NUMBER[MEASURE]
hundred O I_NUMBER[MEASURE]
and O O
forty O B_NUMBER[MEASURE]
- O O
nine O B_NUMBER[MEASURE]
genes O I_NUMBER[MEASURE]
have O O
been O O
identified O O
and O O
functionally O O
grouped O O
according O O
to O O
the O O
deduced O O
amino O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
acid O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
sequences O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
( O O
44 O B_MEASURE
genes O I_MEASURE
involved O O
in O O
cell O B_MEASURE/B_ORGANISM_FUNCTION
polarity O I_MEASURE/I_ORGANISM_FUNCTION
/ O O
morphogenesis O B_DISEASE/B_ORGANISM_FUNCTION
, O O
39 O B_MEASURE
belonging O O
to O O
the O O
actin O B_CELL_COMPONENT[BODY_PART_OR_ORGAN_COMPONENT]/B_DISEASE_ADJECTIVE[DISEASE]
cytoskeleton O I_CELL_COMPONENT[BODY_PART_OR_ORGAN_COMPONENT]/I_DISEASE_ADJECTIVE[DISEASE]
and O O
66 O B_NUMBER[MEASURE]
involved O O
in O O
membrane O B_DISEASE_ADJECTIVE[DISEASE]/B_CELL_FUNCTION[ORGANISM_FUNCTION]
dynamics O B_DISEASE_ADJECTIVE[DISEASE]/I_CELL_FUNCTION[ORGANISM_FUNCTION]
, O O
septation O B_DISEASE_ADJECTIVE[DISEASE]/B_CELL_FUNCTION[ORGANISM_FUNCTION]
and O O
exocytosis O B_CELL[BODY_PART_OR_ORGAN_COMPONENT]/B_CELL_FUNCTION[ORGANISM_FUNCTION]
) O O
. O O

A O O
detailed O O
gene O O
annotation O O
has O O
shown O O
that O O
most O O
components O O
of O O
the O O
cell O O
polarity O O
machinery O O
, O O
morphogenesis O O
and O O
cytoskeleton O O
found O O
in O O
yeasts B B_BIO/B_LOCATION
and O O
filamentous O O
fungi O O
are O O
conserved O O
, O O
although O O
the O O
degree O O
of O O
similarity O O
varies O O
from O O
strong O O
to O O
weak O O
. O O

Microscopic O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
analysis O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
quick O B_PERSON/B_LOCATION
- O O
frozen O O
truffle O B_CHEMICAL_CLASS[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
hyphae O I_CHEMICAL_CLASS[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
detected O O
the O O
characteristic O B_DISEASE_ADJECTIVE[DISEASE]/B_LOCATION
subcellular O B_DISEASE_ADJECTIVE[DISEASE]/I_LOCATION
components O B_DISEASE_ADJECTIVE[DISEASE]/I_LOCATION
of O O
the O O
hyphal O B_DISEASE_ADJECTIVE[DISEASE]/B_GENE
tip O B_DISEASE_ADJECTIVE[DISEASE]/I_GENE
in O O
septate O B_BIO/B_LOCATION
filamentous O I_BIO/I_LOCATION
fungi O I_BIO/I_LOCATION
, O O
while O O
transcript O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
profiles O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
revealed O O
a O O
moderately O O
variable O B_MEASURE/B_DISEASE
pattern O I_MEASURE/I_DISEASE
during O O
the O O
biological O B_TIME[MEASURE]
cycle O I_TIME[MEASURE]
. O O

Proteomics O O
of O O
cryoprotective O O
dehydration O O
in O O
Megaphorura B B_PERSON
arctica I I_PERSON
Tullberg O O
1876 O O
( O O
Onychiuridae O O
: O O
Collembola O O
) O O
. O O

The O O
Arctic B B_BIO
springtail I I_BIO
, O O
Megaphorura B B_BIO/B_LOCATION
arctica I I_BIO/I_LOCATION
Tullberg O O
1876 O O
( O O
Onychiuridae O O
: O O
Collembola O O
) O O
, O O
is O O
one O O
of O O
the O O
few O O
organisms O O
known O O
to O O
survive O O
the O O
extreme O O
stresses O O
of O O
its O O
environment O O
by O O
using O O
cryoprotective O O
dehydration O O
. O O

We O O
have O O
undertaken O O
a O O
proteomics O O
study O O
comparing O O
M B B_SPECIES[BIO]/B_PERSON
. I I_SPECIES[BIO]/I_PERSON
arctica I I_SPECIES[BIO]/I_PERSON
, O O
acclimated O O
at O O
- O O
2 O O
^ O O
0C O O
, O O
the O O
temperature O O
known O O
to O O
induce O O
the O O
production O O
of O O
the O O
anhydroprotectant O O
trehalose O O
in O O
this O O
species O O
, O O
and O O
- O O
6 O O
^ O O
0C O O
, O O
the O O
temperature O O
at O O
which O O
trehalose O O
expression O O
plateaus O O
, O O
against O O
control O O
animals O O
acclimated O O
at O O
+ O O
5 O O
^ O O
0C O O
. O O

Using O O
difference O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
gel O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
electrophoresis O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
, O O
and O O
liquid O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
chromatography O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
tandem O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
mass O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
spectrometry O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
we O O
identified O O
three O B_MEASURE/B_LOCATION
categories O B_MEASURE/I_LOCATION
of O O
differentially O O
expressed O O
proteins O B_GENE/B_DISEASE
with O O
specific O B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
functions O I_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
, O O
up O O
- O O
regulated O O
in O O
both O O
the O O
- O O
2 O B_MEASURE
^ O I_MEASURE
0C O I_MEASURE
and O O
- O O
6 O B_PROTEIN[GENE]/B_LOCATION
^ O I_PROTEIN[GENE]/I_LOCATION
0C O I_PROTEIN[GENE]/I_LOCATION
animals O I_PROTEIN[GENE]/I_LOCATION
, O O
that O O
were O O
involved O O
in O O
metabolism O B_GENE/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
membrane O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
transport O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
and O O
protein O B_DISEASE_ADJECTIVE[DISEASE]/B_GENE
folding O B_DISEASE_ADJECTIVE[DISEASE]/I_GENE
. O O

Proteins O B_BIO/B_GENE
involved O O
in O O
cytoskeleton O B_DISEASE/B_GENE
organisation O I_DISEASE/I_GENE
were O O
only O O
up O O
- O O
regulated O O
in O O
the O O
- O O
6 O B_PERSON/B_MEASURE
^ O I_PERSON/I_MEASURE
0C O I_PERSON/I_MEASURE
animals O I_PERSON/I_MEASURE
. O O

The O O
pyrokinin O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
/ O O
pheromone O B_BODY_PART_OR_ORGAN_COMPONENT/B_DISEASE_ADJECTIVE[DISEASE]
biosynthesis O I_BODY_PART_OR_ORGAN_COMPONENT/I_DISEASE_ADJECTIVE[DISEASE]
- O O
activating O O
neuropeptide O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
( O O
PBAN O B_GENE/B_LOCATION
) O O
family O B_PERSON/B_LOCATION
of O O
peptides O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
and O O
their O O
receptors O B_BIO/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
in O O
Insecta O B_SPECIES[BIO]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
: O O
evolutionary O B_SPECIES[BIO]/B_LOCATION
trace O I_SPECIES[BIO]/I_LOCATION
indicates O O
potential O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
receptor O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
ligand O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
- O O
binding O O
domains O B_LOCATION
. O O

The O O
pyrokinin O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
/ O O
pheromone O B_DISEASE_ADJECTIVE[DISEASE]/B_BODY_PART_OR_ORGAN_COMPONENT
biosynthesis O B_DISEASE_ADJECTIVE[DISEASE]/I_BODY_PART_OR_ORGAN_COMPONENT
- O O
activating O O
neuropeptide O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
( O O
PBAN O B_LOCATION/B_ORGANIZATION
) O O
family O B_PERSON/B_LOCATION
of O O
G O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
- O O
protein O B_PROTEIN[GENE]/B_BACTERIUM[BIO]
- O O
coupled O O
receptors O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PROTEIN[GENE]
and O O
their O O
ligands O B_PERSON/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
have O O
been O O
identified O O
in O O
various O B_SPECIES[BIO]/B_DISEASE_ADJECTIVE[DISEASE]
insects O I_SPECIES[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
. O O

Physiological O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
functions O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
of O O
pyrokinin O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
peptides O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
include O O
muscle O B_DISEASE_ADJECTIVE[DISEASE]/B_ORGANISM_FUNCTION
contraction O B_DISEASE_ADJECTIVE[DISEASE]/I_ORGANISM_FUNCTION
, O O
whereas O O
PBAN O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
regulates O O
, O O
among O O
other O B_PERSON/B_LOCATION
functions O I_PERSON/I_LOCATION
, O O
pheromone O B_DISEASE_ADJECTIVE[DISEASE]/B_ORGANISM_FUNCTION
production O B_DISEASE_ADJECTIVE[DISEASE]/I_ORGANISM_FUNCTION
in O O
moths O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
which O O
indicates O O
the O O
pleiotropic O B_DISEASE_ADJECTIVE[DISEASE]/B_ORGANIZATION
nature O I_DISEASE_ADJECTIVE[DISEASE]/I_ORGANIZATION
of O O
these O O
peptides O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

Based O O
on O O
the O O
alignment O B_LOCATION/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
annotated O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
genomic O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
sequences O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
, O O
the O O
pyrokinin O B_GENE/B_LOCATION
/ O O
PBAN O B_GENE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
family O I_GENE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
receptors O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
have O O
similarity O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
with O O
the O O
corresponding O B_LOCATION/B_DISEASE_ADJECTIVE[DISEASE]
structures O I_LOCATION/I_DISEASE_ADJECTIVE[DISEASE]
of O O
the O O
capa O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
or O O
periviscerokinin O B_BODY_PART_OR_ORGAN_COMPONENT/B_DISEASE_ADJECTIVE[DISEASE]
receptors O I_BODY_PART_OR_ORGAN_COMPONENT/I_DISEASE_ADJECTIVE[DISEASE]
of O O
insects O B_SPECIES[BIO]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
the O O
neuromedin O B_BIO/B_GENE
U O I_BIO/I_GENE
receptors O I_BIO/I_GENE
of O O
vertebrates O B_SPECIES[BIO]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

In O O
our O O
study O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
, O O
evolutionary O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
trace O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_BIO
( O O
ET O B_LOCATION/B_BIO
) O O
analysis O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
on O O
the O O
insect O B_GENE/B_BIO
receptor O I_GENE/I_BIO
sequences O I_GENE/I_BIO
was O O
conducted O O
to O O
predict O O
the O O
putative O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
ligand O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
recognition O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
binding O B_MEASURE/B_DISEASE_ADJECTIVE[DISEASE]
sites O I_MEASURE/I_DISEASE_ADJECTIVE[DISEASE]
. O O

The O O
ET O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
analysis O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
of O O
four O B_BODY_PART_OR_ORGAN_COMPONENT
class O I_BODY_PART_OR_ORGAN_COMPONENT
- O O
specific O B_PROTEIN[GENE]/B_DISEASE_ADJECTIVE[DISEASE]
receptors O I_PROTEIN[GENE]/I_DISEASE_ADJECTIVE[DISEASE]
indicated O O
several O B_LOCATION/B_PERSON
amino O I_LOCATION/I_PERSON
acid O I_LOCATION/I_PERSON
residues O I_LOCATION/I_PERSON
that O O
are O O
conserved O O
in O O
the O O
transmembrane O B_PROTEIN[GENE]/B_LOCATION
domains O I_PROTEIN[GENE]/I_LOCATION
. O O

The O O
receptor O B_PROTEIN[GENE]/B_LOCATION
extracellular O I_PROTEIN[GENE]/I_LOCATION
domains O I_PROTEIN[GENE]/I_LOCATION
exhibit O O
several O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PROTEIN[GENE]
class O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PROTEIN[GENE]
- O O
specific O B_DISEASE_ADJECTIVE[DISEASE]/B_LOCATION
amino O I_DISEASE_ADJECTIVE[DISEASE]/I_LOCATION
acid O I_DISEASE_ADJECTIVE[DISEASE]/I_LOCATION
residues O I_DISEASE_ADJECTIVE[DISEASE]/I_LOCATION
, O O
which O O
could O O
indicate O O
putative O B_LOCATION/B_MEASURE
domains O I_LOCATION/I_MEASURE
for O O
activation O B_GENE/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
of O O
these O O
receptors O B_BIO/B_GENE
by O O
ligand O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_DISEASE_ADJECTIVE[DISEASE]
recognition O I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/I_DISEASE_ADJECTIVE[DISEASE]
and O O
binding O B_TIME[MEASURE]/B_GENE
. O O

acon O O
- O O
3 O O
, O O
the O O
Neurospora B B_SPECIES[BIO]
crassa I I_SPECIES[BIO]
ortholog O O
of O O
the O O
developmental O O
modifier O O
, O O
medA O O
, O O
complements O O
the O O
conidiation O O
defect O O
of O O
the O O
Aspergillus B B_SPECIES[BIO]/B_DISEASE_ADJECTIVE[DISEASE]
nidulans I B_SPECIES[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
mutant O O
. O O

Aspergillus B B_BACTERIUM[BIO]
nidulans I I_BACTERIUM[BIO]
and O O
Neurospora B B_SPECIES[BIO]
crassa I I_SPECIES[BIO]
are O O
ascomycetes O O
that O O
produce O O
asexual O O
spores O O
through O O
morphologically O O
distinct O O
processes O O
. O O

MedA O O
, O O
a O O
protein O O
with O O
unknown O O
function O O
, O O
is O O
required O O
for O O
normal O O
asexual O O
and O O
sexual O O
development O O
in O O
A B B_SPECIES[BIO]/B_PERSON
. I I_SPECIES[BIO]/I_PERSON
nidulans I I_SPECIES[BIO]/I_PERSON
. O O

We O O
determined O O
that O O
the O O
N B B_SPECIES[BIO]
. I I_SPECIES[BIO]
crassa I I_SPECIES[BIO]
ortholog O O
of O O
medA O O
is O O
acon O O
- O O
3 O O
, O O
a O O
gene O O
required O O
for O O
early O O
conidiophore O O
development O O
and O O
female O O
fertility O O
. O O

To O O
test O O
hypotheses O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
about O O
the O O
evolutionary O B_LOCATION/B_DISEASE_ADJECTIVE[DISEASE]
origins O I_LOCATION/I_DISEASE_ADJECTIVE[DISEASE]
of O O
asexual O B_DISEASE_ADJECTIVE[DISEASE]/B_GENE
development O B_DISEASE_ADJECTIVE[DISEASE]/I_GENE
in O O
distinct O B_SPECIES[BIO]/B_DISEASE_ADJECTIVE[DISEASE]
fungal O I_SPECIES[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
lineages O I_SPECIES[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
it O O
is O O
important O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
to O O
understand O O
the O O
degree O B_LOCATION/B_DISEASE_ADJECTIVE[DISEASE]
of O O
conservation O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANISM_FUNCTION
of O O
developmental O B_DISEASE_ADJECTIVE[DISEASE]/B_BIO
regulators O B_DISEASE_ADJECTIVE[DISEASE]/I_BIO
. O O

The O O
amino O O
acid O O
sequences O O
of O O
A B B_SPECIES[BIO]
. I I_SPECIES[BIO]
nidulans I I_SPECIES[BIO]
MedA O O
and O O
N B B_BACTERIUM[BIO]/B_GENE
. I I_BACTERIUM[BIO]/I_GENE
crassa I I_BACTERIUM[BIO]/I_GENE
ACON O O
- O O
3 O O
shared O O
37 O O
% O O
identity O O
and O O
51 O O
% O O
similarity O O
. O O

acon O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
- O O
3 O B_TIME[MEASURE]
is O O
induced O O
at O O
late O B_TIME[MEASURE]/B_LOCATION
time O I_TIME[MEASURE]/I_LOCATION
points O I_TIME[MEASURE]/I_LOCATION
of O O
conidiation O B_DISEASE_ADJECTIVE[DISEASE]/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
. O O

In O O
contrast O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
, O O
medA O B_GENE/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
is O O
constitutively O O
expressed O O
and O O
MedA O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_DISEASE_ADJECTIVE[DISEASE]
protein O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/I_DISEASE_ADJECTIVE[DISEASE]
localizes O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/I_DISEASE_ADJECTIVE[DISEASE]
to O O
nuclei O O
in O O
all O O
tissue O B_BIO/B_CELL[BODY_PART_OR_ORGAN_COMPONENT]
types O B_BIO/I_CELL[BODY_PART_OR_ORGAN_COMPONENT]
. O O

Nonetheless O O
, O O
expression O O
of O O
acon O O
- O O
3 O O
using O O
its O O
native O O
promoter O O
complemented O O
the O O
conidiation O O
defects O O
of O O
the O O
A B B_SPECIES[BIO]/B_MEASURE
. I B_SPECIES[BIO]/I_MEASURE
nidulans I B_SPECIES[BIO]/I_MEASURE
DeltamedA O O
and O O
medA15 O O
mutants O O
. O O

We O O
conclude O O
that O O
the O O
biochemical O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
activity O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
of O O
the O O
medA O B_ENZYME[GENE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
orthologs O I_ENZYME[GENE]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
is O O
conserved O O
for O O
conidiation O B_SPECIES[BIO]/B_DISEASE_ADJECTIVE[DISEASE]
. O O

Towards O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_TIME[MEASURE]
achievement O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_TIME[MEASURE]
of O O
universal O B_PERSON/B_LOCATION
health O I_PERSON/I_LOCATION
care O I_PERSON/I_LOCATION
in O O
India O B_LOCATION
by O O
2020 O B_MEASURE/B_ORGANIZATION
: O O
a O O
call O B_GENE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
to O O
action O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
. O O

To O O
sustain O O
the O O
positive O B_DISEASE_ADJECTIVE[DISEASE]
economic O I_DISEASE_ADJECTIVE[DISEASE]
trajectory O I_DISEASE_ADJECTIVE[DISEASE]
that O O
India O B_LOCATION
has O O
had O O
during O O
the O O
past O B_TIME[MEASURE]/B_DISEASE
decade O I_TIME[MEASURE]/I_DISEASE
, O O
and O O
to O O
honour O O
the O O
fundamental O B_PERSON/B_LOCATION
right O I_PERSON/I_LOCATION
of O O
all O O
citizens O B_PERSON/B_LOCATION
to O O
adequate O B_TIME[MEASURE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
health O I_TIME[MEASURE]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
care O I_TIME[MEASURE]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
the O O
health O B_PERSON/B_LOCATION
of O O
all O O
Indian O B_PERSON/B_LOCATION
people O I_PERSON/I_LOCATION
has O O
to O O
be O O
given O O
the O O
highest O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
priority O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
in O O
public O B_ORGANIZATION/B_LOCATION
policy O I_ORGANIZATION/I_LOCATION
. O O

We O O
propose O O
the O O
creation O O
of O O
the O O
Integrated O O
National O O
Health O O
System O O
in O O
India O O
through O O
provision O O
of O O
universal O O
health O O
insurance O O
, O O
establishment O O
of O O
autonomous O O
organisations O O
to O O
enable O O
accountable O O
and O O
evidence O O
- O O
based O O
good O O
- O O
quality O O
health O O
- O O
care O O
practices O O
and O O
development O O
of O O
appropriately O O
trained O O
human B B_PERSON/B_SPECIES[BIO]
resources O O
, O O
the O O
restructuring O O
of O O
health O O
governance O O
to O O
make O O
it O O
coordinated O O
and O O
decentralised O O
, O O
and O O
legislation O O
of O O
health O O
entitlement O O
for O O
all O O
Indian O O
people O O
. O O

The O O
key O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
characteristics O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
of O O
our O O
proposal O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANIZATION
are O O
to O O
strengthen O O
the O O
public O B_ORGANIZATION/B_LOCATION
health O I_ORGANIZATION/I_LOCATION
system O I_ORGANIZATION/I_LOCATION
as O O
the O O
primary O B_LOCATION/B_PERSON
provider O B_LOCATION/I_PERSON
of O O
promotive O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
preventive O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
, O O
and O O
curative O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_PERSON
health O I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/I_PERSON
services O I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/I_PERSON
in O O
India O B_LOCATION
, O O
to O O
improve O O
quality O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
and O O
reduce O O
the O O
out O O
- O O
of O O
- O O
pocket O B_MEASURE/B_LOCATION
expenditure O B_MEASURE/I_LOCATION
on O O
health O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
care O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
through O O
a O O
well O O
regulated O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_ORGANIZATION
integration O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/I_ORGANIZATION
of O O
the O O
private O B_LOCATION/B_ORGANIZATION
sector O I_LOCATION/I_ORGANIZATION
within O O
the O O
national O B_PERSON/B_LOCATION
health O I_PERSON/I_LOCATION
- O O
care O B_ORGANIZATION/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
system O I_ORGANIZATION/I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
. O O

Dialogue O B_TIME[MEASURE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
consensus O B_LOCATION/B_ORGANIZATION
building O I_LOCATION/I_ORGANIZATION
among O O
the O O
stakeholders O B_PERSON/B_LOCATION
in O O
the O O
government O B_ORGANIZATION/B_LOCATION
, O O
civil O B_ORGANIZATION/B_PERSON
society O I_ORGANIZATION/I_PERSON
, O O
and O O
private O B_ORGANIZATION/B_PERSON
sector O I_ORGANIZATION/I_PERSON
are O O
the O O
next O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
steps O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
to O O
formalise O O
the O O
actions O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANIZATION
needed O O
and O O
to O O
monitor O O
their O O
achievement O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

In O O
our O O
call O B_GENE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
to O O
action O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
, O O
we O O
propose O O
that O O
India O B_LOCATION/B_PERSON
must O O
achieve O O
health O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
care O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
for O O
all O O
by O O
2020 O B_MEASURE/B_ORGANIZATION
. O O

Financing O B_PERSON/B_ORGANIZATION
health O I_PERSON/I_ORGANIZATION
care O I_PERSON/I_ORGANIZATION
for O O
all O O
: O O
challenges O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
opportunities O B_LOCATION/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

India O B_LOCATION
' O I_LOCATION
s O O
health O B_DISEASE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
financing O I_DISEASE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
system O I_DISEASE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
is O O
a O O
cause O B_PERSON/B_DISEASE
of O O
and O O
an O O
exacerbating O O
factor O B_MEASURE/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
in O O
the O O
challenges O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
health O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
inequity O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE
, O O
inadequate O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
availability O I_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
and O O
reach O B_MEASURE/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
unequal O B_DISEASE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
access O I_DISEASE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
and O O
poor O B_DISEASE_ADJECTIVE[DISEASE]/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- O O
quality O B_MEASURE/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
costly O B_DISEASE_ADJECTIVE[DISEASE]/B_PERSON
health O I_DISEASE_ADJECTIVE[DISEASE]/I_PERSON
- O O
care O B_ORGANIZATION/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
services O I_ORGANIZATION/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

Low O B_MEASURE/B_DISEASE_ADJECTIVE[DISEASE]
per O O
person O B_MEASURE
spending O I_MEASURE
on O O
health O B_PERSON/B_ORGANIZATION
and O O
insufficient O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
public O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE
expenditure O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE
result O O
in O O
one O B_NUMBER[MEASURE]/B_LOCATION
of O O
the O O
highest O B_MEASURE/B_PERSON
proportions O I_MEASURE/I_PERSON
of O O
private O B_PERSON
out O O
- O O
of O O
- O O
pocket O B_MEASURE/B_LOCATION
expenses O B_MEASURE/I_LOCATION
in O O
the O O
world O B_LOCATION/B_ORGANIZATION
. O O

Citizens O B_PERSON
receive O O
low O B_MEASURE/B_PERSON
value O B_MEASURE/I_PERSON
for O O
money O B_ORGANIZATION/B_PERSON
in O O
the O O
public O B_ORGANIZATION/B_LOCATION
and O O
the O O
private O B_ORGANIZATION/B_LOCATION
sectors O I_ORGANIZATION/I_LOCATION
. O O

Financial O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
protection O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE
against O O
medical O B_DISEASE
expenditures O I_DISEASE
is O O
far O O
from O O
universal O B_ORGANIZATION/B_DISEASE_ADJECTIVE[DISEASE]
with O O
only O O
10 O B_MEASURE/B_PERSON
% O I_MEASURE/I_PERSON
of O O
the O O
population O B_PERSON/B_LOCATION
having O O
medical O B_PERSON/B_ORGANIZATION
insurance O I_PERSON/I_ORGANIZATION
. O O

The O O
Government O B_ORGANIZATION/B_PERSON
of O O
India O B_LOCATION
has O O
made O O
a O O
commitment O B_PERSON/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
to O O
increase O O
public O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
spending O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
on O O
health O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
from O O
less O B_MEASURE/B_DISEASE_ADJECTIVE[DISEASE]
than O O
1 O B_NUMBER[MEASURE]/B_LOCATION
% O I_NUMBER[MEASURE]/I_LOCATION
to O O
3 O B_MEASURE/B_LOCATION
% O I_MEASURE/I_LOCATION
of O O
the O O
gross O B_MEASURE/B_ORGANIZATION
domestic O I_MEASURE/I_ORGANIZATION
product O I_MEASURE/I_ORGANIZATION
during O O
the O O
next O B_TIME[MEASURE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
few O I_TIME[MEASURE]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
years O I_TIME[MEASURE]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

Increased O O
public O B_ORGANIZATION/B_PERSON
funding O I_ORGANIZATION/I_PERSON
combined O O
with O O
flexibility O B_MEASURE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
financial O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANIZATION
transfers O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_ORGANIZATION
from O O
centre O B_LOCATION/B_ORGANIZATION
to O O
state O B_LOCATION/B_ORGANIZATION
can O O
greatly O O
improve O O
the O O
performance O B_PERSON/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
state O B_LOCATION/B_ORGANIZATION
- O O
operated O O
public O B_ORGANIZATION/B_LOCATION
systems O I_ORGANIZATION/I_LOCATION
. O O

Enhanced O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
public O B_ORGANIZATION/B_PERSON
spending O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_ORGANIZATION
can O O
be O O
used O O
to O O
introduce O O
universal O B_ORGANIZATION/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
medical O I_ORGANIZATION/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
insurance O I_ORGANIZATION/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
that O O
can O O
help O O
to O O
substantially O O
reduce O O
the O O
burden O B_DISEASE/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
private O B_PERSON/B_DISEASE_ADJECTIVE[DISEASE]
out O O
- O O
of O O
- O O
pocket O B_LOCATION/B_MEASURE
expenditures O I_LOCATION/I_MEASURE
on O O
health O B_PERSON/B_ORGANIZATION
. O O

Increased O O
public O B_MEASURE/B_ORGANIZATION
spending O B_MEASURE/I_ORGANIZATION
can O O
also O O
contribute O O
to O O
quality O B_DISEASE_ADJECTIVE[DISEASE]/B_ORGANIZATION
assurance O I_DISEASE_ADJECTIVE[DISEASE]/I_ORGANIZATION
in O O
the O O
public O B_ORGANIZATION/B_LOCATION
and O O
private O B_ORGANIZATION/B_LOCATION
sectors O I_ORGANIZATION/I_LOCATION
through O O
effective O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANIZATION
regulation O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_ORGANIZATION
and O O
oversight O B_PERSON/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

In O O
addition O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
to O O
an O O
increase O B_DISEASE_ADJECTIVE[DISEASE]/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
in O O
public O B_DISEASE_ADJECTIVE[DISEASE]/B_ORGANIZATION
expenditures O I_DISEASE_ADJECTIVE[DISEASE]/I_ORGANIZATION
on O O
health O B_PERSON/B_LOCATION
, O O
the O O
Government O B_ORGANIZATION/B_PERSON
of O O
India O B_LOCATION/B_PERSON
will O I_LOCATION/I_PERSON
, O O
however O O
, O O
need O O
to O O
introduce O O
specific O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANIZATION
methods O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_ORGANIZATION
to O O
contain O O
costs O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
, O O
improve O O
the O O
efficiency O B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANIZATION
of O O
spending O B_PERSON/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
increase O O
accountability O B_DISEASE_ADJECTIVE[DISEASE]/B_ORGANIZATION
, O O
and O O
monitor O O
the O O
effect O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
expenditures O B_DISEASE/B_ORGANIZATION
on O O
health O B_PERSON/B_ORGANIZATION
. O O

Continuing O O
challenge O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
of O O
infectious O B_DISEASE/B_PERSON
diseases O I_DISEASE/I_PERSON
in O O
India O B_LOCATION
. O O

In O O
India O B_LOCATION
, O O
the O O
range O B_MEASURE/B_DISEASE_ADJECTIVE[DISEASE]
and O O
burden O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
of O O
infectious O B_DISEASE
diseases O I_DISEASE
are O O
enormous O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
. O O

The O O
administrative O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANIZATION
responsibilities O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_ORGANIZATION
of O O
the O O
health O B_ORGANIZATION/B_LOCATION
system O I_ORGANIZATION/I_LOCATION
are O O
shared O O
between O O
the O O
central O B_LOCATION/B_ORGANIZATION
( O O
federal O B_ORGANIZATION/B_LOCATION
) O O
and O O
state O B_LOCATION/B_ORGANIZATION
governments O I_LOCATION/I_ORGANIZATION
. O O

Control O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
diseases O B_DISEASE
and O O
outbreaks O B_DISEASE
is O O
the O O
responsibility O B_PERSON/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
the O O
central O B_ORGANIZATION/B_PERSON
Ministry O I_ORGANIZATION/I_PERSON
of O O
Health O B_PERSON/B_ORGANIZATION
, O O
which O O
lacks O O
a O O
formal O B_ORGANIZATION/B_LOCATION
public O I_ORGANIZATION/I_LOCATION
health O I_ORGANIZATION/I_LOCATION
department O I_ORGANIZATION/I_LOCATION
for O O
this O O
purpose O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
. O O

Tuberculosis O O
, O O
malaria O O
, O O
filariasis O O
, O O
visceral O O
leishmaniasis O O
, O O
leprosy O O
, O O
HIV B B_DISEASE
infection O O
, O O
and O O
childhood O O
cluster O O
of O O
vaccine O O
- O O
preventable O O
diseases O O
are O O
given O O
priority O O
for O O
control O O
through O O
centrally O O
managed O O
vertical O O
programmes O O
. O O

Control O O
of O O
HIV B B_DISEASE
infection O O
and O O
leprosy O O
, O O
but O O
not O O
of O O
tuberculosis O O
, O O
seems O O
to O O
be O O
on O O
track O O
. O O

Early O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
success O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
of O O
malaria O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_DISEASE
control O I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/I_DISEASE
was O O
not O O
sustained O O
, O O
and O O
visceral O B_DISEASE_ADJECTIVE[DISEASE]
leishmaniasis O I_DISEASE_ADJECTIVE[DISEASE]
prevalence O I_DISEASE_ADJECTIVE[DISEASE]
has O O
increased O O
. O O

Inadequate O O
containment O O
of O O
the O O
vector O O
has O O
resulted O O
in O O
recurrent O O
outbreaks O O
of O O
dengue O O
fever O O
and O O
re O O
- O O
emergence O O
of O O
Chikungunya B B_DISEASE_ADJECTIVE[DISEASE]/B_BIO
virus I I_DISEASE_ADJECTIVE[DISEASE]/I_BIO
disease O O
and O O
typhus O O
fever O O
. O O

Other O O
infectious O O
diseases O O
caused O O
by O O
faecally O O
transmitted O O
pathogens O O
( O O
enteric O O
fevers O O
, O O
cholera O O
, O O
hepatitis B B_DISEASE/B_PROTEIN[GENE]
A I B_DISEASE/I_PROTEIN[GENE]
and O O
E B B_VIRUS[BIO]/B_LOCATION
viruses I I_VIRUS[BIO]/I_LOCATION
) O O
and O O
zoonoses O O
( O O
rabies O O
, O O
leptospirosis O O
, O O
anthrax O O
) O O
are O O
not O O
in O O
the O O
process O O
of O O
being O O
systematically O O
controlled O O
. O O

Big O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
gaps O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
in O O
the O O
surveillance O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
and O O
response O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_PERSON
system O I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/I_PERSON
for O O
infectious O B_DISEASE/B_PERSON
diseases O I_DISEASE/I_PERSON
need O O
to O O
be O O
addressed O O
. O O

Replication O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
of O O
the O O
model O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
of O O
vertical O B_DISEASE
single O I_DISEASE
- O O
disease O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
control O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE
for O O
all O O
infectious O B_DISEASE_ADJECTIVE[DISEASE]/B_PERSON
diseases O I_DISEASE_ADJECTIVE[DISEASE]/I_PERSON
will O O
not O O
be O O
efficient O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
or O O
viable O B_DISEASE_ADJECTIVE[DISEASE]/B_PROTEIN[GENE]
. O O

India O B_LOCATION
needs O O
to O O
rethink O O
and O O
revise O O
its O O
health O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
policy O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
to O O
broaden O O
the O O
agenda O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
of O O
disease O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
control O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
. O O

A O O
comprehensive O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_TIME[MEASURE]
review O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_TIME[MEASURE]
and O O
redesign O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
the O O
health O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANIZATION
system O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_ORGANIZATION
is O O
needed O O
urgently O O
to O O
ensure O O
equity O B_PERSON/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
quality O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
in O O
health O B_PERSON/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
care O I_PERSON/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

We O O
recommend O O
the O O
creation O B_TIME[MEASURE]/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
of O O
a O O
functional O B_LOCATION/B_ORGANIZATION
public O I_LOCATION/I_ORGANIZATION
health O I_LOCATION/I_ORGANIZATION
infrastructure O I_LOCATION/I_ORGANIZATION
that O O
is O O
shared O O
between O O
central O B_LOCATION/B_ORGANIZATION
and O O
state O B_LOCATION
governments O I_LOCATION
, O O
with O O
professional O B_PERSON
leadership O I_PERSON
and O O
a O O
formally O O
trained O O
public O B_ORGANIZATION/B_PERSON
health O B_ORGANIZATION/I_PERSON
cadre O B_ORGANIZATION/I_PERSON
of O O
personnel O B_PERSON
who O O
manage O O
an O O
integrated O B_LOCATION/B_DISEASE_ADJECTIVE[DISEASE]
control O B_LOCATION/I_DISEASE_ADJECTIVE[DISEASE]
mechanism O B_LOCATION/I_DISEASE_ADJECTIVE[DISEASE]
of O O
diseases O B_DISEASE
in O O
districts O B_LOCATION/B_PERSON
that O O
includes O O
infectious O B_DISEASE
and O O
non O B_DISEASE/B_MEASURE
- O O
infectious O B_DISEASE_ADJECTIVE[DISEASE]/B_BIO
diseases O I_DISEASE_ADJECTIVE[DISEASE]/I_BIO
, O O
and O O
injuries O B_DISEASE
. O O

ATP O O
citrate O O
lyase O O
is O O
required O O
for O O
normal O O
sexual O O
and O O
asexual O O
development O O
in O O
Gibberella B B_SPECIES[BIO]/B_PERSON
zeae I I_SPECIES[BIO]/I_PERSON
. O O

Adenosine O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
triphosphate O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
( O O
ATP O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
) O O
citrate O B_ENZYME[GENE]
lyase O I_ENZYME[GENE]
( O O
ACL O B_DISEASE/B_LOCATION
) O O
is O O
a O O
key O B_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
enzyme O I_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_BIO
in O O
the O O
production O B_PHYSIOLOGIC_FUNCTION[ORGANISM_FUNCTION]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
cytosolic O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
acetyl O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
- O O
CoA O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
, O O
which O O
is O O
crucial O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
for O O
de O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
novo O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
lipid O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
synthesis O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
and O O
histone O B_PHYSIOLOGIC_FUNCTION[ORGANISM_FUNCTION]/B_DISEASE_ADJECTIVE[DISEASE]
acetylation O I_PHYSIOLOGIC_FUNCTION[ORGANISM_FUNCTION]/I_DISEASE_ADJECTIVE[DISEASE]
in O O
mammalian O B_CELL[BODY_PART_OR_ORGAN_COMPONENT]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
cells O I_CELL[BODY_PART_OR_ORGAN_COMPONENT]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

In O O
this O O
study O O
, O O
we O O
characterized O O
the O O
mechanistic O O
roles O O
of O O
ACL O O
in O O
the O O
homothallic O O
ascomycete O O
fungus O O
Gibberella B B_SPECIES[BIO]
zeae I I_SPECIES[BIO]
, O O
which O O
causes O O
Fusarium O O
head O O
blight O O
in O O
major O O
cereal O O
crops O O
. O O

Deletion O B_DISEASE_ADJECTIVE[DISEASE]/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
of O O
ACL O B_GENE/B_DISEASE
in O O
the O O
fungus O B_SPECIES[BIO]
resulted O O
in O O
a O O
complete O B_DISEASE_ADJECTIVE[DISEASE]/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
loss O I_DISEASE_ADJECTIVE[DISEASE]/I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
of O O
self O B_PERSON/B_BIO
and O O
female O B_DISEASE_ADJECTIVE[DISEASE]/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
fertility O I_DISEASE_ADJECTIVE[DISEASE]/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
as O O
well O O
as O O
a O O
reduction O B_DISEASE_ADJECTIVE[DISEASE]/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
in O O
asexual O B_DISEASE/B_ORGANISM_FUNCTION
reproduction O I_DISEASE/I_ORGANISM_FUNCTION
, O O
virulence O B_DISEASE/B_ORGANISM_FUNCTION
, O O
and O O
trichothecene O B_DISEASE/B_BIO
production O I_DISEASE/I_BIO
. O O

When O O
the O O
wild O B_BIO/B_PROTEIN[GENE]
- O O
type O B_MEASURE/B_BIO
strain O I_MEASURE/I_BIO
was O O
spermatized O O
with O O
the O O
ACL O B_DISEASE_ADJECTIVE[DISEASE]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
deletion O B_DISEASE_ADJECTIVE[DISEASE]/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
mutants O B_DISEASE_ADJECTIVE[DISEASE]/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
they O O
produced O O
viable O B_BIO/B_DISEASE
ascospores O B_BIO/I_DISEASE
, O O
however O O
ascospore O B_DISEASE_ADJECTIVE[DISEASE]/B_ORGANISM_FUNCTION
delimitation O B_DISEASE_ADJECTIVE[DISEASE]/I_ORGANISM_FUNCTION
was O O
not O O
properly O O
regulated O O
. O O

Although O O
lipid O B_ORGANISM_FUNCTION/B_GENE
synthesis O I_ORGANISM_FUNCTION/I_GENE
was O O
not O O
affected O O
by O O
ACL O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
deletion O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
, O O
histone O B_GENE/B_ORGANISM_FUNCTION
acetylation O B_GENE/I_ORGANISM_FUNCTION
was O O
dramatically O O
reduced O O
in O O
the O O
ACL O B_BODY_PART_OR_ORGAN_COMPONENT/B_DISEASE_ADJECTIVE[DISEASE]
deletion O I_BODY_PART_OR_ORGAN_COMPONENT/I_DISEASE_ADJECTIVE[DISEASE]
mutants O I_BODY_PART_OR_ORGAN_COMPONENT/I_DISEASE_ADJECTIVE[DISEASE]
during O O
sexual O B_ORGANISM_FUNCTION/B_DISEASE_ADJECTIVE[DISEASE]
development O I_ORGANISM_FUNCTION/I_DISEASE_ADJECTIVE[DISEASE]
, O O
suggesting O O
that O O
the O O
defects O B_DISEASE_ADJECTIVE[DISEASE]
in O O
sexual O B_ORGANISM_FUNCTION/B_DISEASE_ADJECTIVE[DISEASE]
reproduction O I_ORGANISM_FUNCTION/I_DISEASE_ADJECTIVE[DISEASE]
were O O
caused O O
by O O
the O O
reduction O B_DISEASE_ADJECTIVE[DISEASE]
in O O
histone O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
acetylation O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
. O O

This O O
study O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANIZATION
is O O
the O O
first O B_SEQUENCE[MEASURE]
report O I_SEQUENCE[MEASURE]
demonstrating O O
a O O
link O B_PERSON/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
between O O
sexual O B_DISEASE/B_GENE
development O B_DISEASE/I_GENE
and O O
ACL O B_GENE/B_DISEASE
- O O
mediated O O
histone O B_DISEASE/B_GENE
acetylation O I_DISEASE/I_GENE
in O O
fungi O B_BIO/B_BODY_PART_OR_ORGAN_COMPONENT
. O O

Expression O O
of O O
a O O
Brassica B B_BIO
napus I I_BIO
heme O O
oxygenase O O
confers O O
plant O O
tolerance O O
to O O
mercury O O
toxicity O O
. O O

Plant O B_LOCATION/B_DISEASE_ADJECTIVE[DISEASE]
heme O B_LOCATION/I_DISEASE_ADJECTIVE[DISEASE]
oxygenases O I_PERSON
( O O
HOs O B_GENE/B_MEASURE
) O O
regulate O O
biosynthesis O B_PHYSIOLOGIC_FUNCTION[ORGANISM_FUNCTION]/B_ENZYME[GENE]
of O O
phytochrome O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
which O O
accounts O O
for O O
photo O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
- O O
acceptance O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PHYSIOLOGIC_FUNCTION[ORGANISM_FUNCTION]
and O O
- O O
morphogenesis O B_DISEASE/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
. O O

Recent O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
studies O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
have O O
demonstrated O O
that O O
plant O B_BIO/B_GENE
HOs O I_BIO
also O O
regulate O O
many O B_DISEASE_ADJECTIVE[DISEASE]/B_ORGANISM_FUNCTION
other O B_DISEASE_ADJECTIVE[DISEASE]/I_ORGANISM_FUNCTION
physiological O B_DISEASE_ADJECTIVE[DISEASE]/I_ORGANISM_FUNCTION
processes O B_DISEASE_ADJECTIVE[DISEASE]/I_ORGANISM_FUNCTION
including O O
response O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
to O O
environmental O B_DISEASE_ADJECTIVE[DISEASE]
stimuli O I_DISEASE_ADJECTIVE[DISEASE]
. O O

To O O
elucidate O O
the O O
mechanism O O
by O O
which O O
HOs O O
regulate O O
plant O O
adaptation O O
to O O
heavy O O
metal O O
exposure O O
, O O
three O O
novel O O
HOs O O
genes O O
were O O
isolated O O
from O O
rapeseed B B_BIO/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
( O O
Brassica B B_BIO/B_LOCATION
napus I B_BIO/I_LOCATION
) O O
and O O
their O O
expression O O
patterns O O
were O O
analysed O O
. O O

Alignment O O
of O O
deduced O O
protein O O
sequences O O
revealed O O
that O O
the O O
three O O
BnHOs O O
share O O
high O O
identity O O
with O O
their O O
corresponding O O
orthologos O O
( O O
AtHO1 O O
- O O
3 O O
) O O
from O O
Arabidopsis B B_BIO
. O O

To O O
investigate O O
whether O O
the O O
BnHO O O
regulates O O
plant O O
tolerance O O
to O O
Hg O O
toxicity O O
, O O
we O O
constructed O O
B B B_BIO/B_NUMBER[MEASURE]
. I B_BIO/I_NUMBER[MEASURE]
napus I B_BIO/I_NUMBER[MEASURE]
transgenic O O
plants O O
overexpressing O O
BnHO O O
- O O
1 O O
. O O

Under O O
Hg O B_DISEASE_ADJECTIVE[DISEASE]/B_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
stress O B_DISEASE_ADJECTIVE[DISEASE]/I_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
the O O
transgenic O B_BIO
plants O I_BIO
had O O
1 O B_MEASURE/B_LOCATION
. O O
41 O B_MEASURE
- O O
1 O B_NUMBER[MEASURE]
. O O
59 O B_MEASURE
folds O I_MEASURE
higher O I_MEASURE
biomass O I_MEASURE
than O O
the O O
untransformants O B_MEASURE/B_DISEASE_ADJECTIVE[DISEASE]
. O O

However O O
, O O
overexpression O B_GENE/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
of O O
BnHO O B_DISEASE/B_GENE
- O O
1 O B_NUMBER[MEASURE]
resulted O O
in O O
less O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_DISEASE_ADJECTIVE[DISEASE]
accumulation O I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/I_DISEASE_ADJECTIVE[DISEASE]
of O O
Hg O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
in O O
some O O
lines O B_LOCATION/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
transformants O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
than O O
in O O
untransformants O B_BIO/B_MEASURE
. O O

The O O
transgenic O B_BIO/B_GENE
plants O I_BIO/I_GENE
show O O
lower O B_DISEASE_ADJECTIVE[DISEASE]/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
abundance O B_DISEASE_ADJECTIVE[DISEASE]/I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
of O O
reactive O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
oxygen O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
species O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
and O O
attenuated O O
oxidative O B_DISEASE/B_ORGANISM_FUNCTION
injury O I_DISEASE/I_ORGANISM_FUNCTION
compared O O
with O O
the O O
untransgenic O B_BIO/B_PERSON
plants O B_BIO/I_PERSON
. O O

We O O
cloned O O
the O O
promoter O O
sequences O O
of O O
BnHO O O
- O O
1 O O
from O O
B B B_SPECIES[BIO]
. I I_SPECIES[BIO]
napus I I_SPECIES[BIO]
. O O

Analysis O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
revealed O O
that O O
the O O
1119 O B_GENE/B_LOCATION
bp O I_GENE/I_LOCATION
fragment O I_GENE/I_LOCATION
contains O O
a O O
conserved O B_GENE/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
Cd O I_GENE/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
responsive O I_GENE/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
element O I_GENE/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
( O O
CdRE O B_LOCATION/B_ORGANIZATION
) O O
and O O
others O B_LOCATION/B_GENE
responding O O
to O O
multiple O B_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
environmental O I_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
stimuli O I_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
. O O

Transient O O
expression O O
in O O
tobacco B B_ORGANIZATION/B_BIO
leaves O O
showed O O
differential O O
responses O O
to O O
heavy O O
metals O O
( O O
Zn O O
, O O
Cu O O
, O O
Pb O O
, O O
Hg O O
and O O
Cd O O
) O O
. O O

The O O
rate O B_MEASURE/B_LOCATION
- O O
limiting O O
step O B_MEASURE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
for O O
CO O B_LOCATION/B_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
( O O
2 O B_NUMBER[MEASURE]/B_LOCATION
) O O
assimilation O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_PHYSIOLOGIC_FUNCTION[ORGANISM_FUNCTION]
at O O
different O B_DISEASE_ADJECTIVE[DISEASE]/B_BIO
temperatures O B_DISEASE_ADJECTIVE[DISEASE]/I_BIO
is O O
influenced O O
by O O
the O O
leaf O B_MEASURE/B_LOCATION
nitrogen O I_MEASURE/I_LOCATION
content O I_MEASURE/I_LOCATION
in O O
several O B_LOCATION/B_DISEASE_ADJECTIVE[DISEASE]
C O I_LOCATION/I_DISEASE_ADJECTIVE[DISEASE]
( O O
3 O B_NUMBER[MEASURE]/B_LOCATION
) O O
crop O B_BIO/B_LOCATION
species O B_BIO/I_LOCATION
. O O

Effects O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ENT
of O O
nitrogen O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
( O O
N O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
) O O
supply O B_ORGANIZATION/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
on O O
the O O
limiting O O
step O B_MEASURE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
CO O B_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
( O O
2 O B_NUMBER[MEASURE]/B_LOCATION
) O O
assimilation O B_MEASURE/B_LOCATION
rate O I_MEASURE/I_LOCATION
( O O
A O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PROTEIN[GENE]
) O O
at O O
380 O B_MEASURE/B_LOCATION
mumol O I_MEASURE/I_LOCATION
mol O I_MEASURE/I_LOCATION
( O O
- O O
1 O B_MEASURE
) O O
CO O B_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
( O O
2 O B_NUMBER[MEASURE]
) O O
concentration O B_MEASURE
( O O
A O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
( O O
380 O B_MEASURE/B_LOCATION
) O O
) O O
at O O
several O B_DISEASE_ADJECTIVE[DISEASE]/B_BIO
leaf O B_DISEASE_ADJECTIVE[DISEASE]/I_BIO
temperatures O B_DISEASE_ADJECTIVE[DISEASE]/I_BIO
were O O
studied O O
in O O
several O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
crops O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
, O O
since O O
N O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANISM_FUNCTION
nutrition O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_ORGANISM_FUNCTION
alters O O
N O B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
allocation O I_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
between O O
photosynthetic O B_BIO/B_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
components O I_BIO/I_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

Contents O B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
of O O
leaf O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
N O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
, O O
ribulose O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
1 O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
* O O
5 O B_MEASURE
- O O
bisphosphate O B_ENZYME[GENE]
carboxylase O I_ENZYME[GENE]
/ O O
oxygenase O B_ENZYME[GENE]/B_DISEASE
( O O
Rubisco O B_PERSON/B_PROTEIN[GENE]
) O O
and O O
cytochrome O B_ENZYME[GENE]/B_CELL_COMPONENT[BODY_PART_OR_ORGAN_COMPONENT]
f O O
( O O
cyt O B_PROTEIN[GENE]/B_LOCATION
f O O
) O O
increased O O
with O O
increasing O O
N O B_MEASURE
supply O I_MEASURE
, O O
but O O
the O O
cyt O B_CELL_COMPONENT[BODY_PART_OR_ORGAN_COMPONENT]/B_GENE
f O O
/ O O
Rubisco O B_MEASURE/B_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
ratio O B_MEASURE/I_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
decreased O O
. O O

Large O B_DISEASE/B_MEASURE
leaf O I_DISEASE/I_MEASURE
N O I_DISEASE/I_MEASURE
content O I_DISEASE/I_MEASURE
was O O
linked O O
to O O
a O O
high O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
stomatal O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
( O O
g O B_MEASURE/B_CELL[BODY_PART_OR_ORGAN_COMPONENT]
( O O
s O O
) O O
) O O
and O O
mesophyll O B_BIO/B_MEASURE
conductance O B_BIO/I_MEASURE
( O O
g O B_OTHER/B_PROTEIN[GENE]
( O O
m O B_MEASURE/B_DISEASE
) O O
) O O
, O O
but O O
resulted O O
in O O
a O O
lower O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
intercellular O I_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
( O O
C O B_OTHER/B_LOCATION
( O O
i O B_DISEASE/B_PROTEIN[GENE]
) O O
) O O
and O O
chloroplast O B_LOCATION/B_DISEASE_ADJECTIVE[DISEASE]
CO O I_LOCATION/I_DISEASE_ADJECTIVE[DISEASE]
( O O
2 O B_MEASURE/B_LOCATION
) O O
concentration O B_MEASURE/B_LOCATION
( O O
C O B_OTHER/B_LOCATION
( O O
c O B_PROTEIN[GENE]/B_DISEASE
) O O
) O O
because O O
the O O
increase O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
in O O
g O B_PROTEIN[GENE]/B_MEASURE
( O O
s O O
) O O
and O O
g O B_PROTEIN[GENE]/B_MEASURE
( O O
m O B_PROTEIN[GENE]/B_DISEASE
) O O
was O O
insufficient O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
to O O
compensate O O
for O O
change O B_MEASURE/B_DISEASE_ADJECTIVE[DISEASE]
in O O
A O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
( O O
380 O B_MEASURE/B_LOCATION
) O O
. O O

The O O
A O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- O O
C O B_PROTEIN[GENE]/B_MEASURE
( O O
c O B_MEASURE/B_DISEASE
) O O
response O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
was O O
used O O
to O O
estimate O O
the O O
maximum O B_MEASURE
rate O I_MEASURE
of O O
RuBP O B_LOCATION/B_PHYSIOLOGIC_FUNCTION[ORGANISM_FUNCTION]
carboxylation O B_LOCATION/I_PHYSIOLOGIC_FUNCTION[ORGANISM_FUNCTION]
( O O
V O B_MEASURE/B_PROTEIN[GENE]
( O O
cmax O B_MEASURE/B_LOCATION
) O O
) O O
and O O
chloroplast O B_PHYSIOLOGIC_FUNCTION[ORGANISM_FUNCTION]/B_DISEASE_ADJECTIVE[DISEASE]
electron O I_PHYSIOLOGIC_FUNCTION[ORGANISM_FUNCTION]/I_DISEASE_ADJECTIVE[DISEASE]
transport O I_PHYSIOLOGIC_FUNCTION[ORGANISM_FUNCTION]/I_DISEASE_ADJECTIVE[DISEASE]
( O O
J O B_OTHER/B_PROTEIN[GENE]
( O O
max O B_PROTEIN[GENE]/B_BODY_PART_OR_ORGAN_COMPONENT
) O O
) O O
. O O

The O O
J O B_OTHER/B_PROTEIN[GENE]
( O O
max O B_PROTEIN[GENE]/B_BODY_PART_OR_ORGAN_COMPONENT
) O O
/ O O
V O B_OTHER/B_LOCATION
( O O
cmax O B_MEASURE/B_LOCATION
) O O
ratio O B_MEASURE/B_PERSON
decreased O O
with O O
reductions O B_DISEASE_ADJECTIVE[DISEASE]/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
in O O
leaf O B_MEASURE/B_ORGANIZATION
N O I_MEASURE/I_ORGANIZATION
content O I_MEASURE/I_ORGANIZATION
, O O
which O O
was O O
consistent O B_DISEASE_ADJECTIVE[DISEASE]/B_GENE
with O O
the O O
results O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
of O O
the O O
cyt O B_GENE/B_MEASURE
f O O
/ O O
Rubisco O B_MEASURE/B_LOCATION
ratio O I_MEASURE/I_LOCATION
. O O

Analysis O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
using O O
the O O
C O B_PROTEIN[GENE]/B_LOCATION
( O O
3 O B_MEASURE
) O O
photosynthesis O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
model O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
indicated O O
that O O
A O B_OTHER/B_LOCATION
( O O
380 O B_NUMBER[MEASURE]
) O O
tended O O
to O O
be O O
limited O O
by O O
RuBP O B_LOCATION/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
carboxylation O B_LOCATION/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
in O O
plants O B_BIO/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
grown O O
at O O
low O B_DISEASE_ADJECTIVE[DISEASE]
N O I_DISEASE_ADJECTIVE[DISEASE]
concentration O I_DISEASE_ADJECTIVE[DISEASE]
, O O
whereas O O
it O O
was O O
limited O O
by O O
RuBP O B_LOCATION/B_BACTERIUM[BIO]
regeneration O I_LOCATION/I_BACTERIUM[BIO]
in O O
plants O B_BIO/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
grown O O
at O O
high O B_MEASURE/B_DISEASE_ADJECTIVE[DISEASE]
N O I_MEASURE/I_DISEASE_ADJECTIVE[DISEASE]
concentration O I_MEASURE/I_DISEASE_ADJECTIVE[DISEASE]
. O O

We O O
conclude O O
that O O
the O O
limiting O O
step O B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
of O O
A O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PROTEIN[GENE]
( O O
380 O B_MEASURE/B_LOCATION
) O O
depends O O
on O O
leaf O B_MEASURE/B_ORGANIZATION
N O I_MEASURE/I_ORGANIZATION
content O I_MEASURE/I_ORGANIZATION
and O O
is O O
mainly O O
determined O O
by O O
N O B_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
partitioning O O
between O O
Rubisco O B_BIO/B_PHYSIOLOGIC_FUNCTION[ORGANISM_FUNCTION]
and O O
electron O B_PERSON/B_LOCATION
transport O I_PERSON/I_LOCATION
components O I_PERSON/I_LOCATION
. O O

Comparative O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
ionomics O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
and O O
metabolomics O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
in O O
extremophile O B_BIO/B_LOCATION
and O O
glycophytic O B_BIO
Lotus O I_BIO
species O I_BIO
under O O
salt O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
stress O B_DISEASE_ADJECTIVE[DISEASE]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
challenge O O
the O O
metabolic O B_DISEASE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
pre O I_DISEASE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- O O
adaptation O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANIZATION
hypothesis O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_ORGANIZATION
. O O

The O O
legume O B_BIO/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
genus O B_BIO/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
Lotus O B_BIO/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
includes O O
glycophytic O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
forage O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
crops O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
and O O
other O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
species O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
adapted O O
to O O
extreme O B_LOCATION/B_MEASURE
environments O I_LOCATION/I_MEASURE
, O O
such O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
as O O
saline O B_LOCATION
soils O I_LOCATION
. O O

Understanding O O
salt O B_DISEASE_ADJECTIVE[DISEASE]/B_PERSON
tolerance O I_DISEASE_ADJECTIVE[DISEASE]/I_PERSON
mechanisms O I_DISEASE_ADJECTIVE[DISEASE]/I_PERSON
will O O
contribute O O
to O O
the O O
discovery O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
of O O
new O B_DISEASE_ADJECTIVE[DISEASE]/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
traits O I_DISEASE_ADJECTIVE[DISEASE]/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
which O O
may O O
enhance O O
the O O
breeding O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
efforts O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
towards O O
improved O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_ORGANISM_FUNCTION
performance O I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/I_ORGANISM_FUNCTION
of O O
legumes O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
in O O
marginal O B_LOCATION
agricultural O I_LOCATION
environments O I_LOCATION
. O O

Here O O
, O O
we O O
used O O
a O O
combination O O
of O O
ionomic O O
and O O
gas O O
chromatography O O
- O O
mass O O
spectrometry O O
( O O
GC O O
- O O
MS O O
) O O
- O O
based O O
metabolite O O
profilings O O
of O O
complete O O
shoots O O
( O O
pooling O O
leaves O O
, O O
petioles O O
and O O
stems O O
) O O
to O O
compare O O
the O O
extremophile O O
Lotus B B_BIO/B_GENE
creticus I I_BIO/I_GENE
, O O
adapted O O
to O O
highly O O
saline O O
coastal O O
regions O O
, O O
and O O
two O O
cultivated O O
glycophytic O O
grassland O O
forage O O
species O O
, O O
Lotus B B_BIO/B_LOCATION
corniculatus I I_BIO/I_LOCATION
and O O
Lotus B B_BIO/B_LOCATION
tenuis I I_BIO/I_LOCATION
. O O

L B B_BIO/B_PERSON
. I I_BIO/I_PERSON
creticus I I_BIO/I_PERSON
exhibited O O
better O O
survival O O
after O O
exposure O O
to O O
long O O
- O O
term O O
lethal O O
salinity O O
and O O
was O O
more O O
efficient O O
at O O
excluding O O
Cl O O
- O O
from O O
the O O
shoots O O
than O O
the O O
glycophytes O O
. O O

In O O
contrast O B_MEASURE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
Na O B_MEASURE/B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
+ O I_MEASURE/I_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
levels O I_MEASURE/I_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
were O O
higher O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
in O O
the O O
extremophile O B_BIO/B_DISEASE
under O O
both O O
control O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
and O O
salt O B_DISEASE_ADJECTIVE[DISEASE]/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
stress O I_DISEASE_ADJECTIVE[DISEASE]/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
a O O
trait O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
often O O
observed O O
in O O
halophytes O B_BIO/B_LOCATION
. O O

Ionomics O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
demonstrated O O
a O O
differential O B_DISEASE_ADJECTIVE[DISEASE]/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
rearrangement O I_DISEASE_ADJECTIVE[DISEASE]/I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
of O O
shoot O B_CHEMICAL_CLASS[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
nutrient O I_CHEMICAL_CLASS[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
levels O I_CHEMICAL_CLASS[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
in O O
the O O
extremophile O B_BIO/B_DISEASE
upon O O
salt O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_ORGANISM_FUNCTION
exposure O I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/I_ORGANISM_FUNCTION
. O O

Metabolite O O
profiling O O
showed O O
that O O
responses O O
to O O
NaCl O O
in O O
L B B_BIO/B_PERSON
. I I_BIO/I_PERSON
creticus I I_BIO/I_PERSON
shoots O O
were O O
globally O O
similar O O
to O O
those O O
of O O
the O O
glycophytes O O
, O O
providing O O
little O O
evidence O O
for O O
metabolic O O
pre O O
- O O
adaptation O O
to O O
salinity O O
. O O

This O O
study O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
is O O
the O O
first O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
comparing O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
salt O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
acclimation O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
responses O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
between O O
extremophile O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
and O O
non O B_DISEASE
- O O
extremophile O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
legumes O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
, O O
and O O
challenges O O
the O O
generalization O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
of O O
the O O
metabolic O B_DISEASE_ADJECTIVE[DISEASE]
salt O I_DISEASE_ADJECTIVE[DISEASE]
pre O I_DISEASE_ADJECTIVE[DISEASE]
- O O
adaptation O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANISM_FUNCTION
hypothesis O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_ORGANISM_FUNCTION
. O O

The O O
rise O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
of O O
chronic O B_DISEASE/B_BODY_PART_OR_ORGAN_COMPONENT
non O I_DISEASE/I_BODY_PART_OR_ORGAN_COMPONENT
- O O
communicable O B_DISEASE/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
diseases O I_DISEASE/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
in O O
southeast O B_LOCATION/B_PERSON
Asia O I_LOCATION/I_PERSON
: O O
time O B_LOCATION
for O O
action O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
. O O

Southeast O B_LOCATION
Asia O I_LOCATION
faces O O
an O O
epidemic O B_DISEASE
of O O
chronic O B_DISEASE_ADJECTIVE[DISEASE]
non O I_DISEASE_ADJECTIVE[DISEASE]
- O O
communicable O B_DISEASE
diseases O I_DISEASE
, O O
now O O
responsible O B_PERSON/B_DISEASE_ADJECTIVE[DISEASE]
for O O
60 O B_MEASURE/B_LOCATION
% O I_MEASURE/I_LOCATION
of O O
deaths O B_DISEASE/B_PERSON
in O O
the O O
region O B_LOCATION
. O O

The O O
problem O O
stems O O
from O O
environmental O O
factors O O
that O O
promote O O
tobacco B B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
use O O
, O O
unhealthy O O
diet O O
, O O
and O O
inadequate O O
physical O O
activity O O
. O O

Disadvantaged O B_PERSON/B_LOCATION
populations O I_PERSON/I_LOCATION
are O O
the O O
hardest O O
hit O O
, O O
with O O
death O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
rates O I_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
inversely O O
proportional O B_MEASURE/B_PERSON
to O O
a O O
country O B_LOCATION/B_PERSON
' O O
s O B_MEASURE/B_DISEASE
gross O I_MEASURE/I_DISEASE
national O I_MEASURE/I_DISEASE
income O I_MEASURE/I_DISEASE
. O O

Families O B_PERSON/B_SOCIAL_CIRCUMSTANCES
shoulder O O
the O O
financial O B_DISEASE_ADJECTIVE[DISEASE]
burden O I_DISEASE_ADJECTIVE[DISEASE]
, O O
but O O
entire O B_PERSON
economies O I_PERSON
suffer O O
as O O
well O O
. O O

Although O O
attempts O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANIZATION
to O O
control O O
non O B_DISEASE
- O O
communicable O B_DISEASE_ADJECTIVE[DISEASE]/B_PERSON
diseases O I_DISEASE_ADJECTIVE[DISEASE]/I_PERSON
are O O
increasing O O
, O O
more O B_DISEASE_ADJECTIVE[DISEASE]/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
needs O I_DISEASE_ADJECTIVE[DISEASE]/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
to O O
be O O
done O O
. O O

Health O B_PERSON/B_LOCATION
- O O
care O B_ORGANIZATION/B_PERSON
systems O I_ORGANIZATION/I_PERSON
need O O
to O O
be O O
redesigned O O
to O O
deliver O O
chronic O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_ORGANIZATION
care O I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/I_ORGANIZATION
that O O
is O O
founded O O
on O O
existing O O
primary O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
health O I_DISEASE_ADJECTIVE[DISEASE]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- O O
care O B_DISEASE_ADJECTIVE[DISEASE]/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
facilities O I_DISEASE_ADJECTIVE[DISEASE]/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
but O O
supported O O
by O O
good O B_ORGANIZATION/B_PERSON
referral O I_ORGANIZATION/I_PERSON
systems O I_ORGANIZATION/I_PERSON
. O O

Surveillance O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
key O B_DISEASE/B_PERSON
modifiable O I_DISEASE/I_PERSON
risk O I_DISEASE/I_PERSON
factors O I_DISEASE/I_PERSON
is O O
needed O O
to O O
monitor O O
the O O
magnitude O B_MEASURE/B_LOCATION
of O O
the O O
problem O B_DISEASE
and O O
to O O
study O O
the O O
effects O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
interventions O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
. O O

All O O
branches O B_LOCATION
of O O
government O B_ORGANIZATION/B_LOCATION
and O O
all O O
sectors O B_LOCATION/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
society O B_ORGANIZATION/B_LOCATION
have O O
to O O
get O O
involved O O
in O O
establishing O O
environments O B_LOCATION/B_ORGANIZATION
that O O
are O O
conducive O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
to O O
healthy O B_DISEASE_ADJECTIVE[DISEASE]/B_PERSON
living O I_DISEASE_ADJECTIVE[DISEASE]/I_PERSON
. O O

The O O
Association O B_ORGANIZATION
of O O
Southeast O B_PERSON/B_ORGANIZATION
Asian O I_PERSON/I_ORGANIZATION
Nations O I_PERSON/I_ORGANIZATION
is O O
in O O
a O O
unique O B_PERSON
position O I_PERSON
to O O
make O O
a O O
united O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_TIME[MEASURE]
stand O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_TIME[MEASURE]
against O O
chronic O B_DISEASE/B_BODY_PART_OR_ORGAN_COMPONENT
non O I_DISEASE/I_BODY_PART_OR_ORGAN_COMPONENT
- O O
communicable O B_DISEASE/B_PERSON
diseases O I_DISEASE/I_PERSON
in O O
the O O
region O B_LOCATION
. O O

Inaction O B_DISEASE/B_PERSON
will O O
affect O O
millions O B_MEASURE/B_LOCATION
of O O
lives O B_PERSON/B_LANGUAGE
- O O
often O O
, O O
the O O
lives O B_PERSON/B_LANGUAGE
of O O
those O O
who O O
have O O
the O O
least O B_DISEASE
. O O

Aberrant O O
genome O O
size O O
and O O
instability O O
of O O
Phytophthora B B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
ramorum I B_BIO/I_DISEASE_ADJECTIVE[DISEASE]
oospore O O
progenies O O
. O O

The O O
functionality O O
of O O
the O O
sexual O O
cycle O O
in O O
the O O
heterothallic O O
pathogen O O
Phytophthora B B_BACTERIUM[BIO]
ramorum I I_BACTERIUM[BIO]
, O O
causal O O
agent O O
of O O
Sudden O O
Oak O O
Death O O
, O O
has O O
recently O O
been O O
demonstrated O O
. O O

Sexual O B_DISEASE_ADJECTIVE[DISEASE]/B_PERSON
reproduction O I_DISEASE_ADJECTIVE[DISEASE]/I_PERSON
could O O
create O O
genotypic O B_DISEASE/B_BIO
variation O I_DISEASE/I_BIO
and O O
increase O O
the O O
pathogen O B_PERSON/B_DISEASE_ADJECTIVE[DISEASE]
' O I_PERSON/I_DISEASE_ADJECTIVE[DISEASE]
s O I_PERSON/I_DISEASE_ADJECTIVE[DISEASE]
ability O I_PERSON/I_DISEASE_ADJECTIVE[DISEASE]
to O O
adapt O O
to O O
other O B_DISEASE_ADJECTIVE[DISEASE]/B_BIO
host O I_DISEASE_ADJECTIVE[DISEASE]/I_BIO
plants O I_DISEASE_ADJECTIVE[DISEASE]/I_BIO
or O O
changing O O
environments O B_LOCATION
. O O

Genetic O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
characterization O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
using O O
co O B_LOCATION/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- O O
dominant O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
microsatellite O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
markers O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
and O O
flow O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
cytometry O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
of O O
single O B_MEASURE/B_PERSON
- O O
oospore O B_BIO/B_LOCATION
progeny O I_BIO/I_LOCATION
of O O
crosses O B_LOCATION/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
between O O
a O O
European O B_LOCATION/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
A1 O I_LOCATION/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
isolate O O
and O O
North O B_LOCATION/B_NUMBER[MEASURE]
American O I_LOCATION/I_NUMBER[MEASURE]
or O O
European O B_PERSON/B_LOCATION
A2 O I_PERSON/I_LOCATION
isolates O I_PERSON/I_LOCATION
revealed O O
a O O
considerable O B_MEASURE/B_LOCATION
number O I_MEASURE/I_LOCATION
of O O
non O B_DISEASE
- O O
Mendelian O B_GENE/B_PERSON
inheritance O I_GENE/I_PERSON
events O I_GENE/I_PERSON
. O O

This O O
includes O O
inheritance O B_PERSON/B_DISEASE
of O O
more O B_MEASURE
than O O
two O B_PERSON/B_NUMBER[MEASURE]
alleles O I_PERSON/I_NUMBER[MEASURE]
at O O
a O O
locus O B_GENE/B_MEASURE
and O O
non O B_DISEASE
- O O
inheritance O B_PERSON/B_DISEASE
of O O
alleles O B_GENE/B_PERSON
from O O
one O B_PERSON/B_LOCATION
parent O I_PERSON/I_LOCATION
at O O
another O O
locus O B_LOCATION/B_MEASURE
. O O

The O O
progenies O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
were O O
mitotically O O
unstable O B_DISEASE_ADJECTIVE[DISEASE]
: O O
zoospore O B_BIO
and O O
hyphal O B_DISEASE_ADJECTIVE[DISEASE]/B_BIO
tip O B_DISEASE_ADJECTIVE[DISEASE]/I_BIO
derivatives O B_DISEASE_ADJECTIVE[DISEASE]/I_BIO
of O O
the O O
progenies O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
showed O O
genotypic O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
rearrangements O B_DISEASE_ADJECTIVE[DISEASE]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
phenotypic O B_DISEASE_ADJECTIVE[DISEASE]/B_GENE
variation O I_DISEASE_ADJECTIVE[DISEASE]/I_GENE
. O O

Flow O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
cytometry O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
confirmed O O
variation O B_DISEASE_ADJECTIVE[DISEASE]/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
instability O B_DISEASE/B_MEASURE
in O O
DNA O B_MEASURE/B_LOCATION
content O I_MEASURE/I_LOCATION
of O O
the O O
single O B_NUMBER[MEASURE]/B_PERSON
- O O
oospore O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_GENE
progenies O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/I_GENE
. O O

This O O
indicates O O
that O O
single O B_MEASURE/B_PERSON
- O O
oospore O B_BIO/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
progenies O I_BIO/I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
not O O
only O O
display O O
aberrant O B_GENE/B_DISEASE
genomic O I_GENE/I_DISEASE
and O O
phenotypic O B_DISEASE_ADJECTIVE[DISEASE]/B_GENE
variation O I_DISEASE_ADJECTIVE[DISEASE]/I_GENE
due O O
to O O
meiotic O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
irregularities O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
but O O
also O O
extra O B_MEASURE/B_LOCATION
variation O I_MEASURE/I_LOCATION
as O O
a O O
result O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
post O B_DISEASE/B_MEASURE
- O O
meiotic O B_DISEASE_ADJECTIVE[DISEASE]/B_ORGANISM_FUNCTION
genomic O B_DISEASE_ADJECTIVE[DISEASE]/I_ORGANISM_FUNCTION
rearrangements O B_DISEASE_ADJECTIVE[DISEASE]/I_ORGANISM_FUNCTION
. O O

Independent O O
duplications O O
of O O
alpha O O
- O O
amylase O O
in O O
different O O
strains O O
of O O
Aspergillus B B_BACTERIUM[BIO]
oryzae I I_BACTERIUM[BIO]
. O O

Aspergillus B B_BACTERIUM[BIO]/B_PERSON
oryzae I I_BACTERIUM[BIO]/I_PERSON
is O O
a O O
filamentous O O
fungus O O
that O O
has O O
arisen O O
through O O
the O O
ancient O O
domestication O O
of O O
Aspergillus B B_BIO/B_LOCATION
flavus I I_BIO/I_LOCATION
for O O
making O O
traditional O O
oriental O O
foods O O
and O O
beverages O O
. O O

In O O
the O O
many O O
centuries O O
A B B_BIO/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. I B_BIO/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
oryzae I B_BIO/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
has O O
been O O
used O O
for O O
fermenting O O
the O O
starch O O
in O O
rice O O
to O O
simple O O
sugars O O
, O O
it O O
has O O
undergone O O
selection O O
for O O
increased O O
secretion O O
of O O
starch O O
- O O
degrading O O
enzymes O O
. O O

In O O
particular O O
, O O
all O O
A B B_BACTERIUM[BIO]
. I I_BACTERIUM[BIO]
oryzae I I_BACTERIUM[BIO]
strains O O
investigated O O
thus O O
far O O
have O O
two O O
or O O
more O O
copies O O
of O O
a O O
gene O O
encoding O O
alpha O O
- O O
amylase O O
, O O
whereas O O
A B B_SPECIES[BIO]/B_PERSON
. I I_SPECIES[BIO]/I_PERSON
flavus I I_SPECIES[BIO]/I_PERSON
has O O
only O O
one O O
. O O

Here O O
we O O
investigate O O
the O O
duplications O O
leading O O
to O O
these O O
copies O O
in O O
three O O
A B B_SPECIES[BIO]
. I I_SPECIES[BIO]
oryzae I I_SPECIES[BIO]
strains O O
. O O

We O O
find O O
evidence O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
at O O
least O O
three O B_DISEASE_ADJECTIVE[DISEASE]/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
separate O B_DISEASE_ADJECTIVE[DISEASE]/I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
duplications O B_DISEASE_ADJECTIVE[DISEASE]/I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
of O O
alpha O B_PROTEIN[GENE]/B_DISEASE
- O O
amylase O B_GENE
, O O
an O O
example O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
of O O
parallel O B_CELL_OR_MOLECULAR_DYSFUNCTION[DISEASE]/B_ORGANISM_FUNCTION
evolution O I_CELL_OR_MOLECULAR_DYSFUNCTION[DISEASE]/I_ORGANISM_FUNCTION
in O O
a O O
micro O B_MEASURE/B_GENE
- O O
organism O B_BIO/B_GENE
under O O
artificial O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANISM_FUNCTION
selection O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_ORGANISM_FUNCTION
. O O

At O O
least O O
two O B_NUMBER[MEASURE]
of O O
these O O
duplications O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
appear O O
to O O
be O O
associated O O
with O O
activity O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_CELL_OR_MOLECULAR_DYSFUNCTION[DISEASE]
of O O
transposable O B_DISEASE_ADJECTIVE[DISEASE]/B_BIO
elements O I_DISEASE_ADJECTIVE[DISEASE]/I_BIO
of O O
the O O
Tc1 O B_GENE/B_BIO
/ O O
mariner O B_MEASURE
class O I_MEASURE
. O O

Both O O
involve O O
a O O
9 O B_MEASURE
. O O
1 O B_GENE/B_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
kb O I_GENE/I_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
element O I_GENE/I_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
that O O
terminates O O
in O O
inverted O B_GENE
repeats O I_GENE
, O O
encodes O O
a O O
putative O B_GENE
transposase O I_GENE
and O O
another O O
putative O B_ENZYME[GENE]/B_MEASURE
protein O I_ENZYME[GENE]/I_MEASURE
of O O
unknown O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
function O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_BIO
, O O
and O O
contains O O
an O O
unusual O B_MEASURE/B_LOCATION
arrangement O B_MEASURE/I_LOCATION
of O O
four O B_DISEASE_ADJECTIVE[DISEASE]/B_GENE
short O B_DISEASE_ADJECTIVE[DISEASE]/I_GENE
internal O B_DISEASE_ADJECTIVE[DISEASE]/I_GENE
imperfect O B_DISEASE_ADJECTIVE[DISEASE]/I_GENE
repeats O B_DISEASE_ADJECTIVE[DISEASE]/I_GENE
. O O

Although O O
& O O
quot O O
; O O
unusual O O
Mariners O O
& O O
quot O O
; O O
of O O
this O O
size O O
have O O
previously O O
been O O
identified O O
in O O
A B B_SPECIES[BIO]
. I I_SPECIES[BIO]
oryzae I I_SPECIES[BIO]
, O O
Aspergillus B B_SPECIES[BIO]
fumigatus I I_SPECIES[BIO]
and O O
Aspergillus B B_BACTERIUM[BIO]
nidulans I I_BACTERIUM[BIO]
, O O
this O O
is O O
the O O
first O O
evidence O O
we O O
know O O
of O O
that O O
at O O
least O O
some O O
of O O
them O O
are O O
active O O
in O O
modern O O
times O O
and O O
that O O
their O O
activity O O
can O O
contribute O O
to O O
beneficial O O
genetic O O
changes O O
. O O

Response O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
ecosystems O B_LOCATION/B_PERSON
to O O
realistic O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
extinction O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE
sequences O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE
. O O

Recent O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
research O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
suggests O O
that O O
effects O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
species O B_DISEASE_ADJECTIVE[DISEASE]/B_BIO
loss O B_DISEASE_ADJECTIVE[DISEASE]/I_BIO
on O O
the O O
structure O B_LOCATION/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
functioning O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
ecosystems O B_LOCATION/B_BIO
will O O
critically O O
depend O O
on O O
the O O
order O B_MEASURE/B_PERSON
with O O
which O O
species O B_BIO/B_PERSON
go O O
extinct O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
. O O

However O O
, O O
there O O
are O O
few O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
studies O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
of O O
the O O
response O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
natural O B_SPECIES[BIO]/B_DISEASE_ADJECTIVE[DISEASE]
ecosystems O I_SPECIES[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
to O O
realistic O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
extinction O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_BIO
sequences O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_BIO
. O O

Using O O
an O O
extinction O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
scenario O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
based O O
on O O
the O O
International O B_ORGANIZATION/B_LOCATION
Union O I_ORGANIZATION/I_LOCATION
for O O
Conservation O B_LOCATION/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
Nature O B_LOCATION/B_DISEASE
( O O
IUCN O B_DISEASE/B_GENE
) O O
Red O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANIZATION
List O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_ORGANIZATION
, O O
de O B_PERSON/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
Visser O I_PERSON/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
et O I_PERSON/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
al O I_PERSON/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O
sequentially O O
deleted O O
species O B_BIO/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
from O O
a O O
topological O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
model O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
of O O
the O O
Serengeti O B_LOCATION/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
food O I_LOCATION/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
web O I_LOCATION/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

Under O O
this O O
scenario O B_LOCATION/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
large O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
- O O
bodied O B_BIO/B_MEASURE
species O I_BIO/I_MEASURE
like O O
top O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
predators O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
and O O
mega O B_BIO/B_DISEASE
- O O
herbivores O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
go O O
extinct O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
first O O
. O O

The O O
resulting O O
changes O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
in O O
the O O
trophic O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
structure O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
of O O
the O O
food O B_LOCATION/B_ORGANIZATION
web O I_LOCATION/I_ORGANIZATION
might O O
affect O O
the O O
robustness O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
of O O
the O O
ecosystem O B_LOCATION/B_BIO
to O O
future O B_DISEASE_ADJECTIVE[DISEASE]/B_BIO
disturbances O I_DISEASE_ADJECTIVE[DISEASE]/I_BIO
. O O

Host O B_EDU[ORGANIZATION]/B_PERSON
characteristics O I_EDU[ORGANIZATION]/I_PERSON
and O O
environmental O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
factors O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
differentially O O
drive O O
the O O
burden O B_DISEASE_ADJECTIVE[DISEASE]/B_ORGANISM_FUNCTION
and O O
pathogenicity O B_DISEASE_ADJECTIVE[DISEASE]/B_ORGANISM_FUNCTION
of O O
an O O
ectoparasite O B_SPECIES[BIO]/B_DISEASE
: O O
a O O
multilevel O B_SPECIES[BIO]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
causal O I_SPECIES[BIO]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
analysis O I_SPECIES[BIO]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

1 O B_NUMBER[MEASURE]
. O O

Understanding O O
the O O
ecological O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
factors O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
driving O O
the O O
burden O B_DISEASE_ADJECTIVE[DISEASE]/B_ORGANISM_FUNCTION
and O O
pathogenicity O B_DISEASE_ADJECTIVE[DISEASE]
of O O
parasites O B_DISEASE
is O O
challenging O B_DISEASE_ADJECTIVE[DISEASE]/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
. O O

Indeed O O
, O O
the O O
dynamics O B_MEASURE/B_DISEASE_ADJECTIVE[DISEASE]
of O O
host O B_SPECIES[BIO]
- O O
parasite O B_DISEASE_ADJECTIVE[DISEASE]/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
interactions O I_DISEASE_ADJECTIVE[DISEASE]/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
is O O
driven O O
by O O
factors O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
organized O O
across O O
nested O B_LOCATION/B_BIO
hierarchical O I_LOCATION/I_BIO
levels O I_LOCATION/I_BIO
( O O
e O B_GENE/B_DISEASE
. O O
g O B_PROTEIN[GENE]/B_CELL[BODY_PART_OR_ORGAN_COMPONENT]
. O O
hosts O B_PERSON/B_LOCATION
, O O
localities O B_LOCATION/B_DISEASE_ADJECTIVE[DISEASE]
) O O
, O O
and O O
indirect O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
effects O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
are O O
expected O O
owing O O
to O O
interactions O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANIZATION
between O O
levels O B_LOCATION/B_PERSON
. O O

2 O B_NUMBER[MEASURE]
. O O

In O O
this O O
study O O
, O O
we O O
combined O O
Bayesian O O
multilevel O O
models O O
, O O
path O O
analyses O O
and O O
a O O
model O O
selection O O
procedure O O
to O O
account O O
for O O
these O O
complexities O O
and O O
to O O
decipher O O
the O O
relative O O
effects O O
of O O
host O O
- O O
and O O
environment O O
- O O
related O O
factors O O
on O O
the O O
burden O O
and O O
the O O
pathogenicity O O
of O O
an O O
ectoparasite O O
( O O
Tracheliastes O O
polycolpus O O
) O O
on O O
its O O
fish O O
host O O
( O O
Leuciscus B B_BIO
leuciscus I I_BIO
) O O
. O O

We O O
also O O
tested O O
the O O
year O B_TIME[MEASURE]/B_LOCATION
- O O
to O O
- O O
year O B_TIME[MEASURE]
consistency O I_TIME[MEASURE]
of O O
the O O
relationships O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
linking O O
these O O
factors O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
to O O
the O O
burden O B_DISEASE_ADJECTIVE[DISEASE]/B_ORGANISM_FUNCTION
and O O
the O O
pathogenic O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
effects O I_DISEASE_ADJECTIVE[DISEASE]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
T O B_PROTEIN[GENE]/B_LOCATION
. O O
polycolpus O B_DISEASE/B_SPECIES[BIO]
. O O

3 O B_NUMBER[MEASURE]
. O O

We O O
found O O
significant O B_MEASURE/B_DISEASE_ADJECTIVE[DISEASE]
relationships O I_MEASURE/I_DISEASE_ADJECTIVE[DISEASE]
between O O
the O O
parasite O B_MEASURE/B_GENE
burden O B_MEASURE/I_GENE
and O O
host O B_PERSON/B_DISEASE
- O O
related O O
factors O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
: O O
body O B_MEASURE/B_PERSON
length O I_MEASURE/I_PERSON
and O O
age O B_MEASURE/B_BIO
were O O
positively O O
related O O
to O O
parasite O B_DISEASE/B_MEASURE
burden O I_DISEASE/I_MEASURE
and O O
heterozygous O B_PERSON/B_BIO
hosts O I_PERSON/I_BIO
displayed O O
a O O
higher O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
parasite O I_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
burden O I_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
. O O

In O O
contrast O B_MEASURE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
both O O
host O B_PERSON/B_BIO
- O O
and O O
environment O B_BIO/B_DISEASE
- O O
related O O
factors O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
were O O
linked O O
to O O
pathogenic O B_DISEASE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
effects O I_DISEASE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

Pathogenicity O B_DISEASE
was O O
correlated O O
negatively O O
with O O
host O B_MEASURE/B_DISEASE
body O I_MEASURE/I_DISEASE
length O I_MEASURE/I_DISEASE
and O O
positively O O
with O O
age O B_TIME[MEASURE]/B_DISEASE
; O O
this O O
illustrates O O
that O O
some O O
factors O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
( O O
e O O
. O O
g O B_DISEASE/B_MEASURE
. O O
body O B_MEASURE/B_BIO
length O I_MEASURE/I_BIO
) O O
showed O O
inverse O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
relationships O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
with O O
parasite O B_DISEASE/B_MEASURE
burden O I_DISEASE/I_MEASURE
and O O
pathogenicity O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
. O O

Pathogenic O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
effects O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
were O O
stronger O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
in O O
cooler O B_LOCATION/B_BIO
upstream O I_LOCATION/I_BIO
sites O I_LOCATION/I_BIO
and O O
where O O
host O B_MEASURE/B_LOCATION
density O I_MEASURE/I_LOCATION
was O O
lower O B_MEASURE
. O O

Path O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
analyses O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
revealed O O
that O O
these O O
relationships O B_PERSON/B_LOCATION
between O O
environment O B_PERSON/B_BIO
- O O
related O O
factors O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
pathogenic O B_DISEASE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
effects O I_DISEASE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
were O O
direct O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
were O O
not O O
indirect O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
relationships O I_DISEASE_ADJECTIVE[DISEASE]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
mediated O O
by O O
the O O
host O B_PERSON/B_LOCATION
characteristics O I_PERSON/I_LOCATION
. O O

Finally O O
, O O
we O O
found O O
that O O
the O O
strength O B_MEASURE/B_BODY_PART_OR_ORGAN_COMPONENT
and O O
the O O
shape O B_MEASURE
of O O
certain O B_DISEASE_ADJECTIVE[DISEASE]/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
relationships O I_DISEASE_ADJECTIVE[DISEASE]/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
were O O
consistent O B_DISEASE_ADJECTIVE[DISEASE]/B_GENE
across O O
years O B_TIME[MEASURE]/B_PERSON
, O O
while O O
they O O
were O O
clearly O O
not O O
for O O
some O O
others O B_LOCATION
. O O

4 O B_NUMBER[MEASURE]
. O O

Our O O
study O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANIZATION
illustrates O O
that O O
considering O O
conjointly O O
causal O B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANIZATION
relationships O I_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_ORGANIZATION
among O O
factors O B_ORGANIZATION/B_BIO
and O O
the O O
hierarchical O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
structure O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
of O O
host O B_SPECIES[BIO]
- O O
parasite O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
interactions O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
is O O
appropriate O B_DISEASE_ADJECTIVE[DISEASE]
for O O
dissecting O O
the O O
complex O B_LOCATION/B_ORGANIZATION
links O I_LOCATION/I_ORGANIZATION
between O O
hosts O B_BIO/B_DISEASE
, O O
parasites O B_BIO/B_DISEASE
and O O
their O O
common O B_LOCATION/B_PERSON
environment O I_LOCATION/I_PERSON
. O O

Experimental O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
evidence O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
for O O
emergent O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
facilitation O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_BIO
: O O
promoting O O
the O O
existence O B_DISEASE_ADJECTIVE[DISEASE]/B_ORGANISM_FUNCTION
of O O
an O O
invertebrate O B_BIO/B_PERSON
predator O I_BIO/I_PERSON
by O O
killing O O
its O O
prey O B_BIO/B_PERSON
. O O

1 O B_NUMBER[MEASURE]
. O O

Recent O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
theoretical O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
insights O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
have O O
shown O O
that O O
predator O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
species O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
may O O
help O O
each O O
other O B_NUMBER[MEASURE]/B_DISEASE
to O O
persist O O
by O O
size O B_MEASURE/B_DISEASE
- O O
selective O B_DISEASE_ADJECTIVE[DISEASE]/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
foraging O B_DISEASE_ADJECTIVE[DISEASE]/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
on O O
a O O
shared O O
prey O B_BIO/B_LOCATION
. O O

By O O
feeding O O
on O O
a O O
certain O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
prey O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
stage O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
, O O
a O O
predator O B_BIO/B_PERSON
may O O
induce O O
a O O
compensatory O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
response O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
in O O
another O O
stage O B_ENT/B_MEASURE
of O O
the O O
same O B_BIO
prey O I_BIO
species O I_BIO
, O O
thereby O O
favouring O O
other O B_BIO/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
predators O B_BIO/I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
; O O
a O O
phenomenon O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
referred O O
to O O
as O O
emergent O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
facilitation O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE
. O O

2 O B_NUMBER[MEASURE]
. O O

To O O
test O O
whether O O
emergent O O
facilitation O O
may O O
occur O O
in O O
a O O
natural O O
system O O
, O O
we O O
performed O O
an O O
enclosure O O
experiment O O
where O O
we O O
mimicked O O
fish O O
predation O O
by O O
selectively O O
removing O O
large O O
zooplankton O O
and O O
subsequently O O
following O O
the O O
response O O
of O O
the O O
invertebrate O O
predator O O
Bythotrephes B B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
longimanus I I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
. O O

3 O B_NUMBER[MEASURE]
. O O

Positive O O
responses O O
to O O
harvest O O
were O O
observed O O
in O O
the O O
biomass O O
of O O
juvenile O O
individuals O O
of O O
the O O
dominant O O
zooplankton O O
Holopedium B B_BIO/B_LOCATION
gibberum I I_BIO/I_LOCATION
and O O
in O O
Bythotrephes O O
densities O O
. O O

Hence O O
, O O
by O O
removing O O
large O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
prey O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
, O O
we O O
increased O O
the O O
biomass O B_MEASURE/B_PERSON
of O O
small O B_BIO/B_PERSON
prey O I_BIO/I_PERSON
, O O
i O O
. O O
e O O
. O O
stage O B_ENT/B_DISEASE
- O O
specific O B_NUMBER[MEASURE]
biomass O I_NUMBER[MEASURE]
overcompensation O I_NUMBER[MEASURE]
was O O
present O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
in O O
the O O
juvenile O B_BIO/B_DISEASE
stage O I_BIO/I_DISEASE
of O O
Holopedium O B_BIO/B_PERSON
. O O

This O O
favoured O O
Bythotrephes O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
, O O
which O O
preferentially O O
feed O O
on O O
small O B_BIO
Holopedium O I_BIO
. O O

4 O B_NUMBER[MEASURE]
. O O

We O O
argue O O
that O O
the O O
stage O B_ENT/B_TIME[MEASURE]
- O O
specific O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
overcompensation O I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
occurred O O
as O O
a O O
result O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
of O O
increased O O
per O O
capita O B_MEASURE/B_PERSON
fecundity O I_MEASURE/I_PERSON
of O O
adult O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
Holopedium O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
and O O
as O O
a O O
result O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
competitive O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
release O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE
following O O
harvest O B_ORGANISM_FUNCTION/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
. O O

If O O
shown O O
to O O
be O O
common O B_DISEASE_ADJECTIVE[DISEASE]
, O O
emergent O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
facilitation O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_BIO
may O O
be O O
a O O
major O B_DISEASE_ADJECTIVE[DISEASE]/B_LOCATION
mechanism O I_DISEASE_ADJECTIVE[DISEASE]/I_LOCATION
behind O O
observed O B_MEASURE
predator O I_MEASURE
extinctions O I_MEASURE
and O O
patterns O B_LOCATION/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
predator O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
invasions O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
. O O

A O O
clone O B_GENE/B_CELL[BODY_PART_OR_ORGAN_COMPONENT]
- O O
based O O
transcriptomics O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
approach O O
for O O
the O O
identification O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
genes O B_GENE/B_MEASURE
relevant O I_GENE/I_MEASURE
for O O
itaconic O B_DISEASE/B_ORGANISM_FUNCTION
acid O I_DISEASE/I_ORGANISM_FUNCTION
production O I_DISEASE/I_ORGANISM_FUNCTION
in O O
Aspergillus O B_BIO
. O O

Several O B_BIO/B_PERSON
Aspergillus O I_BIO/I_PERSON
species O I_BIO/I_PERSON
are O O
well O O
- O O
known O O
for O O
the O O
production O B_PHYSIOLOGIC_FUNCTION[ORGANISM_FUNCTION]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
a O O
variety O B_ENT/B_MEASURE
of O O
organic O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
acids O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
. O O

In O O
this O O
study O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
, O O
a O O
cloned O B_GENE
based O O
transcriptomics O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANIZATION
approach O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_ORGANIZATION
was O O
used O O
to O O
identify O O
genes O B_GENE
crucial O I_GENE
in O O
the O O
biosynthesis O B_DISEASE_ADJECTIVE[DISEASE]/B_PHYSIOLOGIC_FUNCTION[ORGANISM_FUNCTION]
pathway O B_DISEASE_ADJECTIVE[DISEASE]/I_PHYSIOLOGIC_FUNCTION[ORGANISM_FUNCTION]
for O O
one O B_NUMBER[MEASURE]/B_PERSON
of O O
these O O
acids O B_CHEMICAL_CLASS[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
itaconic O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
acid O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

From O O
a O O
number O O
of O O
different O O
Aspergillus B B_BACTERIUM[BIO]/B_DISEASE_ADJECTIVE[DISEASE]
terreus I B_BACTERIUM[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
controlled O O
batch O O
fermentations O O
, O O
those O O
cultures O O
with O O
the O O
largest O O
difference O O
in O O
itaconic O O
acid O O
titer O O
and O O
productivity O O
were O O
selected O O
for O O
mRNA O O
isolation O O
. O O

cDNAs O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
derived O O
from O O
these O O
mRNA O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
samples O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
were O O
used O O
for O O
subsequent O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
hybridization O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
of O O
glass O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
slide O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
arrays O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
based O O
on O O
a O O
collection O B_LOCATION/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
5000 O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
cDNA O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
clones O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
. O O

A O O
selection O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
of O O
13 O B_GENE/B_LOCATION
cDNA O I_GENE/I_LOCATION
clones O I_GENE/I_LOCATION
resulting O O
in O O
the O O
strongest O B_TIME[MEASURE]
( O O
> O B_NUMBER[MEASURE]
10 O I_NUMBER[MEASURE]
- O O
fold O B_MEASURE
) O O
differential O B_DISEASE_ADJECTIVE[DISEASE]/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
hybridization O B_DISEASE_ADJECTIVE[DISEASE]/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
signals O B_DISEASE_ADJECTIVE[DISEASE]/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
were O O
identified O O
and O O
subsequently O O
the O O
inserts O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
of O O
these O O
clones O B_GENE/B_DISEASE
were O O
sequenced O O
. O O

Sequence O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
analysis O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
revealed O O
the O O
presence O B_LOCATION/B_DISEASE
of O O
in O O
total O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
five O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
different O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
gene O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
inserts O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
among O O
the O O
sequenced O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
clones O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_BIO
. O O

From O O
one O B_NUMBER[MEASURE]
of O O
these O O
sequences O B_DISEASE/B_GENE
, O O
encoding O O
a O O
gene O B_PERSON/B_GENE
of O O
the O O
MmgE O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PROTEIN[GENE]
- O O
PrpD O B_GENE/B_LOCATION
family O I_GENE/I_LOCATION
, O O
the O O
full O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
length O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
coding O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
region O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
was O O
shown O O
to O O
encode O O
one O B_NUMBER[MEASURE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
the O O
crucial O B_DISEASE_ADJECTIVE[DISEASE]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
itaconic O B_DISEASE_ADJECTIVE[DISEASE]/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
acid O B_DISEASE_ADJECTIVE[DISEASE]/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
pathway O B_DISEASE_ADJECTIVE[DISEASE]/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
enzymes O B_DISEASE_ADJECTIVE[DISEASE]/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
cis O B_DISEASE_ADJECTIVE[DISEASE]/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- O O
aconitate O B_ENZYME[GENE]/B_DISEASE_ADJECTIVE[DISEASE]
decarboxylase O I_ENZYME[GENE]/I_DISEASE_ADJECTIVE[DISEASE]
, O O
by O O
heterologous O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
expression O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
in O O
Escherichia O B_BIO
coli O I_BIO
. O O

Expression O O
of O O
this O O
gene O O
in O O
Aspergillus B B_BIO
niger I I_BIO
, O O
which O O
is O O
a O O
natural O O
citric O O
acid O O
producer O O
, O O
resulted O O
in O O
itaconate O O
production O O
. O O

Genome O O
analysis O O
suggests O O
that O O
in O O
A B B_BIO
. I I_BIO
terreus I I_BIO
the O O
cis O O
- O O
aconitate O O
decarboxylase O O
gene O O
is O O
part O O
of O O
an O O
itaconate O O
acid O O
related O O
gene O O
cluster O O
including O O
genes O O
encoding O O
two O O
pathway O O
specific O O
transporters O O
and O O
a O O
Zinc O O
finger O O
protein O O
. O O

Interestingly O O
, O O
this O O
cluster O B_LOCATION/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
is O O
directly O O
linked O O
to O O
the O O
large O B_LOCATION/B_GENE
lovastatin O I_LOCATION/I_GENE
gene O I_LOCATION/I_GENE
cluster O I_LOCATION/I_GENE
. O O

The O O
outcome O O
of O O
competition O O
between O O
the O O
two O O
chrysomonads O O
Ochromonas O O
sp O O
. O O
and O O
Poterioochromonas B B_BACTERIUM[BIO]
malhamensis I I_BACTERIUM[BIO]
depends O O
on O O
pH O O
. O O

We O O
investigated O O
the O O
effect O O
of O O
pH O O
on O O
the O O
competition O O
of O O
two O O
closely O O
related O O
chrysomonad O O
species O O
, O O
Poterioochromonas B B_LOCATION/B_NUMBER[MEASURE]
malhamensis I B_LOCATION/I_NUMBER[MEASURE]
originating O O
from O O
circumneutral O O
Lake O O
Constance O O
, O O
and O O
Ochromonas O O
sp O O
. O O
isolated O O
from O O
a O O
highly O O
acidic O O
mining O O
lake O O
in O O
Austria O O
( O O
pH O O
- O O
2 O O
. O O
6 O O
) O O
. O O

We O O
performed O O
pairwise O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
growth O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
experiments O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
between O O
these O O
two O B_BIO/B_DISEASE
species O I_BIO/I_DISEASE
at O O
four O B_MEASURE/B_LOCATION
different O I_MEASURE/I_LOCATION
pH O I_MEASURE/I_LOCATION
ranging O I_MEASURE/I_LOCATION
from O O
2 O B_MEASURE
. O O
5 O B_MEASURE
to O O
7 O B_MEASURE
. O O
0 O B_MEASURE
. O O

Heterotrophic O B_BIO/B_PERSON
bacteria O B_BIO/I_PERSON
served O O
as O O
food O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANIZATION
for O O
both O O
flagellates O B_BIO
. O O

Results O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
were O O
compared O O
to O O
growth O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
rates O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
measured O O
earlier O O
in O O
single O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
species O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_BIO
experiments O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_BIO
over O O
the O O
same O B_TIME[MEASURE]/B_LOCATION
pH O I_TIME[MEASURE]/I_LOCATION
range O I_TIME[MEASURE]/I_LOCATION
. O O

We O O
tested O O
the O O
hypothesis O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
that O O
the O O
acidotolerant O B_BACTERIUM[BIO]
species O O
benefits O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
from O O
competitive O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANISM_FUNCTION
release O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_ORGANISM_FUNCTION
under O O
conditions O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
acid O B_DISEASE_ADJECTIVE[DISEASE]
stress O I_DISEASE_ADJECTIVE[DISEASE]
. O O

The O O
neutrophilic O B_DISEASE_ADJECTIVE[DISEASE]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
strain O B_DISEASE_ADJECTIVE[DISEASE]/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
numerically O O
dominated O O
over O O
the O O
acidotolerant O B_BACTERIUM[BIO]/B_MEASURE
strain O I_BACTERIUM[BIO]/I_MEASURE
at O O
pH O B_MEASURE
7 O I_MEASURE
. O O
0 O B_MEASURE
, O O
but O O
was O O
the O O
inferior O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
competitor O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
at O O
pH O B_MEASURE
2 O I_MEASURE
. O O
5 O B_MEASURE
. O O

At O O
pH O B_MEASURE
3 O I_MEASURE
. O O
5 O B_MEASURE
and O O
5 O B_MEASURE
. O O
0 O B_MEASURE
both O O
strains O B_BIO/B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
coexisted O O
. O O

Surprisingly O O
, O O
P B B_BACTERIUM[BIO]/B_LOCATION
. I I_BACTERIUM[BIO]/I_LOCATION
malhamensis I I_BACTERIUM[BIO]/I_LOCATION
prevailed O O
over O O
Ochromonas O O
sp O O
. O O
under O O
moderately O O
acidic O O
conditions O O
, O O
i O O
. O O
e O O
. O O
at O O
the O O
pH O O
where O O
growth O O
rates O O
of O O
the O O
latter O O
peaked O O
when O O
grown O O
alone O O
. O O

Since O O
bacterial O B_LOCATION/B_MEASURE
food O I_LOCATION/I_MEASURE
was O O
not O O
limiting O O
, O O
resource O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_ORGANISM_FUNCTION
competition O I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/I_ORGANISM_FUNCTION
is O O
improbable O B_DISEASE_ADJECTIVE[DISEASE]
. O O

It O O
appears O O
more O O
likely O O
that O O
P B B_SPECIES[BIO]/B_PERSON
. I I_SPECIES[BIO]/I_PERSON
malhamensis I I_SPECIES[BIO]/I_PERSON
ingested O O
cells O O
of O O
its O O
slightly O O
smaller O O
competitor O O
. O O

Adverse O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
effects O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
mediated O O
via O O
allelopathy O B_DISEASE_ADJECTIVE[DISEASE]/B_BIO
, O O
either O O
directly O O
on O O
the O O
competing O O
flagellate O B_BIO/B_PERSON
or O O
indirectly O O
by O O
affecting O O
its O O
bacterial O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
food O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
, O O
might O O
also O O
have O O
affected O O
the O O
outcome O B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
of O O
competition O B_DISEASE/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
. O O

Differentially O O
expressed O O
genes O O
in O O
silkworm B B_SPECIES[BIO]
cell O O
cultures O O
in O O
response O O
to O O
infection O O
by O O
Wolbachia O O
and O O
Cardinium O O
endosymbionts O O
. O O

Wolbachia O B_BACTERIUM[BIO]
and O O
Cardinium O B_SPECIES[BIO]/B_DISEASE_ADJECTIVE[DISEASE]
are O O
bacterial O B_BIO
endosymbionts O I_BIO
that O O
are O O
widely O O
distributed O O
amongst O B_BIO/B_LOCATION
arthropods O B_BIO/I_LOCATION
. O O

Both O O
cause O O
reproductive O B_DISEASE_ADJECTIVE[DISEASE]/B_GENE
alterations O I_DISEASE_ADJECTIVE[DISEASE]/I_GENE
, O O
such O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
as O O
cytoplasmic O B_DISEASE/B_ORGANISM_FUNCTION
incompatibility O I_DISEASE/I_ORGANISM_FUNCTION
, O O
parthenogenesis O B_DISEASE/B_ORGANISM_FUNCTION
and O O
feminization O B_DISEASE/B_ORGANISM_FUNCTION
. O O

Here O O
we O O
studied O O
differentially O O
expressed O O
genes O O
in O O
Wolbachia O O
- O O
and O O
Cardinium O O
- O O
infected O O
Bm O O
- O O
aff3 O O
silkworm B B_BIO/B_BODY_PART_OR_ORGAN_COMPONENT
cells O O
using O O
a O O
silkworm B B_BIO/B_GENE
microarray O O
. O O

Wolbachia O B_DISEASE_ADJECTIVE[DISEASE]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
infection O I_DISEASE_ADJECTIVE[DISEASE]/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
did O O
not O O
alter O O
gene O B_DISEASE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
expression O I_DISEASE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
or O O
induce O O
or O O
suppress O O
immune O B_DISEASE/B_GENE
responses O I_DISEASE/I_GENE
. O O

In O O
contrast O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
, O O
Cardinium O B_DISEASE_ADJECTIVE[DISEASE]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
infection O B_DISEASE_ADJECTIVE[DISEASE]/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
induced O O
many O B_DISEASE
immune O I_DISEASE
- O O
related O O
genes O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
, O O
including O O
antimicrobial O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
peptides O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
, O O
pattern O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
recognition O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
receptors O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
and O O
a O O
serine O B_ENZYME[GENE]/B_DISEASE_ADJECTIVE[DISEASE]
protease O I_ENZYME[GENE]/I_DISEASE_ADJECTIVE[DISEASE]
. O O

Host O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
immune O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
responses O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
differed O O
, O O
possibly O O
because O O
of O O
the O O
different O B_DISEASE_ADJECTIVE[DISEASE]/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
cell O I_DISEASE_ADJECTIVE[DISEASE]/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
wall O I_DISEASE_ADJECTIVE[DISEASE]/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
structures O I_DISEASE_ADJECTIVE[DISEASE]/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
Wolbachia O B_BACTERIUM[BIO]
and O O
Cardinium O B_DISEASE_ADJECTIVE[DISEASE]/B_TIME[MEASURE]
because O O
the O O
former O B_BIO/B_DISEASE
lacks O O
genes O B_GENE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
encoding O O
lipopolysaccharide O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
components O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
and O O
two O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
racemases O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
for O O
peptidoglycan O B_DISEASE_ADJECTIVE[DISEASE]
formation O I_DISEASE_ADJECTIVE[DISEASE]
. O O

A O O
few O B_NUMBER[MEASURE]/B_PERSON
possibly O O
non O O
- O O
immune O B_DISEASE/B_ORGANISM_FUNCTION
- O O
related O O
genes O B_GENE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
were O O
differentially O O
expressed O O
, O O
but O O
their O O
involvement O B_PERSON/B_DISEASE
in O O
host O B_DISEASE/B_LOCATION
reproductive O I_DISEASE/I_LOCATION
alteration O I_DISEASE/I_LOCATION
was O O
unclear O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

Neuropeptide O B_GENE/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
Y O I_GENE/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- O O
like O B_DISEASE_ADJECTIVE[DISEASE]/B_GENE
signalling O I_DISEASE_ADJECTIVE[DISEASE]/I_GENE
and O O
nutritionally O O
mediated O O
gene O B_DISEASE_ADJECTIVE[DISEASE]/B_ORGANISM_FUNCTION
expression O B_DISEASE_ADJECTIVE[DISEASE]/I_ORGANISM_FUNCTION
and O O
behaviour O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANISM_FUNCTION
in O O
the O O
honey O B_BODY_PART_OR_ORGAN_COMPONENT/B_SPECIES[BIO]
bee O I_BODY_PART_OR_ORGAN_COMPONENT/I_SPECIES[BIO]
. O O

Previous O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
research O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
has O O
led O O
to O O
the O O
idea O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
that O O
derived O O
traits O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
can O O
arise O O
through O O
the O O
evolution O B_ORGANIZATION/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
novel O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
roles O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
for O O
conserved O B_PERSON/B_GENE
genes O I_PERSON/I_GENE
. O O

We O O
explored O O
whether O O
neuropeptide O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
Y O O
( O O
NPY O B_GENE/B_DISEASE
) O O
- O O
like O B_PROTEIN[GENE]/B_MEASURE
signalling O I_PROTEIN[GENE]/I_MEASURE
, O O
a O O
conserved O B_GENE/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
pathway O B_GENE/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
that O O
regulates O O
food O B_ORGANISM_FUNCTION/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
- O O
related O O
behaviour O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANISM_FUNCTION
, O O
is O O
involved O O
in O O
a O O
derived O O
, O O
nutritionally O O
- O O
related O O
trait O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
, O O
the O O
division O B_MEASURE/B_CELL[BODY_PART_OR_ORGAN_COMPONENT]
of O O
labour O B_ORGANISM_FUNCTION/B_BIO
in O O
worker O B_SPECIES[BIO]
honey O I_SPECIES[BIO]
bees O I_SPECIES[BIO]
. O O

Transcripts O B_GENE/B_MEASURE
encoding O O
two O B_GENE/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
NPY O I_GENE/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- O O
like O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
peptides O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
were O O
expressed O O
in O O
separate O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
populations O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
of O O
brain O B_CELL[BODY_PART_OR_ORGAN_COMPONENT]/B_DISEASE_ADJECTIVE[DISEASE]
neurosecretory O I_CELL[BODY_PART_OR_ORGAN_COMPONENT]/I_DISEASE_ADJECTIVE[DISEASE]
cells O I_CELL[BODY_PART_OR_ORGAN_COMPONENT]/I_DISEASE_ADJECTIVE[DISEASE]
, O O
consistent O B_DISEASE_ADJECTIVE[DISEASE]/B_GENE
with O O
endocrine O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
functions O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
. O O

NPY O B_DISEASE/B_GENE
- O O
related O O
genes O B_GENE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
were O O
upregulated O O
in O O
the O O
brains O B_BODY_PART_OR_ORGAN_COMPONENT/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
older O B_PERSON/B_BIO
foragers O B_PERSON/I_BIO
compared O O
with O O
younger O B_PERSON/B_BIO
bees O I_PERSON/I_BIO
performing O O
brood O B_LOCATION/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
care O I_LOCATION/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
( O O
' O O
nurses O B_MEASURE/B_LOCATION
' O I_MEASURE/I_LOCATION
) O O
. O O

A O O
subset O B_MEASURE/B_PERSON
of O O
these O O
changes O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
can O O
be O O
attributed O O
to O O
nutrition O B_DISEASE/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
but O O
neuropeptide O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
F O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
peptide O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
treatments O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
did O O
not O O
influence O O
sugar O B_MEASURE/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
intake O I_MEASURE/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

These O O
results O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
contrast O O
with O O
recent O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
reports O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
of O O
more O B_MEASURE/B_DISEASE_ADJECTIVE[DISEASE]
robust O I_MEASURE/I_DISEASE_ADJECTIVE[DISEASE]
associations O I_MEASURE/I_DISEASE_ADJECTIVE[DISEASE]
between O O
division O B_DISEASE_ADJECTIVE[DISEASE]/B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
labour O B_ORGANISM_FUNCTION
and O O
the O O
related O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
insulin O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
- O O
signalling O O
pathway O B_LOCATION/B_BIO
and O O
suggest O O
that O O
some O O
elements O B_MEASURE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
molecular O B_DISEASE_ADJECTIVE[DISEASE]/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
pathways O I_DISEASE_ADJECTIVE[DISEASE]/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
associated O O
with O O
feeding O B_ORGANISM_FUNCTION/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
behaviour O I_ORGANISM_FUNCTION/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
may O O
be O O
more O O
evolutionarily O O
labile O B_DISEASE_ADJECTIVE[DISEASE]/B_LOCATION
than O O
others O B_PERSON/B_DISEASE_ADJECTIVE[DISEASE]
. O O

Apolipoprotein O B_DISEASE_ADJECTIVE[DISEASE]/B_PROTEIN[GENE]
E O I_DISEASE_ADJECTIVE[DISEASE]/I_PROTEIN[GENE]
in O O
Alzheimer O B_DISEASE
' O I_DISEASE
s O I_DISEASE
disease O I_DISEASE
and O O
other O B_DISEASE/B_PERSON
neurological O I_DISEASE/I_PERSON
disorders O I_DISEASE/I_PERSON
. O O

Apolipoprotein O B_PROTEIN[GENE]/B_ORGANIZATION
E O I_PROTEIN[GENE]/I_ORGANIZATION
( O O
APOE O B_GENE/B_LOCATION
) O O
is O O
a O O
299 O B_MEASURE
- O O
aminoacid O B_PROTEIN[GENE]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
protein O I_PROTEIN[GENE]/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
encoded O O
by O O
the O O
APOE O B_GENE/B_BODY_PART_OR_ORGAN_COMPONENT
gene O I_GENE/I_BODY_PART_OR_ORGAN_COMPONENT
. O O

Three O B_CELL_OR_MOLECULAR_DYSFUNCTION[DISEASE]/B_GENE
common O I_CELL_OR_MOLECULAR_DYSFUNCTION[DISEASE]/I_GENE
polymorphisms O I_CELL_OR_MOLECULAR_DYSFUNCTION[DISEASE]/I_GENE
in O O
the O O
APOE O B_GENE
gene O I_GENE
, O O
epsilo2 O B_PROTEIN[GENE]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
epsilo3 O B_PROTEIN[GENE]
, O O
and O O
epsilo4 O B_GENE/B_BACTERIUM[BIO]
, O O
result O O
in O O
a O O
single O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
aminoacid O I_DISEASE_ADJECTIVE[DISEASE]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
change O I_DISEASE_ADJECTIVE[DISEASE]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
in O O
the O O
APOE O B_GENE/B_MEASURE
protein O I_GENE/I_MEASURE
. O O

APOE O B_GENE
epsilo2 O I_GENE
, O O
epsilo3 O B_GENE
, O O
and O O
epsilo4 O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
alleles O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
strongly O O
alter O O
, O O
in O O
a O O
dose O B_MEASURE
- O O
dependent O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
manner O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
, O O
the O O
likelihood O B_MEASURE
of O O
developing O O
Alzheimer O B_DISEASE/B_GENE
' O I_DISEASE/I_GENE
s O I_DISEASE/I_GENE
disease O I_DISEASE/I_GENE
and O O
cerebral O B_DISEASE
amyloid O I_DISEASE
angiopathy O I_DISEASE
. O O

In O O
particular O B_DISEASE/B_PERSON
, O O
APOE O B_DISEASE/B_LOCATION
epsilo4 O I_DISEASE/I_LOCATION
is O O
associated O O
with O O
increased O O
risk O B_DISEASE_ADJECTIVE[DISEASE]/B_GENE
for O O
Alzheimer O B_DISEASE/B_LOCATION
' O I_DISEASE/I_LOCATION
s O I_DISEASE/I_LOCATION
disease O I_DISEASE/I_LOCATION
whereas O O
APOE O B_GENE/B_DISEASE
epsilo2 O B_GENE/I_DISEASE
is O O
associated O O
with O O
decreased O O
risk O B_DISEASE
. O O

The O O
effects O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ENT
of O O
APOE O B_DISEASE/B_GENE
genotype O B_DISEASE/I_GENE
on O O
risk O B_DISEASE_ADJECTIVE[DISEASE]
of O O
these O O
diseases O B_DISEASE
are O O
likely O B_TIME[MEASURE]/B_DISEASE_ADJECTIVE[DISEASE]
to O O
be O O
mediated O O
by O O
differential O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
effects O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
APOE O B_GENE
on O O
amyloid O B_GENE/B_DISEASE
- O O
Beta O B_DISEASE_ADJECTIVE[DISEASE]/B_PROTEIN[GENE]
accumulation O B_DISEASE_ADJECTIVE[DISEASE]/I_PROTEIN[GENE]
in O O
the O O
brain O B_BODY_PART_OR_ORGAN_COMPONENT/B_DISEASE_ADJECTIVE[DISEASE]
and O O
its O O
vasculature O B_DISEASE/B_BODY_PART_OR_ORGAN_COMPONENT
. O O

Response O B_TIME[MEASURE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
to O O
treatment O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
for O O
Alzheimer O B_DISEASE
' O I_DISEASE
s O I_DISEASE
disease O I_DISEASE
might O O
differ O O
according O O
to O O
APOE O B_DISEASE_ADJECTIVE[DISEASE]
genotype O I_DISEASE_ADJECTIVE[DISEASE]
. O O

Because O O
convincing O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
evidence O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
ties O O
the O O
APOE O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
genotype O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
to O O
risk O B_TIME[MEASURE]/B_DISEASE_ADJECTIVE[DISEASE]
of O O
Alzheimer O B_DISEASE/B_BODY_PART_OR_ORGAN_COMPONENT
' O I_DISEASE/I_BODY_PART_OR_ORGAN_COMPONENT
s O I_DISEASE/I_BODY_PART_OR_ORGAN_COMPONENT
disease O I_DISEASE/I_BODY_PART_OR_ORGAN_COMPONENT
and O O
cerebral O B_DISEASE
amyloid O I_DISEASE
angiopathy O I_DISEASE
, O O
APOE O B_GENE/B_ORGANIZATION
has O O
been O O
studied O O
in O O
other O B_DISEASE/B_PERSON
neurological O B_DISEASE/I_PERSON
diseases O B_DISEASE/I_PERSON
. O O

APOE O B_DISEASE/B_GENE
epsilo4 O I_DISEASE/I_GENE
is O O
associated O O
with O O
poor O B_DISEASE
outcome O I_DISEASE
after O O
traumatic O B_DISEASE/B_BODY_PART_OR_ORGAN_COMPONENT
brain O I_DISEASE/I_BODY_PART_OR_ORGAN_COMPONENT
injury O I_DISEASE/I_BODY_PART_OR_ORGAN_COMPONENT
and O O
brain O B_DISEASE/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
haemorrhage O I_DISEASE/I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
, O O
although O O
the O O
mechanisms O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
underlying O O
these O O
associations O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANIZATION
are O O
unclear O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

The O O
possibility O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
that O O
APOE O B_GENE/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
has O O
a O O
role O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
in O O
these O O
and O O
other O B_DISEASE
neurological O I_DISEASE
diseases O I_DISEASE
has O O
been O O
of O O
great O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
interest O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
, O O
but O O
convincing O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
associations O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
have O O
not O O
yet O O
emerged O O
. O O

Titrating O O
the O O
cost O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
of O O
plant O B_PERSON/B_LOCATION
toxins O I_PERSON/I_LOCATION
against O O
predators O B_BIO/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
: O O
determining O O
the O O
tipping O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
point O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
for O O
foraging O O
herbivores O B_DISEASE_ADJECTIVE[DISEASE]/B_BIO
. O O

1 O B_NUMBER[MEASURE]
. O O

Foraging O O
herbivores O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
must O O
deal O O
with O O
plant O B_CHEMICAL_CLASS[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
characteristics O I_CHEMICAL_CLASS[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_BIO
that O O
inhibit O O
feeding O B_ORGANISM_FUNCTION/B_BIO
and O O
they O O
must O O
avoid O O
being O O
eaten O O
. O O

Principally O O
, O O
toxins O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
limit O O
food O B_TIME[MEASURE]/B_DISEASE_ADJECTIVE[DISEASE]
intake O I_TIME[MEASURE]/I_DISEASE_ADJECTIVE[DISEASE]
, O O
while O O
predation O B_DISEASE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
risk O I_DISEASE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
alters O O
how O O
long O B_BIO/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
animals O I_BIO/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
are O O
prepared O B_TIME[MEASURE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
to O O
harvest O O
resources O B_BIO/B_MEASURE
. O O

Each O O
of O O
these O O
factors O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
strongly O O
affects O O
how O O
herbivores O B_BIO/B_PERSON
use O O
food O B_DISEASE_ADJECTIVE[DISEASE]/B_BIO
patches O B_DISEASE_ADJECTIVE[DISEASE]/I_BIO
, O O
and O O
both O O
constraints O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
can O O
pose O O
immediate O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
proximate O I_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
costs O I_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
and O O
long O B_TIME[MEASURE]/B_LOCATION
- O O
term O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
consequences O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
to O O
fitness O B_SPORT[ENT]/B_PERSON
. O O

2 O B_NUMBER[MEASURE]
. O O

Using O O
a O O
generalist O O
mammalian O O
herbivore O O
, O O
the O O
common B B_SPECIES[BIO]/B_DISEASE_ADJECTIVE[DISEASE]
brushtail I I_SPECIES[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
possum I I_SPECIES[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
( O O
Trichosurus B B_BIO/B_LOCATION
vulpecula I B_BIO/I_LOCATION
) O O
, O O
our O O
aim O O
was O O
to O O
quantitatively O O
compare O O
the O O
influence O O
of O O
plant O O
toxin O O
and O O
predation O O
risk O O
on O O
foraging O O
decisions O O
. O O

3 O B_NUMBER[MEASURE]
. O O

We O O
performed O O
a O O
titration O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
experiment O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
by O O
offering O O
animals O B_SPECIES[BIO]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
a O O
choice O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
between O O
non O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
- O O
toxic O B_DISEASE/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
food O I_DISEASE/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
at O O
a O O
risky O B_MEASURE/B_LOCATION
patch O I_MEASURE/I_LOCATION
paired O O
with O O
food O B_ORGANIZATION/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
with O O
one O B_NUMBER[MEASURE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
five O B_PERSON/B_CHEMICAL_CLASS[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
toxin O I_PERSON/I_CHEMICAL_CLASS[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
concentrations O I_PERSON/I_CHEMICAL_CLASS[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
at O O
a O O
safe O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
patch O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
. O O

This O O
allowed O O
us O O
to O O
identify O O
the O O
tipping O B_LOCATION/B_PERSON
point O B_LOCATION/I_PERSON
, O O
where O O
the O O
cost O B_MEASURE
of O O
toxin O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
in O O
the O O
safe O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
food O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
patch O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
was O O
equivalent O B_MEASURE/B_DISEASE_ADJECTIVE[DISEASE]
to O O
the O O
perceived O O
predation O B_MEASURE/B_DISEASE
risk O B_MEASURE/I_DISEASE
in O O
the O O
alternative O B_LOCATION/B_BIO
patch O I_LOCATION/I_BIO
. O O

4 O B_NUMBER[MEASURE]
. O O

At O O
low O B_TIME[MEASURE]/B_LOCATION
toxin O I_TIME[MEASURE]/I_LOCATION
concentration O I_TIME[MEASURE]/I_LOCATION
, O O
animals O B_BIO/B_PERSON
ate O O
more O O
from O O
the O O
safe O B_BODY_PART_OR_ORGAN_COMPONENT/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
than O O
the O O
risky O B_PERSON/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
patch O I_PERSON/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

As O O
toxin O B_MEASURE/B_BIO
concentration O B_MEASURE/I_BIO
increased O O
at O O
the O O
safe O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_BODY_PART_OR_ORGAN_COMPONENT
patch O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/I_BODY_PART_OR_ORGAN_COMPONENT
, O O
intake O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
shifted O O
until O O
animals O B_BIO/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
ate O O
mainly O O
from O O
the O O
risky O B_BODY_PART_OR_ORGAN_COMPONENT/B_LOCATION
patch O I_BODY_PART_OR_ORGAN_COMPONENT/I_LOCATION
. O O

This O O
shift O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
was O O
associated O O
with O O
behavioural O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
changes O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE
: O O
animals O B_BIO/B_PERSON
spent O O
more O B_TIME[MEASURE]/B_ENT
time O I_TIME[MEASURE]/I_ENT
and O O
fed O O
longer O O
at O O
the O O
risky O B_LOCATION/B_MEASURE
patch O I_LOCATION/I_MEASURE
, O O
while O O
vigilance O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
increased O O
at O O
both O O
risky O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
safe O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
patches O I_DISEASE_ADJECTIVE[DISEASE]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

5 O B_NUMBER[MEASURE]
. O O

Our O O
results O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
demonstrate O O
that O O
the O O
variation O B_MEASURE
in O O
toxin O B_MEASURE/B_BIO
concentration O I_MEASURE/I_BIO
, O O
which O O
occurs O O
intraspecifically O O
among O O
plants O B_BIO/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
can O O
critically O O
influence O O
the O O
relative O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
cost O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
predation O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
risk O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_BIO
on O O
foraging O B_BIO/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

We O O
show O O
that O O
herbivores O B_BIO/B_PERSON
quantify O O
, O O
compare O O
and O O
balance O O
these O O
two O B_MEASURE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
different O I_MEASURE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
but O O
proximate O O
costs O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
, O O
altering O O
their O O
foraging O B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
patterns O I_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
in O O
the O O
process O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
. O O

This O O
has O O
potential O B_EDU[ORGANIZATION]/B_DISEASE_ADJECTIVE[DISEASE]
ecological O I_EDU[ORGANIZATION]/I_DISEASE_ADJECTIVE[DISEASE]
and O O
evolutionary O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
implications O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
for O O
the O O
production O B_ENT/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
plant O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
defence O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
compounds O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
in O O
relation O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
to O O
spatial O B_DISEASE_ADJECTIVE[DISEASE]
variation O I_DISEASE_ADJECTIVE[DISEASE]
in O O
predation O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
risk O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE
to O O
herbivores O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
. O O

What O O
determines O O
variation O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
in O O
home O B_MEASURE
range O I_MEASURE
size O I_MEASURE
across O O
spatiotemporal O B_LOCATION/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
scales O I_LOCATION/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
in O O
a O O
large O B_LOCATION/B_PERSON
browsing O I_LOCATION/I_PERSON
herbivore O I_LOCATION/I_PERSON
? O O

1 O B_NUMBER[MEASURE]
. O O

Most O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
studies O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
intraspecific O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
variation O I_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
in O O
home O B_MEASURE/B_PERSON
range O B_MEASURE/I_PERSON
size O B_MEASURE/I_PERSON
have O O
investigated O O
only O O
a O O
single O B_MEASURE/B_PERSON
or O O
a O O
few O B_MEASURE/B_PERSON
factors O I_MEASURE/I_PERSON
and O O
often O O
at O O
one O B_MEASURE
specific O I_MEASURE
scale O I_MEASURE
. O O

However O O
, O O
considering O O
multiple O B_MEASURE/B_LOCATION
spatial O I_MEASURE/I_LOCATION
and O O
temporal O B_MEASURE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
scales O I_MEASURE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
when O O
defining O O
a O O
home O B_MEASURE/B_LOCATION
range O B_MEASURE/I_LOCATION
is O O
important O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
as O O
mechanisms O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
that O O
affect O O
variation O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
in O O
home O B_MEASURE/B_LOCATION
range O I_MEASURE/I_LOCATION
size O I_MEASURE/I_LOCATION
may O O
differ O O
depending O O
on O O
the O O
scale O B_MEASURE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
under O O
investigation O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
. O O

2 O B_NUMBER[MEASURE]
. O O

We O O
aim O O
to O O
quantify O O
the O O
relative O O
effect O O
of O O
various O O
individual O O
, O O
forage O O
and O O
climatic O O
determinants O O
of O O
variation O O
in O O
home O O
range O O
size O O
across O O
multiple O O
spatiotemporal O O
scales O O
in O O
a O O
large O O
browsing O O
herbivore O O
, O O
the O O
moose O O
( O O
Alces B B_PERSON/B_BIO
alces I I_PERSON/I_BIO
) O O
, O O
living O O
at O O
the O O
southern O O
limit O O
of O O
its O O
distribution O O
in O O
Norway O O
. O O

3 O B_NUMBER[MEASURE]
. O O

Total O B_MEASURE/B_LOCATION
home O B_MEASURE/I_LOCATION
range O B_MEASURE/I_LOCATION
size O B_MEASURE/I_LOCATION
and O O
core O B_MEASURE/B_LOCATION
home O I_MEASURE/I_LOCATION
range O I_MEASURE/I_LOCATION
areas O I_MEASURE/I_LOCATION
were O O
estimated O O
for O O
daily O O
to O O
monthly O B_MEASURE
scales O I_MEASURE
in O O
summer O B_TIME[MEASURE]
and O O
winter O B_TIME[MEASURE]/B_LOCATION
using O O
both O O
local O B_MEASURE/B_LOCATION
convex O I_MEASURE/I_LOCATION
hull O I_MEASURE/I_LOCATION
( O O
LoCoH O B_PROTEIN[GENE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
) O O
and O O
fixed O B_MEASURE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
kernel O B_MEASURE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
home O B_MEASURE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
range O B_MEASURE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
methods O B_MEASURE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

Variance O B_TIME[MEASURE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
in O O
home O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
range O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
size O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
was O O
analysed O O
using O O
linear O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
mixed O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
- O O
effects O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
models O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
for O O
repeated O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
measurements O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
. O O

4 O B_NUMBER[MEASURE]
. O O

Reproductive O B_TIME[MEASURE]/B_PERSON
status O B_TIME[MEASURE]/I_PERSON
was O O
the O O
most O O
influential O B_PERSON/B_LOCATION
individual O B_PERSON/I_LOCATION
- O O
level O B_TIME[MEASURE]/B_LOCATION
factor O I_TIME[MEASURE]/I_LOCATION
explaining O O
variance O B_MEASURE
in O O
moose O B_MEASURE/B_PERSON
home O B_MEASURE/I_PERSON
range O B_MEASURE/I_PERSON
size O B_MEASURE/I_PERSON
, O O
with O O
females O B_PERSON
accompanied O O
by O O
a O O
calf O B_BIO/B_PERSON
having O O
smaller O B_MEASURE/B_PERSON
summer O I_MEASURE/I_PERSON
ranges O I_MEASURE/I_PERSON
across O O
all O O
scales O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BODY_PART_OR_ORGAN_COMPONENT
. O O

Variation O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
in O O
home O B_MEASURE/B_LOCATION
range O I_MEASURE/I_LOCATION
size O I_MEASURE/I_LOCATION
was O O
strongly O O
correlated O O
with O O
spatiotemporal O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
changes O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
in O O
quantity O B_MEASURE/B_LOCATION
and O O
quality O B_MEASURE/B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
natural O B_PERSON/B_DISEASE_ADJECTIVE[DISEASE]
food O I_PERSON/I_DISEASE_ADJECTIVE[DISEASE]
resources O I_PERSON/I_DISEASE_ADJECTIVE[DISEASE]
. O O

Home O B_MEASURE/B_PERSON
range O B_MEASURE/I_PERSON
size O B_MEASURE/I_PERSON
decreased O O
with O O
increasing O O
browse O B_MEASURE
density O I_MEASURE
at O O
daily O B_TIME[MEASURE]/B_PERSON
scales O I_TIME[MEASURE]/I_PERSON
, O O
but O O
the O O
relationship O B_PERSON/B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
changed O O
to O O
positive O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
at O O
longer O B_TIME[MEASURE]/B_LOCATION
temporal O I_TIME[MEASURE]/I_LOCATION
scales O I_TIME[MEASURE]/I_LOCATION
. O O

In O O
contrast O B_MEASURE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
browse O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
quality O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
was O O
consistently O O
negatively O O
correlated O O
with O O
home O B_MEASURE/B_ORGANISM_FUNCTION
range O I_MEASURE/I_ORGANISM_FUNCTION
size O I_MEASURE/I_ORGANISM_FUNCTION
except O O
at O O
the O O
monthly O B_MEASURE/B_LOCATION
scale O I_MEASURE/I_LOCATION
during O O
winter O B_TIME[MEASURE]/B_LOCATION
when O O
depletion O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_MEASURE
of O O
high O B_DISEASE_ADJECTIVE[DISEASE]/B_GENE
- O O
quality O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
forage O B_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
occurs O O
. O O

Local O B_DISEASE_ADJECTIVE[DISEASE]/B_LOCATION
climate O I_DISEASE_ADJECTIVE[DISEASE]/I_LOCATION
affected O O
total O B_MEASURE/B_DISEASE_ADJECTIVE[DISEASE]
home O B_MEASURE/I_DISEASE_ADJECTIVE[DISEASE]
range O B_MEASURE/I_DISEASE_ADJECTIVE[DISEASE]
size O B_MEASURE/I_DISEASE_ADJECTIVE[DISEASE]
more O B_MEASURE/I_DISEASE_ADJECTIVE[DISEASE]
than O O
core O B_MEASURE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
areas O I_MEASURE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

Temperature O B_TIME[MEASURE]/B_LOCATION
, O O
precipitation O B_LOCATION/B_DISEASE
and O O
snow O B_MEASURE/B_LOCATION
depth O B_MEASURE/I_LOCATION
influenced O O
home O B_MEASURE/B_LOCATION
range O B_MEASURE/I_LOCATION
size O B_MEASURE/I_LOCATION
directly O O
at O O
short O B_TIME[MEASURE]/B_LOCATION
temporal O I_TIME[MEASURE]/I_LOCATION
scales O I_TIME[MEASURE]/I_LOCATION
. O O

5 O B_NUMBER[MEASURE]
. O O

The O O
relative O B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
effects O I_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
of O O
intrinsic O B_TIME[MEASURE]/B_EDU[ORGANIZATION]
and O O
extrinsic O B_DISEASE_ADJECTIVE[DISEASE]/B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
determinants O B_DISEASE_ADJECTIVE[DISEASE]/I_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
variation O B_DISEASE_ADJECTIVE[DISEASE]/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
in O O
home O B_MEASURE/B_LOCATION
range O I_MEASURE/I_LOCATION
size O I_MEASURE/I_LOCATION
differed O O
with O O
spatiotemporal O B_MEASURE/B_LOCATION
scale O I_MEASURE/I_LOCATION
, O O
providing O O
clear O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
evidence O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
that O O
home O B_MEASURE
range O I_MEASURE
size O I_MEASURE
is O O
scale O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
dependent O I_DISEASE_ADJECTIVE[DISEASE]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
in O O
this O O
large O B_LOCATION/B_DISEASE_ADJECTIVE[DISEASE]
browser O I_LOCATION/I_DISEASE_ADJECTIVE[DISEASE]
. O O

Insight O B_PERSON/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
into O O
the O O
behavioural O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
responses O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
of O O
populations O B_LOCATION/B_BIO
to O O
climatic O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
stochasticity O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
and O O
forage O B_MEASURE/B_LOCATION
variability O I_MEASURE/I_LOCATION
is O O
essential O B_TIME[MEASURE]/B_DRUG_ADJECTIVE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
in O O
view O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
of O O
current O B_TIME[MEASURE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
future O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_TIME[MEASURE]
climate O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_TIME[MEASURE]
change O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_TIME[MEASURE]
, O O
especially O O
for O O
populations O B_LOCATION/B_BIO
with O O
thermoregulatory O B_BIO/B_LOCATION
restrictions O I_BIO/I_LOCATION
living O O
at O O
the O O
southern O B_LOCATION/B_MEASURE
limit O I_LOCATION/I_MEASURE
of O O
their O O
distribution O B_ORGANIZATION/B_LOCATION
. O O

Npc1 O O
is O O
involved O O
in O O
sterol O O
trafficking O O
in O O
the O O
filamentous O O
fungus O O
Fusarium B B_BIO/B_CELL[BODY_PART_OR_ORGAN_COMPONENT]
graminearum I B_BIO/I_CELL[BODY_PART_OR_ORGAN_COMPONENT]
. O O

The O O
ortholog O O
of O O
the O O
human B B_SPECIES[BIO]/B_CELL_COMPONENT[BODY_PART_OR_ORGAN_COMPONENT]
gene O O
NPC1 O O
was O O
identified O O
in O O
the O O
plant O O
pathogenic O O
, O O
filamentous O O
fungus O O
Fusarium B B_BIO
graminearum I I_BIO
by O O
shared O O
amino O O
acid O O
sequence O O
, O O
protein O O
domain O O
structure O O
and O O
cellular O O
localization O O
of O O
the O O
mature O O
fungal O O
protein O O
. O O

The O O
FusariumNpc1 O O
gene O O
shares O O
34 O O
% O O
amino O O
acid O O
sequence O O
identity O O
and O O
51 O O
% O O
similarity O O
to O O
the O O
human B B_BIO/B_GENE
gene O O
, O O
has O O
similar O O
domain O O
structure O O
and O O
is O O
constitutively O O
expressed O O
, O O
although O O
up O O
- O O
regulated O O
in O O
ungerminated O O
macroconidia O O
and O O
ascospores O O
. O O

GFP O B_GENE/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- O O
tagged O O
Npc1p O B_GENE
localizes O O
to O O
the O O
fungal O B_CELL_COMPONENT[BODY_PART_OR_ORGAN_COMPONENT]/B_DISEASE_ADJECTIVE[DISEASE]
vacuolar O I_CELL_COMPONENT[BODY_PART_OR_ORGAN_COMPONENT]/I_DISEASE_ADJECTIVE[DISEASE]
membrane O I_CELL_COMPONENT[BODY_PART_OR_ORGAN_COMPONENT]/I_DISEASE_ADJECTIVE[DISEASE]
. O O

Cultures O B_LOCATION/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
derived O O
from O O
a O O
Deltanpc1 O B_GENE/B_BIO
mutant O I_GENE/I_BIO
strain O I_GENE/I_BIO
contain O O
significantly O O
more O O
ergosterol O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
than O O
cultures O B_LOCATION/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
the O O
wildtype O B_SPECIES[BIO]/B_PERSON
. O O

Staining O O
with O O
the O O
fluorescent O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
sterol O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
binding O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
dye O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
filipin O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
, O O
shows O O
that O O
ergosterol O B_DISEASE_ADJECTIVE[DISEASE]
accumulates O I_DISEASE_ADJECTIVE[DISEASE]
in O O
vacuoles O B_CELL[BODY_PART_OR_ORGAN_COMPONENT]/B_BIO
of O O
the O O
Deltanpc1 O B_DISEASE_ADJECTIVE[DISEASE]/B_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
mutant O I_DISEASE_ADJECTIVE[DISEASE]/I_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
but O O
not O O
the O O
wildtype O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
strain O I_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
. O O

The O O
Deltanpc1 O B_DISEASE_ADJECTIVE[DISEASE]/B_GENE
mutant O B_DISEASE_ADJECTIVE[DISEASE]/I_GENE
has O O
a O O
temperature O B_DISEASE_ADJECTIVE[DISEASE]
dependent O I_DISEASE_ADJECTIVE[DISEASE]
reduction O I_DISEASE_ADJECTIVE[DISEASE]
in O O
growth O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANISM_FUNCTION
and O O
greater O B_DISEASE_ADJECTIVE[DISEASE]
sensitivity O I_DISEASE_ADJECTIVE[DISEASE]
to O O
the O O
ergosterol O B_DISEASE_ADJECTIVE[DISEASE]/B_BIO
synthesis O B_DISEASE_ADJECTIVE[DISEASE]/I_BIO
inhibiting O O
fungicide O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
tebuconazole O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
compared O O
with O O
the O O
wildtype O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
strain O I_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
or O O
the O O
mutant O B_PERSON/B_CELL_OR_MOLECULAR_DYSFUNCTION[DISEASE]
complemented O O
with O O
wildtype O B_GENE/B_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
Npc1 O I_GENE/I_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

The O O
mutant O O
also O O
is O O
significantly O O
reduced O O
in O O
pathogenicity O O
to O O
wheat B B_BIO
. O O

Our O O
results O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
are O O
consistent O B_DISEASE_ADJECTIVE[DISEASE]/B_GENE
with O O
the O O
interpretation O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
that O O
Npc1p O B_GENE
is O O
important O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
for O O
normal O B_DISEASE_ADJECTIVE[DISEASE]/B_PHYSIOLOGIC_FUNCTION[ORGANISM_FUNCTION]
transport O B_DISEASE_ADJECTIVE[DISEASE]/I_PHYSIOLOGIC_FUNCTION[ORGANISM_FUNCTION]
of O O
ergosterol O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
from O O
the O O
vacuole O B_CELL_COMPONENT[BODY_PART_OR_ORGAN_COMPONENT]/B_DISEASE_ADJECTIVE[DISEASE]
and O O
is O O
essential O B_DRUG_ADJECTIVE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
for O O
proper O B_DISEASE_ADJECTIVE[DISEASE]/B_ORGANISM_FUNCTION
membrane O B_DISEASE_ADJECTIVE[DISEASE]/I_ORGANISM_FUNCTION
function O B_DISEASE_ADJECTIVE[DISEASE]/I_ORGANISM_FUNCTION
under O O
particular O B_DISEASE_ADJECTIVE[DISEASE]
environmental O I_DISEASE_ADJECTIVE[DISEASE]
conditions O I_DISEASE_ADJECTIVE[DISEASE]
. O O

Genetic O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
diversity O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
and O O
phylogenetic O B_BIO/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
position O B_BIO/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
the O O
subclass O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
Astomatia O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
( O O
Ciliophora O B_MEASURE/B_BIO
) O O
based O O
on O O
a O O
sampling O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
of O O
six O B_BIO/B_PERSON
genera O I_BIO/I_PERSON
from O O
West O B_LOCATION/B_MEASURE
African O I_LOCATION/I_MEASURE
oligochaetes O I_LOCATION/I_MEASURE
( O O
Glossoscolecidae O B_SPECIES[BIO]/B_LOCATION
, O O
Megascolecidae O B_LOCATION/B_MEASURE
) O O
, O O
including O O
description O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
of O O
the O O
new O B_BIO/B_GENE
genus O B_BIO/I_GENE
Paraclausilocola O B_BIO/I_GENE
n O B_BIO/I_GENE
. O O
gen O B_GENE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

To O O
more O O
confidently O O
assess O O
phylogenetic O O
relationships O O
among O O
astome O O
ciliates O O
, O O
we O O
obtained O O
small O O
subunit O O
( O O
SSU O O
) O O
rRNA O O
sequences O O
from O O
nine O O
species O O
distributed O O
in O O
six O O
genera O O
and O O
three O O
families O O
: O O
Almophrya B B_SPECIES[BIO]
bivacuolata I I_SPECIES[BIO]
, O O
Eudrilophrya B B_BACTERIUM[BIO]/B_LOCATION
complanata I I_BACTERIUM[BIO]/I_LOCATION
, O O
Metaracoelophrya O O
sp O O
. O O

1 O B_NUMBER[MEASURE]
, O O
Metaracoelophrya O B_BACTERIUM[BIO]
sp O I_LOCATION
. O O

2 O O
, O O
Metaracoelophrya B B_MEASURE/B_PERSON
intermedia I I_MEASURE/I_PERSON
, O O
Metaradiophrya O O
sp O O
. O O
, O O
Njinella B B_NUMBER[MEASURE]
prolifera I I_NUMBER[MEASURE]
, O O
Paraclausilocola B B_MEASURE/B_DISEASE_ADJECTIVE[DISEASE]
constricta I I_MEASURE/I_DISEASE_ADJECTIVE[DISEASE]
n I I_MEASURE/I_DISEASE_ADJECTIVE[DISEASE]
. I I_MEASURE/I_DISEASE_ADJECTIVE[DISEASE]
gen I I_MEASURE/I_DISEASE_ADJECTIVE[DISEASE]
. I I_MEASURE/I_DISEASE_ADJECTIVE[DISEASE]
, I I_MEASURE/I_DISEASE_ADJECTIVE[DISEASE]
n I I_MEASURE/I_DISEASE_ADJECTIVE[DISEASE]
. I I_MEASURE/I_DISEASE_ADJECTIVE[DISEASE]
sp I I_MEASURE/I_DISEASE_ADJECTIVE[DISEASE]
. I I_MEASURE/I_DISEASE_ADJECTIVE[DISEASE]
, O O
and O O
Paraclausilocola B B_MEASURE/B_DISEASE_ADJECTIVE[DISEASE]
elongata I I_MEASURE/I_DISEASE_ADJECTIVE[DISEASE]
n I I_MEASURE/I_DISEASE_ADJECTIVE[DISEASE]
. I I_MEASURE/I_DISEASE_ADJECTIVE[DISEASE]
sp I I_MEASURE/I_DISEASE_ADJECTIVE[DISEASE]
. I I_MEASURE/I_DISEASE_ADJECTIVE[DISEASE]

The O O
two O B_BIO/B_ENT
new O I_BIO/I_ENT
species O I_BIO/I_ENT
in O O
the O O
proposed O O
new O B_PERSON/B_BIO
clausilocolid O I_PERSON/I_BIO
genus O I_PERSON/I_BIO
Paraclausilocola O I_PERSON/I_BIO
n O I_PERSON/I_BIO
. O O
gen O B_GENE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

are O O
astomes O B_CELL[BODY_PART_OR_ORGAN_COMPONENT]/B_DISEASE_ADJECTIVE[DISEASE]
with O O
no O O
attachment O B_CELL_COMPONENT[BODY_PART_OR_ORGAN_COMPONENT]/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
apparatus O I_CELL_COMPONENT[BODY_PART_OR_ORGAN_COMPONENT]/I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
, O O
two O B_MEASURE/B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
files O B_MEASURE/I_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
contractile O B_BODY_PART_OR_ORGAN_COMPONENT/B_DISEASE_ADJECTIVE[DISEASE]
vacuoles O I_BODY_PART_OR_ORGAN_COMPONENT/I_DISEASE_ADJECTIVE[DISEASE]
, O O
and O O
an O O
arc O B_BODY_PART_OR_ORGAN_COMPONENT/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- O O
like O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_BODY_PART_OR_ORGAN_COMPONENT
anterior O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/I_BODY_PART_OR_ORGAN_COMPONENT
suture O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/I_BODY_PART_OR_ORGAN_COMPONENT
that O O
has O O
differentiations O B_LOCATION
of O O
thigmotactic O B_CELL[BODY_PART_OR_ORGAN_COMPONENT]/B_MEASURE
ciliature O I_CELL[BODY_PART_OR_ORGAN_COMPONENT]/I_MEASURE
on O O
the O O
anterior O B_LOCATION
ends O I_LOCATION
of O O
the O O
left O B_BODY_PART_OR_ORGAN_COMPONENT/B_DISEASE_ADJECTIVE[DISEASE]
kineties O I_BODY_PART_OR_ORGAN_COMPONENT/I_DISEASE_ADJECTIVE[DISEASE]
of O O
the O O
upper O B_BODY_PART_OR_ORGAN_COMPONENT/B_DISEASE_ADJECTIVE[DISEASE]
surface O I_BODY_PART_OR_ORGAN_COMPONENT/I_DISEASE_ADJECTIVE[DISEASE]
. O O

Phylogenetic O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
analyses O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
were O O
undertaken O O
using O O
neighbor O B_PERSON/B_LOCATION
- O O
joining O O
, O O
Bayesian O B_MEASURE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
inference O I_MEASURE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
maximum O B_MEASURE
likelihood O I_MEASURE
, O O
and O O
maximum O B_MEASURE
parsimony O I_MEASURE
. O O

The O O
nine O B_BIO/B_PERSON
species O I_BIO/I_PERSON
of O O
astomes O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
formed O O
a O O
strongly O O
supported O O
clade O B_BIO/B_LOCATION
, O O
showing O O
the O O
subclass O B_DISEASE_ADJECTIVE[DISEASE]/B_PERSON
Astomatia O I_DISEASE_ADJECTIVE[DISEASE]/I_PERSON
to O O
be O O
monophyletic O B_MEASURE/B_DISEASE_ADJECTIVE[DISEASE]
and O O
a O O
weakly O O
supported O O
sister O B_PERSON/B_BIO
clade O I_PERSON/I_BIO
to O O
the O O
scuticociliates O B_BACTERIUM[BIO]/B_MEASURE
. O O

There O O
were O O
two O B_NUMBER[MEASURE]/B_LOCATION
strongly O O
supported O O
clades O B_LOCATION/B_ORGANIZATION
within O O
the O O
astomes O B_BIO/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

However O O
, O O
genera O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
assigned O O
to O O
the O O
same O B_PERSON/B_ORGANIZATION
family O I_PERSON/I_ORGANIZATION
were O O
found O O
in O O
different O B_DISEASE_ADJECTIVE[DISEASE]/B_PERSON
clades O I_DISEASE_ADJECTIVE[DISEASE]/I_PERSON
, O O
and O O
genera O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
assigned O O
to O O
the O O
same O B_PERSON/B_MEASURE
order O I_PERSON/I_MEASURE
were O O
found O O
in O O
both O O
clades O B_LOCATION/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

Thus O O
, O O
astome O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
taxa O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
appear O O
to O O
be O O
paraphyletic O B_DISEASE_ADJECTIVE[DISEASE]/B_BIO
when O O
morphology O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
is O O
used O O
to O O
assign O O
species O B_BIO/B_PERSON
to O O
genera O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
. O O

Negotiating O O
a O O
noisy O B_DISEASE_ADJECTIVE[DISEASE]
, O O
information O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
- O O
rich O B_LOCATION/B_ORGANIZATION
environment O I_LOCATION/I_ORGANIZATION
in O O
search O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
of O O
cryptic O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
prey O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
: O O
olfactory O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
predators O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
need O O
patchiness O B_DISEASE_ADJECTIVE[DISEASE]/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
in O O
prey O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
cues O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
. O O

1 O B_NUMBER[MEASURE]
. O O

Olfactory O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
predator O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
search O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
processes O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
differ O O
fundamentally O O
to O O
those O O
based O O
on O O
vision O B_BIO/B_BODY_PART_OR_ORGAN_COMPONENT
, O O
particularly O O
when O O
odour O B_BIO/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
cues O I_BIO/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
are O O
deposited O O
rather O O
than O O
airborne O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_TIME[MEASURE]
or O O
emanating O O
from O O
a O O
point O B_LOCATION/B_PERSON
source O B_LOCATION/I_PERSON
. O O

When O O
searching O O
for O O
visually O O
cryptic O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
prey O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
that O O
may O O
have O O
moved O O
some O O
distance O B_MEASURE/B_LOCATION
from O O
a O O
deposited O B_PERSON/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
odour O I_PERSON/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
cue O I_PERSON/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
cue O B_MEASURE/B_LOCATION
context O I_MEASURE/I_LOCATION
and O O
spatial O B_MEASURE/B_LOCATION
variability O I_MEASURE/I_LOCATION
are O O
the O O
most O O
likely O B_DISEASE_ADJECTIVE[DISEASE]/B_LOCATION
sources O I_DISEASE_ADJECTIVE[DISEASE]/I_LOCATION
of O O
information O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
about O O
prey O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
location O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
available O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
to O O
an O O
olfactory O B_PERSON/B_BIO
predator O I_PERSON/I_BIO
. O O

2 O B_NUMBER[MEASURE]
. O O

We O O
tested O O
whether O O
the O O
house B B_SPECIES[BIO]/B_DISEASE_ADJECTIVE[DISEASE]
mouse I I_SPECIES[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
( O O
Mus B B_LOCATION/B_BIO
domesticus I I_LOCATION/I_BIO
) O O
, O O
a O O
model O O
olfactory O O
predator O O
, O O
would O O
use O O
cue O O
context O O
and O O
spatial O O
variability O O
when O O
searching O O
for O O
buried O O
food O O
items O O
; O O
specifically O O
, O O
we O O
tested O O
the O O
effect O O
of O O
varying O O
cue O O
patchiness O O
, O O
odour O O
strength O O
, O O
and O O
cue O O
- O O
prey O O
association O O
on O O
mouse B B_BIO/B_DISEASE
foraging O O
success O O
. O O

3 O B_NUMBER[MEASURE]
. O O

Within O O
mouse B B_BIO/B_DISEASE
- O O
and O O
predator O O
- O O
proof O O
enclosures O O
, O O
we O O
created O O
grids O O
of O O
100 O O
sand O O
- O O
filled O O
Petri O O
dishes O O
and O O
buried O O
peanut B B_BIO/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
pieces O O
in O O
a O O
set O O
number O O
of O O
these O O
patches O O
to O O
represent O O
visually O O
cryptic O O
' O O
prey O O
' O O
. O O

By O O
adding O O
peanut B B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
oil O O
to O O
selected O O
dishes O O
, O O
we O O
varied O O
the O O
spatial O O
distribution O O
of O O
prey O O
odour O O
relative O O
to O O
the O O
distribution O O
of O O
prey O O
patches O O
in O O
each O O
grid O O
, O O
to O O
reflect O O
different O O
levels O O
of O O
cue O O
patchiness O O
( O O
Experiment O O
1 O O
) O O
, O O
odour O O
strength O O
( O O
Experiment O O
2 O O
) O O
and O O
cue O O
- O O
prey O O
association O O
( O O
Experiment O O
3 O O
) O O
. O O

We O O
measured O O
the O O
overnight O O
foraging O O
success O O
of O O
individual O O
mice B B_BIO/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
( O O
percentage O O
of O O
searched O O
patches O O
containing O O
prey O O
) O O
, O O
as O O
well O O
as O O
their O O
foraging O O
activity O O
( O O
percentage O O
of O O
patches O O
searched O O
) O O
, O O
and O O
prey O O
survival O O
( O O
percentage O O
of O O
unsearched O O
prey O O
patches O O
) O O
. O O

4 O B_NUMBER[MEASURE]
. O O

Mouse B B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
foraging O O
success O O
was O O
highest O O
where O O
odour O O
cues O O
were O O
patchy O O
rather O O
than O O
uniform O O
( O O
Experiment O O
1 O O
) O O
, O O
and O O
where O O
cues O O
were O O
tightly O O
associated O O
with O O
prey O O
location O O
, O O
rather O O
than O O
randomly O O
or O O
uniformly O O
distributed O O
( O O
Experiment O O
3 O O
) O O
. O O

However O O
, O O
when O O
cues O O
at O O
prey O O
patches O O
were O O
ten O O
times O O
stronger O O
than O O
a O O
uniformly O O
distributed O O
weak O O
background O O
odour O O
, O O
mice B B_BIO/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
did O O
not O O
improve O O
their O O
foraging O O
success O O
over O O
that O O
experienced O O
when O O
cues O O
were O O
of O O
uniform O O
strength O O
and O O
distribution O O
( O O
Experiment O O
2 O O
) O O
. O O

5 O B_NUMBER[MEASURE]
. O O

These O O
results O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
suggest O O
that O O
spatial O B_DISEASE_ADJECTIVE[DISEASE]/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
variability O B_DISEASE_ADJECTIVE[DISEASE]/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
cue O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
context O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
are O O
important O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
means O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
by O O
which O O
olfactory O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
predators O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
can O O
use O O
deposited O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
odour O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
cues O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
to O O
locate O O
visually O O
cryptic O B_DISEASE_ADJECTIVE[DISEASE]/B_LOCATION
prey O I_DISEASE_ADJECTIVE[DISEASE]/I_LOCATION
. O O

They O O
also O O
indicate O O
that O O
chemical O B_BIO/B_PERSON
crypsis O I_BIO/I_PERSON
can O O
disrupt O O
these O O
search O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
processes O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
as O O
effectively O O
as O O
background O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
matching O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
in O O
visually O O
based O O
predator O B_BIO/B_PERSON
- O O
prey O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANIZATION
systems O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_ORGANIZATION
. O O

Behaviour O O
during O O
elevated O O
water O O
temperatures O O
: O O
can O O
physiology O O
explain O O
movement O O
of O O
juvenile O O
Atlantic B B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
salmon I I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
to O O
cool O O
water O O
? O O

1 O B_NUMBER[MEASURE]
. O O

Temperature O B_LOCATION/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
governs O I_LOCATION/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
most O O
physiological O B_DISEASE_ADJECTIVE[DISEASE]/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
processes O B_DISEASE_ADJECTIVE[DISEASE]/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
in O O
animals O B_BIO/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

Ectotherms O B_BIO/B_PERSON
behaviourally O O
thermoregulate O O
by O O
selecting O O
habitats O B_LOCATION/B_PERSON
with O O
temperatures O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
regulating O O
their O O
body O B_MEASURE/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
temperature O B_MEASURE/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
for O O
optimal O B_DISEASE_ADJECTIVE[DISEASE]/B_ORGANISM_FUNCTION
physiological O B_DISEASE_ADJECTIVE[DISEASE]/I_ORGANISM_FUNCTION
functioning O B_DISEASE_ADJECTIVE[DISEASE]/I_ORGANISM_FUNCTION
. O O

However O O
, O O
ectotherms O B_BIO/B_PERSON
can O O
experience O O
temperature O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
extremes O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
forcing O O
the O O
organisms O B_BIO/B_BODY_PART_OR_ORGAN_COMPONENT
to O O
seek O O
temperature O B_DISEASE_ADJECTIVE[DISEASE]/B_BIO
refuge O B_DISEASE_ADJECTIVE[DISEASE]/I_BIO
. O O

2 O B_NUMBER[MEASURE]
. O O

Fish O B_BIO/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
actively O O
avoid O O
potentially O O
lethal O B_DISEASE
temperatures O I_DISEASE
by O O
moving O O
to O O
cool O B_LOCATION/B_PERSON
- O O
water O B_LOCATION/B_ORGANIZATION
sites O I_LOCATION/I_ORGANIZATION
created O O
by O O
inflowing O O
tributaries O B_LOCATION
and O O
groundwater O B_LOCATION
seeps O I_LOCATION
. O O

Juvenile O O
Atlantic B B_SPECIES[BIO]/B_DISEASE_ADJECTIVE[DISEASE]
salmon I I_SPECIES[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
( O O
Salmo B B_DISEASE/B_LOCATION
salar I B_DISEASE/I_LOCATION
) O O
of O O
different O O
age O O
classes O O
exhibit O O
different O O
behavioural O O
responses O O
to O O
elevated O O
temperatures O O
( O O
> O O
23 O O
^ O O
0C O O
) O O
. O O

Yearling O O
( O O
1 O O
+ O O
) O O
and O O
2 O O
- O O
year O O
- O O
old O O
( O O
2 O O
+ O O
) O O
Atlantic B B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
salmon I I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
often O O
cease O O
feeding O O
, O O
abandon O O
territorial O O
behaviour O O
and O O
swim O O
continuously O O
in O O
aggregations O O
in O O
cool O O
- O O
water O O
sites O O
; O O
whereas O O
young O O
- O O
of O O
- O O
the O O
- O O
year O O
( O O
0 O O
+ O O
) O O
fish O O
continue O O
defending O O
territories O O
and O O
foraging O O
. O O

3 O B_NUMBER[MEASURE]
. O O

This O O
study O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
determined O O
whether O O
the O O
behavioural O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
shift O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
in O O
older O B_LOCATION
individuals O I_LOCATION
( O O
2 O B_PERSON/B_LOCATION
+ O I_PERSON/I_LOCATION
) O O
occurred O O
when O O
basal O B_MEASURE/B_BIO
metabolic O B_MEASURE/I_BIO
rate O B_MEASURE/I_BIO
, O O
driven O O
by O O
increasing O O
water O B_MEASURE/B_DISEASE
temperature O I_MEASURE/I_DISEASE
, O O
reached O O
the O O
maximum O B_MEASURE/B_LOCATION
metabolic O B_MEASURE/I_LOCATION
rate O B_MEASURE/I_LOCATION
such O B_MEASURE/I_LOCATION
that O O
anaerobic O B_PERSON/B_CELL[BODY_PART_OR_ORGAN_COMPONENT]
pathways O I_PERSON/I_CELL[BODY_PART_OR_ORGAN_COMPONENT]
were O O
recruited O O
to O O
provide O O
energy O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
to O O
support O O
vital O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANISM_FUNCTION
processes O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_ORGANISM_FUNCTION
. O O

Behaviour O O
( O O
feeding O O
and O O
stress O O
responses O O
) O O
, O O
oxygen O O
consumption O O
, O O
muscle O O
lactate O O
and O O
glycogen O O
, O O
and O O
circulating O O
blood O O
lactate O O
and O O
glucose O O
concentrations O O
were O O
measured O O
in O O
wild O O
0 O O
+ O O
and O O
2 O O
+ O O
Atlantic B B_SPECIES[BIO]/B_DISEASE_ADJECTIVE[DISEASE]
salmon I I_SPECIES[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
acclimated O O
to O O
water O O
temperatures O O
between O O
16 O O
and O O
28 O O
^ O O
0C O O
. O O

4 O B_NUMBER[MEASURE]
. O O

Results O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
indicate O O
that O O
oxygen O B_DISEASE_ADJECTIVE[DISEASE]/B_ORGANISM_FUNCTION
consumption O B_DISEASE_ADJECTIVE[DISEASE]/I_ORGANISM_FUNCTION
of O O
the O O
2 O B_BODY_PART_OR_ORGAN_COMPONENT/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
+ O I_BODY_PART_OR_ORGAN_COMPONENT/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
fish O I_BODY_PART_OR_ORGAN_COMPONENT/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
increased O O
with O O
temperature O B_MEASURE/B_LOCATION
and O O
reached O O
a O O
plateau O B_LOCATION/B_MEASURE
at O O
24 O B_TIME[MEASURE]/B_LOCATION
^ O I_TIME[MEASURE]/I_LOCATION
0C O I_TIME[MEASURE]/I_LOCATION
, O O
a O O
temperature O B_MEASURE/B_LOCATION
that O O
corresponded O O
to O O
cessation O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_TIME[MEASURE]
of O O
feeding O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_ORGANISM_FUNCTION
and O O
a O O
significant O B_MEASURE/B_LOCATION
increase O I_MEASURE/I_LOCATION
in O O
muscle O B_BODY_PART_OR_ORGAN_COMPONENT
and O O
blood O B_BODY_PART_OR_ORGAN_COMPONENT/B_DISEASE_ADJECTIVE[DISEASE]
lactate O I_BODY_PART_OR_ORGAN_COMPONENT/I_DISEASE_ADJECTIVE[DISEASE]
levels O I_BODY_PART_OR_ORGAN_COMPONENT/I_DISEASE_ADJECTIVE[DISEASE]
. O O

By O O
contrast O B_MEASURE/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
, O O
oxygen O B_DISEASE_ADJECTIVE[DISEASE]/B_ORGANISM_FUNCTION
consumption O B_DISEASE_ADJECTIVE[DISEASE]/I_ORGANISM_FUNCTION
in O O
0 O B_BODY_PART_OR_ORGAN_COMPONENT/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
+ O I_BODY_PART_OR_ORGAN_COMPONENT/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
fish O I_BODY_PART_OR_ORGAN_COMPONENT/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
did O O
not O O
reach O O
a O O
plateau O B_MEASURE/B_DISEASE
, O O
feeding O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANISM_FUNCTION
continued O O
and O O
muscle O B_DISEASE_ADJECTIVE[DISEASE]/B_ORGANISM_FUNCTION
lactate O B_DISEASE_ADJECTIVE[DISEASE]/I_ORGANISM_FUNCTION
did O O
not O O
increase O O
, O O
even O O
at O O
the O O
highest O B_MEASURE/B_LOCATION
temperatures O I_MEASURE/I_LOCATION
tested O O
( O O
28 O B_MEASURE
^ O O
0C O B_MEASURE
) O O
. O O

5 O B_NUMBER[MEASURE]
. O O

To O O
conclude O O
, O O
the O O
experiment O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
demonstrated O O
that O O
the O O
0 O B_TIME[MEASURE]/B_PERSON
+ O I_TIME[MEASURE]/I_PERSON
and O O
2 O B_MEASURE/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
+ O I_MEASURE/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
fish O I_MEASURE/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
had O O
different O B_DISEASE_ADJECTIVE[DISEASE]/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
physiological O B_DISEASE_ADJECTIVE[DISEASE]/I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
responses O B_DISEASE_ADJECTIVE[DISEASE]/I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
to O O
the O O
elevated O B_DISEASE_ADJECTIVE[DISEASE]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
water O B_DISEASE_ADJECTIVE[DISEASE]/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
temperatures O B_DISEASE_ADJECTIVE[DISEASE]/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

The O O
results O O
suggest O O
that O O
wild O O
2 O O
+ O O
Atlantic B B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
salmon I I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
employ O O
behavioural O O
responses O O
( O O
e O O
. O O
g O O
. O O
movement O O
to O O
cool O O
- O O
water O O
sites O O
) O O
at O O
elevated O O
temperatures O O
in O O
an O O
effort O O
to O O
mitigate O O
physiological O O
imbalances O O
associated O O
with O O
an O O
inability O O
to O O
support O O
basal O O
metabolism O O
through O O
aerobic O O
metabolic O O
processes O O
. O O

Food O B_ORGANIZATION/B_LOCATION
web O O
complexity O B_MEASURE/B_EDU[ORGANIZATION]
and O O
allometric O B_MEASURE/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
scaling O B_MEASURE/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
relationships O B_MEASURE/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
in O O
stream O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
mesocosms O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
: O O
implications O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
for O O
experimentation O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
. O O

1 O B_NUMBER[MEASURE]
. O O

Mesocosms O B_BIO/B_MEASURE
are O O
used O O
extensively O O
by O O
ecologists O B_PERSON
to O O
gain O O
a O O
mechanistic O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANIZATION
understanding O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_ORGANIZATION
of O O
ecosystems O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
based O O
on O O
the O O
often O O
untested O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
assumption O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
that O O
these O O
systems O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
can O O
replicate O O
the O O
key O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
attributes O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
of O O
natural O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
assemblages O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
. O O

2 O B_NUMBER[MEASURE]
. O O

Previous O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
investigations O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
of O O
stream O B_BIO/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
mesocosm O I_BIO/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
utility O I_BIO/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
have O O
explored O O
community O B_DISEASE_ADJECTIVE[DISEASE]/B_PERSON
composition O I_DISEASE_ADJECTIVE[DISEASE]/I_PERSON
, O O
but O O
here O O
for O O
the O O
first O B_SEQUENCE[MEASURE]/B_ENT
time O I_SEQUENCE[MEASURE]/I_ENT
, O O
we O O
extend O O
the O O
approach O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANIZATION
to O O
consider O O
the O O
replicability O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
and O O
realism O B_PERSON/B_DISEASE_ADJECTIVE[DISEASE]
of O O
food O B_LOCATION/B_ORGANIZATION
webs O I_LOCATION/I_ORGANIZATION
in O O
four O B_LOCATION/B_MEASURE
outdoor O I_LOCATION/I_MEASURE
channels O I_LOCATION/I_MEASURE
( O O
4 O B_MEASURE/B_LOCATION
m O I_MEASURE/I_LOCATION
( O O
2 O B_MEASURE/B_LOCATION
) O O
) O O
. O O

3 O B_NUMBER[MEASURE]
. O O

The O O
four O B_LOCATION/B_BIO
food O I_LOCATION/I_BIO
webs O I_LOCATION/I_BIO
were O O
similarly O O
complex O B_DISEASE_ADJECTIVE[DISEASE]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
consisting O O
of O O
diverse O B_BIO/B_LOCATION
assemblages O I_BIO/I_LOCATION
( O O
61 O B_MEASURE
- O O
71 O B_MEASURE
taxa O I_MEASURE
) O O
with O O
dense O B_LOCATION/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
feeding O I_LOCATION/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
interactions O I_LOCATION/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
( O O
directed O O
connectance O B_MEASURE/B_LOCATION
0 O I_MEASURE/I_LOCATION
. O O
09 O B_MEASURE
- O O
0 O B_MEASURE
. O O
11 O B_MEASURE
) O O
. O O

Mesocosm O B_PERSON/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
food O I_PERSON/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
web O O
structural O B_MEASURE/B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
attributes O B_MEASURE/I_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
were O O
within O O
the O O
range O B_LOCATION/B_MEASURE
reported O O
for O O
82 O B_TIME[MEASURE]/B_PERSON
well O O
- O O
characterized O O
food O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
webs O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
from O O
natural O B_LOCATION
streams O I_LOCATION
and O O
rivers O B_LOCATION
. O O

When O O
compared O O
with O O
112 O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
additional O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_BIO
food O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_BIO
webs O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_BIO
from O O
standing O O
freshwater O B_LOCATION/B_BIO
, O O
marine O B_LOCATION
, O O
estuarine O B_LOCATION/B_BIO
and O O
terrestrial O B_LOCATION/B_PERSON
environments O I_LOCATION/I_PERSON
, O O
stream O B_LOCATION/B_BIO
food O I_LOCATION/I_BIO
webs O I_LOCATION/I_BIO
( O O
including O O
mesocosms O B_BIO/B_LOCATION
) O O
had O O
similar O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
characteristic O I_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
path O I_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
lengths O I_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
, O O
but O O
typically O O
lower O B_MEASURE/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
mean O B_MEASURE/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
food O B_MEASURE/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
chain O B_MEASURE/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
length O B_MEASURE/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
exponents O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
for O O
the O O
species O B_BIO/B_MEASURE
- O O
link O B_MEASURE/B_LOCATION
relationship O I_MEASURE/I_LOCATION
. O O

4 O B_NUMBER[MEASURE]
. O O

Body O B_MEASURE/B_LOCATION
size O B_MEASURE/I_LOCATION
( O O
M O B_OTHER/B_LOCATION
) O O
abundance O B_MEASURE
( O O
N O B_OTHER/B_LOCATION
) O O
allometric O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
scaling O O
coefficients O B_MEASURE/B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
for O O
trivariate O B_MEASURE/B_BIO
taxonomic O I_MEASURE/I_BIO
mesocosm O I_MEASURE/I_BIO
food O I_MEASURE/I_BIO
webs O I_MEASURE/I_BIO
( O O
- O O
0 O B_MEASURE
. O O
53 O B_MEASURE
to O O
- O O
0 O B_NUMBER[MEASURE]
. O O
49 O B_MEASURE
) O O
and O O
individual O B_LOCATION/B_BIO
size O I_LOCATION/I_BIO
distributions O I_LOCATION/I_BIO
( O O
- O O
0 O B_NUMBER[MEASURE]
. O O
60 O B_MEASURE
to O O
- O O
0 O B_NUMBER[MEASURE]
. O O
58 O B_MEASURE
) O O
were O O
consistent O B_DISEASE_ADJECTIVE[DISEASE]/B_GENE
and O O
similar O B_PERSON/B_DISEASE_ADJECTIVE[DISEASE]
to O O
those O O
from O O
natural O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
systems O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
, O O
suggesting O O
that O O
patterns O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
of O O
energy O B_MEASURE/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
flux O B_MEASURE/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
between O O
mesocosm O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
consumers O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
and O O
resources O B_PERSON/B_LOCATION
were O O
realistic O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
approximations O I_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
. O O

5 O B_NUMBER[MEASURE]
. O O

These O O
results O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
suggest O O
that O O
stream O B_LOCATION/B_DISEASE_ADJECTIVE[DISEASE]
mesocosms O I_LOCATION/I_DISEASE_ADJECTIVE[DISEASE]
of O O
this O O
scale O B_LOCATION/B_BIO
can O O
support O O
replicate O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
food O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
webs O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
with O O
a O O
degree O B_MEASURE/B_LOCATION
of O O
biocomplexity O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
that O O
is O O
comparable O B_TIME[MEASURE]/B_DISEASE_ADJECTIVE[DISEASE]
to O O
' O O
natural O B_ORGANIZATION/B_DISEASE_ADJECTIVE[DISEASE]
' O O
streams O B_LOCATION/B_BIO
. O O

The O O
findings O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
highlight O O
the O O
potential O B_MEASURE
value O I_MEASURE
of O O
mesocosms O B_BIO/B_LOCATION
as O O
model O B_CHEMICAL_CLASS[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
systems O I_CHEMICAL_CLASS[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
for O O
performing O O
experimental O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
manipulations O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
to O O
test O O
ecological O B_CHEMICAL_CLASS[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
theories O I_CHEMICAL_CLASS[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_BIO
, O O
at O O
spatiotemporal O B_MEASURE/B_LOCATION
scales O I_MEASURE/I_LOCATION
of O O
relevance O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
to O O
natural O B_BIO/B_EDU[ORGANIZATION]
ecosystems O I_BIO/I_EDU[ORGANIZATION]
. O O

Tuberculosis O B_DISEASE
. O O

Tuberculosis O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
results O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
in O O
an O O
estimated O O
1 O B_MEASURE
* O O
7 O B_MEASURE/B_DISEASE
million O I_MEASURE/I_DISEASE
deaths O I_MEASURE/I_DISEASE
each O O
year O B_TIME[MEASURE]
and O O
the O O
worldwide O B_MEASURE
number O I_MEASURE
of O O
new O B_PERSON/B_DISEASE
cases O I_PERSON/I_DISEASE
( O O
more O B_MEASURE
than O O
9 O B_TIME[MEASURE]
million O I_TIME[MEASURE]
) O O
is O O
higher O B_MEASURE/B_DISEASE_ADJECTIVE[DISEASE]
than O O
at O O
any O O
other O B_TIME[MEASURE]/B_LOCATION
time O B_TIME[MEASURE]/I_LOCATION
in O O
history O B_ORGANIZATION/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

22 O B_MEASURE/B_PERSON
low O I_MEASURE/I_PERSON
- O O
income O B_ORGANIZATION/B_LOCATION
and O O
middle O B_MEASURE/B_PERSON
- O O
income O B_LOCATION/B_PERSON
countries O B_LOCATION/I_PERSON
account O O
for O O
more O B_MEASURE/B_PERSON
than O O
80 O B_MEASURE/B_LOCATION
% O I_MEASURE/I_LOCATION
of O O
the O O
active O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
cases O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
in O O
the O O
world O B_LOCATION
. O O

Due O O
to O O
the O O
devastating O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
effect O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
HIV O B_DISEASE
on O O
susceptibility O B_DISEASE
to O O
tuberculosis O O
, O O
sub O B_DISEASE/B_LOCATION
- O O
Saharan O B_LOCATION/B_ORGANIZATION
Africa O I_LOCATION/I_ORGANIZATION
has O O
been O O
disproportionately O O
affected O O
and O O
accounts O B_ORGANIZATION/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
for O O
four O B_NUMBER[MEASURE]/B_LOCATION
of O O
every O O
five O B_TIME[MEASURE]/B_PERSON
cases O B_TIME[MEASURE]/I_PERSON
of O O
HIV O B_DISEASE/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- O O
associated O O
tuberculosis O B_DISEASE
. O O

In O O
many O B_LOCATION/B_PERSON
regions O I_LOCATION/I_PERSON
highly O O
endemic O B_DISEASE_ADJECTIVE[DISEASE]/B_LOCATION
for O O
tuberculosis O B_DISEASE
, O O
diagnosis O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
continues O O
to O O
rely O O
on O O
century O B_TIME[MEASURE]
- O O
old O B_DISEASE_ADJECTIVE[DISEASE]/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
sputum O B_DISEASE_ADJECTIVE[DISEASE]/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
microscopy O B_DISEASE_ADJECTIVE[DISEASE]/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
; O O
there O O
is O O
no O O
vaccine O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
with O O
adequate O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
effectiveness O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE
and O O
tuberculosis O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
treatment O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
regimens O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
are O O
protracted O B_DISEASE_ADJECTIVE[DISEASE]/B_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
have O O
a O O
risk O B_MEASURE/B_DISEASE_ADJECTIVE[DISEASE]
of O O
toxic O B_DISEASE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
effects O I_DISEASE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

Increasing O O
rates O B_DISEASE_ADJECTIVE[DISEASE]/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
drug O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- O O
resistant O B_DISEASE/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
tuberculosis O I_DISEASE/I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
in O O
eastern O B_LOCATION
Europe O I_LOCATION
, O O
Asia O B_LOCATION
, O O
and O O
sub O B_DISEASE/B_LOCATION
- O O
Saharan O B_LOCATION
Africa O I_LOCATION
now O O
threaten O O
to O O
undermine O O
the O O
gains O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
made O O
by O O
worldwide O B_LOCATION/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
tuberculosis O I_LOCATION/I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
control O I_LOCATION/I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
programmes O I_LOCATION/I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
. O O

Moreover O O
, O O
our O O
fundamental O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
understanding O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
of O O
the O O
pathogenesis O B_DISEASE
of O O
this O O
disease O B_DISEASE
is O O
inadequate O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

However O O
, O O
increased O O
investment O B_ORGANIZATION/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
has O O
allowed O O
basic O B_EDU[ORGANIZATION]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
science O I_EDU[ORGANIZATION]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
translational O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
and O O
applied O O
research O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANIZATION
to O O
produce O O
new O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
data O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
leading O O
to O O
promising O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
progress O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
in O O
the O O
development O B_LOCATION/B_DISEASE_ADJECTIVE[DISEASE]
of O O
improved O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
tuberculosis O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
diagnostics O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
, O O
biomarkers O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
of O O
disease O B_DISEASE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
activity O I_DISEASE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
drugs O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
and O O
vaccines O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_DISEASE
. O O

The O O
growing O O
scientific O B_DISEASE_ADJECTIVE[DISEASE]/B_LOCATION
momentum O I_DISEASE_ADJECTIVE[DISEASE]/I_LOCATION
must O O
be O O
accompanied O O
by O O
much O O
greater O B_ORGANIZATION/B_PERSON
investment O I_ORGANIZATION/I_PERSON
and O O
political O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANIZATION
commitment O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_ORGANIZATION
to O O
meet O O
this O O
huge O B_DISEASE_ADJECTIVE[DISEASE]
persisting O O
challenge O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
to O O
public O B_ORGANIZATION/B_PERSON
health O I_ORGANIZATION/I_PERSON
. O O

Our O O
Seminar O B_LOCATION/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
presents O O
current O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
perspectives O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
on O O
the O O
scale O B_TIME[MEASURE]/B_LOCATION
of O O
the O O
epidemic O B_DISEASE/B_BIO
, O O
the O O
pathogen O B_BIO
and O O
the O O
host O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
response O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_BIO
, O O
present O B_TIME[MEASURE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
emerging O O
methods O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
for O O
disease O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
control O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
( O O
including O O
diagnostics O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
, O O
drugs O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
biomarkers O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
, O O
and O O
vaccines O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
) O O
, O O
and O O
the O O
ongoing O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
challenge O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
tuberculosis O B_DISEASE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
control O I_DISEASE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
in O O
adults O B_PERSON/B_LOCATION
in O O
the O O
21st O B_LOCATION/B_TIME[MEASURE]
century O I_LOCATION/I_TIME[MEASURE]
. O O

Characterization O O
of O O
an O O
omega O O
- O O
class O O
glutathione O O
S O O
- O O
transferase O O
in O O
the O O
stress O O
response O O
of O O
the O O
silkmoth B B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
. O O

The O O
glutathione O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
S O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
- O O
transferase O B_ENZYME[GENE]/B_MEASURE
( O O
GST O B_GENE/B_LOCATION
) O O
superfamily O O
is O O
involved O O
in O O
detoxification O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_PHYSIOLOGIC_FUNCTION[ORGANISM_FUNCTION]
of O O
various O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
xenobiotics O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
. O O

Using O O
real O O
- O O
time O O
PCR O O
, O O
mRNA O O
encoding O O
an O O
omega O O
- O O
class O O
GST O O
of O O
Bombyx B B_SPECIES[BIO]
mori I I_SPECIES[BIO]
( O O
bmGSTO O O
) O O
was O O
shown O O
to O O
be O O
induced O O
after O O
exposure O O
to O O
various O O
environmental O O
stresses O O
. O O

A O O
soluble O O
form O O
of O O
recombinant O O
protein O O
( O O
rbmGSTO O O
) O O
was O O
functionally O O
overexpressed O O
in O O
Escherichia B B_SPECIES[BIO]
coli I I_SPECIES[BIO]
cells O O
and O O
purified O O
to O O
homogeneity O O
. O O

Cys O B_METABOLITE[BODY_PART_OR_ORGAN_COMPONENT]
38 O I_METABOLITE[BODY_PART_OR_ORGAN_COMPONENT]
and O O
Pro O B_MEASURE/B_PERSON
39 O I_MEASURE/I_PERSON
were O O
found O O
to O O
be O O
highly O O
conserved O O
in O O
omega O B_MEASURE/B_PROTEIN[GENE]
- O O
class O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
GSTs O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
, O O
and O O
their O O
roles O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
were O O
investigated O O
by O O
site O B_LOCATION/B_BIO
- O O
directed O O
mutagenesis O B_CELL_OR_MOLECULAR_DYSFUNCTION[DISEASE]/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
/ O O
kinetic O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
analysis O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

Mutations O B_CELL_OR_MOLECULAR_DYSFUNCTION[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
Cys O B_METABOLITE[BODY_PART_OR_ORGAN_COMPONENT]
38 O I_METABOLITE[BODY_PART_OR_ORGAN_COMPONENT]
and O O
Pro O B_MEASURE/B_METABOLITE[BODY_PART_OR_ORGAN_COMPONENT]
39 O I_MEASURE/I_METABOLITE[BODY_PART_OR_ORGAN_COMPONENT]
residues O I_MEASURE/I_METABOLITE[BODY_PART_OR_ORGAN_COMPONENT]
affected O O
the O O
catalytic O B_MEASURE/B_LOCATION
efficiency O B_MEASURE/I_LOCATION
of O O
enzymes O B_ENZYME[GENE]
, O O
indicating O O
that O O
the O O
presence O B_LOCATION/B_DISEASE
of O O
Cys O B_METABOLITE[BODY_PART_OR_ORGAN_COMPONENT]
38 O I_METABOLITE[BODY_PART_OR_ORGAN_COMPONENT]
and O O
Pro O B_METABOLITE[BODY_PART_OR_ORGAN_COMPONENT]
39 O I_METABOLITE[BODY_PART_OR_ORGAN_COMPONENT]
residues O I_METABOLITE[BODY_PART_OR_ORGAN_COMPONENT]
is O O
important O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
for O O
bmGSTO O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
activity O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

Thus O O
, O O
bmGSTO O B_GENE/B_PERSON
could O O
contribute O O
to O O
increasing O O
the O O
environmental O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
stress O I_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
resistance O I_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
of O O
lepidopteran O B_BIO
insects O I_BIO
. O O

Treatment O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_DISEASE_ADJECTIVE[DISEASE]
advances O I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/I_DISEASE_ADJECTIVE[DISEASE]
in O O
neonatal O B_DISEASE_ADJECTIVE[DISEASE]/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
neuroprotection O I_DISEASE_ADJECTIVE[DISEASE]/I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
and O O
neurointensive O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_DISEASE
care O I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/I_DISEASE
. O O

Knowledge O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
the O O
nature O B_DISEASE
, O O
prognosis O B_DISEASE_ADJECTIVE[DISEASE]
, O O
and O O
ways O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_MEASURE
to O O
treat O O
brain O B_DISEASE
lesions O I_DISEASE
in O O
neonatal O B_PERSON/B_DISEASE
infants O I_PERSON/I_DISEASE
has O O
increased O O
remarkably O O
. O O

Neonatal O B_DISEASE/B_BODY_PART_OR_ORGAN_COMPONENT
hypoxic O I_DISEASE/I_BODY_PART_OR_ORGAN_COMPONENT
- O O
ischaemic O B_DISEASE
encephalopathy O I_DISEASE
( O O
HIE O B_LOCATION/B_ORGANIZATION
) O O
in O O
term O B_PERSON/B_BIO
infants O I_PERSON/I_BIO
, O O
mirrors O O
a O O
progressive O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
cascade O B_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
of O O
excito O B_DISEASE_ADJECTIVE[DISEASE]
- O O
oxidative O B_DISEASE_ADJECTIVE[DISEASE]
events O I_DISEASE_ADJECTIVE[DISEASE]
that O O
unfold O O
in O O
the O O
brain O B_BODY_PART_OR_ORGAN_COMPONENT/B_DISEASE_ADJECTIVE[DISEASE]
after O O
an O O
asphyxial O B_DISEASE_ADJECTIVE[DISEASE]
insult O I_DISEASE_ADJECTIVE[DISEASE]
. O O

In O O
the O O
laboratory O B_LOCATION/B_BODY_PART_OR_ORGAN_COMPONENT
, O O
this O O
cascade O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_DISEASE
can O O
be O O
blocked O O
to O O
protect O O
brain O B_BODY_PART_OR_ORGAN_COMPONENT/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
tissue O I_BODY_PART_OR_ORGAN_COMPONENT/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
through O O
the O O
process O B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
of O O
neuroprotection O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_DISEASE
. O O

However O O
, O O
proof O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
of O O
a O O
clinical O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
effect O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
was O O
lacking O O
until O O
the O O
publication O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
of O O
three O B_NUMBER[MEASURE]
positive O I_NUMBER[MEASURE]
randomised O O
controlled O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
trials O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
moderate O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
hypothermia O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
for O O
term O B_PERSON/B_BIO
infants O I_PERSON/I_BIO
with O O
HIE O B_DISEASE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

These O O
results O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANIZATION
have O O
greatly O O
improved O O
treatment O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_DISEASE
prospects O I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/I_DISEASE
for O O
babies O B_PERSON
with O O
asphyxia O B_DISEASE/B_GENE
and O O
altered O O
understanding O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
of O O
the O O
theory O B_EDU[ORGANIZATION]/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
neuroprotection O B_DISEASE/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
. O O

The O O
studies O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
show O O
that O O
moderate O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_DISEASE_ADJECTIVE[DISEASE]
hypothermia O I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/I_DISEASE_ADJECTIVE[DISEASE]
within O O
6 O B_NUMBER[MEASURE]
h O O
of O O
asphyxia O B_DISEASE/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
improves O O
survival O B_TIME[MEASURE]/B_DISEASE_ADJECTIVE[DISEASE]
without O O
cerebral O B_DISEASE
palsy O I_DISEASE
or O O
other O B_DISEASE
disability O I_DISEASE
by O O
about O O
40 O B_MEASURE/B_PERSON
% O I_MEASURE/I_PERSON
and O O
reduces O O
death O B_DISEASE
or O O
neurological O B_DISEASE
disability O I_DISEASE
by O O
nearly O O
30 O B_MEASURE/B_LOCATION
% O I_MEASURE/I_LOCATION
. O O

The O O
search O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
is O O
on O O
to O O
discover O O
adjuvant O B_CHEMICAL_CLASS[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
treatments O I_CHEMICAL_CLASS[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
that O O
can O O
further O O
enhance O O
the O O
effects O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
hypothermia O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_DISEASE
. O O

Origin O B_TIME[MEASURE]/B_DISEASE
and O O
evolution O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
of O O
the O O
canal O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
raphe O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
system O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
in O O
diatoms O B_LOCATION
. O O

One O B_BIO/B_NUMBER[MEASURE]
lineage O B_BIO/I_NUMBER[MEASURE]
of O O
pennate O B_BIO/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
diatoms O I_BIO/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
has O O
a O O
slit O B_LOCATION/B_BODY_PART_OR_ORGAN_COMPONENT
through O O
the O O
siliceous O B_BODY_PART_OR_ORGAN_COMPONENT/B_DISEASE_ADJECTIVE[DISEASE]
cell O I_BODY_PART_OR_ORGAN_COMPONENT/I_DISEASE_ADJECTIVE[DISEASE]
wall O I_BODY_PART_OR_ORGAN_COMPONENT/I_DISEASE_ADJECTIVE[DISEASE]
, O O
called O O
a O O
" O O
raphe O B_BODY_PART_OR_ORGAN_COMPONENT/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
" O O
that O O
functions O B_LOCATION/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
in O O
motility O B_CELL_FUNCTION[ORGANISM_FUNCTION]/B_BIO
. O O

Raphid O B_PERSON/B_LOCATION
pennate O I_PERSON/I_LOCATION
diatoms O O
number O O
in O O
the O O
perhaps O O
tens O B_MEASURE/B_LOCATION
of O O
thousands O B_MEASURE/B_ORGANIZATION
of O O
species O B_BIO/B_TIME[MEASURE]
, O O
with O O
the O O
diversity O B_MEASURE/B_PERSON
of O O
raphe O B_BIO/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
forms O I_BIO/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
potentially O O
matching O O
this O O
number O B_MEASURE/B_PERSON
. O O

Three O B_NUMBER[MEASURE]/B_BIO
lineages O I_NUMBER[MEASURE]/I_BIO
- O O
the O O
Bacillariales O B_SPECIES[BIO]/B_PERSON
, O O
Rhopalodiales O B_BACTERIUM[BIO]/B_PERSON
, O O
and O O
Surirellales O B_BACTERIUM[BIO]
- O O
possess O O
a O O
complex O B_DISEASE_ADJECTIVE[DISEASE]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
presumably O O
highly O O
derived O O
raphe O B_CELL_COMPONENT[BODY_PART_OR_ORGAN_COMPONENT]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
that O O
is O O
physically O O
separated O O
from O O
the O O
cell O B_BODY_PART_OR_ORGAN_COMPONENT/B_PERSON
interior O B_BODY_PART_OR_ORGAN_COMPONENT/I_PERSON
, O O
most O O
often O O
by O O
a O O
set O B_GENE/B_LOCATION
of O O
siliceous O B_DISEASE_ADJECTIVE[DISEASE]/B_CELL_COMPONENT[BODY_PART_OR_ORGAN_COMPONENT]
braces O B_DISEASE_ADJECTIVE[DISEASE]/I_CELL_COMPONENT[BODY_PART_OR_ORGAN_COMPONENT]
. O O

Because O O
the O O
relationship O B_PERSON
among O O
these O O
three O B_BIO/B_LOCATION
lineages O B_BIO/I_LOCATION
is O O
unclear O B_TIME[MEASURE]/B_DISEASE_ADJECTIVE[DISEASE]
, O O
the O O
number O B_MEASURE/B_LOCATION
of O O
origins O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_CELL[BODY_PART_OR_ORGAN_COMPONENT]
of O O
the O O
canal O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
raphe O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
system O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
and O O
the O O
homology O B_DISEASE_ADJECTIVE[DISEASE]/B_LOCATION
of O O
it O O
and O O
its O O
constitutive O B_LOCATION/B_DISEASE
parts O I_LOCATION/I_DISEASE
among O O
these O O
lineages O B_BIO/B_NUMBER[MEASURE]
, O O
is O O
equally O O
unclear O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

We O O
reconstructed O O
the O O
phylogeny O B_BIO/B_GENE
of O O
raphid O B_BIO/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
pennate O I_BIO/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
diatoms O I_BIO/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
included O O
, O O
for O O
the O O
first O B_TIME[MEASURE]/B_ENT
time O I_TIME[MEASURE]/I_ENT
, O O
members O B_PERSON/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
all O O
three O B_BIO/B_PERSON
canal O I_BIO/I_PERSON
raphid O I_BIO/I_PERSON
diatom O I_BIO/I_PERSON
lineages O I_BIO/I_PERSON
, O O
and O O
used O O
the O O
phylogeny O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
to O O
test O O
specific O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANIZATION
hypotheses O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_ORGANIZATION
about O O
the O O
origin O B_DISEASE/B_LOCATION
of O O
the O O
canal O B_BIO/B_DISEASE
raphe O I_BIO/I_DISEASE
. O O

The O O
canal O B_LOCATION/B_DISEASE
raphe O I_LOCATION/I_DISEASE
appears O O
to O O
have O O
evolved O O
twice O O
, O O
once O O
in O O
the O O
common O B_PERSON/B_BIO
ancestor O I_PERSON/I_BIO
of O O
Bacillariales O B_SPECIES[BIO]
and O O
once O O
in O O
the O O
common O B_PERSON/B_BIO
ancestor O I_PERSON/I_BIO
of O O
Rhopalodiales O B_BACTERIUM[BIO]
and O O
Surirellales O B_SPECIES[BIO]/B_LOCATION
, O O
which O O
form O O
a O O
monophyletic O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
group O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
in O O
our O O
analyses O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

These O O
results O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
recommend O O
careful O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
follow O O
- O O
up O O
morphogenesis O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
studies O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
the O O
canal O B_BODY_PART_OR_ORGAN_COMPONENT/B_DISEASE
raphe O I_BODY_PART_OR_ORGAN_COMPONENT/I_DISEASE
in O O
these O O
two O B_BIO/B_PERSON
lineages O B_BIO/I_PERSON
to O O
determine O O
the O O
underlying O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
developmental O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
basis O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
for O O
this O O
remarkable O B_PERSON/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
case O B_PERSON/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
parallel O B_DISEASE
evolution O I_DISEASE
. O O

Osteoporosis O B_TIME[MEASURE]/B_LOCATION
: O O
now O O
and O O
the O O
future O B_TIME[MEASURE]/B_LOCATION
. O O

Osteoporosis O B_DISEASE/B_LOCATION
is O O
a O O
common O B_DISEASE_ADJECTIVE[DISEASE]
disease O I_DISEASE_ADJECTIVE[DISEASE]
characterised O O
by O O
a O O
systemic O B_DISEASE_ADJECTIVE[DISEASE]
impairment O I_DISEASE_ADJECTIVE[DISEASE]
of O O
bone O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
mass O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
and O O
microarchitecture O B_DISEASE_ADJECTIVE[DISEASE]/B_ORGANISM_FUNCTION
that O O
results O O
in O O
fragility O B_DISEASE
fractures O I_DISEASE
. O O

With O O
an O O
ageing O O
population O B_PERSON/B_ORGANIZATION
, O O
the O O
medical O B_PERSON/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
socioeconomic O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
effect O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
osteoporosis O B_DISEASE
, O O
particularly O O
postmenopausal O B_DISEASE/B_PERSON
osteoporosis O I_DISEASE/I_PERSON
, O O
will O O
increase O O
further O O
. O O

A O O
detailed O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
knowledge O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
of O O
bone O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
biology O I_DISEASE_ADJECTIVE[DISEASE]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
with O O
molecular O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
insights O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
into O O
the O O
communication O B_ORGANIZATION/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
between O O
bone O B_BODY_PART_OR_ORGAN_COMPONENT/B_DISEASE
- O O
forming O O
osteoblasts O B_CELL[BODY_PART_OR_ORGAN_COMPONENT]/B_LOCATION
and O O
bone O B_BODY_PART_OR_ORGAN_COMPONENT/B_DISEASE
- O O
resorbing O O
osteoclasts O B_CELL[BODY_PART_OR_ORGAN_COMPONENT]/B_DISEASE
and O O
the O O
orchestrating O O
signalling O B_LOCATION
network O I_LOCATION
has O O
led O O
to O O
the O O
identification O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANIZATION
of O O
novel O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
therapeutic O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
targets O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
. O O

Novel O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
treatment O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
strategies O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
have O O
been O O
developed O O
that O O
aim O O
to O O
inhibit O O
excessive O B_DISEASE/B_GENE
bone O I_DISEASE/I_GENE
resorption O I_DISEASE/I_GENE
and O O
increase O O
bone O B_DISEASE_ADJECTIVE[DISEASE]
formation O I_DISEASE_ADJECTIVE[DISEASE]
. O O

The O O
most O O
promising O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
novel O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
treatments O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
include O O
: O O
denosumab O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
, O O
a O O
monoclonal O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
antibody O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
for O O
receptor O B_GENE/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
activator O B_GENE/I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
of O O
NF O B_DISEASE/B_GENE
- O O
kappaB O B_PROTEIN[GENE]/B_LOCATION
ligand O I_PROTEIN[GENE]/I_LOCATION
, O O
a O O
key O B_GENE
osteoclast O I_GENE
cytokine O I_GENE
; O O
odanacatib O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
, O O
a O O
specific O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
inhibitor O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
of O O
the O O
osteoclast O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
protease O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
cathepsin O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
K O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
; O O
and O O
antibodies O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
against O O
the O O
proteins O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
sclerostin O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
and O O
dickkopf O B_GENE
- O O
1 O B_MEASURE
, O O
two O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
endogenous O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
inhibitors O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
of O O
bone O B_DISEASE/B_GENE
formation O B_DISEASE/I_GENE
. O O

This O O
overview O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANIZATION
discusses O O
these O O
novel O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_DISEASE
therapies O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/I_DISEASE
and O O
explains O O
their O O
underlying O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
physiology O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
. O O

Increasing O O
burden O B_DISEASE_ADJECTIVE[DISEASE]
of O O
liver O B_DISEASE
disease O I_DISEASE
in O O
patients O B_PERSON
with O O
HIV O B_DISEASE
infection O I_DISEASE
. O O

Introduction O B_TIME[MEASURE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
effective O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
combined O O
antiretroviral O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
therapy O I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
has O O
made O O
HIV O B_DISEASE/B_PERSON
infection O I_DISEASE/I_PERSON
a O O
chronic O B_DISEASE_ADJECTIVE[DISEASE]
illness O I_DISEASE_ADJECTIVE[DISEASE]
. O O

Substantial O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
reductions O I_DISEASE_ADJECTIVE[DISEASE]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
in O O
the O O
number O B_MEASURE
of O O
AIDS O B_DISEASE/B_BODY_PART_OR_ORGAN_COMPONENT
- O O
related O O
deaths O B_PERSON/B_DISEASE
have O O
been O O
accompanied O O
by O O
an O O
increase O B_DISEASE_ADJECTIVE[DISEASE]/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
in O O
liver O B_DISEASE
- O O
related O O
morbidity O B_DISEASE
and O O
mortality O B_DISEASE/B_MEASURE
due O O
to O O
co O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
- O O
infection O B_DISEASE/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
with O O
chronic O B_DISEASE
hepatitis O I_DISEASE
B O I_DISEASE
and O O
C O B_DISEASE
viruses O I_DISEASE
. O O

Increases O B_DISEASE_ADJECTIVE[DISEASE]
in O O
non O B_DISEASE
- O O
alcoholic O B_DISEASE_ADJECTIVE[DISEASE]
fatty O I_DISEASE_ADJECTIVE[DISEASE]
liver O I_DISEASE_ADJECTIVE[DISEASE]
disease O I_DISEASE_ADJECTIVE[DISEASE]
and O O
drug O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
- O O
induced O O
hepatotoxicity O B_DISEASE
, O O
together O O
with O O
development O B_DISEASE_ADJECTIVE[DISEASE]
of O O
hepatocellular O B_DISEASE
carcinoma O I_DISEASE
, O O
also O O
potentiate O O
the O O
burden O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
of O O
liver O B_DISEASE
disease O I_DISEASE
in O O
individuals O B_PERSON/B_BIO
with O O
HIV O B_DISEASE
infection O I_DISEASE
. O O

We O O
provide O O
an O O
overview O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
the O O
key O B_DISEASE_ADJECTIVE[DISEASE]
causes O I_DISEASE_ADJECTIVE[DISEASE]
, O O
disease O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
mechanisms O B_DISEASE_ADJECTIVE[DISEASE]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
pathogenesis O B_DISEASE
, O O
and O O
recommendations O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
for O O
treatment O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
options O I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
including O O
the O O
evolving O O
role O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
of O O
liver O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
transplantation O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

Adaptive O O
trade O O
- O O
offs O O
in O O
juvenile O O
salmonid O O
metabolism O O
associated O O
with O O
habitat O O
partitioning O O
between O O
coho B B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
salmon I I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_BIO
and O O
steelhead B B_BIO/B_LOCATION
trout I I_BIO/I_LOCATION
in O O
coastal O O
streams O O
. O O

1 O B_NUMBER[MEASURE]
. O O

Adaptive O B_LOCATION/B_PERSON
trade O I_LOCATION/I_PERSON
- O O
offs O B_SPORT[ENT]/B_LOCATION
are O O
fundamental O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
to O O
the O O
evolution O B_ORGANIZATION/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
of O O
diversity O B_PERSON/B_BIO
and O O
the O O
coexistence O B_DISEASE_ADJECTIVE[DISEASE]/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
similar O B_BIO/B_MEASURE
taxa O I_BIO/I_MEASURE
and O O
occur O O
when O O
complimentary O B_DISEASE_ADJECTIVE[DISEASE]/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
combinations O B_DISEASE_ADJECTIVE[DISEASE]/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
traits O B_BIO/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
maximize O O
efficiency O B_MEASURE/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
of O O
resource O B_DISEASE_ADJECTIVE[DISEASE]/B_ORGANISM_FUNCTION
exploitation O B_DISEASE_ADJECTIVE[DISEASE]/I_ORGANISM_FUNCTION
or O O
survival O B_TIME[MEASURE]/B_DISEASE_ADJECTIVE[DISEASE]
at O O
different O B_MEASURE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
points O I_MEASURE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
on O O
environmental O B_TIME[MEASURE]/B_DISEASE_ADJECTIVE[DISEASE]
gradients O I_TIME[MEASURE]/I_DISEASE_ADJECTIVE[DISEASE]
. O O

2 O B_NUMBER[MEASURE]
. O O

Standard O B_TIME[MEASURE]/B_ORGANIZATION
metabolic O I_TIME[MEASURE]/I_ORGANIZATION
rate O I_TIME[MEASURE]/I_ORGANIZATION
( O O
SMR O B_LOCATION/B_ORGANIZATION
) O O
is O O
a O O
key O B_MEASURE
physiological O I_MEASURE
trait O I_MEASURE
that O O
reflects O O
adaptations O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
to O O
baseline O O
metabolic O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANISM_FUNCTION
performance O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_ORGANISM_FUNCTION
, O O
whereas O O
active O B_DISEASE/B_PROTEIN[GENE]
metabolism O B_DISEASE/I_PROTEIN[GENE]
reflects O O
adaptations O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
to O O
variable O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
metabolic O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
output O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
associated O O
with O O
performance O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
related O O
to O O
foraging O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
, O O
predator O B_DISEASE_ADJECTIVE[DISEASE]/B_ORGANISM_FUNCTION
avoidance O B_DISEASE_ADJECTIVE[DISEASE]/I_ORGANISM_FUNCTION
, O O
aggressive O B_DISEASE_ADJECTIVE[DISEASE]/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
interactions O I_DISEASE_ADJECTIVE[DISEASE]/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
or O O
migratory O B_DISEASE/B_ORGANISM_FUNCTION
movements O I_DISEASE/I_ORGANISM_FUNCTION
. O O

Benefits O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
of O O
high O B_DISEASE_ADJECTIVE[DISEASE]/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
SMR O B_DISEASE_ADJECTIVE[DISEASE]/I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
and O O
active O B_DISEASE/B_LOCATION
metabolism O B_DISEASE/I_LOCATION
may O O
change O O
along O O
a O O
resource O B_LOCATION/B_MEASURE
( O O
productivity O B_LOCATION/B_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
) O O
gradient O B_LOCATION/B_MEASURE
, O O
indicating O O
that O O
a O O
trade O B_ORGANIZATION/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- O O
off O B_MEASURE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
exists O O
among O O
active O B_DISEASE_ADJECTIVE[DISEASE]/B_LOCATION
metabolism O B_DISEASE_ADJECTIVE[DISEASE]/I_LOCATION
, O O
resting O O
metabolism O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
and O O
energy O B_MEASURE/B_ORGANISM_FUNCTION
intake O I_MEASURE/I_ORGANISM_FUNCTION
. O O

3 O B_NUMBER[MEASURE]
. O O

We O O
measured O O
and O O
compared O O
SMR O O
, O O
maximal O O
metabolic O O
rate O O
( O O
MMR O O
) O O
, O O
aerobic O O
scope O O
( O O
AS O O
) O O
, O O
swim O O
performance O O
( O O
UCrit O O
) O O
and O O
growth O O
of O O
juvenile O O
hatchery O O
and O O
wild O O
steelhead B B_BIO/B_LOCATION
and O O
coho B B_SPECIES[BIO]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
salmon I I_SPECIES[BIO]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
held O O
on O O
high O O
- O O
and O O
low O O
- O O
food O O
rations O O
in O O
order O O
to O O
better O O
understand O O
the O O
potential O O
significance O O
of O O
variation O O
in O O
SMR O O
to O O
growth O O
, O O
differentiation O O
between O O
species O O
, O O
and O O
patterns O O
of O O
habitat O O
use O O
along O O
a O O
productivity O O
gradient O O
. O O

4 O B_NUMBER[MEASURE]
. O O

We O O
found O O
that O O
differences O O
in O O
SMR O O
, O O
MMR O O
, O O
AS O O
, O O
swim O O
performance O O
and O O
growth O O
rate O O
between O O
steelhead B B_SPECIES[BIO]/B_LOCATION
trout I I_SPECIES[BIO]/I_LOCATION
and O O
coho B B_BIO/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
salmon I I_BIO/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
were O O
reduced O O
in O O
hatchery O O
- O O
reared O O
fish O O
compared O O
with O O
wild O O
fish O O
. O O

Wild O O
steelhead B B_BIO/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
had O O
a O O
higher O O
MMR O O
, O O
AS O O
, O O
swim O O
performance O O
and O O
growth O O
rate O O
than O O
wild O O
coho B B_BIO/B_GENE
, O O
but O O
adaptations O O
between O O
species O O
do O O
not O O
appear O O
to O O
involve O O
differences O O
in O O
SMR O O
or O O
to O O
trade O O
- O O
off O O
increased O O
growth O O
rate O O
against O O
lower O O
swim O O
performance O O
, O O
as O O
commonly O O
observed O O
for O O
high O O
- O O
growth O O
strains O O
. O O

Instead O O
, O O
we O O
hypothesize O O
that O O
wild O O
steelhead B B_BIO/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
may O O
be O O
trading O O
off O O
higher O O
growth O O
rate O O
for O O
lower O O
food O O
consumption O O
efficiency O O
, O O
similar O O
to O O
strategies O O
adopted O O
by O O
anadromous O O
vs O O
. O O
resident O O
brook B B_BIO/B_LOCATION
trout I I_BIO/I_LOCATION
and O O
Atlantic B B_BIO/B_LOCATION
salmon I B_BIO/I_LOCATION
vs O O
. O O
brook B B_SPECIES[BIO]/B_LOCATION
trout I I_SPECIES[BIO]/I_LOCATION
. O O

This O O
highlights O O
potential O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
differences O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
in O O
food O B_ORGANISM_FUNCTION/B_DISEASE_ADJECTIVE[DISEASE]
consumption O I_ORGANISM_FUNCTION/I_DISEASE_ADJECTIVE[DISEASE]
and O O
digestion O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANISM_FUNCTION
strategies O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_ORGANISM_FUNCTION
as O O
cryptic O B_LOCATION
adaptations O I_LOCATION
ecologically O O
differentiating O O
salmonid O B_BIO/B_LOCATION
species O I_BIO/I_LOCATION
. O O

5 O B_NUMBER[MEASURE]
. O O

We O O
hypothesize O O
that O O
divergent O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
digestive O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
strategies O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
, O O
which O O
are O O
common O B_DISEASE_ADJECTIVE[DISEASE]/B_LOCATION
and O O
well O O
documented O O
among O O
terrestrial O B_SPECIES[BIO]/B_PERSON
vertebrates O I_SPECIES[BIO]/I_PERSON
, O O
may O O
be O O
an O O
important O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
but O O
overlooked O B_MEASURE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
aspect O I_MEASURE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
adaptive O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANISM_FUNCTION
strategies O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_ORGANISM_FUNCTION
of O O
juvenile O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
salmonids O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
, O O
and O O
fish O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_SPECIES[BIO]
in O O
general O B_PERSON/B_LOCATION
. O O

Natal O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
conditions O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
alter O O
age O B_MEASURE/B_PERSON
- O O
specific O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
reproduction O I_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
but O O
not O O
survival O B_DISEASE_ADJECTIVE[DISEASE]/B_ORGANISM_FUNCTION
or O O
senescence O O
in O O
a O O
long O O
- O O
lived O O
bird O B_BIO/B_MEASURE
of O O
prey O B_SPECIES[BIO]/B_LOCATION
. O O

1 O B_NUMBER[MEASURE]
. O O

Natal O B_DISEASE/B_TIME[MEASURE]
conditions O I_DISEASE/I_TIME[MEASURE]
and O O
senescence O B_DISEASE/B_LOCATION
are O O
two O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
major O I_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
factors O I_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
shaping O O
life O B_TIME[MEASURE]/B_PERSON
- O O
history O B_MEASURE/B_LOCATION
traits O B_MEASURE/I_LOCATION
of O O
wild O B_BIO
animals O I_BIO
. O O

However O O
, O O
such O B_PERSON
factors O I_PERSON
have O O
rarely O O
been O O
investigated O O
together O O
, O O
and O O
it O O
remains O O
largely O O
unknown O B_DISEASE_ADJECTIVE[DISEASE]
whether O O
they O O
interact O O
to O O
affect O O
age O B_TIME[MEASURE]/B_PERSON
- O O
specific O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
performance O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

2 O B_NUMBER[MEASURE]
. O O

We O O
used O O
27 O O
years O O
of O O
longitudinal O O
data O O
collected O O
on O O
tawny B B_LOCATION/B_DISEASE_ADJECTIVE[DISEASE]
owls I I_LOCATION/I_DISEASE_ADJECTIVE[DISEASE]
with O O
estimates O O
of O O
prey O O
density O O
( O O
field O O
voles O O
) O O
from O O
Kielder O O
Forest O O
( O O
UK O O
) O O
to O O
investigate O O
how O O
prey O O
density O O
at O O
birth O O
affects O O
ageing O O
patterns O O
in O O
reproduction O O
and O O
survival O O
. O O

3 O B_NUMBER[MEASURE]
. O O

Natal O O
conditions O O
experienced O O
by O O
tawny B B_PERSON/B_LOCATION
owls I I_PERSON/I_LOCATION
, O O
measured O O
in O O
terms O O
of O O
vole O O
density O O
, O O
dramatically O O
varied O O
among O O
cohorts O O
and O O
explained O O
87 O O
% O O
of O O
the O O
deviance O O
in O O
first O O
- O O
year O O
apparent O O
survival O O
( O O
annual O O
estimates O O
ranging O O
from O O
0 O O
* O O
07 O O
to O O
0 O O
* O O
33 O O
) O O
. O O

4 O B_NUMBER[MEASURE]
. O O

We O O
found O O
evidence O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
for O O
senescence O B_DISEASE_ADJECTIVE[DISEASE]
in O O
survival O B_TIME[MEASURE]/B_DISEASE
for O O
females O B_PERSON/B_BIO
as O O
well O O
as O O
for O O
males O B_PERSON/B_DISEASE
. O O

Model O B_PERSON
- O O
averaged O O
estimates O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
showed O O
that O O
adult O B_MEASURE/B_PERSON
survival O I_MEASURE/I_PERSON
probability O I_MEASURE/I_PERSON
declined O O
linearly O O
with O O
age O B_MEASURE
for O O
females O B_PERSON/B_BIO
from O O
age O B_PERSON
1 O I_PERSON
. O O

In O O
contrast O B_MEASURE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
male O B_MEASURE/B_PERSON
survival O B_MEASURE/I_PERSON
probability O B_MEASURE/I_PERSON
, O O
lower O B_MEASURE/B_DISEASE_ADJECTIVE[DISEASE]
on O O
average O B_TIME[MEASURE]/B_PERSON
than O O
for O O
female O B_PERSON
, O O
declined O O
after O O
a O O
plateau O B_MEASURE/B_DISEASE
at O O
age O B_MEASURE/B_PERSON
1 O I_MEASURE/I_PERSON
- O O
3 O B_MEASURE
. O O

5 O B_NUMBER[MEASURE]
. O O

We O O
also O O
found O O
evidence O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
for O O
reproductive O B_DISEASE_ADJECTIVE[DISEASE]/B_PERSON
senescence O I_DISEASE_ADJECTIVE[DISEASE]/I_PERSON
( O O
number O B_TIME[MEASURE]/B_DISEASE_ADJECTIVE[DISEASE]
of O O
offspring O O
) O O
. O O

For O O
females O B_PERSON
, O O
reproductive O B_PERSON/B_DISEASE
performance O B_PERSON/I_DISEASE
increased O O
until O O
age O B_PERSON
9 O I_PERSON
then O O
declined O O
. O O

Males O B_PERSON
showed O O
an O O
earlier O B_DISEASE_ADJECTIVE[DISEASE]/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
decline O I_DISEASE_ADJECTIVE[DISEASE]/I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
in O O
reproductive O B_PERSON/B_MEASURE
performance O B_PERSON/I_MEASURE
with O O
an O O
onset O B_DISEASE_ADJECTIVE[DISEASE]
of O O
senescence O B_DISEASE/B_ORGANISM_FUNCTION
at O O
age O B_PERSON/B_TIME[MEASURE]
3 O B_PERSON/I_TIME[MEASURE]
. O O

6 O B_NUMBER[MEASURE]
. O O

Long O O
- O O
lasting O B_TIME[MEASURE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
effects O B_ENT/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
natal O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
environmental O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
conditions O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
were O O
sex O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
specific O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

Female O B_DISEASE_ADJECTIVE[DISEASE]/B_PERSON
reproductive O I_DISEASE_ADJECTIVE[DISEASE]/I_PERSON
performance O I_DISEASE_ADJECTIVE[DISEASE]/I_PERSON
was O O
substantially O O
related O O
to O O
natal O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
conditions O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
( O O
difference O B_MEASURE
of O O
0 O B_MEASURE
* O O
24 O B_MEASURE/B_ENT
fledgling O I_MEASURE/I_ENT
per O O
breeding O B_TIME[MEASURE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
event O I_TIME[MEASURE]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
between O O
females O B_PERSON/B_BIO
born O O
in O O
the O O
first O B_SEQUENCE[MEASURE]
or O O
third O B_SEQUENCE[MEASURE]/B_LOCATION
quartile O I_SEQUENCE[MEASURE]/I_LOCATION
of O O
vole O B_TIME[MEASURE]/B_PERSON
density O I_TIME[MEASURE]/I_PERSON
) O O
, O O
whereas O O
male O B_MEASURE/B_ORGANISM_FUNCTION
performance O B_MEASURE/I_ORGANISM_FUNCTION
was O O
not O O
. O O

We O O
found O O
no O O
evidence O O
for O O
tawny B B_BIO/B_PERSON
owls I I_BIO/I_PERSON
born O O
in O O
years O O
with O O
low O O
prey O O
density O O
having O O
accelerated O O
rates O O
of O O
senescence O O
. O O

7 O B_NUMBER[MEASURE]
. O O

Our O O
results O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
combined O O
with O O
previous O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
findings O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
, O O
suggest O O
the O O
way O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
natal O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
environmental O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
conditions O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
affect O O
senescence O B_DISEASE_ADJECTIVE[DISEASE]/B_ORGANISM_FUNCTION
varies O O
not O O
only O O
across O O
species O B_BIO/B_PERSON
but O O
also O O
within O O
species O B_BIO/B_PERSON
according O O
to O O
gender O B_PERSON/B_LOCATION
and O O
the O O
demographic O B_MEASURE/B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
trait O B_MEASURE/I_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
considered O O
. O O

Post O B_DISEASE
- O O
splenectomy O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_DISEASE
and O O
hyposplenic O B_DISEASE_ADJECTIVE[DISEASE]/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
states O B_DISEASE_ADJECTIVE[DISEASE]/I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
. O O

The O O
spleen O B_BODY_PART_OR_ORGAN_COMPONENT/B_GENE
is O O
crucial O B_TIME[MEASURE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
in O O
regulating O O
immune O B_DISEASE/B_ORGANISM_FUNCTION
homoeostasis O I_DISEASE/I_ORGANISM_FUNCTION
through O O
its O O
ability O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
to O O
link O O
innate O B_PERSON/B_DISEASE_ADJECTIVE[DISEASE]
and O O
adaptive O B_DISEASE_ADJECTIVE[DISEASE]
immunity O I_DISEASE_ADJECTIVE[DISEASE]
and O O
in O O
protecting O O
against O O
infections O B_DISEASE
. O O

The O O
impairment O B_DISEASE_ADJECTIVE[DISEASE]
of O O
splenic O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANISM_FUNCTION
function O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_ORGANISM_FUNCTION
is O O
defined O O
as O O
hyposplenism O B_DISEASE
, O O
an O O
acquired O O
disorder O B_DISEASE
caused O O
by O O
several O B_DISEASE_ADJECTIVE[DISEASE]
haematological O I_DISEASE_ADJECTIVE[DISEASE]
and O O
immunological O B_DISEASE_ADJECTIVE[DISEASE]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
diseases O B_DISEASE_ADJECTIVE[DISEASE]/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

The O O
term O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
asplenia O I_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
refers O O
to O O
the O O
absence O B_DISEASE
of O O
the O O
spleen O B_BODY_PART_OR_ORGAN_COMPONENT
, O O
a O O
condition O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
that O O
is O O
rarely O O
congenital O B_DISEASE_ADJECTIVE[DISEASE]
and O O
mostly O O
post O B_DISEASE
- O O
surgical O B_PERSON/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
. O O

Although O O
hyposplenism O B_DISEASE
and O O
asplenia O B_DISEASE/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
might O O
predispose O O
individuals O B_PERSON/B_DISEASE
to O O
thromboembolic O B_DISEASE
events O I_DISEASE
, O O
in O O
this O O
Review O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANIZATION
we O O
focus O O
on O O
infectious O B_DISEASE
complications O I_DISEASE
, O O
which O O
are O O
the O O
most O O
widely O O
recognised O O
consequences O B_DISEASE
of O O
these O O
states O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
. O O

Because O O
of O O
the O O
high O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
mortality O I_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
, O O
the O O
fulminant O B_DISEASE/B_MEASURE
course O I_DISEASE/I_MEASURE
, O O
and O O
the O O
refractoriness O B_DISEASE_ADJECTIVE[DISEASE]
to O O
common O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
treatment O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
overwhelming O B_DISEASE
infections O I_DISEASE
caused O O
by O O
encapsulated O B_BACTERIUM[BIO]/B_DISEASE
bacteria O I_BACTERIUM[BIO]/I_DISEASE
, O O
prevention O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_DISEASE
through O O
vaccination O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_DISEASE
and O O
antibiotic O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_DISEASE_ADJECTIVE[DISEASE]
prophylaxis O I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/I_DISEASE_ADJECTIVE[DISEASE]
is O O
the O O
basis O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
of O O
the O O
management O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
of O O
patients O B_PERSON
who O O
have O O
had O O
splenectomy O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_DISEASE
or O O
have O O
hyposplenism O B_DISEASE/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
. O O

In O O
this O O
Review O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANIZATION
, O O
we O O
critically O O
assess O O
clinical O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
diagnostic O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
aspects O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
splenic O B_DISEASE
dysfunction O I_DISEASE
and O O
highlight O O
new O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
perspectives O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
in O O
the O O
prevention O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
of O O
overwhelming O B_DISEASE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
post O I_DISEASE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- O O
splenectomy O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_DISEASE_ADJECTIVE[DISEASE]
infections O I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/I_DISEASE_ADJECTIVE[DISEASE]
. O O

Priority O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
actions O I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
for O O
the O O
non O O
- O O
communicable O B_PERSON/B_ENT
disease O I_PERSON/I_ENT
crisis O I_PERSON/I_ENT
. O O

The O O
UN O B_MEASURE/B_LOCATION
High O I_MEASURE/I_LOCATION
- O O
Level O B_TIME[MEASURE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
Meeting O I_TIME[MEASURE]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
on O O
Non O B_DISEASE/B_PERSON
- O O
Communicable O B_DISEASE_ADJECTIVE[DISEASE]/B_PERSON
Diseases O I_DISEASE_ADJECTIVE[DISEASE]/I_PERSON
( O O
NCDs O B_ORGANIZATION/B_LOCATION
) O O
in O O
September O B_TIME[MEASURE]/B_LOCATION
, O O
2011 O B_MEASURE
, O O
is O O
an O O
unprecedented O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANIZATION
opportunity O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_ORGANIZATION
to O O
create O O
a O O
sustained O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANIZATION
global O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_ORGANIZATION
movement O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_ORGANIZATION
against O O
premature O B_DISEASE_ADJECTIVE[DISEASE]
death O I_DISEASE_ADJECTIVE[DISEASE]
and O O
preventable O B_DISEASE_ADJECTIVE[DISEASE]
morbidity O I_DISEASE_ADJECTIVE[DISEASE]
and O O
disability O B_DISEASE/B_MEASURE
from O O
NCDs O B_DISEASE/B_PERSON
, O O
mainly O O
heart O B_DISEASE/B_BODY_PART_OR_ORGAN_COMPONENT
disease O I_DISEASE/I_BODY_PART_OR_ORGAN_COMPONENT
, O O
stroke O B_DISEASE
, O O
cancer O B_DISEASE
, O O
diabetes O B_DISEASE
, O O
and O O
chronic O B_DISEASE
respiratory O I_DISEASE
disease O I_DISEASE
. O O

The O O
increasing O O
global O O
crisis O O
in O O
NCDs O O
is O O
a O O
barrier O O
to O O
development O O
goals O O
including O O
poverty O O
reduction O O
, O O
health O O
equity O O
, O O
economic O O
stability O O
, O O
and O O
human B B_PERSON/B_BIO
security O O
. O O

The O O
Lancet O O
NCD O O
Action O O
Group O O
and O O
the O O
NCD O O
Alliance O O
propose O O
five O O
overarching O O
priority O O
actions O O
for O O
the O O
response O O
to O O
the O O
crisis O O
- O O
- O O
leadership O O
, O O
prevention O O
, O O
treatment O O
, O O
international O O
cooperation O O
, O O
and O O
monitoring O O
and O O
accountability O O
- O O
- O O
and O O
the O O
delivery O O
of O O
five O O
priority O O
interventions O O
- O O
- O O
tobacco B B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
control O O
, O O
salt O O
reduction O O
, O O
improved O O
diets O O
and O O
physical O O
activity O O
, O O
reduction O O
in O O
hazardous O O
alcohol O O
intake O O
, O O
and O O
essential O O
drugs O O
and O O
technologies O O
. O O

The O O
priority O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANIZATION
interventions O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_ORGANIZATION
were O O
chosen O O
for O O
their O O
health O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
effects O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
, O O
cost O B_MEASURE/B_LOCATION
- O O
effectiveness O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
low O B_MEASURE/B_DISEASE_ADJECTIVE[DISEASE]
costs O I_MEASURE/I_DISEASE_ADJECTIVE[DISEASE]
of O O
implementation O B_PERSON/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
, O O
and O O
political O B_ORGANIZATION/B_PERSON
and O O
financial O B_ORGANIZATION/B_PERSON
feasibility O I_ORGANIZATION/I_PERSON
. O O

The O O
most O O
urgent O O
and O O
immediate O O
priority O O
is O O
tobacco B B_ORGANIZATION/B_DISEASE
control O O
. O O

We O O
propose O O
as O O
a O O
goal O O
for O O
2040 O O
, O O
a O O
world O O
essentially O O
free O O
from O O
tobacco B B_DISEASE/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
where O O
less O O
than O O
5 O O
% O O
of O O
people O O
use O O
tobacco O O
. O O

Implementation O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
of O O
the O O
priority O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANIZATION
interventions O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_ORGANIZATION
, O O
at O O
an O O
estimated O O
global O B_MEASURE/B_ORGANIZATION
commitment O I_MEASURE/I_ORGANIZATION
of O O
about O O
US O B_LOCATION/B_MEASURE
$ O O
9 O B_MEASURE
billion O I_MEASURE
per O O
year O B_TIME[MEASURE]/B_PERSON
, O O
will O O
bring O O
enormous O B_MEASURE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
benefits O I_MEASURE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
to O O
social O B_ORGANIZATION/B_LOCATION
and O O
economic O B_ORGANIZATION/B_LOCATION
development O I_ORGANIZATION/I_LOCATION
and O O
to O O
the O O
health O B_LOCATION/B_ORGANIZATION
sector O I_LOCATION/I_ORGANIZATION
. O O

If O O
widely O O
adopted O O
, O O
these O O
interventions O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_ORGANIZATION
will O O
achieve O O
the O O
global O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
goal O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
of O O
reducing O O
NCD O B_DISEASE
death O I_DISEASE
rates O I_DISEASE
by O O
2 O B_NUMBER[MEASURE]
% O I_NUMBER[MEASURE]
per O O
year O B_TIME[MEASURE]/B_PERSON
, O O
averting O O
tens O B_MEASURE/B_PERSON
of O O
millions O B_MEASURE/B_PERSON
of O O
premature O B_DISEASE/B_PERSON
deaths O I_DISEASE/I_PERSON
in O O
this O O
decade O B_LOCATION
. O O

Serotype O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
replacement O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
in O O
disease O B_DISEASE/B_PERSON
after O O
pneumococcal O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_DISEASE
vaccination O I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/I_DISEASE
. O O

Vaccination O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
with O O
heptavalent O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
pneumococcal O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE
conjugate O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE
vaccine O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE
( O O
PCV7 O B_DISEASE/B_BIO
) O O
has O O
significantly O O
reduced O O
the O O
burden O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
of O O
pneumococcal O B_DISEASE
disease O I_DISEASE
and O O
has O O
had O O
an O O
important O B_DISEASE_ADJECTIVE[DISEASE]
public O I_DISEASE_ADJECTIVE[DISEASE]
health O I_DISEASE_ADJECTIVE[DISEASE]
benefit O I_DISEASE_ADJECTIVE[DISEASE]
. O O

Because O O
this O O
vaccine O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
targets O O
only O O
seven O B_NUMBER[MEASURE]
of O O
the O O
more O B_MEASURE
than O O
92 O B_MEASURE
pneumococcal O I_MEASURE
serotypes O I_MEASURE
, O O
concerns O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
have O O
been O O
raised O O
that O O
non O B_DISEASE/B_MEASURE
- O O
vaccine O B_DISEASE_ADJECTIVE[DISEASE]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
serotypes O B_DISEASE_ADJECTIVE[DISEASE]/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
( O O
NVTs O B_DISEASE/B_PROTEIN[GENE]
) O O
could O O
increase O O
in O O
prevalence O B_MEASURE/B_DISEASE
and O O
reduce O O
the O O
benefits O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
of O O
vaccination O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_DISEASE
. O O

Indeed O O
, O O
among O O
asymptomatic O B_PERSON/B_BIO
carriers O I_PERSON/I_BIO
, O O
the O O
prevalence O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
of O O
NVTs O B_DISEASE
has O O
increased O O
substantially O O
, O O
and O O
consequently O O
, O O
there O O
has O O
been O O
little O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
or O O
no O O
net O B_MEASURE
change O I_MEASURE
in O O
the O O
bacterial O B_MEASURE/B_DISEASE
carriage O I_MEASURE/I_DISEASE
prevalence O I_MEASURE/I_DISEASE
. O O

In O O
many O B_LOCATION/B_PERSON
populations O I_LOCATION/I_PERSON
, O O
pneumococcal O B_DISEASE
disease O I_DISEASE
caused O O
by O O
NVT O B_DISEASE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
has O O
increased O O
, O O
but O O
in O O
most O B_PERSON/B_LOCATION
cases O I_PERSON/I_LOCATION
this O O
increase O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
has O O
been O O
less O B_MEASURE/B_DISEASE_ADJECTIVE[DISEASE]
than O O
the O O
increase O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
in O O
NVT O B_DISEASE_ADJECTIVE[DISEASE]/B_PERSON
carriage O B_DISEASE_ADJECTIVE[DISEASE]/I_PERSON
. O O

We O O
review O O
the O O
evidence O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
for O O
serotype O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
replacement O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
in O O
carriage O B_DISEASE
and O O
disease O B_DISEASE
, O O
and O O
address O O
the O O
surveillance O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
biases O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
that O O
might O O
affect O O
these O O
findings O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
. O O

We O O
then O O
discuss O O
possible O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
reasons O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
for O O
the O O
discrepancy O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
between O O
near O O
- O O
complete O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
replacement O I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
in O O
carriage O B_DISEASE
and O O
partial O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
replacement O I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
for O O
disease O B_DISEASE
, O O
including O O
differences O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
in O O
invasiveness O B_DISEASE/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
between O O
vaccine O B_DISEASE_ADJECTIVE[DISEASE]/B_PERSON
serotypes O I_DISEASE_ADJECTIVE[DISEASE]/I_PERSON
. O O

We O O
contend O O
that O O
the O O
magnitude O B_MEASURE/B_DISEASE_ADJECTIVE[DISEASE]
of O O
serotype O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
replacement O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
in O O
disease O B_DISEASE/B_LOCATION
can O O
be O O
attributed O O
, O O
in O O
part O B_TIME[MEASURE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
to O O
a O O
combination O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
of O O
lower O B_DISEASE_ADJECTIVE[DISEASE]/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
invasiveness O B_DISEASE_ADJECTIVE[DISEASE]/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
the O O
replacing O O
serotypes O B_BIO/B_DISEASE
, O O
biases O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
in O O
the O O
pre O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
- O O
vaccine O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
carriage O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE
data O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE
( O O
unmasking O O
) O O
, O O
and O O
biases O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
in O O
the O O
disease O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
surveillance O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
systems O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
that O O
could O O
underestimate O O
the O O
true O B_MEASURE
amount O I_MEASURE
of O O
replacement O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_DISEASE
. O O

We O O
conclude O O
by O O
discussing O O
the O O
future O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
potential O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
for O O
serotype O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
replacement O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
in O O
disease O B_DISEASE/B_LOCATION
and O O
the O O
need O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
for O O
continuing O O
surveillance O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANIZATION
. O O

Stillbirths O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
: O O
how O O
can O O
health O O
systems O B_LOCATION/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
deliver O O
for O O
mothers O B_PERSON
and O O
babies O B_PERSON
? O O

The O O
causes O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
of O O
stillbirths O B_DISEASE/B_ORGANISM_FUNCTION
are O O
inseparable O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
from O O
the O O
causes O B_DISEASE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
maternal O B_PERSON
and O O
neonatal O B_PERSON/B_DISEASE_ADJECTIVE[DISEASE]
deaths O I_PERSON/I_DISEASE_ADJECTIVE[DISEASE]
. O O

This O O
report O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
focuses O O
on O O
prevention O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
of O O
stillbirths O B_DISEASE
by O O
scale O B_MEASURE/B_LOCATION
- O O
up O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
of O O
care O B_PERSON/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
for O O
mothers O B_PERSON
and O O
babies O B_PERSON
at O O
the O O
health O B_PERSON/B_LOCATION
- O O
system O B_LOCATION/B_ORGANIZATION
level O I_LOCATION/I_ORGANIZATION
, O O
with O O
consideration O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
for O O
effects O B_ENT/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
cost O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

In O O
countries O B_LOCATION/B_PERSON
with O O
high O B_DISEASE/B_LOCATION
mortality O I_DISEASE/I_LOCATION
rates O I_DISEASE/I_LOCATION
, O O
emergency O B_DISEASE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
obstetric O I_DISEASE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
care O I_DISEASE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
has O O
the O O
greatest O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
effect O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
on O O
maternal O B_PERSON
and O O
neonatal O B_PERSON/B_DISEASE
deaths O I_PERSON/I_DISEASE
, O O
and O O
on O O
stillbirths O B_DISEASE_ADJECTIVE[DISEASE]/B_PERSON
. O O

Syphilis O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
detection O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
treatment O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
is O O
of O O
moderate O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
effect O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
but O O
of O O
lower O B_MEASURE
cost O I_MEASURE
and O O
is O O
highly O O
feasible O B_TIME[MEASURE]/B_DISEASE_ADJECTIVE[DISEASE]
. O O

Advanced O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
antenatal O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
care O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
, O O
including O O
induction O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
for O O
post O B_LOCATION/B_DISEASE_ADJECTIVE[DISEASE]
- O O
term O B_DISEASE/B_ORGANISM_FUNCTION
pregnancies O I_DISEASE/I_ORGANISM_FUNCTION
, O O
and O O
detection O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
management O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
of O O
hypertensive O B_DISEASE
disease O I_DISEASE
, O O
fetal O B_DISEASE
growth O I_DISEASE
restriction O I_DISEASE
, O O
and O O
gestational O B_DISEASE
diabetes O I_DISEASE
, O O
will O O
further O O
reduce O O
mortality O B_DISEASE
, O O
but O O
at O O
higher O B_MEASURE
cost O I_MEASURE
. O O

These O O
interventions O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_ORGANIZATION
are O O
best O O
packaged O O
and O O
provided O O
through O O
linked O O
service O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANIZATION
delivery O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_ORGANIZATION
methods O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_ORGANIZATION
tailored O O
to O O
suit O O
existing O O
health O B_PERSON
- O O
care O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANIZATION
systems O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_ORGANIZATION
. O O

If O O
99 O B_MEASURE/B_PERSON
% O B_MEASURE/I_PERSON
coverage O B_MEASURE/I_PERSON
is O O
reached O O
in O O
68 O B_LOCATION/B_MEASURE
priority O B_LOCATION/I_MEASURE
countries O B_LOCATION/I_MEASURE
by O O
2015 O B_MEASURE
, O O
up O O
to O O
1 O B_MEASURE
* O O
1 O B_TIME[MEASURE]
million O I_TIME[MEASURE]
( O O
45 O B_MEASURE/B_PERSON
% O I_MEASURE/I_PERSON
) O O
third O B_SEQUENCE[MEASURE]/B_LOCATION
- O O
trimester O B_ENT/B_MEASURE
stillbirths O B_ENT/I_MEASURE
, O O
201 O B_MEASURE
000 O I_MEASURE
( O O
54 O B_MEASURE/B_PERSON
% O I_MEASURE/I_PERSON
) O O
maternal O B_DISEASE/B_PERSON
deaths O I_DISEASE/I_PERSON
, O O
and O O
1 O B_NUMBER[MEASURE]
* O O
4 O B_TIME[MEASURE]
million O I_TIME[MEASURE]
( O O
43 O B_MEASURE/B_PERSON
% O I_MEASURE/I_PERSON
) O O
neonatal O B_PERSON/B_LOCATION
deaths O I_PERSON/I_LOCATION
could O O
be O O
saved O O
per O O
year O B_TIME[MEASURE]/B_PERSON
at O O
an O O
additional O B_MEASURE/B_ORGANIZATION
total O I_MEASURE/I_ORGANIZATION
cost O I_MEASURE/I_ORGANIZATION
of O O
US O B_LOCATION/B_MEASURE
$ O O
10 O B_MEASURE
* O O
9 O B_MEASURE
billion O I_MEASURE
or O O
$ O O
2 O B_MEASURE
* O O
32 O B_MEASURE
per O O
person O B_PERSON
, O O
which O O
is O O
in O O
the O O
range O B_MEASURE/B_LOCATION
of O O
$ O O
0 O B_MEASURE
* O O
96 O B_MEASURE
- O O
2 O B_MEASURE
* O O
32 O B_MEASURE
for O O
other O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
ingredients O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_BIO
- O O
based O O
intervention O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_ORGANIZATION
packages O I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/I_ORGANIZATION
with O O
only O B_MEASURE/B_DISEASE
recurrent O I_MEASURE/I_DISEASE
costs O I_MEASURE/I_DISEASE
. O O

The O O
contribution O O
of O O
the O O
S O O
- O O
phase O O
checkpoint O O
genes O O
MEC1 O O
and O O
SGS1 O O
to O O
genome O O
stability O O
maintenance O O
in O O
Candida B B_SPECIES[BIO]
albicans I I_SPECIES[BIO]
. O O

Genome O O
rearrangements O O
, O O
a O O
common O O
feature O O
of O O
Candida B B_BACTERIUM[BIO]/B_DISEASE
albicans I I_BACTERIUM[BIO]/I_DISEASE
isolates O O
, O O
are O O
often O O
associated O O
with O O
the O O
acquisition O O
of O O
antifungal O O
drug O O
resistance O O
. O O

In O O
Saccharomyces B B_SPECIES[BIO]
cerevisiae I I_SPECIES[BIO]
, O O
perturbations O O
in O O
the O O
S O O
- O O
phase O O
checkpoints O O
result O O
in O O
the O O
same O O
sort O O
of O O
Gross O O
Chromosomal O O
Rearrangements O O
( O O
GCRs O O
) O O
observed O O
in O O
C B B_SPECIES[BIO]/B_DISEASE
. I I_SPECIES[BIO]/I_DISEASE
albicans I I_SPECIES[BIO]/I_DISEASE
. O O

Several O O
proteins O O
are O O
involved O O
in O O
the O O
S B B_SPECIES[BIO]/B_DISEASE_ADJECTIVE[DISEASE]
. I B_SPECIES[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
cerevisiae I B_SPECIES[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
cell O O
cycle O O
checkpoints O O
, O O
including O O
Mec1p O O
, O O
a O O
protein O O
kinase O O
of O O
the O O
PIKK O O
( O O
phosphatidyl O O
inositol O O
3 O O
- O O
kinase O O
- O O
like O O
kinase O O
) O O
family O O
and O O
the O O
central O O
player O O
in O O
the O O
DNA O O
damage O O
checkpoint O O
. O O

Sgs1p O B_MEASURE/B_LOCATION
, O O
the O O
ortholog O B_GENE/B_PERSON
of O O
BLM O B_GENE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
the O O
Bloom O B_GENE/B_DISEASE
' O I_GENE/I_DISEASE
s O I_GENE/I_DISEASE
syndrome O I_GENE/I_DISEASE
gene O I_GENE/I_DISEASE
, O O
is O O
a O O
RecQ O B_DISEASE/B_GENE
- O O
related O O
DNA O B_ENZYME[GENE]/B_MEASURE
helicase O I_ENZYME[GENE]/I_MEASURE
; O O
cells O B_CELL[BODY_PART_OR_ORGAN_COMPONENT]/B_GENE
from O O
BLM O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
patients O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE
are O O
characterized O O
by O O
an O O
increase O B_DISEASE_ADJECTIVE[DISEASE]/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
in O O
genome O B_DISEASE/B_GENE
instability O I_DISEASE/I_GENE
. O O

Yeast B B_SPECIES[BIO]
strains O O
bearing O O
deletions O O
in O O
MEC1 O O
or O O
SGS1 O O
are O O
viable O O
( O O
in O O
contrast O O
to O O
the O O
inviability O O
seen O O
with O O
loss O O
of O O
MEC1 O O
in O O
S B B_BIO/B_PERSON
. I I_BIO/I_PERSON
cerevisiae I I_BIO/I_PERSON
) O O
but O O
the O O
different O O
deletion O O
mutants O O
have O O
significantly O O
different O O
phenotypes O O
. O O

The O O
mec1Delta O B_PROTEIN[GENE]/B_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
/ O O
Delta O B_PROTEIN[GENE]/B_BIO
colonies O I_PROTEIN[GENE]/I_BIO
have O O
a O O
wild O B_BIO/B_BODY_PART_OR_ORGAN_COMPONENT
- O O
type O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
colony O B_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
morphology O B_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
, O O
while O O
the O O
sgs1Delta O B_GENE/B_DISEASE
/ O O
Delta O B_PROTEIN[GENE]/B_DISEASE_ADJECTIVE[DISEASE]
mutants O I_PROTEIN[GENE]/I_DISEASE_ADJECTIVE[DISEASE]
are O O
slow O O
- O O
growing O O
, O O
producing O O
wrinkled O O
colonies O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
with O O
pseudohyphal O B_BACTERIUM[BIO]/B_CELL[BODY_PART_OR_ORGAN_COMPONENT]
- O O
like O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
cells O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE
. O O

The O O
mec1Delta O B_PROTEIN[GENE]/B_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
/ O O
Delta O B_PROTEIN[GENE]/B_DISEASE_ADJECTIVE[DISEASE]
mutants O I_PROTEIN[GENE]/I_DISEASE_ADJECTIVE[DISEASE]
are O O
only O O
sensitive O B_DISEASE_ADJECTIVE[DISEASE]
to O O
ethylmethane O O
sulfonate O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
( O O
EMS O B_LOCATION/B_ORGANIZATION
) O O
, O O
methylmethane O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
sulfonate O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
( O O
MMS O B_LOCATION/B_ORGANIZATION
) O O
, O O
and O O
hydroxyurea O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
( O O
HU O B_PERSON/B_LOCATION
) O O
but O O
the O O
sgs1Delta O B_PROTEIN[GENE]/B_DISEASE
/ O O
Delta O B_PROTEIN[GENE]/B_DISEASE_ADJECTIVE[DISEASE]
mutants O I_PROTEIN[GENE]/I_DISEASE_ADJECTIVE[DISEASE]
exhibit O O
a O O
high O B_DISEASE_ADJECTIVE[DISEASE]
sensitivity O I_DISEASE_ADJECTIVE[DISEASE]
to O O
all O O
DNA O B_GENE/B_CELL[BODY_PART_OR_ORGAN_COMPONENT]
- O O
damaging O O
agents O B_CHEMICAL_CLASS[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
tested O O
. O O

In O O
an O O
assay O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
for O O
chromosome O B_DISEASE/B_GENE
1 O I_DISEASE/I_GENE
integrity O I_DISEASE/I_GENE
, O O
the O O
mec1Delta O B_PROTEIN[GENE]/B_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
/ O O
Delta O B_PROTEIN[GENE]/B_DISEASE_ADJECTIVE[DISEASE]
mutants O I_PROTEIN[GENE]/I_DISEASE_ADJECTIVE[DISEASE]
exhibit O O
an O O
increase O B_DISEASE_ADJECTIVE[DISEASE]/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
in O O
genome O B_DISEASE_ADJECTIVE[DISEASE]
instability O I_DISEASE_ADJECTIVE[DISEASE]
; O O
no O O
change O B_DISEASE_ADJECTIVE[DISEASE]
was O O
observed O O
in O O
the O O
sgs1Delta O B_PROTEIN[GENE]/B_DISEASE
/ O O
Delta O B_PROTEIN[GENE]/B_DISEASE_ADJECTIVE[DISEASE]
mutants O I_PROTEIN[GENE]/I_DISEASE_ADJECTIVE[DISEASE]
. O O

Finally O O
, O O
loss O B_DISEASE_ADJECTIVE[DISEASE]
of O O
MEC1 O B_GENE
does O O
not O O
affect O O
sensitivity O B_DISEASE
to O O
the O O
antifungal O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
drug O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
fluconazole O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
while O O
loss O B_DISEASE_ADJECTIVE[DISEASE]
of O O
SGS1 O B_GENE/B_DISEASE
leads O O
to O O
an O O
increased O O
susceptibility O B_DISEASE
to O O
fluconazole O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
. O O

Neither O O
deletion O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_CELL_OR_MOLECULAR_DYSFUNCTION[DISEASE]
elevated O O
the O O
level O B_MEASURE
of O O
antifungal O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
drug O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
resistance O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
acquisition O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
. O O

Postural O B_DISEASE
deformities O I_DISEASE
in O O
Parkinson O B_PERSON/B_DISEASE
' O I_DISEASE
s O I_DISEASE
disease O I_DISEASE
. O O

Postural O B_DISEASE/B_MEASURE
deformities O I_DISEASE/I_MEASURE
are O O
frequent O B_DISEASE_ADJECTIVE[DISEASE]
and O O
disabling O O
complications O B_DISEASE_ADJECTIVE[DISEASE]
of O O
Parkinson O B_DISEASE/B_BODY_PART_OR_ORGAN_COMPONENT
' O O
s O B_DISEASE
disease O I_DISEASE
( O O
PD O B_DISEASE/B_PROTEIN[GENE]
) O O
and O O
atypical O B_DISEASE
parkinsonism O I_DISEASE
. O O

These O O
deformities O B_DISEASE
include O O
camptocormia O B_DISEASE
, O O
antecollis O B_DISEASE
, O O
Pisa O B_DISEASE
syndrome O I_DISEASE
, O O
and O O
scoliosis O B_DISEASE
. O O

Recognition O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
specific O B_DISEASE/B_GENE
postural O I_DISEASE/I_GENE
syndromes O I_DISEASE/I_GENE
might O O
have O O
differential O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
diagnostic O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
value O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
in O O
patients O B_PERSON/B_BIO
presenting O O
with O O
parkinsonism O B_DISEASE
. O O

The O O
evidence O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
to O O
date O B_TIME[MEASURE]/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
suggests O O
that O O
postural O B_DISEASE/B_BIO
deformities O I_DISEASE/I_BIO
have O O
a O O
multifactorial O B_DISEASE_ADJECTIVE[DISEASE]
pathophysiology O I_DISEASE_ADJECTIVE[DISEASE]
. O O

Contributing O O
factors O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
include O O
muscular O B_DISEASE
rigidity O I_DISEASE
; O O
axial O B_DISEASE
dystonia O I_DISEASE
; O O
weakness O B_DISEASE
caused O O
by O O
myopathy O B_DISEASE
; O O
body O B_DISEASE
scheme O I_DISEASE
defects O I_DISEASE
due O O
to O O
centrally O O
impaired O B_DISEASE_ADJECTIVE[DISEASE]
proprioception O I_DISEASE_ADJECTIVE[DISEASE]
; O O
and O O
structural O B_DISEASE
changes O I_DISEASE
in O O
the O O
spine O B_BODY_PART_OR_ORGAN_COMPONENT
. O O

The O O
relative O B_MEASURE
contribution O I_MEASURE
of O O
these O O
different O B_DISEASE_ADJECTIVE[DISEASE]/B_GENE
factors O B_DISEASE_ADJECTIVE[DISEASE]/I_GENE
varies O O
between O O
patients O B_PERSON/B_LOCATION
and O O
across O O
specific O B_LOCATION/B_ORGANIZATION
syndromes O I_LOCATION/I_ORGANIZATION
. O O

Improved O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
understanding O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
the O O
mechanisms O B_LOCATION/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
underlying O O
postural O B_DISEASE
deformities O I_DISEASE
in O O
PD O B_DISEASE/B_LOCATION
might O O
ultimately O O
lead O O
us O O
to O O
more O O
effective O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_PERSON
management O I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/I_PERSON
strategies O I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/I_PERSON
for O O
these O O
disabling O B_DISEASE_ADJECTIVE[DISEASE]
and O O
drug O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
- O O
refractory O B_DISEASE_ADJECTIVE[DISEASE]
complications O I_DISEASE_ADJECTIVE[DISEASE]
. O O

Tortricid O O
moths O O
reared O O
from O O
the O O
invasive O O
weed O O
Mexican B B_BIO
palo I I_BIO
verde I I_BIO
, O O
Parkinsonia B B_LOCATION
aculeata I I_LOCATION
, O O
with O O
comments O O
on O O
their O O
host O O
specificity O O
, O O
biology O O
, O O
geographic O O
distribution O O
, O O
and O O
systematics O O
. O O

As O O
part O O
of O O
efforts O O
to O O
identify O O
native O O
herbivores O O
of O O
Mexican B B_LOCATION
palo I I_LOCATION
verde I I_LOCATION
, O O
Parkinsonia B B_PERSON
aculeata I I_PERSON
L O O
. O O

( O O
Leguminosae O O
: O O
Caesalpinioideae O O
) O O
, O O
as O O
potential O O
biological O O
control O O
agents O O
against O O
this O O
invasive O O
weed O O
in O O
Australia O O
, O O
ten O O
species O O
of O O
Tortricidae O O
( O O
Lepidoptera O O
) O O
were O O
reared O O
from O O
Guatemala O O
, O O
Mexico O O
, O O
Nicaragua O O
, O O
and O O
Venezuela O O
: O O
Amorbia O O
concavana O O
( O O
Zeller O O
) O O
, O O
Platynota O O
rostrana O O
( O O
Walker O O
) O O
, O O
Platynota O O
helianthes O O
( O O
Meyrick O O
) O O
, O O
Platynota B B_PERSON/B_LOCATION
stultana I I_PERSON/I_LOCATION
Walsingham O O
( O O
all O O
Tortricinae O O
: O O
Sparganothini O O
) O O
, O O
Rudenia O O
leguminana O O
( O O
Busck O O
) O O
, O O
Cochylis O O
sp O O
. O O

( O O
both O O
Tortricinae O B_BIO/B_PERSON
: O O
Cochylini O B_LOCATION/B_PERSON
) O O
, O O
Ofatulena O B_PERSON/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
duodecemstriata O I_PERSON/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
( O O
Walsingham O B_LOCATION/B_PERSON
) O O
, O O
O O O
. O O
luminosa O B_PERSON
Heinrich O I_PERSON
, O O
Ofatulena O B_BACTERIUM[BIO]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
sp O I_LOCATION
. O O

( O O
all O O
Olethreutinae O B_BIO/B_PERSON
: O O
Grapholitini O B_BACTERIUM[BIO]/B_LOCATION
) O O
, O O
and O O
Crocidosema O B_LOCATION/B_BIO
lantana O I_LOCATION/I_BIO
Busck O I_LOCATION/I_BIO
( O O
Olethreutinae O B_BIO/B_LOCATION
: O O
Eucosmini O B_LOCATION/B_PERSON
) O O
. O O

Significant O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
geographic O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
range O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
extensions O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
are O O
provided O O
for O O
O O B_LOCATION/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O
duodecemstriata O B_DISEASE/B_PERSON
and O O
R O B_OTHER/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O
leguminana O B_DISEASE_ADJECTIVE[DISEASE]/B_SPECIES[BIO]
. O O

These O O
are O O
the O O
first O O
documented O O
records O O
of O O
P B B_BIO
. I I_BIO
aculeata I I_BIO
as O O
a O O
host O O
plant O O
for O O
all O O
but O O
O O O
. O O
luminosa O O
. O O

The O O
four O B_BIO/B_ENT
species O I_BIO/I_ENT
of O O
Sparganothini O B_SPECIES[BIO]/B_LOCATION
are O O
polyphagous O B_DISEASE_ADJECTIVE[DISEASE]/B_BIO
; O O
in O O
contrast O B_MEASURE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
the O O
two O B_NUMBER[MEASURE]/B_BIO
Cochylini O I_NUMBER[MEASURE]/I_BIO
and O O
three O B_PERSON/B_BIO
Grapholitini O I_PERSON/I_BIO
likely O O
are O O
specialists O B_PERSON/B_LOCATION
on O O
Leguminosae O B_BIO/B_LOCATION
. O O

Ofatulena O O
luminosa O O
is O O
possibly O O
host O O
specific O O
on O O
P B B_BIO/B_LOCATION
. I I_BIO/I_LOCATION
aculeata I I_BIO/I_LOCATION
. O O

Host O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
trials O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
with O O
Rudenia O B_PERSON/B_DISEASE_ADJECTIVE[DISEASE]
leguminana O I_PERSON/I_DISEASE_ADJECTIVE[DISEASE]
also O O
provide O O
some O O
evidence O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
of O O
specificity O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
, O O
in O O
contrast O B_MEASURE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
to O O
historical O B_BIO/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
rearing O I_BIO/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
records O I_BIO/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

To O O
examine O O
the O O
possibility O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
that O O
R O B_OTHER/B_LOCATION
. O O
leguminana O B_DISEASE_ADJECTIVE[DISEASE]/B_SPECIES[BIO]
is O O
a O O
complex O B_LOCATION/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
species O B_BIO
, O O
two O B_NUMBER[MEASURE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
data O I_NUMBER[MEASURE]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
sets O I_NUMBER[MEASURE]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
molecular O B_GENE/B_BIO
markers O I_GENE/I_BIO
were O O
examined O O
: O O
( O O
1 O B_SEQUENCE[MEASURE]
) O O
a O O
combined O O
data O B_LOCATION/B_ORGANIZATION
set O I_LOCATION/I_ORGANIZATION
of O O
two O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
mitochondrial O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
markers O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
( O O
a O O
781 O B_MEASURE
- O O
basepair O B_LOCATION/B_MEASURE
region O I_LOCATION/I_MEASURE
of O O
cytochrome O B_ENZYME[GENE]
c O O
oxidase O B_ENZYME[GENE]
I O I_ENZYME[GENE]
( O O
COI O B_GENE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
) O O
and O O
a O O
685 O B_MEASURE
- O O
basepair O B_LOCATION/B_MEASURE
region O I_LOCATION/I_MEASURE
of O O
cytochrome O B_ENZYME[GENE]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
c O O
oxidase O B_ENZYME[GENE]
II O I_ENZYME[GENE]
) O O
and O O
one O B_GENE/B_NUMBER[MEASURE]
nuclear O I_GENE/I_NUMBER[MEASURE]
marker O I_GENE/I_NUMBER[MEASURE]
( O O
a O O
531 O B_MEASURE
- O O
basepair O B_LOCATION/B_MEASURE
region O I_LOCATION/I_MEASURE
of O O
the O O
28S O B_GENE/B_MEASURE
domain O I_GENE/I_MEASURE
2 O I_GENE/I_MEASURE
) O O
; O O
and O O
( O O
2 O O
) O O
the O O
650 O B_MEASURE
- O O
basepair O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
& O O
quot O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
; O O
barcode O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
& O O
quot O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
; O O
region O B_LOCATION/B_MEASURE
of O O
COI O B_GENE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

Analyses O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
of O O
both O O
data O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
sets O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
strongly O O
suggest O O
that O O
individuals O B_PERSON/B_BIO
examined O O
in O O
this O O
study O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
belong O O
to O O
more O B_MEASURE/B_PERSON
than O O
one O B_NUMBER[MEASURE]/B_PERSON
species O I_NUMBER[MEASURE]/I_PERSON
. O O

Evidence O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
for O O
the O O
higher O B_MEASURE/B_PERSON
importance O I_MEASURE/I_PERSON
of O O
signal O B_MEASURE/B_BODY_PART_OR_ORGAN_COMPONENT
size O I_MEASURE/I_BODY_PART_OR_ORGAN_COMPONENT
over O O
body O B_MEASURE/B_PERSON
size O I_MEASURE/I_PERSON
in O O
aposematic O B_DISEASE_ADJECTIVE[DISEASE]/B_ORGANISM_FUNCTION
signaling O B_DISEASE_ADJECTIVE[DISEASE]/I_ORGANISM_FUNCTION
in O O
insects O B_SPECIES[BIO]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

To O O
understand O O
the O O
evolution O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
of O O
warning O O
coloration O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
, O O
it O O
is O O
important O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
to O O
distinguish O O
between O O
different O B_DISEASE_ADJECTIVE[DISEASE]/B_PERSON
aspects O I_DISEASE_ADJECTIVE[DISEASE]/I_PERSON
of O O
conspicuous O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
color O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
patterns O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
. O O

As O O
an O O
example O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
, O O
both O O
pattern O B_MEASURE/B_LOCATION
element O I_MEASURE/I_LOCATION
size O I_MEASURE/I_LOCATION
and O O
body O B_MEASURE/B_LOCATION
size O I_MEASURE/I_LOCATION
of O O
prey O B_BIO/B_PERSON
have O O
been O O
shown O O
to O O
enhance O O
the O O
effectiveness O B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
of O O
warning O O
signals O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PRODUCT[OBJECT]
. O O

However O O
, O O
it O O
is O O
unclear O B_TIME[MEASURE]/B_DISEASE_ADJECTIVE[DISEASE]
whether O O
the O O
effect O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
body O B_MEASURE/B_COLOR
size O I_MEASURE/I_COLOR
is O O
merely O O
a O O
side O B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
effect O I_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
of O O
proportionally O O
increasing O O
pattern O B_MEASURE/B_PERSON
elements O I_MEASURE/I_PERSON
, O O
or O O
if O O
there O O
is O O
an O O
effect O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
body O B_MEASURE/B_COLOR
size O I_MEASURE/I_COLOR
per O O
se O B_LOCATION/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

These O O
possibilities O O
were O O
evaluated O O
by O O
offering O O
different O O
sized O O
artificial O O
caterpillars O O
with O O
either O O
fixed O O
or O O
proportionally O O
increasing O O
aposematic O O
color O O
signal O O
elements O O
to O O
wild O O
great B B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
tits I I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
, O O
Parus B B_BACTERIUM[BIO]/B_LOCATION
major I B_BACTERIUM[BIO]/I_LOCATION
L I B_BACTERIUM[BIO]/I_LOCATION
. I B_BACTERIUM[BIO]/I_LOCATION

( O O
Passeriformes O B_LOCATION/B_PERSON
: O O
Paridae O B_LOCATION/B_BIO
) O O
. O O

The O O
birds O B_TIME[MEASURE]/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
' O B_TIME[MEASURE]/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
hesitation O B_TIME[MEASURE]/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
time O B_TIME[MEASURE]/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
to O O
attack O O
each O O
& O O
quot O B_MEASURE/B_PERSON
; O O
caterpillar O B_MEASURE/B_DISEASE_ADJECTIVE[DISEASE]
& O O
quot O B_MEASURE/B_LOCATION
; O O
was O O
used O O
as O O
a O O
measure O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
of O O
the O O
warning O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
effect O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE
. O O

The O O
hesitation O B_TIME[MEASURE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
time O B_TIME[MEASURE]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
showed O O
a O O
significant O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
, O O
positive O B_MEASURE/B_LOCATION
size O I_MEASURE/I_LOCATION
- O O
dependence O B_DISEASE/B_MEASURE
with O O
the O O
caterpillars O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
whose O O
pattern O B_MEASURE/B_LOCATION
elements O I_MEASURE/I_LOCATION
increased O O
proportionally O O
with O O
their O O
body O B_MEASURE/B_LOCATION
size O I_MEASURE/I_LOCATION
. O O

In O O
contrast O B_MEASURE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
no O O
size O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
dependence O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
was O O
found O O
in O O
the O O
larvae O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
with O O
fixed O O
- O O
size O B_MEASURE/B_BODY_PART_OR_ORGAN_COMPONENT
signal O B_MEASURE/I_BODY_PART_OR_ORGAN_COMPONENT
elements O B_MEASURE/I_BODY_PART_OR_ORGAN_COMPONENT
. O O

Such O B_TIME[MEASURE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
a O O
difference O B_MEASURE
in O O
mortality O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
curves O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
is O O
consistent O B_DISEASE_ADJECTIVE[DISEASE]/B_GENE
with O O
the O O
idea O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANIZATION
that O O
pattern O B_MEASURE/B_DISEASE
element O I_MEASURE/I_DISEASE
size O I_MEASURE/I_DISEASE
is O O
a O O
more O O
important O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
aspect O I_DISEASE_ADJECTIVE[DISEASE]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
than O O
body O B_MEASURE
size O I_MEASURE
in O O
enhancing O O
a O O
warning O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
signal O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

Since O O
no O O
evidence O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
of O O
an O O
effect O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
body O B_MEASURE/B_BIO
size O I_MEASURE/I_BIO
per O O
se O B_LOCATION/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
on O O
signal O B_MEASURE/B_BIO
efficiency O B_MEASURE/I_BIO
was O O
found O O
, O O
this O O
study O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
does O O
not O O
support O O
the O O
hypothesis O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
that O O
aposematic O B_BIO/B_PERSON
insects O B_BIO/I_PERSON
gain O O
more O O
from O O
large O B_DISEASE_ADJECTIVE[DISEASE]/B_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
size O B_DISEASE_ADJECTIVE[DISEASE]/I_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
than O O
cryptic O B_BIO/B_PERSON
ones O I_BIO/I_PERSON
. O O

Wolbachia O O
wSinvictaA B B_DRUG_ADJECTIVE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
infections O O
in O O
natural O O
populations O O
of O O
the O O
fire B B_SPECIES[BIO]/B_DISEASE_ADJECTIVE[DISEASE]
ant I I_SPECIES[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
Solenopsis B I_SPECIES[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
invicta I I_SPECIES[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
: O O
testing O O
for O O
phenotypic O O
effects O O
. O O

Wolbachia O B_BACTERIUM[BIO]/B_PERSON
are O O
intracellular O B_SPECIES[BIO]
bacteria O I_SPECIES[BIO]
that O O
commonly O O
infect O O
many O B_SPECIES[BIO]
arthropods O I_SPECIES[BIO]
and O O
some O O
nematodes O B_BIO/B_DISEASE
. O O

In O O
arthropods O B_BIO
, O O
these O O
maternally O O
transmitted O O
bacteria O B_BIO/B_DISEASE
often O O
induce O O
a O O
variety O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
of O O
phenotypic O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
effects O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
to O O
enhance O O
their O O
own O B_DISEASE
spread O I_DISEASE
within O O
host O B_MEASURE/B_PERSON
populations O I_MEASURE/I_PERSON
. O O

Wolbachia O B_PERSON/B_DISEASE_ADJECTIVE[DISEASE]
phenotypic O I_PERSON/I_DISEASE_ADJECTIVE[DISEASE]
effects O I_PERSON/I_DISEASE_ADJECTIVE[DISEASE]
generally O O
either O O
provide O O
benefits O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
to O O
infected O B_DISEASE/B_BIO
host O B_DISEASE/I_BIO
females O B_DISEASE/I_BIO
( O O
cytoplasmic O B_DISEASE/B_ORGANISM_FUNCTION
incompatibility O I_DISEASE/I_ORGANISM_FUNCTION
, O O
positive O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
fitness O I_DISEASE_ADJECTIVE[DISEASE]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
effects O I_DISEASE_ADJECTIVE[DISEASE]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
) O O
or O O
bias O B_MEASURE/B_LOCATION
host O B_MEASURE/I_LOCATION
sex O B_MEASURE/I_LOCATION
ratio O B_MEASURE/I_LOCATION
in O O
favor O B_PERSON/B_MEASURE
of O O
females O B_PERSON/B_DISEASE
( O O
male O B_PERSON/B_BIO
- O O
killing O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_ORGANISM_FUNCTION
, O O
parthenogenesis O B_DISEASE_ADJECTIVE[DISEASE]/B_ORGANISM_FUNCTION
, O O
feminization O B_DISEASE_ADJECTIVE[DISEASE]/B_ORGANISM_FUNCTION
) O O
, O O
all O O
of O O
which O O
increase O O
the O O
relative O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
production O I_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
of O O
infected O B_PERSON/B_BIO
females O B_PERSON/I_BIO
in O O
host O B_MEASURE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
populations O I_MEASURE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

Wolbachia O B_PERSON/B_BIO
surveys O I_PERSON/I_BIO
have O O
found O O
infections O B_DISEASE/B_SPECIES[BIO]
to O O
be O O
exceedingly O O
common O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
in O O
ants O B_SPECIES[BIO]/B_PERSON
, O O
but O O
little O B_PERSON/B_DISEASE_ADJECTIVE[DISEASE]
is O O
known O O
at O O
this O O
juncture O B_MEASURE/B_LOCATION
as O O
to O O
what O O
phenotypic O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
effects O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE
, O O
if O O
any O O
, O O
they O O
induce O O
in O O
this O O
group O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
. O O

Previous O O
studies O O
have O O
demonstrated O O
that O O
individuals O O
from O O
native O O
populations O O
of O O
the O O
invasive O O
fire B B_LOCATION/B_DISEASE_ADJECTIVE[DISEASE]
ant I I_LOCATION/I_DISEASE_ADJECTIVE[DISEASE]
Solenopsis B I_LOCATION/I_DISEASE_ADJECTIVE[DISEASE]
invicta I I_LOCATION/I_DISEASE_ADJECTIVE[DISEASE]
commonly O O
harbor O O
one O O
or O O
more O O
of O O
three O O
Wolbachia O O
variants O O
. O O

One O O
of O O
the O O
variants O O
, O O
wSinvictaA O O
, O O
typically O O
occurs O O
at O O
low O O
prevalence O O
in O O
S B B_PERSON/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. I I_PERSON/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
invicta I I_PERSON/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
populations O O
, O O
appears O O
to O O
have O O
been O O
transmitted O O
horizontally O O
into O O
S B B_PERSON/B_BIO
. I I_PERSON/I_BIO
invicta I I_PERSON/I_BIO
three O O
or O O
more O O
times O O
, O O
and O O
has O O
been O O
lost O O
repeatedly O O
from O O
host O O
lineages O O
over O O
time O O
. O O

In O O
order O O
to O O
determine O O
the O O
phenotypic O O
effects O O
and O O
likely O O
population O O
dynamics O O
of O O
wSinvictaA B B_SPECIES[BIO]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
infections O O
in O O
these O O
ants O O
, O O
brood O O
production O O
patterns O O
of O O
newly O O
mated O O
fire B B_BIO/B_PERSON
ant I I_BIO/I_PERSON
queens O O
were O O
studied O O
during O O
simulated O O
claustral O O
founding O O
and O O
measured O O
wSinvictaA B B_DISEASE_ADJECTIVE[DISEASE]/B_LOCATION
transmission O O
fidelity O O
within O O
mature O O
single O O
- O O
queen O O
families O O
. O O

No O O
clear O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
evidence O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
was O O
found O O
for O O
Wolbachia O B_BIO/B_PERSON
- O O
induced O O
cytoplasmic O B_DISEASE/B_ORGANISM_FUNCTION
incompatibility O I_DISEASE/I_ORGANISM_FUNCTION
, O O
significant O B_DISEASE_ADJECTIVE[DISEASE]
fitness O I_DISEASE_ADJECTIVE[DISEASE]
effects O I_DISEASE_ADJECTIVE[DISEASE]
, O O
or O O
male O B_PERSON/B_DISEASE
- O O
killing O B_DISEASE/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
. O O

Maternal O B_PERSON/B_DISEASE_ADJECTIVE[DISEASE]
transmission O I_PERSON/I_DISEASE_ADJECTIVE[DISEASE]
was O O
perfect O B_DISEASE_ADJECTIVE[DISEASE]
to O O
both O O
virgin O B_PERSON/B_LOCATION
queens O I_PERSON/I_LOCATION
and O O
males O B_PERSON
. O O

Possible O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
mechanisms O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
for O O
how O O
this O O
variant O B_DISEASE_ADJECTIVE[DISEASE]/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
could O O
be O O
maintained O O
in O O
host O B_MEASURE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
populations O I_MEASURE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
are O O
discussed O O
. O O

Growth O O
inhibition O O
of O O
Beauveria B B_BIO
bassiana I I_BIO
by O O
bacteria O O
isolated O O
from O O
the O O
cuticular O O
surface O O
of O O
the O O
corn B B_BIO
leafhopper I I_BIO
, O O
Dalbulus B B_BIO
maidis I I_BIO
and O O
the O O
planthopper O O
, O O
Delphacodes B B_BIO/B_LOCATION
kuscheli I I_BIO/I_LOCATION
, O O
two O O
important O O
vectors O O
of O O
maize O O
pathogens O O
. O O

The O O
phytosanitary O O
importance O O
of O O
the O O
corn B B_BIO/B_LOCATION
leafhopper O O
, O O
Dalbulus O O
maidis O O
( O O
De O O
Long O O
and O O
Wolcott O O
) O O
( O O
Hemiptera O O
: O O
Cicadellidae O O
) O O
and O O
the O O
planthopper O O
, O O
Delphacodes O O
kuscheli O O
Fennah O O
( O O
Hemiptera O O
: O O
Delphacidae O O
) O O
lies O O
in O O
their O O
ability O O
to O O
transmit O O
phloem O O
- O O
associated O O
plant O O
pathogens O O
, O O
mainly O O
viruses O O
and O O
mollicutes O O
, O O
and O O
to O O
cause O O
considerable O O
mechanical O O
damage O O
to O O
corn O O
plants O O
during O O
feeding O O
and O O
oviposition O O
. O O

Fungi O B_BACTERIUM[BIO]/B_PERSON
, O O
particularly O O
some O O
members O B_PERSON/B_BIO
of O O
the O O
Ascomycota O B_BIO/B_PERSON
, O O
are O O
likely O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
candidates O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
for O O
biocontrol O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_DISEASE
agents O I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/I_DISEASE
against O O
these O O
insect O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
pests O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
, O O
but O O
several O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
studies O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
revealed O O
their O O
failure O B_DISEASE_ADJECTIVE[DISEASE]/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
to O O
invade O O
the O O
insect O B_BIO/B_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
cuticle O I_BIO/I_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
possibly O O
because O O
of O O
the O O
presence O B_LOCATION/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
of O O
inhibitory O B_CHEMICAL_CLASS[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
compounds O I_CHEMICAL_CLASS[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
such O I_CHEMICAL_CLASS[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
as O O
phenols O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
, O O
quinones O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
, O O
and O O
lipids O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
and O O
also O O
by O O
the O O
antibiosis O B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
effect O I_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
of O O
the O O
microbiota O B_BACTERIUM[BIO]
living O O
on O O
the O O
cuticular O B_DISEASE_ADJECTIVE[DISEASE]/B_BODY_PART_OR_ORGAN_COMPONENT
surface O B_DISEASE_ADJECTIVE[DISEASE]/I_BODY_PART_OR_ORGAN_COMPONENT
of O O
the O O
host O B_BIO
. O O

The O O
present O O
work O O
aims O O
to O O
understand O O
interactions O O
between O O
the O O
entomopathogenic O O
fungus O O
Beauveria B B_BIO
bassiana I I_BIO
( O O
Balsamao O O
- O O
Crivelli O O
) O O
Vuillemin O O
( O O
Hypocreales O O
: O O
Cordycipitaceae O O
) O O
and O O
bacterial O O
antagonists O O
isolated O O
from O O
the O O
cuticular O O
surface O O
of O O
D B B_BIO
. I I_BIO
maidis I I_BIO
and O O
D B B_BIO
. I I_BIO
kuscheli I I_BIO
. O O

A O O
total O O
of O O
155 O O
bacterial O O
isolates O O
were O O
recovered O O
from O O
the O O
insect O O
' O O
s O O
cuticle O O
and O O
tested O O
against O O
B B B_SPECIES[BIO]
. I I_SPECIES[BIO]
bassiana I I_SPECIES[BIO]
. O O

Ninety O O
- O O
one O O
out O O
of O O
155 O O
strains O O
inhibited O O
the O O
growth O O
of O O
B B B_SPECIES[BIO]
. I I_SPECIES[BIO]
bassiana I I_SPECIES[BIO]
. O O

Bacterial O O
strains O O
isolated O O
from O O
D B B_BIO
. I I_BIO
maidis I I_BIO
were O O
significantly O O
more O O
antagonistic O O
against O O
B B B_SPECIES[BIO]
. I I_SPECIES[BIO]
bassiana I I_SPECIES[BIO]
than O O
those O O
isolates O O
from O O
D B B_PERSON/B_BIO
. I I_PERSON/I_BIO
kuscheli I I_PERSON/I_BIO
. O O

Among O O
the O O
most O O
effective O O
antagonistic O O
strains O O
, O O
six O O
isolates O O
of O O
Bacillus B B_BACTERIUM[BIO]/B_PERSON
thuringiensis I I_BACTERIUM[BIO]/I_PERSON
Berliner O O
( O O
Bacillales O O
: O O
Bacillaeae O O
( O O
after O O
B B B_MEASURE
. I I_MEASURE
subtilis I I_MEASURE
) O O
) O O
, O O
one O O
isolate O O
of O O
B B B_BACTERIUM[BIO]/B_PERSON
. I I_BACTERIUM[BIO]/I_PERSON
mycoides I I_BACTERIUM[BIO]/I_PERSON
Flugge O O
, O O
eight O O
isolates O O
of O O
B B B_PERSON/B_BACTERIUM[BIO]
. I I_PERSON/I_BACTERIUM[BIO]
megaterium I I_PERSON/I_BACTERIUM[BIO]
de O O
Bary O O
, O O
five O O
isolates O O
of O O
B B B_BACTERIUM[BIO]
. I I_BACTERIUM[BIO]
pumilus I I_BACTERIUM[BIO]
Meyer O O
and O O
Gottheil O O
, O O
one O O
isolate O O
of O O
B B B_BACTERIUM[BIO]/B_PERSON
. I I_BACTERIUM[BIO]/I_PERSON
licheniformis I I_BACTERIUM[BIO]/I_PERSON
( O O
Weigmann O O
) O O
Chester O O
, O O
and O O
four O O
isolates O O
of O O
B B B_BACTERIUM[BIO]/B_PERSON
. I I_BACTERIUM[BIO]/I_PERSON
subtilis I I_BACTERIUM[BIO]/I_PERSON
( O O
Ehrenberg O O
) O O
Cohn O O
were O O
identified O O
. O O

Mig1 O O
is O O
involved O O
in O O
mycelial O O
formation O O
and O O
expression O O
of O O
the O O
genes O O
encoding O O
extracellular O O
enzymes O O
in O O
Saccharomycopsis B B_BACTERIUM[BIO]/B_GENE
fibuligera I I_BACTERIUM[BIO]/I_GENE
A11 O O
. O O

The O O
MIG1 O O
gene O O
of O O
Saccharomycopsis B B_VIRUS[BIO]/B_GENE
fibuligera I I_VIRUS[BIO]/I_GENE
A11 O O
was O O
cloned O O
from O O
its O O
genomic O O
DNA O O
using O O
the O O
degenerated O O
primers O O
and O O
inverse O O
PCR O O
. O O

The O O
MIG1 O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
gene O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
( O O
1152bp O B_GENE
, O O
accession O B_TIME[MEASURE]/B_BIO
number O I_TIME[MEASURE]/I_BIO
: O O
HM450676 O B_MEASURE
) O O
encoded O O
a O O
384 O B_MEASURE
- O O
amino O B_PROTEIN[GENE]/B_DISEASE_ADJECTIVE[DISEASE]
acid O I_PROTEIN[GENE]/I_DISEASE_ADJECTIVE[DISEASE]
protein O I_PROTEIN[GENE]/I_DISEASE_ADJECTIVE[DISEASE]
very O O
similar O B_PERSON/B_DISEASE_ADJECTIVE[DISEASE]
to O O
Mig1s O B_GENE/B_BIO
from O O
other O B_SPECIES[BIO]/B_DISEASE_ADJECTIVE[DISEASE]
fungi O I_SPECIES[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
. O O

Besides O O
their O O
highly O O
conserved O O
zinc O B_LOCATION/B_PERSON
fingers O I_LOCATION/I_PERSON
, O O
the O O
Mig1 O B_BIO/B_GENE
proteins O I_BIO/I_GENE
displayed O O
short O B_LOCATION
conserved O I_LOCATION
motifs O I_LOCATION
of O O
possible O B_MEASURE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
significance O I_MEASURE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
in O O
glucose O B_DISEASE/B_BIO
repression O I_DISEASE/I_BIO
. O O

The O O
MIG1 O O
gene O O
in O O
S B B_DISEASE_ADJECTIVE[DISEASE]/B_BIO
. I B_DISEASE_ADJECTIVE[DISEASE]/I_BIO
fibuligera I B_DISEASE_ADJECTIVE[DISEASE]/I_BIO
A11 O O
was O O
disrupted O O
by O O
integrating O O
the O O
HPT O O
( O O
hygromycin O O
B O O
phosphotransferase O O
) O O
gene O O
into O O
ORF O O
( O O
Open O O
Reading O O
Frame O O
) O O
of O O
the O O
MIG1 O O
gene O O
. O O

The O O
disruptant O B_PROTEIN[GENE]/B_DISEASE
A11 O I_PROTEIN[GENE]/I_DISEASE
- O O
c O B_PROTEIN[GENE]/B_DISEASE
obtained O O
could O O
grow O O
in O O
the O O
media O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
containing O O
hygromycin O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
and O O
2 O B_MEASURE
- O O
deoxy O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ENZYME[GENE]
- O O
d O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
- O O
glucose O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BODY_PART_OR_ORGAN_COMPONENT
, O O
respectively O O
. O O

alpha O B_PROTEIN[GENE]
- O O
Amylase O B_ENZYME[GENE]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
glucoamylse O B_ENZYME[GENE]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
acid O B_ENZYME[GENE]/B_BACTERIUM[BIO]
protease O I_ENZYME[GENE]/I_BACTERIUM[BIO]
and O O
Beta O B_PROTEIN[GENE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- O O
glucosidase O B_ENZYME[GENE]/B_DISEASE_ADJECTIVE[DISEASE]
production O I_ENZYME[GENE]/I_DISEASE_ADJECTIVE[DISEASE]
by O O
the O O
disruptant O B_DISEASE_ADJECTIVE[DISEASE]/B_BIO
and O O
expression O B_GENE
of O O
their O O
genes O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
in O O
the O O
disruptant O B_DISEASE_ADJECTIVE[DISEASE]/B_BIO
were O O
greatly O O
enhanced O O
. O O

This O O
confirms O O
that O O
Mig1 O O
, O O
the O O
transcriptional O O
repressor O O
, O O
indeed O O
regulates O O
expression O O
of O O
the O O
genes O O
and O O
production O O
of O O
the O O
extracellular O O
enzymes O O
in O O
S B B_DISEASE_ADJECTIVE[DISEASE]/B_SPECIES[BIO]
. I B_DISEASE_ADJECTIVE[DISEASE]/I_SPECIES[BIO]
fibuligera I B_DISEASE_ADJECTIVE[DISEASE]/I_SPECIES[BIO]
A11 O O
. O O

At O O
the O O
same O B_TIME[MEASURE]/B_LOCATION
time O B_TIME[MEASURE]/I_LOCATION
, O O
it O O
was O O
found O O
that O O
cell O B_DISEASE/B_ORGANISM_FUNCTION
budding O I_DISEASE/I_ORGANISM_FUNCTION
was O O
enhanced O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
mycelial O B_DISEASE_ADJECTIVE[DISEASE]
formation O I_DISEASE_ADJECTIVE[DISEASE]
was O O
reduced O O
in O O
the O O
disruptant O B_DISEASE_ADJECTIVE[DISEASE]/B_BIO
. O O

Morphological O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
differences O B_DISEASE_ADJECTIVE[DISEASE]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
molecular O B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
phylogeny O I_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
of O O
freshwater O B_LOCATION/B_BIO
blooming O O
species O B_BIO
, O O
Peridiniopsis O B_BACTERIUM[BIO]/B_DISEASE_ADJECTIVE[DISEASE]
spp O O
. O O

( O O
Dinophyceae O B_MEASURE/B_BIO
) O O
from O O
China O B_LOCATION
. O O

In O O
2008 O B_TIME[MEASURE]
- O O
2010 O B_MEASURE
, O O
several O B_DISEASE/B_BIO
freshwater O I_DISEASE/I_BIO
dinoflagellate O I_DISEASE/I_BIO
blooms O I_DISEASE/I_BIO
caused O O
by O O
Peridiniopsis O B_LOCATION/B_BACTERIUM[BIO]
spp O I_LOCATION/I_BACTERIUM[BIO]
. O O
were O O
observed O O
in O O
China O B_LOCATION
. O O

P B B_SPECIES[BIO]/B_PERSON
. I I_SPECIES[BIO]/I_PERSON
penardii I I_SPECIES[BIO]/I_PERSON
and O O
P B B_SPECIES[BIO]/B_PERSON
. I I_SPECIES[BIO]/I_PERSON
niei I I_SPECIES[BIO]/I_PERSON
sampled O O
from O O
various O O
geographical O O
localities O O
were O O
examined O O
by O O
means O O
of O O
light O O
and O O
scanning O O
electron O O
microscopy O O
. O O

After O O
comparing O O
morphological O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
and O O
molecular O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
differences O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
, O O
the O O
new O B_LOCATION/B_PERSON
freshwater O I_LOCATION/I_PERSON
variety O I_LOCATION/I_PERSON
Peridiniopsis O I_LOCATION/I_PERSON
penardii O I_LOCATION/I_PERSON
var O I_LOCATION/I_PERSON
. O O
robusta O B_BIO/B_GENE
var O B_BIO/I_GENE
. O O
nov O B_LOCATION/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

( O O
Peridiniales O B_LOCATION/B_PERSON
, O O
Dinophyceae O B_MEASURE/B_LOCATION
) O O
found O O
in O O
Manwan O B_LOCATION
Reservoir O I_LOCATION
, O O
Yunnan O B_LOCATION
Province O I_LOCATION
was O O
described O O
. O O

The O O
new O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
variety O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
differed O O
from O O
P O B_OTHER/B_LOCATION
. O O
penardii O B_SPECIES[BIO]/B_DISEASE
since O O
it O O
possessed O O
numerous O B_DISEASE_ADJECTIVE[DISEASE]/B_CELL_COMPONENT[BODY_PART_OR_ORGAN_COMPONENT]
robust O B_DISEASE_ADJECTIVE[DISEASE]/I_CELL_COMPONENT[BODY_PART_OR_ORGAN_COMPONENT]
antapical O B_DISEASE_ADJECTIVE[DISEASE]/I_CELL_COMPONENT[BODY_PART_OR_ORGAN_COMPONENT]
spines O B_DISEASE_ADJECTIVE[DISEASE]/I_CELL_COMPONENT[BODY_PART_OR_ORGAN_COMPONENT]
and O O
a O O
conspicuous O B_BODY_PART_OR_ORGAN_COMPONENT/B_DISEASE
apical O I_BODY_PART_OR_ORGAN_COMPONENT/I_DISEASE
spine O I_BODY_PART_OR_ORGAN_COMPONENT/I_DISEASE
. O O

Molecular O O
phylogenetic O O
analyses O O
based O O
on O O
SSU O O
, O O
LSU O O
and O O
ITS O O
indicated O O
P B B_BIO/B_LOCATION
. I B_BIO/I_LOCATION
niei I B_BIO/I_LOCATION
, O O
P O O
. O O
penardii O O
and O O
P O O
. O O
penardii O O
var O O
. O O
robusta O O
were O O
closely O O
related O O
with O O
P O O
. O O
kevei O O
, O O
and O O
clustered O O
into O O
a O O
monophyletic O O
clade O O
. O O

The O O
new O O
variety O O
possessed O O
an O O
endosymbiotic O O
diatom O O
which O O
was O O
similar O O
to O O
P O O
. O O
penardii O O
and O O
P O O
. O O
kevei O O
, O O
whereas O O
the O O
endosymbiont O O
was O O
not O O
present O O
in O O
cells O O
of O O
P B B_BIO
. I I_BIO
niei I I_BIO
. O O

The O O
endosymbiont O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
SSU O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
and O O
ITS O O
phylogenies O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
showed O O
that O O
the O O
endosymbionts O B_BIO/B_GENE
of O O
these O O
three O B_BIO
dinoflagellates O I_BIO
were O O
closely O O
related O O
to O O
members O B_PERSON/B_BIO
of O O
Thalassiosirales O B_SPECIES[BIO]
. O O

Furthermore O O
it O O
was O O
concluded O O
that O O
the O O
endosymbionts O B_BIO
might O O
originate O O
from O O
Discostella O B_BACTERIUM[BIO]
- O O
like O B_BIO
species O I_BIO
. O O

Beta O B_PROTEIN[GENE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- O O
Thymosin O B_GENE
is O O
upregulated O O
by O O
the O O
steroid O B_MEASURE
hormone O I_MEASURE
20 O I_MEASURE
- O O
hydroxyecdysone O B_TIME[MEASURE]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
microorganisms O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BACTERIUM[BIO]
. O O

Thymosins O B_PERSON/B_GENE
have O O
diverse O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
biological O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
activities O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
including O O
actin O B_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BACTERIUM[BIO]
- O O
sequestering O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
and O O
tissue O B_DISEASE_ADJECTIVE[DISEASE]/B_CELL_FUNCTION[ORGANISM_FUNCTION]
repair O B_DISEASE_ADJECTIVE[DISEASE]/I_CELL_FUNCTION[ORGANISM_FUNCTION]
in O O
vertebrates O B_BIO/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
however O O
, O O
there O O
is O O
little O B_DISEASE_ADJECTIVE[DISEASE]/B_PERSON
information O I_DISEASE_ADJECTIVE[DISEASE]/I_PERSON
about O O
the O O
function O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
thymosins O B_GENE/B_BIO
in O O
invertebrates O B_SPECIES[BIO]
. O O

We O O
isolated O O
a O O
Beta O O
- O O
thymosin O O
gene O O
in O O
Helicoverpa B B_SPECIES[BIO]
armigera I I_SPECIES[BIO]
. O O

It O O
has O O
two O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
transcript O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
variants O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
, O O
HaTHY1 O B_PROTEIN[GENE]/B_LOCATION
and O O
HaTHY2 O B_GENE/B_DISEASE
, O O
encoding O O
19 O B_MEASURE
. O O
0 O B_MEASURE
kDa O I_MEASURE
and O O
14 O B_MEASURE
. O O
5 O B_MEASURE
kDa O I_MEASURE
peptides O I_MEASURE
, O O
respectively O O
. O O

HaTHY1 O B_GENE
was O O
mainly O O
transcribed O O
in O O
the O O
integument O B_BODY_PART_OR_ORGAN_COMPONENT/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
midgut O B_BODY_PART_OR_ORGAN_COMPONENT/B_BIO
, O O
while O O
HaTHY2 O B_GENE
was O O
principally O O
presented O O
in O O
the O O
fat O B_BODY_PART_OR_ORGAN_COMPONENT/B_BIO
body O I_BODY_PART_OR_ORGAN_COMPONENT/I_BIO
and O O
haemocytes O B_BODY_PART_OR_ORGAN_COMPONENT/B_BIO
. O O

The O O
transcript O B_MEASURE/B_LOCATION
levels O B_MEASURE/I_LOCATION
of O O
HaTHY2 O B_GENE
showed O O
some O O
fluctuation O B_DISEASE_ADJECTIVE[DISEASE]
; O O
there O O
was O O
an O O
obvious O B_DISEASE_ADJECTIVE[DISEASE]
increase O I_DISEASE_ADJECTIVE[DISEASE]
at O O
the O O
metamorphic O B_DISEASE_ADJECTIVE[DISEASE]/B_LOCATION
stage O I_DISEASE_ADJECTIVE[DISEASE]/I_LOCATION
in O O
the O O
integument O B_BODY_PART_OR_ORGAN_COMPONENT/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
or O O
fat O B_BODY_PART_OR_ORGAN_COMPONENT/B_BIO
body O I_BODY_PART_OR_ORGAN_COMPONENT/I_BIO
. O O

HaTHY O B_GENE
was O O
able O B_DISEASE_ADJECTIVE[DISEASE]
to O O
be O O
upregulated O O
by O O
20 O B_MEASURE
- O O
hydroxyecdysone O B_PROTEIN[GENE]/B_DISEASE_ADJECTIVE[DISEASE]
or O O
by O O
bacterial O B_BACTERIUM[BIO]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
viral O B_DISEASE_ADJECTIVE[DISEASE]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
challenge O B_DISEASE_ADJECTIVE[DISEASE]/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

These O O
data O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
suggest O O
that O O
HaTHY O B_GENE
is O O
upregulated O O
by O O
the O O
steroid O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
hormone O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_BIO
and O O
by O O
responses O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
to O O
microorganism O B_DISEASE/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
infection O B_DISEASE/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

The O O
cell O O
cycle O O
gene O O
MoCDC15 O O
regulates O O
hyphal O O
growth O O
, O O
asexual O O
development O O
and O O
plant O O
infection O O
in O O
the O O
rice B B_BIO/B_LOCATION
blast I I_BIO/I_LOCATION
pathogen I I_BIO/I_LOCATION
Magnaporthe B I_BIO/I_LOCATION
oryzae I I_BIO/I_LOCATION
. O O

Rice O O
blast O O
, O O
caused O O
by O O
the O O
pathogen O O
Magnaporthe B B_BIO
oryzae I I_BIO
, O O
is O O
a O O
serious O O
hindrance O O
to O O
rice B B_BIO/B_LOCATION
production O O
and O O
has O O
emerged O O
as O O
an O O
important O O
model O O
for O O
the O O
characterization O O
of O O
molecular O O
mechanisms O O
relevant O O
to O O
pathogenic O O
development O O
in O O
plants O O
. O O

Similar O O
to O O
other O O
pathogenic O O
fungi O O
, O O
conidiation O O
plays O O
a O O
central O O
role O O
in O O
initiation O O
of O O
M B B_SPECIES[BIO]
. I I_SPECIES[BIO]
oryzae I I_SPECIES[BIO]
infection O O
and O O
spread O O
over O O
a O O
large O O
area O O
. O O

However O O
, O O
relatively O O
little O O
is O O
known O O
regarding O O
the O O
molecular O O
mechanisms O O
that O O
underlie O O
conidiation O O
in O O
M B B_BIO
. I I_BIO
oryzae I I_BIO
. O O

To O O
better O O
characterize O O
these O O
mechanisms O O
, O O
we O O
identified O O
a O O
conidiation O O
- O O
defective O O
mutant O O
, O O
ATMT0225B6 B B_DISEASE/B_LOCATION
( O O
MoCDC15 B B_PROTEIN[GENE]/B_BIO
( I I_PROTEIN[GENE]/I_BIO
T I I_PROTEIN[GENE]/I_BIO
- I I_PROTEIN[GENE]/I_BIO
DNA I I_PROTEIN[GENE]/I_BIO
) I I_PROTEIN[GENE]/I_BIO
) O O
, O O
in O O
which O O
a O O
T O O
- O O
DNA O O
insertion O O
disrupted O O
a O O
gene O O
that O O
encodes O O
a O O
homolog O O
of O O
fission O O
yeast B B_SPECIES[BIO]/B_GENE
cdc15 O O
, O O
and O O
generated O O
a O O
second O O
strain O O
containing O O
a O O
disruption O O
in O O
the O O
same O O
allele O O
( O O
DeltaMoCDC15 O O
( O O
T O O
- O O
DNA O O
) O O
) O O
. O O

The O O
cdc15 O O
gene O O
has O O
been O O
shown O O
to O O
act O O
as O O
a O O
coordinator O O
of O O
the O O
cell O O
cycle O O
in O O
yeast B B_SPECIES[BIO]
. O O

Functional O O
analysis O O
of O O
the O O
MoCDC15 O O
( O O
T O O
- O O
DNA O O
) O O
and O O
DeltaMoCDC15 O O
( O O
T O O
- O O
DNA O O
) O O
mutants O O
revealed O O
that O O
MoCDC15 O O
is O O
required O O
for O O
conidiation O O
, O O
preinfection O O
development O O
and O O
pathogenicity O O
in O O
M B B_BIO
. I I_BIO
oryzae I I_BIO
. O O

Conidia O B_BIO/B_CELL[BODY_PART_OR_ORGAN_COMPONENT]
from O O
these O O
mutants O B_BIO/B_DISEASE
were O O
viable O B_DISEASE_ADJECTIVE[DISEASE]/B_CELL[BODY_PART_OR_ORGAN_COMPONENT]
, O O
but O O
failed O O
to O O
adhere O O
to O O
hydrophobic O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_CELL[BODY_PART_OR_ORGAN_COMPONENT]
surface O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_CELL[BODY_PART_OR_ORGAN_COMPONENT]
, O O
a O O
crucial O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
step O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
required O O
for O O
subsequent O B_DISEASE_ADJECTIVE[DISEASE]/B_ORGANISM_FUNCTION
pathogenic O I_DISEASE_ADJECTIVE[DISEASE]/I_ORGANISM_FUNCTION
development O I_DISEASE_ADJECTIVE[DISEASE]/I_ORGANISM_FUNCTION
. O O

All O O
phenotypic O O
defects O O
observed O O
in O O
mutants O O
were O O
rescued O O
in O O
a O O
strain O O
complemented O O
with O O
wild B B_GENE
type I I_GENE
MoCDC15 I I_GENE
. O O

Together O O
, O O
these O O
data O O
indicate O O
that O O
MoCDC15 O O
functions O O
as O O
a O O
coordinator O O
of O O
several O O
biological O O
processes O O
important O O
for O O
pathogenic O O
development O O
in O O
M B B_SPECIES[BIO]
. I I_SPECIES[BIO]
oryzae I I_SPECIES[BIO]
. O O

Inactivation O O
of O O
a O O
macronuclear O O
intra O O
- O O
S O O
- O O
phase O O
checkpoint O O
in O O
Tetrahymena B B_BIO/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
thermophila I B_BIO/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
with O O
caffeine O O
affects O O
the O O
integrity O O
of O O
the O O
micronuclear O O
genome O O
. O O

Aphidicolin O O
( O O
APH O O
) O O
, O O
an O O
inhibitor O O
of O O
DNA O O
polymerase O O
alpha O O
, O O
arrested O O
cell O O
divisions O O
in O O
Tetrahymena B B_BIO/B_CELL[BODY_PART_OR_ORGAN_COMPONENT]
thermophila I B_BIO/I_CELL[BODY_PART_OR_ORGAN_COMPONENT]
. O O

Surprisingly O O
, O O
low O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_DISEASE_ADJECTIVE[DISEASE]
concentrations O I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/I_DISEASE_ADJECTIVE[DISEASE]
of O O
APH O B_BIO/B_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
induced O O
an O O
increase O B_DISEASE_ADJECTIVE[DISEASE]/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
of O O
macronuclear O B_DISEASE_ADJECTIVE[DISEASE]
DNA O I_DISEASE_ADJECTIVE[DISEASE]
content O I_DISEASE_ADJECTIVE[DISEASE]
and O O
cell O B_MEASURE
size O I_MEASURE
in O O
non O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
- O O
dividing O O
cells O B_CELL[BODY_PART_OR_ORGAN_COMPONENT]/B_BIO
. O O

In O O
spite O B_TIME[MEASURE]/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
of O O
the O O
cell O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
size O B_DISEASE_ADJECTIVE[DISEASE]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
increase O B_DISEASE_ADJECTIVE[DISEASE]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
most O B_DISEASE_ADJECTIVE[DISEASE]/B_ORGANISM_FUNCTION
proliferation O B_DISEASE_ADJECTIVE[DISEASE]/I_ORGANISM_FUNCTION
of O O
basal O B_CELL[BODY_PART_OR_ORGAN_COMPONENT]/B_DISEASE_ADJECTIVE[DISEASE]
bodies O I_CELL[BODY_PART_OR_ORGAN_COMPONENT]/I_DISEASE_ADJECTIVE[DISEASE]
, O O
ciliogenesis O B_DISEASE/B_ORGANISM_FUNCTION
and O O
development O B_DISEASE_ADJECTIVE[DISEASE]/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
of O O
new O B_CELL[BODY_PART_OR_ORGAN_COMPONENT]/B_DISEASE_ADJECTIVE[DISEASE]
oral O I_CELL[BODY_PART_OR_ORGAN_COMPONENT]/I_DISEASE_ADJECTIVE[DISEASE]
primordia O I_CELL[BODY_PART_OR_ORGAN_COMPONENT]/I_DISEASE_ADJECTIVE[DISEASE]
were O O
prevented O O
by O O
the O O
APH O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
treatment O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

The O O
division O B_DISEASE/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
arrest O I_DISEASE/I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
induced O O
by O O
APH O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_CELL[BODY_PART_OR_ORGAN_COMPONENT]
was O O
partly O O
overridden O O
by O O
caffeine O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
( O O
CAF O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
) O O
treatment O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
, O O
which O O
caused O O
the O O
fragmentation O B_DISEASE/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
( O O
" O O
pulverization O B_DISEASE_ADJECTIVE[DISEASE]
" O O
) O O
of O O
the O O
chromosomes O B_CELL_COMPONENT[BODY_PART_OR_ORGAN_COMPONENT]/B_GENE
in O O
G2 O B_CELL[BODY_PART_OR_ORGAN_COMPONENT]/B_BIO
micronuclei O I_CELL[BODY_PART_OR_ORGAN_COMPONENT]/I_BIO
. O O

Somatic O B_MEASURE/B_PERSON
progeny O I_MEASURE/I_PERSON
of O O
dividers O B_BIO/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
with O O
pulverized O B_DISEASE/B_GENE
micronuclei O I_DISEASE/I_GENE
( O O
APH O B_DISEASE/B_PROTEIN[GENE]
+ O B_DISEASE/I_PROTEIN[GENE]
CAF O B_DISEASE/I_PROTEIN[GENE]
strains O B_DISEASE/I_PROTEIN[GENE]
) O O
contained O O
aneuploid O B_DISEASE_ADJECTIVE[DISEASE]
and O O
amicronucleate O B_DISEASE_ADJECTIVE[DISEASE]
cells O I_DISEASE_ADJECTIVE[DISEASE]
. O O

The O O
amicronucleate O B_BODY_PART_OR_ORGAN_COMPONENT/B_DISEASE_ADJECTIVE[DISEASE]
cells O I_BODY_PART_OR_ORGAN_COMPONENT/I_DISEASE_ADJECTIVE[DISEASE]
, O O
after O O
losing O O
their O O
oral O B_CELL_COMPONENT[BODY_PART_OR_ORGAN_COMPONENT]/B_DISEASE_ADJECTIVE[DISEASE]
structures O I_CELL_COMPONENT[BODY_PART_OR_ORGAN_COMPONENT]/I_DISEASE_ADJECTIVE[DISEASE]
and O O
most O B_DISEASE/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
of O O
their O O
cilia O B_BODY_PART_OR_ORGAN_COMPONENT/B_LOCATION
, O O
and O O
undergoing O O
progressive O B_DISEASE_ADJECTIVE[DISEASE]/B_ORGANISM_FUNCTION
disorganization O B_DISEASE_ADJECTIVE[DISEASE]/I_ORGANISM_FUNCTION
of O O
cortical O B_CELL_COMPONENT[BODY_PART_OR_ORGAN_COMPONENT]/B_DISEASE_ADJECTIVE[DISEASE]
structures O I_CELL_COMPONENT[BODY_PART_OR_ORGAN_COMPONENT]/I_DISEASE_ADJECTIVE[DISEASE]
, O O
assumed O O
an O O
irregular O B_DISEASE/B_BODY_PART_OR_ORGAN_COMPONENT
shape O B_DISEASE/I_BODY_PART_OR_ORGAN_COMPONENT
( O O
" O O
crinkled O O
" O O
) O O
and O O
were O O
nonviable O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

" O O
Crinkled O B_PERSON/B_DISEASE_ADJECTIVE[DISEASE]
" O I_PERSON/I_DISEASE_ADJECTIVE[DISEASE]
cells O I_PERSON/I_DISEASE_ADJECTIVE[DISEASE]
were O O
not O O
formed O O
after O O
APH O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_DISEASE
+ O I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/I_DISEASE
CAF O I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/I_DISEASE
treatment O I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/I_DISEASE
of O O
the O O
amicronuclear O B_BIO/B_CELL[BODY_PART_OR_ORGAN_COMPONENT]
BI3840 O B_BIO/I_CELL[BODY_PART_OR_ORGAN_COMPONENT]
strain O B_BIO/I_CELL[BODY_PART_OR_ORGAN_COMPONENT]
, O O
which O O
contains O O
some O O
mic O B_CELL_COMPONENT[BODY_PART_OR_ORGAN_COMPONENT]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- O O
specific O B_DISEASE_ADJECTIVE[DISEASE]/B_GENE
sequences O B_DISEASE_ADJECTIVE[DISEASE]/I_GENE
in O O
its O O
macronucleus O B_GENE/B_SPECIES[BIO]
. O O

Most O B_NUMBER[MEASURE]/B_PERSON
of O O
the O O
APH O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
+ O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
CAF O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
strains O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
had O O
a O O
typical O B_DISEASE/B_GENE
" O O
* O O
" O O
- O O
like O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
conjugation O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
phenotype O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
: O O
they O O
did O O
not O O
produce O O
pronuclei O B_BIO
, O O
but O O
received O O
them O O
unilaterally O O
from O O
their O O
mates O B_PERSON
and O O
retained O O
old O B_BIO/B_PERSON
macronuclei O B_BIO/I_PERSON
. O O

However O O
, O O
4 O B_NUMBER[MEASURE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
among O O
100 O B_PERSON
APH O I_PERSON
+ O I_PERSON
CAF O I_PERSON
clones O I_PERSON
induced O O
arrest O B_DISEASE
at O O
meiotic O B_MEASURE
metaphase O I_MEASURE
I O O
in O O
their O O
wt O B_CELL[BODY_PART_OR_ORGAN_COMPONENT]/B_BIO
mates O I_CELL[BODY_PART_OR_ORGAN_COMPONENT]/I_BIO
. O O

It O O
is O O
likely O B_DISEASE_ADJECTIVE[DISEASE]
that O O
the O O
origin O B_DISEASE_ADJECTIVE[DISEASE]/B_ORGANISM_FUNCTION
of O O
such O B_DISEASE/B_GENE
clones O I_DISEASE/I_GENE
was O O
enhanced O O
by O O
chromosome O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_DISEASE_ADJECTIVE[DISEASE]
pulverization O I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/I_DISEASE_ADJECTIVE[DISEASE]
. O O

Analysis O O
of O O
the O O
Fusarium B B_BIO
graminearum I I_BIO
species I I_BIO
complex I I_BIO
from O O
wheat B B_BIO
, O O
barley B B_BIO
and O O
maize B B_BIO
in O O
South O O
Africa O O
provides O O
evidence O O
of O O
species O O
- O O
specific O O
differences O O
in O O
host O O
preference O O
. O O

Species O O
identity O O
and O O
trichothecene O O
toxin O O
potential O O
of O O
560 O O
members O O
of O O
the O O
Fusarium B B_BIO/B_LOCATION
graminearum I I_BIO/I_LOCATION
species I I_BIO/I_LOCATION
complex I I_BIO/I_LOCATION
( O O
FGSC B B_DISEASE/B_LOCATION
) O O
collected O O
from O O
diseased O O
wheat B B_BIO
, O O
barley B B_BIO
and O O
maize B B_BIO
in O O
South O O
Africa O O
was O O
determined O O
using O O
a O O
microsphere O O
- O O
based O O
multilocus O O
genotyping O O
assay O O
. O O

Although O O
three O B_BIO/B_NUMBER[MEASURE]
trichothecene O B_BIO/I_NUMBER[MEASURE]
types O B_BIO/I_NUMBER[MEASURE]
( O O
3 O B_MEASURE
- O O
ADON O B_DISEASE/B_MEASURE
, O O
15 O B_MEASURE
- O O
ADON O B_DISEASE/B_PROTEIN[GENE]
and O O
NIV O B_MEASURE/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
) O O
were O O
represented O O
among O O
these O O
isolates O B_BIO
, O O
strains O B_BIO/B_DISEASE
with O O
the O O
15 O B_MEASURE
- O O
ADON O B_DISEASE_ADJECTIVE[DISEASE]/B_GENE
type O B_DISEASE_ADJECTIVE[DISEASE]/I_GENE
predominated O O
on O O
all O O
three O B_BIO/B_LOCATION
hosts O I_BIO/I_LOCATION
. O O

A O O
significant O O
difference O O
, O O
however O O
, O O
was O O
identified O O
in O O
the O O
composition O O
of O O
FGSC B B_DISEASE_ADJECTIVE[DISEASE]/B_NUMBER[MEASURE]
pathogens O O
associated O O
with O O
Gibberella O O
ear O O
rot O O
( O O
GER O O
) O O
of O O
maize B B_BIO
as O O
compared O O
to O O
Fusarium O O
head O O
blight O O
( O O
FHB O O
) O O
of O O
wheat B B_BIO
or O O
barley B B_BIO
( O O
P O O
& O O
lt O O
; O O
0 O O
. O O
001 O O
) O O
. O O

F B B_BACTERIUM[BIO]
. I I_BACTERIUM[BIO]
graminearum I I_BACTERIUM[BIO]
accounted O O
for O O
more O O
than O O
85 O O
% O O
of O O
the O O
FGSC B B_DISEASE_ADJECTIVE[DISEASE]/B_BACTERIUM[BIO]
isolates O O
associated O O
with O O
FHB O O
of O O
wheat B B_BIO
and O O
barley B B_BIO
( O O
N O O
= O O
425 O O
) O O
, O O
and O O
was O O
also O O
the O O
dominant O O
species O O
among O O
isolates O O
from O O
maize B B_BIO
roots O O
( O O
N O O
= O O
35 O O
) O O
. O O

However O O
, O O
with O O
the O O
exception O O
of O O
a O O
single O O
isolate O O
identified O O
as O O
an O O
interspecific O O
hybrid O O
between O O
Fusariumboothii B B_BIO
and O O
F B B_BIO
. I I_BIO
graminearum I I_BIO
, O O
GER O O
of O O
maize B B_BIO/B_PERSON
( O O
N O O
= O O
100 O O
) O O
was O O
exclusively O O
associated O O
with O O
F B B_BIO
. I I_BIO
boothii I I_BIO
. O O

The O O
predominance O O
of O O
F B B_BACTERIUM[BIO]
. I I_BACTERIUM[BIO]
graminearum I I_BACTERIUM[BIO]
among O O
FHB O O
isolates O O
, O O
and O O
the O O
near O O
exclusivity O O
of O O
F B B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
. I I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
boothii I I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
among O O
GER O O
isolates O O
, O O
was O O
observed O O
across O O
all O O
cultivars O O
, O O
collection O O
dates O O
, O O
and O O
provinces O O
sampled O O
. O O

Because O O
these O O
results O O
suggest O O
a O O
difference O O
in O O
host O O
preference O O
among O O
species O O
of O O
the O O
FGSC B B_BIO/B_DISEASE
, O O
we O O
hypothesize O O
that O O
F B B_BIO/B_PERSON
. I I_BIO/I_PERSON
graminearum I I_BIO/I_PERSON
may O O
be O O
less O O
well O O
adapted O O
to O O
infect O O
maize B B_SPECIES[BIO]/B_PERSON
ears O O
than O O
other O O
members O O
of O O
the O O
FGSC B B_DISEASE/B_BIO
. O O

Suitability O O
of O O
different O O
media O O
for O O
in O O
vitro O O
cultivation O O
of O O
the O O
ruminal O O
protozoa O O
species O O
Entodinium B B_BACTERIUM[BIO]
caudatum I I_BACTERIUM[BIO]
, O O
Eudiplodinium B B_BACTERIUM[BIO]/B_BODY_PART_OR_ORGAN_COMPONENT
maggii I I_BACTERIUM[BIO]/I_BODY_PART_OR_ORGAN_COMPONENT
, O O
and O O
Epidinium B B_BACTERIUM[BIO]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
ecaudatum I I_BACTERIUM[BIO]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

Three O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
protozoal O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
cultivation O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
media O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
were O O
tested O O
to O O
determine O O
the O O
medium O B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
which O O
best O O
facilitated O O
growth O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANISM_FUNCTION
and O O
viability O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANISM_FUNCTION
of O O
key O B_BODY_PART_OR_ORGAN_COMPONENT/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
B O I_BODY_PART_OR_ORGAN_COMPONENT/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- O O
type O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
ciliates O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
isolated O O
from O O
the O O
sheep O B_BODY_PART_OR_ORGAN_COMPONENT/B_DISEASE_ADJECTIVE[DISEASE]
rumen O I_BODY_PART_OR_ORGAN_COMPONENT/I_DISEASE_ADJECTIVE[DISEASE]
. O O

Entodinium B B_BACTERIUM[BIO]
caudatum I I_BACTERIUM[BIO]
and O O
Eudiplodinium B B_BIO
maggii I I_BIO
were O O
grown O O
anaerobically O O
in O O
50 O O
- O O
ml O O
flasks O O
for O O
32 O O
days O O
in O O
Caudatum O O
- O O
type O O
( O O
C O O
) O O
, O O
Kisidayova O O
( O O
K O O
) O O
or O O
Dehority O O
( O O
M O O
) O O
medium O O
. O O

On O O
day O O
32 O O
, O O
in O O
media O O
K O O
and O O
M O O
, O O
E B B_DISEASE_ADJECTIVE[DISEASE]/B_BACTERIUM[BIO]
. I I_DISEASE_ADJECTIVE[DISEASE]/I_BACTERIUM[BIO]
caudatum I I_DISEASE_ADJECTIVE[DISEASE]/I_BACTERIUM[BIO]
cell O O
counts O O
were O O
high O O
with O O
5 O O
. O O
6x10 O O
( O O
3 O O
) O O
and O O
7 O O
. O O
8x10 O O
( O O
3 O O
) O O
mL O O
( O O
- O O
1 O O
) O O
, O O
respectively O O
, O O
and O O
the O O
proportion O O
of O O
dead O O
cells O O
was O O
low O O
with O O
0 O O
. O O
6 O O
and O O
1 O O
. O O
4 O O
% O O
, O O
respectively O O
. O O

E B B_BIO/B_MEASURE
. I I_BIO/I_MEASURE
maggii I I_BIO/I_MEASURE
concentrations O O
when O O
grown O O
in O O
medium O O
M O O
and O O
C O O
were O O
2 O O
. O O
7x10 O O
( O O
3 O O
) O O
and O O
2 O O
. O O
4x10 O O
( O O
3 O O
) O O
mL O O
( O O
- O O
1 O O
) O O
, O O
respectively O O
, O O
with O O
3 O O
. O O
9 O O
and O O
14 O O
. O O
1 O O
% O O
dead O O
cells O O
. O O

Medium O O
M O O
, O O
which O O
favoured O O
growth O O
of O O
both O O
protozoa O O
species O O
, O O
was O O
tested O O
again O O
and O O
Epidinium B B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PROTEIN[GENE]
ecaudatum I B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PROTEIN[GENE]
was O O
included O O
. O O

Protozoa O B_BIO/B_PERSON
were O O
grown O O
for O O
a O O
4 O B_NUMBER[MEASURE]
- O O
month O B_TIME[MEASURE]
period O I_TIME[MEASURE]
and O O
samples O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
were O O
taken O O
in O O
the O O
last O B_TIME[MEASURE]/B_BODY_PART_OR_ORGAN_COMPONENT
two O I_TIME[MEASURE]/I_BODY_PART_OR_ORGAN_COMPONENT
months O I_TIME[MEASURE]/I_BODY_PART_OR_ORGAN_COMPONENT
on O O
days O B_TIME[MEASURE]
1 O I_TIME[MEASURE]
, O O
7 O B_MEASURE
, O O
35 O B_MEASURE
and O O
57 O B_MEASURE
. O O

Average O O
cell O O
concentrations O O
were O O
10 O O
. O O
0 O O
, O O
0 O O
. O O
8 O O
and O O
0 O O
. O O
5x10 O O
( O O
3 O O
) O O
mL O O
( O O
- O O
1 O O
) O O
for O O
E B B_BIO
. I I_BIO
caudatum I I_BIO
, O O
E B B_BIO
. I I_BIO
maggii I I_BIO
, O O
and O O
E B B_BIO
. I I_BIO
ecaudatum I I_BIO
, O O
respectively O O
. O O

In O O
conclusion O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
, O O
medium O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
M O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
would O O
appear O O
to O O
be O O
the O O
best O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_DISEASE_ADJECTIVE[DISEASE]
choice O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/I_DISEASE_ADJECTIVE[DISEASE]
for O O
cultivating O O
these O O
three O B_BIO/B_DISEASE
species O I_BIO/I_DISEASE
in O O
one O B_LOCATION/B_PERSON
medium O I_LOCATION/I_PERSON
. O O

Synganglion O O
transcriptome O O
and O O
developmental O O
global O O
gene O O
expression O O
in O O
adult O O
females O O
of O O
the O O
American B B_SPECIES[BIO]
dog I I_SPECIES[BIO]
tick I I_SPECIES[BIO]
, O O
Dermacentor B B_SPECIES[BIO]/B_DISEASE_ADJECTIVE[DISEASE]
variabilis I I_SPECIES[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
( O O
Acari O O
: O O
Ixodidae O O
) O O
. O O

454 O O
Pyrosequencing O O
was O O
used O O
to O O
characterize O O
the O O
expressed O O
genes O O
from O O
the O O
synganglion O O
and O O
associated O O
neurosecretory O O
organs O O
of O O
unfed O O
and O O
partially O O
fed O O
virgin O O
and O O
mated O O
replete O O
females O O
of O O
the O O
American B B_SPECIES[BIO]
dog I I_SPECIES[BIO]
tick I I_SPECIES[BIO]
, O O
Dermacentor B B_SPECIES[BIO]/B_DISEASE_ADJECTIVE[DISEASE]
variabilis I I_SPECIES[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
. O O

A O O
total O B_MEASURE/B_LOCATION
of O O
14 O B_MEASURE
, O O
881 O B_MEASURE
contiguous O I_MEASURE
sequences O I_MEASURE
( O O
contigs O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
) O O
was O O
assembled O O
, O O
with O O
an O O
average O B_MEASURE
size O I_MEASURE
of O O
229 O B_NUMBER[MEASURE]
bp O I_NUMBER[MEASURE]
. O O

Gene O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
ontology O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
terms O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
for O O
Level O B_DISEASE_ADJECTIVE[DISEASE]/B_BIO
2 O B_DISEASE_ADJECTIVE[DISEASE]/I_BIO
biological O B_DISEASE_ADJECTIVE[DISEASE]/I_BIO
processes O B_DISEASE_ADJECTIVE[DISEASE]/I_BIO
were O O
assigned O O
to O O
4366 O B_LOCATION/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
contigs O I_LOCATION/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

Seven O B_TIME[MEASURE]/B_ORGANIZATION
acetylcholinesterases O I_TIME[MEASURE]/I_ORGANIZATION
, O O
a O O
muscarinic O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
acetylcholine O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
( O O
ACh O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
) O O
receptor O B_GENE
, O O
two O B_PROTEIN[GENE]/B_DISEASE_ADJECTIVE[DISEASE]
nicotinic O I_PROTEIN[GENE]/I_DISEASE_ADJECTIVE[DISEASE]
ACh O I_PROTEIN[GENE]/I_DISEASE_ADJECTIVE[DISEASE]
receptor O I_PROTEIN[GENE]/I_DISEASE_ADJECTIVE[DISEASE]
Beta O I_PROTEIN[GENE]/I_DISEASE_ADJECTIVE[DISEASE]
- O O
subunits O B_MEASURE
, O O
two O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
ACh O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
unc O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
- O O
18 O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PROTEIN[GENE]
regulators O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PROTEIN[GENE]
, O O
two O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
dopamine O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
receptors O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
, O O
two O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
gamma O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
aminobutyric O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
acid O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
( O O
GABA O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
) O O
receptors O B_PROTEIN[GENE]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
two O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
GABA O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
transporters O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
, O O
two O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
norepinephrine O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
transporters O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
and O O
an O O
octopamine O B_GENE/B_PERSON
receptor O I_GENE/I_PERSON
are O O
described O O
. O O

Microarrays O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
were O O
conducted O O
to O O
examine O O
global O B_GENE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
gene O I_GENE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
expression O I_GENE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
quantitative O B_MEASURE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
real O I_MEASURE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- O O
time O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
polymerase O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
chain O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
reaction O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
was O O
used O O
to O O
verify O O
expression O B_GENE
of O O
selected O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
neuropeptides O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
. O O

Hierarchical O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
clustering O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
of O O
all O O
differentially O O
expressed O O
transcripts O B_GENE/B_BIO
grouped O O
part O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
- O O
fed O O
and O O
replete O B_DISEASE_ADJECTIVE[DISEASE]/B_PERSON
ticks O I_DISEASE_ADJECTIVE[DISEASE]/I_PERSON
as O O
being O O
more O O
similar O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
in O O
terms O B_LOCATION/B_MEASURE
of O O
differentially O O
expressed O O
genes O B_GENE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
with O O
unfed O B_BIO/B_PERSON
ticks O I_BIO/I_PERSON
as O O
the O O
outgroup O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
. O O

Nine O B_NUMBER[MEASURE]/B_BIO
putative O I_NUMBER[MEASURE]/I_BIO
neuropeptides O I_NUMBER[MEASURE]/I_BIO
( O O
allatostatin O B_GENE/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
bursicon O B_GENE/B_BIO
- O O
Beta O B_GENE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
preprocorazonin O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
, O O
glycoprotein O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
hormone O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
alpha O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
, O O
insulin O B_GENE/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- O O
like O B_PROTEIN[GENE]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
peptide O I_PROTEIN[GENE]/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
three O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
orcokinins O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
, O O
preprosulphakinin O B_GENE
) O O
and O O
a O O
gonadotropin O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
releasing O O
hormone O B_GENE
receptor O I_GENE
were O O
differentially O O
expressed O O
, O O
and O O
their O O
developmental O B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
expression O I_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
and O O
role O B_MEASURE/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
in O O
reproduction O B_ORGANISM_FUNCTION/B_BODY_PART_OR_ORGAN_COMPONENT
was O O
investigated O O
. O O

The O O
presence O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
of O O
eclosion O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
hormone O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
, O O
corazonin O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
and O O
bursicon O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
in O O
the O O
synganglion O B_BODY_PART_OR_ORGAN_COMPONENT/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
which O O
in O O
insects O B_BIO/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
regulate O O
behaviour O B_ORGANISM_FUNCTION/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
cuticle O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANISM_FUNCTION
development O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_ORGANISM_FUNCTION
associated O O
with O O
moulting O B_PERSON/B_ORGANISM_FUNCTION
, O O
suggest O O
that O O
this O O
system O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
may O O
be O O
used O O
in O O
ticks O B_SPECIES[BIO]
to O O
regulate O O
blood O B_DISEASE_ADJECTIVE[DISEASE]/B_ORGANISM_FUNCTION
feeding O B_DISEASE_ADJECTIVE[DISEASE]/I_ORGANISM_FUNCTION
, O O
cuticle O B_LOCATION/B_ORGANISM_FUNCTION
expansion O B_LOCATION/I_ORGANISM_FUNCTION
and O O
development O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
related O O
to O O
female O B_DISEASE_ADJECTIVE[DISEASE]/B_ORGANISM_FUNCTION
reproduction O B_DISEASE_ADJECTIVE[DISEASE]/I_ORGANISM_FUNCTION
; O O
adult O B_BIO/B_PERSON
ticks O I_BIO/I_PERSON
do O O
not O O
moult O O
. O O

Endogenous O O
regulation O O
of O O
the O O
growth O O
- O O
rate O O
responses O O
of O O
a O O
spring O O
- O O
dwelling O O
strain O O
of O O
the O O
freshwater O O
alga O O
, O O
Chlorella B B_SPECIES[BIO]/B_LOCATION
minutissima I I_SPECIES[BIO]/I_LOCATION
, O O
to O O
light O O
and O O
temperature O O
. O O

The O O
paper O O
presents O O
a O O
laboratory O O
investigation O O
of O O
the O O
temperature O O
- O O
and O O
light O O
- O O
dependence O O
of O O
autotrophic O O
growth O O
of O O
the O O
alga O O
Chlorella B B_BIO
minutissima I I_BIO
. O O

It O O
was O O
isolated O O
from O O
the O O
storage O B_LOCATION/B_BODY_PART_OR_ORGAN_COMPONENT
basin O I_LOCATION/I_BODY_PART_OR_ORGAN_COMPONENT
of O O
a O O
spring O B_TIME[MEASURE]/B_LOCATION
in O O
the O O
mountains O B_LOCATION
of O O
the O O
Massif O B_LOCATION
Central O I_LOCATION
, O O
France O B_LOCATION
. O O

The O O
alga O B_BIO/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
was O O
grown O O
at O O
temperatures O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
between O O
( O O
10 O B_MEASURE
and O O
35 O B_MEASURE
^ O I_MEASURE
0C O I_MEASURE
) O O
and O O
under O O
irradiances O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
from O O
30 O B_MEASURE
to O O
550 O B_MEASURE/B_LOCATION
mumol O I_MEASURE/I_LOCATION
m O I_MEASURE/I_LOCATION
( O O
- O O
2 O B_MEASURE
) O O
s O O
( O O
- O O
1 O B_MEASURE
) O O
, O O
under O O
a O O
light O B_COLOR/B_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
/ O O
dark O B_LOCATION/B_ENT
cycle O I_LOCATION/I_ENT
. O O

The O O
results O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
were O O
fitted O O
to O O
selected O O
descriptive O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
models O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
, O O
seeking O O
to O O
express O O
, O O
as O O
far O O
as O O
possible O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
the O O
observed O B_MEASURE
physiological O I_MEASURE
behaviour O I_MEASURE
of O O
the O O
strain O B_BIO
and O O
the O O
minimum O B_MEASURE/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
irradiance O B_MEASURE/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
required O O
to O O
sustain O O
net O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANISM_FUNCTION
growth O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_ORGANISM_FUNCTION
. O O

At O O
all O O
temperatures O O
, O O
the O O
maximum O O
rates O O
of O O
growth O O
observed O O
are O O
strikingly O O
slower O O
than O O
those O O
of O O
other O O
Chlorella B B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
strains I I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
and O O
of O O
other O O
small O O
algae O O
, O O
reported O O
in O O
the O O
literature O O
, O O
even O O
when O O
correction O O
is O O
made O O
for O O
continuous O O
light O O
. O O

The O O
Q10 O B_MEASURE
statistic O I_MEASURE
for O O
growth O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANISM_FUNCTION
at O O
temperatures O B_LOCATION/B_ORGANIZATION
& O O
gt O B_ORGANIZATION/B_PROTEIN[GENE]
; O O
20 O B_MEASURE/B_LOCATION
^ O I_MEASURE/I_LOCATION
0C O I_MEASURE/I_LOCATION
rates O I_MEASURE/I_LOCATION
is O O
also O O
noticeably O O
lower O B_MEASURE/B_DISEASE_ADJECTIVE[DISEASE]
than O O
in O O
other O B_MEASURE/B_LOCATION
species O I_MEASURE/I_LOCATION
, O O
while O O
the O O
apparent O B_MEASURE
threshold O I_MEASURE
of O O
any O O
growth O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
is O O
about O O
8 O B_MEASURE
^ O O
0C O B_MEASURE
. O O

Growth O B_MEASURE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
rates O I_MEASURE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
are O O
readily O O
light O B_CHEMICAL_SUBSTANCE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
- O O
saturated O O
at O O
all O O
temperatures O B_MEASURE/B_LOCATION
but O O
with O O
little O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
evidence O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
of O O
adaptation O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
of O O
photosynthesis O B_BIO/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
to O O
low O B_MEASURE/B_DISEASE_ADJECTIVE[DISEASE]
photon O I_MEASURE/I_DISEASE_ADJECTIVE[DISEASE]
- O O
flux O B_MEASURE
rates O I_MEASURE
. O O

No O O
short O B_MEASURE/B_LOCATION
- O O
term O B_MEASURE/B_DISEASE_ADJECTIVE[DISEASE]
flexibility O I_MEASURE/I_DISEASE_ADJECTIVE[DISEASE]
in O O
these O O
properties O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
( O O
over O O
a O O
time O B_MEASURE
- O O
scale O B_MEASURE/B_LOCATION
of O O
days O B_TIME[MEASURE]
) O O
was O O
demonstrated O O
during O O
the O O
course O B_LOCATION/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
our O O
experiments O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

We O O
deduce O O
that O O
the O O
algal O B_BIO/B_DISEASE
strain O I_BIO/I_DISEASE
had O O
become O O
genetically O O
adapted O O
to O O
the O O
relatively O O
constant O B_DISEASE_ADJECTIVE[DISEASE]/B_GENE
, O O
even O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
- O O
temperature O B_MEASURE/B_LOCATION
and O O
low O B_MEASURE/B_DISEASE_ADJECTIVE[DISEASE]
- O O
light O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
conditions O B_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
of O O
the O O
spring O B_LOCATION
- O O
water O B_LOCATION/B_TIME[MEASURE]
habitat O I_LOCATION/I_TIME[MEASURE]
whence O O
it O O
was O O
originally O O
isolated O O
. O O

Characterization O O
of O O
the O O
oxysterol O O
- O O
binding O O
protein O O
gene O O
family O O
in O O
the O O
yellow B B_SPECIES[BIO]
fever I I_SPECIES[BIO]
mosquito I I_SPECIES[BIO]
, O O
Aedes B B_SPECIES[BIO]/B_PROTEIN[GENE]
aegypti I B_SPECIES[BIO]/I_PROTEIN[GENE]
. O O

The O O
oxysterol O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
- O O
binding O O
protein O B_BIO/B_PROTEIN[GENE]
( O O
OSBP O B_DISEASE/B_GENE
) O O
and O O
OSBP O B_DISEASE_ADJECTIVE[DISEASE]/B_GENE
- O O
related O O
proteins O B_PROTEIN[GENE]/B_DISEASE
( O O
ORPs O B_LOCATION/B_DISEASE
) O O
are O O
sterol O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
- O O
binding O O
proteins O B_BIO/B_PROTEIN[GENE]
that O O
may O O
be O O
involved O O
in O O
cellular O B_DISEASE/B_CELL_FUNCTION[ORGANISM_FUNCTION]
sterol O B_DISEASE/I_CELL_FUNCTION[ORGANISM_FUNCTION]
transportation O B_DISEASE/I_CELL_FUNCTION[ORGANISM_FUNCTION]
, O O
sterol O B_CELL_FUNCTION[ORGANISM_FUNCTION]/B_DISEASE_ADJECTIVE[DISEASE]
metabolism O I_CELL_FUNCTION[ORGANISM_FUNCTION]/I_DISEASE_ADJECTIVE[DISEASE]
and O O
signal O B_DISEASE_ADJECTIVE[DISEASE]/B_CELL_FUNCTION[ORGANISM_FUNCTION]
transduction O B_DISEASE_ADJECTIVE[DISEASE]/I_CELL_FUNCTION[ORGANISM_FUNCTION]
pathways O B_DISEASE_ADJECTIVE[DISEASE]/I_CELL_FUNCTION[ORGANISM_FUNCTION]
. O O

Four O O
ORP O O
genes O O
were O O
cloned O O
from O O
Aedes B B_SPECIES[BIO]/B_GENE
aegypti I I_SPECIES[BIO]/I_GENE
. O O

Based O O
on O O
amino O O
acid O O
sequence O O
homology O O
to O O
human B B_PERSON/B_SPECIES[BIO]
proteins O O
, O O
they O O
are O O
AeOSBP O O
, O O
AeORP1 O O
, O O
AeORP8 O O
and O O
AeORP9 O O
. O O

Splicing O B_NUMBER[MEASURE]/B_LOCATION
variants O B_NUMBER[MEASURE]/I_LOCATION
of O O
AeOSBP O B_GENE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
AeORP8 O B_GENE
were O O
identified O O
. O O

The O O
temporal O B_MEASURE/B_DISEASE
and O O
spatial O B_DISEASE_ADJECTIVE[DISEASE]/B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
transcription O B_DISEASE_ADJECTIVE[DISEASE]/I_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
patterns O B_DISEASE_ADJECTIVE[DISEASE]/I_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
members O B_PERSON/B_BIO
of O O
the O O
AeOSBP O B_BIO/B_GENE
gene O I_BIO/I_GENE
family O I_BIO/I_GENE
through O O
developmental O B_DISEASE_ADJECTIVE[DISEASE]/B_ORGANISM_FUNCTION
stages O B_DISEASE_ADJECTIVE[DISEASE]/I_ORGANISM_FUNCTION
and O O
the O O
gonotrophic O B_DISEASE_ADJECTIVE[DISEASE]/B_BODY_PART_OR_ORGAN_COMPONENT
cycle O B_DISEASE_ADJECTIVE[DISEASE]/I_BODY_PART_OR_ORGAN_COMPONENT
were O O
profiled O O
. O O

AeORP1 O B_GENE/B_PERSON
transcription O I_GENE/I_PERSON
seemed O O
to O O
be O O
head O B_BODY_PART_OR_ORGAN_COMPONENT/B_BIO
tissue O I_BODY_PART_OR_ORGAN_COMPONENT/I_BIO
- O O
specific O B_DISEASE_ADJECTIVE[DISEASE]/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
, O O
whereas O O
AeOSBP O B_GENE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
AeORP9 O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
expression O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
was O O
induced O O
by O O
a O O
bloodmeal O B_DISEASE/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

Furthermore O O
, O O
over O O
- O O
expression O O
of O O
AeORPs O O
facilitated O O
[ O O
( O O
3 O O
) O O
H O O
] O O
- O O
cholesterol O O
uptake O O
in O O
Ae B B_SPECIES[BIO]/B_DISEASE_ADJECTIVE[DISEASE]
. I B_SPECIES[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
aegypti I B_SPECIES[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
cultured O O
Aag O O
- O O
2 O O
cells O O
. O O

Identification O O
and O O
expression O O
analysis O O
of O O
nervous O O
wreck O O
, O O
which O O
is O O
preferentially O O
expressed O O
in O O
the O O
brain O O
of O O
the O O
male O O
silkworm B B_SPECIES[BIO]/B_PERSON
moth I I_SPECIES[BIO]/I_PERSON
, O O
Bombyx B B_BIO/B_GENE
mori I B_BIO/I_GENE
. O O

Sexually O O
dimorphic O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
neural O I_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
circuits O I_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
are O O
essential O B_DRUG_ADJECTIVE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_TIME[MEASURE]
for O O
reproductive O B_DISEASE_ADJECTIVE[DISEASE]/B_ORGANISM_FUNCTION
behaviour O B_DISEASE_ADJECTIVE[DISEASE]/I_ORGANISM_FUNCTION
. O O

The O O
molecular O O
basis O O
of O O
sexual O O
dimorphism O O
in O O
the O O
silkworm B B_SPECIES[BIO]
moth I I_SPECIES[BIO]
( O O
Bombyx B B_BIO/B_PROTEIN[GENE]
mori I B_BIO/I_PROTEIN[GENE]
) O O
brain O O
, O O
however O O
, O O
is O O
unclear O O
. O O

We O O
conducted O O
cDNA O O
subtraction O O
screening O O
and O O
identified O O
nervous O O
wreck O O
( O O
Bmnwk O O
) O O
, O O
a O O
synaptic O O
growth O O
regulatory O O
gene O O
, O O
whose O O
expression O O
is O O
higher O O
in O O
the O O
male O O
brain O O
than O O
in O O
the O O
female O O
brain O O
of O O
the O O
silkworm B B_SPECIES[BIO]/B_PERSON
. O O

Bmnwk O B_GENE
was O O
preferentially O O
expressed O O
in O O
the O O
brain O B_BODY_PART_OR_ORGAN_COMPONENT/B_DISEASE_ADJECTIVE[DISEASE]
at O O
the O O
late O B_PERSON
pupae O I_PERSON
and O O
adult O B_DISEASE_ADJECTIVE[DISEASE]/B_PERSON
stages O I_DISEASE_ADJECTIVE[DISEASE]/I_PERSON
. O O

In O O
situ O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
hybridization O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
revealed O O
that O O
Bmnwk O B_GENE/B_LOCATION
is O O
highly O O
expressed O O
in O O
the O O
optic O B_BODY_PART_OR_ORGAN_COMPONENT/B_LOCATION
lobe O I_BODY_PART_OR_ORGAN_COMPONENT/I_LOCATION
of O O
the O O
male O B_BODY_PART_OR_ORGAN_COMPONENT/B_DISEASE_ADJECTIVE[DISEASE]
moth O I_BODY_PART_OR_ORGAN_COMPONENT/I_DISEASE_ADJECTIVE[DISEASE]
brain O I_BODY_PART_OR_ORGAN_COMPONENT/I_DISEASE_ADJECTIVE[DISEASE]
. O O

These O O
findings O O
suggest O O
that O O
Bmnwk O O
has O O
a O O
role O O
in O O
the O O
development O O
and O O
/ O O
or O O
maintenance O O
of O O
the O O
optic O O
lobe O O
in O O
the O O
male O O
silkworm B B_SPECIES[BIO]/B_PERSON
brain O O
. O O

Infraciliature O O
of O O
eight O O
Triplumaria O O
species O O
( O O
Ciliophora O O
, O O
Entodiniomorphida O O
) O O
from O O
Asian B B_LOCATION
elephants I I_LOCATION
with O O
the O O
description O O
of O O
six O O
new O O
species O O
. O O

Intestinal O O
ciliates O O
excreted O O
in O O
the O O
feces O O
of O O
Asian B B_SPECIES[BIO]/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
elephants I I_SPECIES[BIO]/I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
were O O
surveyed O O
. O O

Fourteen O B_BIO/B_PERSON
species O I_BIO/I_PERSON
in O O
the O O
order O B_BIO/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
Entodiniomorphida O B_BIO/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
were O O
detected O O
. O O

Nine O B_BIO/B_PERSON
Triplumaria O B_BIO/I_PERSON
species O B_BIO/I_PERSON
in O O
the O O
family O B_LOCATION
Cycloposthiidae O I_LOCATION
were O O
found O O
. O O

Using O O
the O O
silver O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
impregnation O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
, O O
two O B_NUMBER[MEASURE]/B_PERSON
known O O
species O B_BIO/B_PERSON
, O O
T O B_OTHER/B_PROTEIN[GENE]
. O O
antis O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
and O O
T O B_OTHER/B_GENE
. O O
dvoinosi O B_PERSON/B_SPECIES[BIO]
, O O
were O O
redescribed O O
and O O
six O B_BIO/B_MEASURE
new O B_BIO/I_MEASURE
species O B_BIO/I_MEASURE
, O O
T O B_PROTEIN[GENE]/B_OTHER
. O O
sukuna O B_SPECIES[BIO]/B_GENE
n O O
. O O

sp O B_MEASURE/B_BODY_PART_OR_ORGAN_COMPONENT
. O O
, O O
T O B_OTHER/B_GENE
. O O
zuze O B_PERSON/B_SPECIES[BIO]
n O O
. O O

sp O B_LOCATION/B_PERSON
. O O
, O O
T O B_OTHER/B_GENE
. O O
solea O B_BACTERIUM[BIO]/B_LOCATION
n O I_LOCATION
. O O

sp O B_MEASURE/B_BODY_PART_OR_ORGAN_COMPONENT
. O O
, O O
T O B_OTHER/B_GENE
. O O
suwako O B_SPECIES[BIO]/B_LOCATION
n O I_LOCATION
. O O

sp O B_LOCATION/B_PERSON
. O O
, O O
T O B_OTHER/B_GENE
. O O
fulgora O B_SPECIES[BIO]/B_GENE
n O I_SPECIES[BIO]/I_GENE
. O O

sp O B_MEASURE/B_BODY_PART_OR_ORGAN_COMPONENT
. O O
, O O
and O O
T O B_OTHER/B_GENE
. O O
harpagonis O B_PERSON/B_LOCATION
n O B_PERSON/I_LOCATION
. O O

sp O B_LOCATION/B_GENE
. O O
, O O
were O O
described O O
. O O

T O B_OTHER/B_PROTEIN[GENE]
. O O
sukuna O B_PERSON/B_SPECIES[BIO]
, O O
T O B_OTHER/B_PROTEIN[GENE]
. O O
zuze O B_PERSON/B_SPECIES[BIO]
, O O
T O B_OTHER/B_PROTEIN[GENE]
. O O
solea O B_SPECIES[BIO]/B_PERSON
, O O
and O O
T O B_OTHER/B_LOCATION
. O O
suwako O B_PERSON/B_SPECIES[BIO]
have O O
the O O
perivestibular O B_DISEASE_ADJECTIVE[DISEASE]/B_BODY_PART_OR_ORGAN_COMPONENT
polybrachykinety O B_DISEASE_ADJECTIVE[DISEASE]/I_BODY_PART_OR_ORGAN_COMPONENT
along O O
the O O
vestibular O B_BODY_PART_OR_ORGAN_COMPONENT/B_DISEASE_ADJECTIVE[DISEASE]
opening O I_BODY_PART_OR_ORGAN_COMPONENT/I_DISEASE_ADJECTIVE[DISEASE]
. O O

The O O
buccal O O
infraciliary O O
bands O O
of O O
T O O
. O O
suwako O O
are O O
similar O O
to O O
those O O
of O O
T B B_BIO/B_PERSON
. I I_BIO/I_PERSON
selenica I I_BIO/I_PERSON
found O O
from O O
elephants O O
and O O
the O O
buccal O O
infraciliary O O
bands O O
of O O
T O O
. O O
sukuna O O
, O O
T O O
. O O
zuze O O
, O O
and O O
T O O
. O O
solea O O
are O O
similar O O
to O O
those O O
of O O
T O O
. O O
grypoclunis O O
described O O
from O O
rhinoceroses O O
. O O

T O B_PROTEIN[GENE]/B_OTHER
. O O
antis O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
, O O
T O B_PROTEIN[GENE]/B_LOCATION
. O O
dvoinosi O B_PERSON/B_SPECIES[BIO]
, O O
T O B_PROTEIN[GENE]/B_LOCATION
. O O
fulgora O B_SPECIES[BIO]/B_LOCATION
, O O
and O O
T O B_OTHER/B_GENE
. O O
harpagonis O B_DISEASE_ADJECTIVE[DISEASE]/B_BIO
have O O
the O O
vestibular O B_BODY_PART_OR_ORGAN_COMPONENT/B_DISEASE_ADJECTIVE[DISEASE]
polybrachykinety O I_BODY_PART_OR_ORGAN_COMPONENT/I_DISEASE_ADJECTIVE[DISEASE]
extending O O
down O O
inside O O
the O O
vestibulum O B_BODY_PART_OR_ORGAN_COMPONENT/B_DISEASE_ADJECTIVE[DISEASE]
as O O
found O O
in O O
rumen O B_BIO/B_PERSON
ciliates O I_BIO/I_PERSON
in O O
the O O
family O B_SPECIES[BIO]/B_BODY_PART_OR_ORGAN_COMPONENT
Ophryoscolecidae O I_SPECIES[BIO]/I_BODY_PART_OR_ORGAN_COMPONENT
. O O

The O O
caudalial O B_DISEASE_ADJECTIVE[DISEASE]/B_BIO
ciliary O B_DISEASE_ADJECTIVE[DISEASE]/I_BIO
zones O B_DISEASE_ADJECTIVE[DISEASE]/I_BIO
of O O
T O B_OTHER/B_LOCATION
. O O
dvoinosi O B_PERSON/B_SPECIES[BIO]
and O O
T O B_OTHER/B_PROTEIN[GENE]
. O O
fulgora O B_SPECIES[BIO]/B_LOCATION
were O O
retractable O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
as O O
found O O
in O O
rumen O B_SPECIES[BIO]/B_PERSON
ophryoscolecids O I_SPECIES[BIO]/I_PERSON
. O O

Raabena B B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BACTERIUM[BIO]
bella I B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_BACTERIUM[BIO]
and O O
Pseudoentodinium O O
elephantis O O
showed O O
high O O
composition O O
values O O
over O O
30 O O
% O O
. O O

Ciliate O B_BACTERIUM[BIO]/B_MEASURE
densities O I_BACTERIUM[BIO]/I_MEASURE
in O O
the O O
three O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_CELL[BODY_PART_OR_ORGAN_COMPONENT]
fecal O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_CELL[BODY_PART_OR_ORGAN_COMPONENT]
samples O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_CELL[BODY_PART_OR_ORGAN_COMPONENT]
were O O
0 O B_MEASURE
. O O
15 O B_MEASURE
, O O
1 O B_MEASURE
. O O
09 O B_MEASURE
, O O
and O O
2 O B_MEASURE
. O O
07x10 O B_MEASURE
( O O
4 O B_MEASURE/B_LOCATION
) O O
/ O O
ml O B_MEASURE/B_PERSON
. O O

Prolixicin O O
: O O
a O O
novel O O
antimicrobial O O
peptide O O
isolated O O
from O O
Rhodnius B B_BIO/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
prolixus I I_BIO/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
with O O
differential O O
activity O O
against O O
bacteria O O
and O O
Trypanosoma B B_SPECIES[BIO]
cruzi I I_SPECIES[BIO]
. O O

We O O
identified O O
and O O
characterized O O
the O O
activity O O
of O O
prolixicin O O
, O O
a O O
novel O O
antimicrobial O O
peptide O O
( O O
AMP O O
) O O
isolated O O
from O O
the O O
hemipteran O O
insect O O
, O O
Rhodnius B B_SPECIES[BIO]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
prolixus I I_SPECIES[BIO]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

Sequence O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
analysis O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
reveals O O
one O B_LOCATION
region O I_LOCATION
of O O
prolixicin O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
that O O
may O O
be O O
related O O
to O O
the O O
diptericin O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
/ O O
attacin O B_PERSON/B_LOCATION
family O I_PERSON/I_LOCATION
of O O
AMPs O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
. O O

Prolixicin O B_PROTEIN[GENE]/B_PERSON
is O O
an O O
11 O B_NUMBER[MEASURE]
- O O
kDa O B_PROTEIN[GENE]
peptide O I_PROTEIN[GENE]
containing O O
a O O
putative O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PROTEIN[GENE]
21 O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PROTEIN[GENE]
amino O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PROTEIN[GENE]
acid O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PROTEIN[GENE]
signal O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PROTEIN[GENE]
peptide O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PROTEIN[GENE]
, O O
two O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
putative O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
phosphorylation O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
sites O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
no O O
glycosylation O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
sites O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
. O O

It O O
is O O
produced O O
by O O
both O O
adult O B_BODY_PART_OR_ORGAN_COMPONENT/B_DISEASE_ADJECTIVE[DISEASE]
fat O I_BODY_PART_OR_ORGAN_COMPONENT/I_DISEASE_ADJECTIVE[DISEASE]
body O I_BODY_PART_OR_ORGAN_COMPONENT/I_DISEASE_ADJECTIVE[DISEASE]
and O O
midgut O B_BODY_PART_OR_ORGAN_COMPONENT/B_BIO
tissues O I_BODY_PART_OR_ORGAN_COMPONENT/I_BIO
in O O
response O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
to O O
bacterial O B_DISEASE_ADJECTIVE[DISEASE]/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
infection O B_DISEASE_ADJECTIVE[DISEASE]/I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
of O O
the O O
haemolymph O B_BODY_PART_OR_ORGAN_COMPONENT/B_DISEASE_ADJECTIVE[DISEASE]
or O O
the O O
midgut O B_BODY_PART_OR_ORGAN_COMPONENT/B_BIO
. O O

Unlike O O
most O O
insect O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
antibacterial O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
peptides O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
, O O
the O O
prolixicin O B_GENE/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
gene O I_GENE/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
does O O
not O O
seem O O
to O O
be O O
regulated O O
by O O
NF O B_GENE/B_DISEASE
- O O
kappaB O B_PROTEIN[GENE]/B_DISEASE_ADJECTIVE[DISEASE]
binding O I_PROTEIN[GENE]/I_DISEASE_ADJECTIVE[DISEASE]
sites O I_PROTEIN[GENE]/I_DISEASE_ADJECTIVE[DISEASE]
, O O
but O O
its O O
promoter O B_LOCATION/B_GENE
region O I_LOCATION/I_GENE
contains O O
several O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
GATA O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
sites O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
. O O

Recombinant O O
prolixicin O O
has O O
strong O O
activity O O
against O O
the O O
Gram O O
- O O
negative O O
bacterium O O
Escherichia B B_BACTERIUM[BIO]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
coli I B_BACTERIUM[BIO]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
differential O O
activity O O
against O O
several O O
Gram O O
- O O
negative O O
and O O
Gram O O
- O O
positive O O
bacteria O O
. O O

No O O
significant O O
toxicity O O
was O O
demonstrated O O
against O O
Trypanosoma B B_SPECIES[BIO]/B_DISEASE
cruzi I I_SPECIES[BIO]/I_DISEASE
, O O
the O O
human B B_PERSON/B_SPECIES[BIO]
parasite O O
transmitted O O
by O O
R B B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_SPECIES[BIO]
. I B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/I_SPECIES[BIO]
prolixus I B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/I_SPECIES[BIO]
. O O

Development O O
Time O O
and O O
Body O O
Size O O
in O O
Eupolyphaga B B_LOCATION
sinensis I I_LOCATION
Along O O
a O O
Latitudinal O O
Gradient O O
From O O
China O O
. O O

The O O
responses O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
of O O
organisms O B_BIO/B_GENE
to O O
temperature O B_DISEASE_ADJECTIVE[DISEASE]/B_GENE
variations O I_DISEASE_ADJECTIVE[DISEASE]/I_GENE
may O O
be O O
via O O
short O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_ORGANISM_FUNCTION
term O I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/I_ORGANISM_FUNCTION
responses O I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/I_ORGANISM_FUNCTION
of O O
the O O
phenotype O B_GENE/B_DISEASE
( O O
phenotypic O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
plasticity O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
) O O
, O O
or O O
they O O
could O O
involve O O
long O B_TIME[MEASURE]
- O O
term O B_TIME[MEASURE]/B_LOCATION
evolutionary O I_TIME[MEASURE]/I_LOCATION
change O I_TIME[MEASURE]/I_LOCATION
and O O
adaptation O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
( O O
via O O
selection O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANISM_FUNCTION
) O O
to O O
the O O
genotype O B_GENE/B_LOCATION
. O O

These O O
could O O
involve O O
changes O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
to O O
the O O
mean O B_MEASURE
size O I_MEASURE
of O O
the O O
animal O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
or O O
to O O
the O O
thermal O B_MEASURE/B_LOCATION
reaction O I_MEASURE/I_LOCATION
norm O I_MEASURE/I_LOCATION
. O O

We O O
examined O O
the O O
effects O O
of O O
various O O
temperatures O O
( O O
of O O
22 O O
, O O
25 O O
, O O
28 O O
, O O
and O O
31 O O
^ O O
0C O O
) O O
on O O
development O O
time O O
, O O
adult O O
body O O
size O O
and O O
preadult O O
survivorship O O
in O O
three O O
populations O O
of O O
the O O
cockroach O O
, O O
Eupolyphaga B B_BIO/B_LOCATION
sinensis I B_BIO/I_LOCATION
( O O
Walker O O
) O O
, O O
collected O O
at O O
different O O
latitudes O O
. O O

We O O
found O O
substantial O O
temperature O O
- O O
induced O O
plasticity O O
in O O
development O O
time O O
, O O
body O O
size O O
, O O
and O O
preadult O O
survivorship O O
, O O
indicating O O
that O O
developmental O O
temperatures O O
have O O
strong O O
impacts O O
on O O
growth O O
and O O
life O O
history O O
traits O O
of O O
E B B_BIO
. I I_BIO
sinensis I I_BIO
. O O

Genetic O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
differences O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
for O O
development O B_MEASURE/B_PERSON
time O I_MEASURE/I_PERSON
, O O
body O B_MEASURE/B_PERSON
size O I_MEASURE/I_PERSON
, O O
and O O
preadult O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
survivorship O B_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
were O O
detected O O
among O O
populations O B_LOCATION/B_PERSON
, O O
and O O
the O O
three O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
traits O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
exhibited O O
highly O O
significant O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
variations O B_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
in O O
the O O
responses O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
of O O
different O B_DISEASE_ADJECTIVE[DISEASE]/B_BIO
populations O I_DISEASE_ADJECTIVE[DISEASE]/I_BIO
to O O
various O B_DISEASE/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
temperature O I_DISEASE/I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
conditions O I_DISEASE/I_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
, O O
indicating O O
genetic O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
differences O B_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
among O O
populations O B_LOCATION/B_PERSON
in O O
terms O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
of O O
thermal O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANISM_FUNCTION
reaction O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_ORGANISM_FUNCTION
norms O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_ORGANISM_FUNCTION
. O O

We O O
also O O
found O O
that O O
two O B_PERSON/B_BIO
populations O I_PERSON/I_BIO
seem O O
to O O
support O O
the O O
beneficial O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
acclimation O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
hypothesis O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
whereas O O
the O O
third O B_MEASURE/B_LOCATION
mid O B_MEASURE/I_LOCATION
- O O
latitude O B_LOCATION/B_MEASURE
population O I_LOCATION/I_MEASURE
does O O
not O O
. O O

The O O
results O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
are O O
likely O B_DISEASE_ADJECTIVE[DISEASE]
because O O
of O O
differences O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
in O O
season O B_MEASURE/B_LOCATION
length O I_MEASURE/I_LOCATION
and O O
voltinism O B_MEASURE/B_EDU[ORGANIZATION]
, O O
indicating O O
that O O
not O O
only O O
temperature O B_TIME[MEASURE]/B_BIO
regime O I_TIME[MEASURE]/I_BIO
but O O
also O O
its O O
interactions O B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
with O O
generation O B_TIME[MEASURE]/B_ENT
time O I_TIME[MEASURE]/I_ENT
( O O
and O O
development O B_TIME[MEASURE]/B_LOCATION
time O I_TIME[MEASURE]/I_LOCATION
) O O
, O O
voltinism O B_MEASURE/B_EDU[ORGANIZATION]
, O O
and O O
season O B_TIME[MEASURE]/B_LOCATION
length O B_TIME[MEASURE]/I_LOCATION
are O O
likely O B_TIME[MEASURE]/B_DISEASE_ADJECTIVE[DISEASE]
to O O
have O O
considerable O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
effects O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
on O O
insect O B_MEASURE/B_ORGANISM_FUNCTION
development O I_MEASURE/I_ORGANISM_FUNCTION
time O I_MEASURE/I_ORGANISM_FUNCTION
and O O
body O B_MEASURE
size O I_MEASURE
. O O

Overall O O
, O O
changes O O
in O O
development O O
time O O
, O O
body O O
size O O
, O O
and O O
preadult O O
survivorship O O
in O O
E B B_BIO/B_LOCATION
. I I_BIO/I_LOCATION
sinensis I I_BIO/I_LOCATION
can O O
all O O
be O O
regarded O O
as O O
adaptations O O
to O O
changing O O
thermal O O
regimes O O
. O O

Culture O O
Independent O O
Survey O O
of O O
the O O
Microbiota O O
of O O
the O O
Glassy B B_SPECIES[BIO]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- I I_SPECIES[BIO]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
Winged I I_SPECIES[BIO]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
Sharpshooter I I_SPECIES[BIO]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
( O O
Homalodisca B B_MEASURE/B_DISEASE
vitripennis I I_MEASURE/I_DISEASE
) O O
Using O O
454 O O
Pyrosequencing O O
. O O

The O O
glassy B B_BIO/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- I I_BIO/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
winged I I_BIO/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
sharpshooter I I_BIO/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
Homalodisca B B_BIO/B_LOCATION
vitripennis I I_BIO/I_LOCATION
( I I_BIO/I_LOCATION
Germar I I_BIO/I_LOCATION
) I I_BIO/I_LOCATION
, O O
is O O
an O O
invasive O O
pest O O
that O O
has O O
spread O O
across O O
the O O
southern O O
and O O
western O O
United O O
States O O
. O O

H B B_PERSON/B_BIO
. I I_PERSON/I_BIO
vitripennis I I_PERSON/I_BIO
is O O
highly O O
polyphagous O O
and O O
voracious O O
, O O
feeding O O
on O O
at O O
least O O
100 O O
plant O O
species O O
and O O
consuming O O
up O O
to O O
100 O O
times O O
its O O
weight O O
in O O
xylem O O
fluid O O
daily O O
. O O

The O O
insect O O
is O O
a O O
vector O O
of O O
the O O
phytopathogen O O
Xylella B B_BACTERIUM[BIO]
fastidiosa I I_BACTERIUM[BIO]
( I I_BACTERIUM[BIO]
Wells I I_BACTERIUM[BIO]
) I I_BACTERIUM[BIO]
, O O
which O O
is O O
the O O
causative O O
agent O O
of O O
Pierce O O
' O O
s O O
disease O O
in O O
grapevines O O
. O O

To O O
evaluate O O
the O O
microbial O O
flora O O
associated O O
with O O
H B B_SPECIES[BIO]/B_DISEASE
. I B_SPECIES[BIO]/I_DISEASE
vitripennis I B_SPECIES[BIO]/I_DISEASE
, O O
total O O
DNA O O
extracts O O
from O O
hemolymph O O
, O O
alimentary O O
canal O O
excretions O O
, O O
and O O
whole O O
insect O O
bodies O O
were O O
subjected O O
to O O
16S O O
rDNA O O
pyrosequencing O O
using O O
the O O
bTEFAP O O
methodology O O
and O O
the O O
resulting O O
sequences O O
( O O
370 O O
- O O
520 O O
bp O O
in O O
length O O
) O O
were O O
compared O O
with O O
a O O
curated O O
high O O
quality O O
16S O O
database O O
derived O O
from O O
GenBank O O
http O O
: O O
/ O O
/ O O
www O O
. O O
ncbi O O
. O O
nlm O O
. O O
nih O O
. O O
gov O O
. O O

Species O O
from O O
the O O
genera O O
Wolbachia O O
, O O
Delftia O O
( O O
formerly O O
Pseudomonas O O
) O O
, O O
Pectobacterium O O
, O O
Moraxella O O
, O O
Serratia O O
, O O
Bacillus O O
, O O
and O O
many O O
others O O
were O O
detected O O
and O O
a O O
comprehensive O O
picture O O
of O O
the O O
microbiome O O
associated O O
with O O
H B B_DISEASE/B_BIO
. I I_DISEASE/I_BIO
vitripennis I I_DISEASE/I_BIO
was O O
established O O
. O O

Some O O
of O O
the O O
bacteria O B_BIO
identified O O
in O O
this O O
report O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
are O O
initial O B_DISEASE_ADJECTIVE[DISEASE]
discoveries O I_DISEASE_ADJECTIVE[DISEASE]
; O O
providing O O
a O O
breadth O B_LOCATION/B_MEASURE
of O O
knowledge O B_PERSON/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
to O O
the O O
microbial O B_BIO/B_ORGANIZATION
flora O I_BIO/I_ORGANIZATION
of O O
this O O
insect O B_BIO/B_LOCATION
pest O I_BIO/I_LOCATION
can O O
serve O O
as O O
a O O
reservoir O B_LOCATION/B_PERSON
of O O
information O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
for O O
developing O O
biological O B_LOCATION/B_ORGANIZATION
control O B_LOCATION/I_ORGANIZATION
strategies O B_LOCATION/I_ORGANIZATION
. O O

Infection O O
by O O
Mycorrhizal O O
Fungi O O
Increases O O
Natural O O
Enemy O O
Abundance O O
on O O
Tobacco O O
( O O
Nicotiana B B_BIO/B_LOCATION
rustica I B_BIO/I_LOCATION
) O O
. O O

The O O
presence O B_LOCATION/B_DISEASE_ADJECTIVE[DISEASE]
of O O
arbuscular O B_BIO
mycorrhizal O I_BIO
fungi O I_BIO
( O O
AMF O B_PROTEIN[GENE]/B_DISEASE_ADJECTIVE[DISEASE]
) O O
influences O B_DISEASE_ADJECTIVE[DISEASE]
plant O I_DISEASE_ADJECTIVE[DISEASE]
nutrient O I_DISEASE_ADJECTIVE[DISEASE]
uptake O I_DISEASE_ADJECTIVE[DISEASE]
, O O
growth O B_TIME[MEASURE]/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
, O O
and O O
plant O B_ORGANISM_FUNCTION/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
defensive O I_ORGANISM_FUNCTION/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
chemistry O I_ORGANISM_FUNCTION/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
thereby O O
directly O O
influencing O O
multi O B_BIO/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- O O
trophic O B_DISEASE_ADJECTIVE[DISEASE]
interactions O I_DISEASE_ADJECTIVE[DISEASE]
. O O

Different O B_BIO/B_PERSON
fungal O I_BIO/I_PERSON
isolates O I_BIO/I_PERSON
( O O
genotypes O B_MEASURE/B_DISEASE_ADJECTIVE[DISEASE]
of O O
the O O
same O B_BIO
fungal O I_BIO
species O I_BIO
) O O
have O O
been O O
shown O O
to O O
differ O O
in O O
nutrient O B_DISEASE_ADJECTIVE[DISEASE]
uptake O I_DISEASE_ADJECTIVE[DISEASE]
ability O I_DISEASE_ADJECTIVE[DISEASE]
. O O

Plants O B_BIO/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
infected O O
with O O
different O B_DISEASE_ADJECTIVE[DISEASE]/B_BIO
AMF O B_DISEASE_ADJECTIVE[DISEASE]/I_BIO
genotypes O B_DISEASE_ADJECTIVE[DISEASE]/I_BIO
may O O
vary O O
in O O
foliar O B_DISEASE_ADJECTIVE[DISEASE]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
nutrient O B_DISEASE_ADJECTIVE[DISEASE]/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
or O O
defensive O B_MEASURE/B_DISEASE
chemical O I_MEASURE/I_DISEASE
levels O I_MEASURE/I_DISEASE
, O O
potentially O O
influencing O O
multi O B_BIO/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- O O
trophic O B_DISEASE_ADJECTIVE[DISEASE]
interactions O I_DISEASE_ADJECTIVE[DISEASE]
. O O

Using O O
a O O
completely O O
randomized O O
design O O
, O O
we O O
compared O O
the O O
effect O O
of O O
two O O
isolates O O
of O O
the O O
mycorrhizal O O
fungus O O
Glomus B B_BIO/B_LOCATION
etunicatum I I_BIO/I_LOCATION
W O O
. O O

N O B_OTHER/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

Becker O O
& O O
amp O O
; O O
Gerdemann O O
on O O
silver B B_BIO
leaf I I_BIO
whitefly I I_BIO
( O O
Bemisia B B_PERSON/B_BIO
argentifolii I I_PERSON/I_BIO
Bellows O O
& O O
amp O O
; O O
Perring O O
) O O
( O O
Hemiptera O O
: O O
Aleyrodidae O O
) O O
and O O
parasitic O O
wasp O O
( O O
Eretmocerus B B_PERSON/B_DISEASE
eremicus I I_PERSON/I_DISEASE
Rose O O
& O O
amp O O
; O O
Zolnerowich O O
) O O
( O O
Hymenoptera O O
: O O
Aphelinidae O O
) O O
abundance O O
. O O

Whitefly O B_PERSON/B_DISEASE_ADJECTIVE[DISEASE]
populations O I_PERSON/I_DISEASE_ADJECTIVE[DISEASE]
were O O
not O O
influenced O O
by O O
AMF O B_DISEASE_ADJECTIVE[DISEASE]/B_TIME[MEASURE]
infection O B_DISEASE_ADJECTIVE[DISEASE]/I_TIME[MEASURE]
. O O

Parasite O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
populations O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
were O O
higher O B_MEASURE/B_DISEASE_ADJECTIVE[DISEASE]
on O O
plants O B_BIO/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
infected O O
with O O
the O O
isolate O B_BIO
collected O O
from O O
Georgia O B_LOCATION/B_BIO
, O O
even O O
after O O
controlling O O
for O O
whitefly O B_MEASURE/B_DISEASE_ADJECTIVE[DISEASE]
abundance O I_MEASURE/I_DISEASE_ADJECTIVE[DISEASE]
and O O
plant O B_BIO/B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
architecture O B_BIO/I_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

We O O
propose O O
that O O
AMF O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
indirectly O O
influences O O
parasite O B_MEASURE/B_DISEASE_ADJECTIVE[DISEASE]
abundance O I_MEASURE/I_DISEASE_ADJECTIVE[DISEASE]
and O O
parasitism O B_DISEASE_ADJECTIVE[DISEASE]
through O O
a O O
change O B_MEASURE
in O O
leaf O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
surface O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE
chemicals O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE
that O O
affect O O
parasitic O B_DISEASE/B_ORGANISM_FUNCTION
wasps O I_DISEASE/I_ORGANISM_FUNCTION
. O O

Because O O
of O O
the O O
ubiquity O B_LOCATION/B_MEASURE
of O O
and O O
genetic O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
variation O I_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
in O O
AMF O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
, O O
multi O B_BIO/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- O O
trophic O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
interactions O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
are O O
likely O B_TIME[MEASURE]/B_DISEASE_ADJECTIVE[DISEASE]
to O O
be O O
strongly O O
influenced O O
by O O
belowground O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
processes O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
. O O

The O O
ability O O
of O O
selected O O
pupal O O
parasitoids O O
( O O
hymenoptera O O
: O O
pteromalidae O O
) O O
to O O
locate O O
stable B B_SPECIES[BIO]/B_PERSON
fly I I_SPECIES[BIO]/I_PERSON
hosts O O
in O O
a O O
soiled O O
equine O O
bedding O O
substrate O O
. O O

The O O
ability O O
of O O
Spalangia B B_SPECIES[BIO]/B_LOCATION
cameroni I B_SPECIES[BIO]/I_LOCATION
Perkins O O
, O O
Spalangia B B_PERSON
endius I I_PERSON
Walker O O
, O O
and O O
Muscidifurax B B_BIO/B_LOCATION
raptorellus I I_BIO/I_LOCATION
Kogan O O
and O O
Legner O O
to O O
locate O O
and O O
attack O O
stable B B_SPECIES[BIO]/B_PERSON
fly I I_SPECIES[BIO]/I_PERSON
hosts O O
was O O
evaluated O O
under O O
laboratory O O
conditions O O
. O O

Postfeeding O O
third O O
- O O
instar O O
stable B B_SPECIES[BIO]/B_PERSON
fly I I_SPECIES[BIO]/I_PERSON
larvae O O
were O O
released O O
and O O
allowed O O
to O O
pupate O O
in O O
two O O
arena O O
types O O
: O O
large O O
4 O O
. O O
8 O O
liter O O
chambers O O
containing O O
a O O
field O O
- O O
collected O O
, O O
soiled O O
equine O O
bedding O O
substrate O O
; O O
or O O
120 O O
- O O
ml O O
plastic O O
cups O O
containing O O
wood O O
chips O O
. O O

At O O
the O O
time O B_TIME[MEASURE]/B_LOCATION
of O O
fly O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
pupariation O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
, O O
parasitoids O B_SPECIES[BIO]/B_PERSON
were O O
released O O
and O O
permitted O O
72 O B_MEASURE/B_LOCATION
h O O
to O O
locate O O
and O O
attack O B_DISEASE/B_LOCATION
hosts O I_DISEASE/I_LOCATION
. O O

On O O
average O O
, O O
parasitism O O
rates O O
of O O
freely O O
accessible O O
stable B B_BIO/B_PERSON
fly I I_BIO/I_PERSON
pupae O O
in O O
cups O O
were O O
not O O
significantly O O
different O O
between O O
parasitoid O O
species O O
. O O

However O O
, O O
parasitism O O
rates O O
in O O
chambers O O
containing O O
either O O
Spalangia O O
spp O O
. O O
were O O
= O O
50 O O
- O O
fold O O
more O O
than O O
M B B_SPECIES[BIO]/B_LOCATION
. I I_SPECIES[BIO]/I_LOCATION
raptorellus I I_SPECIES[BIO]/I_LOCATION
. O O

Additional O O
intraspecies O O
analysis O O
revealed O O
that O O
parasitism O O
rates O O
both O O
by O O
S B B_PERSON/B_SPECIES[BIO]
. I I_PERSON/I_SPECIES[BIO]
cameroni I I_PERSON/I_SPECIES[BIO]
and O O
S B B_PERSON/B_BIO
. I I_PERSON/I_BIO
endius I I_PERSON/I_BIO
were O O
not O O
significantly O O
different O O
when O O
pupae O O
were O O
freely O O
accessible O O
or O O
within O O
bedding O O
, O O
whereas O O
M B B_BIO/B_PERSON
. I I_BIO/I_PERSON
raptorellus I I_BIO/I_PERSON
attacked O O
significantly O O
more O O
pupae O O
in O O
cups O O
than O O
in O O
the O O
larger O O
chambers O O
where O O
hosts O O
were O O
distributed O O
within O O
bedding O O
. O O

These O O
results O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
suggest O O
that O O
Spalangia O B_LOCATION/B_BIO
spp O I_LOCATION/I_BIO
. O O
are O O
more O O
suited O O
to O O
successfully O O
locate O O
and O O
attack O O
hosts O B_SPECIES[BIO]
in O O
habitats O B_LOCATION
created O O
by O O
equine O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
husbandry O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_BIO
in O O
Florida O B_LOCATION/B_BIO
. O O

Therefore O O
, O O
commercially O O
available O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
parasitoid O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
mixtures O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
containing O O
Muscidifurax O B_LOCATION/B_SPECIES[BIO]
spp O I_LOCATION/I_SPECIES[BIO]
. O O
may O O
be O O
ineffective O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
if O O
used O O
as O O
a O O
control O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
measure O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_BIO
at O O
Florida O B_LOCATION/B_TIME[MEASURE]
equine O B_LOCATION/I_TIME[MEASURE]
facilities O B_LOCATION/I_TIME[MEASURE]
. O O

